<SEC-DOCUMENT>0001013762-25-004037.txt : 20250328
<SEC-HEADER>0001013762-25-004037.hdr.sgml : 20250328
<ACCEPTANCE-DATETIME>20250328154419
ACCESSION NUMBER:		0001013762-25-004037
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		87
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250328
DATE AS OF CHANGE:		20250328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arbe Robotics Ltd.
		CENTRAL INDEX KEY:			0001861841
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40884
		FILM NUMBER:		25785494

	BUSINESS ADDRESS:	
		STREET 1:		107 HA'HASHMONAIM ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6713321
		BUSINESS PHONE:		972.73.7969804

	MAIL ADDRESS:	
		STREET 1:		107 HA'HASHMONAIM ST
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6713321
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>ea0235828-20f_arbe.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 28 18:58:39 UTC 2025 -->
<html xmlns:arbe="http://www.arberobotics.com/20241231" xmlns:compsci="http://compsciresources.com" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-19185">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement" id="ixv-19186">&#9744;</ix:nonNumeric> <b>REGISTRATION STATEMENT PURSUANT TO SECTION
12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport" id="ixv-19187">&#9746;</ix:nonNumeric> <b>ANNUAL REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-19188"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-19189">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-19190">2024</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="ixv-19191">&#9744;</ix:nonNumeric>&#160;<b>TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the transition period from _________ to
_____________.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport" id="ixv-19192">&#9744;</ix:nonNumeric>&#160;<b>SHELL COMPANY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of event requiring this shell company report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-19193">001-40884</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-19194">Arbe Robotics Ltd.</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as Specified in its Charter)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="ixv-93"><b>Israel</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Jurisdiction of Incorporation or Organization)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-19195">107 HaHashmonaim St</ix:nonNumeric>., <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-19196">Tel Aviv-Yafo</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-19197">Israel</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName" id="ixv-19198">Kobi Marenko</ix:nonNumeric>, Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1" id="ixv-19199">107 HaHashmonaim St</ix:nonNumeric>., <ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown" id="ixv-19200">Tel Aviv-Yafo</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-19201">Israel</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Tel: +<ix:nonNumeric contextRef="c1" name="dei:CityAreaCode" id="ixv-19202">972</ix:nonNumeric>-<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber" id="ixv-19203">73-7969804</ix:nonNumeric>, ext. 200</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Email: <ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress" id="ixv-19204">kobi.m@arberobotics.com</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, Telephone, E-mail and/or Facsimile Number
and Address of Company Contact Person)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered or to be registered pursuant
to Section 12(b) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: bottom; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="vertical-align: top; width: 2%">&#160;</td> <td style="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Each Exchange On Which Registered</b></span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-142"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary shares, par value NIS 0.000216 per share</b></span></ix:nonNumeric></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-148"><b>ARBE</b></ix:nonNumeric></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The <ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-19205">Nasdaq</ix:nonNumeric> Stock Market LLC</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td></tr> <tr style="vertical-align: top; "> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle" id="ixv-158"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol" id="ixv-163"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ARBEW</b></span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The <ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-19206">Nasdaq</ix:nonNumeric> Stock Market LLC</b></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered or to be registered pursuant
to Section 12(g) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">None</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Title of Class)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline">None</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Title of Class)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The number of the issuer&#8217;s ordinary shares as of March 1, 2025
was <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-19207">105,163,188</ix:nonFraction> ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&#160;&#9744;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-19208">No</ix:nonNumeric>&#160;&#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&#160;&#9744;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-19209">No</ix:nonNumeric>&#160;&#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-19210">Yes</ix:nonNumeric>&#160;&#9746;&#160;No&#160;&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span>Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted&#160;pursuant to
Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-19211">Yes</ix:nonNumeric>&#160;&#9746;&#160;No&#160;&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of &#8220;large
accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse; margin-left: auto; margin-right: auto; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 25%">Large accelerated filer &#9744;</td> <td style="width: 25%"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-19212">Accelerated filer</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td> <td style="width: 23%">Non-accelerated filer &#9744;</td> <td style="width: 27%">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="ixv-255"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></td></tr> </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod" id="ixv-19213">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag" id="ixv-19214">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-19215">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indicate by check mark whether any of those
error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to 240.10D-1(b)</b> <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" id="ixv-19216">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 15%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;&#160;<ix:nonNumeric contextRef="c0" name="dei:DocumentAccountingStandard" id="ixv-19217">U.S. GAAP</ix:nonNumeric>&#160;</span></td> <td style="width: 65%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160; International Financial Reporting Standards as issued by the International<br/>
Accounting Standards Board&#160;&#9744;&#160;</span></td> <td style="width: 20%; padding-right: 0.5pt; padding-left: 0.5pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Other&#160;&#9744;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If &#8220;Other&#8221; has been checked in response
to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: Item 17&#160;&#9744;&#160;Item
18&#160;&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this is an annual report, indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-19218">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM 20-F ANNUAL REPORT </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="vertical-align: top; width: 10%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; width: 81%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identity of Directors, Senior Management and Advisers&#160;</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer Statistics and Expected Timetable</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information on the Company</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4A.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating And Financial Review And Prospects</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors, Senior Management and Employees</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 7.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major Shareholders and Related Party Transactions</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 8.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 9.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Offer and Listing</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 10.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Information</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 11.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 12.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities Other than Equity Securities</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART II</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 13.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defaults, Dividend Arrearages and Delinquencies</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 14.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Modifications to the Rights of Security Holders and Use Of Proceeds</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 15.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16A.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee Financial Expert</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16B.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Ethics</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16C.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accountant Fees and Services</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16D.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemptions from the Listing Standards for Audit Committees</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16E.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16F.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Registrant&#8217;s Certifying Accountant</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16G.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16H.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine Safety Disclosure</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16I. </span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16J.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider trading policies</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 16K</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_030"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cybersecurity</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">131</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td colspan="3" style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><a href="#a_031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 17.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132</span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 18.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial Statements</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132</span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 19.</span></td>
    <td style="vertical-align: top; padding-right: 0.5pt; padding-left: 0.5pt"><a href="#a_034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">i</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART I</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated or the context otherwise
requires, all references in this annual report to the terms &#8220;Arbe,&#8221; the &#8220;Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221;
and words of like import refer to Arbe Robotics Ltd., together with its subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Industry and Market Data</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this annual report, we present industry data,
information and statistics regarding the markets in which we compete as well as publicly available information, industry and general publications
and research and studies conducted by third parties. This information is supplemented where necessary with our own internal estimates,
taking into account publicly available information about other industry participants and our management&#8217;s judgment where information
is not publicly available. This information appears in &#8220;Item 5. Operating and Financial Review and Prospects&#8221; &#8220;<i>Item
4. Information on the Company</i>&#8221; and other sections of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Industry publications, research, studies and forecasts
generally state that the information they contain has been obtained from sources believed to be reliable, but that the accuracy and completeness
of such information is not guaranteed. Forecasts and other forward-looking&#160;information obtained from these sources are subject to
the same qualifications and uncertainties as the other forward-looking&#160;statements in this annual report. These forecasts and forward-looking&#160;information
are subject to uncertainty and risk due to a variety of factors, including those described under &#8220;<i>Risk Factors</i>&#8221; in
Section D under Item 3 of this annual report. These and other factors could cause results to differ materially from those expressed in
any forecasts or estimates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Trademarks, Trade Names and Service Marks</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We own or have rights to trademarks, trade names
and service marks that it uses in connection with the operation of its business. In addition, our names, logos and website names and addresses
are their trademarks or service marks. Other trademarks, trade names and service marks appearing in this annual report are the property
of their respective owners. Solely for convenience, in some cases, the trademarks, trade names and service marks referred to in this annual
report are listed without the applicable &#8220;&#169;,&#8221; &#8220;<sup>SM</sup>&#8221; and&#160;&#8220;<sup>TM&#8221;</sup> symbols,
but they will assert, to the fullest extent under applicable law, their rights to these trademarks, trade names and service marks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This annual report contains &#8220;forward-looking
statements&#8221; that are subject to risks and uncertainties. Statements that are not historical facts, including statements about us
and the transactions contemplated by the Business Combination Agreement, and our perspectives and expectations, are forward-looking statements.
Such statements include, but are not limited to, statements regarding possible or anticipated future results of our business, financial
condition, results of operations, liquidity, plans and objectives. The words &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;project,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; &#8220;potential&#8221; and similar words or expressions indicate forward-looking statements. These forward-looking
statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions
about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially
from those indicated or anticipated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The statements contained in this annual report
regarding the following matters are forward-looking&#160;by their nature:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our projection of revenue and other operating results;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our expectation that we will be engaging with Tier 1 automotive suppliers and OEMs which would be building the radars based on our chipset solution, eliminating expenses associated with system completion, requirement for undertaking significant capital expenditures associated with developing mass production manufacturing and the expenses of operating any such manufacturing capability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our expectation that radars are crucial to the automotive industry and will be deployed in nearly all new vehicles as a long range, cost-effective sensor with the fewest environmental limitations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that our radar chipset heralds a breakthrough in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution that meets the safety requirements of Euro New Car Assessment Program (&#8220;Euro-NCAP&#8221;) and the current United States National Highway Traffic Safety Administration (&#8220;NHTSA&#8221;) vehicle safety standard that will make automatic emergency braking (AEB), including pedestrian AEB, standard on all passenger cars and light trucks.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that automakers will choose to integrate advanced driver assistance systems (ADAS L2+/L3) based on several technologies simultaneously (imaging radar, camera and optionally LiDAR), and that it is likely that this trend of integrating technologies into vehicles will continue in the coming&#160;years;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that our 4D imaging radar technology holds significant advantages for a fusion with camera over alternative technologies such as LiDAR laser systems and over current-generation radar technologies that are on the market presently or have been announced for development;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that our ground-breaking technology that contains an advanced processor, consumes relatively low amounts of energy and can scan a vehicle&#8217;s environment at an exceptionally high resolution in real-time, and identify objects and distinguish between them with great long-range accuracy and a wide field of view, differentiates us and will enable us to successfully compete and develop and maintain a leadership position in its target markets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our expectation that our marketing strategy, primarily targeted at Tier 1 manufacturers, will foster cooperation with Tier 1 suppliers to integrate our radar chipsets into their radar systems to be sold to OEMs and that the Tier 1 suppliers that use our radar chipsets will be successful in marketing the systems to automakers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that our engagement of Global Foundries for the manufacturing and supply chain management will provide us with a more secure path in production for quality control and reliability for automotive requirements;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that as automakers seek to develop hands off/eyes off driving, perception and imaging radar will become a critical ingredient and that our radar chipset will meet this need;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that certain operational or registration requirements for some autonomous functions will be removed as state regulators gain better experience with the technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our expectation that awareness among automakers and vehicle owners of the importance and benefits of installing ADAS and partial autonomous driving L2+/L3 (even in the absence of binding regulation) has increased, and that it is likely that in the future, the vast majority of new vehicles will be equipped with these systems;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that our radar chipset solution will make it possible to enable the launch of an autonomous vehicle and will be the primary sensor for autonomous driving in the retail market in tandem with a camera;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that our
    existing infrastructure positions us to capitalize on regulatory changes pertaining to required installation of traffic accident
    prevention systems in general, and radar systems in particular, which is expected to increase the demand for the technology and
    products that we are developing; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our belief that an increased demand for autonomous vehicles and the transition to mass production of Level 2+ and higher autonomous vehicles, requiring advanced systems for automatically integrating vehicles in traffic and preventing traffic accidents, is expected to increase the demand for products in our field of activity in the time frame we anticipate;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preceding list is not intended to be an exhaustive
list of all of our forward-looking&#160;statements. The forward-looking&#160;statements are based on our beliefs, assumptions and expectations
of future performance, taking into account the information currently available to us. These statements are only predictions based upon
our current expectations and projections about future events. There are important factors that could cause our actual results, levels
of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed
or implied by the forward-looking&#160;statements. In particular, you should consider the risks described under &#8220;Risk Factors&#8221;
in Section D under Item 3 of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should not rely upon forward-looking&#160;statements
as predictions of future events. Although we believe that the expectations reflected in the forward-looking&#160;statements are reasonable,
we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking&#160;statements
will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking&#160;statements
for any reason after the date of this annual report, to confirm these statements to actual results or to changes in our expectations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 3. KEY INFORMATION </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization and indebtedness. Not Applicable</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasons for the offer and use of proceeds. Not Applicable.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>An investment in our ordinary shares involves
significant risks. You should carefully consider all of the information in this annual report, including the risks and uncertainties described
below, before making an investment in our ordinary shares. Any of the following risks could have a material adverse effect on our business,
financial condition and results of operations. In any such case, the market price of our ordinary shares could decline, and you may lose
all or part of your investment.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The risks set out below are not exhaustive
and do not comprise all of the risks associated with an investment in us. Additional risks and uncertainties not currently known to us
or which we currently deem immaterial may also have a material adverse effect on our business, financial condition, results of operations,
prospects and/or our share price.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Business and Industry</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have been a research and development
company with a history of losses, and we expect to incur significant expenses and losses as we continue the development of our radar technology.
</i></b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incurred a net loss of approximately $49.3
million on revenues of approximately $0.8 million for the year ended December 31, 2024, a net loss of approximately $43.5 million on revenues
of approximately $1.5 million for year ended December 31, 2023, and a net loss of approximately $40.5&#160;million on revenues of approximately
$3.5 million for the year ended December&#160;31, 2022. No assurance can be made that we can or will become profitable. Our modest level
of revenues through 2024 has been generated from sales of chipsets and prototype radar systems for evaluation and professional services.
As we have not yet received significant production orders as a result of which we have not transitioned to a production company. Although
we are actively marketing our chipset to Tier 1 suppliers and automobile manufacturers, we have been primarily a research and development
company, and we are continuing to incur research and development expenses as we continue to work on the development of our 4D imaging
radar technology. We plan the transition to production of our radar chip for sale to customers during 2026, although we can give no assurance
that this timetable will be met, and we did not meet our previous target to transition to production. Until such time as we begin material
commercial deliveries of our products, we will likely continue to generate losses. Even if we are able to begin making material commercial
deliveries of our products, we can give no assurance that we will be successful in the commercial sale of our products.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate that our losses may continue to
be significant as we:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shift our research and development from production intent to production ready chipset;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand our production capabilities or outsource such production;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand our design, development, installation and servicing capabilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience delays by automobile manufacturers which are making final decisions relating to the next generation of automobiles and the introduction of advanced driver assisted systems (ADAS) as a result of broader economic shifts that we believe are leading to short-term delays in the automobile manufacturers roll-out of advanced driver assistance systems.;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">produce chips for inventory and incur storage charges;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incur costs in providing support and assistance to our initial commercial customers, primarily our Tier 1 suppliers, as they integrate our chipset in their radar product that they market to automotive companies and to our automotive company customers as they introduce our radar in their vehicles.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incur sales and marketing activities costs and develop our distribution infrastructure; and.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incur general and administration costs as we progress with our product development and continue to incur significant expenses in research and development as well as costs related to our status as a publicly traded corporation</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will incur the expenses from these efforts
before we receive sufficient revenues to cover our incremental expenses with respect thereto, and therefore our losses in future periods
may be significant. In addition, we may find that these efforts are more expensive than we currently anticipate or that these efforts
may not result in revenues, which would further increase our losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our limited operating history and evolving
business model makes evaluating our business and future prospects difficult and may increase the risk of your investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have focused primarily on developing our 4D
imaging radar technology products since 2017 and did not generate any revenue until&#160;2020. Our relatively limited operating history
and modest level of revenue to date make it difficult to evaluate our future prospects and the risks and challenges we may encounter.
Further, because we have limited historical financial data and operate in a rapidly evolving market, any predictions about our future
revenue and expenses may not be as accurate as they would be if we had a history of sales in commercial quantities or if we operated in
a more predictable market rather than a market that is itself a developing market that is developing at a slower rate than we had anticipated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From late 2023 through 2024 we broadened our focus
to seek contracts with Tier 1 suppliers and OEMs for orders in commercial quantity in addition to sales of radars for testing purposes.
If this strategy is not successful, and we do not generate orders for commercial quantities of our products, we may incur increased losses
and our transition to production will be delayed. In this connection, as both our business and the market for ADAS vehicles develops,
our operations may undergo other changes that result is a material change in our business and the direction of our business. Any such
modifications could result in increased losses (as pivoting the business may be costly) and future results may differ materially from
those presented herein. The timing of our transition to production is also subject to the timing by automobile manufactures of introducing
cars at a Level 2+ and higher.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any change in our business model, including
changes by automobile manufactures in introducing ADAS features, may make the results of our operations to date less useful in evaluating
our business and prospects and may impact our ability to generate revenue and cash flow from operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we fail to address the risks and difficulties
that we face, including those described elsewhere in this &#8220;Risk Factors&#8221; section, our business, financial condition and results
of operations could be impaired. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently
experienced by growing companies with limited operating histories in rapidly changing industries. Delays by automobile manufacturers which
are making final decisions relating to the next generation of automobiles and the introduction of ADAS capabilities as a result of broader
economic shifts that we believe are leading to short-term delays in the automobile manufacturers roll-out of ADAS functions will impact
our ability to generate revenue and cash flow from operations. If our assumptions regarding these risks and uncertainties, which we use
to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, the results of our operations
could differ materially from our expectations and our business, financial condition and results of operations could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our assumptions regarding these risks and uncertainties,
which we use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, the results
of our operations could differ materially from our expectations and our business, financial condition and results of operations could
be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We expect to continue to invest substantially
in research and development to develop and commercialize new products, and these investments could significantly increase our losses and
may not generate significant revenue for us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our future growth depends on maintaining our technological
leadership in order to introduce new products that achieve market acceptance and penetrate new markets.&#8239;Our research and development
expenses were approximately $35.1 million in 2024, $34.1 million for 2023 and approximately $36.7&#160;million for 2022. We expect that
our research and development expenses are likely to continue to be significant in the future as we seek to expand our research and development
effort to meet the anticipated market need. Because we expense our research and development activities, as we increase these expenses
it will adversely affect the results of our operations. In addition, our research and development program may not produce successful results,
and even if it does successfully produce new products, those products may not achieve market acceptance, create additional revenue or
become profitable. Because the market for our products is both leading edge technology in an evolving industry, we can only be successful
if we can offer leading edge technology. Our failure to offer leading edge technology can materially impair our ability to operate profitably.
Further, since our marketing is primarily directed at Tier 1 suppliers, who incorporate our chipset in the systems that they market to
the automobile manufacturers, which include software and hardware components in addition to our chipset, our business will be impacted
to the extent that the manufacturers select a Tier-1 supplier that does not use our chipsets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Agreements with customers may not generate
the anticipated revenue as we are subject to the risks of cancellation or postponement of contracts or unsuccessful implementation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prospective customers of our products generally
must make significant commitments of resources to test and validate our products and confirm that they can integrate our products with
other technologies before including our products in any particular system, product or model. The development cycles of our products with
new customers vary widely depending on the application, market, customer and the complexity of the product. In the automotive market,
for example, this development cycle can be over several&#160;years. As a result of these lengthy development cycles, we spend significant
time and resources to have our products selected by potential customers for a particular use. If we fail to secure such relationships,
we may not have an opportunity to supply our products within a sector with such a long lead time for a period of several&#160;years. Further,
we are subject to the risk that customers that order products, which are subject to the customer&#8217;s ability to integrate the product
with its other systems, may cancel or postpone orders if the customer is not satisfied that our product and service meet the customer&#8217;s
requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The development cycle of products using
our technology as well as the market for our products that are under development can be impacted by various factors which cannot be predicted,
including international conflicts, climate and weather conditions, global economic conditions and customer trends.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The development process for our products as well
as the timing of our sales and the market for our products can be affected by various factors, many of which are unpredictable. These
factors include such conditions as international trade issues such as tariffs, international conflicts, climate and weather conditions,
significant natural disasters such as the outbreak of a pandemic, such as COVID-19, or other catastrophic events. In recent months the
following conditions have affected or may affect various aspects of our business:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effect of the hostilities in Israel and with its neighboring countries including the effects of the continuing war with Hamas and any further intensification of hostilities with others, including Iran and Hezbollah, and the effect of the call-up of a significant portion of Israel&#8217;s working population, including some of our employees, and the effect of any potential boycott both of Israeli products and business and of stocks in Israeli companies&#160;&#160;as discussed below under the Risk Factor &#8220;Risks Related to our Incorporation and Location in Israel &#8211; Conditions in Israel&#8221; could materially and adversely affect our business.&#8221;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effects of the February 24, 2022 invasion by the Russian Federation of Ukraine, which is ongoing and is discussed below.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extreme weather conditions that may adversely affect manufacturing facilities of our suppliers and/or customers, and cause material delays in our supply chain or to our forecasted orders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effects of any other military conflicts and cybersecurity actions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effects of any tariffs and counter-tariffs which may be imposed; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any other conditions which may affect the automotive industry generally and the ability of automotive companies in their evaluation and purchase of our products or our ability and the ability of our customers and potential customers to evaluate our product or order our product.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any factors which affect the ability or willingness
of customers and potential customers to test our products or purchase our products could materially impair our ability to develop our
business, We cannot predict the extent that any of the foregoing will impact our business nor what other factors which we do not presently
contemplate may impact our business; however, any of these factors, as well as other factors not presently contemplated, may have a material
adverse effect upon our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may need to raise additional funds in
the future in order to execute our business plan and these funds may not be available to us when we need them. If we cannot raise additional
funds when we need them, our business, prospects, financial condition and operating results could be negatively affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are continuing to spend significantly more
in research and development than we are generating in revenue, since most of our revenue is for samples and for testing and we have not
received production orders. Although our working capital on December 31, 2024 was approximately $21.2 million and in January 2025, we
raised $33.1 million gross proceeds from an underwritten public offering and approximately $22.4 million from the release of escrowed
funds following the conversion of a majority of the principal amount of our convertible bonds, we may nonetheless require additional capital
in order to fund our growth strategy and to respond to various factors including, but not limited to. technological advancements, competitive
dynamics or technologies, customer demands, broader economic shifts that are leading to delays in automakers&#8217; roll-out of advanced
driver assistance systems which would use radar systems that use our chipset and the economic cause related to the extension in decision-making
timelines, business opportunities, challenges, acquisitions or unforeseen circumstances, and we anticipate that, if we require financing
we will seek to obtain any such funding through equity, debt or convertible debt financing arrangements, although there can be no assurance
that such financing will be available on acceptable terms or at all.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may not be able to timely secure such debt
or equity financing on favorable terms, or at all. Our ability to incur additional debt may be affected by covenants in the deed of trust
relating to our outstanding convertible bonds. If we raise additional funds through the issuance of equity or convertible debt or other
equity-linked securities, our shareholders could experience significant dilution. In addition, any debt financing we may obtain in the
future, whether in the form of a credit facility or convertible debt, could involve restrictive covenants relating to our capital raising
activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue
business opportunities, including potential acquisitions. If we are unable to obtain adequate financing or financing on terms satisfactory
to us when we require it, our ability to continue to grow or support its business and to respond to business challenges could be significantly
limited. In addition, because our decision to issue debt or equity in the future will depend on market conditions, the restrictions on
incurring debt under the deed of trust relating to our convertible bonds and other factors beyond our control, we cannot predict or estimate
the amount, terms, timing, nature or success of our future capital raising efforts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If market adoption of our products does
not develop, or develops more slowly than we expect, our business will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While our products can be applied for uses in
different markets, many of our products are still relatively new in the market and it is possible that other technologies and devices,
based on new or existing technology or a combination of technologies, will achieve acceptance or leadership as compared to our existing
or future product lines. Even if our products are used, we cannot guarantee that our products will be designed into or included in subsequent
generations of such commercialized technology. In addition, we expect that widescale use of our products may lag behind these initial
applications significantly. The speed of market growth for our products is difficult if not impossible to predict. In addition, to the
extent that a market for our products develops successfully, we expect that there will be increasing competition from alternative providers
and other modalities. If we are not successful in commercializing our products in a timely manner, or not as successful as we expect,
or if other modalities gain acceptance by our potential customers, regulators and safety organizations or other market participants, our
business, results of operations and financial condition will be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to accurately estimate
the supply and demand of our products, which could result in a variety of inefficiencies in our business and hinder our ability to generate
revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is difficult to predict our future revenues
and budget for our expenses, and we may have limited insight into trends that may emerge and affect our business. We expect that we will
be required to provide forecasts of our demand to our potential customers several&#160;months prior to the scheduled delivery date. Currently,
because it is a developing market, there is little historical basis for making judgments on the demand for our products or our ability
to develop, produce, and deliver products, or our profitability in the future. If we overestimate our requirements, we or our potential
suppliers may have excess inventory, which indirectly would increase our costs. If we underestimate our requirements, we or our potential
suppliers may have inadequate inventory, which could interrupt the manufacturing of our products and result in delays in shipments, which
is likely to affect revenue and customer relations. In addition, lead times for materials and components that our potential suppliers
order may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each component at a given
time. If we fail to order sufficient quantities of product components in a timely manner, the delivery of products to our potential customer
base could be delayed, which would harm our business, financial condition and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We target many customers that are large
companies with substantial negotiating power, exacting product standards and potentially competitive internal solutions. If we are unable
to sell our products to these customers, our prospects and results of operations will be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of our customers and potential customers
are large, multinational companies with substantial negotiating power relative to us and, in some instances, may have internal solutions
that are competitive with our products. These large, multinational companies also have significant resources, which may allow them to
acquire or develop competitive technologies either independently or in partnership with others. Accordingly, even after investing significant
resources to develop a product, we may not secure a design win or may not be able to commercialize a product on profitable terms or we
may obtain a commitment from a Tier 1 supplier and that supplier may not be successful in marketing to the automobile manufacturers. Because
our products are a key aspect of the safety of vehicles that use our products and must comply with international standards, our products
will be held to a stringent safety test before they are included in a vehicle. If our products are not selected by these large companies
or if these companies develop or acquire competitive technology or negotiate terms that are disadvantageous to us, it will have an adverse
effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our principal customers include Tier-1 suppliers
with a view to including our chipset as part of a radar system that they market to the automobile industry, and which compete with other
Tier 1 suppliers in marketing to the automotive industry. </i></b></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of our customers and potential customers
are either large, multinational Tier-1 companies which market radar systems that include our chipset in the systems they market to the
automotive industry, including OEMs, or large multinational automobile companies. Thus, we are dependent upon the ability of our Tier
1 suppliers to market their systems to the automotive industry. To the extent our product is part of a radar that is offered by such Tier-1
supplier, we depend on the ability of the Tier-1 supplier to successfully market and sell its product (which includes our product) to
the OEM&#8217;s, many times following a bid process conducted by the OEM. Accordingly, even after investing significant resources to develop
a product, we largely rely on our Tier-1 customers&#8217; efforts to secure a design win in order to be able to commercialize our product
on profitable terms. Because our products are a component on a complete radar product offered by our Tier-1 customer to the OEM, if the
radar products are not selected by these large OEM companies or if these OEM companies develop or acquire competitive technology or negotiate
terms that are disadvantageous to us, it will have an adverse effect on our business. We also market directly to automobile manufacturers
and seek to include our radar system in their automobiles. To the extent that we are not successful in marketing to the automotive industry
our business will be materially impaired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We continue to work with other companies,
including our sole supplier and our Tier 1 companies to develop our business, and these initiatives may prove more costly than we currently
anticipate, and we may not succeed in generating sufficient revenue to operate profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We continue to make investments and implement
initiatives designed to grow our business, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investing in research and development;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaborating
with Tier 1 suppliers to develop a radar product based on our chipsets, with the goal of enabling the Tier 1 to market this product to
the automotive and related industries;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expanding our sales and marketing efforts to attract new customers in new industries;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investing in new applications and markets for our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">further enhancing our manufacturing processes and relationships; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incurring in legal, accounting, and other administrative functions necessary to support our operations as a public company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These initiatives may prove more expensive than
we currently anticipate, and we may not succeed in increasing our revenue, if at all, in an amount sufficient to offset these higher expenses
and to achieve and maintain profitability. The market opportunities we are pursuing are being developed, and it may be years before the
markets we expect to serve generate significant demand for our products at scale, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our revenue may be adversely affected
for a number of reasons, including the development and/or market acceptance and timing of market introduction of new technology that competes
with our products, changes by other market participants with respect to their acceptance or implementation of our technology, failure
of our customers to commercialize autonomous systems that include our products, our inability to effectively manage our inventory or manufacture
products at scale, our failure to enter new markets or to attract new customers or expand orders from existing customers or due to increasing
competition. Furthermore, it is difficult to predict the size and growth rate of our target markets, customer demand for our products,
commercialization timelines, developments in autonomous sensing and related technology, the entry of competitive products, or the success
of existing competitive products and services. Accordingly, we do not expect to achieve profitability over the near term. If our revenue
does not grow over the long term, our ability to achieve and maintain profitability may be adversely affected, and the value of our business
may significantly decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The markets in which we compete are characterized
by rapid technological change, which requires us to continue to develop new products and product innovations and could adversely affect
market adoption of our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we intend to invest substantial amounts
in research and development, continuing technological changes in our technology and competitive technologies could adversely affect adoption
of our products. Our future success will depend upon our ability to develop and introduce a variety of new capabilities and innovations
to our existing product offerings, as well as to introduce a variety of new product offerings to address the changing needs of the markets
in which we offer our products. Delays in delivering new products that meet customer requirements could damage our relationships with
customers and lead them to seek alternative sources of supply.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable to develop products or system
configurations that meet customer requirements, including pricing, on a timely basis or that remain competitive with other technological
alternatives, our products could lose market share, our revenue will decline, it may experience operating losses, and our business and
prospects will be adversely affected.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain of our development and supply arrangements
could be terminated or may not materialize into long-term contracts.</i></b></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have arrangements with Tier 1 suppliers and
other companies for the development of products or for the incorporation of our products in a customer&#8217;s products. Some of these
arrangements are evidenced by memorandums of understandings and early-stage agreements that are used for design and development purposes
but that will require renegotiation at later stages of development or replacement by production or master agreements that have yet to
be implemented under separately negotiated statements of work, each of which could be terminated or may not materialize into next-stage
contracts or long-term contract arrangements. If these arrangements are terminated or if we are unable to enter into next-stage contracts
or long-term operational contracts, our business, prospects, financial condition and operating results may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will be subject to risks associated with
our agreements with Tier 1s and other companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are successful in entering into definitive
agreements with potential suppliers, including Tier 1s, these arrangements will subject us to risks, including risks associated with non-performance
by the third party and sharing proprietary information, any of which may materially and adversely affect our business and prospects. Because
of our limited ability to monitor or control the actions of these third parties, to the extent any of these strategic third parties suffer
negative publicity or harm to their reputation from events relating to their business, we may also suffer negative publicity or harm to
our reputation by virtue of our association with any such third party. In addition, a third party may have different priorities than we
have with the effect that the supplier may not give our products the priority that we consider important, which could impair our ability
to generate revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may experience difficulties in managing
our growth and expanding our operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to experience significant growth in
the scope and nature of our operations. Our ability to manage our operations and future growth will require us to continue to improve
our operational, financial and management controls, compliance programs and reporting systems. We have an ongoing process of reviewing
and strengthening our compliance programs, including those related to export controls, privacy, cybersecurity, anti-corruption and financial
controls. We may not be able to implement improvements in an efficient or timely manner and may discover deficiencies in existing controls,
programs, systems and procedures, which could have an adverse effect on our business, reputation and financial results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Continued pricing pressures may result in
lower than anticipated margins or losses, which may adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost-cutting initiatives adopted by our Tier-1
customers and automobile and other automotive customers as well as the effects of competition may result in increased downward pressure
on pricing. We expect that as our industry develops and competition grows, our agreements with existing customers may require step-downs
in pricing over the term of the agreements or, if commercialized, over the periods of production, and we may not be able to negotiate
price reductions from our suppliers. In addition, our existing or future customers may reserve the right to terminate their supply contracts
for convenience, which enhances their ability to obtain price reductions. Certain large customers may possess significant leverage over
their suppliers, including us, because the market is highly competitive. Accordingly, we expect to be subject to substantial continuing
pressure from our existing and prospective customers to reduce the price of our products. It is possible that pricing pressures beyond
our expectations could intensify as automotive OEMs pursue restructuring, consolidation and cost-cutting initiatives. If we are unable
to generate sufficient production cost savings in the future to offset price reductions, our gross margin and profitability would be adversely
affected. Further, to the extent that the specifications of our chips result in prices which are not competitive, our sales and gross
margin may be impaired and we may not be able to operate profitably.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Adverse conditions within our industry or
the global economy more generally could have adverse effects on our results of operations</i></b>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is directly affected by and significantly
dependent on business cycles and other factors affecting the global automobile industry and the global economy generally. Production and
sales within our industry are cyclical and depend on general economic conditions and other factors, including consumer spending and preferences,
the timing by automobile manufacturers as to the introduction autonomous features that require our technology, changes in interest rates
and credit availability, consumer confidence, fuel costs, fuel availability, environmental impact, governmental incentives and regulatory
requirements and political volatility. In addition, production and sales can be affected by our customers&#8217; ability to continue operating
in response to challenging economic conditions, regulatory requirements and other factors. Any significant adverse change in any of these
factors may result in a reduction in automotive sales and production by our customers and could have a material adverse effect on our
business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of our products for markets other than
the automotive market may not develop or may develop much more slowly than we anticipate, which would adversely affect our business and
prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are investing in and pursuing market opportunities
in various sectors and industries in addition to the automobile industry, such as autonomous delivery vehicles or robotaxies, delivery
robots, autonomous trucks, agriculture, infrastructure and traffic systems. We believe that these potential new markets present growth
opportunity and therefore implement a business development plan aimed at these new markets as they emerge. We are currently approaching
these markets through our existing tier 1, Sensrad, which will be responsible for using our product to address the particular requirements
of each market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Addressing these requirements can be time-consuming
and costly. The market for our existing products and technology outside of our core customer base is relatively new, rapidly developing
and unproven in many markets or industries. Many of the participants in the markets for our core technology outside of our existing target
industries are still in testing and development and we may not succeed in commercializing some or any of these products. We cannot be
certain that our products will be sold into these markets, or any market outside of where we currently operate, at scale. Adoption of
our products outside of the automotive industry will depend on numerous factors, including: whether the technological capabilities of
similar products meet users&#8217; current or anticipated needs, whether the benefits of designing products such as our products into
larger systems outweigh the costs, complexity and time needed to deploy such technology or replace or modify existing systems that may
have used other modalities, whether users in other applications can move beyond the testing and development phases and proceed to commercializing
systems supported by our technology and whether developers of products such as our products can keep pace with rapid technological change
in certain developing markets and the global response to supply chain delays. If technology developed by us does not achieve commercial
success outside of the automotive industry, or if the market develops at a pace slower than we expect, our business, results of operation
and financial condition may be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The software in our chipsets uses artificial
intelligence to enhance its ability to identify objects in or near the path of vehicles and the software to which our products interface,
whether developed or obtained by the Tier 1 supplier or the manufacturer is also likely to use artificial intelligence, all of which are
subject to the risks related to artificial intelligence.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Artificial intelligence technologies, including
generative artificial intelligence, are complex and rapidly evolving, and we face competition from other companies as well as an evolving
regulatory landscape. Several jurisdictions around the globe, including Europe and the United States, have already proposed or enacted
laws governing artificial intelligence and we may need to commit significant resources to maintain business practices that comply with
the evolving regulatory landscape. Our competitors or other third parties may incorporate artificial intelligence into their products
more quickly and successfully than we, which could impair our ability to compete effectively and could adversely affect our results of
operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Artificial intelligence is intended to improve
the efficiency of software in the context with which it is designed. In the automobile and related industries, this means that the software
will enable the vehicle to operate more efficiently and more safely by both avoiding collisions or other accidents and arriving at its
intended destination in the quickest and most efficient manner. Our chipsets are designed to identify objects in the path of the vehicle,
but it is the related software developed or incorporated by the Tier 1 or the automobile or other manufacturer that tells the vehicle
what to do with the information generated by our chipset. To the extent that either our software or the software with which our software
interfaces does not function as intended, which could result in accidents, we may be subject to claims or liability and our reputation
may be impaired which could have a material adverse effect on our business and our reputation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, the vehicle software may be subject
to security breaches, which could result in damages if our software that is incorporated in the automobile or other vehicle is
subject to security breaches. Since radar systems in vehicles are software-based, with manufacturers or software suppliers having
the ability to modify or update software remotely, there is a risk of security breaches that may affect the safety of the vehicle.
We have a legal and contractual obligation to protect the confidentiality and appropriate use of customer data. Any security
breaches with respect to such data could result in the loss of this information, litigation, indemnity obligations and other
liabilities. The security of our products is important in our customers&#8217; decisions to purchase or use our products or services
in their vehicles. Security threats are a significant challenge to companies like us whose business is providing technology products
and services to others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The functionality of systems using our chipset
may be affected by open source software which may increase the risk of security vulnerability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we do not use open source software, including
open source artificial intelligence in our product, it is possible that software that interfaces with our product may use open source
software, which may subject the system that incorporates our product to the risk of open source software, including open source artificial
intelligence. There may be vulnerabilities in open source software and third-party software that may make products that use our chipsets
likely to be harmed by cyberattacks. If there is a security vulnerability in one of these components, and if there is a security exploit
targeting it, such security vulnerability may adversely impact our product vulnerability and we could face increased costs, liability
claims, reduced revenue, or harm to our reputation or competitive position. Because techniques used to obtain unauthorized access or sabotage
systems change frequently and generally are not identified until they are launched against a target, we may be unable to anticipate these
techniques or to implement adequate preventative measures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to the effects of inflationary
pressures, which may impair our gross margins and our ability to operate profitably.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we do not believe that our business was
materially adversely affected by inflation prior to 2024, we have been experiencing cost increases, including increased labor costs, as
a result of the recent inflationary pressures, combined with supply line delays and recent shortages of semiconductors. The effects of
the war in Israel, the Russian invasion of Ukraine, which exacerbated the already existing inflationary pressures and supply line delays
and shortages, may impair our margin and our ability to operate profitable. To the extent that inflation, along with supply line delays
and semiconductor shortages, we may incur increased costs in our components as well as from our contract manufacturers, and we may not
be able to pass on any costs we may incur to our customers. Further, our costs may be affected by any tariffs and counter-tariffs which
are imposed or threatened which may increase inflationary pressures. To the extent that we are unable to pass on costs, our gross margin
may be significantly eroded which may result in increased losses during our developmental phase and may impair our ability to operate
profitable when we are in full production mode. We cannot assure you that these factors will not impair our ability to generate a profit
from our operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business may be impacted by international
trade issues including tariffs and counter-tariffs and restrictions on the export of advanced chips which may impact the cost and availability
of components equipment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The president of the United States, Donald J.
Trump, has stressed the importance of tariffs. We cannot predict the extent of any tariffs that may affect our business, our manufacturer,
our Tier 1 suppliers and the automobile industry generally. To the extent that tariffs are threatened, even if not imposed, it may impact
the automobile industry and may result in a delay in the development of cars with a higher level of autonomy. Any tariffs, which may result
in counter-tariffs, could result in a significant increase in the cost of parts for automobiles with increasing costs of the automobiles
subject to the tariffs as well as significant supply chain delays which would increase costs and time. In addition, the United States
has imposed export restrictions on advanced chips, including artificial intelligence chips, which may affect both the ability of our supplier,
GlobalFoundries, to obtain chips and the price of chips. Any factors which could result in higher prices for automobiles could result
in a reduction in the production of automobiles and a delay in the introduction of new features which require our technology, all of which
could have a material adverse impact on our business and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we seek to expand our business through
acquisition, we may not be successful in identifying acquisition targets or integrating their businesses with our existing business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we may undertake acquisitions
to add new products and technologies, acquire talent, gain new sales channels or enter into new markets or sales territories. To date,
we have no experience either with acquisitions or the integration of acquired technology and personnel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are significant risks associated with any
acquisition program, including, but not limited to, the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may incur significant expenses and devote significant management time to a potential acquisition, and we may be unable to consummate the acquisition on acceptable terms.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If we identify an acquisition, we may face competition from other companies in the industry or from financial buyers seeking to make the acquisition.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The integration of any acquisition with our existing business may be difficult and, if we are not able to integrate the business successfully, it may not only be unable to operate the business profitably, but management may be unable to devote the necessary time to the development of our existing business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key employees who operated the acquired business successfully prior to the acquisition may not be happy working for us and may resign, thus leaving the business without the necessary continuity of management.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even if the business is successful, our senior executive officers may need to devote significant time to the acquired business, which may distract them from their other management activities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the business does not operate as we expect, we may incur an impairment charge based on the value of the assets acquired.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may have difficulty maintaining the necessary quality control over the acquired business and our products and services.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that an acquired company operates at a loss prior to our acquisition, we may not be able to develop profitable operations following the acquisition.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Problems and claims relating to the acquired business that were not disclosed at the time of the acquisition may result in increased costs and may impair our ability to operate the acquired company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquired company may have liabilities or obligations that were not disclosed to us, or the acquired assets, including intellectual property assets, may not have the value we anticipated.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any indemnification obligations of the seller under the purchase agreement may be inadequate to compensate us for any loss, damage or expense that we may sustain, including undisclosed claims or liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent that the acquired company is dependent upon our management to maintain relationships with existing customers, we may have difficulty in retaining the business of these customers if there is a change in management.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government agencies may seek damages after we makes the acquisition for conduct that occurred prior to the acquisition and we may not have adequate recourse against the seller.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may require significant capital both to acquire and to operate the business, and the capital requirements of the business may be greater than we anticipated, and our failure to obtain capital on reasonable terms may impair the value of the acquisition and may impair our continuing operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The acquired company may be impacted by unanticipated events, such as a pandemic such as the COVID-19 pandemic, the effect of climate changes, terrorist or other disruptive activities in Israel, social unrest or other factors over which we may have no control.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of these risks occur, our business, financial
condition and prospects may be impaired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The complexity of our products could result
in unforeseen delays or expenses from undetected defects, errors or bugs in hardware or software which could reduce the market adoption
of our products, damage our reputation with current or prospective customers, expose us to product liability, recalls, warranties and
other claims and adversely affect its operating costs.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products are being designed to be, among other
things, compatible with autonomous control. Autonomous driving technologies are subject to risks and there have been accidents and fatalities
associated with such technologies as well as breakdowns of the systems. The safety of such technologies depends in part on user interaction
and users, as well as other drivers on the roadways, may not be accustomed to using or adapting to such technologies. To the extent accidents
associated with our products that are used with autonomous controls occur, we could be subject to liability, negative publicity, government
scrutiny and further regulation. Any of the foregoing could materially and adversely affect our results of operations, financial condition
and growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products are technologically complex and require
high standards to manufacture. We have experienced in the past and will likely also experience in the future defects, errors or bugs at
various stages of development and manufacturing. We may be unable to timely release new products, manufacture existing products, correct
problems that have arisen or correct such problems to our customers&#8217; satisfaction. Additionally, undetected errors and defects,
especially as new products are introduced or as new versions are released, could result in serious injury, including fatalities, to the
end users of technology incorporating our products, or those in the surrounding area, our customers never being able to commercialize
technology incorporating our products, litigation against us, negative publicity and other consequences. These risks are particularly
prevalent in the highly competitive markets in which we operate. Some errors or defects in our products may only be discovered after they
have been tested, commercialized and deployed by customers. In certain instances, we may provide our customers with a time-limited warranty
for our products. If such errors or defects occur within the respective warranty period, we may incur significant additional development
costs and product recall, repair or replacement costs. These problems may also result in claims against us by our customers or by third
parties. Our reputation or brand may be damaged as a result of these problems and customers may be reluctant to buy our products, which
could adversely affect our ability to retain existing customers and attract new customers and could adversely affect our financial results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we could face material legal claims
for breach of contract, product liability, tort or breach of warranty as a result of these problems. Defending a lawsuit, regardless of
its merit, could be costly and may divert management&#8217;s attention and adversely affect the market&#8217;s perception of us and our
products. In addition, our business liability insurance coverage could prove inadequate with respect to a claim and future coverage may
be unavailable on acceptable terms or at all. These product-related issues could result in claims against us and our business could be
adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will be affected by these problems regardless
of whether the defective product or component was manufactured or assembled by us or by a supplier or contract manufacturer, and we may
not have adequate recourse against the supplier or contract manufacturer, and we may not be able to obtain sufficient product liability
insurance to protect it against such loss or expense, including the cost of litigation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legislation or government regulations may
be adopted which may affect our products and liability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Autonomous driving technology is subject to considerable
regulatory uncertainty as the law evolves to catch up with the rapidly evolving nature of the technology itself, all of which are beyond
our control. Our products also may not achieve the requisite level of autonomous compatibility required for certification and rollout
to consumers or satisfy changing regulatory requirements which could require us and the Tier 1 suppliers that develop and market products
based on our chipset to redesign, modify or update our or their products. Further, accidents, particularly accidents that involve a large
number of deaths, even if our products are not involved, may result in industry-wide reevaluation of the technologies used, with the effect
that there is a slowdown as automobile manufacturers cease making purchase during the reevaluation process, which may result in suppliers
other than us becoming a preferred supplier.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The industry may become subject to increased legislation
and regulation. Such legislation may be triggered by a perceived safety concern, or it may result from a public reaction to accidents
caused by or involving automobiles, drones or other autonomous vehicles. The potential market for our products is international, and each
country or region may impose different and potentially conflicting regulations. These regulations may relate the technical requirement
and standards for end products or the components and may impose liability on the manufacturer or the seller of the product, which liability
may be strict liability, for damage resulting from the autonomous vehicle. Further, the legislation or regulations in different countries
may impose different standards, which may be conflicting. Any legislation or regulations that impose standards or impose liability are
likely to increase our manufacturing costs as well as the cost of compliance and product liability insurance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that the United States adopts regulations
that encourage gas driven automobiles and discourage electric vehicles, the market for automobiles with enhanced ADAS features may be
adversely affected since ADAS operate on electric and not gas-powered vehicles. Any such action may both reduce the market for enhanced
ADAS vehicles and delay the introduction of enhance ADAS vehicles, which could adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We operate in a highly competitive market
against a large number of both established competitors and new market entrants, and some market participants have substantially greater
resources than we have.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The markets for sensing technology applicable
to autonomous solutions across numerous industries are highly competitive. Our future success will depend on our ability to develop and
protect from infringement in a timely manner and to stay ahead of existing and new competitors and to satisfy the market that is technology
is leading edge technology. A large number of companies offer radar-based and LiDAR-based technologies in competition with us. Some of
these companies are better capitalized and better known than we. Our competitors compete with us directly by offering similar products
and indirectly by attempting to solve some of the same challenges with different technology. We face competition both in marketing to
Tier 1 suppliers and manufacturers from other market participants, some of which have significantly greater resources than we have, and,
if our Tier 1 suppliers select our product for the radar solution they are offering to manufacturers, they will compete with radar solutions
offered by other Tier 1 suppliers. Our competitors may commercialize&#160;new technology which may achieve market adoption or stronger
brand recognition as compared to our products. Even in emerging markets, we face substantial competition from numerous competitors seeking
to prove the value of their technology. Additionally, increased competition may result in pricing pressure and reduced margins and may
impede our ability to increase the sales of our products or cause it to lose market share, any of which will adversely affect our business,
results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fluctuation of the results of our earnings
on a quarterly and annual basis, could cause the share price of our ordinary shares to fluctuate or decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The results of our operations to date have primarily
reflected our research and development expenses with limited revenue. From 2020 through 2024, we had modest revenue from sales of our
products and services, primarily to customers making purchases for their own evaluation projects. In the future, sales in any given quarter
can fluctuate based on the timing and success of our customers&#8217; development projects and marketing programs. Accordingly, the results
of any one quarter should not be relied upon as an indication of future performance. Our quarterly financial results may fluctuate as
a result of a variety of factors, many of which are outside of our control and may not fully reflect the underlying performance of our
business. These fluctuations could adversely affect our ability to meet our expectations or those of securities analysts or investors.
If we do not meet these expectations for any period, the value of our securities could decline significantly. Factors that may cause these
quarterly fluctuations include, without limitation, those listed below:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The timing and magnitude of orders and shipments of our products in any quarter;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing changes we may adopt to drive market adoption or in response to competitive pressure;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effect of international trade issues, including tariffs and related supply line problems affecting us and our suppliers or customers and the automobile industry generally;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effect of inflation;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The timing of the completion of our application engineering services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to retain our existing customers and attract new customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to develop, introduce, manufacture, and ship products in a timely manner that meet customer requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disruption in our sales channels or termination of our relationships with important channel partners;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delays in customers; purchasing cycles or deferments of customers; purchases in anticipation of new products or updates from us or our competitors;</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fluctuations in demand pressures for our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The mix of products sold and the gross margin of products sold in any quarter;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The duration of, and responses of governments and industry to any worldwide or regional health crisis;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Events and conditions affecting Israel-based businesses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The timing and rate of broader market adoption of autonomous systems, both generally and those utilizing our smart vision solutions across automotive and other market sectors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market acceptance of our core products and further technological advancements by us, our competitors, and other market participants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability of our customers to commercialize systems that incorporate our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any change in the competitive dynamics of our markets, including the consolidation of competitors, regulatory developments, and new market entrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to effectively manage our inventory;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in the source, cost, availability and regulations pertaining to the materials we use;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse litigation, judgments, settlements, or other litigation-related costs, or claims that may give rise to such costs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse publicity, litigation, and governmental investigations affecting autonomous vehicles, regardless of whether our products are involved;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The war with Hamas, any other conflicts which may involve Israel and the effects of the Russian invasion of Ukraine and the consequences of any settlement of the conflict; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General economic, industry, and market conditions, including trade disputes.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in tax laws or exposure to additional
income tax liabilities could affect our future profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors that could materially affect our future
effective tax rates include but are not limited to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New income or other tax laws or regulations could be enacted at any time, which could adversely affect our business operations and financial performance. Further, existing tax laws and regulations could be interpreted, modified, or applied adversely to us. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual or perceived political instability in Israel or any negative changes in the political environment may, individually or in aggregate, adversely affect the Israeli economy and, in turn, may result in major changes in Israeli tax laws, regulations and tax policies.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in accounting and tax standards or practices;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligibility for beneficial treatment under Israeli tax laws;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in the composition of operating income by tax jurisdiction;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our operating results before taxes; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to use our accumulated tax losses to offset future income.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be subject to regular review and audit by Israeli and other foreign tax authorities. Although we believe our tax estimates are reasonable, the authorities in these jurisdictions could review our tax returns and impose additional taxes, interest, linkage and penalties, and the authorities could claim that various withholding requirements apply to us or our subsidiaries or assert that benefits of tax treaties are not available to us or our subsidiaries, any of which could materially affect our income tax provision, net income, or cash flows in the period or periods for which such determination and settlement is made. Our determinations are not binding on any taxing authorities, and accordingly the final determination in an audit or other proceeding may be materially different than the treatment reflected in our tax provisions, accruals and returns. An assessment of additional taxes because of an audit could have a material adverse effect on our business, financial condition, results of operations and cash flows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There can be no assurance that our effective tax
rate will not increase over time as a result of changes in corporate income tax rates or other changes in the tax laws in the jurisdictions
in which we operate. Any changes in tax laws could have an adverse impact on our financial results. Corporate tax reform, base-erosion
efforts, including the OECD Pillar Two framework and tax transparency continue to be high priorities in many tax jurisdictions where we
have business operations. As a result, policies regarding corporate income and other taxes in numerous jurisdictions are under heightened
scrutiny, and tax reform legislation is being proposed or enacted in a number of jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax benefits that may be available to us require
that we continue to meet various conditions and may be terminated or reduced in the future, which could increase our costs and taxes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in our product mix may impact our
financial performance.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial performance can be affected by the
mix of products we sell during a given period. If our sales include more lower-gross margin products than higher gross margin products,
our results of operations and financial condition may be adversely affected. There can be no guarantees that we will be able to successfully
structure our product mix so that we are selling more of our high-gross margin products. In addition, our earnings forecasts and guidance
are expected to include assumptions about product sales mixes. If actual results vary from this projected product mix of sales, our results
of operations and financial condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are highly dependent on the services
of our co-founders, who are our senior executive officers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are highly dependent on our co-founders,&#160;Kobi
Marenko and Noam Arkind, who have acted as our Chief Executive Officer and Chief Technology Officer, respectively, since inception, and
as such, are deeply involved in all aspects of our business, including product development. The loss of either of them would adversely
affect our business because it could be more difficult for us to, among other things, compete with other market participants, manage our
research and development activities, and retain existing customers or cultivate new ones. Negative public perception of, or negative news
related to, Mr. Marenko or Mr. Arkind may adversely affect our brand, relationship with customers, or standing in the industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business depends on our ability to attract
and retain highly skilled personnel and senior management. Failure to effectively retain, attract and motivate key employees could impair
our ability to operate profitably.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Competition for highly skilled personnel is
often intense, especially in Israel, where our principal office is located, and we may incur significant costs to attract them. We
may face challenges in attracting or retaining qualified personnel to fulfill our current or future needs. The highly competitive
environment for highly skilled personnel can result in higher compensation packages for employees. We have, from time to time,
experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled employees with appropriate
qualifications. In addition, job candidates and existing employees often consider the value of the equity awards they receive in
connection with their employment. If the perceived value of our equity or equity awards declines, it may adversely affect our
ability to retain highly skilled employees. Our stock price may affect their decision as to whether to accept an offer of employment
from us. Our success will depend in part on the attraction, retention, and motivation of executive personnel critical to our
business and operations. If we fail to attract new personnel or fail to retain and motivate our current personnel, we could face
disruptions in our operations, strategic relationships, key information, expertise, or&#160;know-how,&#160;and unanticipated
recruitment and onboarding costs, and our business and future growth prospects could be adversely affected. Further, Israel&#8217;s
calling up employed or employable personnel for military service may affect our ability to hire qualified personnel. We cannot give
assurance that we will be able to hire all the required personnel when we require them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face numerous risks associated with commercial
production.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have manufacturing facilities, and we
rely on third parties for the manufacture of our products. We cannot be sure that our manufacturer, GlobalFoundries, or other companies
with which we may develop a strategic alliance will be able to develop efficient, automated, cost-efficient production capabilities and
processes and reliable sources of component supply that will enable us to meet the quality, price, engineering, design and production
standards, as well as the production volumes, required to successfully mass market our products. GlobalFoundries is a major semiconductor
manufacturer in the automotive industry, among other industries. Even if we and our supplier and strategic alliances are successful in
developing our initial production and further high volume production capability and processes and reliably sourcing our component supply,
we do not know whether we will be able to do so in a manner that avoids significant delays and cost overruns, including as a result of
factors beyond our control such as problems with potential suppliers and strategic partners, tariffs, force majeure events, or in time
to meet our product commercialization schedules or to satisfy the requirements of our potential customer base. Any failure to develop
such production processes and capabilities within our projected costs and timelines could have a material adverse effect on our business,
prospects, financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on third-party suppliers, and because
key components in our products come from limited or sole sources of supply, we are susceptible to supply shortages, long lead times for
components, and supply changes, any of which could disrupt our supply chain and delay deliveries of our products to customers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components that go into the manufacture of
our solutions are sourced from third-party suppliers. Some of the key components used to manufacture our products come from limited or
single-source suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components, as well
as the risk that our suppliers will discontinue or modify components used in our products, which risks may be compounded by any tariffs
or counter-tariffs which may be imposed on the products we import. We purchase semiconductor chips that are an integral part of our products
from GlobalFoundries. To the extent that our Tier 1 suppliers modify their products, it may be necessary for us to make modifications
to the chipset that we sell to the Tier 1 supplier, and we would need to work with GlobalFoundries, to develop and produce a modified
product to meet the Tier 1 supplier&#8217;s cost and timing requirements. If GlobalFoundries fails to deliver or delays the delivery of
the semiconductor products or is otherwise unable to meet our quality and delivery requirements, we may be required to seek an alternative
source of supply. Although alternate chip manufacturers are available, any change in suppliers would necessitate a change in the design
of the semiconductor, a process that could take up to two&#160;years, which would result in a loss of sales and a delay in the development
and marketing of our products, which could materially and adversely affect our results of operation, financial position, and prospects.
Further, we, like other companies in the automotive industry, are affected by an industry-wide semiconductor shortage, which may be exacerbated
by tariffs and international trade issues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reliance on third-party manufacturers
reduces our control over the manufacturing process, including our ability to finalize changes through validation, reduced control
over quality, product costs, and product supply and timing. We may experience delays in shipments or issues concerning product
quality from our third-party manufacturers. If GlobalFoundries experiences interruptions, delays, or disruptions in supplying our
products, including by natural disasters, other health epidemics and outbreaks, work stoppages, capacity constraints, the effects of
the war between Israel and Hamas, or other international conflicts, our ability to ship products to distributors and customers would
be delayed. In addition, unfavorable economic conditions could result in financial distress among third-party manufacturers upon
which we rely, thereby increasing the risk of disruption of supplies necessary to fulfill our production requirements and meet
customer demands. These delays or product quality issues could have an immediate and material adverse effect on our ability to
fulfill orders and could have a negative effect on our operating results. In addition, such delays or issues with product quality
could adversely affect our reputation and our relationship with Tier 1 suppliers and OEMs. If GlobalFoundries or any other
third-party manufacturers experience financial, operational, manufacturing capacity, or other difficulties, or experience shortages
in required components, or if they are otherwise unable or unwilling to continue to manufacture our products in required volumes or
at all, our supply may be disrupted, we may be required to seek alternate manufacturers, and we may be required to re-design our
products. It would be time-consuming, and costly and impracticable to begin to use new manufacturers and designs, and such changes
could cause significant interruptions in supply, have an adverse effect on our ability to meet our scheduled product deliveries, and
subsequently lead to the loss of sales. While we take measures to protect our trade secrets, the use of a third-party manufacturer
may also risk disclosure of our innovative and proprietary manufacturing methodologies, which could adversely affect our business.
In addition, increased component costs could result in lower gross margins. Even where we are able to pass increased component costs
along to our customers, there may be a lapse of time before we are able to do so, such that we must absorb the increased cost. If we
are unable to buy these components in quantities sufficient to meet our requirements on a timely basis, we will not be able to
deliver products to our customers, which may result in such customers using competitive products instead of our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business is subject to the risks of
earthquakes, fires, floods, and other natural catastrophic events, global pandemics, and interruptions by&#160;man-made&#160;problems
such as network security breaches, computer viruses, or terrorism. Material disruptions of our business or information systems resulting
from these events could adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant natural disaster, such as an earthquake,
fire, flood, or significant power outage, or other similar events, such as infectious disease outbreaks or pandemic events, could have
an adverse effect on our business and operating results. Despite the implementation of network security measures, our networks and our
products may also be vulnerable to computer viruses,&#160;break-ins,&#160;and similar disruptions from unauthorized tampering with our
solutions, and we have been subject to cybersecurity breaches that were not material and did not result in access to our technical or
other confidential information. In addition, natural disasters, acts of terrorism, or war could cause disruptions in our remaining manufacturing
operations, our or our customers&#8217; businesses, our suppliers&#8217; businesses, or the economy as a whole. We also rely on information
technology systems to communicate among our workforce and with third parties. Any disruption to our communications, whether caused by
a natural disaster or by man-made problems such as power disruptions, ransomware attacks, or other cybersecurity breaches, could adversely
affect our business. To the extent that any such disruptions result in delays or cancellations of orders or impede our suppliers&#8217;
ability to timely deliver product components or the deployment of our products, our business, operating results, and financial condition
would be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business is sensitive to conditions
affecting the automotive industry, the duration and economic, governmental, and social impact of which are difficult to predict and may
significantly harm our business, prospects, financial condition, and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adverse conditions affecting one or more automotive
manufacturers or the automotive industry in general could have a material adverse effect on our business, prospects, financial condition,
and operating results. Our business may be negatively affected by challenges to the larger automotive ecosystem. In addition, factors,
including the effects of climate change, government regulations, tariffs and threatened tariffs, and the ability of suppliers to obtain
rare earth elements, as well as other conditions that cannot be presently identified, can continue to affect the automotive industry.
To the extent that radar systems in vehicles are software-based, with manufacturers or software suppliers having the ability to modify
or update software remotely, there is a risk of security breaches that may affect the safety of the vehicle.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Increasing attention to, and evolving expectations
regarding, environmental, social and sustainability matters may impact our business and reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Evolving and increased and changing expectations
regarding environmental, social and sustainability initiatives and disclosures may result in increased costs, enhanced compliance disclosure
obligations, or other impacts to our business, financial condition, or results of operations. Moreover, our environmental, social and
sustainability initiatives may be costly and may not have the desired effect, or we may ultimately be unable to complete certain initiatives
or targets, either on the timelines initially announced or at all, due to technological, legal, cost, or other constraints, which may
be within or outside of our control. Moreover, actions or statements that we may take based on expectations, assumptions, or third-party
information that we currently believe to be reasonable may subsequently be determined to be erroneous or be subject to misinterpretation.
If we fail to, or are perceived to fail to, comply with or advance certain environmental, social or sustainability initiatives, we may
be subject to various adverse impacts, including reputational damage, activism and potential stakeholder engagement and/or litigation.
Additionally, many of our customers, suppliers and others with which we have business relationships may be subject to similar expectations,
which may augment or create additional risks, including risks that may not be known to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to adequately protect
or enforce our intellectual property rights or prevent unauthorized parties from copying or reverse engineering our solutions. Our efforts
to protect and enforce our intellectual property rights and prevent third parties from violating our rights may be costly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The success of our products and our business
depends in part on our ability to obtain patents and other intellectual property rights and maintain adequate legal protection for our
products in the United&#160;States, Europe, and other international jurisdictions. We rely on a combination of patent, copyright, service
mark, trademark, and trade secret laws, as well as confidentiality procedures and contractual restrictions, to establish and protect
our proprietary rights, all of which provide only limited protection. We cannot assure you that any patents will be issued with respect
to our currently pending patent applications or that any trademarks will be registered with respect to our currently pending applications
in a manner that gives us adequate defensive protection or competitive advantages, if at all, or that any patents issued to us or any
trademarks registered by us will not be challenged, invalidated, or circumvented. We have filed for patents and trademarks in Israel,
the United&#160;States, Europe, and China. Not all patent applications have resulted in patents, and we cannot assure you that patents
will be granted. Further, patent protection may not be available in all countries in which we operate or in which we seek to enforce
our intellectual property rights, and it may be difficult to enforce our patent rights. Our currently issued patents and trademarks and
any patents and trademarks that may be issued or registered, as applicable, in the future with respect to pending or future applications
may not provide sufficiently broad protection or may not prove to be enforceable in actions against alleged infringers. We cannot be
certain that the steps we have taken will prevent unauthorized use of our technology or the reverse engineering of our technology. Moreover,
others may independently develop technologies that are competitive with us or infringe on our intellectual property.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Protecting against the unauthorized use of our
intellectual property, products, and other proprietary rights is expensive and difficult, particularly internationally. We intend to enforce
the intellectual property portfolio we have developed. Unauthorized parties may attempt to copy or reverse engineer our solutions or certain
aspects of our solutions that we consider proprietary. Litigation may be necessary in the future to enforce or defend our intellectual
property rights, to prevent unauthorized parties from copying or reverse engineering our solutions, to determine the validity and scope
of the proprietary rights of others, or to block the importation of infringing products into countries where we have patent protection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective patent, trademark, service mark, copyright,
and trade secret protection may not be available in every country in which our products are available, and competitors based in other
countries may sell infringing products in one or more markets. An inability to adequately protect and enforce our intellectual property
and other proprietary rights, or an inability to prevent authorized parties from copying or reverse engineering our smart vision solutions
or certain aspects of our solutions that we consider proprietary, could seriously adversely affect our business, operating results, financial
condition, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In addition to patented technology, we rely
on our unpatented proprietary technology, trade secrets, processes, and&#160;know-how.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We rely on proprietary information (such as trade
secrets,&#160;know-how,&#160;and confidential information) to protect intellectual property that may not be patentable or subject to copyright,
trademark, trade dress, or service mark protection, or that we believe is best protected by means that do not require public disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generally seek to protect our proprietary information
by entering into confidentiality agreements, consulting services, or employment agreements that contain&#160;non-disclosure&#160;and&#160;non-use&#160;provisions
with our employees, consultants, contractors, and third parties. However, we may fail to enter into the necessary agreements, and even
if entered into, these agreements may be breached or may otherwise fail to prevent disclosure, third-party infringement, or misappropriation
of our proprietary information, may be limited as to their terms, and may not provide an adequate remedy in the event of unauthorized
disclosure or use of proprietary information. We have limited control over the protection of trade secrets used by our current or future
manufacturing partners and suppliers and could lose future trade secret protection if any unauthorized disclosure of such information
occurs. In addition, our proprietary information may otherwise become known or be independently developed by our competitors or other
third parties. To the extent that our employees, consultants, contractors, advisors, and other third parties use intellectual property
owned by others in their work for us, disputes may arise as to the rights to related or resulting&#160;know-how&#160;and inventions. Costly
and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or
maintain protection for our proprietary information could adversely affect our competitive business position. Furthermore, laws regarding
trade secret rights in certain markets where we operate may afford little or no protection to our trade secrets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also rely on physical and electronic security
measures to protect our proprietary information, but we cannot provide assurance that these security measures will not be breached or
provide adequate protection for our intellectual property. There is a risk that third parties may obtain and improperly utilize our proprietary
information to our competitive disadvantage. We may not be able to detect or prevent the unauthorized use of such information or take
appropriate and timely steps to enforce our intellectual property rights or to protect us against cybersecurity invasions that either
lock our computers so we cannot access our information or discloses our confidential information to others or to the general public. As
an Israeli company, we may be subject to attempts at cybersecurity breaches by persons or countries who seek to attach anything Israeli,
and we have seen increased attempts to do so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Third-party claims that we are infringing
intellectual property, whether successful or not, could subject it to costly and time-consuming litigation or expensive licenses, and
our business could be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we hold patents related to our products,
a number of companies, both within and outside of the industry in which we operate, hold other patents covering various aspects of our
products. In addition to these patents, participants in this industry typically also protect their technology, especially embedded software,
through copyrights and trade secrets. As a result, there is frequent litigation based on allegations of infringement, misappropriation,
or other violations of intellectual property rights. In the future, we may receive inquiries from other intellectual property holders
and may become subject to claims that it infringes on their intellectual property rights, particularly as we expand our presence in the
market. In addition, parties may claim that the names and branding of our products infringe on their trademark rights in certain countries
or territories. If such a claim were to prevail, we may have to change the names and branding of our products in the affected territories,
and we could incur other costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently have a number of agreements in effect
pursuant to which we have agreed to defend, indemnify, and hold harmless our customers, suppliers, and partners from damages and costs
that may arise from the infringement by our products of third-party patents or other intellectual property rights. The scope of these
indemnity obligations varies, but may, in some instances, include indemnification for damages and expenses, including attorneys&#8217;
fees. Our insurance may not cover all intellectual property infringement claims. A claim that our products infringe on a third party&#8217;s
intellectual property rights, even if untrue, could adversely affect our relationships with our customers, deter future customers from
purchasing our products, and expose us to costly litigation and settlement expenses. Even if we are not a party to any litigation between
a customer and a third party relating to infringement by our products, an adverse outcome in any such litigation could make it more difficult
for us to defend our products against intellectual property infringement claims in any subsequent litigation in which it is a named party.
Any of these results could adversely affect our brand and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our defense of intellectual property rights claims
brought against us or our customers, suppliers, and channel partners, with or without merit, could be time-consuming, expensive to litigate
or settle, divert management resources and attention, and force us to acquire intellectual property rights and licenses, which may involve
substantial royalty or other payments and may not be available on acceptable terms or at all. Further, a party making such a claim, if
successful, could secure a judgment that requires us to pay substantial damages or obtain an injunction which will prohibit us from selling
our products. An adverse determination also could invalidate our intellectual property rights, adversely affect our ability to offer our
products to our customers, and may require that we procure or develop substitute products that do not infringe, which could require significant
effort and expense. Any of these events could adversely affect our business, operating results, financial condition, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal and Regulatory Risks Related to our Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our sales and operations in international
markets expose us to operational, financial and regulatory risks.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales to international customers, <span style="text-decoration:underline">i.e.</span>,&#160;customers
located outside of Israel, accounted for almost all of our sales to date. International operations are subject to a number of other risks,
including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange rate fluctuations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Political and economic instability, international terrorism, and anti-American and anti-Israel sentiment, particularly in emerging markets;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reaction to any conflicts involving Israel, including its war with Hamas and conflicts with Hezbollah and others, including any official or unofficial boycotts of Israeli companies;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify">
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The effects of the Russian invasion of Ukraine or any resolution
of the invasion as it may affect suppliers and customers in Europe;</p></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
or regional health crises;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential for violations of anti-corruption laws and regulations, such as those related to bribery or fraud;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preference for locally branded products, and laws and business practices favoring local competition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased difficulty in managing inventory;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less effective protection of intellectual property;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stringent regulation of our products or systems incorporating our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Difficulties and costs of staffing and managing foreign operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Import and export laws and the impact of tariffs; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in">&#160;</td>
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in local tax and customs duty laws or changes in the enforcement, application, or interpretation of such laws.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The occurrence of any of these risks could negatively
affect our international business and, consequently, our business, operating results, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to, and must remain in compliance
with, numerous laws and governmental regulations concerning the manufacturing, use, distribution, and sale of our products. Some of our
customers also require that we comply with their own unique requirements relating to these matters.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products contain electronic components, and
such components may contain materials that are subject to government regulation in the locations where we develop, manufacture, and assemble
our products, as well as the locations where we sell our products. Among other things, certain applicable laws and regulations require
or may in the future require the submission of annual reports to certain governmental agencies certifying that such products comply with
applicable performance standards, the maintenance of manufacturing, testing, and distribution records, and the reporting of certain product
defects to such regulatory agencies or consumers. Because our products are to be included in automobiles throughout the world, our radars
will need to comply with the applicable standards, laws or regulations in every country in which cars with our radar are sold, including
the United States, the European Union, Great Britain, China and Japan. If our products fail to comply with applicable regulations, we
and/or our products could be subjected to a variety of enforcement actions or sanctions, such as product recalls, repairs or replacements,
warning letters, untitled letters, safety alerts, injunctions, import alerts, administrative product detentions or seizures, or civil
penalties. The occurrence of any of the foregoing could harm our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since we operate on a global basis, we must continually
monitor applicable laws and regulations and engage in an ongoing compliance process to take necessary steps so that we and our suppliers
are in compliance with all existing laws and regulations. If there is unanticipated or onerous new legislation or regulation that significantly
impacts our use of various components, including those incorporating AI, or requires more expensive components, such legislation or regulation
could materially adversely affect our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since our products are used for autonomous driving
applications, they are subject to complicated and rapidly evolving laws and regulatory schemes that vary from jurisdiction to jurisdiction
at the state, federal, and international levels, including requirements related to safety, data privacy<i>,</i> artificial intelligence,
security, cybersecurity, and product liability, among other areas. These are rapidly evolving areas in which new or changed requirements
could impose limitations on the use of our products. If we fail to adhere to these new laws and regulations or fail to continually monitor
emerging developments, it may be subject to litigation, loss of customers, or negative publicity, and our business, results of operations,
and financial condition will be adversely affected. We are unable to predict how any future changes will impact it or if such impacts
will be material to our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The evolution of the regulatory framework
for autonomous vehicles and their related components is outside of our control.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is subject to a patchwork of regulations
from local, state and federal authorities. U.S. federal regulations include those imposed by the U.S. Department of Transportation and
the NHTSA. In 2023, the NHTSA promulgated the &#8220;Occupant Protection for Vehicles with Automated Driving Systems&#8221; final rule
to update several Federal Motor Vehicle Safety Standards (&#8220;FMVSS&#8221;) to account for vehicles that are equipped with ADAS and
do not have traditional manual controls associated with human drivers. The NHTSA also proposed rules to update FMVSS for crash avoidance,
safety messaging and passenger-less vehicles as well as jointly proposed a rule with the Federal Motor Carrier Safety Administration regarding
AEB test devices for heavy vehicles.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain states have legal restrictions on self-driving&#160;vehicles,
and many other states are considering them. This patchwork increases the difficulty of maintaining legal compliance. In Europe, certain
vehicle safety regulations apply to self-driving&#160;braking and steering systems, and certain treaties also restrict the legality of
certain higher levels of self-driving&#160;vehicles. Self-driving&#160;laws and regulations are expected to continue to evolve in numerous
jurisdictions in the U.S.&#160;and foreign countries and may restrict autonomous driving features that we may deploy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business may be adversely affected by
changes in automotive safety regulations or concerns that drive further regulation of the automobile safety market.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government vehicle safety regulations are an important
factor for our business. Historically, these regulations have imposed ever-more stringent safety regulations for vehicles. These safety
regulations often require, or customers demand, that vehicles have more safety features per vehicle and more advanced safety products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we believe increasing automotive safety
standards will present a market opportunity for our products, government safety regulations are subject to change based on a number of
factors that are not within our control, including new scientific or technological data, adverse publicity regarding industry recalls
and safety risks of autonomous driving, accidents involving our products, domestic and foreign political developments or considerations,
and litigation relating to our products and our competitors&#8217; products. Changes in government regulations, as well as changes or
evolutions in court doctrines in interpreting those regulations, especially in the autonomous driving industry, could adversely affect
our business. If government priorities shift and we are unable to adapt to changing regulations or to court interpretations of those regulations,
our business may be materially and adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Federal and local regulators impose more stringent
compliance and reporting requirements in response to product recalls and safety issues in the automotive industry. As the vehicles that
use our products go into production, we may become subject to stringent requirements, including a duty to report, strict timing requirements,
and safety defects with our products. Such rules and regulations may impose potentially significant civil penalties for violations, including
the failure to comply with such reporting actions. If we cannot rapidly address any safety concerns or defects with our products, our
business, results of operations, and financial condition may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.S.&#160;Department of Transportation has
issued regulations that require manufacturers of certain autonomous vehicles to provide documentation covering specific topics to regulators,
such as how automated systems detect objects on the road, how information is displayed to drivers, what cybersecurity measures are in
place, and the methods used to test the design and validation of autonomous driving systems. As cars that carry our sensors go into production,
the obligations of complying with safety regulations could increase, and it could require increased resources and adversely affect our
business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failures, or perceived failures, to comply
with privacy, data protection, and information security requirements in the variety of jurisdictions in which we operate may adversely
impact our business, and such legal requirements are evolving, uncertain and may require improvements in, or changes to, our policies
and operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current and potential future operations and
sales are subject to laws and regulations addressing privacy and the collection, use, storage, disclosure, transfer, and protection of
a variety of types of data. For example, the European Commission has adopted the General Data Protection Regulation and California has
enacted the California Consumer Privacy Act&#160;of&#160;2018 and the People&#8217;s Republic of China has laws relating to data protection,
all of which provide for potentially material penalties for&#160;non-compliance.&#160;These regulations may, among other things, impose
data security requirements, disclosure requirements, and restrictions on data collection, use, and sharing that may impact our operations
and the development of our business. While, generally, we do not have access to, collect, store, process, or share information collected
by our products unless our customers choose to proactively provide such information to us, our products may evolve both to address potential
customer requirements or to add new features and functionality. Therefore, the full impact of these privacy regimes on our business is
rapidly evolving across jurisdictions and remains uncertain at this time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may also be affected by cyberattacks and other
means of gaining unauthorized access to our products, systems, and data. For instance, cyber criminals or insiders may target us or third
parties with whom we have business relationships in an effort to harm them, their proper use, or the data stored in them, resulting in
direct and indirect damages, including disruption, interruption, or severance of operations, ransomware, leaks and data loss, theft of
property, espionage, harm to reputation, harm to public trust, and rehabilitation expenses. We work to prevent and reduce exposure to
the risk of cyber-attacks with strategies including the use of information security systems, assimilation of a culture of data security
(including training for managers and employees), refinement and adjustment of procedures, internal control programs, and auditing and
support with the assistance of experts in the field. During 2023, we suffered a cybersecurity breach that did not have any material effect
upon our business. We cannot assure that we will not suffer in the future from cybersecurity attacks that may have a material adverse
effect upon our business and our ability to conduct research and development or to market and sell our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations are rich in technology and computing
and may be exposed to risks related to the stability of the information systems, their compatibility with the scope of our operations,
information security, technical failures, overload of system servers, and the like. An impairment of the stability of computer systems
and an inability on the part of us to return its systems to normal operation within a reasonable timeframe, or a lack of technological
ability to meet commitments or the expectations of potential customers and strategic partners, may damage our reputation and harm our
business outcomes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are assessing the continually evolving
privacy and data security regimes and measures that we believe are appropriate in response. Since these data security regimes are
evolving, uncertain, and complex, especially for a global business like ours, we may need to update or enhance our compliance
measures as our products, markets, and customer demands further develop, and these updates or enhancements may require
implementation costs. The compliance measures we do adopt may prove ineffective. Any failure, or perceived failure, by us to comply
with current and future regulatory or customer-driven privacy, data protection, and information security requirements, or to prevent
or mitigate security breaches, cyberattacks, or improper access to, use of, or disclosure of data, or any security issues or
cyberattacks affecting us, could result in significant liability, costs (including the costs of mitigation and recovery), and a
material loss of revenue resulting from the adverse impact on our reputation and brand, loss of proprietary information and data,
disruption to our business and relationships, and diminished ability to retain or attract customers and business partners. Such
events may result in governmental enforcement actions and prosecutions, private litigation, fines and penalties, or adverse
publicity, and could cause customers and business partners to lose trust in us, which could have an adverse effect on our reputation
and business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be exposed to liabilities under the
U.S.&#160;Foreign Corrupt Practices Act and other U.S.&#160;and foreign anti-corruption, anti-money laundering, export control, sanctions,
and other trade laws and regulations, and any determination that we violated these laws could have a material adverse effect on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to export control and import laws
and regulations, including the U.S.&#160;Export Administration Regulations, U.S.&#160;Customs regulations, and various economic and trade
sanctions regulations administered by the U.S.&#160;Treasury Department&#8217;s Office of Foreign Assets Control. We are or may be also
subject to the U.S.&#160;Foreign Corrupt Practices Act&#160;of&#160;1977, as amended (the &#8220;FCPA&#8221;), the U.S.&#160;domestic
bribery statute contained in 18 U.S.C. &#167; 201, the U.S.&#160;Travel Act, the&#160;USA&#160;PATRIOT Act, the United&#160;Kingdom Bribery
Act&#160;2010, the Proceeds of Crime Act&#160;2002, the anti-bribery laws of the People&#8217;s Republic of China, the European Union&#8217;s
policies and, if enacted, proposed legislation, on bribery and corruption and other anti-bribery and anti-money laundering laws in countries
outside of the United&#160;States in which we conduct our activities or solicit business. Compliance with these laws has been the subject
of increasing focus and activity by regulatory authorities in recent years. Anti-corruption laws are interpreted broadly and prohibit
companies, their employees, and third-party intermediaries from authorizing, promising, offering, providing, soliciting, or accepting,
directly or indirectly, improper payments or benefits to or from any person, whether in the public or private sector. Our activities outside
the United&#160;States may create the risk of unauthorized payments or offers of payments by employees, consultants, sales agents, or
distributors, even though they may not always be subject to our control. It is our policy to implement safeguards to discourage these
practices by our employees, consultants, sales agents, and distributors. However, our existing safeguards and any future improvements
may prove to be less than effective, and our employees, consultants, sales agents, or distributors may engage in conduct for which we
might be held responsible, even if it does not explicitly authorize such activities. Should our export activity be subject to security
oversight, this may have a material effect on our activity. Further, our business may be affected by sanctions that may be imposed on
customers or suppliers who trade with sanctioned countries and/or companies in violation of United States or European restrictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Noncompliance with anti-corruption, anti-money
laundering, export control, sanctions, and other trade laws could subject us to whistleblower complaints, investigations, sanctions, settlements,
prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions,
suspension and/or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage,
and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or
if we do not prevail in any possible civil or criminal litigation, our business, results of operations, and financial condition could
be materially harmed. Responding to any action will likely result in a materially significant diversion of management&#8217;s attention
and resources, significant defense and compliance costs, and other professional fees. In addition, the U.S.&#160;government may seek to
hold us liable for successor liability for FCPA violations committed by companies in which we invest or that we may acquire. As a general
matter, enforcement actions and sanctions could harm our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Regulations related to conflict minerals
may cause us to incur additional expenses and could limit the supply and increase the costs of certain metals used in the manufacturing
of our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the requirements under the&#160;Dodd-Frank
Wall Street Reform and Consumer Protection Act&#160;of 2010, or the&#160;Dodd-Frank Act, that will require us to determine, disclose,
and report whether our products contain conflict minerals. The implementation of these requirements could adversely affect the sourcing,
availability, and pricing of the materials used in the manufacture of components used in our products. In addition, we will incur additional
costs to comply with the disclosure requirements, including costs related to conducting diligence procedures to determine the sources
of conflict minerals that may be used in or necessary to the production of our products and, if applicable, potential changes to products,
processes, or sources of supply as a consequence of such verification activities. It is also possible that our reputation may be adversely
affected if we determine that certain of our products contain minerals not determined to be conflict minerals or if we are unable to alter
our products, processes or sources of supply to avoid the use of such materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become involved in legal and regulatory
proceedings and commercial or contractual disputes, which could have an adverse effect on our profitability and consolidated financial
position.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be, from time to time, involved in litigation,
regulatory proceedings, and commercial or contractual disputes that may be significant. These matters may include, without limitation,
disputes with our potential suppliers and strategic partners and our potential customer base, intellectual property claims, stockholder
litigation, government investigations, class&#160;action lawsuits, personal injury claims, environmental issues, customs and VAT disputes,
and employment and tax issues. In addition, we could face in the future a variety of labor and employment claims against us, which could
include but are not limited to general discrimination, wage and hour, privacy, pension (including, for US employees, ERISA), or disability
claims. In such matters, government agencies or private parties may seek to recover from us very large, indeterminate amounts in penalties
or monetary damages (including, in some cases, treble or punitive damages) or seek to limit our operations in some way. These types of
lawsuits could require significant management time and attention or could involve substantial legal liability, adverse regulatory outcomes,
and/or substantial expenses to defend. Often, these cases raise complex factual and legal issues and create risks and uncertainties. No
assurances can be given that any proceedings and claims will not have a material adverse impact on our operating results and consolidated
financial position or that our established reserves or our available insurance will mitigate this impact.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The results of our operations may be affected
by changes in currency exchange rates.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our results of operations and cash flows are subject
to fluctuations due to changes in foreign currency exchange rates. Currently, most of our revenue is generated in U.S. dollars, while
our expenses are generally denominated in the currencies of the jurisdictions in which we conduct our operations, primarily the Israeli
Shekel, the U.S. dollar and, to some extent, the euro. We have not generated significant revenue to date, and we do not believe that foreign
currency exchange rates have not had, or currently have, a material effect on our business. However, we cannot give any assurance that
changes in foreign currency exchange rates will not have a material impact on us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our cash and cash equivalents could be adversely
affected if the financial institutions in which we hold our cash and cash equivalents fail.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We regularly maintain cash balances at third-party
financial institutions in the United States and in Israel. Maintaining any significant portion of our cash in financial institutions is
subject to adverse conditions in the financial or credit markets, which could impact access to our invested cash or cash equivalents and
adversely impact our operating liquidity and financial performance. We are diversifying our investments for cash designated for our long-term
activities into short-term deposits and money market funds and also considering spreading our cash and cash equivalents among several
financial institutions in order to reduce the risks associated with maintaining all of our cash and cash equivalents at one financial
institution. Notwithstanding these efforts, the failure of one or more of the financial institutions in which our cash and cash equivalents
are held could result in our inability to obtain or a significant delay in obtaining the return of our funds from any of those financial
institutions or any other adverse condition suffered by any of those financial institutions, could impact access to our invested cash
or cash equivalents and could adversely impact our operating liquidity and financial performance. Part of our cash was held in Silicon
Valley Bank (&#8220;SVB&#8221;), and, following the restructure of SVB, in 2023 we transferred substantially all the cash from SVB to
other financial institutions although a modest portion of our cash remains in SVB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our convertible bonds have covenants which
could restrict our ability to incur debt obligations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The deed of trust for our convertible bonds requires
us to comply with the following two covenants as long as the bonds are outstanding:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our shareholders&#8217; equity shall not fall
below $5 million as of the last day of two consecutive quarters.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We shall have cash and cash equivalents of not
less than $5 million as of the last day of one quarter.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the bonds are unsecured obligations,
the deed of trust provides that the Trustee will have a security interest, for the benefit of the bondholders, in the escrow funds. We
are prohibited, as long as the bonds are outstanding, from creating or agreeing to create in favor of any third party any floating charge
of any rank over all of our present and future property and rights to secure any obligation or debt of any kind, unless either the lien
is approved by a special resolution of the bondholders or we create, in favor of the bondholders, concurrently with the grant of the lien
to the third party, a charge of equal ranking with the lien to the third party which is pari passu with the lien to the third party. These
covenants may impair our ability to incur addition debt, including convertible debt.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Incorporation and Location
in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>The
war in Israel and other</i></b></span><b><i> conditions in Israel could materially and adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an Israeli corporation, and many of our
employees, including most of our management members, operate from our offices in Tel Aviv-Yafo, Israel. In addition, the majority of our
officers and directors are residents of Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, political, economic, and military
conditions in Israel and the surrounding region may directly affect our business and operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, Israel has been engaged
in sporadic armed conflicts and since October 2023 has been in a continuous conflict with Hamas and other Islamist terrorist groups that
control the Gaza Strip and with Hezbollah, an&#160;Islamist terrorist group that controls large portions of Lebanon; and with Iranian-backed
military forces throughout the Middle East.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 7, 2023, following a large-scale attack
led by the Hamas organization from the Gaza Strip on <span>civilian and military targets in </span>Israel,
the Israeli government declared a war against Hamas (the &#8220;Iron Swords War&#8221;). <span>In addition,
Hezbollah has also launched attacks against Israeli military sites and troops and against Israeli towns in northern Israel. In response
to these attacks, the Israel Defense Force (&#8220;IDF&#8221;) has carried out a number of targeted strikes on sites belonging to Hezbollah
in southern Lebanon although there is currently a cease fire with Lebanon. Further, Israel faces threats from more distant neighbors,
in particular, Iran which attacked Israel.&#160; The Iran-backed Houthi movement, which controls parts of Yemen and launched a number
of attacks on marine vessels traversing the Red Sea</span>. <span>The Red Sea is a vital maritime route
for international trade traveling to and from Israel and much of the world.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this annual report, the Iron
Swords War and the above-mentioned conflicts are still ongoing and is causing political and economic instability in the Middle East, and
the long-term effects of the war on Israeli tech companies remain uncertain. It is hard to predict how long the Iron Swords War and the
above-mentioned will last or whether the cease fire in Lebanon will continue. All these factors may have a negative impact on us and our
activities. We are examining and evaluating the wars&#8217; effects on our activities and considering different measures to face them
and withstand these risks. The risks we may face include, but are not limited to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of work stoppages, damages to infrastructure, and delays in the supply chain caused by the war, our business activities in Israel may suffer disruptions and may slow down.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The war may lead to a decrease in demand for the products and services of Israeli companies. Negative media coverage surrounding the conflict can damage the image of our company.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. More countries may impose restrictions on doing business with Israel and Israeli companies if hostilities on Israel continue or increase. The war may lead to an increase in input costs, such as labor, raw materials, and energy.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The war has a negative affect on the Israeli economy as a whole.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The war may lead to a decrease in the share price of our ordinary shares as a result of investors&#8217; fear of the geopolitical risks.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since October 7, 2023, the IDF has called up more than 360,000 of its reserve forces to serve. A number of our employees are currently subject to military service in the IDF and many of them have been called to serve. Such disruption could affect our business, prospects, financial condition, and results of operations. Future&#160;call-ups may impact our workforce availability and project timelines as well.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The heightened tensions in the area increased the risk of cyberattacks against us.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Israeli government has pursued
and continues to consider changes to Israel&#8217;s judicial system, which in turn may affect the checks and balances between the authorities
in Israel. These legislative and policy developments have sparked widespread public debate and protests within Israel in the past years,
as well as reactions from international organizations, investors, and credit rating agencies. Critics argue that such changes may negatively
impact Israel&#8217;s business and economic environment, including foreign investment, capital markets, and the country&#8217;s credit
rating. Actual or perceived political instability in Israel or any negative changes in the political environment may, individually or
in aggregate adversely affect the Israeli economy and, in turn, our business, financial condition, results of operations, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These legislative and policy developments have
sparked widespread public debate and protests within Israel, as well as reactions from international organizations, investors and credit
rating agencies. Critics argue that such changes may negatively impact Israel&#8217;s business and economic environment, including foreign
investment, capital markets, and the country&#8217;s credit rating.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become subject to claims for remuneration
or royalties for assigned service invention rights by our employees, which could result in litigation and adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of our intellectual property
has been developed by our employees in the course of their employment with us. Under the Israeli Patent Law,&#160;5727-1967, or the &#8220;Patent
Law&#8221;, inventions conceived by an employee in the course of and as a result of his or her employment with a company are regarded
as &#8220;service inventions,&#8221; which belong to the employer, unless there is a specific agreement between the employee and employer
giving the employee service invention rights. The Patents Law also provides that if there is no such agreement between an employer and
an employee, the Israeli Compensation and Royalties Committee (the &#8220;Committee&#8221;), a body constituted under the Patent Law,
will determine whether the employee is entitled to remuneration for his or her inventions. Case law clarifies that the right to receive
consideration for &#8220;service inventions&#8221; can be waived by the employee and that, in certain circumstances, such waiver does
not necessarily have to be explicit. The Committee will examine, on a case-by-case basis, the general contractual framework between the
parties using the interpretation rules of the general Israeli contract laws. Further, the Committee has not yet determined one specific
formula for calculating this remuneration but rather uses the criteria specified in the Patents Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we generally enter into assignment-of-invention
agreements with our employees pursuant to which such individuals assign to it all rights to any inventions created in the scope of their
employment or engagement with us, we may face claims demanding remuneration in consideration for assigned inventions. As a consequence
of such claims, we could be required to pay additional remuneration or royalties to our current and/or former employees, or be forced
to litigate such claims, which could negatively affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The potential tax benefits that may be available
to us require us to meet various conditions and may not be available to us, which could increase our costs and taxes.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may be eligible for certain tax benefits provided
to &#8220;Preferred Technology Enterprises&#8221; under the Israeli Law for the Encouragement of Capital Investments, 5719-1959, referred
to as the Investment Law. We have not yet applied for these benefits. In order to receive and remain eligible for the tax benefits for
the Preferred Technology Enterprises tax benefits, we must continue to meet certain conditions stipulated in the Investment Law and its
regulations. If these tax benefits are reduced, cancelled or discontinued, our Israeli taxable income from would be subject to regular
Israeli corporate tax rates. The standard corporate tax rate for Israeli companies has been 23% since 2018. Additionally, if we increase
our activities outside of Israel through acquisitions, for example, our expanded activities might not be eligible for inclusion in future
Israeli tax benefit programs. See &#8220;<i>Certain Material Israeli Tax Considerations</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The terms of grants received from the Israeli
government require us to satisfy specified conditions in order to transfer the manufacture of products based on know-how funded by the
Israel Innovation Authority outside of Israel or to transfer outside of Israel the know-how itself.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Encouragement of Research, Development,
and Technological Innovation in Industry Law,&#160;5744-1984, or the Innovation Law, research, and development programs that meet specified
criteria and may be approved by a committee of the Israel Innovation Authority of the Israeli Ministry of Economy and Industry, or IIA,
are eligible for grants from the IIA.&#160;The grant amounts are determined by the research committee and are typically a percentage of
the project&#8217;s expenditures. Under most programs, the grantee is required to pay royalties to the State of Israel from the sale of
products developed under the program.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development efforts in relation
to our product have been partially financed through royalty-bearing and non-royalty bearing grants from the IIA in the total amount of
approximately $4.0&#160;million through December 31, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms and conditions of the IIA grants
provided to us and pursuant to applicable laws, we are required to pay royalties from sales of products and services that incorporate
know-how developed with the IIA-funded, royalty-bearing grants. Such royalties are due up to an amount equal to 100% of the IIA grants
received, linked to the U.S.&#160;dollar, plus interest on the unpaid amount received based on the 12-month Secured Overnight Financing
Rate, known as SOFR, from the year the grant was approved. If we will manufacture IIA-funded products outside of Israel and generate sales,
the ceiling may increase based on the percentage of production that is outside of Israel, up to a maximum of 300% of the IIA grants, linked
to the dollar and bearing interest as detailed above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Local Manufacturing Obligation.</i> Under the regulations promulgated under the Innovation Law and the guidelines issued by the IIA, the manufacturing of products that incorporate know-how developed with the IIA-funded outside of Israel by us or by another entity may be subject to certain approvals and\or limitations, and if we fail to obtain the required approval, we may be subject to fines and/or an acceleration of our royalty obligation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Know-How transfer limitation</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Innovation Law restricts the ability to transfer know-how funded by the IIA outside of Israel. Transfer of IIA-funded know-how outside of Israel requires prior approval of the IIA and may be subject to additional payments to the IIA, calculated according to formulae provided under the Innovation Law. If we wish to transfer IIA-funded know-how, the terms for approval will be determined according to the nature of the transaction and the consideration paid to us in connection with such a transfer.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval of transfer the of IIA-funded know-how to another Israeli company may be granted only if the recipient abides by the provisions of the Innovation Law and related regulations, including the restrictions on the transfer of know-how and manufacturing rights outside of Israel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change of Control.</i> Any non-Israeli citizen, resident, or entity that, among other things, (i)&#160;becomes a holder of 5% or more of our share capital or voting rights, (ii)&#160;is entitled to appoint one or more of our directors or the chief executive officer, or (iii)&#160;serves as one of our directors or as our chief executive officer, is required to notify the IIA and undertake to comply with the Innovation Law and the rules and regulations thereunder as applicable to the grant programs of the IIA, including the restrictions on transfer described above.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approval to manufacture products outside of Israel
or consent to the transfer of IIA-funded know-how, if requested, is within the discretion of the IIA.&#160;Furthermore, the IIA may impose
certain conditions on any arrangement under which it permits us to transfer IIA-funded know-how or manufacturing out of Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration available to our shareholders
in a future transaction involving the transfer outside of Israel of know-how developed with IIA funding (such as a merger or similar transaction)
may be reduced by any amounts that we are required to pay to the IIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Restated Articles contain a forum selection
clause for substantially all disputes between us and our shareholders under the Israeli Companies Law and the Israeli Securities Law,
which could limit our shareholders&#8217; ability to bring claims and proceedings against us, our directors, officers, and other employees.
Enforcement of a U.S.&#160;judgment against us or our officers and directors in Israel or the United&#160;States, or assertion of a U.S.&#160;securities
law claim in Israel or serving process on our officers and directors, may also be difficult.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our Restated Articles, the competent courts
of Tel Aviv, Israel, will be the exclusive forum for (i)&#160;any derivative action or proceeding brought on our behalf, (ii)&#160;any
action asserting a claim of breach of fiduciary duty owed by any director, officer, or other employee to us or our shareholders, or (iii)&#160;any
action asserting a claim arising pursuant to any provision of the Israeli Companies Law or the Israeli Securities Law,&#160;1968-5728
(the &#8220;Israeli Securities Law&#8221;). This exclusive forum provision is intended to apply to claims arising under Israeli law and
would not apply to claims brought pursuant to the Securities Act or the Exchange&#160;Act. Our Restated Articles also provide that, unless
we consent in writing to the selection of an alternative forum and the Company consents in writing to the selection of an alternative
forum, the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting
a cause of action arising under the Securities Act, including all causes of action asserted against any defendant to such a complaint.
This provision does not affect any other claim for which federal district courts in the United States would have exclusive jurisdiction
and expressly does not apply to causes of action arising under the Securities Exchange Act. Such exclusive forum provision in the Restated
Articles will not relieve us of our duties to comply with federal securities laws and the rules and regulations thereunder, and our shareholders
will not be deemed to have waived their compliance with these laws, rules, and regulations. This exclusive forum provision may limit a
shareholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with us, our directors, officers, or other
employees, which may discourage lawsuits against us, our directors, officers, and employees. Investors cannot waive compliance with the
federal securities laws and the rules and regulations thereunder, including the provisions of the Securities Act that provide that state
and federal courts in the United States both have jurisdiction over claims based on the Securities Act. A United States court may not
enforce the provision in our Restated Articles that provides for exclusive jurisdiction of the federal district courts in actions under
the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another obstacle to the assertion of claims
against us or our directors or officers is the fact that most of them are not residents of the United&#160;States, and most of their
and our assets are located outside the United&#160;States. Service of process upon us or our non-U.S.&#160;resident directors and
officers and enforcement of judgments obtained in the United&#160;States against us or our non-U.S.&#160;directors and executive
officers may therefore be difficult to effect within the United&#160;States. It may be difficult to assert claims under
U.S.&#160;securities laws in original actions instituted in Israel or obtain a judgment based on the civil liability provisions of
U.S.&#160;federal securities laws. Israeli courts may refuse to hear a claim based on a violation of U.S.&#160;securities laws
against us or our non-U.S.&#160;officers and directors because Israel may not be the most appropriate forum to bring such a claim.
In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S.&#160;law are applicable
to the claim. If U.S.&#160;law is found to be applicable, the content of applicable U.S.&#160;law must be proven as a fact, which
can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little
binding case law in Israel addressing these matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the acceptance of foreign judgment
in Israel is mainly regulated in the Foreign Judgment Enforcement Law, 5718-1958, pursuant to which Israeli courts might not enforce judgments
obtained in the United&#160;States against us or our non-U.S.&#160;directors and executive officers, which may make it difficult to collect
on judgments rendered against us or our non-U.S.&#160;officers and directors. An Israeli court will not enforce a non-Israeli judgment
if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases),
if our enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence
of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit
in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The rights and responsibilities of our shareholders
will be governed by Israeli law, which may differ in some respects from the rights and responsibilities of shareholders of U.S.&#160;corporations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because we are incorporated under Israeli law,
the rights and responsibilities of our shareholders are governed by our Restated Articles and the Israeli Companies Law, with minor exceptions
pertaining to U.S. securities laws. These rights and responsibilities differ in some respects from the rights and responsibilities of
shareholders in typical U.S.&#160;corporations. In particular, pursuant to the Israeli Companies Law, each shareholder of an Israeli company
has to act in good faith in exercising such shareholder&#8217;s rights and fulfilling such shareholder&#8217;s obligations toward the
company and other shareholders and to refrain from abusing such shareholder&#8217;s power in the company, including, among other things,
in voting at the general meeting of shareholders and class meetings on amendments to a company&#8217;s articles of association, increases
in a company&#8217;s authorized share capital, mergers, and transactions requiring shareholders&#8217; approval under the Israeli Companies
Law. In addition, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine
the outcome of a shareholder vote, who has the power to appoint or prevent the appointment of a director or officer in the company, or
who has other powers toward the company, has a duty to act in fairness towards the company. Moreover, a shareholder also has a general
duty to refrain from discriminating against other shareholders. These provisions may be interpreted to impose additional obligations and
liabilities on our shareholders that are not typically imposed on shareholders of U.S.&#160;corporations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Provisions of Israeli law and our Restated
Articles may delay, prevent, or make undesirable an acquisition of all or a significant portion of our shares or assets.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of Israeli law and our Restated
Articles could have the effect of delaying or preventing a change in control, may make it more difficult for a third party to acquire
us or our shareholders to elect different individuals to our board of directors, even if doing so would be beneficial to our shareholders,
and may limit the price that investors may be willing to pay in the future for our ordinary shares. Among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Companies Law regulates acquisitions and requires that a tender offer be effected when certain thresholds of percentage ownership of voting power in a company are exceeded (subject to certain conditions);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Israeli Companies Law requires special approvals for certain transactions involving directors, officers, or significant shareholders and regulates other matters that may be relevant to these types of transactions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Israeli Companies Law does not provide for shareholder action by written consent for public companies, thereby requiring all shareholder actions to be taken at a general meeting of shareholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Restated Articles divide our directors into three classes, each of which is elected for a three-year term once every three&#160;years;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Restated Articles provide that certain articles can be amended or changed only by the majority of at least sixty percent (60%) of the total voting power of the shareholders. </span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Restated Articles do not permit a director to be removed except by a vote of a majority of the voting power of the shareholders represented at a general meeting in person or by proxy and voting thereon, as one class, and disregarding abstentions from the count of the voting power of the shareholders present and voting; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Restated Articles provide that director vacancies may be filled by our board of directors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Israeli tax considerations may make potential
transactions undesirable to us or to some of our shareholders, especially whose country of residence does not have a tax treaty with Israel
granting tax relief to such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to
the same extent as U.S.&#160;tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances but makes
the deferral contingent on the fulfillment of numerous conditions, including a restrictive period of two&#160;years from the date of the
transaction during which certain sales and dispositions of shares of the participating companies are restricted. Moreover, with respect
to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if the
shares have not been disposed of. See the section titled &#8220;<i>Material Israeli Tax Considerations&#160;&#8212;&#160;Taxation of Our
Shareholders</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has sole discretion as
to whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend upon our
future, operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, and other factors
that our directors may deem relevant. The Israeli Companies Law imposes restrictions on our ability to declare and pay dividends. See
the section titled &#8220;<i>Item 10.B Additional Information&#8212;Dividend and Liquidation Rights&#8221;</i> for additional information.
Payment of dividends may also be subject to Israeli withholding taxes. See the section titled &#8220;<i>Material Israeli Tax Considerations</i>&#8221;
for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to the Israeli Privacy Protection
Law and its regulations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the Israeli Privacy Protection
Law,&#160;5741-1981, and the regulations promulgated thereunder and guidelines issued by the Israeli Privacy Protection Authority with
respect to the manner in which personal data is processed, maintained, transferred, disclosed, accessed, and secured. In this respect,
the privacy regulations governing information security may require us to adjust certain data protection and data security practices, information
security measures, certain organizational procedures, applicable positions, and other technical and organizational measures. Failure to
comply with the Israeli privacy laws may expose us to administrative fines, civil claims (including class&#160;actions), and, in certain
cases, criminal liability. An amendment to the Israeli Privacy Protection Law, recently approved by the Israeli parliament and expected
to become effective in August 2025, increases the legal obligations of controllers and processors of personal data, and empowers the Israeli
Privacy Protection Authority&#8217;s authorities and enables it to impose administrative sanctions, including in monetary sanctions in significant
amounts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;As a foreign private issuer, under
Nasdaq rules, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly
from Nasdaq corporate governance listing standards, which, if we follow such practices, may afford our shareholders less protection than
they would enjoy if we complied with the Nasdaq corporate governance standards.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli corporation that meets the
definition of a foreign private issuer, we are generally subject to the Nasdaq corporate governance listing standards. However,
Nasdaq rules permit a foreign private issuer like us to follow the corporate governance practices of our home country, which is
Israel, in lieu of Nasdaq corporate governance requirements relating to independent directors and the formation and composition of
board committees, with respect to the disclosure of third-party director and nominee compensation and the requirement to distribute
annual and interim reports. These corporate governance practices in Israel may differ significantly from Nasdaq corporate governance
listing standards. Currently, we do not plan to rely on the home country practice exemption with respect to our corporate
governance, other than (i) the quorum requirements, (ii) the Nasdaq requirement of obtaining shareholder approval for certain
issuances of 20% or more of our ordinary shares at a price less than the market price, as defined by Nasdaq, or (iii) the Nasdaq
requirement of shareholder approval for stock option plans. Our Restated Articles provide that two shareholders holding 25% of the
voting shares constitute a quorum, as contrasted with the Nasdaq requirement of a minimum of one-third of a company&#8217;s
outstanding voting securities and, accordingly, our board has the authority to issue ordinary shares without obtaining shareholder
approval under circumstances where shareholder approval would be required under the Nasdaq corporate governance regulations. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Restated Articles do not require shareholder approval for stock issuances or for the adoption of a stock option plan. If we choose
to take advantage of other home country practices in the future, our shareholders may be afforded less protection than they
otherwise would enjoy under Nasdaq corporate governance listing standards applicable to U.S.&#160;domestic issuers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Ordinary Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The dual listing of our ordinary shares
on the Tel Aviv Stock Exchange may affect the trading dynamics of our ordinary shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares are listed on both the Nasdaq
Stock Market and the Tel Aviv Stock Exchange (&#8220;TASE&#8221;) and are subject to the rules of both exchanges. Companies traded on
both exchanges benefit from reporting exemptions under Israeli regulations governing relief to companies listed in Nasdaq. However, the
trading dynamics of dual listing can lead to price discrepancies between the two markets. These discrepancies arise from differences in
trading currencies - U.S. dollars on Nasdaq and NIS on TASE, as well as trading hours, time zones and holidays. Additionally, exchange
rate fluctuations and market activity on one exchange can influence share prices on the other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Market conditions may adversely affect the
liquidity and price of our securities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The price of our securities may fluctuate significantly.
An active trading market for our securities may not be sustained on either Nasdaq or the TASE. In addition, the price of our securities
can vary due to general economic conditions and forecasts, our general business condition, and the release of our financial reports. Additionally,
if our securities become delisted from Nasdaq and TASE and are quoted on the OTC Markets (an inter-dealer automated quotation system for
equity securities that is not a national securities exchange), the liquidity and price of our securities may be more limited than if we
were quoted or listed on the NYSE, Nasdaq, TASE or another national securities exchange, in which event you may be unable to sell your
securities unless a market can be established or sustained.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We anticipate that we will redeem our outstanding
convertible bonds</i>. </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2024, we issued convertible bonds in the
principal amount of NIS 110,000,000 to Israeli investors. These bonds, are listed for trade on the TASE. The proceeds from the sale of
bonds were placed in an escrow account, and will be released to the Company upon satisfaction of the following release conditions:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The Company wins a tender or contract to supply its products as a single supplier of chips of imaging
radar (directly or through one of the international Tier 1 manufacturers) to one of ten named major automobile manufactures.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The average closing trading price of the Company&#8217;s ordinary shares on Nasdaq is not less than $3.10
per share during 30 consecutive trading days, and the average combined trading volume on Nasdaq and TASE during such 30 trading days is
at least 300,000 shares per day.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">The closing price of the Company&#8217;s ordinary shares on Nasdaq on the date the Company presents to
the Trustee the documentation confirming the fulfillment of the abovementioned conditions precedent, is not less than $3.10.</td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above release conditions were originally to
be satisfied by March 31, 2025, but following an extension dated March 20, 2025, which was approved by the holder of a majority of the
outstanding bonds, we have until December 31, 2025 to meet the conditions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not meet the release conditions by December
31, 2025, we will be required to effect an early redemption of the remaining bonds which will result in the use of the funds in the escrow
account to pay the bonds and we will be required to pay to the Trustee such additional amounts as are required to pay the interest and
any payment due as a result of the differential in the exchange rate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any bonds are converted, the funds in the escrow
account that are associated with the converted bonds are released to us immediately. In January 2025, bonds in the principal amount of
NIS 78,462,184 were converted and approximately $22.4 million (including interest) was released to us from the escrow account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this report, we did not meet
the release conditions, and unless we meet the conditions by December 31, 2025, the remaining funds in the escrow account, together with
any interest and other payments we are required to pay to the trustee, will be used to redeem the remaining bonds other than any bonds
which may be converted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As long as the bonds are outstanding, we will
remain subject to restrictive covenants under the deed of trust, limiting our operational and financial flexibility. These include negative
pledges prohibiting floating charges or secured debt (except unsecured debt up to $2 million), issuing additional bonds unless compliant,
and certain restrictions on dividend distributions. Some of the foregoing restrictions will be terminated if the principal amount of the
outstanding bonds equal to less than NIS 10 million (approximately $2.7 million). The deed of trust also includes default provisions such
as covenant breaches, TASE delisting, and an unapproved merger, which may trigger a bondholders&#8217; meeting to consider the requirement
for an immediate repayment.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our internal controls over financial reporting
may not be effective, which could have a significant and adverse effect on our business and reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The&#160;Sarbanes-Oxley Act&#160;requires, among
other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing
to develop and refine our disclosure controls, internal control over financial reporting, and other procedures that are designed to ensure
that information required to be disclosed by us in the reports that we file with the SEC is recorded, processed, summarized, and reported
within the time periods specified in SEC rules and forms, and that information required to be disclosed in reports under the&#160;Exchange&#160;Act&#160;is
accumulated and communicated to our principal executive and financial officers. If we are not able to protect our computer system, including
our financial records and client and personnel information, against cybersecurity attacks, including ransomware attacks, we may not be
able to maintain effective disclosure controls or internal controls over financial reporting. In our financial statements for the year
ended December 31, 2024, we corrected the diluted net loss per ordinary share for the year ended December 31, 2023 and for the year ended
December 31, 2022, which resulted in a reduction in the applicable net loss per ordinary share, due to an increase in the average shares
outstanding for from the numbers shown in our financial statements that we filed as part of our Form 20-F for the year ended December
31, 2023. The adjustment in diluted earnings per ordinary share in the year ended December 31, 2023, and diluted earnings per ordinary
share in the year ended December 31, 2022 take into consideration warrant liabilities revaluations used in determining diluted loss per
ordinary share. See Note 11 of Notes to Consolidated Financial Statements.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current controls and any new controls that
we develop may become inadequate because of changes in conditions in our business. Further, weaknesses in our internal controls may be
discovered in the future. Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation
or improvement, could adversely affect our operating results, or cause us to fail to meet our reporting obligations and may result in
a restatement of our financial statements for prior periods. Any failure to implement and maintain effective internal controls could also
adversely affect the results of operations. Ineffective disclosure controls and procedures and internal control over financial reporting
could also cause investors to lose confidence in our reported financial and other information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to maintain and improve the effectiveness
of our disclosure controls and procedures and internal control over financial reporting, we have expended and are continuing to expend
significant resources, including accounting-related costs, and provide significant management oversight. Any failure to maintain the adequacy
of our internal controls, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating
costs and materially and adversely affect our ability to operate our business. In the event that our internal controls are perceived as
inadequate or that we are unable to produce timely or accurate financial statements, investors may lose confidence in our operating results,
and the stock price of our ordinary shares could decline. In addition, if we are unable to continue to meet these requirements, we may
not be able to maintain listings on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our independent registered public accounting firm
is not required to attest to the effectiveness of our internal controls over financial reporting and will not be required to attest to
such effectiveness as long as we continue to be an emerging growth company. At such time as our independent registered public accounting
firm is required to attest to the effectiveness of our internal controls, such firm may issue a report that our internal controls are
not effective if it is not satisfied with the level at which our controls are documented, designed, or operating. Any failure to maintain
effective disclosure controls and internal control over financial reporting could have a material and adverse effect on our business and
operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may issue additional ordinary shares
or other securities without shareholder approval, which would dilute existing ownership interests and may depress the market price of
our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may issue additional ordinary shares or other
securities (including convertible securities) in the future in connection with, among other things, our equity incentive plan without
shareholder approval, although we require shareholder approval for the creation of a class or series of preferred shares. Our issuance
of additional ordinary shares would have the following effects:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our existing shareholders&#8217; proportionate ownership interest may decrease;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of cash available per share, including for the payment of dividends in the future, may decrease;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The relative voting strength of each previously outstanding ordinary share may be diminished; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The market price of our ordinary shares may decline.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because our executive officers and directors
and their affiliate beneficially own or control approximately 25% of our ordinary shares, they may be able to control any action requiring
shareholder approval.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our executive officers and directors and their
affiliates beneficially own or control the voting rights with respect to approximately 25% of our ordinary shares. They will have the
power to control any action for which shareholder approval is required or sought by us, particularly since our Restated Articles provide
that a quorum for action by shareholders at a meeting called by the board of directors is two shareholders holding at least 25%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we have a classified board of directors,
it may be more difficult for a third party to obtain control of us.</i></b></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide for a classified
board of directors, with each class of directors being elected for a term of three&#160;years. As a result, the shareholders will vote
for only one-third of the board each year. A classified board of directors may make it more difficult for a third party to gain control
of us, which may affect the opportunity of our shareholders to receive any potential benefit that could be available from a third party
seeking to obtain control over us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain outstanding warrants are accounted
for as liabilities, and the changes in value of these warrants could have a material effect on our financial results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the October 2021 merger with
Industrial Tech Acquisitions Inc. (&#8220;ITAC&#8221;), we issued ordinary shares and warrants to the holders of ITAC common stock and
warrants. We treat the 3,112,080 warrants issued in exchange for ITAC&#8217;s private warrants as liabilities. E. Scott Crist, one of
our directors, holds 2,303,031 of these warrants. Other warrants that we issued prior to the merger with ITAC are also treated as liabilities.
Under GAAP, the remeasurement of the fair value of such derivatives at each balance sheet date, with a resulting non-cash gain or loss
related to the change in the fair value being recognized in earnings in the statements of operations. As a result of the recurring fair
value measurement, as long as the warrants are outstanding, our financial statements and results of operations may fluctuate quarterly
based on factors that are outside of our control. Due to the recurring fair value measurement, we will recognize non-cash gains or losses
on the private warrants each reporting period based on the change in the derivative liability, and the amount of such gains or losses
could be material. Further, the gain or loss on the derivative liability, which will not be related to our operations, could result in
our reporting a loss in a period in which our operations are profitable and net income in a period in which we have a significant loss
from operations. Since the amount of the warrant liability reflects the market price of our ordinary shares, to the extent that the market
price of our ordinary shares increases from period to period, we are likely to recognize a financial expense, and to the extent that the
market price of our ordinary shares declines from period to period, we would recognize financial income. The Pre-Funded Warrants to purchase
3,956,043 ordinary shares, the Tranche A Warrants to purchase up to 8,250,000 ordinary shares, and Tranche B Warrants to purchase 8,250,000
ordinary shares which were issued in our November 2024 financing are treated as permanent equity and not as liabilities. The Pre-Funded
Warrants, the Tranche A Warrants and the Tranche B Warrants are described in Item 12.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any projections, forecasts, or guidance
that we may issue may not be an indication of the actual results of the transaction or our future results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we issue guidance as to our
estimated results. Any such guidance is prepared based on numerous variables and assumptions that are inherently uncertain and may be
beyond our control. Furthermore, they may exclude, among other things, certain material items such as transaction-related expenses, and
they may include a non-GAAP measure. Any such forecasts are subject to the risks, including those described in these risk factors, and
should not be relied upon as an indicator of future results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sales of our ordinary shares by investors
may adversely affect the market price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all of our outstanding ordinary
shares may be publicly sold, either because they were issued pursuant to an effective registration statement or were issued more than
six months ago and may be sold to the public pursuant to Rule 144, although Rule 144 places some limitations on sales by affiliates. In
addition, ordinary shares issuable upon exercise or conversion of warrants are also saleable either because the underlying shares were
registered under the Securities Act and may be sold pursuant to Rule 144, In addition, we may raise funds through the issuance of ordinary
shares and convertible debt securities. The sale or anticipated sales of such ordinary shares or convertible debt securities may adversely
affect the market price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market price of our ordinary shares
has been and may be volatile and subject to wide fluctuations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading price of our ordinary shares has been
and could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the
factors listed below could have a material adverse effect on your investment in our securities, and our securities may trade at prices
significantly below the price you paid for them. In such circumstances, the trading price of our securities may not recover and may experience
a further decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors affecting the trading price of our securities
may include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to them;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the market&#8217;s expectations about our operating results or about the market introduction of vehicles that use our technology;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">public sales by us of our stock in negotiated transactions at a discount from the market price to investors who may immediately sell the shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">success of competitors;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the market&#8217;s attitude toward Israel and Israeli technology companies;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our operating results failing to meet the expectations of securities analysts or investors in a particular period;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in financial estimates and recommendations by securities analysts concerning us or the market or potential market for driverless cars and other vehicles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating and share price performance of other companies that investors deem comparable to us;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the market&#8217;s perception of our ability to develop and market our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the market&#8217;s perception as to our ability to develop and maintain any perceived technological advantage it may have;</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions by social media users to seek to increase activity in our securities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes or anticipated changes in laws and regulations affecting our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to meet compliance requirements, including compliance with the Nasdaq continued listing requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement of, or involvement in, litigation involving us or the automotive industry in general;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the volume of our ordinary shares available for public sale;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in trading patterns resulting from social media action not related to the results of our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the effect of our ordinary shares being dual listed
    on Nasdaq and the TASE;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any major change in our board or management;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales of substantial amounts of our ordinary shares by our directors, executive officers, or significant shareholders, or the perception that such sales could occur;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic and political conditions such as recessions, interest rates, international currency fluctuations, and acts of war or terrorism; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of the risks described in these Risk Factors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broad market and industry factors may materially
harm the market price of our securities, irrespective of our operating performance. Global stock markets in general including both the
Nasdaq and the TASE, have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating
performance of the particular companies affected. The trading prices and valuations of these stocks and our securities are not predictable.
A loss of investor confidence in the market for retail stocks or the stocks of other companies that investors perceive to be similar to
us could depress our share price regardless of our business, prospects, financial conditions, or results of operations. Moreover, since
our ordinary shares are traded on both Nasdaq and TASE in different currencies and time zones, price discrepancies between the two markets
may occur due to factors such as exchange rate fluctuations, variations in liquidity, or differing investor sentiment in each market.
A decline in the market price of our securities could also adversely affect our ability to issue additional securities and our ability
to obtain additional financing in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Articles and Israeli law could prevent
a takeover that shareholders could consider favorable and could also reduce the market price of our ordinary shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of Israeli law and our Restated
Articles could have the effect of delaying or preventing a change in control and may make it more difficult for a third party to acquire
us or for our shareholders to elect different individuals to our board of directors, even if doing so would be beneficial to our shareholders,
and may limit the price that investors may be willing to pay in the future for our ordinary shares. For example, Israeli corporate law
regulates mergers, requires that a tender offer be effected when certain thresholds of percentage ownership of voting power in a company
are exceeded (subject to certain conditions), and establishes a high ownership threshold to squeeze out minority shareholders in a full
tender offer. Further, Israeli tax considerations may make potential transactions undesirable to us or to some of our shareholders, especially
whose country of residence does not have a tax treaty with Israel granting tax relief to such shareholders from Israeli tax. See the section
titled &#8220;<i>Material Israeli Tax Considerations&#160;&#8212;&#160;Taxation of Our Shareholders</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not intend to pay dividends in
the foreseeable future. Accordingly, you may not receive any return on investment unless you sell your ordinary shares for a price
greater than the price you paid for your ordinary shares or, if you purchased ITAC common stock prior to the Merger with ITAC, the
price you paid for your ITAC common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently intend to retain all available funds
and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our ordinary shares in
the foreseeable future. Consequently, you may be unable to realize a gain on your investment only if you are able to sell such shares
at a price that is greater than your purchase price, which may never occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has broad discretion about
whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend upon our future,
operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, and other factors that
our directors may deem relevant. The Companies Law imposes restrictions on our ability to declare and pay dividends.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry analysts do not
publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding
our ordinary shares adversely, then the price and trading volume of our ordinary shares could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading market for our ordinary shares is
influenced by the research and reports that industry or financial analysts publish about us or our business. We do not control these analysts
or the content and opinions included in their reports. As a young public company, we may be slow to attract research coverage, and the
analysts who publish information about our ordinary shares may have had relatively little experience with us, which could affect their
ability to accurately forecast our results and make it more likely that we fail to meet their estimates. If any of the analysts who cover
us issue an inaccurate or unfavorable opinion regarding it, our share price will likely decline. In addition, the share prices of many
companies in the technology industry have declined significantly after those companies failed to either meet or significantly exceed,
the financial guidance publicly announced by the companies or the expectations of analysts. If our financial results fail to meet or significantly
exceed, our announced guidance or the expectations of analysts or public investors, analysts could downgrade our ordinary shares or publish
unfavorable research about it. If one or more of these analysts cease coverage of us or fail to publish reports on it regularly, our visibility
in the financial markets could decrease, which in turn could cause our share price or trading volume to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The IRS may not agree that we should be
treated as a non-U.S.&#160;corporation for U.S.&#160;federal income tax purposes.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we are incorporated and tax residents
in Israel, the IRS may assert that we should be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax purposes pursuant
to Section&#160;7874 of the Code. For U.S.&#160;federal income tax purposes, a corporation is generally considered a U.S.&#160;&#8220;domestic&#8221;
corporation if it is created or organized in or under the laws of the U.S., any state thereof, or the District of Columbia. Because we
are not so created or organized (but are instead incorporated only in Israel), we would generally be classified as a foreign corporation
(that is, a corporation other than a U.S.&#160;&#8220;domestic&#8221; corporation) under these rules. Section&#160;7874 of the Code provides
an exception under which a corporation created or organized under foreign law may, in certain circumstances, be treated as a U.S.&#160;corporation
for U.S.&#160;federal income tax purposes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As more fully described in Item 10.E in the section
titled &#8220;<i>Certain Material U.S.&#160;Federal Income Tax Considerations&#160;&#8212;&#160;U.S.&#160;Federal Income Tax Treatment&#8212;&#160;Tax
Residence of Arbe for U.S.&#160;Federal Income Tax Purposes</i>,&#8221; based on the terms of the Merger, the rules for determining share
ownership under Code Section&#160;7874, and the Treasury regulations promulgated under Code Section&#160;7874 (the &#8220;Section&#160;7874
Regulations&#8221;), and certain factual assumptions, we are not currently expected to be treated as a U.S.&#160;corporation for U.S.&#160;federal
income tax purposes under Code Section&#160;7874. However, the application of Section&#160;7874 of the Code is complex, is subject to
detailed regulations (the application of which is uncertain in various respects and would be impacted by changes in such U.S.&#160;tax
laws and regulations with possible retroactive effect) and is subject to certain factual uncertainties. Accordingly, there can be no assurance
that the IRS will not challenge our status as a foreign corporation under Code Section&#160;7874 or that such a challenge would not be
sustained by a court.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the IRS were to successfully challenge under
Code Section&#160;7874 our status as a foreign corporation for U.S.&#160;federal income tax purposes, we and certain of our shareholders
could be subject to significant adverse tax consequences, including a higher effective corporate income tax rate on us and future withholding
taxes on certain of our shareholders, depending on the application of any income tax treaty that might apply to reduce such withholding
taxes. In particular, holders of our ordinary shares and/or warrants would be treated as holders of stock and warrants of a U.S.&#160;corporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Item 10.E, &#8220;<i>Certain Material U.S.&#160;Federal
Income Tax Considerations&#160;&#8212;&#160;U.S.&#160;Federal Income Tax Treatment of Arbe&#160;&#8212;&#160;Tax Residence of Arbe for
U.S.&#160;Federal Income Tax Purposes,</i>&#8221; for a more detailed discussion of the application of Code Section&#160;7874 to the Merger.
Investors should consult their own advisors regarding the application of Code Section&#160;7874 to the Merger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>U.S.&#160;Holders of our ordinary shares
and/or warrants may suffer adverse tax consequences if we are treated as a passive foreign investment company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A non-U.S.&#160;corporation generally will be
treated as a &#8220;passive foreign investment company,&#8221; or a PFIC, for U.S.&#160;federal income tax purposes, in any taxable year
if either (1)&#160;at least 75% of its gross income for such year is passive income (such as interest, dividends, rents, and royalties
(other than rents or royalties derived from the active conduct of a trade or business) and gains from the disposition of assets giving
rise to passive income) or (2)&#160;at least 50% of the value of its assets (based on an average of the quarterly values of the assets)
during such year is attributable to assets that produce or are held for the production of passive income. Although based on the current
and anticipated composition of the income, assets, and operations of us and our subsidiaries, we do not believe we will be treated as
a PFIC for U.S.&#160;federal income tax purposes for its current taxable year and do not expect to become one for U.S.&#160;federal income
tax purposes in the near future. This is a factual determination that depends on, among other things, the composition of our income and
assets and the market value of its shares and assets, including the composition of income and assets and the market value of shares and
assets of our subsidiaries, from time to time. Accordingly, a complete determination can only be made annually after the close of each
taxable year. Thus, no assurance can be given as to whether we will be a PFIC in 2025 or for any future taxable year. In addition, our
U.S.&#160;counsel does not express any opinion with respect to our PFIC status for 2025 or future taxable&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are a PFIC for any taxable year, a U.S.&#160;Holder
of our ordinary shares and/or warrants may be subject to adverse tax consequences and may incur certain information reporting obligations.
Under the PFIC rules, unless such U.S.&#160;Holder makes an election available under the Code (which election could itself have adverse
consequences for such U.S.&#160;Holder), such U.S.&#160;Holder may be subject to U.S.&#160;federal income tax at the then prevailing maximum
rates on ordinary income and possibly an &#8220;interest&#8221; charge, in respect of &#8220;excess distributions&#8221; and upon any
gain from the disposition of our ordinary shares and/or warrants, as if the excess distribution or gain had been recognized ratably over
such U.S.&#160;Holder&#8217;s holding period of our ordinary shares and/or warrants. Certain elections, including a qualified electing
fund election (a QEF election or a mark-to-market election, that may be available to U.S.&#160;Holders of our ordinary shares to mitigate
some of the adverse tax consequences resulting from PFIC treatment, however, are not available with respect to our warrants. Additionally,
there can be no assurance that we will have timely knowledge of our status as a PFIC in the future or that we will timely provide information
that would be required in order for a U.S.&#160;Holder to make a QEF election. For a further discussion, see Item 10.E, &#8220;<i>Certain
Material U.S.&#160;Federal Income Tax Considerations&#160;&#8212;&#160;U.S.&#160;Holders&#160;&#8212;&#160;U.S.&#160;Federal Income Tax
Consequences of the Ownership and Disposition of ordinary shares and Warrants to U.S.&#160;Holders&#160;&#8212;&#160;Passive Foreign Investment
Company Rules</i>.&#8221; U.S.&#160;Holders of our ordinary shares and/or warrants are strongly encouraged to consult their own advisors
regarding the potential application of these rules to us and the ownership of our ordinary shares and/or warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 4. INFORMATION ON THE COMPANY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. History and Development of the Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Organization</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our corporate name is Arbe Robotics Ltd. We are
an Israeli corporation founded on November&#160;4, 2015. The mailing address for our principal executive office is 107 HaHashmonaim St.
Tel Aviv-Yafo, Israel. Our telephone number is +972-73-7969804, ext. 200.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli corporation, we are organized pursuant
to and subject to the provisions of the Israeli Companies Law, 5759-1999, as amended and the regulations promulgated thereunder (collectively
the &#8220;Israeli Companies Law&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have two wholly-owned subsidiaries, one in
the United States -- Arbe Robotics US Inc., a Delaware corporation, and one, Shanghai Arbe Technologies Co., Ltd., organized under the
laws of the People&#8217;s Republic of China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Status as a Foreign Private Issuer under
the Exchange&#160;Act</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a &#8220;foreign private issuer&#8221;
under SEC rules. Consequently, for so long as we continue to meet such qualification, we will be subject to the reporting requirements
under the Exchange&#160;Act applicable to foreign private issuers. We are required to file our annual report for each year with the SEC
by April 30 of the following year. In addition, we will furnish reports on Form&#160;6-K&#160;to the SEC regarding certain information
that is distributed or required to be distributed by us to our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on such foreign private issuer status, under
existing rules and regulations, we will not be required to file periodic reports and financial statements with the SEC as frequently or
as promptly as a U.S.&#160;company whose securities are registered under the Exchange&#160;Act. We will also not be required to comply
with Regulation&#160;FD, which addresses certain restrictions on the selective disclosure of material information. In addition, among
other matters, our officers, directors and principal shareholders are exempt from the reporting and &#8220;short-swing&#8221; profit recovery
provisions of Section&#160;16 of the Exchange&#160;Act and the rules under the Exchange&#160;Act with respect to their purchases and sales
of ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Despite our exemption due to our foreign private
issuer status, we nevertheless currently expect to issue interim quarterly financial information publicly and to furnish it to the SEC
on Form&#160;6-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Status as an Emerging Growth Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company,&#8221;
as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the JOBS Act. As such, we will be eligible to take advantage
of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth
companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley&#160;Act, reduced disclosure obligations regarding executive compensation in their periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding&#160;advisory vote on executive compensation and shareholder approval of
any golden parachute payments not previously approved. As long as we remain an emerging growth company we will be exempt from the auditor
attestation requirement. If some investors find our securities less attractive as a result, there may be a less active trading market
for our securities and the prices of our securities may be more volatile.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section&#160;102(b)(1)&#160;of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that
a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging&#160;growth
companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means
that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth
company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of our financial statements with certain other public companies difficult or impossible because of the potential differences in accounting
standards used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain an emerging growth company until
the earlier of: (i)&#160;the last&#160;day of the fiscal year (a)&#160;following the fifth anniversary of the closing of our initial public
offering, (b)&#160;in which our total annual gross revenue of at least $1.235&#160;billion, or (c)&#160;in which we are deemed to be a
large accelerated filer, which means the market value of our ordinary shares that is held by non-affiliates&#160;exceeds $700&#160;million
as of the last business&#160;day of our most recently completed second fiscal quarter; and (ii)&#160;the date on which we have issued
more than $1.00&#160;billion in non-convertible&#160;debt securities during the prior three-year&#160;period. References to &#8220;emerging
growth company&#8221; in this proxy statement/annual report have the meaning associated with that term in the JOBS Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Functional and Reporting Currency</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A substantial portion of our activity, including
transactions with customers, as well as equity transactions and cash investments, are incurred in U.S.&#160;dollars. Our management believes
that the U.S.&#160;dollar is the currency of the primary economic environment in which we operate. Thus, our functional and reporting
currency is the U.S.&#160;dollar.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Where to get Additional Information</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC maintains an Internet site that contains
reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. We are subject
to the information requirements of the Exchange Act and will file annual and other reports, including this annual report, and other information
with the SEC. You can read our SEC filings, over the Internet at the SEC&#8217;s website at www.sec.gov. These documents, and other information
concerning us, is available on our website at https://arberobotics.com/. Information contained on, or that can be accessed through, our
website or any other website is expressly not incorporated by reference into and is not a part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Business Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a provider of 4D imaging radar solutions,
and we are leading a radar revolution, enabling safe driver-assist systems today while paving the way for fully autonomous driving in
the future. We are a Tier 2 supplier, empowering Tier-1 companies, which are companies that supply parts or systems directly to OEMs (car
manufacturers), autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with next-generation
sensing based on our proprietary chipset and perception algorithms. While the role of automotive radars in the traditional perception
paradigm was limited to &#8220;legacy ADAS features&#8221;, such as Adaptive Cruise Control (ACC) and Automatic Emergency Braking (AEB),
the introduction of our imaging radar with its a high channel count delivers an order of magnitude better native resolution than existing
radar solutions profoundly changes this paradigm, making the radar a key player in the overall driving solution including hands-free and
eyes-off features. We believe that our imaging radar is essential for Level 2+ and higher levels of autonomy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide long-range high resolution in 4D -
the distance, the angular measurement of objects, both horizontally and vertically, and their relative speed. This is designed to enable
the vehicle to determine the exact location and shape of objects. For example, it could determine whether a stationary object in front
of a vehicle is a manhole cover you can drive over or a guardrail you need to avoid. Our 4D imaging radar is the world&#8217;s first radar
to separate, track and identify objects in any weather or lighting condition using a 2K virtual channel array. Radar resolution without
false alarm (&#8220;grating lobes&#8221;) is determined by the number of channels, much like camera resolution is defined by pixels. Traditional
automotive radars offered in the range of 16 channels, and advanced radars reach approximately 200 channels. We have made a groundbreaking
leap, delivering a 2,304-channel array, which we believe is ten more channels than leading alternatives, thereby-providing unparalleled
resolution and performance, with ultra-high resolution in both azimuth and elevation, delivering an image that we believe is 100 times
more detailed than any commercial radar presently on the market. We achieve this capability with our proprietary RF chipset and a groundbreaking
radar processor chip, the first dedicated processor designed specifically for the performance and power saving requirements of the automotive
industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through our state-of-the-art analysis of the vehicle&#8217;s
surroundings, we believe that our cutting-edge radar chipset incorporates the first radar technology detailed enough to enhance the OEM&#8217;s
perception algorithms, elevating L2+ and higher applications from nice-to-have comfort solutions to must-have safety features. The data
captured by our perception radar, based on our chipset technology, has the fidelity, richness and resolution to support artificial intelligence
algorithms that identify, classify and track objects to create a full free space map ahead of the vehicle based on radar data only, as
well as an analysis of the evolving hazards sensed by the radars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Radar Systems</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are developing advanced radar solutions, which
are mainly intended to be used in Advanced Driver Assistance Systems (&#8220;ADAS&#8221;) and autonomous vehicles&#8217; (&#8220;AV&#8221;)
sensor suites as well as a wide array of safety applications with advanced sensing and paradigm changing perception.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The target market for our chipsets is automotive
module manufacturers called Tier 1 automotive suppliers, the target market for radars systems developed by the Tier 1 supplier based on
our chipset are car makers - automotive manufacturers (OEMs) worldwide, although we are also marketing to the manufacturers. Additionally,
alongside these potential customers, there is a large target market for traffic monitoring, robotized vehicles and transportation applications
such as last-mile delivery robots, robot taxis and shuttles, heavy machinery, trucks, construction, busses and trains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our chipset solution includes three types of
chips: transmitter (Tx), receiver (Rx) and processor, which together are referred to as our &#8220;radar chipset&#8221; or the
&#8220;chipset.&#8221; We believe our radar chipset solution is a first of its kind, capable of high-resolution sensing &#8220;in
four dimensions&#8221; generating tens of thousands of detections per frame with a point cloud density that we believe is
unparalleled by any other radar solution on the market. The chipset distinguishes itself through its improved ability to support
multi-channel processing&#160;-&#160;up to 2,304 virtual channels, through a combination of up to two transmitters (24 channels
each) and up to four receivers (12 channels each). By comparison, other current-generation radar systems presently utilize 12
virtual channels, while the newest, best in class systems available in the market by our competitors are utilizing 256 virtual
channels at best, although other companies are working on the development of improvements in their products and might have systems
with higher capacity under development.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our solution addresses the core issues that have
caused the recent autonomous vehicle and autopilot accidents such as detection of stationary objects, identifying vulnerable road users,
operation at poor lighting conditions and eliminating false alarms at low latency with no range, Doppler, and angular ambiguities. Unlike
the vast majority of the radars on the market, our radar technology is designed to address all driving scenarios and use cases, which
we believe makes it a mandatory technology for any vehicles program targeting ADAS features (L2), supervised autonomous driving features
(L2+) and up to unsupervised autonomous driving (L3 &amp; L4). However, while our system can identify the object, the vehicle&#8217;s
computer systems determine how the vehicle will respond to this information provided by our system.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a Tier-2 semiconductor company, developing
advanced radar technology and solutions &#8211; multi-channel Radio Frequency Integrated Circuit (RF IC) for transmission and reception
and a dedicated radar processing IC that includes specialized Radar Processing Unit (&#8216;RPU&#8217;) and additional general-purpose
processing/control cores. We do not have our own manufacturing facilities. We rely on GlobalFoundries for manufacturing our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on our advanced technology, our radar chipset
solution is capable of sensing the vehicle environment, at long ranges and with a wide field of view, at a rate of up to 30 frames per
second, allowing it to generate a reliable ultra-high-definition image, under all weather and lighting conditions, with great precision,
while minimizing the likelihood of false alarms. Information about the environment is &#8217;sensed&#8217; by the Tx and Rx elements of
the chipset, at the 77 &#8211; 81 GHz RF band. The data is then processed at the Radar Processor, by an advanced proprietary algorithms
into a 4D image&#160;&#8212;&#160;range, radial (on line-of-sight) velocity, azimuth and elevation&#160;&#8212;&#160;at ultra-high resolution
with high fidelity and low latency, which is an input to the perception algorithm, sensor fusion and to the vehicle control, to allow
emergency braking in any conditions, to enable safe adaptive cruise control, lane-change assist, and up to advanced automated and autonomous
driving features, scaling up with the industry&#8217;s evolution toward hands-free, eyes-off and full autonomous driving.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We designed two radar development platforms:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Phoenix Perception Radar, with its 2K ultra-high resolution, enables what we believe is an unmatched level of safety, and enriches perception algorithms for advanced capabilities including Free Space Mapping, object tracking, and Simultaneous Localization and Mapping (SLAM) at a cost that we believe is comparable in cost, size, power and heat with currently available radars that provide fewer than 200 channels. No matter the speed, elevation, range, or surrounding weather and lighting conditions, Phoenix differentiates true threats from false alarms to provide a safe road ahead for drivers, pedestrians and other vulnerable road users. We believe it is the industry&#8217;s first perception radar.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed primarily for corner and back installation, Lynx &#8211; (4D imaging Radar) complements Phoenix Perception Radar to deliver a 360&#176; view around the vehicle. Lynx offers a full set of benefits at what we believe is an affordable price &#8211; true long-range performance, high resolution, small form factor and a very wide field of view. We believe that it effortlessly outperforms the current industry 3X4 corner radars and even the leading 12*16 long-range radars on the market, providing perception and superior imaging that are critical for safe autonomous driving.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this annual report, we are working
with four Tier-1s &#8211; Magna, Hirain, Weifu and Sensrad &#8211; which are currently developing a total of seven different radar products
based on our chipset. Radars that are based on our chipset were submitted by the Tier 1s pursuant to eleven RFIs/RFQs that are currently
active with OEMs, robotaxis, delivery robots, and autonomous trucks projects as well as other fields like traffic infrastructure. We have
been selected for eight &#8220;imaging radar - based perception&#8221; projects, two of which are with the top five global OEMs which
are progressing towards a selection in 2025 and 2026. These selection dates reflect a delay from the earlier target of 2024. As of the
first quarter of 2025, one of these OEMs has advanced our project to a worldwide data collection stage which is launching this year with
radars that are based on our chipset for which we anticipate further feedback at the end of second quarter of 2025 or beginning of the
third quarter of 2025. Our solution was also selected to provide perception radars for autonomous trucks and automated guided vehicles,
known as AGVs, across ports in China. Our solution is constantly evaluated in field trials, including&#160;day and night performance,
in variable weather and lighting conditions. The trials, thus far, have revealed what we believe is superior and promising performance:
Our radar chipset solution senses its environment according to its spec, with the highest native resolution available in the market, while
maintaining low false alarm rate in each frame and therefore enables an accurate and separate identification of all objects in the environment
at their actual position, and it distinguishes between vehicles, vulnerable road users (pedestrians, animals, cyclists, motorcyclists)
and objects and obstacles along the way. Based on the sensing of the environment created by the chipset at any given moment, the radar
system can alert the vehicle central computer unit, allowing the driver assistance system to take control of the car, and activate safety
applications such as emergency braking and lane control assist, or to activate autonomous control functions to avoid the danger.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our radar chipset solution is designed to
integrate into the radar systems of next-generation ADAS in autonomous vehicles of all levels of autonomous driving, thanks in part
to its ability to accurately scan an increased range of detection (of 350 meters) in a wide field of view, while optimizing costs
and power-consumption, without its functionality being impaired by interference from other radar systems in the environment. The
system maintains efficacy under conditions of low signal-to-noise ratio (&#8220;SNR&#8221;) and in multi-object scenarios
(conditions under which alternative technologies struggle to provide effective solutions)&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
both in respect of false positives (error category&#160;I) and false negatives (error category&#160;II).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our chipset solves some of the
challenges faced by current-generation radar systems, by providing a system that enables:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased resolution and improved capability to differentiate between adjacent objects;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhanced detection of stationary objects;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generation of a high-resolution radar image of all the objects in the scene;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with the European NCAP and the NHTSA standards for installation in Level 2 and higher autonomous vehicles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduction of false alarms;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ability to process the huge volumes of data generated when imaging the environment in four dimensions, at high update rate in real-time;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reducing mutual interference between radars that operate in the environment simultaneously;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reduced energy consumption; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain competitive retail radar costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our technology is the first to create
a high-fidelity, high-resolution radar image, that facilitates tracking, and SLAM and real-time decision-making. Our radar chipset heralds
a breakthrough in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution
that meets the current safety requirements of Euro-NCAP and NHTSA for autonomous vehicles at all levels of autonomous driving.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although our radar systems can identify images,
each auto maker has its own computer system that instructs the vehicle how to respond to the images identified by our radar. If the computer
system does not address the response to the image generated, the automobile may not operate as planned.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart shows the number of radar
sensors, cameras and LiDAR units in vehicles with different levels of autonomy. As the level of autonomy increases, the number of radar
sensors and cameras increases. LiDAR units are not expected to be included in any vehicle with an autonomy level less than 3. The number
of radar sensors is a function of the autonomy level of the vehicle.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recognizing the different levels of innovation
and autonomy and the need to standardize the approaches across the spectrum of possibilities for the sake of safety, the Society of Automotive
Engineers (SAE) has developed and defined six levels of automation for autonomous vehicles: Level 0 through Level 5. These levels have
been adopted by the U.S.&#160;Department of Transportation. These levels are:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 0 &#8212;&#160;No Automation: A
vehicle that is fully controlled by a driver.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 1 &#8212;&#160;Driver Assistance:
A vehicle controlled by the driver, featuring minimal autonomous control components, designed to assist the driver. For example: a button
that when pressed, keeps the vehicle at a constant speed, parking assistance or staying inside a lane.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 2 &#8212;&#160;Partial
Automation: A vehicle that includes integrated automation systems, where the driver is still required to control and monitor the
environment at all times. For example: A system capable of detecting lanes and driving independently (cruise control) but alerts the
driver to emergencies (driver involvement is required to operate the steering wheel and brakes). The industry refers to a level that
was not originally recognized by the SAE, Level 2+, which adds in surround perception and AI to improve the safety and convenience
of human-driven vehicles. While the driver is still responsible for the car, the platform can perform automated maneuvers for a more
seamless driving experience&#160;&#8212;&#160;such as making highway entrances and exits, lane changes and merges.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 3 &#8212;&#160;Conditional Automation:
Requires the presence of a driver behind the wheel, but the driver is not required to monitor the environment. The driver must be prepared
to seize control of the vehicle at any given time upon receipt of an alert. For example: The driver can press the control button and be
relieved of the need to monitor the route (and can attend to other matters during this time), but the driver&#8217;s presence and alertness
are still essential. At this level, the vehicle can be used as an autonomous vehicle only when road and weather conditions allow it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 4 &#8212;&#160;High Automation:
The vehicle is capable of performing all driving functions under certain conditions. The driver has the option of taking over control
of the vehicle.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">Level 5 &#8212;&#160;Full Automation:
The vehicle is capable of performing all driving functions under all conditions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pictured below is our Production Intent System
(&#8220;B Sample&#8221; in automotive terminology), and below the picture is an infographic of the specifications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;<img alt="" src="image_002.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><img alt="" src="image_003.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We believe that the dimensions of radar systems based on our radar
chipset, and the projected affordable price point are expected to facilitate its integration into mass production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate that we will be able to offer our
radar chipset solution in commercial quantities in 2026; however, such schedule is based on our completing the chipset development and
making our product suitable as a commercial product and obtaining orders for commercial quantities of our chipset, which will be affected
by the timing of manufacturers introducing vehicles with the ADAS features that require our technology. We can give no assurance that
we will be able to sell the radar chipset solution in commercial quantities or that our manufacturer will have the facilities available
to manufacture the chipsets in such quantities.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Outlook</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The automotive industry is increasingly harnessing
sophisticated technologies in its aim to develop and enhance safety and introduce autonomous driving vehicles. Today, the leading technologies
are based primarily on cameras, high resolution radar sensors, and in some cases Lidar sensors, combined with data processing based on
complex algorithms. The various technologies differ from each other in their features and performance in different conditions and scenarios.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant investment and rapid growth in this
industry are being driven by the need to increase road safety. Given the stakes involved in commercializing autonomous driving features,
the technologies and products needed for truly safe driver assist solutions require long development and validation cycles and must ensure
safety prior to commercial deployment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the last decade, the world&#8217;s leading
car manufacturers have begun to incorporate advanced automation systems in vehicles, aiming to assist the driver and even control certain
driving functions. The vision for the future is that within several&#160;years, the technology will transition from enabling autonomous
vehicle capabilities to the production of driverless vehicles, including development of unmanned shuttle services (robotaxis) that would
complement traditional public transport services. The vision of a fully autonomous vehicle (driverless) is seen as a potential solution
for reducing the number of traffic accidents (due to the elimination of the &#8220;human element&#8221; from the equation), and as an
incentive to create innovative autonomous vehicle-sharing services that will lead to the public foregoing the purchase of private vehicles,
to reduce the problem of traffic congestion, and to potentially significantly reduce fuel consumption and air pollution. However, as automobiles
become more autonomous, government regulatory authorities may increase regulations to address concerns about driverless vehicles, particularly
on city streets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another significant area of development is the
increasing integration of advanced sensor systems and artificial intelligence (AI) technologies. Market projections by Global Market
Insights<sup>1</sup> indicate substantial growth in automotive AI software, reaching an estimated $200 billion by 2032, with particular
emphasis on enhanced safety features and autonomous capabilities. The convergence of high-resolution radar systems with AI-driven decision-making
algorithms is anticipated to be a critical factor in achieving regulatory safety standards for autonomous vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">1</td><td style="text-align: justify">https://www.gminsights.com/industry-analysis/artificial-intelligence-ai-in-automotive-market</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to a forecast by Goldman Sachs Research,
growth is expected in sales volumes of Level 2 and Level 2+ automated vehicles, reaching approximately 30% of new car sales by 2027. Sales
of Level 3 and Level 4 vehicles are also expected to grow, reaching approximately 10% and 2.5% of new car sales, respectively, by 2030.
These levels of automation offer increasing degrees of driver assistance, with Level 3 allowing drivers to take their eyes off the road
and hands off the wheel in select situations. By 2040, AV adoption is expected to be highest in China (~90% of sales), followed by Europe
(~80%), and then the US (~65%).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_004.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* Source: Goldman Sachs Research, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advanced Driver Assistance Systems (ADAS) include
advanced automation functions (based on camera and radar) designed to reduce the risk of traffic accidents, alert the driver to obstacles
on the road, and even take control of the vehicle under certain conditions. The ADAS category includes the following systems, among others:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Distance maintenance system</span>&#160;-&#160;designed to warn of a collision with a vehicle ahead or behind, by alerting the driver of imminent danger and flagging the need to take preventive action. This type of system may be an effective tool to compensate for the driver&#8217;s lack of concentration or distraction while driving.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;<span style="text-decoration:underline">Lane departure control system</span>&#160;&#8212;&#160;designed to alert the driver when veering off a lane without signaling.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Autonomous braking system</span>&#160;&#8212;&#160;designed to operate the brake system autonomously, or increase their power when identifying risk of harm to road users (pedestrians, cyclists, vehicles, etc.).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, automakers have been installing
ADAS such as those mentioned above as standard features in many vehicle models, and these systems have also been installed electively
by vehicle owners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alongside development and production of current-generation
ADAS, there has been accelerated development of advanced technology for next-generation systems, designed to support autonomous driving,
in preparation for manufacture of Level 2+ and higher autonomy. The currently deployed radar technology holds a central position in the
ADAS category. This type of technology is installed in adaptive cruise control (ACC) systems, blind spot detection (BSD) systems, forward
collision warning (FCW) systems, and intelligent park assist systems, among others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In many cases, automakers choose to integrate
ADAS based on several technologies simultaneously (radar and cameras). We believe that it is likely that as the technology advances, this
trend of sensor fusion, or integrating multiple technologies into vehicles and collectively taking inputs from each, will increase and
further strengthen detection certainty for L2+ and beyond. In fact, Transparency Market Research indicates that the sensor fusion market
is expected to expand from $3.9M in 2023 to $4B by 2034, advancing at a CAGR of 23.7%, and advanced radar detailed enough to support sensor
fusion will likely continue to play a core role.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to MarketsandMarkets,<sup>2</sup> the
automotive radar market is expected to experience significant growth, from $6.6B today to $33B by 2030, registering a CAGR of 31.1% IDTechEx
Research<sup>3</sup> suggests that this growth will be driven by both increasing adoption of side radars for features like blind spot
detection in Level 1 and 2 vehicles, as well as the growing demand for more sophisticated radar systems in Level 2+, 3, and 4 autonomous
vehicles. Growth in radar systems for higher levels of automation is also anticipated, as these systems require more advanced sensing
capabilities. However, these developments are dependent upon the timing of the automobile manufacturers decision to introduce vehicles
with ADAS features.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Growth Strategies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our growth strategies include the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Extending engagements with OEMs and driving stack providers:</i> While we keep focus on the well-established production path with our Tier 1 customers, we are extending our focus to better fit the age-of-autonomy: Working directly with OEM&#8217;s feature owners, perception teams and driving stack providers (NVIDIA and others) to enhance the mutual understanding for the need for an imaging radar and how it is to be used for advanced ADAS and higher level of autonomy. We plan to extend the work through collaborative field tests, radar datasets, radar and waveform design, perception and fusion early integrations with perception radars, feature benchmarking and development of innovative algorithms that maximizes the benefits of such a radar to these partners, providing them with what we believe is an invaluable competitive edge.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalize on The L2++/L3 becoming the new competition frontier: </i>The ADAS/L2 features are becoming commoditized across OEMs and as such, becoming also extremely cost-sensitive. We will continue to extend our focus of the more advanced L2+ (supervised) and L3/L4 (unsupervised) features, which are becoming the leading, competitive features of all key OEMs. These features require advanced systems, and specifically, imaging radar, for automatically integrating vehicles in traffic, preventing traffic accidents and eventually bring hands-off and potentially eyes-off driving features to the masses. Such features are expected to dramatically increase the demand for products in our field of activity, to achieve the required level of performance and safety.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalize on regulatory changes. </i>We believe that our existing infrastructure positions us well to capitalize on regulatory changes pertaining to required installation of active traffic accident prevention systems in general, and radar systems in particular, which is expected to increase the demand for the technology and products that we are developing.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>https://www.electronicproducts.com/automotive-radar-and-lidar-sensors-one-masterpiece-and-another-in-the-making/#</i></span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><sup>3</sup></td><td style="text-align: justify">https://www.electricvehiclesresearch.com/articles/32433/three-key-takeaways-from-idtechexs-new-automotive-radar-market-report3</td>
</tr></table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Expand Product Applications. </i>Our activities are presently mainly focused on chipsets for vehicle radars systems. However, the technology developed by us (originally intended to facilitate drone monitoring and control) may also be used for other non-automotive target markets (to be understood in this context to mean all markets that are not mass-produced cars) which we are approaching, such as autonomous ground vehicles, robots; agricultural tools; automation for industry and factories; intelligent traffic systems; train junctions; heavy transportation and heavy machinery. In the future, we intend to consider developing new products based on its technology such as consumer electronics and Internet of Things (IoT); biotech and medical fields.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sales and Marketing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In light of the ability of technological systems
to reduce the risk of traffic accidents, authorities, organizations and governments around the world have established regulations that
require the installation of ADAS in certain vehicles and operation of autonomous driving features. For instance, in 2024 the U.S. Department
of Transportation&#8217;s National Highway Traffic Safety Administration (NHTSA) has officially established a Federal Motor Vehicle Safety
Standard mandating the inclusion of automatic emergency braking (AEB), encompassing pedestrian AEB, as a default feature in all passenger
cars and light trucks by September 2029. This safety measure is poised to notably diminish rear-end collisions and incidents involving
pedestrians. AEB systems utilize sensors to identify proximity to potential collisions with vehicles or pedestrians ahead and autonomously
engage the brakes in the absence of driver intervention. Pedestrian AEB technology will be functional both during daylight and in low-light
conditions, thereby significantly curbing injuries, property damage, and the associated expenses resulting from such accidents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The European New Car Assessment Program, otherwise
referred to as NCAP, rates vehicles by safety features. The rating system has been successful at influencing consumers to make vehicle
purchases based on how high the NCAP rating is, making safety a priority for consumers. The mission of NCAP is &#8220;Vision Zero&#8221;
to eventually have zero accidents or fatalities on the road, with this vision, automotive technology companies and automakers are looking
for technologies that will enable them to develop more safety features that can predict and prevent car accidents before they happen.
Vision Zero will require that all vehicles shift from passively protecting individuals to actively protecting them&#160;-&#160;both in
the vehicle as well as outside the car.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our go to market strategy is primarily targeted
at Tier 1 suppliers, with the aim of fostering cooperation with the Tier 1 suppliers to integrate our radar chipsets into the radar systems
that Tier 1 manufacturers will sell to OEMs.&#160;Our sales and marketing team continues to focus on expanding its relationships with
OEMs and radar focused Tier-1 suppliers and seeks to leverage its existing relationships to expand its market to other industries. We
are considered a Tier-2 automotive supplier because we sell our product to Tier-1 companies that then integrate our product into the overall
system supplied to the OEMs.&#160;Our business model of being a Tier-2 supplier that subcontracts its manufacturing, together with its
market leadership, results in an advantageous cost structure that requires minimal sales and marketing expenses with respect to OEMs.
We are taking marketing steps intended to position us as a leading company in research and development of chip technology for next-generation
imaging radar systems in autonomous vehicles. Marketing is directed by the chief marketing officer who works from our headquarters in
Israel, and by the chief business officer who works in the United&#160;States, and the vice president of sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The marketing strategies employed include participation
in industry conferences, public relations publications, issuing newsletters and proactive inquiries to potential customers. We leverage
a variety of channels to reach prospects which include organic and paid social media activity, joint events, webinars and media and analyst
relations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of our marketing program, our radar solution
is available on the open NVIDIA platform. NVIDIA is a scalable, software-defined, end-to-end AI platform for the transportation industry
and companies around the world, including auto- and truck makers, Tier 1 automotive suppliers, robotaxis, sensor and mapping companies
and autonomous vehicle startups are developing on NVIDIA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Material Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are party to certain agreements that we believe
are important to our business. Some of these agreements are memoranda of understanding, with a definitive agreement to be negotiated in
the future. We can give no assurance that these memoranda of understanding will develop into agreement or will generate significant, if
any, revenue for us. Further, our ability to generate revenue from any of these agreements is dependent upon our ability to develop and
deliver products that meet the customer&#8217;s requirement, as to which no assurance can be given.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Strategic Agreements</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business strategy is based primarily on cooperation
with Tier 1 automotive manufacturers to integrate our radar chipset into the radar systems manufactured by the Tier 1 manufacturers, which
will ultimately be sold by the Tier 1 manufacturers to the OEMs.&#160;To implement this strategy, we are also working with the OEMs to
create an interest in our products. We are party to strategic agreements with Tier 1 automotive manufacturers, as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Magna</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of October 2022, we were selected by Veoneer
(then one of the top five automotive radar suppliers) as the radar chipset solution for their next generation imaging radar. On October
6, 2022, Veoneer signed a memorandum of understanding with us establishing a technical collaboration and business alliance relating to
its plans to co-develop radars for automotive-grade safety and advanced driver assistance systems based on our chipsets. During 2023,
Magna International Inc. acquired the active safety division of Veoneer. Magna is continuing the work done by Veoneer and it is sampling
its next generation for the imaging radar to OEM, including a long-range, high-resolution radar with 48x48 RF channels. During 2022 through
2024, multiple Request for Quotation (RFQ) or Request for Information (RFI) were submitted based on our chipsets in the United States,
Europe and China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Hirain</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 1, 2020, we entered into a memorandum
of understanding with Hirain Technologies, a Tier 1 automotive manufacturer in China, pursuant to which Hirain will develop and manufacture
radar systems for vehicles based on our radar chips, backed by funding from a bi-national Israel-China research foundation (Beijing).
On August 19, 2020, a distribution agreement was signed between the parties, granting Hirain the right to sell our demo systems to its
customers in China. Effective March 1, 2021, we and Hirain entered into an agreement under which Hirain will develop and manufacture automotive
radar systems based on our radar chipset. The agreement with Hirain included, inter alia, a commitment by Hirain to pay us for chipset
costs, support in development, system design and documentation. During the fourth quarter of 2022, Hirain issued a preliminary order for
340,000 radar chipsets in order to secure capacity for its anticipated production ramp-up. In January 2024, Hirain announced that it will
begin sampling its imaging radars by the end of 2024, following a successful development of a high-performance B-sample (a production
intent system design). Hirain is currently positioned to embark on a rigorous data collection phase, with plans to cover 1 million kilometers
using a vehicle fleet equipped with Hirain&#8217;s LRR610 and other derivatives imaging radars, powered by our chipset. This development
initiative is designed to optimize the fusion and perception system, which enables key automotive safety and comfort features.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Weifu</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January&#160;8, 2020, we entered into an agreement
with Weifu High-Technology Group Co., Ltd ( &#8220;Weifu&#8221;), a Tier 1 automotive manufacturer in China pursuant to which Weifu agreed
to develop and manufacture vehicle radar systems based on our radar chips. The agreement with Weifu included, inter alia, a commitment
by Weifu to pay us for chipset costs, support in development, system design and documentation. On December&#160;18, 2020, we and Weifu
expanded the joint project and agreed to increase the scope of the project for an additional fee. The agreement also stipulated the price
that Weifu will pay to buy the chips during the mass production phase. Weifu is in the process of developing radar systems based on our
radar chips, and has begun performing demonstrations to OEMs in China, using a sample provided by us. Weifu announced it reached a road
pilot phase of our chipset based radar systems. On July 18, 2023, we entered into a technical services agreement with Weifu for services
and support to be provided by us to Weifu. On July 28, 2023, Weifu issued an $11.6 million preliminary order for our radar chipsets, for
its estimated requirements in 2025 and beyond.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Ordering samples (proof of concept)&#160;-&#160;OEMs</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, we had received orders
from OEMs, Tier 1 suppliers and other companies who seek to take advantage of the market opportunity to purchase from us our I samples,
which are systems for the purpose of testing capabilities and development. The agreements grant the right of use to the recipients of
the samples while safeguarding our intellectual property and limiting our liability. The volume of revenue for selling samples is not
significant. In October 2021, we were chosen by a European OEM to participate in its artificial intelligence-based technologies for environment
perception (radar sensors) innovation project. The revenue from this project is not significant. In 2023, we were chosen by two European
OEM for perception projects and by a Japanese OEM for a perception project. The revenue from these projects has not been significant to
date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These selections were further extended to expected
participation as a short listing in RFQ for high volume serial production. Although our primary focus is on seeking orders for commercial
production, we believe these agreements with OEMs and Tier 1 manufacturers represent an important part of our marketing effort directed
at the OEMs and Tier 1 suppliers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Chips for non-retail automotive radar systems</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sensrad</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October&#160;16, 2020, we entered into an agreement
with Qamcom Research&#160;&amp; Technology AB (&#8220;Qamcom&#8221;), which set out principles of cooperation between the parties for
the development of radar systems based on our radar chips, for non-automotive target markets, such as delivery robots, agricultural tools,
smart traffic lights, train junctions, and other markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 11, 2021, we entered into a strategic
agreement with Qamcom under which Qamcom will develop and manufacture imaging radars based on our chipset to be used in the non-automotive
market. The agreement with Qamcom included, inter alia, a commitment by Qamcom to pay us for the chipset cost and portion of the module
hardware cost, for the receipt of support in development, system design and documentation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2023, Sensrad was incorporated as a spin-off
venture from Qamcom Group&#8217;s radar division to offer a unique imaging radar sensor based on the latest software and hardware technology,
including our radar chipset. Sensrad is co-owned by Qamcom and Gapwaves, which is considered a major company within antenna and radar
technology industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2023, Sensrad announced significant
customer orders for radar systems leveraging our chipset. The recent orders from global companies underscore the market&#8217;s recognition
of the transformative impact of our radar chipset technology, integrated into Sensrad&#8217;s Hugin Imaging Radar systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2024, Sensrad&#160;announced that
it signed a framework agreement worth an estimated $7.3 million to Sensrad for Sensrad to supply 4D imaging radars, powered by our technology,
to Tianyi Transportation Technology in China for vehicle-road-cloud integration technology. This framework agreement followed an extensive,
year-long evaluation of our advanced chipset technology. We believe there are significant opportunities for growth in the non-automotive
market, and we are supporting Sensrad in delivering radar solutions and driving innovation in such key markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KargoBot</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 28, 2023, we and Weifu announced a strategic
cooperation with DIDI Global&#8217;s KargoBot, an autonomous truck company, for developing and marketing safe L4 autonomous trucks with
4D Imaging Radars based on our proprietary chipset. We and Weifu are working to accelerate the implementation on the platform fleets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Evaluations</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our radar is also being evaluated by other leading
Tier-1s and we are engaged in discussions with OEMs that did not approve our releasing their names.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our chipset was selected by one of the top ten
OEMs worldwide for the development of its next-generation imaging radar aimed at serial production.&#160;The selection of our technology
presents a significant commercial opportunity given its applicability across a wide range of vehicle classes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A&#160;global leader in autonomous driving selected
the Hirain LRR610 radar, which is powered by our chipset, for its robotaxi fleet scheduled for mass production in 2025.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Arbe collaborated with a leading European truck
manufacturer, which plans to incorporate our radar chipset into its next-generation sensor suite.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A large Japanese automotive client is working
to complete a massive data collection initiative with our radar solution this year, as part of the development of an advanced ADAS/AD
architecture.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Three large European automotive OEMs are in deep
evaluation of Tier 1s solutions which use our chipset as part of their radar solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Two large US OEMs are in the early evaluation
process of Tier 1 solutions based on our radar.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Manufacturing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&#160;27, 2022, we entered into a manufacturing
agreement with GlobalFoundries Singapore Pte. Ltd. (&#8220;GlobalFoundries&#8221;) for the manufacture of our semiconductor products,
as well as other services, including pre-production, quality assurance, assembly, testing and supply-chain management. The initial term
of the agreement is five years. The agreement includes customary terms for semiconductor manufacturing agreements, such as product recalls,
warranty and business continuity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We depend on GlobalFoundries to manufacture our
semiconductor products. This agreement helps us secure the production of our semiconductor products and GlobalFoundries is committed to
supply our binding forecasts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We leverage GlobalFoundries capabilities as a
silicon manufacturer and for chipset supply chain management in turn-key work model to better secure production capacity to meet our customers&#8217;
fulfillment and quality and reliability automotive requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We were founded as a research and development
company, developing microchips for miniature radar systems for companies operating drone fleets, with the aim of providing a technological
solution that would enable the drone to detect at high speeds and improved resolution various obstacles, using little electrical power.
Once drone technology was developed, we decided to change the focus of our strategy and research and development to the field of chips
for radar systems for automotive industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development activities are conducted
in Israel. We have received Israel Innovation Authority (&#8220;IIA&#8221;) grant approval for certain approved programs. We received
grants from IIA and the European Community that, as of March 1, 2025, amount to approximately $4.0&#160;million, based on the exchange
rate when the grants were received. We are obligated to pay royalties to the IIA, amounting to 4% of the sales of the products and other
related revenues generated from such projects. The maximum aggregate royalties paid generally cannot exceed 100% of the grants received,
plus annual interest generally equal to 12-months SOFR applicable to dollar deposits, as published on the first business day of each calendar
year. The obligation to pay these royalties is contingent on sales of the products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal operating expenses are research
and development expenses, which were approximately $35.1 million, $34.1 million and $36.7 million for the years ended December 31, 2024,
2023 and 2022, respectively. Our research and development efforts are focused on enhancing and developing the 4D imaging radar chipset
solution and the accompanying software. The increase in research and development expenses reflects the ramp up in our operations, including
hiring and starting work toward our full production plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our intellectual property is a crucial part of
our business. Our IP rights are protected by a combination of patents, trade secret protection, confidentiality agreements, and other
contractual agreements with employees and third parties. We have applied for patent protection in several jurisdictions including Israel,
United&#160;States, Europe, Japan and China and have been granted patents in both Israel, the United States and the PRC. Unpatented trade
secrets are also an important aspect of our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We filed patent applications for 18 unique patent
families covering a wide range of fields related to our products features and aspects including radar signal processing, radar Tx/Rx integrated
circuit design, radar coexistence and mutual&#160;interface mitigation techniques, package design, antenna design, post-processing methods
and algorithms, and system design. We filed these applications, including utility and provisional applications, in jurisdictions that
we believe are the main automotive markets and development centers around the world, principally the United&#160;States, the European
Union, Japan and China. Twenty-two patents, covering thirteen different inventions, have been granted in the United States, Israel and
China, with patents generally having a term of 20&#160;years from their filing date. Among the patents granted are patents covering methods
for mitigation of mutual interference between automotive radars including frequency hopping multiband chirp techniques, nonlinear frequency
hopping fractional bandwidth multiband chirp techniques, methods for multi-stage radar signal processing, radar system self-test techniques,&#160;a
radome for automotive radar patch antennas, RFIC packaging techniques including low loss transmission lines, a radar-based system for
real-time simultaneous localization and mapping, known as SLAM, a MIMO radar array antenna, and a method for separating targets and clutter
from noise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for competitive automotive sensing
solutions that enable autonomous driving is an emerging market with many potential applications in the development stage. As a result,
we face competition from a range of companies (from large corporations to start-ups) seeking to have their products incorporated into
these developing applications and it may take a period of time for its primary competitors to emerge.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ADAS market is formed of Tier 1 manufacturers
which manufacture radar systems, as well as companies that develop and manufacture software and hardware such as chips and sensors for
the radar systems, which are called Tier 2 suppliers. We are a Tier 2 supplier, which has its products manufactured by a third-party manufacturer.
As a Tier 2 supplier, we supply imaging radar chipset to Tier 1 manufacturers who are building imaging radar systems and to OEMs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the following strengths differentiate
us and will enable us to successfully compete and maintain our leadership position in our target markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Technology. </i>We believe that our 4D imaging radar technology brings the fundamental leap required to achieve true radar imaging capabilities to the level that it can be used as a primary sensor for perception in tandem with cameras and optionally LiDAR. Our technology addresses the key challenges in the automotive radar domain while maintaining competitive size, power and cost for the Level 2+, Level 3 and Level 4 mass market, for high-density, high-resolution RF front-end, through cutting-edge algorithms to effectively utilize the radar and the powerful radar processing unit required to run the radar. We believe our technology will bring safety and autonomy to the mass market in all drivable weather conditions and all lighting conditions with redundancy at an attractive cost.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost and Energy Efficient High-Performance Radar Solutions. </i>Tier-1 manufacturers and automakers are extremely sensitive to the cost of any component in the vehicle, and especially to relatively highly priced individual components such as radar sensors. They demand competitive prices and put significant weight on this parameter when deciding on vendors. We expect that our products will be competitively priced as a result of mass production. We believe that our products will be competitively prices will offer better performance.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Global Coverage and Large Ecosystem. </i>Our products are marketed worldwide and amenable to implementation globally.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant Interest from Leading Companies in the industry. </i>Our progress has garnered the interest of major companies in the industry.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px; font-size: 10pt">&#160;</td>
    <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Automotive grade development and production. </i>Vehicle components are required to have a high functional safety grade. Achieving compliance with functional safety standards is a time-consuming and labor-intensive process that requires significant cooperation with automotive grade industry participants, such as Tier-1 suppliers and automobile manufacturers. Since 2018, we have worked closely with leading Tier-1 suppliers such as Magna, Hirain and Weifu, to develop a radar solution that meets these rigorous requirements. This process has included continuous and extensive product-safety auditing. As a result of our close work with these Tier&#160;1 automotive suppliers, we have developed rigorous safety and quality expertise. We believe that this experience provides us with a competitive advantage in marketing against companies that have not worked with Tier 1 automotive suppliers in the development of their products.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Relationships with multiple Tier-1 suppliers enable market penetration. </i>OEMs design their future models and vehicles several&#160;years in advance and often then freeze the design in order to produce and deliver the vehicles on time. Therefore, designs for mass-production of reliable Level 2+ to Level 3 and Level 4 consumer car programs where imaging and perception radars are required, is expected in&#160;2026-2030 &#160;are being decided in&#160;2025-2026. Radar solutions that will be candidates for inclusion in these programs must go through the process of automotive-grade manufacturing and audit by the OEMs and Tier-1 suppliers. We believe that our experience working with Tier 1 automotive suppliers and OEMs places us in a better position to market to the next generation of autonomous vehicles.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our chipset has the highest channel count in the
industry, which provides the highest resolutions, true 4-dimensional view of the vehicle&#8217;s environment, including separation in
high resolution in elevation with low false alarm rate, an industry first. In addition, our dedicated radar processor chip, which was
designed specifically for the automotive industry sets it apart from competition, providing not only fast time to market, but more importantly
the ability to reduce power consumption, and overall solution cost.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following chart compares the performance of
radar chipset, to our chipset:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_005.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While Texas Instruments and NXP offer a low-resolution
radar chip of 4Rx * 4Tx, capable of scaling up to 16Rx * 16 Tx without a dedicated processor for current generation radars, other companies
are targeting the imaging radar space with high resolution radar chipsets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Mobileye</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After previously announcing the development of
a 2,304 virtual channels radar (48x48 Rx*Tx), Mobileye has announced that it updated its channel count to 1,536 virtual channels (32x48),
which we believe gives up some image quality resolution and decreases the throughput and required processing power. We believe that on
the one hand Mobileye&#8217;s decision to develop a 4D imaging radar is significant to the automotive market in acknowledging Mobileye&#8217;s
view of the imaging radar&#8217;s key role in the overall perception solution, while on the other hand we believe that our excess channel
count indicates that our solution has a higher angular native resolution with lower native false alarms and an efficient handling of high
throughput and processing. To the best of our knowledge, Mobileye's production may be lagging ours by around two years. We also believe
that Mobileye plans to play some of the roles of the Tier 1 automotive supplier, and compete with our customers, who are leading automotive
radar Tier 1s, with&#160;years of experience in this space. We believe, based on the specification Mobileye published, that our current
chipset has better performance, price and power and that using our radar chipset solution would better meet the needs of the developing
autonomous vehicle market.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160; &#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Current ADAS Radars</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Traditional commercial radar systems have 5-degree
(or worse) resolution. Due to their low azimuth resolution and lack of elevation resolution, traditional radars, that were originally
designed for controlling emergency braking and adaptive cruise control, are limited to detecting moving vehicles and discarding all detections
of the stationary environment and cannot address free space mapping that requires high elevation resolution. Traditional radars have
a high level of false alarms that trigger reports of phantom objects and false positives and may lead to accidents. We have revolutionized
radar by addressing these core issues that have caused recent driverless vehicle and autopilot accidents by detecting stationary objects,
identifying vulnerable road users, and eliminating false alarms without radar ambiguities allowing radar-based free space mapping.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Ambarella for short range radar</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2021, Ambarella acquired Oculii, which
was established in 2013, and offers a software solution which is implemented on top of traditional 4Rx * 3Tx radar chips, with the aim
to improve the elevation and azimuth resolution and to expand the field of view. This approach will also lead to a denser point cloud,
which in turn would allow more advanced signal processing. However, we believe that this software solution is not applicable to autonomy
level beyond level 2.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Continental ARS 540</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Continental system is based on four Texas
Instrument 3Rx * 4Tx chips, cascaded to achieve a 16*12 array, as well as the Xilinx FPGA (field-programmable gate array) board, and not
a radar processor on a chip like our solution. FPGA is not designed for large scale automotive solutions, and therefore has many drawbacks
- it is expensive, the continental system costs in the range of $200 in high volumes, it requires high power consumption, has heat dissipation
issues, and supports fewer frames per second and very low number of detections per frame. The platform may have ambiguity issues increasing
the false alarm rate as well as filtering out real detection.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Environmental, Social and Governance (ESG)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an auto-tech company, we have developed what
we believe is a revolutionary radar that will enable truly safe driver-assist systems that can save lives on the road. Our mission is
to strengthen and enhance the safety of vehicle users and others in the industry who can apply the technology to their service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Environmental, Social and Governance (ESG)
practices are guided by our social mission of saving lives and securing people&#8217;s safety on the road. Notably, the social element
in ESG is reflected in the essence of our product as we created a system that assists with the prevention of injuries and fatalities while
driving. As part of our community involvement. we encourage our employees to participate in in volunteering initiatives in the local community.
As part of our spirit, we strengthen diversity and equality through equal pay and affirmative action towards recruiting and advancing
qualified women.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conduct our business activities based on a
firm commitment to ethical values and corporate governance best practices. Our policy is to follow leading ESG principles in relation
to our supply chain, including, evaluating, and engaging responsible suppliers. Our suppliers must operate in compliance with all applicable
national and international laws and regulations, as well as implementing the principles of the Responsible Business Alliance (RBA) Code
of Conduct. We are working with GlobalFoundries, a company that we believe values, supports and leads best ESG practices. Notably, in
October 2024, ISS recognized GlobalFoundries with a 'Prime' rating for its corporate ESG performance.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe in the importance of promoting and
adopting practices that support ESG implementation within our activities. During 2024, we identified significant ESG topics relevant across
all company activities. We will continue to advance our commitment to ESG practices across our operations, as well as monitor the development
of regulatory requirements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Regulations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The automotive industry is subject to high standards
of safety and quality. The integration of Advanced Driver Assistance Systems may stem from binding regulatory directives or from initiative
on the part of the car manufacturers themselves (driven, inter alia, by the wish to obtain a higher safety rating or to accommodate demand
from vehicle consumers). Our products will need to meet quality and safety control standards, regional and international ISO standards
and dedicated standards pertaining to ADAS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Autonomous vehicles are subject to emerging regulatory
frameworks at the federal and state levels that are in a rapid state of change. In general, at both the federal and state level, the U.S.&#160;has
provided a positive and relatively permissive legal environment to allow the safe testing and development of autonomous functionality.
We do not anticipate any near-term federal standards that would impede the foreseeable deployments of our radar technology. Some states,
however, particularly California and New&#160;York, still enforce certain operational or registration requirements for certain autonomous
functions. For example, California has been regulating autonomous vehicles in some fashion since 2012 through various restrictions and
appears poised to continue to do so. In December 2022, California introduced legislation that prohibits full self-driving marketing claims.
On the other hand, while California state lawmakers considered a bill that would have prohibited autonomous trucks and self-driving vehicles
weighing more than 10,001 without human drivers behind the wheel. It was ultimately vetoed by the Governor. It is possible that restrictions
at the state level in the U.S. will further ease or be removed as the data and experience supporting the safety of autonomous functionality
continues to grow, but we cannot predict when or whether that might happen. However, we believe such hurdles will be removed as state
regulators gain better experience with the technology. U.S.&#160;federal regulations, however, remain largely permissive of deployments
of higher levels of safe and responsible autonomous functionality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2015, NHTSA announced a plan to update the
criteria for 5-star safety ratings, to encourage automakers to use technology to prevent traffic accidents. In 2016, NHTSA added automated
braking systems to the list of technologies required to achieve a 5-star safety ratings. The technologies currently recommended by NHTSA
include: forward collision warning, lane departure warning, rear view video system, and automatic emergency breaking.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2023, NHTSA promulgated the &#8220;Occupant
Protection for Vehicles with Automated Driving Systems&#8221; final rule to update several FMVSS to account for vehicles that are equipped
with ADAS and do not have traditional manual controls associated with human drivers. NHTSA also proposed rules to update FMVSS for crash
avoidance, safety messaging and passenger-less vehicles and jointly proposed a rule with the Federal Motor Carrier Safety Administration
regarding AEB test devices for heavy vehicles.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2024 NHTSA officially established a Federal
Motor Vehicle Safety Standard mandating the inclusion of AEB, encompassing pedestrian AEB, as a default feature in all passenger cars
and light trucks by September 2029.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Foreign markets such as China and the EU also
continue to develop their respective standards to define deployment requirements for higher levels of autonomy. In China, for example,
the government has undertaken numerous efforts to promote autonomous vehicle development, including its February&#160;2020 release of
the Strategies for Innovation and Development of Autonomous Vehicles by China&#8217;s National Development and Reform Commission and ten
other agencies. This initiative sets forth an ambitious plan to create a systematic framework for technical innovation, industrial ecology,
infrastructure, regulations and standards, product regulation and network security in the autonomous vehicles market by 2025, and from
2035 to 2050, to fully establish an ecosystem for autonomous vehicles. Much of the emerging regulatory and legislative activity around
autonomous vehicles in the EU has been focused on data privacy and security, given the volume and types of data collected, stored and
transmitted by autonomous vehicles. A key part of Europe&#8217;s emerging autonomous vehicles strategy is the creation of a common European
mobility data space, to be further developed in the EU&#8217;s &#8220;Smart and Sustainable Transport Strategy.&#8221; Given the intense
work in these areas, we expect a workable path forward in the near-term in these markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The automotive industry in Japan puts all automotive
and telecommunications technologies through a rigorous certification process prior to commercial evaluation in the region. In February
2022, we obtained the Japanese Telecommunication and Radio certification for radar samples based on our mass production RF chipset.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Like all companies operating in similar industries,
we are subject to environmental regulation, including water use; air emissions; use of recycled materials; energy sources; the storage,
handling, treatment, transportation and disposal of hazardous materials; and the remediation of environmental contamination. Compliance
with these rules may include the need to obtain permits and licenses and to allow inspections of our facilities and products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall, the autonomous vehicles regulatory landscape
is still evolving rapidly. We may become subject to additional regulatory schemes and requirements as the development of federal, state
and foreign legal frameworks around autonomous vehicles continues to develop and change.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent&#160;years, governments, authorities
and organizations around the world have sought to tackle the problem of traffic accidents, through, among other methods,&#160; regulation
and legislation that encourage, and even require, installation of ADAS in vehicles. Such trends are gaining momentum and are being promoted
by the NHTSA and Euro-NCAP, among others, who institute standards for safety ratings for new vehicles, and provide the highest rating
(5 stars) where advanced technology for the prevention of traffic accidents is installed. A similar trend applies to the Chinese car safety
assessment program CNCAP which incorporates &#8220;Active Safety&#8221; criteria into its 5-star rating. In Israel, for instance, in 2015,
the government approved the Ministry of Transport&#8217;s plan to provide a financial incentive for private vehicle owners to install
lifesaving safety systems, and to establish that buses and trucks would be required to install a system for identifying pedestrians as
a condition for renewing the vehicle&#8217;s license.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_006.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Source: Yole, Driving Radar Resolution, February&#160;2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It should be noted that in addition to the regulatory
trends, awareness among automakers and vehicle owners of the importance and benefits of installing ADAS (even in the absence of binding
regulation) has increased, and it is likely that in the future, the vast majority of new vehicles will be equipped with such systems.
This trend is expected to accelerate due to various factors, including improvements that have enabled price reduction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regulation or standardization may stipulate that
automakers or vehicle-owners install ADAS in general, and radar systems in particular, which could facilitate our penetration into potential
target markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Similarly, internal regulation adopted by OEMs
voluntarily, or regulation by insurance companies requiring ADAS as a prerequisite for an insurance policy may also benefit our operations
and business outcomes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli company, we are subject to laws
and regulations applicable to all companies, including export controls, privacy, cybersecurity, anti-corruption, labor relations and workplace
laws and regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not currently a party to any legal proceedings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Organizational Structure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have two wholly-owned subsidiaries, one in
the United States -- Arbe Robotics US Inc., a Delaware corporation, and one, Shanghai Arbe Technologies Co., Ltd., organized under the
laws of the People&#8217;s Republic of China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>D. Property, plants and equipment.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any material tangible fixed assets.
We do not own any real estate. We rent offices from third parties, extending over an area of approximately 2,000 square meters located
in 105 and 107 HaHashmonaim Street in Tel Aviv. We pay monthly rent of approximately $46,400. The offices serve for both our R&amp;D activities
and our corporate headquarters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 4A. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion and analysis of our financial
condition and results of operations should be read in conjunction with our audited financial statements as of December 31, 2024 and 2023
and for the&#160;years ended December&#160;31, 2024, 2023 and 2022 and notes to those statements included elsewhere in this annual report.
Some of the information contained in this discussion and analysis or set forth elsewhere in this annual report, including information
with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As
a result of many factors, including those factors set forth in the &#8220;Cautionary Note&#160;Concerning Forward-Looking Statements&#8221;
and &#8220;Risk Factors&#8221; in Section D under Item 3 of this annual report, our actual results could differ materially from the results
described in or implied by the forward-looking statements contained in the following discussion and analysis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are driving a radar revolution, utilizing an
outstanding, truly safe, commercially viable, 4D imaging radar solution. As a global leader in radar technology, we enable safe roads
today while paving the way to full autonomy for passenger cars, autonomous trucks, delivery robots, robotaxies and commercial vehicles,
and we empower a wide array of safety applications with advanced sensing and paradigm-changing perception.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Founded in 2015 by Chief Executive Officer Kobi
Marenko, Chief Technology Officer Dr. Noam Arkind, and former Chief Operations Officer Oz Fixman, our breakthrough technology has transformed
radar as a sensor for ADAS (advanced driver assistance systems) and autonomous vehicles from the chip-level up, with technological breakthroughs
across all core components. As a result, we have created what we believe is the leading imaging radar sensor. Ours is the only radar capable
of enhancing perception algorithm that also meets the demanding performance, safety, and cost requirements for Level 2+ through Level
5 autonomous vehicles. It bypasses the traditional limitations of legacy radar technology - low resolution, inability to sense stationary
objects and high false alarm rate, to name a few. Integrating the advanced hardware with our custom AI stack enables support for advanced
perception capabilities at mass market prices, with top performance in all environments, weather and lighting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our 4D imaging radar, which we believe delivers
an image100 times more detailed than any commercial radar on the market, sets a new standard for safety in the industry. It is designed
to enable accurate and reliable sensing in some of the most common and challenging autonomous vehicle use cases&#8211; providing free
space mapping in a tunnel, detecting a tire on the road ahead in heavy rain, tracking pedestrians in the dark, and other demanding road
scenarios. This is achieved by the development of a chipset with what we believe is the highest channel count in the industry, proprietary
radar processing algorithms, and our industry-first radar-based perception applications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe our advanced semiconductors technology
has made us one of the leading providers of radar systems for the world&#8217;s top OEMs. With 138 employees, as of March 1, 2025 and
with 22 patents granted in the United States, Israel and China covering thirteen different inventions, we have more than 40 evaluation
projects and have been advised that we are on the short list with eleven OEMs, robotaxi, delivery robot, and autonomous truck projects.
We have been selected for evaluation by eight &#8220;Imaging Radar - Based Perception&#8221; projects, out of which two are top five global
OEM and are progressing towards selection in 2025, a delay from the previously anticipated selection date in 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for the ADAS/AD radar industry is expected
to have an estimated total addressable market opportunity of approximately $13.5 billion in 2028<sup>6</sup>. Our model to capture this
opportunity is to work directly with top established Tier 1 automotive suppliers in order to power their next generation radars. Correspondingly,
we have established relationships with four Tier-1 suppliers who are building production radars based on our chipset - Magna, Hirain,
Weifu and Sensrad. GlobalFoundries, our chip manufacturer responsible for chip production and supply chain management, has advised us
that it will have the capacity necessary to meet our anticipated commitments for 2025and we believe that it will have the capacity necessary
also for 2026. We are in advanced negotiations with an additional Tier-1 supplier that we believe can widen coverage of the market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>6</sup></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yole Group, Driving Radar Resolution, September&#160;2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Key Factors Affecting our Operating Results</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 92.15pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our future performance and success
depends to a substantial extent on the following factors, each of which is in turn subject to significant risks and challenges, including
those discussed below and in the section of this annual report in Item 3 under &#8220;Risk Factors.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our industry, staying ahead hinges on delivering
cutting-edge technology at competitive prices. Success requires us to consistently offer the latest advancements, which is why we channel
our research and development towards maintaining our technological edge. Our ability to thrive is closely tied to the worldwide demand
for ADAS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we believe that widespread adoption of
4D imaging radar across applications for safety and autonomy is approaching and that we are well-positioned in both automotive and non-automotive
markets to take advantage of this opportunity, mass production passenger vehicles OEMs are just beginning to develop level 2+ and autonomous
systems that will rely on incorporating imaging radar technology. We expect the rate of actual adoption and commercialization of radar-based
solutions by automotive OEMs and their suppliers will impact our results of operations, including revenue and gross margins for the foreseeable
future. Government regulations relating to ADAS and autonomous driving solutions are also key factors in the development of the market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also intend to target markets beyond mass production
passenger vehicles, including vehicle applications like trucks, shuttles, automated ground delivery vehicles, and industrial verticals
like industrial robots, security systems, ground protection, drones, traffic monitoring. Our solution has the potential to be a primary
sensor candidate for many autonomous and semi-autonomous applications and next generation perception platforms. As a result, we believe
that we could operate in some of those markets in parallel with the automotive market.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a Tier 2 supplier of advanced technology to
Tier 1 automotive suppliers and OEMs, our results of operations will be impacted by the timing and the level of demand for our product
from Tier 1 automotive suppliers and OEMs which base their radars on our chipset solution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are competing for talent in a highly competitive
environment, which results in higher compensation packages to employees. We cannot give assurance that we will be able to hire all required
positions when they are required or to retain those that we hire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our radar system is being evaluated by eleven
of the top-15 global automakers by sales, reflecting the significant commercial interest in perception and imaging radars. We anticipate
that these automakers will make their decisions with respect to their radar technology commencing in 2025 and 2026. We also have a preliminary
order from Hirain, a leading Chinese ADAS Tier 1 supplier, for the first months of production, which when the order becomes a binding
order will move us into the mass production phase. The order consists of 340,000 radar chipsets that will be supplied to Hirain&#8217;s
customers throughout China. We also have a preliminary order from Weifu, a high-technology group, a prominent Tier 1 supplier in the Chinese
automotive market, for a $11.6 million. Because of the preliminary nature of the orders, they are not included in our backlog.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to achieve profitability, we need to
generate orders and binding commitments from our current evaluation projects. Additional delays in the autonomy programs of the OEMs to
which we provide our chipset, currently or in the future, could adversely affect our ability to meet our revenue targets and achieve profitability
in the time frame we anticipate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since OEMs rely on Tier-1 automotive suppliers
for components such as radar-based product, if a leading Tier1 supplier goes into production with an imaging radar that is based on our
chips the chances of an OEM basing its radar on our technology is likely to increase. We believe that the fact that Tier-1 suppliers already
have radar production lines that they need to upgrade for imaging radar, reduces dramatically the risk and the cost in taking our technology
to the mainstream.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As with other companies engaged in ADAS, our business
is dependent upon regulations relating to autonomous driving solutions. Although we believe that our systems comply with applicable regulations,
any new regulations may have the effect of preferring one technology over other technologies, Since the nature and scope of future regulations
may be affected by conditions and events, we cannot predict the nature of any future regulations and their effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b><i>Market Trends and Uncertainties </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We estimate the total addressable market for Advanced
Drive Assistance Systems, known as ADAS, and autonomous driving technology, will grow to approximately $65.1 billion or more in 2030<sup>7</sup>
and we believe that this growth will result in a demand for our imaging radar chips. As automotive OEMs have shifted their focus from
Level 4/5 autonomy to Level 2+, we believe we have the opportunity to generate significant business with our first-to-market 4D imaging
radar. We believe that we can be the market leaders, with deeply integrated hardware and software products that currently meet the OEM
specification requirements for safe Level 2+ to Level 5 autonomy, which constitutes a significant portion of the market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that we have multiple levers for sustained
growth and market opportunities beyond the automotive industry, focusing on attractive, high-growth, and profitable markets. Specifically,
we are targeting passenger cars, commercial trucks and robotaxi fleets. Each of these represents a significant global opportunity, historically
underserved or completely unaddressed by existing technologies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our immediate market focus is on passenger and
commercial vehicle safety on highways and ADAS applications. We see significant potential to improve standard ADAS and crash avoidance
systems. The growing demand for ADAS is primarily driven by increasingly stringent safety regulations and consumer preferences in China,
Europe, and North America. We are well-positioned to capitalize on this demand. However, while increasing automotive performance requirements
may generate higher demand, our success depends on our ability to anticipate and adapt quickly to evolving regulatory standards and industry
requirements. Ultimately, market acceptance of active safety technology is influenced by numerous factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adverse economic conditions may also result in
a higher rate of losses on future accounts receivables due to credit defaults. As a result, a downturn in the worldwide economy could
have a material adverse effect on our business, results of operations, and/or financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>War with Hamas, Terrorism and Related Conflicts
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 7, 2023, Hamas terrorists infiltrated
Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas also launched
extensive rocket attacks on Israel&#8217;s civilian population and industrial centers along Israel&#8217;s border with the Gaza Strip
and in the Central District of Israel. Following the attack, Israel&#8217;s government declared war against Hamas and a military campaign
against Hamas. In addition, Hezbollah has attacked military and civilian targets in northern Israel, to which Israel has responded. How
long and how intense the current conflict in Gaza becomes is unknown at this time and any continued clash among Israel, Hamas or Hezbollah
or other countries in the region including Syria and Iran, may escalate in the future into a greater regional conflict. Although there
is a ceasefire with Lebanon, we cannot predict when or whether the ceasefire will end. As a result of these hostilities, call-up of significant
portion of Israel&#8217;s working population, including some of our employees, and the effect of any potential boycott both of Israeli products
and business and of stocks in Israeli companies may affect our business. To date, our operations and financial results have not been affected
in any material affect, and we are constantly considering and taking different measures to address this conflict risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Effects of Tariffs Threatened Tariffs and Export
Restrictions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The president of the United States has
stressed the importance of tariffs. We cannot predict the extent of any tariffs or any counter-tariffs which may be adopted that may
affect our business, our manufacturer, our Tier 1 suppliers and the automobile industry generally. To the extent that tariffs are
threatened, even if not imposed, it may impact the automobile industry and may result in a delay in the development and introduction
of cars with a higher level of autonomy. Any tariffs, which may result in counter-tariffs, could result in a significant increase in
the cost of parts for automobiles with increasing costs of the automobiles subject to the tariffs as well as significant supply
chain delays which would increase costs and time. In addition, the United States has imposed export restrictions on advanced chips,
including artificial intelligence chips, which may affect both the ability of our supplier, Global Foundries, to obtain chips and
the price of chips. Any factors which could result in higher prices for automobiles could result in a reduction in the production of
automobiles and a delay in the introduction of new ADAS features which require our technology, all of which could have a material
adverse impact on our business and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Global Demand </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is related to global automotive sales
and automotive vehicle production by our Tier-1 customers and their OEM customers and engagements. Economic conditions in North America,
Europe and Asia can have a significant impact on the production volume of new vehicles and the introduction of ADAS features, and, accordingly,
on our revenue. OEM customers&#8217; production can vary from period to period due to global demand, market conditions and competitive
conditions. We expect to continue to seek to capitalize on our strong and collaborative relationships with Tier 1 suppliers and OEMs to
expand our presence in key markets and capture the long-term growth opportunities within them.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ADAS and Autonomous Driving Regulation&#8239;&#8239;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Demand for our solutions is influenced by the
impact of regulation and the ratings systems deployed by the various NCAPs, particularly the Euro NCAP and the U.S. NCAP, administered
by the National Highway Traffic Safety Administration. As these NCAPs demand more ADAS applications like automatic emergency braking,
we believe that OEMs will increasingly include ADAS as a standard feature in their models to maintain or to achieve the highest safety
ratings. In many countries, these safety assessments have created a &#8220;market for safety&#8221; as car manufacturers seek to demonstrate
that their models satisfy the NCAPs&#8217; highest ratings. We expect national NCAPs. led by the Euro NCAP, to continue to add specific
ADAS applications to their evaluation items over the next several&#8239;years. In recent&#8239;years, as regulatory requirements and NCAP
ratings have increased, OEMs have also begun to highlight their safety features as a competitive advantage. As additional regulations
are implemented around the world, we expect this to lead to increased global adoption of ADAS, and we believe that we are well positioned
to benefit from these increasing safety regulations globally, particularly due to the verifiable nature of our current and future solutions.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fully autonomous vehicles are still nascent, and
regulation of autonomous driving is evolving around the world on both the local and national levels. We anticipate that regulatory bodies
will demand that AV functionality undergo certain validation and audit requirements before autonomous driving is permitted. The potential
impact of regulatory requirements and initiatives on the timing for widespread adoption of fully or even partially autonomous driving
and on the cost of developing and introducing autonomous driving solutions is uncertain. Nevertheless, we see a clear trend of adopting
partial autonomous driving features, operated in specific scenarios, under specific conditions, and at different levels of supervision.
Radars based on our chipset can help develop such features and make them available on private vehicles at a high level of safety and affordability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot provide any assurance regarding how
any such regulations will impact us and the extent of such impact, particularly if autonomous driving is prohibited in certain areas.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>7</sup></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">https://www.marketsandmarkets.com/Market-Reports/driver-assistance-systems-market-1201.html</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reliance on Supplier</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since we rely on GlobalFoundries for our manufacturing,
to the extent that any of the factors described above affect GlobalFoundries, including its ability to obtain the semiconductors necessary
for our product, our ability to deliver any products that are ordered from us will be impaired, which may impact our ability to obtain
orders for our products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Public company expenses</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a public company, we will be implementing additional
procedures and processes for the purpose of addressing the standards and requirements applicable to public companies. Specifically, we
expect our accounting, legal and personnel-related expenses to increase as we establish more comprehensive compliance and governance functions
and hire additional personnel to support such functions, maintain and review internal controls over financial reporting in accordance
with the Sarbanes-Oxley Act, and prepare and distribute periodic reports in accordance with SEC rules.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Years Ended December 31, 2024, 2023 and 2022</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year&#160;Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(dollars in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-indent: -9pt; padding-left: 9pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">768</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,470</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,517</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Cost of Revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,553</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,508</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,283</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Gross Profit (Loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(785</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,234</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Research and Development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,731</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Sales and Marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,430</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,194</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,621</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">General and Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,347</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,571</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,613</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Total Operating Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">48,868</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">46,847</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,965</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Operating Loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(49,653</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(46,885</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(47,731</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Financial (Income), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(336</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,385</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net Loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(43,500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(40,494</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Basic loss per share attributable to ordinary shareholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.60</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.64</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Weighted-average number of ordinary shares used in computing basic loss per share ordinary share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">80,949,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">72,021,520</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">63,489,983</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Diluted loss per share attributable to ordinary shareholders</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.66</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Weighted-average number of ordinary shares
    used in computing diluted loss per ordinary share \</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">80,949,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">72,053,372</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">63,629,206</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth our revenue for
the years ended December&#160;31, 2024, 2023 and 2022 by geographic region (dollars in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year&#160;Ended December&#160;31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year&#160;Ended<br/> December&#160;31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year&#160;Ended<br/> December&#160;31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Revenue</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>% of Revenue</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Revenue</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>% of Revenue</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Revenue</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>%
of Revenue</b></p></td><td style="white-space: nowrap; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Revenue by Geography:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-indent: -9pt; padding-left: 9pt">China</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">254</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">33.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">639</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">43.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">1,476</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">42.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Sweden</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">224</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">Israel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">Italy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total revenue</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">768</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,470</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,517</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reduction in revenue in 2024 compared to 2023
was driven by lower samples unit sold, as we progress toward production, and by the reduction in professional services sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reduction in revenue in 2023 compared to 2022
was mainly due to reduction in chipsets sales and to lesser extent due to reduction in professional services, as we shifted our focus
to chips for production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of Revenue</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue includes the manufacturing cost
of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel and an allocated portion of facility, IT costs and depreciation. Once we are operating on a production
basis, we expect cost of revenue to increase as we increase our revenue, however, we expect the cost per unit to decrease over time as
we shift from the manufacturing of prototype full radar system to production of chipsets sales in response to orders in commercial quantities.
We expect that the fixed cost components (most notably labor cost) will also drive margin improvement upon revenue increase due to leveraging
economy of scale notwithstanding increased labor costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue for 2024 was approximately $1.6
million, resulting in a gross loss of approximately $0.8 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue for 2023 was approximately $1.5
million, resulting in a gross loss of approximately $0.04 million. Cost of revenue for 2022 was approximately $1.3 million, resulting
in a gross profit of approximately $2.2 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross Margin</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross margin for 2024 was negative margin of 102.2%
compared to 2.6% negative gross margin in 2023 and to 63.5% positive gross margin in 2022. The negative gross margin in 2024 primarily
resulted from low level of revenue and the increase in our labor cost. The negative gross margin in 2023 primarily resulted from reduced
revenue and fixed costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating Expenses</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and Development Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development efforts are focused
on enhancing and developing the 4D imaging radar chipset solution and the accompanying software.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; "></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personnel-related expenses, including salaries, benefits, and share-based compensation expense for personnel in research and engineering functions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses related to materials, software licenses, supplies and third-party services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prototype expenses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operation costs related to develop manufacturing processes;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocated portion of facility and IT costs and depreciation; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation grants received from the Israel Innovation Authority (&#8220;IIA&#8221;) and the European Union &#8220;Ecsel&#8221; program (Electronic Components and Systems for European Leadership), which reduced our research and development expense in 2024, 2023 and 2022.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal operating expenses is research and
development, which was approximately $35.1 million in 2024, $34.1 million in 2023 and $36.7 million in 2022. The increase of $1.0 million
in 2024 compared to 2023 was mainly due to an increase in share-based compensation expenses and an increase in our work force and subcontractors
costs, partially offset by the reduction in material costs expenses associated with our advancement toward production ramp up. The reduction
of $2.6 million in 2023 compared to 2022 was mainly due to reduction in subcontractors cost and in cost of materials purchased, as we
progress towards production items and to a lesser extent, the reduction related to favorable foreign exchange rate impact, partially offset
by increase in share-based compensation to employees.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses in 2025 will
include mainly activities relating to product enhancement, pre-production costs and new products as well as the development of the next
generation radar system.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sales and Marketing Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Marketing expenses include the cost of sales commissions,
marketing programs, trade shows, consulting services, promotional materials, demonstration equipment and an allocated portion of facility,
IT costs and depreciation. Labor cost related expenses consist of salaries and benefits. We expect that our sales and marketing expenses
will increase in absolute dollars over time as we hire additional sales and marketing personnel to support our customers, Tier-1 supplier
relationships, and OEM relationships, as we will also increase our marketing activities and penetration and grow our domestic and international
footprint.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales and marketing expenses were approximately
$5.4 million in 2024 compared to $5.2 million in 2023 and $4.6 million in 2022. The increase of $0.2&#160;million in 2024 was primarily
attributed to an increase in workforce and to an increase in share-based compensation expenses. The increase of $0.6&#160;million in 2023
was primarily attributed to an increase in employee share-based compensation, partially offset by favorable foreign exchange rate impact.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General and Administrative Expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses consist of
personnel-related expenses for corporate, executive, finance, and other administrative functions, expenses for outside professional services,
including insurance, legal, audit, accounting services and other costs related to our status as a publicly traded company as well as expenses
for facilities, depreciation, and travel. Personnel-related expenses consist of salaries, benefits, foreign exchange rate impact and employee
share-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses, which were
approximately $8.3&#160;million in 2024, approximately $7.6&#160;million in 2023 and approximately $8.6&#160;million in 2022. The increase
of $0.7 million in 2024 was related to the increase in share-based compensation, the provision of doubtful debt and to a lesser extent
increase in labor, those were partially offset by savings in our directors and officers&#8217; (D&amp;O) insurance premium. The decrease
of $1.1 million in 2023 was primarily related to a reduction in our directors and officers&#8217; (D&amp;O) insurance premium.&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Financial Expenses (income), Net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that our financial expenses is based
on a change in warrant liability and convertible bond, as our stock and bond prices increases the warrant liability increases with a result
that we incur a financing charge as a result of an increased liability, and as our stock price decreases, we incur financing income which
has a positive effect in the results of our operations as a result of a decreased liability. Our financial expenses also include exchange
rates revaluations, interest income from bank deposits, bonds related expenses and bank fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial income, net of $0.3&#160;million in
2024, was primarily related to bank deposit interest, and to a lesser extent, warrants revaluation income partially offset by bond financing
expenses and to a lesser extent unfavorable foreign exchange rate revaluations. Financial income, net of $3.4&#160;million in 2023, was
primarily related to deposit interest, favorable foreign exchange rate revaluations and to a lesser extent, warrants revaluation income.
Financial expenses, net of $7.2&#160;million in 2022, was primarily related to revaluations of warrants issued to shareholders partially
offset by loan interest and exchange rate impact.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2024, we issued convertible bonds in the
principal amount of NIS&#160;110 million&#160;(approximately $30 million( on TASE. The proceeds from the sale of the bonds, which were
approximately NIS&#160;112.4 million&#160;(approximately $30.5 million), were placed in escrow, to be released to us upon meeting certain
conditions by March 31, 2025, or earlier upon conversion of the bonds, all as set forth in the deed of trust pursuant to which the bonds
were issued. At December 31, 2024, all of the bonds were outstanding and all of the funds were held in the escrow account. During January
2025, bonds in the principal amount of NIS 78.5 million were converted into 8,233,177 ordinary shares, and we received NIS 78.5 million
(approximately $22.4 million gross proceeds including interest&#160;from the escrow funds). The deed of trust pursuant to which the bonds
were issued provides for the release of the funds from escrow (to the extent not released upon conversion of the bonds) if certain conditions
are met by March 31, 2025. On March 20, 2025, following approval by the holders of a majority of the outstanding bonds, the date by which
we must meet the conditions to the release of the funds from escrow was extended from March 31, 2025 to December 31, 2025. On December
31, 2024 and on the date of this annual report, these conditions had not been met. If we do not meet the release conditions by December
31, 2025, we will be required to effect an early redemption of the bonds, which will result in using the remaining funds in the escrow
account to pay the bonds, and we will be required to pay the trustee such additional amounts as are required to pay the interest and any
payment due as a result of the differential in the exchange rate. We will use our available funds to make any necessary payments to the
trustee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, we sold, in an underwritten
public offering, an aggregate of (i)&#160;4,293,957&#160;ordinary shares, (ii) Pre-Funded Warrants to purchase an aggregate of&#160;3,956,043&#160;ordinary
shares (which were issued in lieu of ordinary shares), (iii) Tranche A Warrants to purchase up to an aggregate of&#160;8,250,000&#160;ordinary
shares, and (iv) Tranche B Warrants to purchase an aggregate of&#160;8,250,000&#160;ordinary shares, although the holders of Tranche B
Warrants may elect to receive Pre-Funded Warrants in lieu of an equal number of ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each ordinary share or Pre-Funded Warrant, as
applicable, was sold together with&#160;one&#160;Tranche A Warrant to purchase&#160;one&#160;ordinary share and&#160;one&#160;Tranche
B warrant to purchase&#160;one&#160;ordinary share. The net proceeds from the offering, after deducting underwriting discounts and other
offering costs paid by us, was approximately $13.8&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During January 2025, 118,134 Tranche A Warrants
and 118,134 Tranche B Warrants were exercised into 236,268 ordinary shares in consideration for gross proceeds of $0.49 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During January 2025, we raised gross proceeds
of approximately $33.1 million in a public offering of sale of 10,332,031 ordinary shares at a price to the pubic of $3.20 per share.
The aggregate net proceeds received by us from the offering were approximately $30.9 million&#160;net of underwriting discounts and other
offering costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The bonds, the Pre-Funded warrants, the Tranche
A Warrants and the Tranche B Warrants are described in Item 12. The form of these securities is filed as an exhibit to this annual report,
and the descriptions in this annual report are qualified in their entireties by the terms of the securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Selected Balance Sheet Information (dollars in
thousands).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31.</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">57,631</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47,436</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Working capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,225</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,225</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(252,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(203,640</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,496</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,093</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, we had cash and cash
equivalents totaling $13.5 million and short term bank deposits totaling $10.8 million. We use our funds primarily for our operating activities.
Cash and cash equivalents are invested in accordance with our investment policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash Flow Summary</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes our cash flows
for the years ended December 31, 2024, 2023 and 2022 (in thousands):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Years Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net cash used in operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(32,502</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(33,513</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(40,362</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net cash provided by (used in) investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,987</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,251</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,318</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash provided by (used in) financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,199</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,941</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net decrease in cash and cash equivalents and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,240</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,612</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,432</td><td style="text-align: left">)</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Operating Activities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2024, operating
activities used approximately $32.5&#160;million in cash. The primary factors affecting operating cash flows during 2024 were the net
loss of approximately $49.3&#160;million, reduced by non-cash charges of approximately $16.5&#160;million consisting of $15.7 million
of share-based compensation, depreciation of approximately $0.6&#160;million and revaluation of warrant liability and bond-related expenses
of approximately $0.2 million. Additionally, our working capital has increased by approximately $0.3&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2023, operating
activities used approximately $33.5&#160;million in cash. The primary factors affecting operating cash flows during this period were net
loss of approximately $43.5&#160;million, impacted by non-cash charges of approximately $13.4&#160;million consisting of $13.6 million
of share-based compensation and depreciation of approximately $0.6&#160;million offset by warrants revaluation of approximately $0.8 million.
Additionally, our working capital has decreased by approximately $3.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, operating
activities used approximately $40.4&#160;million in cash. The primary factors affecting operating cash flows during this period were net
loss of approximately $40.5&#160;million, impacted by non-cash charges of approximately $1.5&#160;million consisting of $8.1 million revaluations
of warrants, share-based compensation of approximately $9.1&#160;million as well as depreciation of approximately $0.5&#160;million. Additionally,
our working capital has decreased by approximately $1.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investing Activities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2024, cash
provided by investing activities was approximately $4.0 million, which was primarily from cash provided by short-term deposits consist
of approximately $4.6 million and purchase from cash used to equipment and leasehold improvements of approximately $0.6.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2023, cash
used in investing activities was approximately $15.3 million, which was primarily from cash used to short-term deposits consist of approximately
$15.0 million and purchase from cash used to equipment and leasehold improvements of approximately $0.3.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, cash
used in investing activities was approximately $1.3&#160;million, which was primarily from cash used to purchase equipment and leasehold
improvements of approximately $0.9&#160;million and a short-term deposit of approximately $0.4&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financing Activities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2024, cash
provided by financing activities was approximately $13.5&#160;million, consisting primarily of proceeds from issuance of ordinary shares
of approximately $13.8&#160;million, exercise of options of approximately $0.2 million and payment of $0.5 million of issuance costs related
to our convertible bonds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2023, cash
provided by financing activities was approximately $23.2&#160;million, consisting primarily of proceeds from issuance of ordinary shares
of approximately $22.5&#160;million and exercise of options of approximately $0.7 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, cash
used in financing activities was approximately $4.9&#160;million, consisting primarily of repayment of short-term loan of approximately
$5.2&#160;million, partially offset by issuance and exercise of options of approximately $0.3 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Funding Requirements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect our 2025 expenses to be in line with
or slightly greater than our 2024 level. Our production build-up efforts have stabilized, and we have progressed toward the production
phase, alongside our efforts to streamline our expenses and to emphasize resources to support our next step target to the production and
commercialization stage. We continue to expand our research and development activities and expect to incur commercialization expenses
related to product sales, marketing, manufacturing and distribution. Our costs and revenue can be impacted by the conditions described
in the &#8216;Overview under Market Trends and Uncertainties&#8217; as well as the factors described in Risk Factors, which would affect
our requirement for additional funding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also expect to continue to incur losses before
we receive sufficient revenues to offset our expenses. We anticipate that we will shift toward profitable operations in the coming years.
We anticipate the current cash balance together with our revenues will enable us to continue until we are cash flow positive from operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our losses will be driven by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanding production capabilities to bring our chipset to automotive grade production;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">expanding our design, development, installation
    and servicing capabilities;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">.</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays by automobile manufacturers in making final decisions relating to the next generation of automobiles requiring ADAS features and the introduction of advanced driver assisted capabilities as a result of broader economic shifts that we believe are leading to short-term delays in the automobile manufacturers roll-out of advanced driver assistance systems;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant investment in research and development;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase our sales and marketing activities and develop our distribution infrastructure; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase our general and administrative expenses to support the growth and public company infrastructure.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we may find that these efforts are
more expensive than we currently anticipate or that these efforts may not result in sufficient revenues, which would further increase
our losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During January 2025, we raised gross proceeds
of $55.5 from an underwritten registered public offering ($33.1 million) and from the release from escrow of funds ($22.4 million) upon
the conversion of a portion of our outstanding convertible bonds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we believe that our balance sheet is
strong, following the funds raised in November 2024 and January 2025, in the event that we need additional funding in anticipation of
our proposed production ramp up in 2025, we will consider seeking to raise funds through the sale of equity securities or convertible
debt. As of the date of this annual report, we have no plans for any such offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Item 11 with respect to Quantitative and Qualitative
Disclosures about Market Risk</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Estimates</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We prepare our consolidated financial statements
in accordance with US GAAP. The preparation of these consolidated financial statements requires us to make estimates, assumptions and
judgments that can significantly impact the amounts we report as assets, liabilities, revenue, costs and expenses and the related disclosures.
We base our estimates on historical experience and other assumptions that we believe are reasonable under the circumstances. Our actual
results could differ significantly from these estimates under different assumptions and conditions. We believe that the accounting policies
discussed below are critical to understanding our historical and future performance as these policies involve a greater degree of judgment
and complexity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>Share-Based Compensation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize the cost of share-based awards granted
to employees and directors based on the estimated grant-date fair value of the awards. We elected to recognize share-based compensation
costs on a straight-line method for awards. Forfeitures are accounted for as they occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of each option award is estimated
on the grant date using the Black-Scholes option pricing model. The application of the Black-Scholes model utilizes significant assumptions,
including volatility. Significant judgment is required in determining the expected volatility of our ordinary share. Due to the limited
history of trading of our Ordinary Shares, we determined expected volatility based on a peer group of publicly traded companies. Increases
(decreases) in the assumptions result in a directionally similar impact to the fair value of the option award.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Warrant liabilities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrants recorded as liabilities are recorded
at their fair value and remeasured on each reporting date with changes in estimated fair value of ordinary share warrant liability in
the consolidated statement of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In evaluating warrants liabilities, we, with the
assistance of third-party valuations, utilize the Black-Scholes valuation model to estimate the fair value of these warrants at each reporting
date. The application of the Black-Scholes model utilizes significant assumptions, including volatility. Significant judgment is required
in determining the expected volatility of our ordinary share. Due to the limited history of trading of our Ordinary Shares, we determined
expected volatility based on a peer group of publicly traded companies. Increases (decreases) in the assumptions result in a directionally
similar impact to the fair value of the ordinary share warrant liability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Emerging Growth Company Status</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 102(b)(1) of the Jumpstart Our Business
Startups Act of 2012 (&#8220;JOBS Act&#8221;) exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act
provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply
to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &#8220;emerging growth company&#8221;
as defined in Section 2(a) of the Securities Act, and have elected to take advantage of the benefits of the extended transition period
for new or revised financial accounting standards. Following the consummation of the Business Combination, our Post-Combination Company
will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of our ordinary
shares that held by non-affiliates exceeds $700 million as of the end of that year&#8217;s second fiscal quarter, (ii) the last day of
the fiscal year in which we achieve total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation),
(iii) the date on which we issue more than $1 billion in non-convertible debt in the prior three-year period or (iv) five fiscal years
after we complete an initial public offering, which was in October 2021. We expect to continue to take advantage of the benefits of the
extended transition period, although we may decide to early adopt such new or revised accounting standards to the extent permitted by
such standards. This may make it difficult or impossible to compare our financial results with the financial results of another public
company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended
transition period exemptions because of the potential differences in accounting standards used.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Recent Accounting Pronouncements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Note 2 of Notes to Consolidated Financial Statements for information
related to recent accounting pronouncements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Directors and Senior Management </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides information about
our directors and our senior management. Our senior management consists of our chief executive officer and those current executive officers
who have responsibility for a major segment of our business (<i>&#8220;<b>Senior Management</b>&#8221;)</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="width: 29%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 61%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position(s)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yair Shamir</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director and Chairman of the Board</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ehud Levy</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boaz Schwartz, PhD</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.&#160;Scott Crist</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thilo Koslowski</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander Hitzinger</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yonina Eldar, PhD</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kobi Marenko</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director (co-founder)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noam Arkind, PhD</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Technology Officer and Director (co-founder)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karine Pinto-Flomenboim</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ram Machness</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Business Officer</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shlomit Hacohen</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Marketing Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shay Naeh</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President Operations</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nadav Snir</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President IC</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Yair Shamir, Chairman of the Board</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&#160;Shamir was appointed as a director on
December&#160;9, 2019, and he has served as Chairman of the Board since December 16, 2021. Mr.&#160;Shamir is co-founding and managing
partner of Catalyst Investments. Mr.&#160;Shamir was elected as a member of the 19<sup>th</sup> Knesset (Israeli Parliament) and served
as Minister of Agriculture and Rural Development for the Government of Israel from 2013 until&#160;2015. Mr.&#160;Shamir serves as chairman
of the Shalem College, a research and educational institute in Jerusalem. Mr.&#160;Shamir has formerly served as chairman of the National
Road Safety Authority and of four government companies: Metropolitan Mass Transit System (NTA), Israel Aerospace Industries (IAI), EL-AL
Israel Airways and the National Roads Company.&#160; Mr.&#160;Shamir has served as a member of numerous company boards within Catalyst&#8217;s
investment portfolio. From 2003 to-2007, Mr.&#160;Shamir was the Chairman of Shamir Optical Industry Ltd (NASDAQ:&#160;SHMR). From&#160;1997-2006,
Mr.&#160;Shamir served as the CEO and Chairman of VCON Telecommunications Ltd. From&#160;2005-2013, he served as a board member of DSP
Group Corporation (NASDAQ:&#160;DSPG). Mr.&#160;Shamir was the CEO of Elite Food Industries, Ltd. between the&#160;years of 1994 and 1995.
From 1995 to 1997, Mr.&#160;Shamir served as Executive Vice President of the Challenge Fund L.P.&#160;Prior to this he was Executive VP
of Scitex Corporation and General Manager of Scitex Israel from 1988 until&#160;1993.&#160;Mr.&#160;Shamir was the Chairman of Gvahim
from 2006 to 2013. He was also a Board Member of Mikveh Israel from 2010 until&#160;2013. Mr.&#160;Shamir was also a member of the Board
of Governors of the Technion University and sat on the executive committee of the Beer Sheva University from 1990 until&#160;2013. Mr.&#160;Shamir
served in the Israeli Air Force as a pilot and engineer from&#160;1965-1988. During his term in the Air Force, Mr.&#160;Shamir attained
the rank of colonel and served as head of the electronics department, the highest professional electronics position within the Israeli
Air Force. Mr.&#160;Shamir holds a B.Sc. in Electronics Engineering from the Technion, Israel Institute of Technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Ehud Levy, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&#160;Levy was appointed as a director on March&#160;29,
2016. Mr.&#160;Levy is the Managing General Partner of Canaan Partners Israel, and a Venture Partner with Lenovo Capital heading its investment
opportunities in Israel. Mr. Levy is also an active private investor in tech companies operating as a partner with a leading investment
team, Kaedan Capital. Prior to these activities, Mr.&#160;Levy was a Managing Partner at Vertex VC for seven&#160;years. Among other successful
investments, Mr.&#160;Levy identified Waze as a bright star from the start, leading the first investment round in the company and serving
on its board of directors until its acquisition by Google for over $1 billion. Previously, Mr.&#160;Levy co-founded and served as Chairman
and CEO of Ki-Bi Mobile Technologies, a mass-market device specialist for mobile content distribution and led the business from concept
to commercial success, an IPO in London and eventual acquisition. Earlier, Mr.&#160;Levy served as COO and CFO of Telegate, a telecommunications
company, where he was responsible for a restructuring plan leading to the successful acquisition of the company for over US$400 million.
Prior to Telegate, Mr.&#160;Levy was an investment banker in New&#160;York and Tel Aviv, served on the board of directors of several technology
companies. Mr.&#160;Levy holds a BSc in Computer Engineering (with honors) from the Technion in Israel, and an MBA from Columbia Business
School, New&#160;York.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Boaz Schwartz PhD, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr.&#160;Schwartz was appointed as a director
on October 7, 2021, upon closing of the Merger. Dr. Schwartz is a seasoned finance professional and a tech investor. Dr.&#160;Schwartz
has founded and managed Deutsche Bank Israel for 24&#160;years and until December&#160;2020. Following his retirement from Deutsche Bank,
Dr. Schwartz became an active tech investor in both early and late-stage companies. He has a wide portfolio of investments in Fintech,
Autotech and other technology related ventures. Dr.&#160;Schwartz is an active investor and works closely with his investee companies
helping on both strategy and finance related matters. Dr.&#160;Schwartz has developed Deutsche Bank Israel to become one of the leading
global investment banks operating in Israel with very strong corporate finance advisory franchise, the leading project finance bank in
Israel, the top foreign bank on TASE, and a leading trader in the Israeli fixed income and forex. Dr.&#160;Schwartz is a senior advisor
to Vitruvian Partners in Israel; a board member and chairman of the finance committee&#160;of IDC Herzliya&#160;&#8212;&#160;the only
private university in Israel&#160;;board member of iArgento Ltd&#160;&#8212;&#160;a traded venture capital fund; Covercy Ltd&#160;&#8212;&#160;a
real estate investment management SaaS platform and Foretellix Ltd. - a verification and validation automation tool for autonomous vehicles;
a board observer of Addionics Ltd. - an enabling battery technology for automotive industry and Trieye - a leading HD SWIR imaging and
3D camera developer;&#160;and the vice-Chairman of Zabar Solar Ltd.&#160;&#8212;&#160;a leading green energy developer and operator. Dr.&#160;Schwartz
is also a long time member of the Israeli chapter of the YPO.&#160;Dr.&#160;Schwartz earned a PhD in Finance from the University of Chicago;
MBA with Distinction from the Wharton School at the University of Pennsylvania; MSc and BSc in Electrical Engineering from the University
of Tel Aviv.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>E.&#160;Scott Crist, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr.&#160;Crist was appointed as a director on
October 7, 2021, upon closing of the Merger. Mr. Crist is managing partner for Texas Ventures as well as CEO of Osperity, a leader in
AI-driven computer vision for the industrial sector. Mr.&#160;Crist has an extensive background as an entrepreneur and venture capitalist
and was the former CEO of Infrastructure Networks and founder/CEO of Telscape International (NASDAQ), a telecommunications company focused
on certain emerging markets around the world. Prior to that, he served as President and CEO for Matrix Telecom, which Inc. Magazine once
ranked 7<sup>th</sup> on its list of the 500 fastest growing private companies in the US.&#160;Previously, Mr.&#160;Crist worked for Trammell
Crow Group, IBM and Booz-Allen Hamilton. Mr.&#160;Crist has a Master of Business Administration from the Kellogg School at Northwestern
University and a Bachelor of Science in Electrical Engineering from NC State University. Mr.&#160;Crist is also an Entrepreneur of the
Year recipient from NASDAQ/Ernst&#160;&amp; Young. In addition, Mr.&#160;Crist is chairman of the VA-Gov Housing fund, the nation&#8217;s
largest lender for the Veteran Administration&#8217;s Homeless Shelter Program.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Thilo Koslowski, Director </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Mr. Koslowski was appointed
as a director on February 21, 2022. Mr. Koslowski is a board advisor and an executive strategic consultant to various companies and startups
in the technology, automotive and digital business markets and to venture capital firms. Mr. Koslowski has an extensive background in
the fields of autonomous cars, smart-mobility and digital customer experience. From 2016 to 2020, Mr. Koslowski was the founder and CEO
of Porsche Digital, a wholly owned subsidiary of Porsche AG, serving as the technology and digital unit of Porsche AG. From 1999-2016,
Mr. Koslowski was VP and practice leader at Gartner, Inc, a leading technological research and advisory firm, where he established Gartner&#8217;s
global automotive advisory-services. Mr. Koslowski is a board member, observer and investor in international startups. In addition, as
part of Mr. Koslowski&#8217;s years at Porsche Digital, he was the co-founder and board member of APX, Europe&#8217;s leading early-stage
joint venture capital, backed by both Axel Springer and Porsche.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Alexander Hitzinger, Director </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Mr. Hitzinger was appointed
as a director on May 2, 2022. Mr. Hitzinger led the self- driving development, was a member of the management board of Volkswagen Commercial
Vehicles from January 2019 to June 2020 and from June 2020 to February 2022 served as chief executive officer of Artemis GmbH, where he
was the chief architect of the revolutionary vehicle concept for next generation autonomous mobility for their flagship-product Audi Landjet.
Prior to his role at VW Group, from April 2016 to January 2019, Mr. Hitzinger held the position of head of product design for autonomous
transportation at Apple, where he was responsible for building and leading the automotive team at the company. He was also the technical
director and chief engineer for the Porsche 919, which was the winner of 24 hours of Le Mans and the World Endurance Championship for
three consecutive years. Mr. Hitzinger also serves as a Board Member and Advisor to multiple technology companies in the United States
and Israel, such as Arbe Robotics, Electra Vehicles, Tau Motors and Foretellix. Mr. Hitzinger holds a Bachelor in Mechanical Engineering
and a Masters in Business Administration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Yonina Eldar PhD, Director</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prof. Eldar was appointed as a director on November
7, 2023. Prof. Eldar is the&#160;Israel Prize laureate for 2025 in the field of Engineering Research and Engineering Sciences. Prof. Eldar
is a professor in the Department of Mathematics and Computer Science, Weizmann Institute of Science, Rehovot, Israel, where she holds
the Dorothy and Patrick Gorman Professorial Chair and heads the Center for Biomedical Engineering. Prof. Eldar was previously a professor
in the Department of Electrical Engineering at the Technion, where she held the Edwards Chair in Engineering. Prof. Eldar is also a visiting
professor at MIT, a visiting scientist at the Broad Institute, a visiting research collaborator at Princeton, an adjunct professor at
Northeastern University and Duke University, an advisory professor of Fudan University, a distinguished visiting professor of Tsinghua
University, and was a visiting professor at Stanford. Prof. Eldar is a member of the Israel Academy of Sciences and Humanities (elected
2017) and of the Academia Europaea (elected 2023), an IEEE Fellow, a EURASIP Fellow, a Fellow of the Asia-Pacific Artificial Intelligence
Association, and a Fellow of the 8400 Health Network. Prof. Eldar is author of the book &#8220;Sampling Theory: Beyond Bandlimited Systems&#8221;
and co-author of eight other books in the areas of convex optimization, compressed sensing, radar, communications, imaging, information
theory and machine learning. Prof. Eldar received her B.Sc. degree in physics and B.Sc. degree in Electrical Engineering from Tel-Aviv
University, and her Ph.D. in electrical engineering and computer science from the Massachusetts Institute of Technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Senior Management</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Kobi Marenko<i>, </i>Chief Executive Officer,
Co-Founder and Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Marenko has served as a director and our Chief
Executive Officer since inception on November 4, 2015. Jacob Marinka, who is also known as Kobi Marenko, is an entrepreneur with over
20&#160;years of experience in leading technology and media startups from seed stage to acquisition. Prior to founding us, from 2012 to
2014, Mr.&#160;Marenko was the founder and President of Taptica, a mobile DSP listed on the London Stock Exchange (LON: TRMR). Prior to
this experience, from 2004-2012, Mr. Marenko was the founder and CEO of Logia, a mobile content platform acquired by Digital Turbine (NASDAQ:
APPS). For over 20 years, Mr. Marenko was leading tech and media startups from seed to acquisition. Mr.&#160;Marenko holds a BA in Philosophy
from Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Noam Arkind PhD, Chief Technology Officer,
Co-Founder and Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Arkind has served as a director and our Chief
Technology Officer since inception on November 4, 2015. Dr.&#160;Arkind has over 10&#160;years of experience in R&amp;D and holds a Ph.D.
in Applied Mathematics from the Robotics Lab at Weizmann Institute of Science. Prior to founding us, from 2013 to 2015, Dr.&#160;Arkind
led the algorithm development at Taptica and the Space IL control system. Dr.&#160;Arkind holds a B.Sc. in Applied Mathematics from Bar
Ilan University, a M.Sc. and PhD in Mathematics and Computer Science from the Weizmann Institute of Science.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Karine Pinto-Flomenboim, Chief Financial Officer
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms.&#160;Pinto-Flomenboim has served as our Chief
Financial Officer since November 8, 2021. Ms.&#160;Pinto-Flomenboim has more than 25 years of financial experience, having worked with
multinational publicly traded companies. Prior to joining us, from 2019 to 2021, Ms.&#160;Pinto-Flomenboim served as the Chief Financial
Officer of TIBA, a leading manufacturer of parking access and revenue control systems, where she led the company&#8217;s exit for $135M
and navigated the company through a reorganization, M&amp;A and COVID-19. Prior to this experience, from 2011 to 2018, Ms. Pinto-Flomenboim
held the position of director of business controlling and head of corporate FP&amp;A at Caesarstone Ltd. (Nasdaq: CSTE), a global publicly
traded company that invented and pioneered quartz surfaces. From 2003 to 2011, Ms. Pinto-Flomenboim held the position of head of FP&amp;A
at the process diagnostic and control (PDC) division of Applied Materials, Inc. (Nasdaq: AMAT). From 2000 to 2003 Ms.&#160;Pinto-Flomenboim
served at various financial positions at Intel Fab 8 (Nasdaq: INTC). Ms. Pinto-Flomenboim holds a master&#8217;s in economics from the
Hebrew University of Jerusalem, graduated from The National Investor Relations Institute (NIRI), and is an active member of the Israeli
CFO Forum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Ram Machness, Chief Business Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Machness has served as our Chief Business
Officer since April 30, 2018. Mr. Machness leads the product management, customer support, sales and business development.&#160; Mr.&#160;Machness
has over 30&#160;years of experience in embedded systems and the semiconductor and automotive industries. Prior to joining us from 2007
to 2018, Mr.&#160;Machness managed the business development, customer engagement and product marketing at Texas Instruments (Nasdaq: TXN),
a Global American based technology company that designs and manufactures semiconductors. Prior to this experience, from 2003-2007, Mr.&#160;Machness
served in various consulting position in companies such DSP Group (Nasdaq: DSPG), a global leader in wireless communications and voice
processing chipsets and algorithms for a wide range of smart-enabled devices, and Microsoft (Nasdaq: MSFT), A multinational technology
corporation which produces computer software, consumer electronics, personal computers, and related services. His professional experience
also includes roles in system engineering and R&amp;D management. Mr.&#160;Machness holds a B.A in Computer Science from The Open University
and an MBA Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shlomit Hacohen, Chief Marketing Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms.&#160;Hacohen has served as our Chief Marketing
Officer since November 27, 2017. Ms.&#160;Hacohen is a seasoned marketer with over 20&#160;years of experience in developing marketing
strategies, launching products, and building brand awareness. Prior to joining us, from 2015 to 2017, Ms.&#160;Hacohen was CMO and executive
marketer in organizations such as DEEP, Collabrium, Viaccess Orca, Comverse (Nasdaq: CMVT), and Check Point (Nasdaq: CHKP). Ms.&#160;Hacohen
holds a BA in Management and Sociology from Tel Aviv University and an MBA from the Technion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shay Naeh, Vice President Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Naeh has served as our Vice President Operations
since December 6, 2020. Mr.&#160;Naeh has over 23&#160;years of experience in semiconductors design, program management, quality, and
operations with automotive Tier 1s and OEMs.&#160;Prior to joining us, from 1998 to 2020, Mr.&#160;Naeh worked with Texas Instruments
(Nasdaq: TXN) and Valens (NYSE: VLN). Mr.&#160;Naeh holds a B.Sc. in Electrical Engineering and an MBA both from the Tel Aviv University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nadav Snir, Vice President IC</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Snir has served as our Vice President IC since
February 2023. As Vice President IC, Mr. Snir leads our IC Research and Development group. From July 2018, Mr. Snir led our RFIC R&amp;D
team. Prior to joining us, Mr. Snir worked as an RFIC Design Engineer at DSP Group and at ELIPSE RFIC Array Devices. Mr. Snir received
an MBA degree from the Technion, and a B.Sc. in Electrical and Computer Engineering from Ben Gurion University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an Israeli company, we are subject to various
corporate governance requirements under the Israeli Companies Law. Pursuant to regulations promulgated under the Israeli Companies Law,
companies with shares traded on certain U.S.&#160;stock exchanges, including Nasdaq, may, subject to certain conditions, opt out from
the Israeli Companies Law requirements to appoint external directors and related Israeli Companies Law rules concerning the composition
of the audit committee, compensation committee and nominating committee of the board of directors (other than the gender diversification
rule under the Israeli Companies Law, which requires the appointment of a director from the other gender if at the time a director is
appointed all members of the board of directors are of the same gender). In accordance with these regulations, we have elected to opt
out of those requirements of the Israeli Companies Law. These exemptions will continue to be available to us so long as: (i)&#160;we do
not have a &#8220;controlling shareholder&#8221; as defined under the Israeli Companies Law, (ii)&#160;our shares are traded on certain
U.S.&#160;stock exchanges, including Nasdaq, and (iii)&#160;we comply with the director independence requirements and the audit committee,
compensation committee and nominating committee composition requirements under U.S.&#160;laws (including applicable Nasdaq rules) applicable
to U.S.&#160;domestic issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to certain matters (including various
related party transactions), a controlling shareholder is deemed to include a shareholder that holds 25% or more of the voting rights
in a public company if no other shareholder holds more than 50% of the voting rights in the company, but excludes a shareholder whose
power derives solely from his or her position as a director of the company or from any other position with the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We comply with Nasdaq rule&#160;5605(b)(1), which
requires that the board of directors be comprised of a majority of independent directors, although as long as we are a foreign private
issuer, we may elect to follow Israeli law in lieu of certain Nasdaq requirements, including the independent director requirement. A&#160;majority
of our board of directors is composed of directors who are &#8220;independent&#8221; as defined by the rules of Nasdaq, and all of the
non-executive directors qualify as &#8220;independent&#8221; under these standards. The board of directors established categorical standards
to assist it in making its determination of director independence. We use the definition of &#8220;independence&#8221; of Nasdaq to make
this determination. Nasdaq Listing Rule&#160;5605(a)(2)&#160;provides that an &#8220;independent director&#8221; is a person other than
an officer or employee or any other individual having a relationship which, in the opinion of the Board, would interfere with the exercise
of independent judgment in carrying out the responsibilities of a director, and includes specific relationships that would disqualify
a director from being independent, including being an employee during the past three years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors will assess on a regular
basis, at least annually, which members are independent, and the Nomination and Corporate Governance Committee will assess the independence
of each nominee for director as part of its duties in designating nominations for the board of director&#8217;s nominees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a foreign private issuer, we are permitted
to comply with Israeli corporate governance practices instead of the Nasdaq corporate governance rules,&#160;provided&#160;that, we disclose
which requirements we are not following and the equivalent Israeli requirement. We rely on this &#8220;home country practice exemption&#8221;
with respect to the quorum requirement for shareholder meetings publication of the annual reports or proxy materials, and with respect
to the Nasdaq requirement of obtaining shareholder approval for the certain issuance of 20% or more of our ordinary shares at a price
below the minimum price as defined by Nasdaq, and for the adoption or amendment of equity-based compensation plans without shareholder
approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As permitted under the Israeli Companies Law,
pursuant to our Restated Articles, the quorum required for an ordinary meeting of shareholders consist of at least two shareholders present
in person, by proxy or by other voting instrument in accordance with the Israeli Companies Law, who hold at least 25% of the voting power
of its shares (and in an adjourned meeting, with some exceptions, any number of shareholders). Israeli law does not require us to send
annual reports or proxy materials directly to our shareholders, however we do make available those documents through our public website.
Generally, Israeli law has no requirement for obtaining shareholder approval for the issuance of equity securities and, accordingly, our
board has the authority to issue ordinary shares without obtaining shareholder approval under circumstances where shareholder approval
would be required under the Nasdaq corporate governance regulations for the issuance of 20% or more of our ordinary shares at a price
less than the minimum price, as defined in the Nasdaq rule. Although we comply with the rules generally applicable to U.S.&#160;domestic
companies listed on Nasdaq, we may in the future decide to use the foreign private issuer exemption with respect to some or all of the
other corporate governance rules. To the extent that we elect to take advantage of the exceptions permitted to foreign private issuers,
we must disclose those exceptions and describe the relevant Israeli law provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. B. Compensation&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Required Approvals under the Israeli Companies
Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, terms of office
and employment of executive officers and directors, are generally subject to the approval of the compensation committee and the board
of directors and must generally be consistent with the Company&#8217;s Compensation Policy, which is mandated by the Israeli Companies
Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, the compensation
of a public company&#8217;s directors generally requires the approval of its compensation committee, the subsequent approval of its board
of directors and, unless exempted under regulations promulgated under the Israeli Companies Law, the approval of its shareholders at a
general meeting. If the compensation is inconsistent with the Company&#8217;s compensation policy, the shareholder approval will require
the Compensation Majority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The term &#8220;Compensation Majority&#8221; refers
to an approval requirement under the Israeli Companies Law, pursuant to which, certain compensation arrangements are subject to a simple
majority vote of the shares present and voting at a shareholders meeting, in person or by proxy, and voting thereon, provided that either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -26.7pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">such majority includes at least a majority of the shares held by disinterested shareholders who vote at the general meeting, with disinterested shareholders being defined as shareholders who are not controlling shareholders and do not have a personal interest in such compensation arrangement or the compensation policy, as applicable; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the total number of shares of&#160;the disinterested shareholders who vote against the policy, does not exceed 2% of the company&#8217;s aggregate voting rights.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Executive Officers (Other than the Chief Executive
Officer)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law requires that the compensation
of a public company&#8217;s executive officers (other than the chief executive officer) shall be approved by the compensation committee,
and the subsequent approval of its board of directors. If such compensation arrangement is inconsistent with the company&#8217;s approved
compensation policy, then shareholder approval by the vote of a Compensation Majority is also required. However, if the shareholders of
the company do not approve such compensation arrangement with an executive officer, then the compensation committee and board of directors
may override the shareholders&#8217; decision, provided that they have stated detailed reasons for their decisions.&#160; In addition,
our Compensation Policy enables our chief executive officer to approve immaterial changes in the terms of employment of an executive officer
(provided that the changes of the terms of employment are consistent with our Compensation Policy) and allows us to exculpate, indemnify
and insure its executive officers and directors subject to certain limitations as set forth therein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, the compensation
of a public company&#8217;s chief executive officer is required to be approved by the compensation committee, the subsequent approval
of its board of directors and, unless exempted under regulations promulgated under the Israeli Companies Law, the approval of its shareholders
at a general meeting, by a vote of a Compensation Majority, whether or not consistent with the Compensation Policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, if the shareholders do not approve the
compensation arrangement with the chief executive officer, then the compensation committee and board of directors may override the shareholders&#8217;
decision, based on detailed reasons for their decision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CEO and Director Nominees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholder approval may not be required for the
compensation terms of a candidate for the chief executive officer position or a director nominee, for the period commencing on the appointment
and until the upcoming shareholders meeting, if the board of directors and the compensation committee have approved such terms and have
determined that the compensation arrangement is consistent with our Compensation Policy, and that the proposed compensation terms are
generally under the same circumstances and are not materially different than the predecessor of such candidate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in certain circumstances, the compensation
committee may waive the need in shareholder approval requirement with regard to the approval of the engagement terms of a candidate for
the chief executive officer position (or a director nominee who is not an executive director) if they determine, by detailed reasons,
that the compensation arrangement is consistent with the company&#8217;s Compensation Policy, that the chief executive officer (or the
director nominee) did not have any affiliation or prior business relationship with the company or a controlling shareholder of the company,
and that seeking shareholder approval for the engagement terms would be detrimental to our ability to engage this chief executive officer
candidate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Aggregate Compensation of Executive Officers and Directors </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2024 and 2023,
we paid an aggregate of $5.7 million and $5.0 million, respectively, in cash and benefits in-kind, including equity compensation, to or
accrued on behalf of all of our directors and members of Senior Management for their services in all capacities during 2024 and 2023,
and directors&#8217; fees. These amounts include amounts set aside or accruals for pension, severance, retirement or similar benefits
or expenses, in the amounts of approximately $309,000 and $274,000, for the years ended December 31, 2024 and 2023, respectively, but
does not include reimbursement of business travel, relocation, professional and business association dues and expenses, and other benefit
costs commonly reimbursed or paid by companies in Israel which are not treated as compensation. In addition, we incurred $3,465,000 and
$2,640,000 of share-based compensation expense related to equity awards made by us to our Senior Management and directors for the years
ended December 31, 2024 and 2023, respectively.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, (i) options to purchase
2,266,173 ordinary shares, and (ii) 1,368,411 restricted stock units granted to our current Senior Management and directors were outstanding
under our equity incentive plans at a weighted-average exercise price of $4.81 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity-based compensation granted to Senior Management
generally vests over a period of four years, commencing one year after the date of grant, with equity-based compensation granted to Senior
Management generally vests over a period of four years, commencing one year after the date of grant, with quarterly vesting thereafter.
However, during 2024 and 2023, equity-based compensation was granted as an additional award, and vested one-year after the date of grant.
For directors, equity-based compensation generally vests over a period of three years with a quarterly vesting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">vesting thereafter, however, equity-based compensation
granted in 2024 and 2023 as an additional award, vests one-year after the date of grant. For directors, equity-based compensation generally
vests over a period of three years with a quarterly vesting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Individual Compensation of Covered Executives</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The table below sets
forth the compensation paid to our five most highly compensated &#8216;office holders&#8217; (as defined by the Israeli Companies Law)
during or with respect to the year ended December&#160;31, 2024, and as recorded in the financial statements for such period. We refer
to those five individuals for whom disclosure is provided herein as our &#8220;Covered Executives.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The term &#8220;compensation&#8221;
for purposes of this section regarding the Covered Executives refers to the term &#8220;Terms of Office and Employment&#8221; as defined
under the Israeli Companies Law, which includes amounts accrued or paid in connection with salary cost, consultancy fees, bonuses, equity-based
compensation, retirement or termination payments, benefits and perquisites such as car, phone and social benefits to the extent applicable,
and any undertaking to provide such compensation. Each of the Covered Executives was covered by our directors and officers liability insurance
policy and was entitled to indemnification and exculpation in accordance with applicable law and our articles of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><i>Summary Compensation Table: </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="21" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Information Regarding the Covered Executive<sup>(1)</sup></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Principal Position<sup>(2)</sup></b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary<sup>(3)</sup></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus<sup>(4)</sup></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Financial </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Expense for </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity-Based<br/>
    Compensation<sup>(5)</sup></b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other<br/>
Compensation&#160;<sup>(6)</sup></b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kobi Marenko, Chief Executive Officer</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">319,832</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">473,380</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,016</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">796,228</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noam Arkind PhD, Chief Technology Officer</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">327,960</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">473,304</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,016</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">804,280</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ram Machness, Chief Business Officer</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276,653</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">636,242</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,164</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">934,059</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karine Pinto-Flomenboim, Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">215,535</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,710</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">526,193</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,016</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">758,454</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ben Rathaus, PhD, Vice President AI and Perception</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,216</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">412,960</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,016</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">649,192</span></td>
    <td>&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All amounts reported in the table are in terms of our cost as reflected in our consolidated financial statements for the year ended December&#160;31, 2024, plus compensation paid to such Covered Executives in 2025 in respect of employment provided during 2024.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Covered Executive listed in the table are full-time employees.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary includes the Covered Executive&#8217;s gross salary plus payment of social benefits made by us on behalf of such Covered Executive. Such benefits may include, to the extent applicable to the Covered Executive, payments, contributions and/or allocations for savings funds (such as managers&#8217; life insurance policy), education funds (referred to in Hebrew as &#8220;keren hishtalmut&#8221;), pension, severance, risk insurances (such as life, or work disability insurance), payments for social security and tax gross-up payments, vacation, convalescence recreation pay and other benefits and perquisites consistent with our policies, to the extent applicable.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We did not pay bonuses to our Covered Executives for 2024, other than bonus for our CFO for the efforts related to our fundraise activities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The equity-based compensation represents the &#8220;financial expense&#8221; as reflected in our consolidated financial statements for the year ended December&#160;31, 2024, with respect to equity-based compensation vested during 2024. The amount of equity-based compensation does not represent the market value, nor does it represent the number of RSUs or options granted to our Covered Executives; rather it reflects the non-cash financial expenses amortized for such equity-based compensation in our financial statements for the year ended December&#160;31, 2024. Assumptions and key variables used in the calculation of such amounts are described in Note 10 of Notes to our Consolidated Financial Statements, which are included in this annual report.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All other compensation represents mainly incidental monetary benefits.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Non-Employee Director Remuneration </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current composition of our Board of Directors
includes three directors who do not occupy executive positions with us (Mr. Shamir, Mr. Levy and Mr. Crist, hereinafter &#8220;<b>Non-Executive
Directors</b>&#8221;), four directors who we consider to be industry experts (Dr. Schwartz, Mr. Koslowski, Mr. Hitzinger, and Prof. Eldar,
hereinafter &#8220;<b>Industry Expert Directors</b>&#8221;), and two directors who are executive officers (Mr. Marenko and Dr. Arkind,
hereinafter &#8220;<b>Executive Directors</b>&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our Compensation Policy for directors
and officers, our Compensation Committee, Board and the shareholders, have approved that the Non-Executive Directors shall receive an
annual fee of $30,000 plus applicable value added tax as remuneration for their service on the Board, and that Industry Expert Directors
shall receive an annual fee of $100,000, other than Prof. Eldar who is a full time professor and researcher at the Weizmann Institute
of Science who receives $50,000, plus applicable value added tax as remuneration for their service on the Board.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our Compensation Committee, Board
and the shareholders have approved, consistent with our Compensation Policy, the grant to our Non-Executive and Industry Expert Directors
equity-based compensation, that generally vests over a period of three years with a quarterly vesting, for a term of ten years (subject
to early expiration in the event of termination of services and as described in our 2021 Plan) as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name of Director</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares<br/>
 Subject to<br/>
 Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fully Vested</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: justify">Dr. Boaz Schwartz</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">81,589</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">8.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: center">October 2024</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">August 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Thilo Koslowski</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">March 2025</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">August 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Alexander Hitzinger</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">May 2025</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">August 2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Prof. Yonina Eldar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.074</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">November 2026</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Mr. Yair Shamir</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2026<i>&#160;&#160;</i></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Mr. Ehud Levy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2026<i>&#160;&#160;</i></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Mr. Scott Crist</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.873</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2026<i>&#160;&#160;</i></span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to their services and for participating
in board meetings, we reimburse our directors for travel expenses, in accordance with Company policy as applicable for our employees (and
for Industry Expert Directors up to an amount of 9,000 Euros a year).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Executive Directors&#8217; Remuneration</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Employment terms</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Kobi Marenko, has served as a director and
Chief Executive Officer since inception on November 4, 2015. Dr. Noam Arkind has served as a director and Chief Technology Officer since
inception on November 4, 2015. The Company believes that Mr. Marenko and Dr. Arkind are deeply involved and familiar with the Company&#8217;s
business and personnel, as well as having broad knowledge and experience, thus being best equipped to serve as our Chief Executive Officer
and Chief Technology Officer, respectively, while being part of the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under his employment agreement, Mr. Marenko is
currently entitled to a monthly salary of NIS 80,000 (approximately $22,223) and Dr. Arkind is currently entitled to a monthly base salary
of NIS 80,000 (approximately $22,223). As approved at the 2022 annual shareholder meeting, each of Mr. Marenko and Dr. Arkind was awarded
a special cash bonus in connection with his efforts, amounting to an aggregate amount of NIS240,000 (approximately US$71,428).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bonus Plan</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2023, our shareholders approved, following
the approvals of the Compensation Committee and the Board, a framework annual cash bonus plan to each of Mr. Marenko, our Chief Executive
Officer, and Dr. Arkind, our Chief Technology Officer, based on performance-based measurable criteria for each calendar year as of the
year ended December 31, 2023 and onwards, until the year ended December 31, 2025 (&#8220;<b>Bonus Plan</b>&#8221;). The proposed Bonus
Plan is intended to incentivize those officers by closely aligning their personal economic interest with our performance and share price
appreciation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Bonus Plan, the target bonus in
the event of 100% achievement of the target goals is three months&#8217; salaries, while for overachievement performance of 120% and above,
the officer may be eligible for an additional one month&#8217;s salary, totaling four months&#8217; salaries. Our Compensation Committee
and the Board may set during the first quarter of each year, the performance targets for each calendar year, while performance targets
will be comprised of 70% measurable criteria and up to 30% of non-measurable criteria.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In special circumstances (e.g., regulatory changes,
significant changes in the business environment, a significant organizational change, merger and acquisition events, or other similar
events etc.), our Compensation Committee and the Board may make adjustments to the objectives, and in such special circumstances, to modify
the objectives and/or their relative weights or the amount of bonus payouts (including decreasing such amounts to zero), in connection
with the applicable bonus period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2024, the Company determined, by action
of the Compensation Committee and approval of the Board, the performance goals of each of the CEO and the CTO, to include metrics, key
performance indicators and discretionary criteria which will entitle the officers with an annual bonus with respect to 2024, to be reviewed
during the first quarter of 2025, after having the annual financial results of 2024. In accordance with the authority of the Compensation
Committee and the Board, the weights concerning the operating performance measures have been changed since the previous shareholder meeting
discussing the Bonus Plan. Pursuant to the Bonus Plan&#8217;s terms, both our CEO and the CTO will not be eligible for an annual bonus
with respect to the year ended on December 31, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity-based compensation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to each of the executive directors,
the following equity-based awards were granted:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name of Executive Director</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Subject to Equity Awards</td><td style="text-align: center; padding-bottom: 6pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fully Vested</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 58%; text-align: justify; padding-bottom: 1.5pt">Mr. Kobi Marenko</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; width: 10%; text-align: right">8,326</td><td style="width: 1%; padding-bottom: 6pt; text-align: left"><sup>(1)</sup></td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1.5pt; width: 10%; text-align: right">1.221</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 15%; text-align: center; padding-bottom: 1.5pt">March 1, 2024</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">300,000</td><td style="padding-bottom: 6pt; text-align: left"><sup>(1)</sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">6.44</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">December 16, 2025</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">185,000</td><td style="padding-bottom: 6pt; text-align: left"><sup>(2)</sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">April 1, 2025</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt">Dr. Noam Arkind</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">7,771</td><td style="padding-bottom: 6pt; text-align: left"><sup>(1)</sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">1.221</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">March 1, 2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">300,000</td><td style="padding-bottom: 6pt; text-align: left"><sup>(1)</sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">6.44</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">December 16, 2025</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">185,000</td><td style="padding-bottom: 6pt; text-align: left"><sup>(2)</sup></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">April 1, 2025</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Options to purchase ordinary shares of the Company</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Restricted share units.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Policy under the Israeli Companies
Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Required approvals</span></i>. In general,
under the Israeli Companies Law, a public company must have a compensation policy approved by the board of directors after receiving and
considering the recommendations of the compensation committee. In addition, a compensation policy must be approved at least once every
three&#160;years by the board of directors, upon recommendation of its compensation committee, and thereafter, approval of the vote of
shareholders by a Compensation Majority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the shareholders fail to approve
the compensation policy in a duly convened general meeting by the Compensation Majority, the board of directors may nevertheless override
that decision, provided that the compensation committee and then the board of directors decide, on the basis of detailed reasons and after
further review of the compensation policy, that approval of the compensation policy is for the benefit of the company despite the failure
of the shareholders to approve the policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy for Executive Officers
and Directors became effective upon the completion of our merger with ITAC, which is when our ordinary shares became publicly traded,
It will remain in effect for term of five&#160;years from that date. Our Compensation Policy for Executive Officers and Directors is filed
as an exhibit to this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Objectives</span></i>. The compensation policy
must serve as the basis for decisions concerning the financial terms of employment or engagement of Office Holders, including exculpation,
insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy
must relate to certain factors, including advancement of the company&#8217;s objectives, business plan and long-term strategy, and creation
of appropriate incentives for Office Holders. It must also consider, among other things, the company&#8217;s risk management, size, and
the nature of its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy, which became effective
immediately after the consummation of the Merger, is designed to promote retention and motivation of directors and executive officers,
incentivize superior individual excellence, align the interests of our directors and executive officers with our long-term performance
and provide a risk management tool. To that end, a portion of an executive officer compensation package is targeted to reflect the short
and long-term goals, as well as the executive officer&#8217;s individual performance. On the other hand, our Compensation Policy includes
measures, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and
the total compensation of an executive officer and minimum vesting periods for equity-based compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Compensation features</span></i>. The Compensation
Policy also addresses our executive officers&#8217; individual characteristics (such as their respective positions, education, scope of
responsibilities and contribution to the attainment of its goals) as the basis for compensation variation among its executive officers
and considers the internal ratios between compensation of its executive officers and directors and other employees. Pursuant to our Compensation
Policy, the compensation that may be granted to an executive officer may include: base salary, annual bonuses and other cash bonuses (such
as a signing bonus and special bonuses with respect to any special achievement), equity-based compensation, benefits and retirement and
termination of service arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Fair market value</span></i>. In order to calculate
the caps set forth in the Compensation Policy, the determination of the fair market value of equity-based awards at the time of grant,
are prorated into each vesting year of the award, according to acceptable valuation and accounting practices; so that, the cap will be
applicable to the value of the award at each vesting year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Cash bonuses</span></i>. An annual cash bonus
may be awarded to executive officers upon the attainment of&#160;pre-set&#160;periodic objectives and individual targets. The annual cash
bonus that may be granted to our executive officers other than the CEO and the CTO who are subject to the Bonus Plan as approved, will
be based on performance objectives and a discretionary evaluation of the executive officer&#8217;s overall performance by the chief executive
officer and subject to minimum thresholds. Furthermore, our chief executive officer will be entitled to recommend performance objectives,
and such performance objectives will be approved by the Compensation Committee and by our board of directors. All cash bonuses are limited
to a maximum amount linked to the executive officer&#8217;s base salary. In addition, the total variable compensation components (annual
bonus and equity-based compensation) may not exceed 85% of each executive officer&#8217;s total compensation package with respect to any
calendar year. See &#8220;<i>CEO and CTO Annual Bonus Plan</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Performance measures</span></i>. The measurable
performance objectives of our chief executive officer will be determined annually by our Compensation Committee (and, if required by
law, by our board of directors) and will include the weight to be assigned to each achievement in the overall evaluation. A less significant
portion of the chief executive officer&#8217;s annual cash bonus may be based on a discretionary evaluation of the chief executive officer&#8217;s
overall performance by the Compensation Committee and the board of directors based on quantitative and qualitative criteria. Our board
of directors has determined measurable performance objectives for our executive directors for the year 2024 under the Bonus Plan, but
currently there is no eligibility for bonus under such plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Equity-based compensation</span></i>. The equity-based
compensation under the Compensation Policy for our Office Holders is designed in a manner consistent with the underlying objectives in
determining the base salary and the annual cash bonus. Primary objectives include enhancing the alignment between the executive officers&#8217;
interests and our long-term interests and those of its shareholders and strengthening the retention and the motivation of executive officers
in the long term. Our Compensation Policy provides for executive officer compensation in the form of share options or other equity-based
awards, such as restricted shares and restricted share units, in accordance with its share incentive plan then in place. Generally, all
equity-based incentives granted to executive officers will be subject to vesting periods in order to promote long-term retention of the
awarded executive officers. Equity-based compensation will be granted from time to time and be individually determined and awarded according
to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities of the executive
officer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Director remuneration</span></i>. The Compensation
Policy also provides for compensation to the members of our board of directors either (i)&#160;in accordance with the amounts provided
in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director)&#160;5760-2000, as amended by the
Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel)&#160;5760-2000, as such regulations may
be amended from time to time, or (ii)&#160;in accordance with the amounts determined in the Compensation Policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy, which was approved by
our board of directors and shareholders, became effective upon the completion of our merger with ITAC, which is when our ordinary shares
became publicly traded, and is filed as an exhibit to this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Clawback policy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Compensation Policy contains a compensation
recovery provision which allows us under certain conditions to recover bonuses paid in excess due to an accounting restatement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, our Board of Directors adopted
a clawback policy covering our executive officers. An &#8220;executive officer&#8221; is our chief executive officer, president, principal
financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president in charge
of a significant principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs
a policy-making function, or any other person who performs similar policy-making functions for us. The executive officers named in Item
6.A are part of our executive officers for the purpose of the clawback policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The clawback policy relates to incentive-based
compensation, which is any compensation that is granted, earned or vested based wholly or in part upon the attainment of a financial reporting
measure. The clawback policy covers the recovery of incentive-based compensation from an executive officer only in the event that we are
required to prepare an accounting restatement due to the material noncompliance of our financial reporting requirement under the United
States securities laws, including any required accounting restatement to correct an error in previously issued financial statements that
is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected
in the current period or left uncorrected in the current period. Questions as to &#8220;materiality&#8221; will be made by the Compensation
Committee in coordination with the Audit Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The incentive-based compensation subject to recovery
is the incentive-based compensation received during the three completed fiscal years immediately preceding the date that we are required
to prepare an accounting restatement as described above, provided that the person served as an executive officer at any time during the
performance period applicable to the incentive-based compensation in question provided that the clawback policy shall only apply if the
incentive-based compensation is received while we have a class of securities listed on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our clawback policy is available on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment Agreements </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into employment agreements with
each of our executive officers. Under these agreements, each of our executive officers is employed for unlimited period. We may terminate
employment for cause, at any time, without advance notice or remuneration, for certain acts of the executive officer, such as a conviction
or plea of guilty to a felony or any crime involving moral turpitude, negligent or dishonest acts to our detriment, or misconduct or a
failure to perform agreed duties. We may also terminate an executive officer&#8217;s employment without cause upon an advance written
notice of one or two months. In such case of termination by us, we will provide severance payments to the executive officer as expressly
required by applicable law of the jurisdiction where the executive officer is based. The executive officer may resign at any time with
the same advance written notice.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each executive officer has agreed to hold, both
during and after the termination or expiration of his or her employment agreement, in confidence and not to use, except as required in
the performance of his or her duties in connection with the employment or pursuant to applicable law, any of our confidential information
or trade secrets, any confidential information or trade secrets of our clients or prospective clients, or the confidential or proprietary
information of any third party received by us and for which we have confidential obligations. The executive officers have also agreed
to disclose to us all inventions, designs and trade secrets which they conceive, develop or reduce to practice during the executive officer&#8217;s
employment with us and to assign all right, title and interest in them to us, and assist us in obtaining and enforcing patents, copyrights
and other legal rights for these inventions, designs and trade secrets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, each executive officer has agreed
to be bound by non-competition and non-solicitation restrictions during the term of his or her employment and typically for one year following
the last date of employment. Specifically, each executive officer has agreed not to (i) approach our suppliers, clients, customers or
contacts or other persons or entities introduced to the executive officer in his or her capacity as a representative of us for the purpose
of doing business with such persons or entities that will harm our business relationships with these persons or entities; (ii) assume
employment with or provide services to any of our competitors, or engage, whether as principal, partner, licensor or otherwise, with any
of our competitors, without our express consent; or (iii) seek directly or indirectly, to solicit the services of any of our employees
who is employed by us on or after the date of the executive officer&#8217;s termination, or in the year preceding such termination, without
our express consent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Insurance, Indemnification and Release </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, our Compensation Committee and
Board approved the purchase of an insurance coverage in respect of the liability of Office Holders currently in office and any additional
or others which may be appointed from time to time in the future, for up to $10&#160;million in coverage, consistent with the Company&#8217;s
Compensation Policy as originally approved by the shareholders under the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have also entered into indemnification agreements
with each of our Office Holders<i>. </i>Under these agreements, we agree to indemnify our directors and executive officers against certain
liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director or officer of our
company. The maximum indemnification amount set forth in such agreements is limited to the greater of (i)&#160;25% of our shareholders&#8217;
equity on a consolidated basis, based on the most recent financial statements made publicly available before the date on which the indemnity
payment is made; and (ii) $25&#160;million. The maximum amount set forth in such agreements is in addition to any amount paid (if paid)
under insurance&#160;and/or&#160;by a third-party&#160;pursuant to an indemnification arrangement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has approved the indemnification
of Mr. Marenko to cover any guarantees and personal undertakings he may be providing on our behalf and for our benefit, with respect to
contractual obligations provided by us to third parties, such as landlords and lessors, limited to the face value of such guarantee, based
on the indemnity terms provided to all of our executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Equity Incentive Plans </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>2016 Incentive Share Option Plan </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our 2016 Incentive Share Option Plan (the &#8220;2016
Plan&#8221;) was adopted by our board of directors on September&#160;25, 2016. The 2016 Plan provides for the grant of options to our
employees, directors, Office Holders, service providers and consultants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Authorized Shares. </i>As of December 31, 2024,
there were 1,698,404 ordinary shares subject to options under the 2016 plan and 395,868 ordinary shares reserved and available for issuance
under the 2016 Plan. The 2016 Plan provides that ordinary shares subject to options granted under the 2016 Plan that expire or become
un-exercisable without having been exercised will become available again for future grants under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Administration. </i>Our board of directors
had authorized the compensation committee to serve as administrator (the &#8220;<b>Administrator</b>&#8221;) of the 2016 Plan. Under the
2016 Plan, the administrator has the full power and authority, subject to applicable law, to, among other things: (i)&#160;designate participants
in the 2016 Plan; (ii)&#160;determine the terms and provisions of the respective option agreements, including, but not limited to, the
number of options to be granted to each optionee, the number of shares to be covered by each option, provisions concerning the time and
the extent to which the option may be exercised and the nature and duration of restriction as to the transferability and to amend, cancel,
suspend, convert or substitute such option agreements, as necessary; (iii)&#160;determine the Fair Market Value of the shares covered
by each option; (iv)&#160;make an election as to the type of Section&#160;102 approved option; (v)&#160;designate the type of options;
(vi)&#160;interpret the provisions and supervise the administration of the 2016 Plan; (vii)&#160;accelerate the right of an optionee to
exercise in whole or in part, any previously granted option; (viii)&#160;determine the exercise price of the option; (ix)&#160;prescribe,
amend and rescind rules and regulation relating to the 2016 Plan; (x)&#160;extend the period of the 2016 Plan; and (xi)&#160;make all
other determinations deemed necessary or advisable for the administration of the 2016 Plan, including, without limitation, to adjust the
terms of the 2016 Plan or any option agreement so as to reflect (a)&#160;changes in applicable law and (b)&#160;the laws of other jurisdictions
within which we wish to grant options.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Eligibility.</i> The 2016 Plan provides for
granting Options under the Israeli tax regime, including in compliance with Section&#160;102 (&#8220;Section&#160;102&#8221;) of the Israeli
Income Tax Ordinance (New Version),&#160;5721-1961 (the &#8220;Ordinance&#8221;), and Section&#160;3(i)&#160;of the Ordinance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&#160;102 of the Ordinance allows employees,
directors and officers who are not &#8220;controlling shareholders&#8221; (as used under the Ordinance) and are considered Israeli residents
to receive favorable tax treatment for compensation in the form of shares or options under certain terms and conditions. Our non-employee
service providers and controlling shareholders who are considered Israeli residents may only be granted options under section 3(i)&#160;of
the Ordinance, which does not provide for similar tax benefits. Section&#160;102 includes two alternatives for tax treatment involving
the issuance of options or shares to a trustee for the benefit of the grantees and also includes an additional alternative for the issuance
of options or shares directly to the grantee. Section&#160;102(b)(2)&#160;of the Ordinance, which provides the most favorable tax treatment
for the grantee, permits the issuance to a trustee under the &#8220;capital gain track.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Grant.</i> Options granted pursuant to the
2016 Plan are evidenced by (i)&#160;a resolution of our board of directors and/or a written option agreement with the optionee, in such
form as the Administrator has from time to time approved and (ii)&#160;any all other documents required by us, whether before or after
the grant of the options (including, without limitation, any customary documents and undertaking towards the trustee, if applicable, and/or
the tax authorities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each option agreement states, among other matters,
the number of shares to which the option relates, the type of option granted thereunder, the vesting dates, the exercise price per share,
the expiration date and such other terms and conditions as the Administrator in its discretion may prescribe, provided that they are consistent
with the 2016 Plan. In case of a conflict between the provisions of the 2016 Plan and an option agreement, the provisions of the 2016
Plan will prevail, unless otherwise specifically stated in the option agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Awards. </i>The 2016 Plan provides for the
grant of options to purchase ordinary shares pursuant to the 2016 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercise. </i>An option under the 2016 Plan
may be exercised by providing us with a written notice of exercise and full payment of the exercise price for such shares, in such form
and method as may be determined by the administrator and, when applicable, by the trustee in accordance with the requirements of Section&#160;102,
the Ordinance and any other applicable law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Transferability. </i>Other than by will, the
laws of descent and distribution or as otherwise provided under the 2016 Plan, neither the options nor any right in connection with such
options are assignable or transferable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of Employment.</i> In the event
of termination of an optionee&#8217;s employment or service with us or any of our affiliates, all unvested and exercisable awards held
by such optionee as of the date of termination will expire, unless extended as specified below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of an optionee&#8217;s termination
of employment or service, on the termination date, the unvested portion of the optionee&#8217;s option will cease to vest and such unvested
options will expire and will not become exercisable. In the event of termination of employment or service of an optionee, vested options
as of the termination date will expire.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding any of the foregoing, and unless
otherwise stated in the optionee&#8217;s option agreement, an option may be exercised after the termination of employment for an additional
period of time, but only with respect to the options that had vested at the time of such termination of employment, if: (i)&#160;termination
is without cause (as defined in the 2016 Plan), by us or by the optionee, or retirement at the retirement age as defined in the applicable
law, in which event any vested options as of the termination date may be exercised within 60&#160;days after the date of such termination
of employment, but in no event subsequent to the expiration date of such option. After such 60-day period, all such unexercised awards
will terminate, and the shares covered by such awards will again be available for issuance or (ii)&#160;termination is the result of death
or disability of the optionee, in which event any vested options as of termination date may be exercised within a period of twelve (12)&#160;months
after the date of such termination, but in any event no later than the expiration date of such option; or (iii)&#160;at any time the administrator
may authorize, in its sole and absolute discretion and without such act constituting a precedent in respect of any other optionee, an
extension of the terms of all or part of the vested options beyond the date of such termination for a period not to exceed the period
during which the options by their terms would otherwise have expired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Adjustments. </i>In the event of any merger,
reorganization, consolidation, recapitalization, share dividend, share split, share distribution, spin off, combination or reclassification
of our ordinary shares or any other change in corporate structure affecting the number of the ordinary shares, an adjustment in the number
of ordinary shares to be covered by the 2016 Plan, or the exercise price, will be made by the administrator, in its sole direction, consistent
with its determinations under the 2016 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a transaction involving us, the
unexercised options then outstanding under the 2016 Plan or a portion thereof may be, subject to the approval of the board of directors
and the successor company, assumed or substituted for an appropriate number of options or shares or other securities of the successor
company (or a parent or subsidiary of the successor company). In the event of such assumption and/or substitution of options, appropriate
adjustments will be made to the exercise price so as to reflect such action and all other terms and conditions of the option agreement
will remain unchanged, including, but not limited to, the vesting schedule, unless otherwise determined by the Administrator, which determination
will be in its sole discretion and final. In any such transaction, if the successor company (or parent or subsidiary of the successor
company) does not agree to assume or substitute the options, the board will have full power and authority to determine that (i)&#160;the
vesting dates will be accelerated so that any unvested option or any portion thereof will be immediately vested upon the occurrence of
the transaction; or (ii)&#160;any unvested options will be cancelled or cashed out in connection with the transaction. Notwithstanding
anything to the contrary in the 2016 Plan and subject to the above, if, in a transaction, the successor company (or parent or subsidiary
of the successor company) does not agree to assume or substitute the options, unless determined otherwise by the board, all unexercised
options and all unvested options will expire as of the date of the transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Board&#8217;s decision on August
2024 to extend the expiration term of all equity-based awards granted under the 2016 Incentive Share Option Plan, each granted option
will expire no later than ten&#160;years from the date of the grant thereof (instead of seven years), unless a shorter term of expiration
is otherwise designated by the administrator.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the adoption of the 2021 Equity Incentive
Plan (the &#8220;2021 Plan&#8221;), we have not granted any awards pursuant to the 2016 Plan anymore (although previously granted options
under the 2016 Plan remain outstanding and governed by the 2016 Plan). Any remaining ordinary shares reserved and available for issuance
under the 2016 Plan have been assigned to be awarded under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2021 Equity Incentive Plan </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 7, 2021, we adopted the 2021 Plan,
under which we may grant equity-based incentive awards to attract, motivate and retain the talent for which it competes. The maximum number
of shares that may be issued pursuant to the 2021 Plan is the sum of (a) 4,079,427 ordinary shares plus (and without the need to further
amend the Plan) (b) on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2031, a number
of ordinary shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December 31 of the immediately
preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar year in which
the increase will occur. In addition, any remaining ordinary shares reserved and available for issuance under the 2016 Plan can be issued
pursuant to the 2021 Plan. As of December 31, 2024, there were 7,804,378 ordinary shares subject to options under the 2021 plan and 136,101
ordinary shares reserved and available for issuance under the 2021 Plan. Following the increase in the size of the reserved and available
option pool on December 18, 2024, by an additional 3,698,746 ordinary shares, there were a total of 4,230,715 ordinary shares reserved
and available for issuance under the 2021 Plan (including any remaining ordinary shares reserved and available for issuance under the
2016 Plan).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Administration.</i> Our board of directors
had authorized the compensation committee of our board of directors, to administer the 2021 Plan. Under the 2021 Plan, the administrator
has the authority, subject to applicable law, to interpret the terms of the 2021 Plan and any award agreements or awards granted thereunder,
designate recipients of awards, determine and amend the terms of awards, including the exercise price of an option award, the fair market
value of an ordinary share, the time and vesting schedule applicable to an award or the method of payment for an award, accelerate or
amend the vesting schedule applicable to an award, prescribe the forms of agreement for use under the 2021 Plan and take all other actions
and make all other determinations necessary for the administration of the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The administrator also has the authority to amend
and rescind rules and regulations relating to the 2021 Plan or terminate the 2021 Plan at any time before the date of expiration of its
ten-year term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Eligibility.</i> The 2021 Plan provides for
granting awards under various tax regimes, including, without limitation, for awards granted to our Israeli employees or service providers,
in compliance with Section&#160;102 of the Ordinance or Section&#160;3(i)&#160;of the Ordinance and for awards granted to non-Israeli
employees or service providers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section&#160;102 of the Ordinance allows employees,
directors and officers who are not &#8220;controlling shareholders&#8221; (as used under the Ordinance) and are considered Israeli residents
to receive favorable tax treatment for compensation in the form of shares or options. Our non-employee service providers and controlling
shareholders may only be granted options under section 3(i)&#160;of the Ordinance, which does not provide for similar tax benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Grant.</i> All awards granted pursuant to the
2021 Plan will be granted pursuant to a resolution of our Compensation Committee (and the Board, if it necessary under the Israeli Companies
Law) and an award agreement, in a form approved, from time to time, by the administrator. The award agreement will set forth the terms
and conditions of the award, including the type of award, number of shares subject to such award, vesting schedule and conditions (including
performance goals or measures) and the exercise price, if applicable. Certain awards under the 2021 Plan may constitute or provide for
a deferral of compensation, subject to Section&#160;409A of the Code, which may impose additional requirements on the terms and conditions
of such awards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Awards.</i> The 2021 Plan provides for the
grant of stock options (including incentive stock options and nonqualified stock options), ordinary shares, restricted shares, restricted
share units and other share-based awards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercise.</i> An award under the 2021 Plan
may be exercised by providing us with a written or electronic notice of exercise and full payment of the exercise price for such shares
underlying the award, if applicable, in such form and method as may be determined by the administrator and permitted by applicable law.
An award may not be exercised for a fraction of a share. With regard to tax withholding, exercise price and purchase price obligations
arising in connection with awards under the 2021 Plan, the administrator may, in its discretion, accept cash, provide for net withholding
of shares in a cashless exercise mechanism or, if the issuance of the shares is subject to an effective registration statement under the
Securities Act, direct a securities broker to sell shares and deliver all or a part of the proceeds to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Transferability.</i> Other than by will, the
laws of descent and distribution or as otherwise provided under the 2021 Plan, neither the options nor any right in connection with such
options are assignable or transferable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of Employment. </i>In the event
of termination of a grantee&#8217;s employment or service with us or any of our affiliates, all vested and exercisable awards held by
such grantee as of the date of termination may be exercised within three&#160;months after such date of termination, unless otherwise
determined by the Compensation Committee. After such period, all such unexercised awards will terminate and the shares covered by such
awards will again be available for issuance under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of termination of a grantee&#8217;s
employment or service with us or any of its affiliates due to such grantee&#8217;s death, permanent disability or retirement, all vested
and exercisable awards held by such grantee as of the date of termination may be exercised by the grantee or the grantee&#8217;s legal
guardian, estate, or by a person who acquired the right to exercise the award by bequest or inheritance, as applicable, within twelve&#160;months
after such date of termination, unless otherwise provided by the administrator. Any awards which are unvested as of the date of such termination
or which are vested but not then exercised within such date, will terminate and the shares covered by such awards will again be available
for issuance under the 2021 Plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding any of the foregoing, if a grantee&#8217;s
employment or services with us or any of its affiliates is terminated for &#8220;cause&#8221; (as defined in the 2021 Plan), all outstanding
awards held by such grantee (whether vested or unvested) will terminate on the date of such termination (and in certain circumstances
defined in the 2021 Plan, within 12&#160;months thereafter), and the shares covered by such awards shall again be available for issuance
under the 2021 Plan .</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Transactions.</i> In the event of a recapitalization
event, as defined in the 2021 Plan, including share split, reverse share split, share dividend, combination or reclassification of our
shares, or any other increase or decrease in the number of issued shares effected without receipt of consideration by us, the administrator
in its sole discretion will make an appropriate adjustment in the number of shares related to each outstanding award and to the number
of shares reserved for issuance under the 2021 Plan, to the class&#160;and kind of shares subject to the 2021 Plan, as well as the exercise
price per share of each outstanding award, as applicable, the terms and conditions concerning vesting and exercisability and the term
and duration of outstanding awards, or any other terms that the administrator adjusts in its discretion, or the type or class of security,
asset or right underlying the award (which need not be only that of us, and may be that of the surviving corporation or any affiliate
thereof or such other acquiring party or entity party to any of the above transactions); provided that any fractional shares resulting
from such adjustment will be rounded down to the nearest whole share unless otherwise determined by the administrator.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a merger or consolidation of us,
or a sale of all, or substantially all, of the our shares or assets or other transaction having a similar effect on us, or a change of
control event (including an acquisition of 50% or more of the share capital) or change in the composition of the board of directors, or
liquidation or dissolution, a structural change, as defined in the 2021 Plan, or such other transaction or circumstances that the board
of directors determines to be a relevant transaction, then without the consent of the grantee, the administrator may but is not required
to (i)&#160;cause any outstanding award to be assumed or substituted by such successor corporation, or (ii)&#160;regardless of whether
or not the successor corporation assumes or substitutes the award (a)&#160;provide the grantee with the option to exercise the award as
to all or part of the shares, and may provide for an acceleration of vesting of unvested awards, or (b)&#160;cancel the award and pay
in cash, shares of us, the acquirer or other corporation which is a party to such transaction or other property as determined by the administrator
as fair in the circumstances. Notwithstanding the foregoing, in the event of a Merger/Sale the administrator may upon such event amend,
modify or terminate the terms of any award as it shall deem, in good faith, appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Board Practices </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terms of Directors and Officers </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to our Restated Articles, our directors
are generally appointed by our shareholders. Our board is classified into three classes as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class I directors, who serve until the annual general meeting to be held in 2025. Mr. Ehud Levy, Dr. Noam Arkind and Mr. Alexander Hitzinger are our Class I directors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class II directors, who serve until the annual general meeting in 2026. Dr. Boaz Schwartz, Thilo Koslowski and Prof. Yonina Eldar are our Class II directors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class III directors, who serve until the annual general meeting in 2027. Mr. Yair Shamir, Mr. Kobi Marenko and Mr. E. Scott Crist are our Class III directors.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At each annual general meeting, the shareholders
will vote for the election of the directors of the class whose term expires at such annual general meeting, and such directors shall be
elected to hold office until the third annual general meeting next succeeding his/her election and until his/her respective successor
shall have been elected and qualified until such earlier time as such director&#8217;s office is vacated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our officers are appointed by our Chief Executive
Officer and serve according to the direction of the Chief Executive Officer and the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees of the Board of Directors </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors has the following standing
committees: an Audit Committee, a Compensation Committee and a Nominating&#160;and Corporate Governance Committee. Each of the committees
of the board of directors has the composition and responsibilities as described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Audit Committee consists of three independent
directors, each of whom is financially literate and one of whom is an audit committee financial expert. Pursuant to regulations promulgated
under the Israeli Companies Law and governing relief to companies which are generally listed in Nasdaq, we are exempt from the Israeli
composition and qualification requirements with respect to the Audit Committee members, however we are still obliged to maintain such
committee also for Israeli law purposes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Nasdaq regulations, a member of our
Audit Committee may not accept any consulting, advisory, or other compensatory fee from us other than for board service, and they must
not be an affiliated person and not have participated in the preparation of our or our subsidiaries&#8217; financial statements at any
time during the past three years. At least one member of the Audit Committee must be an audit committee financial expert, which is a person
who has past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable
experience or background which results in the individual&#8217;s financial sophistication, including being or having been a chief executive
officer, chief financial officer or other senior officer with financial oversight responsibilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee is responsible, among its
other duties and responsibilities, for overseeing our accounting and financial reporting processes, audits of financial statements, qualifications
and independence of the independent registered public accounting firm, the effectiveness of internal control over financial reporting,
risk management and the performance of the internal audit function and independent registered public accounting firm. The Audit Committee
reviews and assesses the qualitative aspects of our financial reporting, processes to manage business and financial risks, and compliance
with significant applicable legal, ethical and regulatory requirements and is directly responsible for the appointment, compensation,
retention and oversight of the independent registered public accounting firm. In addition, pursuant to the Israeli Companies Law the Audit
Committee is responsible for the following additional matters:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending to the board of directors the retention and termination of the internal auditor, and the internal auditor&#8217;s engagement fees and terms, in accordance with the Israeli Companies Law as well as approving the yearly or periodic work plan proposed by the internal auditor;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing with the general counsel and/or external counsel, as deemed necessary, legal and regulatory matters that could have a material impact on the financial statements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying irregularities in the company&#8217;s business administration, including by consulting with the internal auditor or with the independent auditor, and suggesting corrective measures to the board of directors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing policies and procedures with respect to transactions (other than transactions related to the compensation or terms of services) between the company and officers and directors, or affiliates of officers or directors, or transactions that are not in the ordinary course of our business and deciding whether to approve such acts and transactions if so required under the Israeli Companies Law; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing procedures for the handling of employees&#8217; complaints as to the management of our business and the protection to be provided to such employees.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has also the authority, with
respect to the following matters:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style=" font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the assistance of management, to advise the Board and any other Board committee if the clawback provisions of our clawback policy are
triggered based upon a financial statement restatement or other financial statement change.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style=" font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
implement and oversee our cybersecurity and information security policies and periodically review the policies and manage potential cybersecurity
incidents.</span></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter of the Audit Committee is available
on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Audit Committee are Dr. Boaz
Schwartz, Mr. Ehud Levy and Mr. Thilo Koslowski. Each member is an independent director and &#8220;financially literate&#8221; under the
Nasdaq rules, and Dr. Boaz Schwartz, the chairman of our Audit Committee is an &#8220;audit committee financial expert.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Under Nasdaq
corporate governance rules, we are required to maintain a compensation committee consisting of at least two independent directors, and
the board shall have determined that the members of the Compensation Committee </span>have the <span>ability
to be independent from management in connection with the duties of a Compensation Committee member.</span> We are also required to maintain
a compensation committee for purposes of the Israeli law; however, we are exempt from the Israeli composition and qualification requirements
with respect to its members generally because of our Nasdaq listing. The Compensation Committee is responsible, among its other duties
and responsibilities, for reviewing and approving all forms of compensation to be provided to, and employment agreements with, our executive
officers and directors, establishing the general compensation policies of us and our subsidiaries and reviewing, approving and overseeing
the administration of our employee benefits plans and reviewing our compensation plans and policies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee has the authority to
retain compensation consultants, outside counsel and other advisers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee is also responsible
for the following pursuant to the Israeli Companies Law:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending to the board of directors with respect to the approval of the compensation policy for &#8220;Office Holders&#8221; (a term used under the Israeli Companies Law, which essentially means directors and executive officers, and also includes some officers who are not listed as Senior Management);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, once every three&#160;years, reviewing and approving any extensions to the Compensation Policy;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing the implementation of the compensation policy and periodically recommending to the board of directors with respect to any amendments or updates of the compensation plan;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.7pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">resolving whether or not to approve arrangements with respect to the terms of office and employment of Office Holders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exempting, under certain circumstances, from the requirement of approval by the general meeting of shareholders, transactions with our chief executive officer; and,</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee shall have, with the
assistance of management, the authority and responsibility to, either by itself or in coordination with the Audit Committee, make any
determinations and take or authorize the taking of any action contemplated by our clawback policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter of the Compensation Committee is available
on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Compensation Committee are
Dr. Boaz Schwartz, chairman, Mr. E. Scott Crist, and Mr. Yair Shamir. Each member of the Compensation Committee is an independent director
under to the Nasdaq standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nominating and Governance Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Nominating and Governance Committee is responsible,
among other things, for:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing and assisting its board in reviewing and recommending nominees for election as directors, including determining whether a nominee for election as a director is an independent director;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing the performance of the members of the board and the committees; and</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing the performance of the members of the board; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing and maintaining effective corporate governance policies and practices, including, but not limited to, developing and recommending to the board a set of corporate governance guidelines applicable to us.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charter for the Nominating and Governance
Committee is available on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The members of the Nominating and Governance Committee
are Mr. Ehud Levy, chairman, Mr. Yair Shamir and Mr. Alexander Hitzinger. Each member of the Nominating and Governance Committee is independent
under the Nasdaq standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Diversity</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nasdaq rules provide that each company listed
on Nasdaq must have or explain why it does not have at least two members of its board of directors including (i) at least one diverse
director who self identifies as female and (ii) at least one diverse director who self-identifies as an underrepresented minority or LGBTQ+.
For foreign issuers &#8220;diverse&#8221; means an individual who self-identifies as one or more of the following: female, LGBTQ+, or
an underrepresented individual based on national, racial, ethnic, indigenous, cultural, religious or linguistic identity in the country
of the company&#8217;s principal executive offices. In addition, Nasdaq rules provided for issuers to provide a board diversity matrix
in the from provided by Nasdaq, which we provide on our website. On December 11, 2024, the United States Court of Appeals for the Fifth
Circuit struck down Nasdaq&#8217;s board diversity rules, and the SEC did not appeal the ruling. As a result, companies listed on Nasdaq
no longer need to comply with Nasdaq&#8217;s board diversity rule requirements including the board diversity matrix, although they may elect
to do so.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Israeli law, if, at the time of a director
is appointed or elected all members of the board who are neither controlling shareholders nor their relatives are of the same gender,
then the new director must be of the other gender. Since we have a female member of our board, we satisfy the diversity requirement under
Israeli law. <b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Chairperson of the Board </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Articles provide that the board shall, from
time to time, elect one of its members to be the chairperson of the board, remove such chairperson from office and appoint another in
his/her place. Under the Companies Law, if the chief executive officer (or any relative thereof, or subordinate employee) is nominated
to serve as the chairperson of the board, such appointment shall be subject to a shareholder approval in a special disinterested majority
vote.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current chairperson of our board of directors
is Mr. Yair Shamir.<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Internal Auditor</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, the board of
directors of a public company must appoint an internal auditor based on the recommendation of the audit committee. The role of the internal
auditor is, among other things, to examine whether a company&#8217;s actions comply with applicable law and orderly business procedure.
Under the Israeli Companies Law, the internal auditor cannot be an interested party or an Office Holder or a relative of an interested
party or an Office Holder, nor may the internal auditor be the company&#8217;s independent auditor or its representative. An &#8220;interested
party&#8221; is defined in the Israeli Securities Law as: (i)&#160;a holder of 5% or more of the issued share capital or voting power
in a company, (ii)&#160;any person or entity who has the right to designate one or more directors or to designate the chief executive
officer of the company, or (iii)&#160;any person who serves as a director or as a chief executive officer of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board, following the recommendation of our
Audit Committee, appointed Ms. Dana Gottesman as our internal auditor. Ms. Gottesman is a partner at BDO Israel Consulting Group.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors reviewed the materiality
of any relationship that each of our proposed directors has with us, either directly or indirectly. Based on this review, the board determined
that Mr. Yair Shamir, Mr. Ehud Levy, Prof. Yonina Eldar, Dr. Boaz Schwartz, Mr. Thilo Koslowski, Mr. Alexander Hitzinger and Mr. Scott
Crist are &#8220;independent directors&#8221; as defined by Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>External Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See the section entitled &#8220;Election and Removal
of Directors&#8221; in Item 10.B</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no family relationship among any of our
directors or executive officers.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Involvement in Certain Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No executive officer or director of ours has been involved in the last
ten years in any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any bankruptcy petition filed by or against any business or property of such person, or of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being the subject of or a party to any judicial or administrative order, judgment, decree or finding, not subsequently reversed, suspended or vacated relating to an alleged violation of any federal or state securities or commodities law or regulation, or any law or regulation respecting financial institutions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail, fraud, wire fraud or fraud in connection with any business entity; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Being the subject of or a party to any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act, any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Employees </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, we had 144 employees
and consultants, of which nine individuals provide services to us through consulting agreements. 135 of our employees and consultants
were based in Israel, two in the United States, two in China, one in Thailand, one in Canada one in United Kingdom and two in Germany.
The following table sets forth a breakdown of our global workforce by category of activity as of December 31, 2024:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Category of Activity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0.5pt">Research and development and operations</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">115</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">114</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.5pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt">General and Administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt; padding-left: 0.5pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">144</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">137</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 1, 2025, our global workforce decreased
to 138 employees. The reduction was primarily aimed to shift focus towards our main growth path, while reducing certain positions, mainly
in the research and development department.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of our employees are represented by a labor
union, and we consider our employee relations to be <span>satisfactory</span>. To date, we have not experienced
any work stoppages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>E. Share Ownership</b>.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of our ordinary shares are entitled to
vote together as a single class on all matters submitted to shareholders for approval. No holder of ordinary shares has different voting
rights from any other holders of ordinary shares. We are not aware of any arrangement that may, at a subsequent date, result in a change
of control of our company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding
the beneficial ownership of ordinary shares on March 1, 2025, by</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 27px">&#160;</td>
    <td style="text-align: justify; width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each person known by us to be the beneficial owner of more than 5% of the outstanding ordinary shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 27px">&#160;</td>
    <td style="text-align: justify; width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of our directors, chief executive officer, chief financial officer and other members of Senior Management; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 27px">&#160;</td>
    <td style="text-align: justify; width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of our Senior Management and directors as a group.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise indicated, we believe that all
persons named in the table below have sole voting and investment power with respect to all shares beneficially owned by them. Except as
otherwise noted herein, the number and percentage of ordinary shares beneficially owned is determined in accordance with Rule&#160;13d-3&#160;of
the Exchange&#160;Act, and information provided to us, and the information is not necessarily indicative of beneficial ownership for any
other purpose. Under such rule, beneficial ownership includes any ordinary shares as to which the holder has sole or shared voting power
or investment power and also any ordinary shares which the holder has the right to acquire within 60&#160;days of March 1, 2025 through
the exercise of any option, warrant, convertible security or other right. As of March 1, 2025, there were 105,163,188 ordinary shares
outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Address of Beneficial Owner<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> Ordinary <br/> Shares <br/> Beneficially <br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Directors and Senior Management:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kobi Marenko<sup>(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,879,418</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2.73</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noam Arkind<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,535,503</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.40</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karine Pinto-Flomenboim<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">219,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ehud Levy<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,040,243</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.59</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yair Shamir<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,360,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.00</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boaz Schwartz<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.&#160;Scott Crist<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,647,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.39</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thilo Koslowski<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99,999</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander Hitzinger<sup>(10)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prof. Yonina Eldar<sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt">All directors and Senior Management as a group</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,712,809</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25.28</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0.5pt">Five Percent Holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AWM Investment Company, Inc. <sup>(11)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,796,934</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.99</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canaan Partners Israel (CPI) (Cayman) L.P.<sup>(12)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,040,243</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.59</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alyeska Master Fund, L.P.<sup>(13)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,336,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.26</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEL Catalyst Mobility Ltd. and Catalyst IV Fund L.P <sup>(14)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,360,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.00</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
than 1%</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise noted, the address for each named beneficial owner who is a director or senior management is c/o Arbe Robotics Ltd., HaHashmonaim
St. 107, Tel Aviv-Yafo, Israel.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of 2,299,232 ordinary shares held directly by Mr.&#160;Marenko, 252,076 ordinary shares subject to options, 185,000 restricted stock
units and&#160;&#160;143,110 ordinary shares held by Inter &#8212; Development of Content in Internet Company Ltd. (&#8220;Inter&#8221;),
which is owned by Mr.&#160;Marenko, who has the right to vote and dispose of shares owned by Inter.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of 2,098,982 ordinary shares held directly by Mr.&#160;Arkind, 251,521 ordinary shares subject to options and 185,000 restricted stock
units.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of ordinary shares subject to options and restricted stock units.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of (i) 9,000,243 ordinary shares identified in footnote (12) below, and (ii) 40,000 ordinary shares subject to options granted to Mr.
Levy. Mr.&#160;Levy is affiliated with Canaan Partners Israel (CPI) (Cayman) L.P and may be deemed to have beneficial ownership with
respect to these shares. Mr.&#160;Levy disclaims beneficial interest in the shares owned by Canaan Partners except to the extent of any
pecuniary interest he may have therein directly or indirectly.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of (i) 7,320,929 ordinary shares identified in footnote (14) below, and (ii) 40,000 ordinary shares subject to options granted to Mr.
Shamir. &#160;Mr.&#160;Shamir is affiliated with CEL Catalyst Mobility Ltd. but disclaims any beneficial ownership of the shares owned
by CEL Catalyst Mobility Ltd. except to the extent of any pecuniary interest Mr. Shamir may have therein, directly or indirectly.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consist
of: (i) 298,619 ordinary shares held by Geneva Insurance Group (Barbados) Inc. in respect of Separate Account&#160;2020-418-VUL (the
&#8220;Account&#8221;), which account is held for the benefit of a trust (the &#8220;Master Trust&#8221;), of which Mr.&#160;Schwartz,
alongside others, is an indirect beneficiary, and (ii) 101,588 ordinary shares subject to options. Accordingly, Mr.&#160;Schwarz may
be deemed to have an indirect beneficial ownership interest with respect to the shares. Furthermore, Mr.&#160;Schwartz is one of three
members of the Investment Committee of the Master Trust, which holds the Account. The Investment Committee operates by majority, and
Mr.&#160;Schwartz does not have any independent control of the Investment Committee and may only act with the vote of one or more of
the other members of the Investment Committee.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of (i) 964,182 ordinary shares owned by Mr. Crist, (ii) 340,000 ordinary shares held by Texas Ventures Mgmt, LLC (&#8220;Texas Ventures&#8221;),
(iii) 2,303,031 ordinary shares issuable upon exercise of private warrants owned by Mr. Crist and (iv) 40,000 ordinary shares subject
to options granted to Mr. Crist.&#160;&#160;Mr. Crist is chief executive officer and majority owner of Texas Ventures and has the right
to vote and dispose of securities held by Texas Ventures. Mr. Crist disclaims any beneficial ownership of the shares held by Texas Ventures
other than to the extent of any pecuniary interest he may have therein, directly or indirectly.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consist
of ordinary shares subject to options.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of (i) 64,777 ordinary shares and (ii) 93,332 ordinary shares subject to options.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="text-align: justify">Consists of: (i) 2,906,526 Ordinary Shares, 2,008,449 Pre-Funded Warrants
and 4,016,898 warrants held by Special Situations Fund III QP, L.P. (ii) 910,669 Ordinary Shares, 477,400 Pre-Funded warrants and 954,800
warrants held by Special Situations Cayman Fund, L.P. (iii) 395,453 Ordinary Shares, 352,963 Pre-Funded Warrants and 705,926 warrants
held by Special Situations Private Equity Fund, L.P. (iv) 272,347 Ordinary Shares, 212,721 Pre-Funded Warrants and 425,442 warrants held
by Special Situations Technology Fund, L.P. and (v), 1,443,810 Ordinary Shares, 904,510 Pre-Funded Warrants and 1,809,020 warrants held
by Special Situations Technology Fund II, L.P. The warrants described herein may only be exercised to the extent that the total number
of Ordinary Shares beneficial owned by the holder and its affiliates after such exercise does not exceed 9.99% of the outstanding shares.
&#160;AWM Investment Company, Inc., a Delaware corporation (&#8220;AWM&#8221;), is the investment adviser to Special Situations Cayman
Fund, L.P., a Cayman Islands Limited Partnership (&#8220;SSF CAYMAN&#8221;), Special Situations Fund III QP, L.P., a Delaware limited
partnership (&#8220;SSFQP&#8221;), Special Situations Private Equity Fund, L.P., a Delaware limited partnership (&#8220;SSPE&#8221;),
Special Situations Technology Fund, L.P., a Delaware limited partnership (&#8220;SSF TECH&#8221;) and Special Situations Technology Fund
II, L.P., a Delaware limited partnership (&#8220;SSF TECH II&#8221;). Mr. David M. Greenhouse (&#8220;Greenhouse&#8221;) and Mr. Adam
C. Stettner (&#8220;Stettner&#8221;) are limited partners of MGP Advisers Limited Partnership, a Delaware limited partnership, the general
partner of SSFQP. Greenhouse and Stettner are members of, SSCayman, L.L.C., a Delaware limited liability company, the general partner
of SSF CAYMAN, MG Advisers, L.L.C., a New York limited liability company, the general partner of SSPE and SST Advisers, L.L.C., a Delaware
limited liability company, the general partner of SSF TECH and SSF TECH II. Greenhouse and Stettner are also the controlling principals
of AWM and have the power to direct, vote and dispose of the shares The business address for AMW is c/o Special Situations Funds, 527
Madison Avenue, Suite 2600, New York, NY 10022.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(12)</td><td style="text-align: justify">Canaan Partners Israel (CPI) GP L.P. (&#8220;CPI General Partner&#8221;)
is the general partner of Canaan Partners Israel (CPI) (Cayman) L.P.&#160;CPI General Partner has the power to direct Canaan Partners
Israel (CPI) (Cayman) L.P. to vote and dispose of the shares by decision of its managing partner Mr.&#160;Ehud Levy. The business address
of the foregoing person is c/o Canaan Partners Israel (CPI) (Cayman) L.P, 12/11 Rav Ashi St. Tel Aviv, Israel.</td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(13)</td><td style="text-align: justify">Consist of: 1,424,448 Ordinary Shares and 7,912,086 warrants
held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., the investment manager of Alyeska Master Fund, L.P. (the &#8220;Alyeska
Master Fund&#8221;), has voting and investment control of the shares held by Alyeska Master Fund. Anand Parekh is the Chief Executive
Officer of Alyeska Investment Group, L.P. and may be deemed to be the beneficial owner of such shares. Mr. Parekh, however, disclaims
any beneficial ownership of the shares held by Alyeska Master Fund. The warrants described herein may only be exercised to the extent
that the total number of Ordinary Shares then beneficial owned does not exceed 9.99% of the outstanding shares. &#160;The registered
address of Alyeska Master Fund, L.P. is at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street George
Town, Grand Cayman, KY1-1104, Cayman Islands. Alyeska Investment Group, L.P. is located at 77 W. Wacker, Suite 700, Chicago IL 60601.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
of: (i) 5,423,493 ordinary shares issued to CEL Catalyst Mobility Ltd. (ii) 1,897,436 ordinary shares issued to CATALYST IV FUND L.P.
and (iii) 40,000 ordinary shares subject to options granted to Mr. Shamir. CEL Catalyst Mobility Ltd. is held by CEL Catalyst China Israel
Fund L.P and Catalyst CEL Fund L.P.&#160;The directors of CEL Catalyst Mobility Ltd. are Yair Shamir and Shengyan Fan who have the power
to direct it to vote and dispose of the shares and each such director has shared voting and investment power over the shares. Each director
disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest such member may have therein,
directly or indirectly. The business address of each of the foregoing persons is c/o Catalyst Investment (Israel)&#160;III Ltd., 28 Ha&#8217;arbaa
St., Tel Aviv 6473925, Israel.</span></td>
</tr></table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Major Shareholders</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See Section E, &#8220;Share Ownership,&#8221; under Item 6 for information
as to our major shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party Transactions</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section refers to related-party transactions
with respect to our directors and executive officers, which are unusual and not in the ordinary course of business of the Company and
does not include compensation or indemnification of Senior Management, which is disclosed above in <i>Item 6.B. Compensation</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kobi Marenko, our CEO, has a non-controlling interest in Taya Ventures L.P, which is a minority shareholder.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inter, a company owned by Kobi Marenko, purchased 50,167 ordinary shares in October 2022 for $501,670 as part of our PIPE offering.&#160;&#160;The purchase was made on the same terms as other investors in the PIPE offering, which involved the sale of 10,000,000 ordinary shares at $10.00 per share contemporaneously with the merger with ITAC.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We and certain investor shareholders (the &#8220;<b>Investor Shareholders</b>&#8221;) are parties to an investor rights agreement, as amended, which grants the Investor Shareholders certain registration rights with respect to their ordinary shares, which agreement includes standard covenants and indemnification provisions. In the event that we wish to provide additional registration rights, we may be required to obtain the approval of the holders of majority of the ordinary shares held by the Investor Shareholders for as long they, as a group, continue to hold such majority upon completion of the merger with ITAC. Such approval is not required if the proposed transaction is approved by the majority of our independent directors (currently, a majority of our board of directors are independent directors). This investor rights agreement will continue and survive for a period of five&#160;years after the closing of the merger, or earlier upon the consummation of any consolidation or merger of the Company with or into a third party as described under the agreement. The Investor Shareholders are able to sell their ordinary shares pursuant to Rule 144 as long as we are current in our required SEC filings. With this filing of this annual report on Form 20-F, we will continue to be current with our required SEC filing.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June 2023, we raised $23.0 million from Special Situations Funds, a family of funds focused primarily on growth oriented small public companies with a concentration on the technology and life sciences industries, pursuant to which we issued a total of 11,794,873 Ordinary Shares at a purchase price of $1.95 per share. Existing investors participated in this offering.&#160;&#160;The aggregate net proceeds received by us from the offering were $22.5 million&#160;net of issuance costs.&#160;&#160;Two of the investors in the financing are affiliates of two of our directors.&#160;&#160;Catalyst Investments, and Geneva Insurance Group, invested $5.3 million and $250,000, respectively.&#160;&#160;Mr. Yair Shamir, chairman and a director is co-founder and managing partner of Catalyst Investments, and Mr. Boaz Scwartz, a director, is a beneficiary of a master trust held by Geneva Insurance Group (Barbados) Inc. and Mr. Schwartz is one of three members of the investment committee of the master trust.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the approvals required under
Israeli law for related-party transactions, disclosure of personal interest and transactions with controlling shareholders, see under
&#8220;Item 10.B.&#8212;Conflict of Interest.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the approvals required under
Israeli law for compensation arrangements of officers and directors, see &#8220;Item 6.B.-&#160;Compensation of Directors and Executive
Officers.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fiduciary Duties of Directors and Executive
Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law provides for fiduciary
duties that Office Holders owe to a company. An &#8216;Office Holder&#8217; is defined under the Israeli Companies Law as a general manager,
chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities of any of these positions
regardless of such person&#8217;s title, a director and any other manager directly subordinate to the general manager. Each person listed
in the table under the section A of Item 6 as Senior Management is an Office Holders under the Israeli Companies Law. However, there are
certain additional persons who are not listed in the above table who may meet the definition of an Officer Holder but who are not part
of our Senior Management as defined in our organizational structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An Office Holder&#8217;s fiduciary duties consist
of a duty of care and a duty of loyalty. The duty of care requires an Office Holders to act with a reasonable level of care and generally
requires to obtain:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">information on the appropriateness of a given action submitted for his or her approval or performed by virtue of his or her position; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all other important information pertaining to these actions.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The duty of loyalty requires an Office Holder
to act in good faith and in the best interests of a company and generally includes the following duties:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from any conflict of interest between the performance of his or her duties in the company and his performance of duties with respect to another position or his or her personal affairs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from any activity that is competitive with the business of the company;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from exploiting any business opportunity of the company in order to receive a personal gain for himself or herself or others; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose to the company any information or documents relating to the company&#8217;s affairs which the Office Holders received as a result of his or her position as Office Holders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shareholder Duties</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Israeli Companies Law, a shareholder
has a duty to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or
her power with respect to the company, including, among other things, in voting at a general meeting and at shareholder class meetings
with respect to the following matters:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an amendment to a company&#8217;s articles of association;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an increase of a company&#8217;s authorized share capital;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a merger; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interested party transactions that require shareholder approval.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, a shareholder has a general duty
to refrain from discriminating against other shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A controlling shareholder also has a duty of fairness
toward the company. For the definition of a &#8220;controlling shareholder&#8221; see above at Item 6.B &#8211; &#8220;Director Independence.&#8221;
The Israeli Companies Law does not define the substance of this duty of fairness, except to state that the remedies generally available
upon a breach of the fiduciary duty will also apply in the event of a breach of the duty of fairness.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Interests of Experts and Counsel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 8. FINANCIAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Consolidated Statements and Other Financial Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our consolidated financial statements begin on
page F-1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &#8220;Legal Proceeding&#8221; under Section
B of &#8220;Item 4. Information on the Company&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Dividends</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have never declared or paid any dividend on
our ordinary shares and we do not anticipate paying any dividends on our ordinary shares in the future. We currently intend to retain
all future earnings to finance our operations and to expand our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>No Significant Changes</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as disclosed elsewhere in this annual report,&#160;no
other significant changes to our financial condition have occurred since the date of the annual financial statements contained herein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -70pt">&#160;</p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9. THE OFFER AND LISTING</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Offer and Listing Details</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares, par value NIS0.000216 per
share, and public warrants are listed for trading on the Nasdaq Stock Market under the symbols &#8220;ARBE&#8221; and &#8220;ARBEW,&#8221;
respectively. Our ordinary shares are also traded on the TASE under the symbol &#8220;ARBE.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our publicly traded ordinary shares and public
warrants are issued in book entry form, and are not subject to any transfer restrictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent for our ordinary shares and
warrant agent for our public warrants is Continental Stock Transfer &amp; Trust Company, One State Street, 30<sup>th</sup> Floor, New
York, New York 10004, telephone: (212) 509-4000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have also listed for trade convertible bonds,
which are traded on the TASE. For further information see Item 12 below under &#8220;<i>Debt Securities.</i>&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Plan of Distribution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Markets</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares and public warrants are currently
traded on the Nasdaq Stock Market. Our ordinary shares are also traded on the TASE.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. Selling Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>E. Dilution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>F. Expenses of the Issuer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 10. ADDITIONAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>A. Share Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Memorandum and Articles of Association</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an Israeli corporation and our affairs
are governed by our Restated Articles of Association (the &#8220;Restated Articles&#8221;) and the Israeli Companies Law. The following
are summaries of material provisions of our Restated Articles and the Israeli Companies Law insofar as they relate to the material terms
of our ordinary shares. This description does not purport to be complete and is qualified in its entirety by reference to the full text
of our Restated Articles, which is filed as an exhibit to this Form 20-F, and by the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section summarizes the material rights of
the holders of ordinary shares under Israeli Companies Law, and the material provisions of the Restated Articles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Authorized Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The authorized share capital consists of&#160;165,000,000
ordinary shares, par value NIS 0.000216. As of March 1, 2025, we had 105,163,188 ordinary shares outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the outstanding ordinary shares are validly
issued, fully paid and&#160;non-assessable.&#160;The ordinary shares are not redeemable and do not entitle their holders to pre-emptive
rights. Our Restated Articles and the Israeli Companies Law do not restrict in any way the ownership or voting of ordinary shares by non-residents
or persons who are not citizens of Israel, except with respect to subjects of nations which are in a state of war with Israel which currently
include Iran, Syria and Lebanon. All ordinary shares have identical rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the rights of holders of shares with
special rights (if such shares are issued in the future), holders of paid up ordinary shares are entitled to participate in the payment
of dividends and, in the event of a winding-up of Arbe, in the distribution of assets available for distribution, in proportion to their
respective shareholdings and in respect of which such dividend is being paid or such distribution is being made, without considering any
premium those holders might have paid in excess of that par value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares with preferential rights relating, among
other things, to dividends, voting and repayment of share capital can be created by adoption of a resolution of the shareholders at a
general meeting of shareholders at which a quorum is present, by a majority of the voting power represented at the meeting in person or
by proxy and voting thereon. We can effect a share distribution or share dividend with board approval. A stock split (as well as other
changes to our authorized capital, including an increase to the authorized capital) approval of the holders of a majority of the outstanding
ordinary shares present with the required quorum. If we have more than one class of shares outstanding, modification or abrogation of
the rights of any class of shares requires the approval of a majority of the shareholders, acting as a single class at a meeting at which
a quorum is present, without any required separate resolution of any class of shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any transaction that has the effect of reducing
the share capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits, requires
the approval of both the board of directors and an Israeli court.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Election and Removal of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our Restated Articles, directors will
be appointed by a simple majority vote of holders of the voting shares, participating and voting at an annual general meeting of the shareholders
at which a quorum is present. Our ordinary shares are currently our only voting shares. Our Restated Articles provide that the board of
directors consist of not fewer than three and not more than nine directors</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, an Israeli public
company is required to appoint at least two natural persons as &#8220;external directors,&#8221; unless the company elects to opt out
of the requirement to maintain such regime. Appointments of external directors are to be for a term of three years and may be extended
for additional three-year terms, subject to certain conditions as provided under the Israeli Companies Law and regulations promulgated
thereunder. We have opted out of the external director requirement because our board or directors consists of a majority of independent
directors, using the Nasdaq definition of independent director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors are divided into three classes,
with one class being elected each year at the Company&#8217;s annual general meeting of shareholders for a term of approximately three
years, until the third annual general meeting following such election or&#160;re-election&#160;or generally until they are removed by
a vote of a majority of the voting power of the shareholders represented at the general meeting in person or by proxy and voting thereon,
and disregarding abstentions from the count of the voting power of the shareholders present and voting. The term of office of each class
directors currently serving on our board shall expire as set forth in Item 6.C. Any change in our Restated Articles to amend the provisions
relating to a classified board requires the approval of the holders of 60% of the ordinary shares outstanding on the applicable record
date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our Restated Articles, a director shall
vacate his or her office if that director dies; is declared bankrupt; is declared to be legally incompetent; resigns such office by notice
in writing given to the Company; is not&#160;re-elected&#160;by the shareholders upon expiration of his or her term at the relevant annual
general meeting of shareholders, or otherwise as provided in the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, our Restated Articles allow our board
of directors to fill vacancies on the board of directors or to appoint new directors up to the maximum number of directors permitted under
our Restated Articles (which is currently nine members). Such directors serve for a term of office equal to the remaining period of the
term of office of the directors(s)&#160;whose office(s)&#160;have been vacated or in the case of new directors, for a term of office according
to the class to which such director was assigned upon appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividends and Liquidation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not require shareholder approval of a dividend
distribution and provide that dividend distributions may be determined by the board of directors; provided that any declaration of a dividend
in the absence of sufficient retained earnings or profits, requires the approval of both the board of directors and an Israeli court.
In certain circumstances provided by regulations promulgated under the Israeli Companies Law, our Board may also approve distributions
in the absence of sufficient retained earnings or profits, without the approval of the Israeli court, subject to complying with certain
conditions as provided therein.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Israeli Companies Law, dividends
may be distributed only out of&#160;earnings or earnings generated over the two&#160;years preceding the distribution, according to the
company&#8217;s most recently reviewed or audited financial statements, provided that the end of the period to which the financial statements
relate is not more than six&#160;months prior to the date of the distribution. If a company does not meet such criteria, then it may distribute
dividends only with court approval. In each case, we would only be permitted to distribute a dividend if the board of directors and the
court, if applicable, determines that there is no reasonable concern that distribution of the dividend will prevent us from being able
to meet our existing and foreseeable obligations as they become due. The deed of trust relating to our convertible bonds has restrictions
on our making distributions, The convertible bonds are described in Item 12.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of liquidation, after satisfaction
of liabilities to our creditors, our assets will be distributed to the holders of the ordinary shares in proportion to their shareholdings.
This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to
holders of a class of shares with preferential rights which may be authorized in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shareholder Meetings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Israeli Companies law, we are required to
hold an annual general meeting of our shareholders once every calendar year (an &#8220;annual meeting&#8221;) and no later than 15&#160;months
after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred
to in our Restated Articles as special meetings (&#8220;special meetings,&#8221; and, together with the annual meeting, &#8220;general
meetings&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Israeli Companies Law provides
that the board of directors is required to convene a special meeting upon the written request of (i)&#160;any two or more of our directors
or&#160;one-quarter&#160;or more of the members of our board of directors or (ii)&#160;one or more shareholders holding, in the aggregate,
either (a)&#160;10% or more of our issued and outstanding shares and 1% or more of our outstanding voting power or (b)&#160;10% or more
of our outstanding voting power.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of the Israeli Companies
Law and regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of
record on a date to be decided by the board of directors, which may generally be between four and sixty&#160;days prior to the date of
the meeting, pursuant to amended regulations governing relief to Israeli public companies traded abroad.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, the Israeli Companies Law requires
that resolutions regarding the following matters must be passed at a general meeting of shareholders:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendments to the articles of association;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment or termination of auditors;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointment of external directors (to the extent required);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approval of certain related party transactions as required by law;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases or reductions of authorized share capital and the creation of preferred shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a merger; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">resolutions required for the management of the company, if the board of directors is unable to resolve or perform its duties.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law and regulations promulgated
thereunder require that a notice of any annual general meeting or special meeting be provided to shareholders at least 21&#160;days prior
to the meeting and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with Office
Holders or interested or related parties, an approval of a merger, approval of compensation policy or approval of compromise or settlement
between the company to its creditors or shareholders, notice must be provided at least 35&#160;days prior to the meeting. Under the Israeli
Companies Law and our Restated Articles, shareholders are permitted act by way of written consent in lieu of a meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Quorum</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Restated Articles, holders of
ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before the shareholders at a general meeting.
The quorum required for our general meetings consists of at least two shareholders present in person or by proxy and holding shares representing,
in the aggregate, at least 25% of our voting power. A meeting adjourned for lack of a quorum will be adjourned either to (i)&#160;to the
same day in the next week, at the same time and place, or (ii)&#160;to such&#160;day and at such time and place as indicated in the notice
of such meeting, or (iii)&#160;to such&#160;day and at such time and place as the chairperson of the meeting shall determine (which may
be earlier or later than the date pursuant to clause (i)&#160;above). At the adjourned meeting, one or more shareholders, present in person
or by proxy shall constitute a quorum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Requirements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide that all shareholder
resolutions require a majority vote of those present and voting at the meeting, provided a quorum is present, unless otherwise required
by the Israeli Companies Law or by a specific provision of our Restated Articles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders may vote, in person or by proxy,
the number of voting shares that they own on the record date for the applicable general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles also provide that the removal
of any director from office requires a vote of a majority of the votes cast at a general meeting if a quorum is present. Any amendment
of the provisions relating to our classified board requires the vote of 60% of the total voting power of the shareholders. A resolution
for the voluntary winding up, or an approval of a scheme of arrangement or reorganization, pursuant to the Israeli Companies Law requires
the approval of holders of at least 75% of the voting rights represented at the meeting and voting on the resolution provided that a quorum
is present.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, each of (i)&#160;the
approval of an extraordinary transaction with a controlling shareholder; (ii)&#160;the terms of employment or other engagement of the
controlling shareholder of the company or such controlling shareholder&#8217;s relative (even if such terms are not extraordinary) or
(iii) the approval of certain compensation-related matters of officers and directors &#8211; generally require a special disinterested
majority approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to required approvals with respect
to compensation-related matters see also under &#8220;<i>Item 6.B Board Practices&#160;&#8212;&#160;Committees of the Board of Directors&#160;&#8212;&#160;Compensation
Committee</i>&#8221; and &#8220;&#8212;&#160;<i>Compensation Policy under the Israeli Companies Law</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Disclosure of Personal Interests of an Office
Holder and Approval of Certain Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law requires that an Office
Holder promptly disclose to the board of directors any personal interest that he or she may have and all related material information
known to him or her concerning any existing or proposed transaction with the company. Under the Israeli Companies Law, a &#8216;personal
interest&#8217; includes an interest of any person in an act or transaction of the company, excluding a personal interest arising solely
from holding shares in the company, but including the personal interest (i) of his/her immediate family, spouses, siblings, parents, grandparents,
descendants, spouse&#8217;s descendants, siblings or parents or the spouse of any of such persons, or; (ii) of an entity in which such
person or a relative of such person is a 5% or greater shareholder, director or general manager or in which he or she has the right to
appoint at least one director or the general manager. In addition, under the Israeli Companies Law, in case of a person voting by proxy,
&#8220;personal interest&#8221; includes the personal interest of either the proxy holder or the shareholder granting the proxy, whether
the proxy holder has discretion to vote or not.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an Office Holder has a personal interest in
a non-extraordinary transaction, meaning any transaction that is in the ordinary course of business, on market terms and that is not likely
to have a material impact on the company&#8217;s profitability, assets or liabilities, approval by the board of directors is required
for the transaction, unless the company&#8217;s articles of association provide for a different method of approval.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an Office Holder has a personal interest in
any transaction (i) that is not in the ordinary course of business, (ii) not on market terms or (iii) that is likely to have a material
impact on the company&#8217;s profitability, assets or liabilities (each, an &#8216;extraordinary transaction&#8217;), then an approval
is first required by the company&#8217;s audit committee and subsequently by the board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A director and any other Office Holder who has
a personal interest in a transaction which is being considered by the board of directors or the audit committee, may not be present at
such a meeting or vote on that matter. However, if a majority of the directors (whether of the audit committee or of the board of directors)
has a personal interest in the matter, then it is allowed for those directors to participate, deliberate and vote in such meeting, provided
however, that, a shareholder approval is also required to approve such transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain disclosures and approval requirements
apply under Israeli law to certain transactions with controlling shareholders, certain transactions in which a controlling shareholder
has a personal interest and certain arrangements regarding the terms of service or employment of a controlling shareholder. For these
purposes, a controlling shareholder is any shareholder can direct the company&#8217;s actions, including any shareholder holding 25% or
more of the voting rights provided that no other shareholder owns more than 50% of the voting rights in the company. Two or more shareholders
with a personal interest in the approval of the same transaction are deemed to be one shareholder for the purpose of computing such threshold.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli law requires that on certain related-party
transactions, including matters requiring Compensation Majority, each shareholder voting thereon is required to state whether the shareholder
is a Controlling&#160;Shareholder and/or if the shareholder has any personal interest in the matter in the proposed resolution.&#160;If
any shareholder casting a vote in connection hereto does not explicitly indicate on the proxy card the foregoing, then the shareholder&#8217;s
vote on the applicable item will not be counted. Pursuant to recently amended regulations, a shareholder may be regarded as not having
any personal interest unless the shareholder expressly notifies the company, which notification may be through its proxy card or by another
method.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a description of the approvals required under
Israeli law for compensation arrangements of officers and directors, see &#8220;Item 6 &#8212;&#160;Compensation of Directors and Executive
Officers.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Access to Corporate Records</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, all shareholders
generally have the right to review minutes of the general meetings, the shareholders register, the material shareholders register (which,
according to the Israeli Companies Law, is a register of holders of 5% or more of a company&#8217;s voting shares), the articles of association,
the financial statements, and any document that a company is required by law to file publicly with the Israeli Companies Registrar and
other documents as provided in the Israeli Companies Law. Any shareholder who specifies the purpose of its request may request to review
any document in our possession that relates to any action or transaction with a related party which requires shareholder approval under
the Israeli Companies Law. We may deny a request to review a document if we determine that the request was not made in good faith, that
the document contains a commercial secret or a patent or that the document&#8217;s disclosure may otherwise impair the interests of the
company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitations on Liability and Indemnification
of Officers and Directors -- Exemption, Insurance and Indemnification of Directors and Officers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Exemption.</span></i>&#160;Under the Israeli
Companies Law, a company may not exempt an Office Holder from liability for a breach of the duty of loyalty or from liability arising
out of a prohibited distribution to shareholders. Our Articles of Association allow us to exempt in advance, an Office Holder from liability
towards the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care that is not a breach
of the duty of loyalty or liability arising out of a prohibited distribution to shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Indemnification.</span></i>&#160;Under the
Israeli Companies Law, a company may indemnify an Office Holder in respect of the following liabilities and expenses incurred by him or
her for acts performed by him or her as an Office Holder, either in advance of an event or following an event, provided a provision authorizing
such indemnification is contained in its articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify an Office Holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify was given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances.&#160;&#160;Such undertaking shall detail the abovementioned events and amount or criteria;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the Office Holder in connection with a monetary sanction or as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding,&#160;<i>provided</i>&#160;that (i)&#160;no indictment was filed against such Office Holder as a result of such investigation or proceeding; and (ii)&#160;no financial liability, such as a criminal penalty, was imposed upon him or her in lieu of criminal proceedings or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the Office Holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf or by a&#160;third-party&#160;or in connection with criminal proceedings in which the Office Holder was acquitted or as a result of a conviction for an offense that does not require proof of criminal intent.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide our directors and other Office Holders
with the maximum indemnity permitted by the Israeli Companies Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">D&amp;O Insurance</span>.&#160;</i>Under the
Israeli Companies Law, a company may insure an Office Holder against the following liabilities incurred for acts performed as an Office
Holder if and to the extent provided in the company&#8217;s articles of association:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of the duty of loyalty, provided that the Office Holder acted in good faith and had reasonable grounds to assume that the act that resulted in such breach would not prejudice the interests of the company;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of duty of care to the company or to any other person;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on such Office Holder in respect to his or her capacity as an Office Holder in favor of any other person; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other event, occurrence, matter or circumstances under any law with respect to which the company may, or will be able to, insure an Office Holder, and to the extent such law requires the inclusion of a provision permitting such insurance in the articles of association, then such provision is deemed to be included and incorporated by reference (including, without limitation, in accordance with section&#160;56h(b)(1)&#160;of the Securities Law, if and to the extent applicable, Section&#160;50P of the Competition Law).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Limitations on Exemption, Insurance, and
Indemnification.</span></i>&#160;Under the Israeli Companies Law, a company may not indemnify, exculpate, or insure an Office Holder against
any of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of the duty of loyalty, except to the extent that the Office Holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the Office Holder;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an act or omission committed with intent to derive illegal personal benefit; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fine or forfeiture levied against the Office Holder.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Required Approvals.</span></i>&#160;Under the
Israeli Companies Law, exculpation, indemnification and insurance of Office Holders must be approved by the compensation committee and
the board of directors and, with respect to directors and the CEO, also by the general meeting of the shareholders. Under certain circumstances
set forth in the Israel Companies Law, shareholder approval may be exempted, subject to our meeting the conditions provided thereunder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles permit us to exempt, indemnify
and insure our Office Holders to the extent permitted by law and the Restated Articles. The Office Holders are currently covered by a
directors and officers&#8217; (D&amp;O) liability insurance policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into indemnification, insurance
and exculpation agreements with each of our directors and certain executive officers, undertaking to indemnify, insure and exculpate them
to the fullest extent permitted by law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In so far as indemnification for liabilities arising
under the Securities Act&#160;of&#160;1933 may be permitted to directors, officers and controlling persons of the company, we have been
advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
Securities Act&#160;of&#160;1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the company of expenses incurred or paid by a director, officer or controlling person of the company in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final adjudication of such issue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no pending litigation or proceeding against
any of our Office Holders as to which indemnification is being sought, nor are we aware of any pending or threatened litigation that may
result in claims for indemnification by any Office Holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Exclusive Jurisdiction of Certain Actions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide that unless we consent
in writing to the selection of an alternative forum, the federal district courts of the United&#160;States of America shall be the exclusive
forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933. Since the Securities Act
of 1933 provide for both federal and state court jurisdiction, a state court in the United States may be reluctant to enforce the exclusive
jurisdiction provisions to the extent that they are deemed to preclude state court jurisdiction for claims arising under the Securities
Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Restated Articles provide that unless we consent
in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel will be the exclusive forum for (i)&#160;any
derivative action or proceeding brought on behalf of us, (ii)&#160;any action asserting a claim of breach of a duty owed by any director,
officer or other of our employees to us or our shareholders, or (iii)&#160;any action asserting a claim arising pursuant to any provision
of the Israeli Companies Law or the Israeli Securities Law, 5728-1968 or otherwise arising from the holding of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transfer Agent and Warrant Agent</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transfer agent for our ordinary shares and
the warrant agent for our warrants is Continental Stock Transfer&#160;&amp; Trust Company, 1 State Street, 30<sup>th</sup>&#160;Floor,
New&#160;York, New&#160;York 10004, telephone: (212)&#160;509-4000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover&#160;Provisions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Acquisitions under Israeli Law</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(a)</i></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Full Tender Offer</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A person wishing to acquire shares of a public
Israeli company and who could as a result hold over 90% of the target company&#8217;s voting rights or the target company&#8217;s issued
and outstanding share capital (or of a class thereof), is required by the Israeli Companies Law to make a tender offer to all of the company&#8217;s
shareholders for the purchase of all of the issued and outstanding shares of the company (or the applicable class). If (a)&#160;the shareholders
who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and
the shareholders who accept the offer constitute a majority of the offerees that do not have a personal interest in the acceptance of
the tender offer or (b)&#160;the shareholders who do not accept the tender offer hold less than 2% of the issued and outstanding share
capital of the company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the
acquirer by operation of law . A shareholder who had its shares transferred may petition the court within six&#160;months from the date
of acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer
was for less than fair value and whether the fair value should be paid as determined by the court. However, an offeror may provide in
the offer that a shareholder who accepted the offer will not be entitled to appraisal rights as described in the preceding sentence if
the offeror and the company disclosed the information required by law in connection with the tender offer. If the full tender offer was
not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its
holdings to more than 90% of the company&#8217;s issued and outstanding share capital (or of the applicable class) from shareholders who
accepted the tender offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(b)</i></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Special Tender Offer</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law provides that an acquisition
of shares of an Israeli public company must be made by means of a special tender offer if, because of the acquisition, the purchaser would
become a holder of 25% or more of the voting rights in the company. This rule does not apply if there is already another holder of 25%
or more of the voting rights in the company. Similarly, the Israeli Companies Law provides that an acquisition of shares in an Israeli
public company must be made by means of a tender offer if as a result of the acquisition the purchaser would become a holder of more than
45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights
in the company. These requirements do not apply if the acquisition (i)&#160;occurs in the context of a private placement by the company
that received shareholder approval, (ii)&#160;was from a shareholder holding 25% or more of the voting rights in the company and resulted
in the acquirer becoming a holder of 25% or more of the voting rights in the company, or (iii)&#160;was from a holder of more than 45%
of the voting rights in the company and resulted in the acquirer becoming a holder of more than 45% of the voting rights in the company.
A special tender offer may be consummated and is deemed to be accepted only if (i)&#160;at least 5% of the voting power attached to the
company&#8217;s outstanding shares will be acquired by the offeror and (ii)&#160;the number of shares tendered in the offer exceeds the
number of shares whose holders objected to the offer (excluding controlling shareholders, holders of 25% or more of the voting rights
in the company and any person having a personal interest in the acceptance of the tender offer).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that a special tender offer is made,
the company&#8217;s board of directors is required to express its opinion on the advisability of the offer and may abstain from expressing
any opinion if it is unable to do so,&#160;<i>provided</i>&#160;that it gives the reasons for its abstention. An Office Holder in a company
who, in his or her capacity as an Office Holder, performs an action for the purpose of causing failure of an existing or foreseeable special
tender offer or is to impair the chances of its acceptance, will personally be liable for the damages to the purchaser and shareholders,
unless such Office Holder acted in good faith and had reasonable grounds to believe he or she was acting for the benefit of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a special tender offer is accepted, then shareholders
who did not respond to or that had objected to the offer may accept the offer within four&#160;days of the last&#160;day set for the acceptance
of the offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that a special tender offer is accepted,
the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity may
not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company
for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or
merger in the initial special tender offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(c)</i></span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mergers</i></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law permits merger transactions
if approved by (i) the board of directors of each of the merging companies and, (ii) unless certain conditions described under the Israeli
Companies Law are met, a majority of the shareholders of each of the merging companies voted on the matter, provided that a proper quorum
was present. The board of directors of a merging company is required, pursuant to the Israeli Companies Law, to discuss and determine
whether in its opinion there is a reasonable concern that as a result of a proposed merger, the surviving company will not be able to
satisfy its obligations to its creditors, such determination taking into account the financial status of the merging companies. If the
board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of
directors of each of the merging companies, the boards of directors of the merging companies must jointly prepare a merger proposal to
submit to the Israeli Registrar of Companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of the shareholder vote, unless
a court rules otherwise, if one of the merging companies (or any person who holds 25% or more of the outstanding shares or the right to
appoint 25% or more of the directors of one of the merging companies) holds shares in the other merging company, the merger will not be
deemed approved if a majority of the shares voted at the shareholders meeting by shareholders other than the other party to the merger,
or by any person who holds 25% or more of the outstanding shares or the right to appoint 25% or more of the directors of the other party,
vote against the merger. In addition, if the&#160;non-surviving&#160;entity of the merger has more than one class of shares, the merger
must be approved by each class of shareholders. If the transaction would have been approved but for the separate approval of each class
or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders
of at least 25% of the voting rights of the company, if the court holds that the merger is fair and reasonable, taking into account the
value of the parties to the merger and the consideration offered to the shareholders. If a merger is with a company&#8217;s controlling
shareholder or if the controlling shareholder has a personal interest in the merger, the merger is instead subject to the same special
majority approval that governs all extraordinary transactions with controlling shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Israeli Companies Law, each merging
company must inform its secured creditors of the proposed merger plan. Upon the request of a creditor of either party to the proposed
merger, the court may delay or prevent the merger if it concludes that there is a reasonable concern that, because of the merger, the
surviving company will be unable to satisfy the obligations of any of the parties to the merger. The court also may give further instructions
to secure the rights of the creditors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, a merger may not be completed unless
at least 50&#160;days have passed from the date that a merger proposal was filed with the Israeli Registrar of Companies, and 30&#160;days
have passed since obtaining the approval of the shareholders of both merging companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Anti-Takeover Measures</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Israeli Companies Law allows us to create
and issue shares with different rights from those attached to its ordinary shares, including shares providing certain preferred rights
such as voting, distributing, pre-emptive rights or other matters. No preferred shares are currently authorized under our Restated Articles.
In the future, if we authorize, create, and issue a specific class of preferred shares, such class of shares, depending on the specific
rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from
realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred
shares will require an approval by the shareholders at a general meeting. The convening of the meeting, the shareholders entitled to participate,
and the majority vote required to be obtained at such a meeting will be subject to the requirements set forth in the Israeli Companies
Law as described above in&#160;<i>&#8220;&#8212;&#160;Voting Rights&#8221;</i>.&#160;In addition, as disclosed under&#160;<i>&#8220;&#8212;&#160;Election
of Directors&#8221;</i>&#160;we have a classified board structure, which limits the ability of any investor or potential investor or group
of investors or potential investors to gain immediate control of our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>C. Material Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 27, 2022, we entered into a manufacturing
agreement with GlobalFoundries Singapore Pte. Ltd. (&#8220;GlobalFoundries&#8221;) for the manufacturing of our semiconductor products,
as well as other services, including pre-production, quality assurance, assembly, testing and supply-chain management. The initial term
of the agreement is five years. The agreement includes other customary terms for semiconductor manufacturing agreements, such as product
recalls, warranty and business continuity. We depend on GlobalFoundries to manufacture our semiconductor products. As of the date of this
annual report, we have not engaged GlobalFoundries to manufacture products in commercial quantities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>D. Exchange Controls</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, Israeli residents may freely deal in
foreign currency and foreign assets, and non-residents may freely deal in Israeli currency and Israeli assets. There are currently no
Israeli currency control restrictions on remittances of dividends on the ordinary shares or the proceeds from the sale of the shares provided
that all taxes were paid or withheld. Non-residents of Israel may freely hold and trade our securities. Neither our Restated Article nor
Israeli laws restrict in any way the ownership or voting of ordinary shares by non-residents, except those restrictions that may exist
with respect to citizens of countries which are in a state of war with Israel under Israeli legislation, or persons or individuals listed
on weapon of mass destruction or terror sanctions lists.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.E. Taxation </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following summary of the material Israeli
and U.S. tax consequences of an investment in our ordinary shares is based upon laws and relevant interpretations thereof in effect as
of the date hereof, all of which are subject to change, possibly with retroactive effect. This summary is not intended to be, nor should
it be construed as, legal or tax advice and is not exhaustive of all possible tax considerations. This summary also does not deal with
all possible tax consequences relating to an investment in our ordinary shares, such as the tax consequences under state, local, non-U.S.
and non-Israeli tax laws. Investors should consult their own tax advisors with respect to the tax consequences of the acquisition, ownership
and disposition of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>I.</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material Israeli Income Tax Considerations</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following description is not intended to constitute
a complete analysis of all tax consequences relating to the acquisition, ownership, and disposition of our ordinary shares. You should
consult your own tax advisor concerning the tax consequences of your situation, as well as any tax consequences that may arise under the
laws of any state, local, foreign or other taxing jurisdiction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary of material Israeli Income tax considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of certain material
Israeli income tax laws applicable to us. This section also contains a discussion of certain material Israeli income tax consequences
concerning the ownership and disposition of ordinary shares purchased by investors. This summary does not discuss all the aspects of Israeli
tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors
subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are
subject to special tax regimes not covered in this discussion. To the extent that the discussion is based on tax legislation that has
not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the courts
will accept the views expressed in this discussion. The discussion below is not intended, and should not be construed, as legal or professional
tax advice and is not exhaustive of all possible tax considerations. The discussion is subject to change, including due to amendments
under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the
tax consequences described below, possibly with a retroactive effect.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THEREFORE, YOU ARE URGED TO CONSULT YOUR OWN
TAX ADVISORS AS TO THE ISRAELI OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES, INCLUDING,
IN PARTICULAR, THE EFFECT OF ANY FOREIGN, STATE OR LOCAL TAXES.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General corporate tax structure in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli companies are generally subject to corporate
tax at a flat rate. In December&#160;2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying
the Economic Policy for the 2017 and 2018 Budget&#160;Years) which reduced the corporate income tax rate from 25% to 24% effective from
January&#160;1, 2017, and to 23% effective from January&#160;1, 2018, and thereafter. However, the effective tax rate payable by a company
that derives income from an Approved Enterprise, a Preferred Enterprise, a Benefited Enterprise or a Technological Enterprise (as discussed
below) may be considerably less. Capital gains derived by an Israeli company are generally subject to corporate tax rate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Law for the Encouragement of Industry (Taxes),&#160;5729-1969</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Law for the Encouragement of Industry (Taxes),&#160;5729-1969,
generally referred to as the Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221; We may
qualify as an Industrial Company within the meaning of the Industry Encouragement Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Industry Encouragement Law defines an &#8220;Industrial
Company&#8221; as an Israeli resident-company, of which 90% or more of its income in any tax year, other than income from certain government
loans, capital gains, interest and dividends, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel
or in the &#8220;Area&#8221;, in accordance with the definition under section 3A of the Israeli Income Tax Ordinance New Version 5721-1961,
or the Ordinance. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise whose principal activity in a given tax year is industrial
production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following are the main tax benefits available
to Industrial Companies:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of the cost of purchased patent, rights to use a patent and know-how, which are used for the development or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in which such rights were first exercised;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under limited conditions, an election to file consolidated tax returns with controlled Israeli Industrial Companies; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses related to a public offering are deductible in equal amounts over three&#160;years commencing on the year of the offering.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eligibility for benefits under the Industry Encouragement
Law is not contingent upon approval of any governmental authority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tax benefits and grants for research and development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli tax law allows, under certain conditions,
a tax deduction for expenditures related to research and development, including capital expenditures, for the year in which such expenditures
are incurred. Expenditures are deemed related to scientific research and development projects, if:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The research and development must be for the promotion of the company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The research and development are carried out by or on behalf of the company seeking such tax deduction.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of such deductible expenses is reduced
by the sum of any funds received through government grants for the finance of such scientific research and development projects. No deduction
under these research and development deduction rules is allowed if such deduction is related to an expense invested in an asset depreciable
under the general depreciation rules of the Ordinance. Expenditures that are unqualified under the conditions above are deductible in
equal amounts over three&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, we may apply to the Israel
Innovation Authority for approval to allow a tax deduction for all or most of research and development expenses during the year incurred.
There can be no assurance that such application will be accepted. If we will not be able to deduct research and development expenses during
the year of the payment, we may be able to deduct research and development expenses in equal amounts over a period of three&#160;years
commencing in the year of the payment of such expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Law for the Encouragement of Capital Investments,&#160;5719-1959</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Law for the Encouragement of Capital Investments,&#160;5719-1959,
generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible
assets). Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, referred to as
an Approved Enterprise, a Beneficiary Enterprise, a Preferred Enterprise, a Preferred Technological Enterprise, or a Special Preferred
Technological Enterprise, is entitled to benefits as discussed below. These benefits may include cash grants from the Israeli government
and tax benefits, based upon, among other things, the geographic location of the facility in which the investment is made in Israel. In
order to qualify for these incentives, we are required to comply with the requirements of the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Investment Law was significantly amended effective
as of April&#160;1, 2005 (the &#8220;<span style="text-decoration:underline">2005 Amendment</span>&#8221;), as of January&#160;1, 2011 (the &#8220;<span style="text-decoration:underline">2011 Amendment</span>&#8221;)
and as of January&#160;1, 2017 (the &#8220;<span style="text-decoration:underline">2017 Amendment</span>&#8221;). Pursuant to the 2005 Amendment, tax benefits granted in accordance
with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force, but any benefits granted subsequently
are subject to the provisions of the amended Investment Law. Similarly, the 2011 Amendment introduced new benefits to replace those granted
in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. However, companies entitled to benefits
under the Investment Law as in effect prior to January&#160;1, 2011, were entitled to choose to continue and enjoy such benefits, provided
that certain conditions are met, or instead elect, irrevocably, to forego such benefits and have the benefits of the 2011 Amendment apply.
The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax benefits under the 2011 Amendment</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2011 Amendment canceled the availability of
the benefits granted to Industrial Companies under the Investment Law prior to 2011 and, instead, introduced new benefits for income generated
by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law)
as of January&#160;1, 2011. The definition of a Preferred Company includes a company incorporated in Israel that is not fully owned by
a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant
to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its income derived by its
Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a specified development zone, in which case the rate
will be 10%. Under the 2011 Amendment, such corporate tax rate was reduced from 15% and 10%, respectively, to 12.5% and 7%, respectively,
in 2013, 16% and 9% respectively, in 2014, 2015 and 2016, and 16% and 7.5%, respectively, in 2017 and thereafter. Income derived by a
Preferred Company from a &#8220;Special Preferred Enterprise&#8221; (as such term is defined under the Investment Law) would be entitled,
subject to certain conditions and during a benefits period of 10&#160;years, to further reduced tax rates of 8%, or 5% if the Special
Preferred Enterprise is located in a certain development zone.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends distributed from income which is attributed
to a &#8220;Preferred Enterprise&#8221; will be subject to tax at the following rates: (i)&#160;Israeli resident corporations&#160;&#8212;&#160;0%
(although, if such dividends are subsequently distributed to individuals or a non-Israeli company the below rates detailed in sub sections
(ii)&#160;and (iii)&#160;shall apply) (ii)&#160;Israeli resident individuals&#160;&#8212;&#160;20% (iii)&#160;Non-Israeli residents (both
individuals and corporations)&#160;&#8212;&#160;20%, or a reduced tax rate as determined under the provisions of any applicable double
tax treaty, when relevant. These rates are subject to the receipt of a valid certificate from the Israel Tax Authority (the &#8220;ITA&#8221;)
allowing for a reduced tax rate in advance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2011 Amendment also provided transitional
provisions to address companies already enjoying existing tax benefits under the Investment Law. These transitional provisions provide,
among other things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect
to income to be derived as of January&#160;1, 2011, a Beneficiary Enterprise can elect to continue to benefit from the benefits provided
to it before the 2011 Amendment came into effect, provided that certain conditions are met.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>New tax benefits under the 2017 Amendment
that became effective on January&#160;1, 2017</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2017 Amendment was enacted as part of the
Economic Efficiency Law that was published on December&#160;29, 2016 and is effective as of January&#160;1, 2017. The 2017 Amendment provides
new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described below, and is in addition to the other existing
tax beneficial programs under the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2017 Amendment provides that a Preferred Company
satisfying certain conditions will qualify as having a &#8220;Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced
corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income&#8221;, as defined under the Investment Law.
The corporate tax rate is further reduced to 7.5% with respect to a Preferred Technological Enterprise located in &#8220;Development Zone
A&#8221;. In addition, a Preferred Technological Company will enjoy a reduced corporate tax rate of 12% on capital gains derived from
the sale of certain &#8220;Benefitted Intangible Assets&#8221; (as defined under the Investment Law) to a related foreign company if the
Benefitted Intangible Assets were acquired from a foreign company on or after January&#160;1, 2017, for at least NIS 200&#160;million,
and the sale receives a prior approval from the Israel Innovation Authority.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2017 Amendment further provides that a Preferred
Company satisfying certain conditions (including group consolidated revenues of at least NIS 10&#160;billion) will qualify as a &#8220;Special
Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate tax rate of 6% on &#8220;Preferred Technological
Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition, a Special Preferred Technological Enterprise
will enjoy a reduced corporate tax rate of 6% on capital gains derived from the sale of certain &#8220;Benefitted Intangible Assets&#8221;
to a related foreign company if the Benefitted Intangible Assets were either developed by the Special Preferred Enterprise or acquired
from a foreign company on or after January&#160;1, 2017, and the sale received a prior approval from the Israel Innovation Authority.
A Special Preferred Technological Enterprise that acquires Benefitted Intangible Assets from a foreign company for more than NIS 500&#160;million
will be eligible for these benefits for at least ten&#160;years, subject to certain approvals as specified in the Investment Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends distributed by a Preferred Technological
Enterprise or a Special Preferred Technological Enterprise, paid out of Preferred Technological Income, are generally subject to tax at
the rate of 20% or a lower rate as may be provided in an applicable tax treaty. These rates are subject to the receipt of a valid certificate
from the ITA allowing for a reduced tax rate in advance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if such dividends are distributed
to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company, and other conditions
are met, the withholding tax rate will be 4% (subject to the receipt of a valid certificate from the Israel Tax Authority allowing for
a reduced tax rate in advance). However, if such dividends are paid to an Israeli company, no tax is required to be withheld.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that we may be eligible to the tax
benefits under the 2017 Amendment. This will be further examined when relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Taxation of our shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital Gains Tax on Sales of our ordinary
shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Israeli law generally imposes a capital gains
tax on the sale of any capital assets by Israeli residents, as defined for Israeli tax purposes, and on the sale of capital assets by
non-Israeli resident, if such assets (i) are located in Israel, (ii) are shares or rights to shares in an Israeli resident company, or
(iii) represent, directly or indirectly, rights to assets located in Israel, unless a specific exemption is available or unless a tax
treaty between Israel and the shareholder&#8217;s country of residence provides otherwise. The Ordinance distinguishes between real gain
and inflationary surplus. The inflationary surplus is a portion of the total capital gain equivalent to the increase of the relevant asset&#8217;s
purchase price attributable to an increase in the Israeli consumer price index, or, in certain circumstances, a foreign currency exchange
rate, between the date of purchase and the date of sale. Inflationary surplus is currently not subject to tax in Israel under certain
conditions. The real gain is the excess of the total capital gain over the inflationary surplus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital gains taxes applicable to non-Israeli
resident shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A non-Israeli resident that derives capital gains
from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading on a stock exchange
outside of Israel, will be exempt from Israeli tax if, among other conditions, the shares were not held through a &#8220;permanent establishment&#8221;
that the non-resident maintains in Israel. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli
residents, whether directly or indirectly: (i)&#160;have a controlling interest of more than 25% in such non-Israeli corporation or (ii)&#160;are
the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation. In addition, such an
exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">If not exempt, a non-Israeli
resident corporate shareholder will generally be subject to tax on capital gain at the ordinary corporate tax rate (23% in 2025), or at
the rate of 25%, if generated by an individual, or 30%, if generated by an individual who is a &#8220;Substantial Shareholder&#8221;,
at the time of sale or at any time during the preceding 12-month period (or if the shareholder claims a deduction for interest and linkage
differences expenses in connection with the purchase and holding of such shares). However, withholding tax rates may be higher than the
above tax rates, and therefore in order to be eligible for the capital gains rates mentioned, the taxpayer will need to perform certain
administrative procedures with the ITA and obtain a tax certificate from the ITA. Individual and corporate shareholders dealing in securities
in Israel are taxed at the tax rates applicable to business income (a corporate tax rate for a corporation (23% in 2025) and a marginal
tax rate of up to 47% for an individual (assuming the activity does rise to a level of business) in 2025, excluding Surtax as discussed
below), unless contrary provisions in a relevant tax treaty apply.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, a sale of securities by a non-Israeli
resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under the Convention
Between the Government of the United&#160;States of America and the Government of the State of Israel with respect to Taxes on Income,
as amended (the &#8220;United&#160;States Israel Tax Treaty&#8221;), the sale, exchange or other disposition of shares by a shareholder
who is a United&#160;States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to claim the benefits
afforded to such a resident by the U.S.&#160;Israel Tax Treaty (a &#8220;U.S.&#160;Resident&#8221;) is generally exempt from Israeli capital
gains tax unless:&#160;(i)&#160;the capital gain arising from such sale, exchange or disposition is attributed to real estate located
in Israel; (ii)&#160;the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii)&#160;the capital
gain arising from such sale, exchange or disposition is attributed to a permanent establishment in Israel, under certain terms; (iv)&#160;such
U.S.&#160;Resident holds, directly or indirectly, shares representing 10% or more of the voting power during any part of the 12 month
period preceding the disposition, subject to certain conditions; or (v)&#160;such U.S.&#160;Resident is an individual and was present
in Israel for 183&#160;days or more during the relevant taxable year. In any such case, the sale, exchange or disposition of such shares
by the U.S.&#160;Resident would be subject to tax in Israel (unless exempt under the Israeli domestic law as described above). Under the
United&#160;States Israel Tax Treaty, the gain may be treated as foreign source income for United&#160;States foreign tax credit purposes,
upon an election by the U.S.&#160;Resident, and such U.S.&#160;Resident may be permitted to claim a credit for such taxes against the
United&#160;States federal income tax imposed on such sale, subject to the limitations under the United&#160;States federal income tax
laws applicable to foreign tax credits. The United&#160;States Israel Tax Treaty does not provide such credit against any United&#160;States
state or local taxes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regardless of whether shareholders may be liable
for Israeli tax on the sale of our ordinary shares, the payment of the consideration may be subject to withholding tax at Israel. Shareholders
may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid tax withholding at the time of sale
(i.e., provide certificate of residency and other relevant documentation to the ITA in order to obtain a withholding tax exemption from
the ITA)<i>. </i>Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a
merger or otherwise, the ITA may require shareholders who are not liable for Israeli tax to sign declarations in forms specified by the
ITA or obtain a specific exemption from the ITA to confirm their status as non-Israeli resident, and, in the absence of such declarations
or exemptions, may require the purchaser of the shares to withhold taxes at source.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital gains taxes applicable to Israeli
resident shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, an Israeli resident corporation that
derives capital gains from the sale of shares in an Israeli resident company that were purchased after the company was listed for trading
on a stock exchange outside of Israel will generally be subject to tax on the real capital gains generated on such sale at the corporate
tax rate (currently of 23%).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An Israeli resident individual will generally
be subject to capital gain tax at the rate of 25%. However, if the individual shareholder claims deduction of interest expenditures or
is a &#8220;Substantial Shareholder&#8221; at the time of the sale or at any time during the preceding twelve&#160;months period, such
gain will be taxed at the rate of 30%. Individual holders dealing in securities in Israel for whom the income from the sale of securities
is considered &#8220;business income&#8221; as defined under section 2(1)&#160;of the Ordinance are taxed at the marginal tax rates applicable
to business income (up to 47% in 2025 plus 3% Surtax, when applicable).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain Israeli institutions who are exempt from
tax under section 9(2)&#160;or section 129C(a)(1)&#160;of the Ordinance (such as exempt trust funds and pension funds) may be exempt from
capital gains tax from the sale of the shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taxation of Israeli shareholders on receipt
of dividends</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An Israeli resident individual is generally subject
to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, plus 3% or 5% Surtax as discussed below,
when applicable. With respect to a person who is a &#8220;Substantial Shareholder&#8221; at the time of receiving the dividend or on any
time during the preceding twelve&#160;months, the applicable tax rate is 30%, plus 3% or 5% Surtax as discussed below 	, when applicable.
Such dividends are generally subject to Israeli withholding tax at a rate of 25% if the shares are registered with a nominee company (whether
the recipient is a substantial shareholder or not).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the recipient of the dividend is an Israeli
resident corporation such dividend income will be exempt from tax provided the income from which such dividend is distributed was derived
or accrued within Israel and was received directly or indirectly from another corporation that is subject to Israeli corporate tax.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An exempt trust fund, pension fund or other entity
that is exempt from tax under section 9(2)&#160;or section 129C(a)(1)&#160;of the Ordinance is exempt from tax on dividend.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividend distribution by a Preferred Technology
Enterprise or a Special Preferred Technology Enterprise is subject to beneficial withholding tax rates. For a further discussion, see
&#8220;Certain Material Israeli Tax Considerations&#160;&#8212;&#160;Law for the Encouragement of Capital Investments,&#160;5719-1959&#160;&#8212;&#160;New
tax benefits under the 2017 Amendment that became effective on January&#160;1, 2017.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taxation of non-Israeli shareholders on
receipt of dividends</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-Israeli residents (either individuals or corporations)
are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25% (without taking
into account surtax), which tax will be withheld, unless relief is provided in a treaty between Israel and the shareholder&#8217;s country
of residence. With respect to a person who is a &#8220;Substantial Shareholder&#8221; at the time of receiving the dividend or on any
time during the preceding twelve&#160;months, the applicable tax rate is 30%. Such dividends are generally subject to Israeli withholding
tax at a rate of 25% if the shares are registered with a nominee company (whether the recipient is a Substantial Shareholder or not),
unless a reduced rate is provided under an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel
Tax Authority allowing for a reduced tax rate). For example, under the United&#160;States Israel Tax Treaty, the maximum rate of tax that
may be withheld in Israel on dividends paid to a holder of our ordinary shares who is a U.S.&#160;Resident is 25%. However, the maximum
rate of withholding tax on dividends, not generated by a Preferred Enterprise, Approved Enterprise or Beneficial Enterprise, that are
paid to a United&#160;States corporation holding 10% or more of the outstanding voting capital throughout the tax year in which the dividend
is distributed as well as during the previous tax year, is 12.5%, provided that not more than 25% of the gross income for such preceding
year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income attributed
to an Approved Enterprise, Benefited Enterprise or Preferred Enterprise are not entitled to such reduced rate under the tax treaty but
are subject to a withholding tax rate of 15% for a shareholder that is a U.S.&#160;corporation, provided that the conditions related to
the outstanding voting rights and the gross income for the previous year (as set forth in the previous sentences) are met. If the dividend
is attributable partly to income derived from an Approved Enterprise, Benefited Enterprise or Preferred Enterprise, and partly to other
sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. We cannot
assure you that we will designate the profits that we may distribute in a way that will reduce shareholders&#8217; tax liability. Application
for the reduced tax rate requires appropriate documentation to be presented and specific instruction received from the Israeli Tax Authorities
to be followed. To the extent tax is withheld at source at the maximum rates (see above), a qualified tax treaty recipient will be required
to comply with certain administrative procedures with the Israeli Tax Authorities in order to receive a refund of the excess tax withheld.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A foreign resident receiving dividend income from
an Israeli company, from which the full tax was withheld, will generally be exempt from filing a tax return in Israel, provided that (i)
such income was not generated from business conducted in Israel by the foreign resident, (ii) the foreign resident has no other taxable
sources of income in Israel with respect to which a tax return is required to be filed and (iii) the foreign resident is not liable to
Surtax (see below) in accordance with section 121B of the Ordinance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividend distribution by a Preferred Technology
Enterprise or a Special Preferred Technology Enterprise is subject to beneficial withholding tax rates. For a further discussion, see
&#8220;Certain Material Israeli Tax Considerations&#160;&#8212;&#160;Law for the Encouragement of Capital Investments,&#160;5719-1959&#160;&#8212;&#160;New
tax benefits under the 2017 Amendment that became effective on January&#160;1, 2017.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Surtax</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the provisions of an applicable tax
treaty, individuals (Israeli and non-Israeli) who are subject to tax in Israel are also subject to an additional tax at a rate of 3% on
their annual income (including, but not limited to, dividends, interest and capital gain) exceeding an annual threshold of NIS 721,560
(as of 2025).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moreover, subject to the provisions of an applicable
tax treaty, as of January 1, 2025, in addition to the surtax described above, an additional surtax at a rate of 2% is imposed on an individual&#8217;s
(Israeli and non-Israeli) taxable income derived from &#8216;capital source&#8217; exceeding an annual threshold NIS 721,560 (as of 2025).
For this purpose, income derived from &#8216;capital source&#8217; shall include any income, except for &#8220;business income&#8221;
as defined under section 2(1) of the Ordinance and income from employment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Estate and Gift Tax</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, Israel does not impose estate tax and
gifts are generally exempt from tax.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE ISRAELI TAX DISCUSSION SET FORTH ABOVE
IS INCLUDED FOR GENERAL INFORMATION ONLY AND MAY NOT BE APPLICABLE TO YOU DEPENDING UPON YOUR PARTICULAR SITUATION.&#160;YOU ARE URGED
TO CONSULT YOUR OWN TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES TO YOU OF THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES AND WARRANTS,
AS APPLICABLE, INCLUDING THE TAX CONSEQUENCES UNDER ISRAELI TAX LAW AND OTHER NON-ISRAELI TAX LAWS AND TAX TREATIES AND THE POSSIBLE EFFECTS
OF CHANGES IN ISRAELI&#160;OR OTHER TAX LAWS.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>II. Certain Material U.S.&#160;Federal Income
Tax Considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion summarizes the material
U.S.&#160;federal income tax consequences to U.S. Holders (as defined below) of the ownership and disposition of ordinary shares and warrants.
This discussion applies only to the ordinary shares and warrants, as the case may be, that are held as &#8220;capital assets&#8221; within
the meaning of Section&#160;1221 of the U.S.&#160;Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) (generally, property
held for investment).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following does not purport to be a complete
analysis of all potential tax effects arising in connection with the ownership and disposition of ordinary shares and warrants. The effects
of other U.S.&#160;federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S.&#160;tax laws are
not discussed. This discussion is based on the Code, Treasury regulations promulgated thereunder, judicial decisions, and published rulings
and administrative pronouncements of the U.S.&#160;Internal Revenue Service (the &#8220;IRS&#8221;), in each case in effect as of the
date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may
be applied retroactively in a manner that could adversely affect the tax consequences discussed below. We have not sought and will not
seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS will not take or a court will not
sustain a contrary position regarding the tax consequences discussed below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This discussion does not address all U.S.&#160;federal
income tax consequences relevant to a holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on
net investment income and the alternative minimum tax. In addition, it does not address consequences relevant to holders subject to special
rules, including, without limitation:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks, insurance companies, and certain other financial institutions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated investment companies and real estate investment trusts;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers, dealers, or traders in securities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders in securities that elect to mark to market;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 27px">&#160;</td>
    <td style="width: 27px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt&#160;organizations or governmental organizations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.&#160;expatriates and former citizens or long-term&#160;residents of the U.S.;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons holding ordinary shares and/or warrants, as the case may be, as part of a hedge, straddle, constructive sale, or other risk reduction strategy or as part of a conversion transaction or other integrated or similar transaction;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons subject to special tax accounting rules as a result of any item of gross income with respect to ordinary shares and/or warrants, as the case may be, being taken into account in an applicable financial statement;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons that actually or constructively own 5% or more (by vote or value) of the outstanding ordinary shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">founders, sponsors, officers or directors of ITAC or holders of private placement warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S.&#160;federal income tax (and their shareholders);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S corporations, partnerships, or other entities or arrangements treated as partnerships or other flow-through&#160;entities for U.S.&#160;federal income tax purposes (and investors therein);</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.&#160;Holders having a functional currency other than the U.S.&#160;dollar;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons who hold or received ordinary shares and/or warrants, as the case may be, pursuant to the exercise of any employee stock option or otherwise as compensation; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-qualified&#160;retirement plans.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an entity or arrangement treated as a partnership
for U.S.&#160;federal income tax purposes holds ordinary shares and/or warrants, the tax treatment of an owner of such entity will depend
on the status of the owner or participant in the arrangement, the activities of the entity or arrangement, and certain determinations
made at the owner or participant level. Accordingly, entities or arrangements treated as partnerships for U.S.&#160;federal income tax
purposes and the partners in such partnerships should consult their tax advisors regarding the U.S.&#160;federal income tax consequences
to them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this discussion, a &#8220;U.S.&#160;Holder&#8221;
is any beneficial owner of ordinary shares and/or warrants, as the case may be, that is for U.S.&#160;federal income tax purposes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an individual who is a citizen or resident of the U.S.;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a corporation (or other entity taxable as a corporation) created or organized in, or under the laws of, the U.S., any state thereof, or the District of Columbia;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an estate, the income of which is subject to U.S.&#160;federal income tax regardless of its source; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a trust that (1)&#160;is subject to the primary supervision of a U.S.&#160;court and the control of one or more &#8220;United&#160;States persons&#8221; (within the meaning of Section&#160;7701(a)(30)&#160;of the Code) or (2)&#160;has a valid election in effect to be treated as a United&#160;States person for U.S.&#160;federal income tax purposes.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE U.S.&#160;FEDERAL INCOME TAX TREATMENT
OF THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES AND/OR WARRANTS TO ANY PARTICULAR HOLDER WILL DEPEND ON THE HOLDER&#8217;S PARTICULAR
TAX CIRCUMSTANCES.&#160;YOU ARE URGED TO CONSULT YOUR TAX ADVISOR REGARDING THE U.S.&#160;FEDERAL, STATE, LOCAL, AND NON-U.S.&#160;INCOME
AND OTHER TAX CONSEQUENCES TO YOU, IN LIGHT OF YOUR PARTICULAR INVESTMENT OR TAX CIRCUMSTANCES, OF THE OWNERSHIP AND DISPOSITION OF ORDINARY
SHARES AND/OR WARRANTS.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. Federal Income Tax Treatment of Arbe</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax Residence of Arbe for U.S.&#160;Federal
Income Tax Purposes</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we are incorporated and tax resident
in Israel, the IRS may assert that we should be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax purposes pursuant
to Section&#160;7874 of the Code. For U.S.&#160;federal income tax purposes, a corporation is generally considered a U.S.&#160;&#8220;domestic&#8221;
corporation if it is created or organized in or under the laws of the U.S., any state thereof, or the District of Columbia. Because we
are not so created or organized (but is instead incorporated only in Israel), it would generally be classified as a foreign corporation
(that is, a corporation other than a U.S.&#160;&#8220;domestic&#8221; corporation) under these rules. Section&#160;7874 of the Code provides
an exception under which a corporation created or organized only under foreign law may, in certain circumstances, be treated as a U.S.&#160;corporation
for U.S.&#160;federal income tax purposes. The Section&#160;7874 rules are complex and require analysis of all relevant facts, and there
is limited guidance and significant uncertainties as to their application.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Code Section&#160;7874, a corporation created
or organized outside the U.S.&#160;(i.e., a foreign corporation) will nevertheless be treated as a U.S.&#160;corporation for U.S.&#160;federal
income tax purposes when (i)&#160;the foreign corporation directly or indirectly acquires substantially all of the assets held directly
or indirectly by a U.S.&#160;corporation (including the indirect acquisition of assets of the U.S.&#160;corporation by acquiring the outstanding
shares of the U.S.&#160;corporation), (ii)&#160;the shareholders of the acquired U.S.&#160;corporation hold, by vote or value, at least
80% of the shares of the foreign acquiring corporation after the acquisition by reason of holding shares in the U.S.&#160;acquired corporation
(the &#8220;Section&#160;7874 Percentage&#8221;), and (iii)&#160;the foreign corporation&#8217;s &#8220;expanded affiliated group&#8221;
does not have substantial business activities in the foreign corporation&#8217;s country of creation or organization relative to such
expanded affiliated group&#8217;s worldwide activities (the &#8220;Substantial Business Activities Exception&#8221;). In order to satisfy
the Substantial Business Activities Exception, at least 25% of the employees (by headcount and compensation), real and tangible assets,
and gross income of the foreign acquiring corporation&#8217;s &#8220;expanded affiliated group&#8221; must be based, incurred, located,
and derived, respectively, in the country in which the foreign acquiring corporation is created or organized. The Section&#160;7874 Regulations
further provide for a number of special rules that aggregate multiple acquisitions of U.S.&#160;corporations for purposes of Code Section&#160;7874
that are made as part of a plan or made over a 36-month&#160;period, making it more likely that Code Section&#160;7874 will apply to a
foreign acquiring corporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We indirectly acquired substantially all of the
assets of ITAC through the Merger. Based upon the terms of the Merger, the rules for determining share ownership under Code Section&#160;7874
and the Section&#160;7874 Regulations, and certain factual assumptions, we currently expect that the Section&#160;7874 Percentage of ITAC
stockholders in us should be less than 80% after the Merger. Accordingly, we are not expected to be treated as a U.S.&#160;corporation
for U.S.&#160;federal income tax purposes under Section&#160;7874 of the Code. The calculation of the Section&#160;7874 Percentage is
complex, is subject to detailed regulations (the application of which is uncertain in various respects and could be impacted by changes
in U.S.&#160;tax laws and regulations with possible retroactive effect) and is subject to certain factual uncertainties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The remainder of this discussion assumes that
we will not be treated as a U.S.&#160;corporation for U.S.&#160;federal income tax purposes under Section&#160;7874 of the Code.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>U.S.&#160;Federal Income Tax Consequences
of the Ownership and Disposition of ordinary shares and warrants to U.S.&#160;Holders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Distributions on ordinary shares</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we make distributions of cash or property on
the ordinary shares, such distributions will be treated first as a dividend to the extent of our current and accumulated earnings and
profits (as determined for U.S.&#160;federal income tax purposes), and then as a tax-free&#160;return of capital to the extent of the
U.S.&#160;Holder&#8217;s tax basis, with any excess treated as gain from the sale or exchange of the shares. The amount of any such distribution
will include any amounts withheld by us (or another applicable withholding agent). If we do not provide calculations of its earnings and
profits under U.S.&#160;federal income tax principles, a U.S.&#160;Holder should expect all cash distributions to be reported as dividends
for U.S.&#160;federal income tax purposes. Any dividend will not be eligible for the dividends received deduction allowed to corporations
in respect of dividends received from U.S.&#160;corporations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the discussions above under &#8220;&#8212;&#160;<i>Utilization
of ITAC&#8217;s Tax Attributes and Certain Other Adverse Tax Consequences to Arbe and Arbe&#8217;s Shareholders</i>&#8221; and below under
&#8220;&#8212;&#160;<i>Passive Foreign Investment Company Rules</i>,&#8221; dividends received by certain non-corporate&#160;U.S.&#160;Holders
(including individuals) may be &#8220;qualified dividend income,&#8221; which is taxed at the lower applicable capital gains rate, provided
that:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">either (a)&#160;the shares are readily tradable on an established securities market in the U.S.&#160;or (b)&#160;we are eligible for the benefits of a qualifying income tax treaty with the U.S.&#160;that includes an exchange of information program;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are neither a PFIC (as discussed below under below under &#8220;&#8212;&#160;Passive Foreign Investment Company Rules&#8221;) nor treated as such with respect to the U.S.&#160;Holder for our taxable year in which the dividend is paid or the preceding taxable year;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the U.S.&#160;Holder satisfies certain holding period requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the U.S.&#160;Holder is not under an obligation to make related payments with respect to positions in substantially similar or related property; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the taxpayer does not take the dividends into account as investment income under Code Section&#160;163(d)(4)(B).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There can be no assurances that we will be eligible
for benefits of an applicable comprehensive income tax treaty between the U.S.&#160;and Israel. In addition, there also can be no assurance
that ordinary shares will be considered &#8220;readily tradable&#8221; on an established securities market in accordance with applicable
legal authorities. Furthermore, we will not constitute a qualified foreign corporation for purposes of these rules if it is a PFIC for
the taxable year in which it pays a dividend or for the preceding taxable year. See &#8220;&#8212;&#160;<i>Passive Foreign Investment
Company Rules.</i>&#8221; U.S.&#160;Holders should consult their tax advisors regarding the availability of the lower rate for dividends
paid with respect to ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of any dividend distribution paid in
foreign currency will be the U.S.&#160;dollar amount calculated by reference to the applicable exchange rate in effect on the date of
actual or constructive receipt, regardless of whether the payment is in fact converted into U.S.&#160;dollars at that time. A U.S.&#160;Holder
may have foreign currency gain or loss if the dividend is converted into U.S.&#160;dollars after the date of receipt.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to certain exceptions, dividends on ordinary
shares will constitute foreign source income for foreign tax credit limitation purposes. If the dividends are qualified dividend income
(as discussed above), the amount of the dividend taken into account for purposes of calculating the foreign tax credit limitation will
be limited to the gross amount of the dividend, multiplied by a fraction, the numerator of which is the reduced rate applicable to qualified
dividend income and the denominator of which is the highest rate of tax normally applicable to dividends. The limitation on foreign taxes
eligible for credit is calculated separately with respect to specific classes of income. For this purpose, dividends distributed by us
with respect to the ordinary shares generally will constitute &#8220;passive category income&#8221; but could, in the case of certain
U.S.&#160;Holders, constitute &#8220;general category income&#8221;. The rules governing foreign tax credits are complex and U.S.&#160;Holders
are urged to consult their tax advisors regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming
a foreign tax credit, a U.S.&#160;Holder may, in certain circumstances, deduct foreign taxes in computing the holder&#8217;s taxable income,
subject to generally applicable limitations under U.S.&#160;law. Generally, an election to deduct foreign taxes instead of claiming foreign
tax credits applies to all foreign taxes paid or accrued in the taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sale, Exchange, Redemption or Other Taxable
Disposition of ordinary shares and warrants</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the discussion below under &#8220;&#8212;&#160;<i>Passive
Foreign Investment Company Rules</i>,&#8221; a U.S.&#160;Holder generally will recognize gain or loss on any sale, exchange, redemption
or other taxable disposition of ordinary shares or warrants in an amount equal to the difference between (i)&#160;the amount realized
on the disposition and (ii)&#160;such U.S.&#160;Holder&#8217;s adjusted tax basis in such shares and/or warrants. Any gain or loss recognized
by a U.S.&#160;Holder on a taxable disposition of ordinary shares or warrants generally will be capital gain or loss. A non-corporate&#160;U.S.&#160;Holder,
including an individual, who has held the ordinary shares and/or warrants for more than one year generally will be eligible for reduced
tax rates for such long-term&#160;capital gains. The deductibility of capital losses is subject to limitations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any such gain or loss recognized generally will
be treated as U.S.&#160;source income or loss. Accordingly, in the event any Israeli tax (including withholding tax)&#160;is imposed upon
such sale or other disposition, a U.S.&#160;Holder may not be able to utilize foreign tax credits unless such holder has foreign source
income or gain in the same category from other sources. Moreover, there are special rules under the income tax treaty between the U.S.&#160;and
Israel (the &#8220;<i>Treaty</i>&#8221;), which may impact a U.S.&#160;Holder&#8217;s ability to claim a foreign tax credit. U.S.&#160;Holders
are urged to consult their tax advisor regarding the ability to claim a foreign tax credit and the application of the Treaty to such U.S.&#160;Holder&#8217;s
particular circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Exercise, Lapse, or Redemption of warrants</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the PFIC rules discussed below, a U.S.&#160;Holder
generally will not recognize gain or loss upon the acquisition of an ordinary share on the exercise of the warrants for cash. A U.S.&#160;Holder&#8217;s
tax basis in an ordinary shares received upon exercise of the warrants generally should be an amount equal to the sum of the U.S.&#160;Holder&#8217;s
tax basis in the warrants exchanged therefor (assuming the Merger is not a taxable transaction) and the exercise price. The U.S.&#160;Holder&#8217;s
holding period for an ordinary share received upon exercise of the warrants will begin on the date following the date of exercise (or
possibly the date of exercise) of the warrants and will not include the period during which the U.S.&#160;Holder held the warrants. If
the warrants are allowed to lapse unexercised, a U.S.&#160;Holder generally will recognize a capital loss equal to such holder&#8217;s
tax basis in the warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax consequences of a cashless exercise of
the warrants are not clear under current tax law. Subject to the PFIC rules discussed below, a cashless exercise may be tax-deferred,
either because the exercise is not a gain realization event or because the exercise is treated as a recapitalization for U.S.&#160;federal
income tax purposes. In either tax-deferred&#160;situation, a U.S.&#160;Holder&#8217;s basis in the ordinary shares received generally
would equal the U.S.&#160;Holder&#8217;s basis in the warrants exercised therefor. If the cashless exercise is not treated as a gain realization
event, a U.S.&#160;Holder&#8217;s holding period in the ordinary shares would be treated as commencing on the date following the date
of exercise (or possibly the date of exercise) of the warrants and will not include the period during which the U.S.&#160;Holder held
the warrants. If the cashless exercise were treated as a recapitalization, the holding period of the ordinary shares would include the
holding period of the warrants exercised therefor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is also possible that a cashless exercise of
the warrants could be treated in part as a taxable exchange in which gain or loss would be recognized in the manner set forth above under
&#8220;&#8212;&#160;<i>Sale, Exchange, Redemption or Other Taxable Disposition of ordinary shares and warrants</i>.&#8221; In such event,
a U.S.&#160;Holder could be deemed to have surrendered warrants equal to the number of ordinary shares having an aggregate fair market
value equal to the exercise price for the total number of warrants to be exercised. Subject to the PFIC rules discussed below, the U.S.&#160;Holder
would recognize capital gain or loss with respect to the warrants deemed surrendered in an amount generally equal to the difference between
(i)&#160;the fair market value of the ordinary shares that would have been received in a regular exercise of the warrants deemed surrendered,
net of the aggregate exercise price of such warrants and (ii)&#160;the U.S.&#160;Holder&#8217;s tax basis in such warrants. In this case,
a U.S.&#160;Holder&#8217;s aggregate tax basis in the ordinary shares received would equal the sum of (i)&#160;U.S.&#160;Holder&#8217;s
tax basis in the warrants deemed exercised and (ii)&#160;the aggregate exercise price of such warrants. A U.S.&#160;Holder&#8217;s holding
period for the ordinary shares received in such case generally would commence on the date following the date of exercise (or possibly
the date of exercise) of the warrants and will not include the period during which the U.S.&#160;Holder held the warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the absence of authority on the U.S.&#160;federal
income tax treatment of a cashless exercise of warrants, including when a U.S.&#160;Holder&#8217;s holding period would commence with
respect to the ordinary share received, there can be no assurance regarding which, if any, of the alternative tax consequences and holding
periods described above would be adopted by the IRS or a court of law. Accordingly, U.S.&#160;Holders should consult their tax advisors
regarding the tax consequences of a cashless exercise of warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the PFIC rules described below, if
we redeem warrants for cash pursuant to the redemption provisions of the Warrant Agreement or if we purchase warrants in an open market
transaction, such redemption or purchase generally will be treated as a taxable disposition to the U.S.&#160;Holder, taxed as described
above under &#8220;&#8212;&#160;<i>Sale, Exchange, Redemption or Other Taxable Disposition of ordinary shares and warrants</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Possible Constructive Distributions</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of each warrant provide for an adjustment
to the number of ordinary shares for which the warrants may be exercised or to the exercise price of the warrants in certain events, as
discussed in the section of this registration statement captioned &#8220;Description of warrants.&#8221; An adjustment which has the effect
of preventing dilution generally is not taxable. A U.S.&#160;Holder of the warrants would, however, be treated as receiving a constructive
distribution from us if, for example, the adjustment increases the holder&#8217;s proportionate interest in our assets or earnings and
profits (for instance, through an increase in the number of ordinary shares that would be obtained upon exercise of such warrant) as a
result of a distribution of cash or other property such as other securities to the holders of the ordinary shares which is taxable to
the U.S.&#160;Holders of such shares as described under &#8220;&#8212;&#160;<i>Distributions on ordinary shares</i>&#8221; above. Such
constructive distribution would be subject to tax as described under that section in the same manner as if the U.S.&#160;Holder of such
warrants received a cash distribution from us equal to the fair market value of such increase in interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Passive Foreign Investment Company Rules</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The treatment of U.S.&#160;Holders of the ordinary
shares and warrants could be materially different from that described above, if we are treated as a &#8220;passive foreign investment
company,&#8221; or PFIC, for U.S.&#160;federal income tax purposes. An entity treated as a foreign corporation for U.S.&#160;federal income
tax purposes generally will be a PFIC for U.S.&#160;federal income tax purposes for any taxable year if either:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at least 75% of its gross income for such year is passive income (such as interest, dividends, rents and royalties (other than rents or royalties derived from the active conduct of a trade or business) and gains from the disposition of assets giving rise to passive income); or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at least 50% of the value of its assets (based on an average of the quarterly values of the assets) during such year is attributable to assets that produce passive income or are held for the production of passive income.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For this purpose, we will be treated as owning
our proportionate share of the assets and earning its proportionate share of the income of any other entity treated as a corporation for
U.S.&#160;federal income tax purposes in which we own, directly or indirectly, 25% or more (by value) of the stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whether we are treated as a PFIC is determined
on an annual basis. Although based on the current and anticipated composition of the income, assets and operations of us and our subsidiaries,
we do not believe we will be treated as a PFIC for U.S.&#160;federal income tax purposes for our current taxable year, and do not expect
to become one for U.S.&#160;federal income tax purposes in the near future, this is a factual determination that depends on, among other
things, the composition of our income and assets, and the market value of our shares and assets, including the composition of income and
assets and the market value of shares and assets of its subsidiaries, from time to time, and thus the determination can only be made annually
after the close of each taxable year. Thus, no assurance can be given as to whether we will be a PFIC in 2025 or for any future taxable
year. In addition, our U.S.&#160;counsel expresses no opinion with respect to our PFIC status for 2025 or future taxable&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the PFIC rules, if we were considered a
PFIC at any time that a U.S.&#160;Holder owns ordinary shares or warrants, we would generally continue to be treated as a PFIC with respect
to such holder in a particular year unless (i)&#160;we has ceased to be a PFIC and (ii)&#160;(a)&#160;the U.S.&#160;Holder has made a
valid &#8220;QEF election&#8221; (as described below) for the first taxable year in which the holder owned such holder&#8217;s ordinary
shares in which we were a PFIC, (b)&#160;a valid mark-to-market&#160;election (as described below) is in effect for the particular year,
or (c)&#160;the U.S.&#160;Holder has made a &#8220;deemed sale&#8221; election under the PFIC rules. If such a &#8220;deemed sale&#8221;
election is made, a U.S.&#160;Holder will be deemed to have sold its ordinary shares at their fair market value on the last&#160;day of
the last taxable year in which we are classified as a PFIC, and any gain from such deemed sale would be subject to the consequences described
below. After the &#8220;deemed sale&#8221; election, the ordinary shares with respect to which the &#8220;deemed sale&#8221; election
was made will not be treated as shares in a PFIC unless we subsequently become a PFIC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For each taxable year that we are treated as a
PFIC with respect to a U.S.&#160;Holder&#8217;s ordinary shares or warrants, the U.S.&#160;Holder will be subject to special tax rules
with respect to any &#8220;excess distribution&#8221; (as defined below) received and any gain realized from a sale or disposition (including
a pledge of ordinary shares and under proposed regulations transfers of warrants and certain transfers of ordinary shares that would otherwise
qualify as nonrecognition transactions for U.S.&#160;federal income tax purposes) of its ordinary shares or warrants (collectively the
&#8220;<i>excess distribution rules</i>&#8221;), unless, with respect to the ordinary shares, the U.S.&#160;Holder makes a valid QEF or
mark-to-market&#160;election as discussed below. Generally, distributions received by a U.S.&#160;Holder in a taxable year that are greater
than 125% of the average annual distributions received by such U.S.&#160;Holder during the shorter of the three preceding taxable&#160;years
or the portion of such U.S.&#160;Holder&#8217;s holding period for the ordinary shares or warrants that preceded the taxable year of the
distribution will be treated as excess distributions. Under these special tax rules:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the excess distribution or gain will be allocated ratably over the U.S.&#160;Holder&#8217;s holding period for the ordinary shares or warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to the U.S.&#160;Holder&#8217;s taxable year in which the U.S.&#160;Holder recognized the gain or received the excess distribution or to the period in the U.S.&#160;Holder&#8217;s holding period before the first&#160;day of our first taxable year in which we are a PFIC, will be treated as ordinary income; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to each other taxable year (or portions thereof) of the U.S.&#160;Holder and included in such holder&#8217;s holding period will be subject to the highest tax rate in effect for individuals or corporations, as applicable, for each such year without regard to the U.S.&#160;Holder&#8217;s other items of income and loss for such year; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the interest charge generally applicable to underpayments of tax will be imposed on the U.S.&#160;Holder with respect to the resulting tax attributable to each such year.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the excess distribution rules, the tax liability
for amounts allocated to taxable&#160;years prior to the year of disposition or excess distribution cannot be offset by any net operating
losses, and gains (but not losses) realized on the sale of the ordinary shares or warrants cannot be treated as capital gains, even though
the U.S.&#160;Holder holds the ordinary shares or warrants as capital assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of the PFIC rules may impact U.S.&#160;Holders
with respect to equity interests in subsidiaries and other entities which we may hold, directly or indirectly, that are PFICs (collectively,
&#8220;Lower-Tier&#160;PFICs&#8221;). There can be no assurance, however, that we do not own, or will not in the future acquire, an interest
in a subsidiary or other entity that is or would be treated as a Lower-Tier&#160;PFIC.&#160;U.S.&#160;Holders should consult their tax
advisors regarding the application of the PFIC rules to any of our subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are a PFIC, a U.S.&#160;Holder of our shares
may avoid taxation under the excess distribution rules described above in respect to the ordinary shares by making a timely and valid
&#8220;qualified electing fund&#8221; (&#8220;QEF&#8221;) election (if eligible to do so). However, a U.S.&#160;Holder may make a QEF
election with respect to its ordinary shares only if we provide U.S.&#160;Holders on an annual basis with certain financial information
specified under applicable U.S.&#160;Treasury regulations, including the information provided in a PFIC Annual Information Statement.
There can be no assurance, however, that we will have timely knowledge of its status as a PFIC in the future or that we will timely provide
such information for such&#160;years. The failure to provide such information on an annual basis could prevent a U.S.&#160;Holder from
making a QEF election or result in the invalidation or termination of a U.S.&#160;Holder&#8217;s prior QEF election.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A U.S.&#160;Holder that makes a QEF election with
respect to its ordinary shares would generally be required to include in income for each year that we are treated as a PFIC the U.S.&#160;Holder&#8217;s
pro rata share of our ordinary earnings for the year (which would be subject to tax as ordinary income) and net capital gains for the
year (which would be subject to tax at the rates applicable to long-term&#160;capital gains), without regard to the amount of any distributions
made in respect of the ordinary shares. Any net deficits or net capital losses of us for a taxable year, however, would not be passed
through and included on the tax return of the U.S.&#160;Holder. A U.S.&#160;Holder&#8217;s basis in the ordinary shares would be increased
by the amount of income inclusions under the QEF rules. Dividends actually paid on the ordinary shares generally would not be subject
to U.S.&#160;federal income tax to the extent of prior income inclusions and would reduce the U.S.&#160;Holder&#8217;s basis in the ordinary
shares by a corresponding amount. If we own any interests in a Lower-Tier&#160;PFIC, a U.S.&#160;Holder generally must make a separate
QEF election for each Lower-Tier&#160;PFIC, subject to our providing the relevant tax information for each Lower-Tier&#160;PFIC on an
annual basis. There can be no assurance that we will have timely knowledge of the status of any such Lower-Tier&#160;PFIC.&#160;In addition,
we may not hold a controlling interest in any such Lower-Tier&#160;PFIC and thus there can be no assurance that we will be able to cause
the Lower-Tier&#160;PFIC to provide such required information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder does not make a QEF election
effective from the first taxable year of a U.S.&#160;Holder&#8217;s holding period for the ordinary shares in which we are a PFIC (or
a mark-to-market&#160;election, as discussed below), then the U.S.&#160;Holder generally will remain subject to the excess distribution
rules. A U.S.&#160;Holder that first makes a QEF election in a later year may avoid the continued application of the excess distribution
rules to its ordinary shares by making a &#8220;deemed sale&#8221; election. In that case, the U.S.&#160;Holder will be deemed to have
sold the ordinary shares at their fair market value on the first&#160;day of the taxable year in which the QEF election becomes effective,
and any gain from such deemed sale would be subject to the excess distribution rules described above. As a result of the &#8220;deemed
sale&#8221; election, the U.S.&#160;Holder will have additional basis (to the extent of any gain recognized on the deemed sale) and, solely
for purposes of the PFIC rules, a new holding period in the ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is not entirely clear how various aspects of
the PFIC rules apply to the warrants. However, a U.S.&#160;Holder may not make a QEF election with respect to its warrants. As a result,
if a U.S.&#160;Holder sells or otherwise disposes of such warrants (other than upon exercise of such warrants) and we were a PFIC at any
time during the U.S.&#160;Holder&#8217;s holding period of such warrants, any gain recognized generally will be treated as an excess distribution,
taxed as described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder that exercises such warrants
properly makes and maintains a QEF election with respect to the newly acquired ordinary shares (or has previously made a QEF election
with respect to the ordinary shares), the QEF election will apply to the newly acquired ordinary shares. Notwithstanding such QEF election,
the rules relating to &#8220;excess distributions&#8221; discussed above, adjusted to take into account the current income inclusions
resulting from the QEF election, will continue to apply with respect to such newly acquired ordinary shares (which under proposed regulations
will be deemed to have a holding period for purposes of the PFIC rules that includes the period the U.S.&#160;Holder held the warrants),
unless the U.S.&#160;Holder makes a &#8220;deemed sale&#8221; election under the PFIC rules. U.S.&#160;Holders are urged to consult their
tax advisors as to the application of the rules governing &#8220;deemed sale&#8221; elections to their particular circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The QEF election is made on a shareholder-by-shareholder&#160;basis
and, once made, can be revoked only with the consent of the IRS.&#160;A U.S.&#160;Holder that is eligible to make a QEF election with
respect to its ordinary shares generally may do so by providing the appropriate information to the IRS in the U.S.&#160;Holder&#8217;s
timely filed tax return for the year in which the election becomes effective. Retroactive QEF elections generally may be made only by
filing a protective statement with such return and if certain other conditions are met or with the consent of the IRS.&#160;U.S.&#160;Holders
should consult their tax advisors regarding the availability and tax consequences of a retroactive QEF election under their particular
circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S.&#160;Holders should consult their tax advisors
as to the availability and desirability of a QEF election.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alternatively, if we are a PFIC and ordinary shares
constitute &#8220;marketable stock&#8221; (as defined below), a U.S.&#160;Holder may make a mark-to-market&#160;election for such holder&#8217;s
ordinary shares with respect to such shares for the first taxable year in which it holds (or is deemed to hold) ordinary shares and each
subsequent taxable year to elect out of the excess distribution rules discussed above. If a U.S.&#160;Holder makes a mark-to-market&#160;election
with respect to its ordinary shares, such U.S.&#160;Holder generally will include in income for each year that we are treated as a PFIC
with respect to such ordinary shares an amount equal to the excess, if any, of the fair market value of the ordinary shares as of the
close of the U.S.&#160;Holder&#8217;s taxable year over the adjusted basis in the ordinary shares. A U.S.&#160;Holder will be allowed
a deduction for the excess, if any, of the adjusted basis of the ordinary shares over their fair market value as of the close of the taxable
year. However, deductions will be allowed only to the extent of any net mark-to-market&#160;gains on the ordinary shares included in the
U.S.&#160;Holder&#8217;s income for prior taxable&#160;years. Amounts included in income under a mark-to-market&#160;election, as well
as gain on the actual sale or other disposition of the ordinary shares, will be treated as ordinary income. Ordinary loss treatment will
also apply to the deductible portion of any mark-to-market&#160;loss on the ordinary shares, as well as to any loss realized on the actual
sale or disposition of the ordinary shares, to the extent the amount of such loss does not exceed the net mark-to-market&#160;gains for
such ordinary shares previously included in income. A U.S.&#160;Holder&#8217;s basis in the ordinary shares will be adjusted to reflect
any mark-to-market&#160;gain or loss. If a U.S.&#160;Holder makes a mark-to-market&#160;election, any distributions we make would generally
be subject to the rules discussed above under &#8220;<i>&#8212;&#160;Distributions on ordinary shares</i>,&#8221; except the lower rates
applicable to qualified dividend income would not apply. Currently, U.S.&#160;Holders of warrants will not be able to make a mark-to-market&#160;election
with respect to their warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The mark-to-market&#160;election is available
only for &#8220;marketable stock,&#8221; which is stock that is regularly traded on a qualified exchange or other market, as defined in
applicable U.S.&#160;Treasury regulations. The ordinary shares, which listed on Nasdaq, are expected to qualify as marketable stock for
purposes of the PFIC rules, but there can be no assurance that ordinary shares will be &#8220;regularly traded&#8221; for purposes of
these rules. If made, a mark-to-market&#160;election would be effective for the taxable year for which the election was made and for all
subsequent taxable&#160;years unless ordinary shares cease to qualify as &#8220;marketable stock&#8221; for purposes of the PFIC rules
or the IRS consents to the revocation of the election. Because a mark-to-market&#160;election cannot be made for equity interests in any
Lower-Tier&#160;PFICs, a U.S.&#160;Holder that does not make the applicable QEF elections generally will continue to be subject to the
excess distribution rules with respect to its indirect interest in any Lower-Tier&#160;PFICs as described above, even if a mark-to-market&#160;election
is made for ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a U.S.&#160;Holder does not make a mark-to-market&#160;election
(or a QEF election, as discussed above) effective from the first taxable year of a U.S.&#160;Holder&#8217;s holding period for the ordinary
shares in which we are a PFIC, then the U.S.&#160;Holder generally will remain subject to the excess distribution rules. A U.S.&#160;Holder
that first makes a mark-to-market&#160;election with respect to the ordinary shares in a later year will continue to be subject to the
excess distribution rules during the taxable year for which the mark-to-market&#160;election becomes effective, including with respect
to any mark-to-market&#160;gain recognized at the end of that year. In subsequent&#160;years for which a valid mark-to-mark&#160;election
remains in effect, the excess distribution rules generally will not apply. A U.S.&#160;Holder that is eligible to make a mark-to-market&#160;with
respect to such holder&#8217;s ordinary shares may do so by providing the appropriate information on IRS Form&#160;8621 and timely filing
that form with the U.S.&#160;Holder&#8217;s tax return for the year in which the election becomes effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S.&#160;Holders should consult their tax advisors
as to the availability and desirability of a mark-to-market&#160;election, as well as the impact of such election on interests in any
Lower-Tier&#160;PFICs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A U.S.&#160;Holder of a PFIC may be required to
file an IRS Form&#160;8621 on an annual basis and to provide such other information as may be required by the U.S.&#160;Treasury Department.
Failure to do so, if required, will extend the statute of limitations applicable to such U.S.&#160;Holder until such required information
is furnished to the IRS.&#160;U.S.&#160;Holders should consult their tax advisors regarding any reporting requirements that may apply
to them if we are a PFIC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rules dealing with PFICs and with the QEF,
&#8220;deemed sale,&#8221; and mark-to-market&#160;elections are very complex and are affected by various factors in addition to those
described above. U.S.&#160;Holders are strongly encouraged to consult their tax advisors regarding the application of the PFIC rules to
their particular circumstances.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE U.S.&#160;FEDERAL INCOME TAX DISCUSSION
SET FORTH ABOVE IS INCLUDED FOR GENERAL INFORMATION ONLY AND MAY NOT BE APPLICABLE TO YOU DEPENDING UPON YOUR PARTICULAR SITUATION.&#160;YOU
ARE URGED TO CONSULT YOUR OWN TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES TO YOU OF THE OWNERSHIP AND DISPOSITION OF ORDINARY SHARES
AND WARRANTS, AS APPLICABLE, INCLUDING THE TAX CONSEQUENCES UNDER STATE, LOCAL, FOREIGN AND OTHER TAX LAWS AND TAX TREATIES AND THE POSSIBLE
EFFECTS OF CHANGES IN U.S.&#160;OR OTHER TAX LAWS.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.F. Dividends and Paying Agents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.G. Statement by Experts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.H. Documents on Display</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the informational requirements
of the Securities Exchange Act of 1934, as amended, and will file reports, registration statements and other information with the SEC.
Our reports, registration statements and other information can be inspected on the SEC&#8217;s website at www.sec.gov and such information
can also be inspected and copies ordered at the public reference facilities maintained by the SEC at the following location: 100 F Street
NE, Washington, D.C. 20549. You may also visit our website at https://arberobotics.com. Information contained on, or that can be accessed
through, our website or any other website is expressly not incorporated by reference into and is not a part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>I. Subsidiary Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 121; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are exposed to various market risks, which
may result in potential losses arising from adverse changes in market rates, such as interest rates, foreign exchange rates and inflation
and supply line factors. The effect of inflation and supply line factors and interest rates are described in Item 5. Operating and Financial
Review and Prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interest Rate Risk</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, we had $13.5 million
in cash and cash equivalents and $10.8 million in short term bank deposits, which consisted of funds held in interest-bearing checking
accounts. Our primary exposure to interest rate sensitivity affects the interest income we receive and is affected by changes in the general
level of Bank of Israel and the United States Fed Funds rate, affects bank interest rates. Due to the short-term nature and the low-risk
profile of our interest-bearing accounts, an immediate change in interest rates would not have a material effect on the fair market value
of our cash and cash equivalents and short-term restricted bank deposits or on our financial position or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Foreign Currency Exchange Risk</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our results of operations and cash flows are subject
to fluctuations due to changes in foreign currency exchange rates. Currently most of our revenue is generated in US Dollar while our expenses
are generally denominated in the currencies of the jurisdictions in which we conduct our operations, primarily Israeli Shekel, US Dollar
and Euro to some extent. We have not generated significant revenue to date and we do not believe that foreign currency exchange rates
have not had, or currently have, a material effect on our business, but we cannot give any assurance that changes in foreign currency
exchange rates will not have a material impact on us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN
EQUITY SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>A. Debt Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2024, we issued our convertible bonds
(the &#8220;bonds &#8220;) in the principal amount of NIS 110,000,000 (approximately $30 million). The bonds were issued solely to Israeli
investors and were not offered in the United States or to U.S. persons. The bonds bear interest on the principal amount of the bonds at
the rate or 6.5% per annum, mature on May 30, 2028, and are convertible into our ordinary shares at a conversion price of NIS 9.53 (approximately
$2.60) per share. The bonds are listed for trading on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;) under the symbol ARBE.C1, and trading
commenced on June 6, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the bonds are denominated in NIS, the
principal and interest are indexed to the US dollar, such that if on any date that interest or principal is payable, the exchange rate
is different from the basic rate, which is 3.7 NIS for $1.00, there will be a proportional increase or decrease in the amount of the interest
or principal payment, as applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The bonds were issued pursuant to a deed of trust
dated May 30, 2024 by and between us and Mishmeret Trust Company Ltd., as trustee (the &#8220;Trustee&#8221;) pursuant to a public bid
under Israeli law on June 3, 2023 at a price of NIS 1,031 per bonds in the principal amount of NIS 1,000 pursuant to a prospectus filed
with the Israel Securities Authority and the TASE. Prior to the public bid, we obtained preliminary commitments from classified investors,
who are investors who, under Israeli securities law, do not require the delivery of a prospectus. Certain classified investors who committed
to purchase bonds in advance of the public bid, received a commission in the aggregate amount of NIS 1,028,073, which was effected as
a reduction of their purchase price. The proceeds from the sale of the bonds, which were approximately NIS 112,400,000 (approximately
$30.5 million), were held in escrow subject to release to us upon satisfaction of the following release conditions by December 31, 2025,
or earlier upon conversion of the bonds.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We win a tender or contract to supply its products
as a single supplier of chips of imaging radar (directly or through one of the international Tier 1 manufacturers) to one of ten named
major automobile manufactures.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The average closing trading price of our ordinary
shares on Nasdaq is not less than $3.10 per share during 30 consecutive trading days, and the average combined trading volume on Nasdaq
and TASE during such 30 trading days is at least 300,000 shares per day.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The closing price of the Company&#8217;s ordinary
shares on Nasdaq on the date the Company presents to the Trustee the documentation confirming the fulfillment of the abovementioned conditions
precedent, is not less than $3.10.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 122; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 20, 2025, following approval by the holders
of a majority of the outstanding bonds, the date by which we must meet the conditions to the release of funds from escrow was changed
from March 31, 2025 to December 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At December 31, 2024 and on the date of this annual
report, these conditions had not been met. If we do not meet the release conditions by December 31, 2025, we will be required to effect
an early redemption of the bonds, which will result in the use of the funds in the escrow account to pay the bonds, and we will be required
to pay to the Trustee such additional amounts as are required to pay the interest and any payment due as a result of the differential
in the exchange rate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, in the event that
any bonds are converted into ordinary shares, the funds in the escrow account that relate to the converted bonds will be released to us
provided that the amount remaining in the escrow account after the payment to us is not less than the principal amount of the outstanding
bonds.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The deed of trust requires us to comply with the
following two covenants as long as the bonds are outstanding:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our shareholders&#8217; equity shall not fall
below $5 million as of the last day of two consecutive quarters.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We shall have cash and cash equivalents of not
less than $5 million as of the last day of one quarter.</span></td></tr></table><div>

</div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the bonds are unsecured obligations,
the deed of trust provides that the Trustee will have a security interest, for the benefit of the bondholders, in the escrow funds. We
are prohibited, as long as the bonds are outstanding, from creating or agreeing to create in favor of any third party any floating charge
of any rank over all of our present and future property and rights to secure any obligation or debt of any kind, unless either the lien
is approved by a special resolution of the bonds holders or we create, in favor of the bondholders, concurrently with the grant of the
lien to the third party, a charge of equal ranking with the lien to the third party which is pari passu with the lien to the third party.
We are also prohibited from incurring financial debt (bonds, bank and non-bank credit) except for unsecured financial debt of up to $500,000.
Financial debt does not include current liabilities in the framework of our current operations and our normal course of business, which
are included in our working capital in respect of inventories, supplier obligations and trade receivables. The Company also has limited
rights to issue other series of bonds as long as the Company is in compliance with the provisions of the deed of trust.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are prohibited from making any distribution
with respect to our ordinary shares; except that this restriction does not apply if the outstanding principal amount of the bonds is less
than NIS 10 million, except that, in such event we can only make a distribution if, following the distribution, our equity capital is
not less than NIS 24 million (approximately $6.5 million).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The deed of trust has customary default provisions,
including the Company&#8217;s failure to meet the covenants, the failure of the bonds to be traded on the TASE and the Company&#8217;s
merger with another entity without prior approval of the bond holders unless the Company or the surviving entity has stated, at least
ten business days prior to the date of the merger, that there is no reasonable concern that the Company or the surviving entity, as the
case may be, will not be able to meet the Company&#8217;s obligations towards the bond holders. If any of the default events occurs, the
Trustee is required to convene a meeting of the bond holders for the purpose of approving a resolution to call for the immediate repayment
of the bonds, on ten business days&#8217; notice to the Company, except that such notice is not required if there is reasonable concern
that the giving of notice will impair the Company&#8217;s ability to immediately repay the bonds. The Trustee shall also call such a meeting
on receipt of notice from one or more bond holders who hold in the aggregate at least 5% of the principal amount of bonds. The deed of
trust also sets for a procedure for the appointment of bond holders to grant the Company an extension of time for complying with the financial
covenants of up to 90 days or until the publication of the Company&#8217;s financial statements, whichever is earlier</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any payment of principal or interest not made
within seven business days from the date such payment is due, for a reason dependent upon the Company, shall bear interest at the current
interest rate plus 5% from the date payment is due until the date of payment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have the right to prepay the all of bonds if
we effects a going private transaction or enter into a binding agreement to enter into such a transaction, in which event the bonds are
convertible into ordinary shares at a conversion price of NIS 8.53 (approximately $2.32). The TASE may delist the bonds if the outstanding
principal amount of bonds is less than the amount required for listing, which is currently NIS 1.6 million, by public holders. If the
TASE delist the bonds, the Company shall be required to redeem the bonds, and the redemption price shall be the highest of the following
(i) the market value of the bonds; (ii) the principal amount of the bonds and (iii) the cash flow balance of the outstanding bonds in
circulation. The cash flow balance is the principal plus the interest that the bonds carry upon forced early redemption (including penalty
interest, if applicable) and the accrued currency rate differential, discounted according to the government bond yield (as defined below)
plus interest at a rate of 0.9%, calculated on the basis of a daily calculation (365 days a year). The government bond yield means the
average yield (gross) to maturity in the seven business day period that ends two business days before the date of the notice of forced
early redemption, of two series of US Dollar -denominated bond series of the State of Israel, whose average life is the closest to the
average life of the bonds on the relevant date, i.e. one series whose closest average life is higher than the average life of the bonds
on the relevant date, and one series whose closest average life is lower than the average life of the bonds on the relevant date, and
whose weighted value will reflect the average life of the bonds on the relevant date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2024, bonds in aggregate principal
amount of NIS 110,000,000 (approximately $30 million) were outstanding. During the period between January 1, 2025, and March 20, 2025,
bonds in the principal amount of NIS 78,462,184 were converted and $22.4 million (including interest) was released from the escrow to
us, with outstanding bonds in the principal amount of NIS 31,537,816 (approximately $8.6 million) remaining outstanding on March 20, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>B. Warrants and Rights&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warrants issued in connection with the merger
with ITAC.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our publicly traded warrants were issued pursuant
to the business combination agreement among us, our subsidiary and Industrial Tech Acquisitions, Inc. (&#8220;ITAC&#8221;), which was
a special purpose acquisition company generally known as a SPAC. Each of our publicly traded warrants entitles the holder thereof to purchase
one ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing December&#160;11,
2021. These warrants will expire October 7, 2026, which is five&#160;years after the effective time of the Merger, at 5:00&#160;p.m.,
New&#160;York City time, or earlier upon redemption or liquidation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not be obligated to deliver any ordinary
shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement
under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto
is current, subject to our satisfying our obligations described below with respect to registration. No warrant will be exercisable and
we will not be obligated to issue ordinary shares unless the ordinary shares issuable upon such warrant exercise have been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the
event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant
will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required
to net cash settle any warrant.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of the warrants was registered pursuant
to a registration statement on Form F-4 relating to the issuance of our ordinary shares and warrants to the holders of ITAC&#8217;s common
stock and warrants pursuant to the Merger with ITAC. We are required to maintain a current prospectus relating to those ordinary shares
until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the ordinary shares
issuable upon exercise of the warrants is not effective, warrant holders may, until such time as there is an effective registration statement
and during any period when we will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless
basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if the
ordinary shares at the time of any exercise of a warrant are not listed on a national securities exchange such that it satisfies the definition
of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the Securities Act, we may, at our option, require holders of
public warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)&#160;of
the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, and
in the event we do not so elect, we will use our best efforts to register or qualify the shares under applicable blue sky laws to the
extent an exemption is not available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may call the warrants for redemption (excluding
the private warrants as described below):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in whole and not in part;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a price of $0.01 per warrant;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon not less than 30&#160;days&#8217; prior written notice of redemption (the &#8220;30-day&#160;redemption period&#8221;) to each warrant holder; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if, and only if, the reported last sale price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a 30-trading&#160;day period ending three&#160;business days before we send the notice of redemption to the warrant holders.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If and when the warrants become redeemable by
us, we may not exercise our redemption right if the issuance of the ordinary shares upon exercise of the warrants is not exempt from registration
or qualification under applicable state blue sky laws or we are unable to effect such registration or qualification. We will use our best
efforts to register or qualify such ordinary shares under the blue sky laws of the state of residence in those states in which the ITAC
warrants were offered by ITAC in its IPO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The last of the redemption criterion discussed
above is designed to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price.
If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to
exercise its warrant prior to the scheduled redemption date. However, the price of our ordinary shares may fall below the $18.00 redemption
trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 warrant
exercise price after the redemption notice is issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we call the warrants for redemption as described
above, we will have the option to require any holder that wishes to exercise its warrant to do so on a &#8220;cashless basis.&#8221; In
determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221; our \management will consider,
among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our shareholders of issuing
the maximum number of ordinary shares issuable upon the exercise of the warrants. If our management takes advantage of this option, all
holders of warrants would pay the exercise price by surrendering their warrants for that number of our ordinary shares equal to the quotient
obtained by dividing (x)&#160;the product of the number of ordinary shares underlying the warrants, multiplied by the difference between
the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair
market value&#8221; shall mean the average reported last sale price of our ordinary shares for the 10&#160;trading days ending on the
third&#160;trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If our management takes
advantage of this option, the notice of redemption will contain the information necessary to calculate the number of ordinary shares to
be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case. Requiring a cashless exercise in
this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. If we call the
warrants for redemption and our management does not take advantage of this option, the ITAC Sponsor and its permitted transferees would
still be entitled to exercise their warrants issued in respect of their private ITAC warrants for cash or on a cashless basis using the
same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise
their warrants on a cashless basis, as described in more detail below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder of a warrant may notify us in writing
in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent
that after giving effect to such exercise, such person (together with such person&#8217;s affiliates), to the warrant agent&#8217;s actual
knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the ordinary shares outstanding
immediately after giving effect to such exercise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the number of outstanding ordinary shares is
increased by a stock dividend payable in ordinary shares, or by a split-up&#160;of shares of ordinary shares or other similar event, then,
on the effective date of such stock dividend, split-up&#160;or similar event, the number of ordinary shares issuable on exercise of each
warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering to holders of ordinary
shares entitling holders to purchase ordinary shares at a price less than the fair market value will be deemed a stock dividend of a number
of ordinary shares equal to the product of (i)&#160;the number of ordinary shares actually sold in such rights offering (or issuable under
any other equity securities sold in such rights offering that are convertible into or exercisable for ordinary shares) and (ii)&#160;one
(1)&#160;minus the quotient of (x)&#160;the price per ordinary share paid in such rights offering divided by (y)&#160;the fair market
value. For these purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for ordinary shares, in determining
the price payable for ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional
amount payable upon exercise or conversion and (ii)&#160;fair market value means the volume weighted average price of our ordinary shares
as reported during the ten (10)&#160;trading day period ending on the&#160;trading day prior to the first date on which our ordinary shares
trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, if we, at any time while the warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of ordinary shares
on account of such ordinary shares (or other shares into which the warrants are convertible), other than (a)&#160;as described above,
(b)&#160;certain ordinary cash dividends, then the warrant exercise price will be decreased, effective immediately after the effective
date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each ordinary share in
respect of such event.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the number of outstanding ordinary shares is
decreased by a consolidation, combination, reverse stock split or reclassification of ordinary shares or other similar event, then, on
the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of our ordinary
shares issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever the number of ordinary shares purchasable
upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant
exercise price immediately prior to such adjustment by a fraction (x)&#160;the numerator of which will be the number of ordinary shares
purchasable upon the exercise of the warrants immediately prior to such adjustment, and (y)&#160;the denominator of which will be the
number of ordinary shares so purchasable immediately thereafter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In case of any reclassification or reorganization
of the outstanding ordinary shares (other than those described above or that solely affects the par value of such ordinary shares), or
in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are
the continuing corporation and that does not result in any reclassification or reorganization of our outstanding ordinary shares), or
in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially
as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive,
upon the basis and upon the terms and conditions specified in the warrants and in lieu of the ordinary shares immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately
prior to such event. If less than 70% of the consideration receivable by the holders of ordinary shares in such a transaction is payable
in the form of ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an
established over-the-counter&#160;market, or is to be so listed for trading or quoted immediately following such event, and if the registered
holder of the warrant properly exercises the warrant within thirty&#160;days following public disclosure of such transaction, the warrant
exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes&#160;value (as defined in the warrant
agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when
an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise
do not receive the full potential value of the warrants in order to determine and realize the option value component of the warrant. This
formula is to compensate the warrant holder for the loss of the option value portion of the warrant due to the requirement that the warrant
holder exercise the warrant within 30&#160;days of the event. The Black-Scholes&#160;model is an accepted pricing model for estimating
fair market value where no quoted market price for an instrument is available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants were issued in registered form under
a warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, and us, which reflects an assumption
and amendment to the warrant agreement between Continental Stock Transfer&#160;&amp; Trust Company and ITAC and provides that we assume
the obligations of ITAC under the warrant agreement. You should review a copy of the warrant assumption and amendment agreement, which
is filed as an exhibit to this annual report, for a complete description of the terms and conditions applicable to our warrants. The warrant
agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any
defective provision, but requires the approval by the holders of a majority of the then outstanding public warrants to make any change
in the warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders
do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive
ordinary shares. After the issuance of ordinary shares upon exercise of the warrants, each holder will be entitled to one (1)&#160;vote
for each ordinary share held of record on all matters to be voted on by shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The warrants issued to the holders of the ITAC
private warrants will not be redeemable by us so long as they are held by the Sponsor, the underwriters of ITAC&#8217;s IPO or their permitted
transferees. The Sponsor, the underwriters and their permitted transferees, have the option to exercise the private placement warrants
on a cashless basis. Except as described below, the warrants issued in respect of ITAC private warrants have terms and provisions that
are identical to those of the warrants issued to holders of the ITAC public warrants, including as to exercise price, exercisability and
exercise period. If the warrants issued in respect of the ITAC private warrants are held by holders other than the sponsor, the underwriters
or their permitted transferees, such warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants
issued in respect of the ITAC public warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If holders of the private placement warrants elect
to exercise them on a cashless basis, they would pay the exercise price by surrendering their warrants for that number of ordinary shares
equal to the quotient obtained by dividing (x)&#160;the product of the number of ordinary shares underlying the warrants, multiplied by
the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair
market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of our ordinary shares for the 10&#160;trading
days ending on the third&#160;trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we have granted certain registration
rights to the holders of our private warrant that are held by the former holders of the ITAC&#8217;s private placement warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Warrants and Pre-Funded Warrants issued in November 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2024, we issued, in an offering registered
pursuant to the Securities Act, 4,293,957 ordinary shares, warrants to purchase up to 8,250,000 ordinary shares at an exercise price of
$2.35 per share (the &#8220;Tranche A Warrants&#8221;), warrants to purchase up to 8,250,000 ordinary shares at an exercise price of $1.82
per share (the &#8220;Tranche B Warrants&#8221;) and Pre-Funded Warrants to purchase 3,956,043 ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tranche A Warrants, Tranche B Warrants and
Pre-Funded Warrants are described below. These summaries are subject to and qualified by the form of Tranche A Warrant, Tranche B Warrant
and Pre-Funded Warrants which are filed as exhibits to this annual report. There is no trading market for the Tranche A Warrants, Tranche
B Warrants or Pre-Funded Warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tranche A Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Tranche A Warrant has an initial exercise
price per ordinary share equal to $2.35. The Tranche A Warrants are immediately exercisable and expire on November 4, 2029. The exercise
price and number of ordinary shares issuable upon exercise is subject to appropriate adjustment in the event of share dividends, share
splits, reorganizations or similar events affecting our ordinary shares and the exercise price. Subject to the rules and regulations of
the applicable trading market, we may at any time during the term of the Tranche A Warrant, subject to the prior written consent of the
holders, reduce the then current exercise price to any amount and for any period of time deemed appropriate by our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder (together with its affiliates) may not
exercise any portion of the Tranche A Warrant to the extent that the holder would own more than 4.99% of the outstanding ordinary shares
immediately after exercise, except that upon at least 61 days&#8217; prior notice from the holder to us, the holder may increase the amount
of beneficial ownership of outstanding shares after exercising the holder&#8217;s Tranche A Warrants up to 9.99% of the number of our
ordinary shares outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of the Tranche A Warrants. Purchasers of Tranche A Warrants in this had the right to have the initial exercise limitation
set at 9.99% of our outstanding ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, at the time a holder exercises its Tranche
A Warrants, a registration statement registering the issuance of the ordinary shares underlying the Tranche A Warrants under the Securities
Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated
to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of ordinary shares determined according to a formula set forth in the Tranche A warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional ordinary shares will be issued upon
the exercise of the Tranche A Warrants. Rather, at our election, the number of ordinary shares to be issued will be rounded up to the
next whole share or we will pay a cash adjustment in an amount equal to such fraction multiplied by the exercise price.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Tranche A
Warrants or by virtue of such holder&#8217;s ownership of ordinary shares, the holders of the Tranche A Warrants do not have the rights
or privileges of holders of our ordinary shares, including any voting rights, until they exercise their Tranche A Warrants. However, the
Tranche A Warrants provide that the holders of the Tranche A Warrants have the right to participate in distributions or dividends paid
on our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of any fundamental transaction, as
described in the Tranche A Warrants and generally including any merger with or into another entity, sale of all or substantially all of
our assets, tender offer or exchange offer, or reclassification of our ordinary shares, then upon any subsequent exercise of a Tranche
A Warrant, the holder will have the right to receive as alternative consideration, for each ordinary share that would have been issuable
upon such exercise immediately prior to the occurrence of such fundamental transaction, the number of ordinary shares of the successor
or acquiring corporation or of our company, if it is the surviving corporation, and any additional consideration receivable upon or as
a result of such transaction by a holder of the number of ordinary shares for which the Tranche A Warrant is exercisable immediately prior
to such event. Notwithstanding the foregoing, in the event of a fundamental transaction, the holders of the Tranche A Warrants have the
right to require us or a successor entity to redeem the Tranche A Warrants for cash in the amount of the Black-Scholes Value (as defined
in the Tranche A Warrant) of the unexercised portion of the Tranche A Warrants concurrently with or within 30 days following the consummation
of a fundamental transaction; provided, that if we, directly or indirectly, in one or more related transactions consummate a transaction
(including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another person or
group of persons whereby such other person or group acquires 100% of our outstanding ordinary shares or 100% of the voting power of our
common equity (a &#8220;Going Private Transaction&#8221;) then, if the holder has not exercised the Holder Repurchase Option (as that
term is defined in the Tranche A Warrant) we have the right, but are not obligated to, repurchase the Tranche A Warrant from the holder
for a payment in cash equal to the Black Scholes Value of the remaining unexercised portion of the Tranche A Warrant on the date of the
consummation of such Going Private Transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, in the event of a fundamental transaction
which is not in our control, including a fundamental transaction not approved by our board of directors, the holders of the Tranche A
Warrants will only be entitled to receive from us or our successor entity, as of the date of consummation of such fundamental transaction
the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of the Tranche
A Warrant that is being offered and paid to the holders of our ordinary shares in connection with the fundamental transaction, whether
that consideration is in the form of cash, stock or any combination of cash and stock, or whether the holders of our ordinary shares are
given the choice to receive alternative forms of consideration in connection with the fundamental transaction. If the holders of our ordinary
shares are not offered or paid any consideration in such fundamental transaction, then such holders will be deemed to have received ordinary
shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tranche B Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Tranche B Warrant has an initial exercise
price per ordinary share equal to $1.82. At the election of the holder, in lieu of receiving ordinary shares upon the exercise of a Tranche
B Warrant, the holder can choose to receive Pre-Funded Warrants having the same terms as the Pre-Funded Warrants, in which event the exercise
price of the Tranche B Warrant will be reduced by the per-share exercise price of the pre-funded warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tranche B Warrants expire on the earliest
to occur of (i) the 20<sup>th</sup> trading day after we have provided notice of the occurrence of a Triggering Event or November 4, 2027.
A Triggering Event means the occurrence of the following events:(i) we shall have publicly announced that we have entered into a definitive
supply agreement with a named European automotive original equipment manufacturer pursuant to which such manufacturer has agreed to purchase
a minimum of 500,000 radar chipsets over the term of such agreement (the &#8220;Definitive Agreement Announcement&#8221;), (ii) on or
prior to the one year anniversary following the Definitive Agreement Announcement (the &#8220;Definitive Agreement Announcement Period&#8221;),
the VWAP (as defined below) for each Trading Day in any period of ten consecutive trading days following the date of the Definitive Agreement
Announcement (such period, the &#8220;Measurement Period&#8221;) is equal to or exceeds $2.25 (subject to adjustment for forward and reverse
stock splits, recapitalizations, stock dividends and the like after the Initial Exercise Date), (iii) the trading volume of our ordinary
shares (as reported by Bloomberg L.P. (&#8220;Bloomberg&#8221;)) on each Trading Day during the Measurement Period is at least 250,000
ordinary shares (subject to adjustment for forward and reverse stock splits, recapitalizations, stock dividends and the like after the
Initial Exercise Date), and (iv) the ordinary shares issuable upon the exercise the Tranche B Warrants and any ordinary shares issuable
upon exercise of any Pre-Funded Warrants issued upon the exercise of Tranche B Warrants (collectively, the &#8220;Saleable Shares&#8221;)
are covered by an effective registration statement and a current prospectus which can be used for the sale or other disposition of the
Saleable Shares and we have no reason to believe that such registration statement and prospectus will not continue to be available for
the Saleable Shares for the next thirty (30) trading days</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 128; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price and number of ordinary shares
issuable upon exercise is subject to appropriate adjustment in the event of share dividends, share splits, reorganizations or similar
events affecting our ordinary shares and the exercise price. Subject to the rules and regulations of the applicable trading market, we
may at any time during the term of the Tranche B Warrant, subject to the prior written consent of the holders, reduce the then current
exercise price to any amount and for any period of time deemed appropriate by our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Tranche B Warrants will be exercisable, at
the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for
the number of ordinary shares purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together
with its affiliates) may not exercise any portion of the Tranche B Warrant to the extent that the holder would own more than 4.99% of
the outstanding ordinary shares immediately after exercise, except that upon at least 61 days&#8217; prior notice from the holder to us,
the holder may increase the amount of beneficial ownership of outstanding shares after exercising the holder&#8217;s Tranche B Warrants
up to 9.99% of the number of our ordinary shares outstanding immediately after giving effect to the exercise, as such percentage ownership
is determined in accordance with the terms of the Tranche B Warrants. Purchasers of Tranche B Warrants had the opportunity to elect prior
to issuance of the Tranche B Warrants to have the initial exercise limitation set at 9.99% of our outstanding ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If, at the time a holder exercises its Tranche
B Warrants, a registration statement registering the issuance of the ordinary shares underlying the Tranche B Warrants under the Securities
Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated
to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of ordinary shares determined according to a formula set forth in the Tranche B Warrant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the Triggering Event Period and the Definitive
Agreement Announcement Period, a holder of a Tranche B Warrant, to the extent the Tranche B Warrant remains unexercised in whole or in
part, will not be permitted to, directly or indirectly or through an affiliate, enter into or effect any &#8220;short sale&#8221; of our
ordinary shares or other hedging transaction which establishes a net short position with respect to our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional ordinary shares will be issued upon
the exercise of the Tranche B Warrants. Rather, at our election, the number of ordinary shares to be issued will be rounded up to the
next whole share or we will pay a cash adjustment in an amount equal to such fraction multiplied by the exercise price.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Tranche B
Warrants or by virtue of such holder&#8217;s ownership of ordinary shares, the holders of the Tranche B Warrants do not have the rights
or privileges of holders of our ordinary shares, including any voting rights, until they exercise their Tranche B Warrants. The Tranche
B Warrants provide that the holders of the Tranche B Warrants have the right to participate in distributions or dividends paid on our
ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of any fundamental transaction, as
described in the Tranche B Warrants and generally including any merger with or into another entity, sale of all or substantially all of
our assets, tender offer or exchange offer, or reclassification of our ordinary shares, then upon any subsequent exercise of a Tranche
B Warrant, the holder will have the right to receive as alternative consideration, for each ordinary share that would have been issuable
upon such exercise immediately prior to the occurrence of such fundamental transaction, the number of ordinary shares of the successor
or acquiring corporation or of our company, if it is the surviving corporation, and any additional consideration receivable upon or as
a result of such transaction by a holder of the number of ordinary shares for which the Tranche B Warrant is exercisable immediately prior
to such event. Notwithstanding the foregoing, in the event of a fundamental transaction, the holders of the Tranche B Warrants have the
right to require us or a successor entity to redeem the Tranche B Warrants for cash in the amount of the Black-Scholes Value (as defined
in each Tranche B Warrant) of the unexercised portion of the Tranche B Warrants concurrently with or within 30 days following the consummation
of a fundamental transaction; provided, that in a Going Private Transaction, if the holder has not exercised the Holder Repurchase Option
(as that term is defined in the Tranche B Warrant) we have the right, but are not obligated to, repurchase the Tranche B Warrant from
the holder for a payment in cash equal to the Black Scholes Value of the remaining unexercised portion of the Tranche B Warrant on the
date of the consummation of such Going Private Transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, in the event of a fundamental transaction
which is not in our control, including a fundamental transaction not approved by our board of directors, the holders of the Tranche B
Warrants will only be entitled to receive from us or our successor entity, as of the date of consummation of such fundamental transaction
the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of the Tranche
B Warrant that is being offered and paid to the holders of our ordinary shares in connection with the fundamental transaction, whether
that consideration is in the form of cash, stock or any combination of cash and stock, or whether the holders of our ordinary shares are
given the choice to receive alternative forms of consideration in connection with the fundamental transaction. If the holders of our ordinary
shares are not offered or paid any consideration in such fundamental transaction, then such holders will be deemed to have received ordinary
shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pre-Funded Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Pre-Funded Warrant has an initial exercise
price per ordinary share equal to $0.0001. The Pre-Funded Warrants are immediately exercisable and will expire when exercised in full.
The exercise price and number of ordinary shares issuable upon exercise is subject to appropriate adjustment in the event of share dividends,
share splits, reorganizations or similar events affecting our ordinary shares and the exercise price. Subject to the rules and regulations
of the applicable trading market, we may at any time during the term of the Pre-Funded Warrant, subject to the prior written consent of
the holders, reduce the then current exercise price to any amount and for any period of time deemed appropriate by our board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A holder (together with its affiliates) may not
exercise any portion of the Pre-Funded Warrant to the extent that the holder would own more than 4.99% of the outstanding ordinary shares
immediately after exercise, except that upon at least 61 days&#8217; prior notice from the holder to us, the holder may increase the amount
of beneficial ownership of outstanding shares after exercising the holder&#8217;s Pre-Funded Warrants up to 9.99% of the number of our
ordinary shares outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance
with the terms of the Pre-Funded Warrants. Purchasers of Pre-Funded Warrants had the opportunity to elect prior to issuance of the Pre-Funded
Warrants to have the initial exercise limitation set at 9.99% of our outstanding ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In lieu of making the cash payment otherwise contemplated
to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of ordinary shares determined according to a formula set forth in the Pre-Funded Warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No fractional ordinary shares will be issued upon
the exercise of the Pre-Funded Warrants. Rather, at our election, the number of ordinary shares to be issued will be rounded up to the
next whole share or we will pay a cash adjustment in an amount equal to such fraction multiplied by the exercise price.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise provided in the Pre-Funded
Warrants or by virtue of such holder&#8217;s ownership of ordinary shares, the holders of the Pre-Funded Warrants do not have the rights
or privileges of holders of our ordinary shares, including any voting rights, until they exercise their Pre-Funded Warrants. The Pre-Funded
Warrants provide that the holders of the Pre-Funded Warrants have the right to participate in distributions or dividends paid on our ordinary
shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a fundamental transaction, as
described in the Pre-Funded Warrants and generally including any reorganization, recapitalization or reclassification of our ordinary
shares, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with
or into another person, the acquisition of more than 50% of our outstanding ordinary shares, or any person or group becoming the beneficial
owner of 50% of the voting power represented by our outstanding ordinary shares, the holders of the Pre-Funded Warrants will be entitled
to receive upon exercise of the Pre-Funded Warrants the kind and amount of securities, cash or other property that the holders would have
received had they exercised the Pre-Funded Warrants immediately prior to such fundamental transaction on a net exercise basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>C. Other Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>D. American Depository Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART II</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Not Applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>ITEM 15. CONTROLS AND PROCEDURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Evaluation of Disclosure Controls and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain disclosure controls and procedures
(as that term is defined in Rules&#160;13a-15(e)&#160;and&#160;15d-15(e)&#160;under the Securities Exchange Act of 1934, as amended (&#8220;Exchange
Act&#8221;)) that are designed to ensure that information required to be disclosed in the Company&#8217;s reports under the Exchange Act
is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information
is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate,
to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide
only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our Chief Executive Officer
and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as
of December&#160;31,&#160;2024, Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as
of December&#160;31, 2024, our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance
level.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Management&#8217;s Report on Internal Control
over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, under the supervision of our Chief
Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over our financial
reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Internal control over financial reporting is designed to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of its inherent limitations, internal
control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can
provide only reasonable assurances with respect to financial statement preparation and presentation. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, including our Chief Executive
Officer and Chief Financial Officer, conducted an evaluation, pursuant to Rule 13a-15(c) promulgated under the Exchange Act, of the effectiveness,
as of the end of the period covered by this annual report, of our internal control over financial reporting based on the framework in
Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013). Based
on the results of this evaluation, our management concluded that as of December 31, 2024, our internal control over financial reporting
was effective. However, the accompanying financial statements for the year ended December 31, 2024, we corrected the net loss per ordinary
share for the years ended December 31, 2024 and 2023, which resulted in a reduction in the net loss per ordinary share on a diluted basis,
for the year ended December 31, 2023 and for the year ended December 31, 2022 due to an increase in the average shares outstanding for
the appliable loss per ordinary share from the numbers shown in our financial statements that we filed as part of our Form 20-F for the
year ended December 31, 2023. The adjustment in the number of ordinary shares used in computing diluted loss per share reflected the revaluation
of warrants used in determining warrant liability. Since the net loss was not affected, the prior financial statements have been corrected
but are not treated as restated. See Note 11 of Notes to Consolidated Financial Statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Attestation Report of the Registered Public
Accounting Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">As an &#8220;emerging
growth company,&#8221; as defined in the JOBS Act, we may take advantage of certain temporary exemptions from various reporting requirements,
including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act (and the SEC rules and regulations thereunder). When these exemptions cease to apply, we expect to incur additional expenses and devote
increased management effort toward ensuring compliance with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Changes in Internal
Control over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no changes in our internal controls
over financial reporting (as such term is defined in Rules&#160;13a-15(f)&#160;and&#160;15d-15(f)&#160;under the Securities Exchange Act)
that occurred during the period covered by this annual report that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16. [RESERVED]</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our board of directors has determined that Dr.
Boaz Schwartz is an &#8220;audit committee financial expert.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16B. CODE OF ETHICS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a Code of Ethics that applies
to our principal executive and financial officers, and that also applies to all of our employees. The Code of Ethics is publicly available
on our website at www.arberobotics.com and is filed as an exhibit to this annual report. We will disclose on our website any amendment
to, or waiver from, a provision of our Code of Ethics and Conduct that applies to our directors or executive officers to the extent required
under the rules of the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM &#160;16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Somekh Chaikin, a member
firm of KPMG International, located in Tel Aviv, Israel (PCAOB ID <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-19219">1057</ix:nonNumeric>), has served as our independent registered public accounting firm
since 2021. The following are Somekh Chaikin&#8217;s fees for 2024 and 2023:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Audit fees (1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">315,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">170,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax fees (2)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,600</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">353,100</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">192,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Audit
fees&#8221; include fees for services performed by our independent public accounting firm in connection with the audit of our annual
consolidated financial statements for 2024 and 2023, certain procedures regarding our annual report submitted on Form 20-F, our quarterly
financial results submitted on Form 6-K, and consultation concerning financial accounting and reporting standards.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Tax
fees&#8221; include fees for professional services rendered and performed during the period by our independent registered public accounting
firm for tax compliance and tax advice and tax planning services on actual or contemplated transactions.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b>Audit Committee&#8217;s
Pre-Approval Policies and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Our Audit Committee has
adopted a pre-approval policy for the engagement of our independent accountant to perform certain audit and non-audit services. Pursuant
to this policy, which is designed to assure that such engagements do not impair the independence of our auditors, the audit committee
pre-approves a maximum amount for certain potential services and approval is provided prior to any service performed by the independent
accountant. Prior to any engagement of&#160;the independent accountant by the Company or its subsidiaries to render audit or non-audit
services, a detailed description of the particular service to be performed as well as the fee structure are pre-approved by the Company&#8217;s
audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16G. CORPORATE GOVERNANCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ordinary shares are listed on the Nasdaq Capital
Market and on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;). As such, we follow corporate governance standards applicable to us under
Israeli Law and requirements imposed by Nasdaq listing rules and the TASE listing rules. Under Nasdaq rules, foreign private issuers,
such as us, may, in general, follow their home country corporate governance practices in lieu of some of the Nasdaq corporate governance
requirements. A Nasdaq-listed foreign private issuer is required to provide a general summary of the significant differences either on
the company website or in its annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, we do not plan to rely on the home
country practice exemption with respect to its corporate governance, other than with respect to the following: (i) the quorum requirements;
(ii) the home country exception from the Nasdaq requirement for obtaining shareholder approval for certain issuances of 20% or more of
our ordinary shares; (iii) we are not sending annual reports or proxy materials to our shareholders, since Israeli law does not require
us to distributes such documents directly to our shareholders, however we do make available those documents through our public website;
(iv) we are not requiring shareholder approval with respect to our equity-based compensation plans, as we follow Israeli corporate governance
practice which requires to obtain only the approval of the board of directors for the adoption or amendment of our equity-based compensation
plans. Our Restated Articles provide that two shareholders holding 25% of the voting shares constitute a quorum, as contrasted with the
Nasdaq requirement of one-third of a company&#8217;s outstanding voting securities. Israeli law has no requirement for obtaining shareholder
approval for the issuance of 20% or more of our ordinary shares, and, accordingly, we are able to issue more than 20% of our ordinary
shares without shareholder approval, including issuances which would otherwise require shareholder approval under the Nasdaq regulations.
This exception does not apply to increases in our authorized capital stock or the issuance of preferred shares both of which requires
shareholder approval under Israeli law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 16H. MINE SAFETY DISCLOSURE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b>&#160;</p><div>

</div><div><a id="a_028"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_029"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16J. INSIDER TRADING POLICIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have an <ix:nonNumeric contextRef="c32" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-19220">insider</ix:nonNumeric> tradition policy governing
the purchase, sale, and other dispositions of the registrant&#8217;s securities by directors, senior management, and employees. Our insider
trading policy is filed as an exhibit to this Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 16K. CYBERSECURITY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="ixv-12254"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Risk Management</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We manage significant and persistent cybersecurity
risks due to the need to protect our business, including our intellectual property and intellectual property of others that is licensed
for our use, our confidential information and information concerning our personnel and others with whom we conduct business. As other
technology companies we occasionally face threats from actors who seek to disrupt our business as well as others who are engaging in malicious
activities or for reputation damage. Disclose of certain information as a result of a cybersecurity breach may result in a breach of privacy
laws. <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" id="ixv-19221">The substantial level of harm that could occur to us and our suppliers and customers were we to suffer impacts of a material cybersecurity
incident; and our use of third-party products, services and components requires us to maintain robust governance and oversight of these
risks and to implement mechanisms, technologies and processes designed to help us assess, identify, and eliminate these risks.</ix:nonNumeric></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we have not, as of the date of this Form
20-F, experienced a cybersecurity threat or incident that resulted in a material adverse impact to our business or operations, <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" id="ixv-19222">we cannot
assure you that we will <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="ixv-19223">not</ix:nonNumeric> experience such an incident in the future.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="ixv-19224">While we did suffer a cybersecurity incident in 2023 which did
not result in any material adverse impact to our business, we did not experience any disclosure of our proprietary information, and following
such incident we took additional steps to protect ourselves from cybersecurity incidents.</ix:nonNumeric> Any cybersecurity incidents, whether or not
successful, could result in our incurring additional costs related to, for example, rebuilding our internal systems, implementing additional
threat protection measures, responding to regulatory inquiries or actions, paying damages or making payments to obtain access to our computer
systems, or taking other remedial steps with respect to third parties, as well as incurring significant reputational harm. We have seen
an increase in cyberattack volume, frequency, and sophistication. We seek to detect and investigate unauthorized attempts and attacks
against our network, products, and services, and to prevent their occurrence and recurrence where practicable through changes or updates
to our internal processes and tools and changes or updates to our products and services; however, while diligently taking actions to eliminate
and reduce cyber risks, we remain potentially vulnerable to known or unknown threats. In some instances, we, our suppliers, our customers,
and the users of our products and services can be unaware of a threat or incident or its magnitude and effects. Further, there are increasing
regulation requirements regarding responses to cybersecurity incidents, including reporting to regulators, which could subject us to additional
liability and reputational harm.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="ixv-12270"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Governance</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2" id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We aim to incorporate industry best practices
throughout our cybersecurity program. Our cybersecurity strategy focuses on implementing effective and efficient controls, technologies,
and other processes to assess, identify, and manage material cybersecurity risks.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_3" id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cybersecurity program is designed to be aligned
with applicable industry standards, and we have engaged outside sources to assist in this effort. We have processes in place to assess,
identify, manage, and address material cybersecurity threats and incidents. We have ISO 27001:2013 certification, which is an early standard
for information security management. Steps taken by us include, among other things: an audit which was conducted by the company&#8217;s
internal auditor during 2023 through 2024 of the cybersecurity measures and practices of the Company, the engagement with professional
service providers (such as a chief information security officer (&#8220;CISO&#8221;) and security operations center services), security
awareness training for employees; mechanisms to detect and monitor unusual network activity; and containment and incident response tools.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_4" id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We monitor issues that are internally discovered
or externally reported that may affect our products and have processes to assess those issues for potential cybersecurity impact or risk.
We also have a process in place to manage cybersecurity risks associated with third-party service providers. We are in the process of
implementing additional technical and organizational security measures to follow our information security program.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our CISO, who is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" id="ixv-19225">third party</ix:nonNumeric> engaged by us,
and our VP infrastructure, lead the strategy and guidelines, and work with senior management and IT engineering, to operate and implement
cybersecurity of the Company. The CISO is responsible for handling the risk management by assessment, analysis, reporting, managing the
cyber protection following the relevant requirements, the work with the Information Technology team, implementing information security
awareness among the employees, and updating the company&#8217;s security policies. Our CISO provides annual analysis and updates to the
management on our cybersecurity and information security policies and programs, as well as ad hoc updates on information security and
cybersecurity matters. The CISO and management provide updates to the Audit Committee on the Company&#8217;s cybersecurity policies, risks
and mitigation strategies. <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="ixv-19226">In addition, and as part of our policy, our CISO is also responsible for informing the Audit Committee of material
cybersecurity threats and incidents, based on management&#8217;s assessment of risk.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="ixv-19227">Our board of directors has overall oversight responsibility
for our risk management, and delegates cybersecurity risk management oversight to the audit committee of our board of directors (the &#8220;Audit
Committee&#8221;). Under our cybersecurity governance framework the Audit Committee, in its charter, is empowered to implement and oversee
our cybersecurity and information security policies and periodically review their compliance and mitigate potential cybersecurity threats.</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="ixv-19228">The Audit Committee is <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" id="ixv-19229">responsible</ix:nonNumeric> for ensuring that management has in place processes designed to identify and assess cybersecurity risks,
and implement processes and programs designed to manage and mitigate and remediate such risks and incidents.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" id="ixv-19230">Both management and the Audit
Committee also report material cybersecurity risks to our full board of directors, based on management&#8217;s assessment of risk.</ix:nonNumeric></p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART III</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 17. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 18. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Index to Financial Statements on Page F-1</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 19. EXHIBITS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 9%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 1%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="width: 90%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390024094164/ea021993101ex3-1_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Articles of Association of Arbe <sup>(1)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1861841/000121390022016391/f20f2021ex2-1_arberobotics.htm" style="-sec-extract: exhibit">Description of Securities<sup>(6)</sup></a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021033361/ff42021ex4-4_arberobotics.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agreement dated September&#160;8, 2020, between Continental Stock Transfer&#160;&amp; Trust Company, LLC and ITAC<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1861841/000121390021054688/ea149261ex4-1_arberobotics.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment No. 1 to Warrant Agreement among Continental Stock Transfer&#160;&amp; Trust Company, LLC, ITAC and Arbe<sup>(9)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021033361/ff42021ex10-3_arberobotics.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Rights Agreement dated September&#160;8, 2020&#160;among ITAC, Industrial Tech Partners LLC and the holders signatory thereto<sup>(2)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4*</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021033361/ff42021ex10-9_arberobotics.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016 Incentive Share Option Plan of Arbe<sup>(2)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5*</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021055243/ff12021a1ex10-9_arberobotics.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021 Share Incentive Plan of Arbe<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021043224/ff42021a2ex10-11_arberobo.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Director and Officer Indemnification Agreement for Arbe<sup>(2)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021043224/ff42021a2ex10-12_arberobo.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Policy of Arbe for Officers and Directors<sup>(2)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390021048275/ff42021a4ex10-13_arberobo.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Amended and Restated Investor Rights Agreement<sup>(3)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390024053871/ea020803001ex99-1_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">English translation (unofficial) of the deed of trust dated May 30, 2024 by and between the Company and Mishmeret Trust Company<sup>(4)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea023582801ex4-10_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">English translation (unofficial) of amendment dated March 20,.2025 to deed of trust dated Maty 20, 2024 by and between the Company and Mishmeret Trust Company<sup>(7)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390024093759/ea021977601ex4-1_arberobo.htm">Form of Pre-Funded Warrant<sup>(5)</sup></a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390024093759/ea021977601ex4-2_arberobo.htm">Form of Tranche A Warrant<sup>(5)</sup></a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390024093759/ea021977601ex4-3_arberobo.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Tranche &#160;B Warrant<sup>(5)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea023582801ex8-1_arbe.htm">List of Subsidiaries of Arbe<sup>(7)</sup></a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390022016391/f20f2021ex11-1_arberobotics.htm">Code of Ethics of Arbe<sup>(6)</sup></a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea023582801ex12-1_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002<sup>(7)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea023582801ex12-2_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002<sup>(7)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea023582801ex13-1_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer<sup>(7)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1861841/000121390023022143/f20f2022ex19-1_arberobotics.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider trading policy<sup>(8)</sup></span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="ea023582801ex23-1_arbe.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Somekh Chaikin Member Firm of KPMG International<sup>(7)</sup></span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify">97.1</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1861841/000121390024026942/ea020246101ex97-1_arberobo.htm" style="-sec-extract: exhibit">Clawback
    Policy<sup>(10)</sup></a><p></p></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Definition Linkbase Document.</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
a management contract or compensation plan.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as an exhibit to the Report on Form 6-K, filed by Arbe with the SEC on November 4, 2024 (document 241424335), and incorporated herein by reference.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as an exhibit to the Registration Statement on Form F-4, File No.&#160;333-257250, filed by the Company with the SEC, and incorporated herein by reference.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as an exhibit to the Registration Statement on Form F-1, File No. 333-259757, filed by the Company with the SEC, and incorporated herein by reference.</span></td></tr>
  </table><div>
</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Filed as an exhibit to the Company&#8217;s Form 6-K/A, filed
by the Company with the SEC on June 18, 2024 and incorporated herein by reference.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">Filed as an exhibit to the Company&#8217;s Form 6-K, filed by
the Company with the SEC on November 4, 2024 (document 241420936) and incorporated herein by reference.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as an exhibit to the Company&#8217;s Form 20-F for the year ended December 31, 2021, filed by the Company with the SEC on March 31, 2022, and incorporated herein by reference.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>
  <tr style="vertical-align: top">
    <td>(8)</td>
    <td style="text-align: justify">Filed as an exhibit to the Company&#8217;s Form 20-F for the year ended December 31, 2022, filed by the Company with the SEC on March 22, 2023, and incorporated herein by reference.</td></tr>
  <tr style="vertical-align: top">
    <td>(9)</td>
    <td style="text-align: justify">Filed as an exhibit to the Company&#8217;s Form 6-K, filed
by the Company with the SEC on October 27, 2021 and incorporated herein by reference.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left">(10)</td>
    <td style="text-align: justify">Filed as an exhibit to the Company&#8217;s Form 20-F for the year ended December 31, 2023, filed by the Company with the SEC on March 28, 2024, and incorporated herein by reference.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registrant hereby certifies that it meets
all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report
on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 28, 2025</span></td>
    <td colspan="2" style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARBE ROBOTICS LTD</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="width: 4%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="width: 36%; padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jacob (Kobi) Marinka</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob (Kobi) Marinka</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt">&#160;</td>
    <td style="padding-right: 0.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ARBE ROBOTICS LTD. AND SUBSIDIARIES</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 90%; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="#f_001"><span style="font-size: 10pt">Report of Independent Registered Public Accounting Firm</span></a></td>
    <td style="text-align: center"><span style="font-size: 10pt">F-2</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><a href="#f_002"><span style="font-size: 10pt">Consolidated Balance Sheets</span></a></td>
    <td style="text-align: center"><span style="font-size: 10pt">F-3</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="#f_003"><span style="font-size: 10pt">Consolidated Statements of Operations</span></a></td>
    <td style="text-align: center"><span style="font-size: 10pt">F-5</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><a href="#f_004"><span style="font-size: 10pt">Consolidated Statements of Changes in Shareholders&#8217; Equity</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-6</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><a href="#f_005"><span style="font-size: 10pt">Consolidated Statements of Cash Flows</span></a></td>
    <td style="text-align: center"><span style="font-size: 10pt">F-7</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><a href="#f_006"><span style="font-size: 10pt">Notes to the Consolidated Financial Statements</span></a></td>
    <td style="text-align: center"><span style="font-size: 10pt">F-8</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><img alt="" src="fin_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Somekh Chaikin</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">KPMG Millennium Tower</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">17 Ha&#8217;arba&#8217;a Street, PO
Box 609</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Tel Aviv 61006, Israel</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">+972 3 684 8000</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="f_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">To the Shareholders and Board of Directors<br/>
Arbe Robotics Ltd.:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AuditorOpinionTextBlock-c0_cont_1" escape="true" name="dei:AuditorOpinionTextBlock" id="ixv-12819"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Opinion on the Consolidated Financial Statements</i></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_AuditorOpinionTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Arbe Robotics Ltd. and its subsidiaries, (hereinafter: &#8220;the Company&#8221;) as of December 31, 2024 and 2023,
the related consolidated statements of operations, changes in shareholders&#8217; equity and cash flows for each of the years in the three-year
period ended December 31, 2024, and the related notes (collectively, &#8220;the consolidated financial statements&#8221;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31,
2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31,
2024, in conformity with U.S generally accepted accounting principles.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Basis for Opinion </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements are the
responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based
on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and
are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide
a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-19231">Somekh Chaikin</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Somekh Chaikin</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Member Firm of KPMG International</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&#8217;s auditor
since 2021</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-19232">Tel Aviv, Israel</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">March 28, 2025</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>



</div><div><a id="f_002"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">ARBE ROBOTICS
LTD. AND SUBSIDIARIES</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">CONSOLIDATED
BALANCE SHEETS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: justify">ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">CURRENT ASSETS:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 76%; text-align: justify">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-19233">13,488</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-19234">28,587</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: justify">Restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" unitRef="usd" id="ixv-19235">280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashCurrent" scale="3" unitRef="usd" id="ixv-19236">163</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify">Short term bank deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" unitRef="usd" id="ixv-19237">10,793</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="3" unitRef="usd" id="ixv-19238">15,402</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: justify">Trade receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd" id="ixv-19239">153</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd" id="ixv-19240">1,258</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify">Other assets - funds held in escrow</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-19241">30,417</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: justify">Prepaid expenses and other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-19242">2,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-19243">2,026</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-19244">57,631</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-19245">47,436</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">NON-CURRENT ASSETS:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: justify">Operating lease right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-19246">1,782</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-19247">1,740</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: justify">Property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-19248">1,374</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-19249">1,309</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-19250">3,156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd" id="ixv-19251">3,049</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Total assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-19252">60,787</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-19253">50,485</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 3; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED BALANCE SHEETS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: justify">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">CURRENT LIABILITIES:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: justify">Trade payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd" id="ixv-19254">624</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd" id="ixv-19255">1,149</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19256">551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19257">436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify">Employees and payroll accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-19258">3,283</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-19259">2,916</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify">Convertible bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="arbe:ConvertibleBonds" scale="3" unitRef="usd" id="ixv-19260">30,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt">Accrued expenses and other payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-19261">1,334</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-19262">1,710</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-19263">36,406</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-19264">6,211</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">LONG-TERM LIABILITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: normal; text-indent: -0.125in; padding-left: 0.25in; font-style: normal; text-align: justify">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19265">1,457</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19266">1,306</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt">Warrant liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd" id="ixv-19267">428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd" id="ixv-19268">875</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt">Total long-term liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd" id="ixv-19269">1,885</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd" id="ixv-19270">2,181</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">8SHAREHOLDERS&#8217; EQUITY:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Ordinary Shares, NIS&#160;<ix:nonFraction contextRef="c5" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-19271"><ix:nonFraction contextRef="c6" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-19272">0.000216</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-19273">165,000,000</ix:nonFraction> authorized shares as of December 31, 2024 and <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-19274">130,000,000</ix:nonFraction> as of December 31, 2023; <ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-19275">85,749,331</ix:nonFraction> and <ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-19276">77,925,095</ix:nonFraction> outstanding shares at December 31, 2024 and 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-2; font-size: 10pt">*)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-3; font-size: 10pt">*)</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-19277">275,453</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-19278">245,733</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-19279">252,957</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd" id="ixv-19280">203,640</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: justify; padding-bottom: 1.5pt">Total shareholders&#8217; equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19281">22,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19282">42,093</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: justify; padding-bottom: 4pt">Total liabilities and shareholders&#8217; equity</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-19283">60,787</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-19284">50,485</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*)</td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US">Represents less than $1.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The accompanying notes are an integral part of these
consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>



</div><div><a id="f_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><div>

</div><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left; text-indent: -0.125in">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-19286">768</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-19287">1,470</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-19288">3,517</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Costs of revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-19289">1,553</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-19290">1,508</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" unitRef="usd" id="ixv-19291">1,283</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Gross profit (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" sign="-" unitRef="usd" id="ixv-19292">785</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" sign="-" unitRef="usd" id="ixv-19293">38</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd" id="ixv-19294">2,234</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Research and development, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-19295">35,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-19296">34,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" unitRef="usd" id="ixv-19297">36,731</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-19298">5,430</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-19299">5,194</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd" id="ixv-19300">4,621</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-19301">8,347</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-19302">7,571</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd" id="ixv-19303">8,613</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">Total operating expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-19304">48,868</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-19305">46,847</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-19306">49,965</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">Operating loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19307">49,653</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19308">46,885</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19309">47,731</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in">Financial income, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-19310">336</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-19311">3,385</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" unitRef="usd" id="ixv-19312">7,237</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt; text-indent: -0.125in">Net loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19313">49,317</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19314">43,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19315">40,494</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt; text-indent: -0.125in">Basic net loss per ordinary share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-19316">0.61</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-19317">0.60</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-19318">0.64</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt; text-indent: -0.125in">Weighted-average number of ordinary shares used in computing basic net loss per ordinary share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-19319">80,949,032</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-19320">72,021,520</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-19321">63,489,983</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt; text-indent: -0.125in">Diluted net loss per ordinary share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-19322">0.61</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-19323">0.61</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-19324">0.66</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt; text-indent: -0.125in">Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-19325">80,949,032</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-19326">72,053,372</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-19327">63,629,206</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>



</div><div><a id="f_004"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">ARBE ROBOTICS
LTD. AND SUBSIDIARIES</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Additional</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Ordinary Shares</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">paid-in</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">Accumulated</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">shareholders&#8217;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">capital</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">deficit</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">equity</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; text-indent: -9pt; padding-left: 9pt">Balance at December 31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c9" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-19328">63,016,856</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19329">199,469</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">(<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-19330">119,646</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19331">79,823</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-19332">8,793</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-19333">8,793</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock-based compensation to service providers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-19334">354</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-19335">354</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Exercise of options and vested RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19336">1,144,034</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-9; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19337">277</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19338">277</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19339">40,494</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19340">40,494</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">Balance at December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-19341">64,160,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-13; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19342">208,893</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-19343">160,140</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19344">48,753</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Issuance of ordinary shares, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-19345">11,794,873</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-14; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-19346">22,496</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-19347">22,496</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-19348">13,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-19349">13,012</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock-based compensation to service providers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-19350">629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-19351">629</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Exercise of options and vested RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19352">1,969,332</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-20; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19353">703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19354">703</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19355">43,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19356">43,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -9pt; padding-left: 9pt">Balance at December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-19357">77,925,095</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-24; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19358">245,733</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-19359">203,640</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19360">42,093</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Issuance of ordinary shares and warrants, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-19361">4,293,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-19362">13,787</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-19363">13,787</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-19364">14,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" unitRef="usd" id="ixv-19365">14,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Stock-based compensation to service providers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-19366">1,186</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd" id="ixv-19367">1,186</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Exercise of options and vested RSUs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19368">3,530,279</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19369">205</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19370">205</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19371">49,317</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19372">49,317</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Balance at December 31, 2024</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c29" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-19373">85,749,331</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;*</span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19374">275,453</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-19375">252,957</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-19376">22,496</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*)</span></td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US">Represents less than $1.</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">&#160;</p><div>

</div><div><a id="f_005"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">ARBE ROBOTICS
LTD. AND SUBSIDIARIES</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">CONSOLIDATED
STATEMENTS OF CASH FLOWS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><span style="text-decoration:underline">Cash flows from operating activities:</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: justify">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19378">49,317</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19379">43,500</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19380">40,494</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19381">585</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19382">557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19383">481</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19384">14,542</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19385">13,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19386">8,793</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Stock<span style="font-size: 10pt">-</span>based compensation to service providers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd" id="ixv-19387">1,186</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd" id="ixv-19388">629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd" id="ixv-19389">354</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Revaluation of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" sign="-" unitRef="usd" id="ixv-19390">447</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" sign="-" unitRef="usd" id="ixv-19391">756</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentOfWarrantsGrantedForServices" scale="3" sign="-" unitRef="usd" id="ixv-19392">8,122</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Revaluation of convertible bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="arbe:RevaluationOfConvertibleLoan" scale="3" sign="-" unitRef="usd" id="ixv-19393">81</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Issuance costs related to convertible bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="arbe:IssuanceCostsRelatedToConvertibleBonds" scale="3" unitRef="usd" id="ixv-19394">737</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Trade receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd" id="ixv-19395">1,105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd" id="ixv-19396">694</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-19397">2,015</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Prepaid expenses and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-19398">474</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-19399">187</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" sign="-" unitRef="usd" id="ixv-19400">1,219</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Operating lease ROU assets and liabilities, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19401">224</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19402">86</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" sign="-" unitRef="usd" id="ixv-19403">84</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Trade payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd" id="ixv-19404">553</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd" id="ixv-19405">103</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" sign="-" unitRef="usd" id="ixv-19406">769</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Employees and payroll accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-19407">367</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-19408">55</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-19409">234</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" sign="-" unitRef="usd" id="ixv-19410">101</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" sign="-" unitRef="usd" id="ixv-19411">375</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Accrued expenses and other payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-19412">376</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-19413">3,899</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" unitRef="usd" id="ixv-19414">884</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19415">32,502</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19416">33,513</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19417">40,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-decoration: underline; text-align: justify">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Change in bank deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="arbe:PaymentForChangeInBankDeposits" scale="3" sign="-" unitRef="usd" id="ixv-19418">4,609</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="arbe:PaymentForChangeInBankDeposits" scale="3" unitRef="usd" id="ixv-19419">15,002</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="arbe:PaymentForChangeInBankDeposits" scale="3" unitRef="usd" id="ixv-19420">400</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Purchase of property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19421">622</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19422">249</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19423">918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Net cash provided by (used in) investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" unitRef="usd" id="ixv-19424">3,987</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19425">15,251</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19426">1,318</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-decoration: underline; text-align: justify">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Repayment of short-term loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="3" unitRef="usd" id="ixv-19427">5,218</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Proceeds from issuance of ordinary shares <span style="font-size: 10pt">and warrants</span>, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd" id="ixv-19428">13,787</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd" id="ixv-19429">22,496</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Issuance costs related to convertible bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" sign="-" unitRef="usd" id="ixv-19430">459</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Proceeds from exercise of options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19431">205</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19432">703</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-19433">277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-19434">13,533</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-19435">23,199</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" sign="-" unitRef="usd" id="ixv-19436">4,941</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Effect of exchange rate fluctuations on cash and cash equivalent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-19437">258</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-19438">47</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19439">1,189</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">Decrease in cash, cash equivalents and restricted cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-19440">15,240</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-19441">25,612</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-19442">45,432</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 1.5pt">Cash, cash equivalents and restricted cash at the beginning of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19443">28,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19444">54,315</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19445">100,936</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 4pt">Cash, cash equivalents and restricted cash at the end of the year</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19446">13,768</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19447">28,750</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-19448">54,315</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: justify">Supplemental non-cash disclosure:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 4pt">Issuance of convertible bonds with proceeds placed in escrow</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" scale="3" unitRef="usd" id="ixv-19449">30,695</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 4pt">Lease liabilities arising from obtaining right-of-use assets</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19450">660</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19451">1,713</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19452">797</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 4pt">Purchase of property and equipment</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" unitRef="usd" id="ixv-19453">28</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" unitRef="usd" id="ixv-19454">8</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" unitRef="usd" id="ixv-19455">7</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: justify">Supplemental disclosure of cash flows activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify; padding-bottom: 4pt">Interest paid</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-19456">1,928</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-19457">250</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">*)</td><td style="text-align: justify">Represents less than $1.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><div><a id="f_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: center; text-indent: -56.7pt">NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_NatureOfOperations-c0_cont_1" escape="true" name="us-gaap:NatureOfOperations" id="ixv-15288"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">NOTE
1:- GENERAL</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">a.</td><td style="text-align: justify">Arbe Robotics Ltd. (the &#8220;Company&#8221;) was founded and registered on November 4, 2015 and commenced
its activities in January 2016. The Company, a global leader in perception radar solutions, is spearheading a radar revolution, enabling
safe driver-assist systems today while paving the way to full autonomous-driving. The Company&#8217;s radar technology is a critical sensor
for L2+ and higher autonomy. The Company is empowering automakers, Tier 1 suppliers, autonomous ground vehicles, commercial and industrial
vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. The Company&#8217;s ordinary
shares and Warrants are listed on the Nasdaq Capital Market under the symbols &#8220;ARBE&#8221; and &#8220;ARBEW,&#8221; respectively<span style="font-family: Times New Roman, Times, Serif">.</span>
The convertible bond are listed on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">b.</td><td style="text-align: justify">On October 26, 2017, the Company established a Delaware subsidiary, Arbe Robotics US Inc. Arbe Robotics
US Inc is engaged mainly in the Company&#8217;s sales and will operate as the Company&#8217;s distributor in the U.S.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">c.</td><td style="text-align: justify">On February 5, 2024, the Company established a Chinese subsidiary, Shanghai Arbe Technologies Co., Ltd
(&#8220;Arbe China&#8221;). Arbe China was formed to assist mainly in providing customer support in the China region.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">d.</td><td style="text-align: justify">On October 7, 2021, the Company consummated the merger (the &#8220;Merger&#8221;) pursuant to which the
Company&#8217;s wholly-owned subsidiary, Autobot MergerSub, Inc. (&#8220;Merger Sub&#8221;) was merged with an into Industrial Tech Acquisitions
Inc. (&#8220;ITAC&#8221;) pursuant to which ITAC became a wholly-owned&#160;subsidiary of the Company, and the Company issued ordinary
shares and warrants to the holders of ITAC common stock and warrants, respectively. In connection with the Merger, the name of ITAC was
changed to Autobot HoldCo, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in">In connection with
the Merger, and immediately prior to the closing of the Merger, the Company effected a recapitalization (the &#8220;Recapitalization&#8221;),
which was approved by the Company&#8217;s directors and shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Pursuant to the
Merger, Arbe issued to ITAC securityholders (a) <ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-19458">3,866,842</ix:nonFraction> ordinary shares to the holders of ITAC common stock and (b) <ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-19459">10,735,680</ix:nonFraction> Arbe
warrants to the holders of ITAC warrants, of which <ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-19460">7,623,600</ix:nonFraction> warrants are public warrants and <ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-19461">3,112,080</ix:nonFraction> warrants are private warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Total gross proceeds
resulted from the Merger and the related PIPE financing were approximately $<ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd" id="ixv-19462">118,288</ix:nonFraction>, of which total transaction costs amounted to approximately
$<ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="arbe:TransactionCosts" scale="3" unitRef="usd" id="ixv-19463">16,707</ix:nonFraction>. The total gross proceeds include the $<ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd" id="ixv-19464">100,000</ix:nonFraction> from the sale of <ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19465">10,000,000</ix:nonFraction> ordinary shares to the PIPE investors at $<ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19466">10.00</ix:nonFraction> per
share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">On December 31,
2024, the Company completed the liquidation of ITAC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">d.</td><td style="text-align: justify">On May 30, 2024, the Company registered its ordinary shares on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;),
and its ordinary shares are now traded on both Nasdaq and the Tel Aviv Stock Exchange. Pursuant to statutory exemption available for dual
listed companies under the Israeli securities and companies&#8217; laws, the Company&#8217;s reporting requirements are in substance in accordance
with the provisions applicable by Nasdaq on foreign private issuers.</td></tr></table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: -27.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: -27.75pt"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: -27.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: -27.75pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">NOTE
1:- GENERAL (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><ix:continuation id="_NatureOfOperations-c0_cont_1"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">e.</td><td style="text-align: justify">On June 2, 2024, the Company completed an offering of convertible bonds in the principal amount of NIS
<ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralPartnersOfferingCosts" scale="0" unitRef="ils" id="ixv-19467">110,000,000</ix:nonFraction> (approximately $<span style="-sec-ix-hidden: hidden-fact-49">30</span><span style="font-family: Times New Roman, Times, Serif">,</span>000). The bonds were issued solely to Israeli
investors and were not offered in the United States or to U.S. persons. The bonds bear interest on the principal amount at the rate of
<ix:nonFraction contextRef="c41" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" unitRef="pure" id="ixv-19468">6.5</ix:nonFraction>% per annum, mature on May 30, 2028, and are convertible into the Company&#8217;s ordinary shares at a conversion price of NIS <ix:nonFraction contextRef="c42" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="ilsPershares" id="ixv-19469">9.53</ix:nonFraction>
(approximately $<ix:nonFraction contextRef="c42" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-19470">2.60</ix:nonFraction>) per share. The bonds are listed for trading on the TASE. Refer to Note 9.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">f.</td><td style="text-align: justify">On November 4, 2024, the Company completed a public offering of its securities. The gross proceeds from
this offering were approximately $<ix:nonFraction contextRef="c43" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-19471">15</ix:nonFraction> million, before deducting the underwriters&#8217; discounts and commissions and other offering expenses
payable by the Company of approximately $<ix:nonFraction contextRef="c43" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="6" unitRef="usd" id="ixv-19472">1.2</ix:nonFraction> million. The securities were sold as a unit for $<ix:nonFraction contextRef="c44" decimals="2" format="ixt:num-dot-decimal" name="arbe:SecuritiesSoldPerUnits" scale="0" unitRef="usdPershares" id="ixv-19473">1.82</ix:nonFraction> per unit, with each unit consisting
of <ix:nonFraction contextRef="c45" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-19474">one</ix:nonFraction> ordinary share (or <ix:nonFraction contextRef="c46" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-19475">one</ix:nonFraction> pre-funded warrant in lieu of <ix:nonFraction contextRef="c47" decimals="0" format="ixt-sec:numwordsen" name="arbe:PreFundedWarrantInLieuOfOrdinaryShare" scale="0" unitRef="shares" id="ixv-19476">one</ix:nonFraction> ordinary share), one Tranche A Warrant and one Tranche B Warrant. In the
offering, the Company issued an aggregate of <ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19477">8,250,000</ix:nonFraction> ordinary shares (or pre-funded warrants in lieu thereof) and by Tranche A Warrants
to purchase up to <ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19478">8,250,000</ix:nonFraction> ordinary shares at $<ix:nonFraction contextRef="c49" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19479">2.35</ix:nonFraction> per share and Tranche B Warrants to purchase up to <ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19480">8,250,000</ix:nonFraction> ordinary shares $<ix:nonFraction contextRef="c51" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19481">1.82</ix:nonFraction>
per share. The Tranche A Warrants are immediately exercisable upon issuance and expire on November 4, 2029. The Tranche B Warrants are
immediately exercisable upon issuance and will expire on the earlier of (i) the 20<sup>th</sup> trading day after the Company has given
notice of a Triggering Event, as defined in the Tranche B Warrant or (ii) November 4, 2027. Refer to Note 10c.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">g.</td><td style="text-align: justify">The Company depends on one supplier for the development and productization of its products. If this supplier
fails to deliver or delays the delivery of the necessary products, the Company will be required to seek alternative sources of supply.
A change in supplier could result in manufacturing delays and increased costs, which could result in a possible loss of sales which would
adversely affect the Company&#8217;s business, prospects, results of operations and financial position.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">h.</td><td style="text-align: justify">As the Company operates internationally and substantially its revenue is derived from sales outside of
Israel, the business is affected by inflation, supply chain issues and economic conditions in countries in which the Company is seeking
to conduct business, security and cybersecurity issues, fiscal and monetary policies, tariffs, interest rates and regulations affection
the automotive industry, the timing by the automotive and other industries on the introduction of unmanned automobiles and other unmanned
devices, safety concerns and well as the effect of regional conflicts and steps taken by governments with respect to parties to such conflicts.&#160;As
an Israeli company, the Company is also subject to the effect on Israel and the Israeli economy of the present war with Hamas as well
as any other regional conflicts, including Hezbollah, Syria and Iran, which may develop and the relationship between Israel and other
countries, including the United States, China and the European Union.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">i.</td><td style="text-align: justify">The Company has incurred losses from operations since its inception and has negative cash flow from operating
activities. During January 2025, the company raised gross proceeds of $<ix:nonFraction contextRef="c52" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="6" unitRef="usd" id="ixv-19482">55.5</ix:nonFraction> million in an underwritten offering and from the conversation
of our convertible bonds and the release of funds from escrow upon such conversion. Refer to Note 14.</td></tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-15429"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">NOTE
2:- SIGNIFICANT ACCOUNTING POLICIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-15432"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">a.</td><td style="text-align: justify">Basis of presentation:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2" id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The consolidated financial statements
have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant
accounting policies followed in the preparation of the financial statements applied on a consistent basis for all years presented in these
financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The consolidated
financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-15445"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">b.</td><td style="text-align: justify">Use of estimates:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_UseOfEstimates-c0_cont_2" id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The preparation
of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions
including fair value of warrants, stock-based compensation and the underlying fair value of the Company&#8217;s ordinary shares issued
prior to the Merger.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation id="_UseOfEstimates-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company bases
these estimates on historical and anticipated results, trends and other assumptions that it believes are reasonable under the circumstances,
including assumptions as to future events. Actual results could differ from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-15458"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">c.</td><td style="text-align: justify">Consolidated financial statements in U.S. dollars:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A substantial portion
the Company&#8217;s activity including transactions with customers, as well as equity transactions and cash investments, are incurred
in U.S. dollars. The Company&#8217;s management believes that the U.S. dollar is the currency of the primary economic environment in which
the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar<span style="font-family: Times New Roman, Times, Serif">.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_3" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The subsidiaries
functional currency is the currency of the primary economic environment in which the subsidiaries operate; normally, that is the currency
of the environment in which the subsidiaries primarily generate and expend cash. In making the determination of the appropriate functional
currency for the subsidiaries, the Company considers cash flow indicators, local market indicators, financing indicators and the subsidiaries&#8217;
relationship with both the parent company and other subsidiaries. The Company has determined the functional currency of its subsidiaries
to be the U.S. dollar.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_4" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Monetary accounts
maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting Standard
Codification (&#8220;ASC&#8221;) No. 830 &#8220;Foreign Currency Matters&#8221; (&#8220;ASC No. 830&#8221;). All transaction gains and
losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or expenses as
appropriate.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">note
2:- Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Transactions in foreign currency are
translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, <i>Foreign Currency Transaction</i>. Monetary
assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing
rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the
exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities denominated in currencies
other than the respective functional currencies are included in the consolidated statements of operations.</p></ix:continuation>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-15515"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">d.</td><td style="text-align: justify">Concentration of credit risk:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_2" id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Most of the Company&#8217;s
cash and cash equivalents, restricted cash, short-term deposits and funds held in escrow were deposited with Israeli banks and were comprised
mainly of cash deposits and short-term deposits.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
Company&#8217;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#8217; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="ixv-15528"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">e.</td><td style="text-align: justify">Cash and cash equivalents and restricted cash:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<ix:continuation continuedAt="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_2" id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company considers all highly liquid
short-term deposits with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist
primarily of amounts invested in short-term deposits.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Restricted cash consists of deposits
at a financial institution that serves as collateral for a credit card agreement and lease agreements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="arbe_ShortTermDepositsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="arbe:ShortTermDepositsPolicyPolicyTextBlock" id="ixv-15541"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">f.</td><td style="text-align: justify">Short term deposits:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:continuation id="arbe_ShortTermDepositsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Short-term deposits are bank deposits
with an original maturity of more than three months and less than one year from the date of acquisition. The deposits are presented according
to their terms of deposit. As of December 31, 2024 and 2023, these bank deposit bearing annual interest rates in the range of&#160;<ix:nonFraction contextRef="c53" decimals="2" format="ixt:num-dot-decimal" name="srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid" scale="-2" unitRef="pure" id="ixv-19483">4</ix:nonFraction>%-<ix:nonFraction contextRef="c54" decimals="2" format="ixt:num-dot-decimal" name="srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid" scale="-2" unitRef="pure" id="ixv-19484">6</ix:nonFraction>%.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-15551"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">g.</td><td style="text-align: justify">Fair value of financial instruments:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The estimated fair value of financial
instruments has been determined by the Company using available market information and valuation methodologies. Considerable judgment is
required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company could realize in a current
market exchange. The following methods and assumptions were used by the Company in estimating the fair value of their financial instruments:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The carrying values of cash and cash
equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables, employees and payroll accruals,
accrued expenses and other current liabilities approximate their fair values due to the short-term maturities of these instruments.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">note
2:- Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company applies ASC No. 820, &#8220;Fair
Value Measurements and Disclosures&#8221; (&#8220;ASC No. 820&#8221;), with respect to fair value measurements of all financial assets
and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term deposits and warrant liability at fair value.
Short-term deposits are classified within Level&#160;1 because these assets are valued using quoted market prices. Fair value represents
the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in
pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for
inputs used in the valuation methodologies in measuring fair value:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 1&#8212;Observable inputs that reflect quoted prices (unadjusted)
for identical assets or liabilities in active markets.</td>
</tr></table></ix:continuation>

<p style="margin: 0">&#160;</p>


<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 2&#8212;Include other inputs that are directly or indirectly
observable in the marketplace.</td>
</tr></table></ix:continuation>

<p style="margin: 0">&#160;</p>


<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 3&#8212;Unobservable inputs which are supported by little
or no market activity.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The fair value hierarchy also requires
an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">In
connection with the October 7, 2021 merger with Industrial Tech Acquisition Corp. (&#8220;ITAC&#8221;), the Company (i) assumed a derivative
warrant liability related to Company&#8217;s warrants that were issued to the holders of private placement warrants that had been issued by
ITAC in connection with its initial public offering, and (ii) issued equity instrument in connection with warrants that had been issued
as part of ITAC&#8217;s initial public offering and, pursuant to the Merger, became warrants to purchase the Company&#8217;s ordinary
shares. The fair value of the Company&#8217;s public warrants is measured based on the market price of such warrants and are considered
a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private
placement warrants which are considered a Level 3 fair value measurement.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<ix:continuation continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_10" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
Company&#8217;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
Refer to Note 8.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">For
convertible bonds measurement under fair value, see 2u below.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_CreditLossFinancialInstrumentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CreditLossFinancialInstrumentPolicyTextBlock" id="ixv-15639"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">h.</td><td style="text-align: justify">Trade receivables, net</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<ix:continuation continuedAt="_CreditLossFinancialInstrumentPolicyTextBlock-c0_cont_2" id="_CreditLossFinancialInstrumentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#8217;s best estimate of the amount of credit losses with respect to its existing trade receivable.
The Company&#8217;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#8220;CECL&#8221;) standard.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; ">&#160;</p>

<ix:continuation continuedAt="_CreditLossFinancialInstrumentPolicyTextBlock-c0_cont_3" id="_CreditLossFinancialInstrumentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; ">The Company
estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#8217;s customers to
make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected
credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions
and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation of collectability,
customer creditworthiness, historical levels of credit losses, and future expectations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<ix:continuation id="_CreditLossFinancialInstrumentPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
allowance for credit losses for the year ended December 31, 2024, recorded for the first time, was $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" unitRef="usd" id="ixv-19485">896</ix:nonFraction> and <span style="-sec-ix-hidden: hidden-fact-51"><span style="-sec-ix-hidden: hidden-fact-52">not</span></span> material for the years
ended December 31, 2023 and 2022.</p></ix:continuation></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">note
2:- Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-15693"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">i.</td><td style="text-align: justify">Property and equipment:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Property and equipment
are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost
of assets disposed and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
statement of operation. Repair and maintenance costs are expensed as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock" id="ixv-15703"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_4" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and peripheral equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><ix:nonFraction contextRef="c55" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-19486">15</ix:nonFraction>-<ix:nonFraction contextRef="c56" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-19487">33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><ix:nonFraction contextRef="c57" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-19488">7</ix:nonFraction>-<ix:nonFraction contextRef="c58" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-19489">15</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Vehicles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center"><ix:nonFraction contextRef="c59" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure" id="ixv-19490">15</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><div style="-sec-ix-hidden: hidden-fact-50">(*)</div></td><td style="text-align: left"/></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US">Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.</ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ixv-15746"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">j.</td><td style="text-align: justify">Impairment of long-lived assets:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Long-lived assets
are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; a (&#8220;ASC 360&#8221;), whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when the carrying
value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to be recognized
is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December 31, 2024,
2023 and 2022, no impairment losses were identified.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_PostemploymentBenefitPlansPolicy-c0_cont_1" escape="true" name="us-gaap:PostemploymentBenefitPlansPolicy" id="ixv-15756"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">k.</td><td style="text-align: justify">Accrued post-employment benefit:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_PostemploymentBenefitPlansPolicy-c0_cont_2" id="_PostemploymentBenefitPlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The employees of
Arbe Ltd. are included under section 14 of the Israeli Severance Compensation Act, 1963 (&#8220;Section 14&#8221;). Pursuant to Section
14, the Company&#8217;s Israeli employees are entitled to monthly deposits, at a rate of&#160;<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="arbe:SeverancePercentageOfMonthlySalary" scale="-2" unitRef="pure" id="ixv-19492">8.33</ix:nonFraction>% of their monthly salary, deposited
on their behalf to their chosen insurance funds. By making the payments in accordance with Section 14, the Company is released from any
future severance payments in respect of those employees. The obligation to make the monthly deposits is expensed as incurred. The deposits
pursuant to Section 14 are not recorded as an asset in the consolidated balance sheet, and there is no liability recorded as the Company
does not have a future obligation to make any additional payments. Severance costs amounted to approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd" id="ixv-19493">1,227</ix:nonFraction>, $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd" id="ixv-19494">1,166</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="3" unitRef="usd" id="ixv-19495">1,240</ix:nonFraction>
for the years ended December 31, 2024, 2023 and 2022, respectively.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">note
2:-  Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation id="_PostemploymentBenefitPlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s U.S. subsidiary
has a 401(k) defined contribution plan covering one employee in the United States. The expense recorded by the U.S. subsidiary for matching
contributions for the years ended December 31, 2024, 2023 and 2022 were immaterial.</p></ix:continuation>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-15805"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">l.</td><td style="text-align: justify">Stock-based compensation:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2" id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for stock-based compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, which requires the measurement
and recognition of compensation expense based on estimated fair values for all stock-based payment awards made to employees, nonemployees
and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing
model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the Company&#8217;s statements
of operations over the applicable service periods.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company measures its stock-based
payment awards made to employees, directors, and non-employee service providers based on estimated fair values. The fair value of each
option award is estimated on the grant date using the Black-Scholes option pricing model which requires several assumptions, of which
the most significant are the expected share price volatility and the expected option term. The Company recognizes forfeitures of equity-based
awards as they occur. For graded vesting awards, the Company recognizes compensation expenses based on the straight-line method over the
applicable service period.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-15818"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">m.</td><td style="text-align: justify">Net loss per ordinary share:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company computes net loss per
share using the two-class method required for participating securities. There were no participating securities in the years ended December
31, 2024, 2023 and 2022.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company&#8217;s basic net loss
per ordinary share is calculated by dividing net loss by the weighted-average number of ordinary shares outstanding for the period, without
consideration of potentially dilutive securities. The diluted net loss per ordinary share is calculated by giving effect to all potentially
dilutive securities outstanding for the period using the treasury share method or the if-converted method based on the nature of such
securities. Diluted net loss per ordinary share is the same as basic net loss per share in periods when the effects of potentially dilutive
shares of ordinary shares are anti-dilutive. Refer to Note 11.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ComprehensiveIncomePolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="ixv-15831"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">n.</td><td style="text-align: justify">Other comprehensive loss:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_ComprehensiveIncomePolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company has no components of comprehensive
loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods presented.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">note
2:- Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-15877"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">p.</td><td style="text-align: justify">Revenue recognition:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company follows the provisions
of ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which apply to all contracts with customers. Under Topic
606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition
for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Identify the contract(s) with a customer;</td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_4" id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Identify the performance obligations in the contract;</td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_5" id="_RevenueRecognitionPolicyTextBlock-c0_cont_4"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Determine the transaction price;</td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_6" id="_RevenueRecognitionPolicyTextBlock-c0_cont_5"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Allocate the transaction price to the performance obligations
in the contract; and</td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_7" id="_RevenueRecognitionPolicyTextBlock-c0_cont_6"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Recognize revenue when (or as) the entity satisfies a performance
obligation.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_8" id="_RevenueRecognitionPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">At contract inception, once the contract
is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines
the performance obligations and assesses whether each promised good or service is distinct<span style="font-family: Times New Roman, Times, Serif">.</span>
The Company evaluates each performance obligation to determine if it is satisfied at a point in time or over time. Refer to Note 3.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_9" id="_RevenueRecognitionPolicyTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i>Nature of Products and Services</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_10" id="_RevenueRecognitionPolicyTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company derives its revenues mainly
from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional services. Revenue from chipsets
and prototype radar systems is recognized at the point in time when the control of the goods is transferred to the customer, generally
upon delivery, and the Company has no remaining performance obligations.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">note
2:-  Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_11" id="_RevenueRecognitionPolicyTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i>Right of Return</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company&#8217;s general terms
and conditions for its contracts do not contain a right of return that allows the customer to return products and receive a credit. Therefore,
the Company does not estimate returns and generally recognizes revenue at contract price upon product delivery.</p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_CostOfSalesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock" id="ixv-15982"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">q.</td><td style="text-align: justify">Cost of revenues:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_CostOfSalesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Cost of revenue includes the manufacturing
cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-15992"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">r.</td><td style="text-align: justify">Research and development expenses, net:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Research and development costs, net
of grants received, are charged to the consolidated statement of operations as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-16002"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">s.</td><td style="text-align: justify">Income taxes:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company accounts for income taxes
in accordance with ASC 740, &#8220;Income Taxes&#8221;. This standard prescribes the use of the asset and liability method whereby deferred
tax asset and liability account balances are determined based on differences between the financial statement carrying amount and the tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are
expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is more
likely than not to be realized<span style="font-family: Times New Roman, Times, Serif">.</span> The Company recognizes the tax benefit
from a tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. A tax position that meets the more-likely-than-not recognition threshold is measured at
the largest amount that is greater than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-19496">50</ix:nonFraction> percent likely of being realized upon settlement with the taxing authority using the facts,
circumstances, and information available at the reporting date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ContingentLiabilityReserveEstimatePolicy-c0_cont_1" escape="true" name="us-gaap:ContingentLiabilityReserveEstimatePolicy" id="ixv-16013"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">t.</td><td style="text-align: justify">Contingent liabilities</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation id="_ContingentLiabilityReserveEstimatePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies.&#8221; A provision is recorded when it is both
probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions
are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
information and events pertaining to a particular matter. As of December&#160;31, 2024 and 2023, the Company is not a party to any litigation
that could have a material adverse effect on the Company&#8217;s business, financial position, results of operations or cash flows.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">note
2:-  Significant Accounting Policies (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" continuedAt="arbe_ConvertibleBondsPolicyTextBlock-c0_cont_1" escape="true" name="arbe:ConvertibleBondsPolicyTextBlock" id="ixv-16057"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">u.</td><td style="text-align: justify">Convertible bonds:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="arbe_ConvertibleBondsPolicyTextBlock-c0_cont_2" id="arbe_ConvertibleBondsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company recognized
its convertible bonds as a liability and the cash held in escrow as other assets funds held in escrow, in the balance sheet. As the convertible
debt contained embedded features not closely related to the host contract, the Company elected to apply the fair value option to it. The
fair value of the convertible bonds is measured under FV level 1 and is based on the quoted price of the bonds on the TASE. The Company
elected to measure the bonds initially and subsequently at fair value. Thus, the convertible bonds&#8217; issuance costs expensed as incurred
to statement of operations. The fair value of the convertible debt is based on its quoted price.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation id="arbe_ConvertibleBondsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company recorded
financial income amounting to $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" unitRef="usd" id="ixv-19497">81</ix:nonFraction> for the year ended on December 31, 2024. Refer to Note 9.</p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-16070"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">v.</td><td style="text-align: justify">Leases:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for leases under Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company elected
the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize a lease liability
and a right-of-use (&#8220;ROU&#8221;) asset on the balance sheet for leases with a term of twelve months or less. The Company recognizes
the associated lease payments on such leases in the consolidated statements of income on a straight-line basis over the lease term.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_4" id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Under Topic 842,
the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement date based
on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable payments
at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental borrowing
rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing
rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset is recorded
net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain
that the Company will exercise such options.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Payments under the
Company&#8217;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common area maintenance,
real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. Refer to Note 6.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-16089"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">w.</td><td style="text-align: justify">Impact of recently issued accounting standard:</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In November 2023,
the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their
reportable segments&#8217; significant expenses and other segment items on an annual basis. Public entities with a single reportable segment
are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements
in ASC 280 on an annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted.
The Company adopted ASU 2023-07 during the year ended December 31, 2024. Refer to Note 13.</p></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.15pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.15pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b>NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="ixv-16135"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">x.</td><td style="text-align: justify">Recently not yet adopted accounting pronouncements<span style="font-family: Times New Roman, Times, Serif">:</span></td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation continuedAt="_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock-c0_cont_2" id="_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic
220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense
categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning
after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is in the
process of assessing the impacts and method with no early adoption of the standard<span style="font-family: Times New Roman, Times, Serif">.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.15pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:continuation id="_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">ASU 2023-09, Improvements
to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components
of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The ASU will be effective for fiscal years
beginning after December 15, 2025, and allows adoption on a prospective basis, with a retrospective option. The Company is in the process
of assessing the impacts and method with no early adoption of the standard<span style="font-family: Times New Roman, Times, Serif">.</span></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="ixv-16153"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b>NOTE 3:-
REVENUE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Disaggregation
of Revenues</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="ixv-16160"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Revenue disaggregated
by geography for the years ended December 31, 2024, 2023 and 2022, based on the billing address of the Company&#8217;s customers, consists
of the following<span style="font-family: Times New Roman, Times, Serif">:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Revenue by geography:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">China (excluding Hong Kong)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19498">254</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c62" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19499">33.1</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c63" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19500">639</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c64" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19501">43.5</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c65" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19502">1,476</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c66" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19503">42.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19504">266</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c70" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19505">18.1</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sweden</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19506">224</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c74" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19507">29.2</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19508">247</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c76" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19509">16.8</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19510">1,276</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c78" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19511">36.3</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19512">220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c80" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19513">28.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19514">148</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c82" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19515">10.1</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19516">135</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c84" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19517">3.8</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19518">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c86" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19519">2.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19520">81</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c88" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19521">5.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c89" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19522">284</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c90" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19523">8.1</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Israel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19524">50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c92" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19525">6.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c93" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19526">50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c94" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19527">3.4</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c95" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19528">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c96" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19529">0.7</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Italy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c101" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19530">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c102" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19531">3.5</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19532">197</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c108" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19533">5.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c111" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19534">39</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c112" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19535">2.6</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total revenue</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19536">768</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19537">100</ix:nonFraction></td><td style="text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19538">1,470</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19539">100</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" unitRef="usd" id="ixv-19540">3,517</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-19541">100</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Remaining Performance
Obligation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s
remaining performance obligations are comprised of product and services revenue not yet performed. As of December&#160;31, 2024 and 2023
the aggregate amount of the transaction price allocated to remaining performance obligations was $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" unitRef="usd" id="ixv-19542">290</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" unitRef="usd" id="ixv-19543">977</ix:nonFraction>, respectively. The Company
expects to recognize 2024 remaining performance obligations as revenue during 2025.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock" id="ixv-16510"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">NOTE 4:- PREPAID
EXPENSES AND OTHER RECEIVABLES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="ixv-16513"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Government authorities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="arbe:GovernmentAuthorities" scale="3" unitRef="usd" id="ixv-19544">668</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="arbe:GovernmentAuthorities" scale="3" unitRef="usd" id="ixv-19545">385</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositAssets" scale="3" unitRef="usd" id="ixv-19546">69</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepositAssets" scale="3" unitRef="usd" id="ixv-19547">69</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Grants receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivableCurrent" scale="3" unitRef="usd" id="ixv-19548">308</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivableCurrent" scale="3" unitRef="usd" id="ixv-19549">310</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt">Prepaid expenses and other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-19550">1,455</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="3" unitRef="usd" id="ixv-19551">1,262</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.5in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-19552">2,500</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-19553">2,026</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-16627"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
5:-  Property and Equipment</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-16630"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Cost:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 11.35pt">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c115" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19554">2,838</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c116" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19555">2,448</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 11.35pt">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19556">831</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c117" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19557">582</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 11.35pt">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19558">144</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19559">133</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 11.35pt">Vehicles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19560">149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19561">149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19562">3,962</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-19563">3,312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19564">2,588</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19565">2,003</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt">Property and equipment, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-19566">1,374</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-19567">1,309</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Depreciation expense
for the years ended December 31, 2024, 2023 and 2022 was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19568">585</ix:nonFraction>, $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19569">557</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" unitRef="usd" id="ixv-19570">481</ix:nonFraction>, respectively.</p></ix:nonNumeric><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock" id="ixv-16758"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
6:- LEASES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">The
Company has six non-cancelable operating lease agreements for office spaces in Israel. The leases have original lease periods expiring
until 2027, some of which may include options to extend the leases for up to three additional years. The Company does not assume exercise
of renewal options in its determination of the lease term unless the renewals are considered as reasonably certain to be exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<ix:nonNumeric contextRef="c0" continuedAt="_LeaseCostTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LeaseCostTableTextBlock" id="ixv-16765"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Supplemental
cash flow information related to leases was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Cash payments and expenses related to operating leases</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd" id="ixv-19571">557</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd" id="ixv-19572">451</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Operating lease right-of-use assets and liabilities, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet" scale="3" unitRef="usd" id="ixv-19573">226</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet" scale="3" unitRef="usd" id="ixv-19574">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-16809"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Maturities
of lease liabilities as of December 31, 2024, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd" id="ixv-19575">563</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd" id="ixv-19576">528</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" unitRef="usd" id="ixv-19577">466</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">2028 and after</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" unitRef="usd" id="ixv-19578">905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd" id="ixv-19579">2,462</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" unitRef="usd" id="ixv-19580">454</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-19581">2,008</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
6:- LEASES (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal; text-transform: none">&#160;</span></p><div>

</div><ix:continuation id="_LeaseCostTableTextBlock-c0_cont_1"><ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Supplemental
balance sheet information related to operating leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use assets</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-19582">1,782</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-19583">1,740</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Current maturities of operating leases</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19584">551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-19585">436</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-term operating lease liabilities</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19586">1,457</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-19587">1,306</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Weighted average remaining lease term (in years)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-19588">4.73</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c6" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-19589">5.5</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted average discount rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-19590">9.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-19591">9.4</ix:nonFraction></td><td style="text-align: left">%</td></tr> </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-16970"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
7:- COMMITMENTS AND CONTINGENT LIABILITIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company participated
in programs sponsored mainly by the Israeli Innovation Authority (&#8220;IIA&#8221;), an Israeli government agency, for the support of
its research and development activities. Through December 31, 2024, the Company had obtained grants aggregating to $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrantsReceivable" scale="3" unitRef="usd" id="ixv-19592">3,970</ix:nonFraction> for certain
of its research and development projects. The Company is obligated to pay royalties to the IIA, amounting to <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="arbe:RoyaltyPercentage" scale="-2" unitRef="pure" id="ixv-19593">4</ix:nonFraction>% of the sales of the products
and other related revenues generated from such projects. The maximum aggregate royalties paid generally cannot exceed <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="arbe:GrantsReceived" scale="-2" unitRef="pure" id="ixv-19594">100</ix:nonFraction>% of the grants
received, plus annual interest generally equal to 12-months secured overnight financing rate knows as SOFR applicable to dollar deposits,
as published on the first business day of each calendar year. The obligation to pay these royalties is contingent on sales of the products
and in the absence of such sales, no payment is required.&#160;</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: left; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="ixv-16977"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
8:- warrants liabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company issued
in 2019 warrants to purchase a number of convertible Series B-1 convertible preferred shares, for an aggregate exercise price of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalCollateralAggregateFairValue" scale="3" unitRef="usd" id="ixv-19595">550</ix:nonFraction>.
As a result of the Merger and the related Recapitalization, the warrants became convertible into the Company&#8217;s ordinary shares.
The Company classified the warrants as freestanding and treated as liability pursuant to ASC 480 and remeasured every reporting period
with any change to fair value recorded within financial expenses in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As a result of the
Merger with ITAC, the Company assumed a derivative warrant liability related to <ix:nonFraction contextRef="c121" decimals="0" format="ixt:num-dot-decimal" name="arbe:DerivativeWarrantLiabilityShares" scale="0" unitRef="shares" id="ixv-19596">3,112,080</ix:nonFraction> private placement warrants assumed by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company utilizes
a Black-Scholes option pricing model to estimate the fair value of the private placement warrants and the convertible warrants (hereinafter:
the &#8220;warrants&#8221;) and are considered a Level 3 fair value measurement. Black-Scholes option pricing model takes into consideration
certain parameters in computation of the fair value of the warrants which the significant parameter is expected volatility. The Company
computed a sensitivity analysis of the fair value to changes of the expected volatility. The volatility impact of +/-<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-19597">5</ix:nonFraction>% on the warrants&#8217;
fair value is approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd" id="ixv-19598">28</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The warrants are
measured at each reporting period, with changes in fair value recognized in the statement of operations. During 2024, 2023 and 2022, the
Company recognized $<ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-19599">447</ix:nonFraction>, $<ix:nonFraction contextRef="c123" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-19600">756</ix:nonFraction> and $<ix:nonFraction contextRef="c124" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd" id="ixv-19601">8,425</ix:nonFraction>, respectively, with respect with those warrants as a finance income.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock" id="ixv-17018"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="text-transform: uppercase"><b>Note
9:- CONVERTIBLE BONDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">On June 2, 2024,
the Company issued convertible bonds in the principal amount of NIS <ix:nonFraction contextRef="c125" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="ils" id="ixv-19602">110,000,000</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c125" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="3" unitRef="usd" id="ixv-19603">30,000</ix:nonFraction>). The bonds were issued pursuant
to a deed of trust dated May 30, 2024, by and between the Company and Mishmeret Trust Company Ltd., as trustee (the &#8220;Trustee&#8221;)
pursuant to a public bid under Israeli law on June 3, 2024, at a price of NIS <ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="arbe:BidPricePerShare" scale="0" unitRef="ilsPershares" id="ixv-19604">1,031</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c126" decimals="2" format="ixt:num-dot-decimal" name="arbe:BidPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19605">0.28</ix:nonFraction>) per bond in the principal amount
of NIS <ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="arbe:BidPricePerShare" scale="0" unitRef="ilsPershares" id="ixv-19606">1,000</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c128" decimals="2" format="ixt:num-dot-decimal" name="arbe:BidPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19607">0.27</ix:nonFraction>) pursuant to a prospectus filed with the Israel Securities Authority and the TASE. Certain classified
investors who committed to purchase bonds in advance of the public bid, received a commission in the aggregate amount of NIS <ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="arbe:AggregateCommissionReceived" scale="0" unitRef="ils" id="ixv-19608">1,028,073</ix:nonFraction>
(approximately $<ix:nonFraction contextRef="c126" decimals="-3" format="ixt:num-dot-decimal" name="arbe:AggregateCommissionReceived" scale="3" unitRef="usd" id="ixv-19609">278</ix:nonFraction>), which was recorded as a reduction of their purchase price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The proceeds from
the sale of the bonds, which were approximately NIS <ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="0" unitRef="ils" id="ixv-19610">112,400,000</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c129" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="3" unitRef="usd" id="ixv-19611">30,500</ix:nonFraction>), are held in escrow and will be released to the
Company upon meeting certain conditions by March 31, 2025, or earlier if the bonds are converted at the election of the bonds&#8217; holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The bonds will be
released to the Company upon satisfaction of the following release conditions by March 31, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The Company wins a tender or contract to supply its products
as a single supplier of chips of imaging radar (directly or through one of the international Tier 1 manufacturers) to one of ten named
major automobile manufactures.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">The average closing trading price of the Company&#8217;s
ordinary shares on Nasdaq is not less than $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="arbe:TradingPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19612">3.10</ix:nonFraction> per share during <ix:nonNumeric contextRef="c130" format="ixt-sec:durday" name="arbe:NumberOfConsecutiveTradingDays" id="ixv-19613">30</ix:nonNumeric> consecutive trading days, and the average combined trading volume
on Nasdaq and TASE during such <ix:nonNumeric contextRef="c131" format="ixt-sec:durday" name="arbe:NumberOfConsecutiveTradingDays" id="ixv-19614">30</ix:nonNumeric> trading days is at least <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="arbe:NumberOfTradingVolumeSharesPerDay" scale="0" unitRef="shares" id="ixv-19615">300,000</ix:nonFraction> shares per day.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">The closing price of the Company&#8217;s ordinary shares
on Nasdaq on the date the Company presents to the Trustee the documentation confirming the fulfillment of the abovementioned conditions
precedent, is not less than $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="arbe:TradingPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19616">3.10</ix:nonFraction>.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As of the date hereof,
the Company does not meet the release conditions If the conditions are not meet by March 31, 2025, the Company is to use the funds in
escrow to prepay the bonds and the Company is obligated to pay any interest or other amounts due in excess of the amount held in escrow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">During January 2025, convertible bonds,
in the principal amount of NIS <ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="0" unitRef="ils" id="ixv-19617">78,462,184</ix:nonFraction> ($ <ix:nonFraction contextRef="c132" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" unitRef="usd" id="ixv-19618">22.4</ix:nonFraction> million) were converted and funds were released from escrow. See also Note 14b.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The above release
conditions to be satisfied by March 31, 2025, were extended to December 31, 2025 following an approval by the holder of a majority of
the outstanding bonds signed on March 20, 2025, See also Note 14c.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-17056"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
10:-  Shareholders&#8217; equity</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">a.</td><td style="text-align: justify">In October 2021, the Company adopted its restated articles, pursuant to which the Company&#8217;s authorized
capital consisted of <ix:nonFraction contextRef="c133" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-19619">130,000,000</ix:nonFraction> ordinary shares, with a par value of NIS <ix:nonFraction contextRef="c133" decimals="6" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="ilsPershares" id="ixv-19620">0.000216</ix:nonFraction> per share. </td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">b.</td><td style="text-align: justify">During June 2023, the Company raised $<ix:nonFraction contextRef="c134" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitIssuanceValue" scale="3" unitRef="usd" id="ixv-19621">23,000</ix:nonFraction> with Special Situations Funds, pursuant to which the Company
issued a total of <ix:nonFraction contextRef="c134" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonUnitIssued" scale="0" unitRef="shares" id="ixv-19622">11,794,873</ix:nonFraction> ordinary shares at a purchase price of $<ix:nonFraction contextRef="c134" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-19623">1.95</ix:nonFraction> per share. Existing investors, including two affiliates of the
Company&#8217;s directors, also participated in this offering. The aggregate net proceeds, after issuance costs, received by the Company
from the offering were $<ix:nonFraction contextRef="c135" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd" id="ixv-19624">22,496</ix:nonFraction>.</td></tr></table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
10:- Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">c.</td><td style="text-align: justify">During September 2024, the Company increased its authorized capital to <ix:nonFraction contextRef="c136" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-19625">165,000,000</ix:nonFraction> ordinary shares. The
increase in authorized capital shares was approved by the Company&#8217;s shareholders at the 2024 annual general meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">d.</td><td style="text-align: justify">In November 2024, the Company sold, in an underwritten public offering, an aggregate of (i)&#160;<ix:nonFraction contextRef="c137" decimals="0" format="ixt:num-dot-decimal" name="arbe:UnderwrittenPublicOffering" scale="0" unitRef="shares" id="ixv-19626">4,293,957</ix:nonFraction>&#160;ordinary
shares, (ii) prefunded warrants to purchase an aggregate of&#160;<ix:nonFraction contextRef="c138" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-19627">3,956,043</ix:nonFraction>&#160;ordinary shares (which were issued in lieu of ordinary
shares), (iii) Tranche A Warrants to purchase up to an aggregate of&#160;<ix:nonFraction contextRef="c139" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19628">8,250,000</ix:nonFraction>&#160;ordinary shares, and (iv) Tranche B Warrants to
purchase an aggregate of&#160;<ix:nonFraction contextRef="c140" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19629">8,250,000</ix:nonFraction>&#160;ordinary shares. Each share or pre-funded warrant, as applicable, was sold together with&#160;<ix:nonFraction contextRef="c141" decimals="0" format="ixt-sec:numwordsen" name="arbe:SaleOfPreFundedWarrantShares" scale="0" unitRef="shares" id="ixv-19630">one</ix:nonFraction>&#160;Tranche
A Warrant to purchase&#160;<ix:nonFraction contextRef="c141" decimals="0" format="ixt-sec:numwordsen" name="arbe:WarrantToPurchaseOfOrdinaryShares" scale="0" unitRef="shares" id="ixv-19631">one</ix:nonFraction>&#160;ordinary share and&#160;<ix:nonFraction contextRef="c142" decimals="0" format="ixt-sec:numwordsen" name="arbe:SaleOfPreFundedWarrantShares" scale="0" unitRef="shares" id="ixv-19632">one</ix:nonFraction>&#160;Tranche B warrant to purchase&#160;<ix:nonFraction contextRef="c142" decimals="0" format="ixt-sec:numwordsen" name="arbe:WarrantToPurchaseOfOrdinaryShares" scale="0" unitRef="shares" id="ixv-19633">one</ix:nonFraction>&#160;ordinary share. The net
proceeds from the offering, after deducting underwriting discounts and commissions and offering expenses payable by us of approximately
$<ix:nonFraction contextRef="c143" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NoninterestExpenseOfferingCost" scale="6" unitRef="usd" id="ixv-19634">13.8</ix:nonFraction>&#160;million.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">The Warrants were
classified in permanent equity, as the Warrants are considered indexed to the Company&#8217;s own stock and meet the additional requirements
for equity classification in accordance with ASC 815-40-25-10.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify">On January 7, 2025, the Company raised gross proceeds of $<ix:nonFraction contextRef="c144" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" unitRef="usd" id="ixv-19635">33.1</ix:nonFraction> million in an underwritten registered direct
public offering. Refer to Note 14.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">f.</td><td style="text-align: justify">Share options and RSU&#8217;s:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During 2016, the
Company adopted the 2016 Share Incentive Plan (the &#8220;2016 Plan&#8221;) which provides the Company with the ability to grant its employees,
directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined by the Board of
Directors at the date of grant. Pursuant to the 2016 Plan, <ix:nonFraction contextRef="c145" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19636">3,384,454</ix:nonFraction> Ordinary Shares were reserved for issuance. Each option granted under
the Plan expires no later than <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="ixv-19637">seven years</ix:nonNumeric> from the date of grant or 60 days after termination of engagement. The vesting period of the
share options is generally <ix:nonNumeric contextRef="c146" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-19638">four years</ix:nonNumeric>. In 2024, the term of the options granted under the 2016 Plan was extended to <ix:nonNumeric contextRef="c146" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="ixv-19639">ten years</ix:nonNumeric> from the
date of grants. The expense related to the extension is included in stock-based compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In August 2021, the
Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive Plan (the
&#8220;2021 Plan&#8221;) which became effective on October 7, 2021. The 2021 Plan covers (a) <ix:nonFraction contextRef="c147" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19640">4,079,427</ix:nonFraction> ordinary shares plus (b) and without
the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January
1, 2031, a number of Shares equal to the lesser of: (i) <ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="arbe:PercentageOfOrdinarySharesOutstanding" scale="-2" unitRef="pure" id="ixv-19641">5</ix:nonFraction>% of the total number of ordinary shares outstanding on December 31 of the immediately
preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar year in which
the increase will occur. As of December 31, 2024, there were <ix:nonFraction contextRef="c148" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19642">7,804,378</ix:nonFraction> ordinary shares subject to options under the 2021 plan and <ix:nonFraction contextRef="c149" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19643">136,101</ix:nonFraction>
ordinary shares reserved and available for issuance under the 2021 Plan. Following the increase in the size of the reserved and available
option pool on December 18, 2024, by an additional <ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19644">3,698,746</ix:nonFraction> ordinary shares, there were a total of <ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" unitRef="shares" id="ixv-19645">4,230,715</ix:nonFraction> ordinary shares reserved
and available for issuance under the 2021 Plan (including any remaining ordinary shares reserved and available for issuance under the
2016 Plan).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
10:- Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Upon the adoption
of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under the 2016
Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not been issued
or which expired unexercised may be issued pursuant to the 2021 Plan. <ix:nonNumeric contextRef="c152" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" id="ixv-19646">The vesting period of the awards is generally <ix:nonNumeric contextRef="c152" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-19647">four years</ix:nonNumeric>. Generally,
under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the first anniversary of
the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Share option and
RSU&#8217;s plans:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="ixv-17178"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A summary of the
stock option activity under the Company&#8217;s equity plans during the years ended December 31, 2024, 2023 and 2022 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding<br/>
share<br/>
options</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Weighted-</p> <p style="margin-top: 0; margin-bottom: 0">average<br/> exercise<br/> price ($)</p></td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Aggregate<br/> intrinsic<br/> value ($ in<br/> thousands)</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Options:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Outstanding as of December&#160;31, 2021</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c153" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19648">5,461,337</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c153" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19649">3.102</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c154" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-19650">5.363</ix:nonNumeric></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-19651">16,713,971</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-19652">1,630,142</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19653">6.833</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c155" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-19654">468,814</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19655">5.557</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c155" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19656">570,451</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19657">0.482</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding as of December&#160;31, 2022</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c156" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19658">6,052,214</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c156" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19659">4.166</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonNumeric contextRef="c155" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-19660">5.570</ix:nonNumeric></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c156" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-19661">7,761,705</ix:nonFraction></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c157" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-19662">430,874</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c157" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19663">2.728</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c157" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-19664">351,671</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c157" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19665">7.767</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c157" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19666">1,074,162</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c157" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19667">0.654</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding as of December&#160;31, 2023</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c158" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19668">5,057,255</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c158" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19669">4.543</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonNumeric contextRef="c157" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-19670">5.662</ix:nonNumeric></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c158" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-19671">2,352,517</ix:nonFraction></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c159" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" unitRef="shares" id="ixv-19672">80,000</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c159" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19673">1.91</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c159" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" unitRef="shares" id="ixv-19674">291,124</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c159" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19675">6.08</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c159" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-19676">255,756</ix:nonFraction></td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c159" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19677">0.81</ix:nonFraction></td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><b>Outstanding as of December&#160;31, 2024 </b></td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19678">4,590,375</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19679">4.62</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c159" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-19680">5.87</ix:nonNumeric></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" unitRef="usd" id="ixv-19681">1,364,975</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Exercisable as of December&#160;31, 2024</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" unitRef="shares" id="ixv-19682">3,716,507</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-19683">4.43</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonNumeric contextRef="c159" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="ixv-19684">5.42</ix:nonNumeric></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" unitRef="usd" id="ixv-19685">1,364,975</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Options available for future grants</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c160" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-19686">531,969</ix:nonFraction></td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
10:- Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="ixv-17691"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A summary of the Company&#8217;s
RSUs activity during the years ended December 31, 2024, 2023 and 2022 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Numbers of RSUs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">RSUs:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Outstanding as of December&#160;31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c161" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19687">1,968,794</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c162" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-19688">1,619,898</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c162" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" unitRef="shares" id="ixv-19689">417,025</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c162" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" scale="0" unitRef="shares" id="ixv-19690">573,583</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December&#160;31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c163" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19691">2,598,084</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c164" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-19692">2,908,983</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c164" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" unitRef="shares" id="ixv-19693">370,067</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c164" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" scale="0" unitRef="shares" id="ixv-19694">895,170</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December&#160;31, 2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c165" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19695">4,241,830</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c166" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="0" unitRef="shares" id="ixv-19696">4,377,834</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c166" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="0" unitRef="shares" id="ixv-19697">432,018</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c166" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" scale="0" unitRef="shares" id="ixv-19698">3,274,523</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Outstanding as of December&#160;31, 2024</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c167" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" unitRef="shares" id="ixv-19699">4,913,123</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Fair value
factors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-17809"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The following table
sets forth the parameters used in computation of the options compensation to employees and service providers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Expected term, in years</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-19700">6.11</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c7" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-19701">5.82</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c168" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-19702">4.41</ix:nonNumeric>-<ix:nonNumeric contextRef="c169" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-19703">6.11</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-19704">51.75</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right"><ix:nonFraction contextRef="c170" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-19705">47</ix:nonFraction>%-<ix:nonFraction contextRef="c171" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-19706">51.75</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right"><ix:nonFraction contextRef="c168" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-19707">47</ix:nonFraction>%-<ix:nonFraction contextRef="c169" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-19708">48</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-19709">4.23</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right"><ix:nonFraction contextRef="c170" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-19710">4.15</ix:nonFraction>%-<ix:nonFraction contextRef="c171" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-19711">4.55</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right"><ix:nonFraction contextRef="c168" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-19712">1.74</ix:nonFraction>%-<ix:nonFraction contextRef="c169" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-19713">3.96</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected dividend yield</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-19714">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-19715">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-19716">0</ix:nonFraction></td><td style="text-align: left">%</td></tr> </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Fair value<span style="font-family: Times New Roman, Times, Serif">:</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The fair value of
the ordinary shares is the market price of the ordinary shares on the date of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Expected volatility:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As the Company was
privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock options. Therefore,
the Company uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly
traded companies which were selected based upon industry similarities.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
10:- Shareholders&#8217; equity (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Expected term
(years):</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Expected term represents
the period that the Company&#8217;s option grants are expected to be outstanding. There is not sufficient historical share exercise data
to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method to value option grants.
Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting term and the contractual
term of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Risk-free interest
rate:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company determined
the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect
as of the date of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Expected dividend
yield:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company does
not anticipate paying any dividends in the foreseeable future. Thus, the Company used <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-19717">0</ix:nonFraction>% as its expected dividend yield.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="ixv-17970"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
following table presents stock-based compensation expense to employees included in the Company&#8217;s consolidated statements of operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19718">9,684</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c173" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19719">8,721</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c174" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19720">5,726</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c175" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19721">2,384</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c176" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19722">2,229</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c177" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19723">1,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c178" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19724">2,187</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c179" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19725">1,786</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c180" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19726">1,537</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19727">287</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c182" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19728">276</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19729">127</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19730">14,542</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19731">13,012</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-19732">8,793</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>Share
based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits related
to the </span>stock<span>-based compensation for the years ended December&#160;31, 2024, 2023 and 2022.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above grants of stock-based compensation issued
to service providers their fair value using Black-Scholes model, which requires inputs such as exercise price, estimated ordinary share
price, expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2024, 2023 and 2022, the
Company recognized the total fair value of the stock-based compensation of development-related service providers in the amounts of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-19733">1,186</ix:nonFraction>,
$<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-19734">629</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" unitRef="usd" id="ixv-19735">354</ix:nonFraction>, respectively.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-weight: normal">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"><span style="font-weight: normal">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:EarningsPerShareTextBlock" id="ixv-18127"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NOTE 11:- NET LOSS PER
SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-18131"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-weight: normal; ">The
following table sets forth the computation of basic and diluted net loss per ordinary share for the periods presented: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;<b>Year ended </b>&#160;<b>December 31,</b></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2024</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><b><span style="text-decoration:underline">Basic</span></b></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><b>Numerator:</b></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt; width: 64%; text-align: left">Net loss</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19736">49,317</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19737">43,500</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19738">40,494</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-indent: -10pt"><b>Denominator:</b></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-19739">80,949,032</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-19740">72,021,520</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-19741">63,489,983</ix:nonFraction></td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Loss per share attributable to ordinary shareholders, basic</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-19742">0.61</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-19743">0.60</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-19744">0.64</ix:nonFraction></td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>

</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Diluted</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Adjusted Net loss*</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" sign="-" unitRef="usd">49,317</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" sign="-" unitRef="usd">44,696</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" sign="-" unitRef="usd">41,698</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Denominator:</b></p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-19748">80,949,032</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-19749">72,053,372</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-19750">63,629,206</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left">Loss per share attributable to ordinary shareholders, diluted*</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.61</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" id="ix_4_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.61</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" id="ix_5_fact" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares">0.66</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US"><span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#8217;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</span></ix:footnote></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="arbe:ScheduleOfAdjustedNetIncomeLossTableTextBlock" id="ixv-18360"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19754">49,317</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19755">43,500</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd" id="ixv-19756">40,494</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Revaluation of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="arbe:RevaluationOfWarrants" scale="3" sign="-" unitRef="usd" id="ixv-19757">196</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="arbe:RevaluationOfWarrants" scale="3" sign="-" unitRef="usd" id="ixv-19758">1,204</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Adjusted Net loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" sign="-" unitRef="usd" id="ixv-19759">49,317</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" sign="-" unitRef="usd" id="ixv-19760">44,696</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" sign="-" unitRef="usd" id="ixv-19761">41,698</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="ixv-18448"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0pt"><span style="font-weight: normal">The
potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2024, 2023 and 2022 because including them would have been anti-dilutive are as follows:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Convertible bonds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19762">11,542,497</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19763">23,796,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19764">3,112,080</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19765">3,112,080</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Outstanding share options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19766">9,503,498</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19767">9,299,085</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c192" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19768">8,650,298</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19769">44,842,077</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19770">12,411,165</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-19771">11,762,378</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-18585"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NOTE 12:- TAXES ON INCOME</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">a.</td><td style="text-align: justify">General:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Israeli tax rate:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Corporate tax
rate in Israel relevant to the Company is <ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-19772"><ix:nonFraction contextRef="c93" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-19773"><ix:nonFraction contextRef="c95" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-19774">23</ix:nonFraction></ix:nonFraction></ix:nonFraction>% in 2024, 2023 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>United States:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s
United States subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of <ix:nonFraction contextRef="c79" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-19775">21</ix:nonFraction>%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">b.</td><td style="text-align: justify">Loss before income taxes:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="ixv-18610"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The following
are the domestic (i.e. Israeli) and foreign components of the Company&#8217;s loss before income taxes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Domestic</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd" id="ixv-19776">49,317</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd" id="ixv-19777">43,500</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" unitRef="usd" id="ixv-19778">40,494</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-19779">49,317</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-19780">43,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-19781">40,494</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">c.</td><td style="text-align: justify">Taxes on income:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-18709"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The reconciliation
of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#8217;s reported income tax (benefit)
is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt">Loss before income taxes, as reported in the consolidated statements of operations</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-19782">49,317</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-19783">43,500</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-19784">40,494</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Statutory tax rate</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-19785">23</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-19786">23</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-19787">23</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax benefit at statutory tax rate</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-19788">11,343</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-19789">10,005</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" sign="-" unitRef="usd" id="ixv-19790">9,314</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of Non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd" id="ixv-19791">3,573</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd" id="ixv-19792">3,063</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="3" unitRef="usd" id="ixv-19793">475</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Remeasurement of deferred taxes from currency exchange*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" id="ix_6_fact" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" unitRef="usd">3,517</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-19795">7,770</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-19796">7,508</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-19797">5,322</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" sign="-" unitRef="usd" id="ixv-19798">566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Reported income taxes benefit</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>*</b></td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-19800">25</ix:nonFraction>%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.</ix:footnote></td>
</tr></table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
12:- TAXES ON INCOME (<span style="text-transform: none">Cont</span>.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">d.</td><td style="text-align: justify">Net operating loss carryforward:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>As
of December&#160;31, 2024, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-19801">157,627</ix:nonFraction> These
net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">e.</td><td style="text-align: justify">Deferred tax assets and liabilities:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Deferre d tax
assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-18939"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The principal components
of the Company&#8217;s deferred tax assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 76%; text-align: left">Net operating loss carry forwards</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-19802">36,254</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-19803">28,032</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="3" unitRef="usd" id="ixv-19804">5,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="3" unitRef="usd" id="ixv-19805">6,252</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Employees and payroll accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-19806">352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-19807">299</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19808">100</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-19809">79</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total deferred tax assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd" id="ixv-19810">42,432</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd" id="ixv-19811">34,662</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-19812">42,432</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-19813">34,662</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Deferred tax assets, net of valuation allowance</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Based on the available
evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net operating loss carryforwards
and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has been provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">f.</td><td style="text-align: justify">Tax assessments:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Israeli
entity&#8217;s&#8217; income tax assessments are considered final through 2019<span style="font-size: 10pt; ">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">g.</td><td style="text-align: justify">Unrecognized Tax Benefits:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>As
of December&#160;31, 2024, 2023 and 2022, the Company did not have any unrecognized tax benefits and does not expect that the amount of
unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue interest
and penalties related to an underpayment of income taxes as a component of income tax expense.</span></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ARBE ROBOTICS LTD. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. dollars in thousands (except share and
per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p><div>


</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock" id="ixv-19118"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>NOTE 13:- SEGMENT INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
Company operates in <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" unitRef="pure" id="ixv-19814"><ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" unitRef="pure" id="ixv-19815">one</ix:nonFraction></ix:nonFraction> operating and reportable segment. Operating segments are defined as components of an enterprise about which separate
financial information is evaluated regularly by the chief operating decision maker, who is the Company&#8217;s chief executive officer,
in deciding how to allocate resources and assessing performance. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
segment structure reflects the financial information and reports used by the Company&#8217;s management, specifically its CODM, to make
decisions regarding the Company&#8217;s business, including resource allocations and performance assessments, as well as the current operating
focus in compliance with ASC&#160;280,&#160;Segment Reporting. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
Company&#8217;s chief operating decision maker allocates resources and assesses performance based upon discrete financial information
at the consolidated level. As a single reportable segment entity, the Company&#8217;s segment performance measure is net loss. The Company
adopted ASU 2023-07 in December 2024. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><b>Major Customers:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During the year ended December 31,
2024, the Company had four customers that accounted for <ix:nonFraction contextRef="c193" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19816">19.5</ix:nonFraction>%, <ix:nonFraction contextRef="c194" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19817">18.4</ix:nonFraction>%, <ix:nonFraction contextRef="c195" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19818">16.9</ix:nonFraction>% and <ix:nonFraction contextRef="c196" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19819">14.5</ix:nonFraction>%, respectively, of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During the year ended December 31,
2023, the Company had three customers that accounted for <ix:nonFraction contextRef="c197" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19820">38.9</ix:nonFraction>%, <ix:nonFraction contextRef="c198" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19821">18.1</ix:nonFraction>% and <ix:nonFraction contextRef="c199" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19822">12.7</ix:nonFraction>%, respectively, of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During the year ended December 31,
2022, the Company had three customers that accounted for <ix:nonFraction contextRef="c200" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19823">33.4</ix:nonFraction>%, <ix:nonFraction contextRef="c201" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19824">19.4</ix:nonFraction>% and <ix:nonFraction contextRef="c202" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-19825">18.9</ix:nonFraction>%, respectively, of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">No other customer accounted for 10%
or more of revenues in 2024, 2023 or 2022. The 10% customers were different customers in each of 2024, 2023 and 2022.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-19148"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>NOTE 14:- SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">a.</td><td style="text-align: justify">On January 7, 2025, the Company raised gross proceeds of $<ix:nonFraction contextRef="c203" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="6" unitRef="usd" id="ixv-19826">33.1</ix:nonFraction> million in an underwritten registered public
offering, for the sale of <ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-19827">10,332,031</ix:nonFraction> ordinary shares at a purchase price of $<ix:nonFraction contextRef="c205" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-19828">3.20</ix:nonFraction> per share. The aggregate net proceeds received by us
from the offering were $<ix:nonFraction contextRef="c203" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-19829">30.9</ix:nonFraction> million,&#160;net of underwriting discounts and other offering costs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">b.</td><td style="text-align: justify">During January 2025, convertible bonds in the principal amount of NIS <ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="0" unitRef="ils" id="ixv-19830">78,462,184</ix:nonFraction> were converted into <ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares" id="ixv-19831">8,233,177</ix:nonFraction>
ordinary shares, and $<ix:nonFraction contextRef="c132" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIssuedPrincipal" scale="6" unitRef="usd" id="ixv-19832">22.4</ix:nonFraction> million (including interest) were released from the escrow to the Company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 20, 2025, following approval by the holders of a majority of the outstanding bonds, the the Company and the trustee entered into an amendment to the deed of trust pursuant to which, among other changes, date by which the Company must meet the conditions to the release of the funds from escrow was extended from March 31, 2025 to December 31, 2025.</span></td></tr>
  </table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">F-29</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c6" id="hidden-fact-0" name="us-gaap:OtherAssetsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-1" name="arbe:ConvertibleBonds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-3" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-4" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-7" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-8" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-9" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-10" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-11" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-12" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-13" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-14" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-16" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-17" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-18" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-19" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-21" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-22" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-23" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-24" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-25" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-26" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-27" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-28" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-29" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-30" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-31" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-32" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-33" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-34" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-35" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-36" name="arbe:RevaluationOfConvertibleLoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-37" name="arbe:RevaluationOfConvertibleLoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-38" name="arbe:IssuanceCostsRelatedToConvertibleBonds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-39" name="arbe:IssuanceCostsRelatedToConvertibleBonds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-40" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-41" name="us-gaap:RepaymentsOfShortTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-42" name="us-gaap:RepaymentsOfShortTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-43" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-44" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-45" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-46" name="arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-47" name="arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-48" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c40" decimals="-3" id="hidden-fact-49" name="us-gaap:GeneralPartnersOfferingCosts" unitRef="usd">30000000</ix:nonFraction>
<ix:nonFraction contextRef="c60" id="hidden-fact-50" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-51" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-52" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-53" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-54" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-55" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-56" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c97" id="hidden-fact-57" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c98" id="hidden-fact-58" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c99" id="hidden-fact-59" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c100" id="hidden-fact-60" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c103" id="hidden-fact-61" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-62" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-63" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c106" id="hidden-fact-64" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-65" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-66" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-67" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c114" id="hidden-fact-68" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-69" name="arbe:RevaluationOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-70" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c186" id="hidden-fact-71" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-72" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-73" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-74" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-75" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-76" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-77" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-78" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-79" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-80" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-81" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-82" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-83" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-19919">0001861841</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-19920">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-19921">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode" id="ixv-19922">6329302</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-19923">6329302</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="arbe-20241231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="hidden-fact-2 hidden-fact-3" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-4 hidden-fact-11 hidden-fact-13 hidden-fact-14 hidden-fact-18 hidden-fact-24 hidden-fact-25 hidden-fact-31 hidden-fact-35" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-50" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact ix_5_fact" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-75 hidden-fact-76 ix_6_fact" toRefs="ix_4_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:OrdinarySharesParValueNIS0000216PerShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:WarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-10-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PublicWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PrivateWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-02</xbrli:startDate>
    <xbrli:endDate>2024-06-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-04</xbrli:startDate>
    <xbrli:endDate>2024-11-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-04</xbrli:startDate>
    <xbrli:endDate>2024-11-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:PreFundedWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-04</xbrli:startDate>
    <xbrli:endDate>2024-11-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-04</xbrli:startDate>
    <xbrli:endDate>2024-11-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-04</xbrli:startDate>
    <xbrli:endDate>2024-11-04</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-31</xbrli:startDate>
    <xbrli:endDate>2025-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUb4go9VfBQD5Y7eBMcK7Hjxo+qJGH9V7C79vIfu+QZ4vbgUilPQJBxah1LJB9I5F32xF2kD18NTd7R+hFy80oo6GKOF4xVC7lqFetvxJsjxnLtzhmOcaZXkZ4mMypqUK4r4HmWLxKAfdfyeWOZvMs/tu2nHvJUkOdVWnLVX2zsKV/nxZTcXcEf] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:TheTrusteeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-02</xbrli:startDate>
    <xbrli:endDate>2024-06-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-03</xbrli:startDate>
    <xbrli:endDate>2024-06-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:TheTrusteeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-03</xbrli:startDate>
    <xbrli:endDate>2024-06-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-03</xbrli:startDate>
    <xbrli:endDate>2024-06-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:TheTrusteeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-31</xbrli:startDate>
    <xbrli:endDate>2025-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:NasdaqMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-31</xbrli:startDate>
    <xbrli:endDate>2025-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-30</xbrli:startDate>
    <xbrli:endDate>2024-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:PreFundedWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-30</xbrli:startDate>
    <xbrli:endDate>2024-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-30</xbrli:startDate>
    <xbrli:endDate>2024-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-30</xbrli:startDate>
    <xbrli:endDate>2024-11-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:DirectPublicOfferingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-07</xbrli:startDate>
    <xbrli:endDate>2025-01-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandSixteenIncentivePlanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2016-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:TwoThousandSixteenIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:TwoThousandTwentyOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:TwoThousandTwentyOneMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-12-31</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer4Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-07</xbrli:startDate>
    <xbrli:endDate>2025-01-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-07</xbrli:startDate>
    <xbrli:endDate>2025-01-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001861841</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-01-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="ilsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ILS</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.10
<SEQUENCE>2
<FILENAME>ea023582801ex4-10_arbe.htm
<DESCRIPTION>ENGLISH TRANSLATION (UNOFFICIAL) OF AMENDMENT DATED MARCH 20,.2025 TO DEED OF TRUST DATED MATY 20, 2024 BY AND BETWEEN THE COMPANY AND MISHMERET TRUST COMPANY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.10</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Addendum no. 1 to the Deed of Trust dated
May 30, 2024</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Entered into and executed in Tel Aviv as of this
20<SUP>th</SUP> day of March 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Between:</B></FONT></TD>
    <TD STYLE="width: 75%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>ARBE ROBOTICS LTD</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Company No. 51-533312-8</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">107 HaChasmonaim St., Tel Aviv - Yafo</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">(hereinafter: the &ldquo;<B>Company</B>&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 87.7pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>The first party</U></B>;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>And between: </B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Mishmeret
    </B></FONT><B><FONT STYLE="font-family: Symbol">-</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">Trust Company Ltd. </FONT></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Company Reg. No.: 51-368347-4</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">48 Menachem Begin Rd.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Tel Aviv</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">(hereinafter: the &ldquo;<B>Trustee</B>&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>The second party</U></B>;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 19%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Whereas:</B></FONT></TD>
    <TD STYLE="width: 81%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company engaged with the Trustee, as
a trustee for the Bonds (Series A) under a Deed of Trust that was signed on May 30 (hereinafter: the &ldquo;<B>Deed of Trust</B>&rdquo;)
in connection with the terms of the Bonds (Series A);</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>And whereas: </B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company wishes to extend the period of
time for the fulfillment of the condition precedent, as stated in sections 7.2 and 7.3.10 of the Deed of Trust from March 31, 2025, until
December 31, 2025;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>And whereas: </B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company wishes to make a number of additional
amendments in sections 3.1, 6.3, 6.7.1, 9.1.25 of the Deed of Trust, as stated hereunder;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Now, Therefore, it is Declared, Stipulated
and Agreed between the Parties as Follows:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">Preamble, interpretation, and definitions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.1.</TD><TD STYLE="text-align: justify">The preamble hereto shall be deemed an integral part of this Addendum no. 1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.2.</TD><TD STYLE="text-align: justify">Upon the signing hereof, this Addendum no. 1 shall be deemed as an integral part of the Deed of Trust
and all terms used in this Addendum no. 1 shall have the meaning ascribed thereto in the Deed of Trust, as the case may be, unless otherwise
stated in this Addendum no. 1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.3.</TD><TD STYLE="text-align: justify">Save as provided expressly in this Addendum no. 1, the other provisions of the Deed of Trust shall remain
intact, and the entire provisions of the Deed of Trust shall be in full force and effect unless otherwise stated expressly in this Addendum
no. 1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.4.</TD><TD STYLE="text-align: justify">The provisions of this Addendum no. 1 shall add to the provisions of the Deed of Trust and shall not derogate
therefrom, and in the event of discrepancy between the provisions of this Addendum no. 1 and the provisions of the Deed of Trust, the
provisions of the Deed of Trust shall take precedence. The Trust Deed and this Addendum No. 1 shall be read jointly and construed as complementary
(forming a single instrument).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><B><U>Amendments to the Deed of Trust </U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.1.</TD><TD STYLE="text-align: justify"><U>In section 3.1 of the Deed of Trust</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;&hellip;this undertaking of
the Company shall expire and shall be deemed null and void unless more than 90% of the bonds (par value) have been converted into the
shares of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">shall be replaced with the following
sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;&hellip;this undertaking of
the Company shall expire and be deemed null and void if the balance of the par value of the bonds in circulation falls below ILS ten million.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.2.</TD><TD STYLE="text-align: justify"><U>In section 6.3 of the Deed of Trust</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;Notwithstanding the provisions
of this section, this undertaking by the Company shall expire and be deemed null and void unless more than 90% of the bonds (par value)
have been converted into the shares of the Company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">shall be replaced with the following
sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;Notwithstanding the provisions
of this section, this undertaking by the Company shall expire and be deemed null and void if the outstanding par value of the bonds in
circulation falls below ILS 10 million.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.3.</TD><TD STYLE="text-align: justify"><U>In section 6.7.1 of the Deed of Trust</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The following sentences:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;An unsecured financial debt for
a cumulative amount of up to 500 thousand dollars&rdquo; and &ldquo;notwithstanding the provisions of this section, this undertaking of
the Company shall expire and shall be deemed null and void unless more than 90% of the bonds (par value) have been converted into the
shares of the Company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">shall be replaced with the following sentences:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;an unsecured financial debt
in a cumulative amount of up to 2 million dollars&rdquo; and &ldquo;notwithstanding the provisions of this section, this undertaking of
the Company shall expire and become null and void if the balance of the par value of the bonds in circulation falls below ILS 10 million.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.4.</TD><TD STYLE="text-align: justify"><U>In section 7.2 of the Deed of Trust</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The following sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;The transfer of the issuance
proceeds to the Company from the issuance proceeds account held by the Trustee is conditional on the fulfillment of the following three
(3) conditions until March 31, 2025 (hereinafter: the &ldquo;<B>Condition Precedent</B>&rdquo;)&hellip;&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">shall be replaced with the following
sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;The transfer of the issuance
proceeds to the Company from the issuance proceeds account that will be held by the Trustee is conditional on the fulfillment of the following
three (3) conditions until December 31, 2025 (hereinafter: the &ldquo;<B>Condition Precedent</B>&rdquo;)&hellip;&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.5.</TD><TD STYLE="text-align: justify"><U>In section 7.3.10 of the Deed of Trust</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The following sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;To the extent that until March
31, 2025, as stated in section 7.2 above (hereinafter: the &ldquo;<B>Determining Period</B>&rdquo;), no approvals are provided&hellip;the
Company shall carry out a mandatory early redemption&hellip;&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">shall be replaced with the following
sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;To the extent that until December
31, 2025, as stated in section 7.2 above (hereinafter: the &ldquo;<B>Determining Period</B>&rdquo;) no approvals are provided&hellip;the
Company shall carry out a mandatory early redemption&hellip;&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.6.</TD><TD STYLE="text-align: justify"><U>In section 9.1.25 of the Deed of Trust</U>:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The following sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;and/or if more than 90% of the
bonds (par value) have been converted into the shares of the Company&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">shall be replaced with the following
sentence:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&ldquo;It is agreed that no grounds
for immediate payment under this section shall arise if the amount of the par value of the bonds in circulation is lower than ILS ten
million&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">[Remainder of page intentionally left
blank; signature page to follow]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>In Witness Whereof The Parties Hereto Have Hereunto
Set Their Hands on this 20<SUP>th</SUP> day of March, 2025:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature]</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 20%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: center; font-size: 10pt">[Signature]</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARBE ROBOTICS LTD </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARBE ROBOTICS LTD, Private Company No. 515333128
    </B></P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mishmeret Trust Company Ltd. </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, the undersigned, Adv. Maya Bar-On, hereby confirm
that this Addendum was signed by <U>Kobi Marenko and Karine Pinto-Flomenboim</U>, and their signature, together with the stamp of the
Company or its printed name, binds ARBE ROBOTICS LTD in in anything related to this Addendum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; text-align: center; font-size: 10pt">[Signature]</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adv. Maya Bar-On</B></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>3
<FILENAME>ea023582801ex8-1_arbe.htm
<DESCRIPTION>LIST OF SUBSIDIARIES OF ARBE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 8.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Subsidiaries of Arbe Robotics Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Subsidiary</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction of Incorporation</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arbe Robotics US, Inc.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Delaware</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai Arbe Technologies Co., Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">People&rsquo;s Republic of China</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>ea023582801ex12-1_arbe.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SARBANES-OXLEY ACT OF 2002 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">I, Jacob Marinka (a/k/a Kobi
Marenko), certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">1.  I
have reviewed this annual report on Form 20-F of Arbe Robotics Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">2.  Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">3.  Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">4. The registrant&rsquo;s
other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify">5.  The registrant&rsquo;s
other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant&rsquo;s auditors and the audit committee
of the registrant&rsquo;s board of directors (or persons performing the equivalent function):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">a) all significant
deficiencies in the design or operation of internal controls which could adversely affect the registrant&rsquo;s ability to record, process,
summarize and report financial data and have identified for the registrant&rsquo;s auditors any material weaknesses in internal controls;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">b) any fraud,
whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal controls
over financial reporting. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Dated: March 28, 2025</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/ Jacob (Kobi) Marinka</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Jacob (Kobi) Marinka</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Principal Executive Officer)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>ea023582801ex12-2_arbe.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SARBANES-OXLEY ACT OF 2002 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">I, Karine Pinto-Flomenboim,
certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">1.  I
have reviewed this annual report on Form 20-F of Arbe Robotics Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">2.  Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">3.  Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">4. The registrant&rsquo;s
other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; </FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt 0; text-align: justify">5.  The registrant&rsquo;s
other certifying officer and I have disclosed, based on our most recent evaluation, to the registrant&rsquo;s auditors and the audit committee
of the registrant&rsquo;s board of directors (or persons performing the equivalent function):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">a) all significant
deficiencies in the design or operation of internal controls which could adversely affect the registrant&rsquo;s ability to record, process,
summarize and report financial data and have identified for the registrant&rsquo;s auditors any material weaknesses in internal controls;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">b) any fraud,
whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal controls
over financial reporting. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Dated: March 28,  2025</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/ Karine Pinto-Flomenboim</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Karine Pinto-Flomenboim</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Principal Financial Officer)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>ea023582801ex13-1_arbe.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Annual
Report of Arbe Robotics Ltd. (the &ldquo;Company&rdquo;) on Form 20-F for the year ended December 31, 2024 as filed with the Securities
and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Jacob (Kobi) Marinka, chief executive officer of the Company,
and I, Karine Pinto-Flomenboim, chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley
Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange
Act of 1934; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">Date: March 28, 2025</TD>
    <TD STYLE="width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/Jacob (Kobi) Marinka</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Jacob (Kobi) Marinka</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Principal Executive Officer)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Karine Pinto-Flomenboim</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Karine Pinto-Flomenboim</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Principal Financial Officer)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>ea023582801ex23-1_arbe.htm
<DESCRIPTION>CONSENT OF SOMEKH CHAIKIN MEMBER FIRM OF KPMG INTERNATIONAL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference in
the registration statements (No. 333-284158, 333-280319 and 333-269235) on Form F-3, in the registration statements (No. 333-280320 and
333-269230) on Form S-8, and in the post-effective amendment no. 2 of registration statement (No. 333-259757) on Form F-3 of our report
dated March 28, 2025, with respect to the consolidated financial statements of Arbe Robotics Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Somekh Chaikin</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 60%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Somekh Chaikin</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Member Firm of KPMG International</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel Aviv, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 28, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>arbe-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 28 18:58:39 UTC 2025 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2024" targetNamespace="http://www.arberobotics.com/20241231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:arbe="http://www.arberobotics.com/20241231" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20241231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20241231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20241231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="arbe-20241231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet" id="arbe_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals" id="arbe_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement" id="arbe_r_ConsolidatedIncomeStatement">
        <link:definition>995303 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquityType2or3" id="arbe_r_ShareholdersEquityType2or3">
        <link:definition>995304 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow" id="arbe_r_ConsolidatedCashFlow">
        <link:definition>995305 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/General" id="arbe_r_General">
        <link:definition>995306 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SignificantAccountingPolicies" id="arbe_r_SignificantAccountingPolicies">
        <link:definition>995307 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/Revenue" id="arbe_r_Revenue">
        <link:definition>995308 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables" id="arbe_r_PrepaidExpensesandOtherReceivables">
        <link:definition>995309 - Disclosure - Prepaid Expenses and Other Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PropertyandEquipment" id="arbe_r_PropertyandEquipment">
        <link:definition>995310 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/Leases" id="arbe_r_Leases">
        <link:definition>995311 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities" id="arbe_r_CommitmentsandContingentLiabilities">
        <link:definition>995312 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/WarrantsLiabilities" id="arbe_r_WarrantsLiabilities">
        <link:definition>995313 - Disclosure - Warrants Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConvertibleBonds" id="arbe_r_ConvertibleBonds">
        <link:definition>995314 - Disclosure - Convertible Bonds</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquity" id="arbe_r_ShareholdersEquity">
        <link:definition>995315 - Disclosure - Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders" id="arbe_r_NetLossPerShareAttributibletoOrdinarySharholders">
        <link:definition>995316 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/TaxesonIncome" id="arbe_r_TaxesonIncome">
        <link:definition>995317 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SegmentInformation" id="arbe_r_SegmentInformation">
        <link:definition>995318 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SubsequentEvents" id="arbe_r_SubsequentEvents">
        <link:definition>995319 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/AccountingPoliciesByPolicy" id="arbe_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables" id="arbe_r_SignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/RevenueTables" id="arbe_r_RevenueTables">
        <link:definition>996002 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables" id="arbe_r_PrepaidExpensesandOtherReceivablesTables">
        <link:definition>996003 - Disclosure - Prepaid Expenses and Other Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PropertyandEquipmentTables" id="arbe_r_PropertyandEquipmentTables">
        <link:definition>996004 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/LeasesTables" id="arbe_r_LeasesTables">
        <link:definition>996005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquityTables" id="arbe_r_ShareholdersEquityTables">
        <link:definition>996006 - Disclosure - Shareholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables" id="arbe_r_NetLossPerShareAttributibletoOrdinarySharholdersTables">
        <link:definition>996007 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/TaxesonIncomeTables" id="arbe_r_TaxesonIncomeTables">
        <link:definition>996008 - Disclosure - Taxes on Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/GeneralDetails" id="arbe_r_GeneralDetails">
        <link:definition>996009 - Disclosure - General (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails" id="arbe_r_SignificantAccountingPoliciesDetails">
        <link:definition>996010 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" id="arbe_r_ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable">
        <link:definition>996011 - Disclosure - Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/RevenueDetails" id="arbe_r_RevenueDetails">
        <link:definition>996012 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable" id="arbe_r_ScheduleofRevenueDisaggregatedbyGeographyTable">
        <link:definition>996013 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable" id="arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable">
        <link:definition>996014 - Disclosure - Prepaid Expenses and Other Receivables - Schedule of Prepaid Expenses and Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/PropertyandEquipmentDetails" id="arbe_r_PropertyandEquipmentDetails">
        <link:definition>996015 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable" id="arbe_r_ScheduleofPropertyandEquipmentTable">
        <link:definition>996016 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUb4go9VfBQD5Y7eBMcK7Hjxo+qJGH9V7C79vIfu+QZ4vbgUilPQJBxah1LJB9I5F32xF2kD18NTd7R+hFy80oo6GKOF4xVC7lqFetvxJsjxnLtzhmOcaZXkZ4mMypqUK4r4HmWLxKAfdfyeWOZvMs/nIe/4OF/RqVC6+wIfyH4GdyJw69NpwIN] CSR-->
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofLeaseCostTable" id="arbe_r_ScheduleofLeaseCostTable">
        <link:definition>996017 - Disclosure - Leases - Schedule of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable" id="arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable">
        <link:definition>996018 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails" id="arbe_r_CommitmentsandContingentLiabilitiesDetails">
        <link:definition>996019 - Disclosure - Commitments and Contingent Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails" id="arbe_r_WarrantsLiabilitiesDetails">
        <link:definition>996020 - Disclosure - Warrants Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ConvertibleBondsDetails" id="arbe_r_ConvertibleBondsDetails">
        <link:definition>996021 - Disclosure - Convertible Bonds (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ShareholdersEquityDetails" id="arbe_r_ShareholdersEquityDetails">
        <link:definition>996022 - Disclosure - Shareholders&#8217; Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable" id="arbe_r_ScheduleofStockOptionActivityTable">
        <link:definition>996023 - Disclosure - Shareholders&#8217; Equity - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable" id="arbe_r_ScheduleofRSUsActivityTable">
        <link:definition>996024 - Disclosure - Shareholders&#8217; Equity - Schedule of RSUs Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable" id="arbe_r_ScheduleofCompensationtoEmployeesTable">
        <link:definition>996025 - Disclosure - Shareholders&#8217; Equity - Schedule of Compensation to Employees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable" id="arbe_r_ScheduleofShareBasedCompensationExpenseTable">
        <link:definition>996026 - Disclosure - Shareholders&#8217; Equity - Schedule of Share Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" id="arbe_r_ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable">
        <link:definition>996027 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable" id="arbe_r_ScheduleofAdjustedNetlossTable">
        <link:definition>996028 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Adjusted Net loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" id="arbe_r_ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable">
        <link:definition>996029 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/TaxesonIncomeDetails" id="arbe_r_TaxesonIncomeDetails">
        <link:definition>996030 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable" id="arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable">
        <link:definition>996031 - Disclosure - Taxes on Income  - Schedule of Company&#8217;s Loss Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable" id="arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable">
        <link:definition>996032 - Disclosure - Taxes on Income  - Schedule of Reconciliation Income Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable" id="arbe_r_ScheduleofDeferredTaxAssetsTable">
        <link:definition>996033 - Disclosure - Taxes on Income  - Schedule of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SegmentInformationDetails" id="arbe_r_SegmentInformationDetails">
        <link:definition>996034 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/SubsequentEventsDetails" id="arbe_r_SubsequentEventsDetails">
        <link:definition>996035 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.arberobotics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:element name="ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
  <xs:element name="ScheduleOfRevenueDisaggregatedByGeographyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract"/>
  <xs:element name="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfPropertyAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfLeaseCostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfLeaseCostAbstract"/>
  <xs:element name="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfRsusActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfRsusActivityAbstract"/>
  <xs:element name="ScheduleOfCompensationToEmployeesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfCompensationToEmployeesAbstract"/>
  <xs:element name="ScheduleOfShareBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfShareBasedCompensationExpenseAbstract"/>
  <xs:element name="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
  <xs:element name="ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract"/>
  <xs:element name="ScheduleOfReconciliationIncomeTaxBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract1"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract2"/>
  <xs:element name="RevenueByGeographyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_RevenueByGeographyAbstract"/>
  <xs:element name="OptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OptionsAbstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnlabeledAbstract5"/>
  <xs:element name="BasicAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_BasicAbstract"/>
  <xs:element name="ConvertibleBonds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="arbe_ConvertibleBonds"/>
  <xs:element name="RevaluationOfConvertibleLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_RevaluationOfConvertibleLoan"/>
  <xs:element name="IssuanceCostsRelatedToConvertibleBonds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_IssuanceCostsRelatedToConvertibleBonds"/>
  <xs:element name="PaymentForChangeInBankDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="arbe_PaymentForChangeInBankDeposits"/>
  <xs:element name="IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow"/>
  <xs:element name="ShortTermDepositsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
  <xs:element name="ConvertibleBondsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ConvertibleBondsPolicyTextBlock"/>
  <xs:element name="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
  <xs:element name="ScheduleOfAdjustedNetIncomeLossTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems"/>
  <xs:element name="GovernmentAuthorities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_GovernmentAuthorities"/>
  <xs:element name="OperatingLeaseRightofuseAssetsAndLiabilitiesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
  <xs:element name="ShareholdersEquityScheduleofStockOptionActivityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable"/>
  <xs:element name="ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems"/>
  <xs:element name="ShareholdersEquityScheduleofRSUsActivityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable"/>
  <xs:element name="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems"/>
  <xs:element name="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable"/>
  <xs:element name="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems"/>
  <xs:element name="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable"/>
  <xs:element name="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems"/>
  <xs:element name="RevaluationOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_RevaluationOfWarrants"/>
  <xs:element name="GeneralDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_GeneralDetailsTable"/>
  <xs:element name="TransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_TransactionCosts"/>
  <xs:element name="SecuritiesSoldPerUnits" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="arbe_SecuritiesSoldPerUnits"/>
  <xs:element name="PreFundedWarrantInLieuOfOrdinaryShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PreFundedWarrantInLieuOfOrdinaryShare"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="SeverancePercentageOfMonthlySalary" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_SeverancePercentageOfMonthlySalary"/>
  <xs:element name="RoyaltyPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_RoyaltyPercentage"/>
  <xs:element name="GrantsReceived" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_GrantsReceived"/>
  <xs:element name="WarrantsLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_WarrantsLiabilitiesDetailsTable"/>
  <xs:element name="WarrantsLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_WarrantsLiabilitiesDetailsLineItems"/>
  <xs:element name="DerivativeWarrantLiabilityShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DerivativeWarrantLiabilityShares"/>
  <xs:element name="ConvertibleBondsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ConvertibleBondsDetailsTable"/>
  <xs:element name="BidPricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_BidPricePerShare"/>
  <xs:element name="AggregateCommissionReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="arbe_AggregateCommissionReceived"/>
  <xs:element name="TradingPricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="arbe_TradingPricePerShare"/>
  <xs:element name="NumberOfConsecutiveTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_NumberOfConsecutiveTradingDays"/>
  <xs:element name="NumberOfTradingVolumeSharesPerDay" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_NumberOfTradingVolumeSharesPerDay"/>
  <xs:element name="ShareholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_ShareholdersEquityDetailsTable"/>
  <xs:element name="UnderwrittenPublicOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_UnderwrittenPublicOffering"/>
  <xs:element name="SaleOfPreFundedWarrantShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="arbe_SaleOfPreFundedWarrantShares"/>
  <xs:element name="WarrantToPurchaseOfOrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="arbe_WarrantToPurchaseOfOrdinaryShares"/>
  <xs:element name="PercentageOfOrdinarySharesOutstanding" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="arbe_PercentageOfOrdinarySharesOutstanding"/>
  <xs:element name="TaxesonIncomeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_TaxesonIncomeDetailsTable"/>
  <xs:element name="SegmentInformationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SegmentInformationDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="arbe_SubsequentEventsDetailsTable"/>
  <xs:element name="ConvertibleBondsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ConvertibleBondsMember"/>
  <xs:element name="Customer1Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer1Member"/>
  <xs:element name="Customer2Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer2Member"/>
  <xs:element name="Customer3Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer3Member"/>
  <xs:element name="Customer4Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_Customer4Member"/>
  <xs:element name="DirectPublicOfferingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DirectPublicOfferingMember"/>
  <xs:element name="ITACMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_ITACMember"/>
  <xs:element name="NasdaqMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_NasdaqMember"/>
  <xs:element name="OrdinarySharesParValueNIS0000216PerShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
  <xs:element name="OtherGeographicalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_OtherGeographicalMember"/>
  <xs:element name="PIPEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PIPEMember"/>
  <xs:element name="PreFundedWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PreFundedWarrantMember"/>
  <xs:element name="PrivateWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PrivateWarrantsMember"/>
  <xs:element name="PublicWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_PublicWarrantsMember"/>
  <xs:element name="TheTrusteeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TheTrusteeMember"/>
  <xs:element name="TrancheAWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TrancheAWarrantsMember"/>
  <xs:element name="TrancheBWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TrancheBWarrantsMember"/>
  <xs:element name="TwoThousandSixteenIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TwoThousandSixteenIncentivePlanMember"/>
  <xs:element name="TwoThousandTwentyOneEquityIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
  <xs:element name="TwoThousandTwentyOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_TwoThousandTwentyOneMember"/>
  <xs:element name="WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_WarrantsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="arbe_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>arbe-20241231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 28 18:58:39 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedBalanceSheet" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedIncomeStatement" roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedCashFlow" roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable" roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofPropertyandEquipmentTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable" roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable" roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBonds"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="arbe_ConvertibleBonds" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfRevenue" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfConvertibleLoan" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="arbe_RevaluationOfConvertibleLoan" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="arbe_IssuanceCostsRelatedToConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_IssuanceCostsRelatedToConvertibleBonds"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="arbe_IssuanceCostsRelatedToConvertibleBonds" order="7" weight="1"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUb4go9VfBQD5Y7eBMcK7Hjxo+qJGH9V7C79vIfu+QZ4vbgUilPQJBxah1LJB9I5F32xF2kD18NTd7R+hFy80oo6GKOF4xVC7lqFetvxJsjxnLtzhmOcaZXkZ4mMypqUK4r4HmWLxKAfdfyeWOZvMs/nIe/4OF/RqU63lgg/wR2cqQ2hUTEqzht] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="arbe_PaymentForChangeInBankDeposits" xlink:href="arbe-20241231.xsd#arbe_PaymentForChangeInBankDeposits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="arbe_PaymentForChangeInBankDeposits" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="arbe_GovernmentAuthorities" xlink:href="arbe-20241231.xsd#arbe_GovernmentAuthorities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="arbe_GovernmentAuthorities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_DepositAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_GrantsReceivableCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>arbe-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 28 18:58:39 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedBalanceSheet" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedIncomeStatement" roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquityType2or3" roleURI="http://www.arberobotics.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedCashFlow" roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_General" roleURI="http://www.arberobotics.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SignificantAccountingPolicies" roleURI="http://www.arberobotics.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_Revenue" roleURI="http://www.arberobotics.com/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PrepaidExpensesandOtherReceivables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PropertyandEquipment" roleURI="http://www.arberobotics.com/role/PropertyandEquipment"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_Leases" roleURI="http://www.arberobotics.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_CommitmentsandContingentLiabilities" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_WarrantsLiabilities" roleURI="http://www.arberobotics.com/role/WarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConvertibleBonds" roleURI="http://www.arberobotics.com/role/ConvertibleBonds"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquity" roleURI="http://www.arberobotics.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholders" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_TaxesonIncome" roleURI="http://www.arberobotics.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SegmentInformation" roleURI="http://www.arberobotics.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SubsequentEvents" roleURI="http://www.arberobotics.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_AccountingPoliciesByPolicy" roleURI="http://www.arberobotics.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SignificantAccountingPoliciesTables" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_RevenueTables" roleURI="http://www.arberobotics.com/role/RevenueTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PrepaidExpensesandOtherReceivablesTables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PropertyandEquipmentTables" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_LeasesTables" roleURI="http://www.arberobotics.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquityTables" roleURI="http://www.arberobotics.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholdersTables" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_TaxesonIncomeTables" roleURI="http://www.arberobotics.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofRevenueDisaggregatedbyGeographyTable" roleURI="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable" roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofPropertyandEquipmentTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofLeaseCostTable" roleURI="http://www.arberobotics.com/role/ScheduleofLeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable" roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofStockOptionActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofRSUsActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofCompensationtoEmployeesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofShareBasedCompensationExpenseTable" roleURI="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" roleURI="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofAdjustedNetlossTable" roleURI="http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" roleURI="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable" roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_GeneralDetails" roleURI="http://www.arberobotics.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SignificantAccountingPoliciesDetails" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_RevenueDetails" roleURI="http://www.arberobotics.com/role/RevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PropertyandEquipmentDetails" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_CommitmentsandContingentLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_WarrantsLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConvertibleBondsDetails" roleURI="http://www.arberobotics.com/role/ConvertibleBondsDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquityDetails" roleURI="http://www.arberobotics.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_TaxesonIncomeDetails" roleURI="http://www.arberobotics.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SegmentInformationDetails" roleURI="http://www.arberobotics.com/role/SegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SubsequentEventsDetails" roleURI="http://www.arberobotics.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#DocumentAndEntityInformation" roleURI="http://www.arberobotics.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_ShortTermInvestments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBonds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="arbe_ConvertibleBonds" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockValue" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="24" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpenses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_Depreciation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfConvertibleLoan" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="arbe_RevaluationOfConvertibleLoan" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_IssuanceCostsRelatedToConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_IssuanceCostsRelatedToConvertibleBonds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="arbe_IssuanceCostsRelatedToConvertibleBonds" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PaymentForChangeInBankDeposits" xlink:href="arbe-20241231.xsd#arbe_PaymentForChangeInBankDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="arbe_PaymentForChangeInBankDeposits" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" xlink:href="arbe-20241231.xsd#arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_InterestPaidNet" order="29" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/General" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/Revenue" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/PropertyandEquipment" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/WarrantsLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ConvertibleBonds" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquity" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/TaxesonIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SegmentInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:href="arbe-20241231.xsd#arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsPolicyTextBlock" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="arbe_ConvertibleBondsPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="arbe-20241231.xsd#arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/RevenueTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquityTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/TaxesonIncomeTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:to="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OtherGeographicalMember" xlink:href="arbe-20241231.xsd#arbe_OtherGeographicalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="arbe_OtherGeographicalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CN" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_HK"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_HK" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_SE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_SE" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_DE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_DE" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IT" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IT"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IT" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CH" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="arbe_GovernmentAuthorities" xlink:href="arbe-20241231.xsd#arbe_GovernmentAuthorities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="arbe_GovernmentAuthorities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_DepositAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_GrantsReceivableCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofLeaseCostTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfLeaseCostAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfLeaseCostAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:href="arbe-20241231.xsd#arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUb4go9VfBQD5Y7eBMcK7Hjxo+qJGH9V7C79vIfu+QZ4vbgUilPQJBxah1LJB9I5F32xF2kD18NTd7R+hFy80oo6GKOF4xVC7lqFetvxJsjxnLtzhmOcaZXkZ4mMypqUK4r4HmWLxKAfdfyeWOZvMs/nIe/4OF/RqWCWQz6G9JiJAoZbbbYBRH9] CSR-->
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfWarrants" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="arbe_RevaluationOfWarrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockOptionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/GeneralDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PublicUtilitiesGeneralDisclosuresLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_GeneralDetailsTable" xlink:href="arbe-20241231.xsd#arbe_GeneralDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="arbe_GeneralDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_GeneralDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ITACMember" xlink:href="arbe-20241231.xsd#arbe_ITACMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="arbe_ITACMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PublicWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_PublicWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_PublicWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PrivateWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_PrivateWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_PrivateWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PIPEMember" xlink:href="arbe-20241231.xsd#arbe_PIPEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_PIPEMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PreFundedWarrantMember" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="arbe_PreFundedWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TrancheAWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheAWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="arbe_TrancheAWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TrancheBWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheBWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="arbe_TrancheBWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="arbe_ConvertibleBondsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TransactionCosts" xlink:href="arbe-20241231.xsd#arbe_TransactionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="arbe_TransactionCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralPartnersOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralPartnersOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_GeneralPartnersOfferingCosts" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_OtherExpenses" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SecuritiesSoldPerUnits" xlink:href="arbe-20241231.xsd#arbe_SecuritiesSoldPerUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="arbe_SecuritiesSoldPerUnits" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PreFundedWarrantInLieuOfOrdinaryShare" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantInLieuOfOrdinaryShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="arbe_PreFundedWarrantInLieuOfOrdinaryShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="arbe_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SeverancePercentageOfMonthlySalary" xlink:href="arbe-20241231.xsd#arbe_SeverancePercentageOfMonthlySalary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="arbe_SeverancePercentageOfMonthlySalary" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_SeveranceCosts1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherIncome" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/RevenueDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_GrantsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_RoyaltyPercentage" xlink:href="arbe-20241231.xsd#arbe_RoyaltyPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="arbe_RoyaltyPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_GrantsReceived" xlink:href="arbe-20241231.xsd#arbe_GrantsReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="arbe_GrantsReceived" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_WarrantsLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_WarrantsLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="arbe_WarrantsLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_WarrantsLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_WarrantsLiabilitiesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCollateralAggregateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_DerivativeWarrantLiabilityShares" xlink:href="arbe-20241231.xsd#arbe_DerivativeWarrantLiabilityShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="arbe_DerivativeWarrantLiabilityShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ConvertibleBondsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="arbe_ConvertibleBondsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ConvertibleBondsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ConvertibleBondsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ConvertibleBondsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TheTrusteeMember" xlink:href="arbe-20241231.xsd#arbe_TheTrusteeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="arbe_TheTrusteeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_NasdaqMember" xlink:href="arbe-20241231.xsd#arbe_NasdaqMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="arbe_NasdaqMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="arbe_ConvertibleBondsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_BidPricePerShare" xlink:href="arbe-20241231.xsd#arbe_BidPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="arbe_BidPricePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_AggregateCommissionReceived" xlink:href="arbe-20241231.xsd#arbe_AggregateCommissionReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="arbe_AggregateCommissionReceived" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TradingPricePerShare" xlink:href="arbe-20241231.xsd#arbe_TradingPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="arbe_TradingPricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_NumberOfConsecutiveTradingDays" xlink:href="arbe-20241231.xsd#arbe_NumberOfConsecutiveTradingDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="arbe_NumberOfConsecutiveTradingDays" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_NumberOfTradingVolumeSharesPerDay" xlink:href="arbe-20241231.xsd#arbe_NumberOfTradingVolumeSharesPerDay"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="arbe_NumberOfTradingVolumeSharesPerDay" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="arbe_ShareholdersEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_DirectPublicOfferingMember" xlink:href="arbe-20241231.xsd#arbe_DirectPublicOfferingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="arbe_DirectPublicOfferingMember" order="1" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PreFundedWarrantMember" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="arbe_PreFundedWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TrancheAWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheAWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="arbe_TrancheAWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TrancheBWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheBWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="arbe_TrancheBWarrantsMember" order="2" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandTwentyOneMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandTwentyOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="arbe_TwoThousandTwentyOneMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonUnitIssuanceValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonUnitIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_UnderwrittenPublicOffering" xlink:href="arbe-20241231.xsd#arbe_UnderwrittenPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="arbe_UnderwrittenPublicOffering" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_SaleOfPreFundedWarrantShares" xlink:href="arbe-20241231.xsd#arbe_SaleOfPreFundedWarrantShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="arbe_SaleOfPreFundedWarrantShares" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantToPurchaseOfOrdinaryShares" xlink:href="arbe-20241231.xsd#arbe_WarrantToPurchaseOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="arbe_WarrantToPurchaseOfOrdinaryShares" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_PercentageOfOrdinarySharesOutstanding" xlink:href="arbe-20241231.xsd#arbe_PercentageOfOrdinarySharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="arbe_PercentageOfOrdinarySharesOutstanding" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="19" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/TaxesonIncomeDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_TaxesonIncomeDetailsTable" xlink:href="arbe-20241231.xsd#arbe_TaxesonIncomeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="arbe_TaxesonIncomeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SegmentInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SegmentInformationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="arbe_SegmentInformationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="srt_MajorCustomersAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain_0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer1Member" xlink:href="arbe-20241231.xsd#arbe_Customer1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer2Member" xlink:href="arbe-20241231.xsd#arbe_Customer2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer3Member" xlink:href="arbe-20241231.xsd#arbe_Customer3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer4Member" xlink:href="arbe-20241231.xsd#arbe_Customer4Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="arbe_Customer4Member" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:label="arbe_SubsequentEventsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="arbe_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="arbe_SubsequentEventsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="arbe_ConvertibleBondsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.arberobotics.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20241231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_OrdinarySharesParValueNIS0000216PerShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsMember" xlink:href="arbe-20241231.xsd#arbe_WarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="arbe_WarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorOpinionTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="37" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>arbe-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 28 18:58:39 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Decrease in cash, cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">General [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">Prepaid Expenses and Other Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOperatingAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeasesOperatingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Maturities of Lease Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingent Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Warrants Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl" xml:lang="en-US">Convertible Bonds [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Shareholders&#8217; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl" xml:lang="en-US">Schedule of Stock Option Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding share options, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value, ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, Numbers of RSUs, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl0" xml:lang="en-US">Outstanding, Numbers of RSUs, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract_lbl" xml:lang="en-US">Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract_lbl" xml:lang="en-US">Schedule of Ordinary Shares That Were Excluded From the Computation of Diluted Net Loss Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:to="arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Taxes on Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Company&#8217;s Loss Before Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Loss before income taxes, as reported in the consolidated statements of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract_lbl" xml:lang="en-US">Schedule of Reconciliation Income Tax Benefit [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Reported income taxes benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax assets, net of valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract_lbl" xml:lang="en-US">Segment Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_SegmentReportingInformationRevenueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xml:lang="en-US">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short term bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade receivable, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other assets - funds held in escrow</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract" xlink:to="arbe_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Current maturities of operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and payroll accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBonds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ConvertibleBonds_lbl" xml:lang="en-US">Convertible bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBonds" xlink:to="arbe_ConvertibleBonds_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">LONG-TERM LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Long-term operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">8SHAREHOLDERS&#8217; EQUITY:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary Shares, NIS 0.000216 par value per share; 165,000,000 authorized shares as of December 31, 2024 and 130,000,000 as of December 31, 2023; 85,749,331 and 77,925,095 outstanding shares at December 31, 2024 and 2023, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Ordinary shares, par value (in New Shekels per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary Shares, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Authorized ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary Shares, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Costs of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Financial income, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per ordinary share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Loss per share attributable to ordinary shareholders, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average number of ordinary shares used in computing basic net loss per ordinary share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per ordinary share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Loss per share attributable to ordinary shareholders, diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock-based compensation to service providers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options and vested RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options and vested RSUs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Exercised, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares and warrants, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares and warrants, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Ordinary share issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Total stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock-based compensation to service providers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Revaluation of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfConvertibleLoan" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RevaluationOfConvertibleLoan_lbl" xml:lang="en-US">Revaluation of convertible bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfConvertibleLoan" xlink:to="arbe_RevaluationOfConvertibleLoan_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_IssuanceCostsRelatedToConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_IssuanceCostsRelatedToConvertibleBonds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_IssuanceCostsRelatedToConvertibleBonds_lbl" xml:lang="en-US">Issuance costs related to convertible bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_IssuanceCostsRelatedToConvertibleBonds" xlink:to="arbe_IssuanceCostsRelatedToConvertibleBonds_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease ROU assets and liabilities, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Employees and payroll accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract0" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract0" xlink:to="arbe_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract1" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract1" xlink:to="arbe_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of ordinary shares and warrants, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Net of issuance costs (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance costs related to convertible bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract2" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract2" xlink:to="arbe_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental non-cash disclosure:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" xlink:href="arbe-20241231.xsd#arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow_lbl" xml:lang="en-US">Issuance of convertible bonds with proceeds placed in escrow</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" xlink:to="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Lease liabilities arising from obtaining right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flows activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Trade receivable, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PaymentForChangeInBankDeposits" xlink:href="arbe-20241231.xsd#arbe_PaymentForChangeInBankDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="arbe_PaymentForChangeInBankDeposits_lbl" xml:lang="en-US">Change in bank deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PaymentForChangeInBankDeposits" xlink:to="arbe_PaymentForChangeInBankDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Repayment of short-term loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate fluctuations on cash and cash equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20241231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl" xml:lang="en-US">Ordinary shares, par value NIS 0.000216 per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:to="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsMember" xlink:href="arbe-20241231.xsd#arbe_WarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_WarrantsMember_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsMember" xlink:to="arbe_WarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">GENERAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="arbe-20241231.xsd#arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl" xml:lang="en-US">Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">REVENUE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue Disaggregated by Geography</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RevenueByGeographyAbstract" xlink:href="arbe-20241231.xsd#arbe_RevenueByGeographyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RevenueByGeographyAbstract_lbl" xml:lang="en-US">Revenue by geography:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevenueByGeographyAbstract" xlink:to="arbe_RevenueByGeographyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">% of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">PREPAID EXPENSES AND OTHER RECEIVABLES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GovernmentAuthorities" xlink:href="arbe-20241231.xsd#arbe_GovernmentAuthorities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_GovernmentAuthorities_lbl" xml:lang="en-US">Government authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GovernmentAuthorities" xlink:to="arbe_GovernmentAuthorities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositAssets_lbl" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivableCurrent_lbl" xml:lang="en-US">Grants receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl" xml:lang="en-US">Cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Supplemental Cash Flow Information Related to Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:href="arbe-20241231.xsd#arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028 and after</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">WARRANTS LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">CONVERTIBLE BONDS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OptionsAbstract" xlink:href="arbe-20241231.xsd#arbe_OptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OptionsAbstract_lbl" xml:lang="en-US">Options:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OptionsAbstract" xlink:to="arbe_OptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life (years), ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable, Weighted-average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Exercisable, Weighted average remaining contractual life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Exercisable, Aggregate intrinsic value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Options available for future grants, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of RSUs Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Granted, Numbers of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract3" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract3" xlink:to="arbe_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract4" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract4" xlink:to="arbe_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnlabeledAbstract5" xlink:href="arbe-20241231.xsd#arbe_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract5" xlink:to="arbe_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Compensation to Employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term, in years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_BasicAbstract" xlink:href="arbe-20241231.xsd#arbe_BasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_BasicAbstract_lbl" xml:lang="en-US">Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BasicAbstract" xlink:to="arbe_BasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Adjusted Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock_lbl" xml:lang="en-US">Schedule of Adjusted Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock" xlink:to="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RevaluationOfWarrants" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RevaluationOfWarrants_lbl" xml:lang="en-US">Revaluation of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfWarrants" xlink:to="arbe_RevaluationOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Anti-dilutive shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Company&#8217;s Loss Before Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation Income Tax Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Effect of Non-deductible expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Remeasurement of deferred taxes from currency exchange</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Employees and payroll accrual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash payments and expenses related to operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Forfeited, Outstanding share options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Forfeited, Numbers of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Vested, Numbers of RSUs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers and peripheral equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office furniture and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvement	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold improvement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CN_lbl" xml:lang="en-US">China (excluding Hong Kong) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_HK"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_HK_lbl" xml:lang="en-US">Hong Kong [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl"/>
    <loc xlink:type="locator" xlink:label="country_SE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_SE_lbl" xml:lang="en-US">Sweden [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SE" xlink:to="country_SE_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">USA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_US_lbl0" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <loc xlink:type="locator" xlink:label="country_DE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_DE_lbl" xml:lang="en-US">Germany [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IT" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IT"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IT_lbl" xml:lang="en-US">Italy [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IT" xlink:to="country_IT_lbl"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_CH_lbl" xml:lang="en-US">Switzerland [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_OtherGeographicalMember" xlink:href="arbe-20241231.xsd#arbe_OtherGeographicalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_OtherGeographicalMember_lbl" xml:lang="en-US">Other [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OtherGeographicalMember" xlink:to="arbe_OtherGeographicalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockOptionMember_lbl0" xml:lang="en-US">Outstanding share options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">RSUs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Sales and marketing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and administrative [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of revenues [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Warrants to purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Total gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Net proceeds received offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_TransactionCosts" xlink:href="arbe-20241231.xsd#arbe_TransactionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TransactionCosts_lbl" xml:lang="en-US">Transaction costs (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TransactionCosts" xlink:to="arbe_TransactionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Ordinary shares par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralPartnersOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralPartnersOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralPartnersOfferingCosts_lbl" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralPartnersOfferingCosts" xlink:to="us-gaap_GeneralPartnersOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xml:lang="en-US">Principal amount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other offering expenses payable (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SecuritiesSoldPerUnits" xlink:href="arbe-20241231.xsd#arbe_SecuritiesSoldPerUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SecuritiesSoldPerUnits_lbl" xml:lang="en-US">Securities sold per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SecuritiesSoldPerUnits" xlink:to="arbe_SecuritiesSoldPerUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PreFundedWarrantInLieuOfOrdinaryShare" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantInLieuOfOrdinaryShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PreFundedWarrantInLieuOfOrdinaryShare_lbl" xml:lang="en-US">Lieu amount of ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PreFundedWarrantInLieuOfOrdinaryShare" xlink:to="arbe_PreFundedWarrantInLieuOfOrdinaryShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Purchase price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Gross proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl" xml:lang="en-US">Bank deposit bearing annual interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl" xml:lang="en-US">Allowance for credit losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SeverancePercentageOfMonthlySalary" xlink:href="arbe-20241231.xsd#arbe_SeverancePercentageOfMonthlySalary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SeverancePercentageOfMonthlySalary_lbl" xml:lang="en-US">Deposits rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeverancePercentageOfMonthlySalary" xlink:to="arbe_SeverancePercentageOfMonthlySalary_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeveranceCosts1_lbl" xml:lang="en-US">Severance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Tax percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Financial income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Remaining performance obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Grants value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_RoyaltyPercentage" xlink:href="arbe-20241231.xsd#arbe_RoyaltyPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_RoyaltyPercentage_lbl" xml:lang="en-US">Royalty percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RoyaltyPercentage" xlink:to="arbe_RoyaltyPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GrantsReceived" xlink:href="arbe-20241231.xsd#arbe_GrantsReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_GrantsReceived_lbl" xml:lang="en-US">Maximum aggregate royalties paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GrantsReceived" xlink:to="arbe_GrantsReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCollateralAggregateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue_lbl" xml:lang="en-US">Aggregate exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalCollateralAggregateFairValue" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_DerivativeWarrantLiabilityShares" xlink:href="arbe-20241231.xsd#arbe_DerivativeWarrantLiabilityShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_DerivativeWarrantLiabilityShares_lbl" xml:lang="en-US">Derivative warrant liability shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DerivativeWarrantLiabilityShares" xlink:to="arbe_DerivativeWarrantLiabilityShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Volatility impact rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xml:lang="en-US">Convertible bonds principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_BidPricePerShare" xlink:href="arbe-20241231.xsd#arbe_BidPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_BidPricePerShare_lbl" xml:lang="en-US">Bid price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BidPricePerShare" xlink:to="arbe_BidPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_AggregateCommissionReceived" xlink:href="arbe-20241231.xsd#arbe_AggregateCommissionReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_AggregateCommissionReceived_lbl" xml:lang="en-US">Commission received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_AggregateCommissionReceived" xlink:to="arbe_AggregateCommissionReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TradingPricePerShare" xlink:href="arbe-20241231.xsd#arbe_TradingPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TradingPricePerShare_lbl" xml:lang="en-US">Average closing trading price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TradingPricePerShare" xlink:to="arbe_TradingPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_NumberOfConsecutiveTradingDays" xlink:href="arbe-20241231.xsd#arbe_NumberOfConsecutiveTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_NumberOfConsecutiveTradingDays_lbl" xml:lang="en-US">Number of consecutive trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumberOfConsecutiveTradingDays" xlink:to="arbe_NumberOfConsecutiveTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_NumberOfTradingVolumeSharesPerDay" xlink:href="arbe-20241231.xsd#arbe_NumberOfTradingVolumeSharesPerDay"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_NumberOfTradingVolumeSharesPerDay_lbl" xml:lang="en-US">Number of trading volume shares per day</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumberOfTradingVolumeSharesPerDay" xlink:to="arbe_NumberOfTradingVolumeSharesPerDay_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Converted and funds were released from escrow</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl0" xml:lang="en-US">Convertible bonds in the principal amoun (in New Shekels)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonUnitIssuanceValue_lbl" xml:lang="en-US">Ordinary shares issue value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssuanceValue" xlink:to="us-gaap_CommonUnitIssuanceValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonUnitIssued_lbl" xml:lang="en-US">Ordinary shares issue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Purchase price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_UnderwrittenPublicOffering" xlink:href="arbe-20241231.xsd#arbe_UnderwrittenPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_UnderwrittenPublicOffering_lbl" xml:lang="en-US">Underwritten public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnderwrittenPublicOffering" xlink:to="arbe_UnderwrittenPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SaleOfPreFundedWarrantShares" xlink:href="arbe-20241231.xsd#arbe_SaleOfPreFundedWarrantShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_SaleOfPreFundedWarrantShares_lbl" xml:lang="en-US">Pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SaleOfPreFundedWarrantShares" xlink:to="arbe_SaleOfPreFundedWarrantShares_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantToPurchaseOfOrdinaryShares" xlink:href="arbe-20241231.xsd#arbe_WarrantToPurchaseOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_WarrantToPurchaseOfOrdinaryShares_lbl" xml:lang="en-US">Warrant to purchase of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantToPurchaseOfOrdinaryShares" xlink:to="arbe_WarrantToPurchaseOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl" xml:lang="en-US">Offering expenses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares were reserved for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Plan expiration period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Options vested period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PercentageOfOrdinarySharesOutstanding" xlink:href="arbe-20241231.xsd#arbe_PercentageOfOrdinarySharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PercentageOfOrdinarySharesOutstanding_lbl" xml:lang="en-US">Percentage of ordinary shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PercentageOfOrdinarySharesOutstanding" xlink:to="arbe_PercentageOfOrdinarySharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xml:lang="en-US">Vesting period, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign holding percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Operating segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Reportable segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Percentage of revenue of customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Converted into odinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUb4go9VfBQD5Y7eBMcK7Hjxo+qJGH9V7C79vIfu+QZ4vbgUilPQJBxah1LJB9I5F32xF2kD18NTd7R+hFy80oo6GKOF4xVC7lqFetvxJsjxnLtzhmOcaZXkZ4mMypqUK4r4HmWLxKAfdfyeWOZvMs/nIe/4OF/RqXqaKqlIbS7FutVU+8tirCG] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Consolidated financial statements in U.S. dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of credit risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:href="arbe-20241231.xsd#arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Short term deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair value of financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl" xml:lang="en-US">Trade receivables, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xml:lang="en-US">Accrued post-employment benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net loss per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Other Comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and development expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl" xml:lang="en-US">Contingent Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsPolicyTextBlock" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ConvertibleBondsPolicyTextBlock_lbl" xml:lang="en-US">Convertible bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBondsPolicyTextBlock" xlink:to="arbe_ConvertibleBondsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Impact of recently issued accounting standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">Recently not yet adopted accounting pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ITACMember" xlink:href="arbe-20241231.xsd#arbe_ITACMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ITACMember_lbl" xml:lang="en-US">ITAC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ITACMember" xlink:to="arbe_ITACMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PublicWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_PublicWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PublicWarrantsMember" xlink:to="arbe_PublicWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PrivateWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_PrivateWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PrivateWarrantsMember_lbl" xml:lang="en-US">Private Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PrivateWarrantsMember" xlink:to="arbe_PrivateWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PIPEMember" xlink:href="arbe-20241231.xsd#arbe_PIPEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PIPEMember_lbl" xml:lang="en-US">PIPE [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PIPEMember" xlink:to="arbe_PIPEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_ConvertibleBondsMember_lbl" xml:lang="en-US">Convertible Bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBondsMember" xlink:to="arbe_ConvertibleBondsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_PreFundedWarrantMember" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_PreFundedWarrantMember_lbl" xml:lang="en-US">Pre-Funded Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PreFundedWarrantMember" xlink:to="arbe_PreFundedWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TrancheAWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheAWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TrancheAWarrantsMember_lbl" xml:lang="en-US">Tranche A Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TrancheAWarrantsMember" xlink:to="arbe_TrancheAWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TrancheBWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheBWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TrancheBWarrantsMember_lbl" xml:lang="en-US">Tranche B Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TrancheBWarrantsMember" xlink:to="arbe_TrancheBWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TheTrusteeMember" xlink:href="arbe-20241231.xsd#arbe_TheTrusteeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TheTrusteeMember_lbl" xml:lang="en-US">The Trustee [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TheTrusteeMember" xlink:to="arbe_TheTrusteeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_NasdaqMember" xlink:href="arbe-20241231.xsd#arbe_NasdaqMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_NasdaqMember_lbl" xml:lang="en-US">Nasdaq [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NasdaqMember" xlink:to="arbe_NasdaqMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_DirectPublicOfferingMember" xlink:href="arbe-20241231.xsd#arbe_DirectPublicOfferingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_DirectPublicOfferingMember_lbl" xml:lang="en-US">Direct Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DirectPublicOfferingMember" xlink:to="arbe_DirectPublicOfferingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember_lbl" xml:lang="en-US">2016 Share Incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandSixteenIncentivePlanMember" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember_lbl0" xml:lang="en-US">Two Thousand Sixteen Incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandSixteenIncentivePlanMember" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xml:lang="en-US">2021 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TwoThousandTwentyOneMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandTwentyOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_TwoThousandTwentyOneMember_lbl" xml:lang="en-US">2021 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandTwentyOneMember" xlink:to="arbe_TwoThousandTwentyOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer1Member" xlink:href="arbe-20241231.xsd#arbe_Customer1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer1Member_lbl" xml:lang="en-US">Customer One [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer1Member" xlink:to="arbe_Customer1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer2Member" xlink:href="arbe-20241231.xsd#arbe_Customer2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer2Member_lbl" xml:lang="en-US">Customer Two [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer2Member" xlink:to="arbe_Customer2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer3Member" xlink:href="arbe-20241231.xsd#arbe_Customer3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer3Member_lbl" xml:lang="en-US">Customer Three [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer3Member" xlink:to="arbe_Customer3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_Customer4Member" xlink:href="arbe-20241231.xsd#arbe_Customer4Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="arbe_Customer4Member_lbl" xml:lang="en-US">Customer Four [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer4Member" xlink:to="arbe_Customer4Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:to="arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US">Product and Service [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Schedule of Revenue Disaggregated by Geography [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Schedule of Property and Equipment [LIne Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Stock Option Activity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:to="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Stock Option Activity (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of RSUs Activity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:to="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems_lbl" xml:lang="en-US">Schedule of RSUs Activity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Compensation to Employees (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:to="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems_lbl" xml:lang="en-US">Schedule of Compensation to Employees [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Statement of Income Location, Balance [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity - Schedule of Share Based Compensation Expense (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:to="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems_lbl" xml:lang="en-US">Schedule of Share Based Compensation Expense [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:to="arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_GeneralDetailsTable" xlink:href="arbe-20241231.xsd#arbe_GeneralDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GeneralDetailsTable_lbl" xml:lang="en-US">General (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GeneralDetailsTable" xlink:to="arbe_GeneralDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PublicUtilitiesGeneralDisclosuresLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems_lbl" xml:lang="en-US">General [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesDetailsTable" xlink:to="arbe_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SignificantAccountingPoliciesDetailsLineItems" xlink:to="arbe_SignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_WarrantsLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantsLiabilitiesDetailsTable_lbl" xml:lang="en-US">Warrants Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsLiabilitiesDetailsTable" xlink:to="arbe_WarrantsLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_WarrantsLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantsLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Warrants Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsLiabilitiesDetailsLineItems" xlink:to="arbe_WarrantsLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ConvertibleBondsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ConvertibleBondsDetailsTable_lbl" xml:lang="en-US">Convertible Bonds (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBondsDetailsTable" xlink:to="arbe_ConvertibleBondsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionLineItems_lbl" xml:lang="en-US">Convertible Bonds [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="us-gaap_DebtConversionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title and Position [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ShareholdersEquityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShareholdersEquityDetailsTable_lbl" xml:lang="en-US">Shareholders&#8217; Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShareholdersEquityDetailsTable" xlink:to="arbe_ShareholdersEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Shareholders&#8217; Equity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_TaxesonIncomeDetailsTable" xlink:href="arbe-20241231.xsd#arbe_TaxesonIncomeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TaxesonIncomeDetailsTable_lbl" xml:lang="en-US">Taxes on Income (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TaxesonIncomeDetailsTable" xlink:to="arbe_TaxesonIncomeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Taxes on Income [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xml:lang="en-US">Customer [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SegmentInformationDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SegmentInformationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SegmentInformationDetailsTable_lbl" xml:lang="en-US">Segment Information (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SegmentInformationDetailsTable" xlink:to="arbe_SegmentInformationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_SubsequentEventsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SubsequentEventsDetailsTable" xlink:to="arbe_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Events [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_AggregateCommissionReceived_lbl0" xml:lang="en-US">Represent the amount of aggregate commission received.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_AggregateCommissionReceived" xlink:to="arbe_AggregateCommissionReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_BidPricePerShare_lbl0" xml:lang="en-US">Number of shares are bid price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BidPricePerShare" xlink:to="arbe_BidPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ConvertibleBonds_lbl0" xml:lang="en-US">Convertible bonds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBonds" xlink:to="arbe_ConvertibleBonds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ConvertibleBondsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy convertible bonds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBondsPolicyTextBlock" xlink:to="arbe_ConvertibleBondsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_DerivativeWarrantLiabilityShares_lbl0" xml:lang="en-US">Derivative warrant liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DerivativeWarrantLiabilityShares" xlink:to="arbe_DerivativeWarrantLiabilityShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_GovernmentAuthorities_lbl0" xml:lang="en-US">Government Authorities means any national, provincial, municipal or local government, administrative or regulatory body or department, court, tribunal, arbitrator or any body that exercises the function of a regulator.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GovernmentAuthorities" xlink:to="arbe_GovernmentAuthorities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_GrantsReceived_lbl0" xml:lang="en-US">Grants received for maximum aggregate royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GrantsReceived" xlink:to="arbe_GrantsReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_IssuanceCostsRelatedToConvertibleBonds_lbl0" xml:lang="en-US">Issuance costs related to convertible bonds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_IssuanceCostsRelatedToConvertibleBonds" xlink:to="arbe_IssuanceCostsRelatedToConvertibleBonds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow_lbl0" xml:lang="en-US">Issuance of convertible bonds with proceeds placed in escrow.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" xlink:to="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_NumberOfConsecutiveTradingDays_lbl0" xml:lang="en-US">Number of consecutive trading days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumberOfConsecutiveTradingDays" xlink:to="arbe_NumberOfConsecutiveTradingDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_NumberOfTradingVolumeSharesPerDay_lbl0" xml:lang="en-US">Represent the number of trading volume shares per day.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumberOfTradingVolumeSharesPerDay" xlink:to="arbe_NumberOfTradingVolumeSharesPerDay_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl0" xml:lang="en-US">Operating lease right-of-use assets and liabilities net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_PaymentForChangeInBankDeposits_lbl0" xml:lang="en-US">The amount of payment for change in bank deposits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PaymentForChangeInBankDeposits" xlink:to="arbe_PaymentForChangeInBankDeposits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_PercentageOfOrdinarySharesOutstanding_lbl0" xml:lang="en-US">Percentage of ordinary shares outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PercentageOfOrdinarySharesOutstanding" xlink:to="arbe_PercentageOfOrdinarySharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_PreFundedWarrantInLieuOfOrdinaryShare_lbl0" xml:lang="en-US">Per share amount of pre funded warrant in lieu of ordinary share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PreFundedWarrantInLieuOfOrdinaryShare" xlink:to="arbe_PreFundedWarrantInLieuOfOrdinaryShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the useful lives of property, plant and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_RevaluationOfConvertibleLoan_lbl0" xml:lang="en-US">The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity&apos;s common stock, at the option of the issuer or the holder.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfConvertibleLoan" xlink:to="arbe_RevaluationOfConvertibleLoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_RevaluationOfWarrants_lbl0" xml:lang="en-US">Amount of revaluation of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfWarrants" xlink:to="arbe_RevaluationOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_RoyaltyPercentage_lbl0" xml:lang="en-US">Percentage of sales that royalties are paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RoyaltyPercentage" xlink:to="arbe_RoyaltyPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_SaleOfPreFundedWarrantShares_lbl0" xml:lang="en-US">The number of pre-funded warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SaleOfPreFundedWarrantShares" xlink:to="arbe_SaleOfPreFundedWarrantShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of adjusted net income (Loss).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock" xlink:to="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_SecuritiesSoldPerUnits_lbl0" xml:lang="en-US">Per share amount of securities sold per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SecuritiesSoldPerUnits" xlink:to="arbe_SecuritiesSoldPerUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_SeverancePercentageOfMonthlySalary_lbl0" xml:lang="en-US">Percentage of monthly salary monthly severance rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeverancePercentageOfMonthlySalary" xlink:to="arbe_SeverancePercentageOfMonthlySalary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Policy disclosure of short term deposits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_TradingPricePerShare_lbl0" xml:lang="en-US">Number of trading price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TradingPricePerShare" xlink:to="arbe_TradingPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_TransactionCosts_lbl0" xml:lang="en-US">Represent the amount of transaction costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TransactionCosts" xlink:to="arbe_TransactionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_UnderwrittenPublicOffering_lbl0" xml:lang="en-US">The amount of underwritten public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnderwrittenPublicOffering" xlink:to="arbe_UnderwrittenPublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="arbe_WarrantToPurchaseOfOrdinaryShares_lbl0" xml:lang="en-US">The number of warrants purchase of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantToPurchaseOfOrdinaryShares" xlink:to="arbe_WarrantToPurchaseOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_BasicAbstract_lbl0" xml:lang="en-US">Basic Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BasicAbstract" xlink:to="arbe_BasicAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl0" xml:lang="en-US">Credit Loss, Financial Instrument [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:to="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_HK_lbl0" xml:lang="en-US">HONG KONG</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_HK" xlink:to="country_HK_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PublicWarrantsMember_lbl0" xml:lang="en-US">Public Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PublicWarrantsMember" xlink:to="arbe_PublicWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl0" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfPropertyAndEquipmentAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfPropertyAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfPropertyAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="arbe_ScheduleOfPropertyAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TradingPricePerShare_lbl1" xml:lang="en-US">Trading Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TradingPricePerShare" xlink:to="arbe_TradingPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_DerivativeWarrantLiabilityShares_lbl1" xml:lang="en-US">Derivative Warrant Liability Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DerivativeWarrantLiabilityShares" xlink:to="arbe_DerivativeWarrantLiabilityShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl0" xml:lang="en-US">Contingent Liability Reserve Estimate, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl0" xml:lang="en-US">Accounts Payable, Trade, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssued_lbl0" xml:lang="en-US">Common Unit, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PreFundedWarrantInLieuOfOrdinaryShare_lbl1" xml:lang="en-US">Pre Funded Warrant In Lieu Of Ordinary Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PreFundedWarrantInLieuOfOrdinaryShare" xlink:to="arbe_PreFundedWarrantInLieuOfOrdinaryShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RevaluationOfWarrants_lbl1" xml:lang="en-US">Revaluation Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfWarrants" xlink:to="arbe_RevaluationOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl1" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PreFundedWarrantMember_lbl0" xml:lang="en-US">Pre Funded Warrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PreFundedWarrantMember" xlink:to="arbe_PreFundedWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Short Term Deposits Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="arbe_ShortTermDepositsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositAssets_lbl0" xml:lang="en-US">Deposit Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl1" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl0" xml:lang="en-US">Two Thousand Twenty One Equity Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="arbe_TwoThousandTwentyOneEquityIncentivePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl0" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssuanceValue_lbl0" xml:lang="en-US">Common Unit, Issuance Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssuanceValue" xlink:to="us-gaap_CommonUnitIssuanceValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ConvertibleBondsPolicyTextBlock_lbl1" xml:lang="en-US">Convertible Bonds Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBondsPolicyTextBlock" xlink:to="arbe_ConvertibleBondsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl0" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl1" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TrancheBWarrantsMember_lbl0" xml:lang="en-US">Tranche BWarrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TrancheBWarrantsMember" xlink:to="arbe_TrancheBWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl0" xml:lang="en-US">Demand Deposit Liabilities, Interest-Bearing, Average Rate Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TransactionCosts_lbl1" xml:lang="en-US">Transaction Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TransactionCosts" xlink:to="arbe_TransactionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TheTrusteeMember_lbl0" xml:lang="en-US">The Trustee Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TheTrusteeMember" xlink:to="arbe_TheTrusteeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl0" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_SE_lbl0" xml:lang="en-US">SWEDEN</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SE" xlink:to="country_SE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantToPurchaseOfOrdinaryShares_lbl1" xml:lang="en-US">Warrant To Purchase Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantToPurchaseOfOrdinaryShares" xlink:to="arbe_WarrantToPurchaseOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract3" xlink:to="arbe_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl0" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract2" xlink:to="arbe_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract5" xlink:to="arbe_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract4" xlink:to="arbe_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TwoThousandSixteenIncentivePlanMember_lbl1" xml:lang="en-US">Two Thousand Sixteen Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandSixteenIncentivePlanMember" xlink:to="arbe_TwoThousandSixteenIncentivePlanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract1" xlink:to="arbe_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract0" xlink:to="arbe_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow_lbl1" xml:lang="en-US">Issuance Of Convertible Bonds With Proceeds Placed In Escrow</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" xlink:to="arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GrantsReceived_lbl1" xml:lang="en-US">Grants Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GrantsReceived" xlink:to="arbe_GrantsReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeveranceCosts1_lbl0" xml:lang="en-US">Severance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl0" xml:lang="en-US">Ordinary Shares Par Value NIS0000216 Per Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OrdinarySharesParValueNIS0000216PerShareMember" xlink:to="arbe_OrdinarySharesParValueNIS0000216PerShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl1" xml:lang="en-US">Equity Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl1" xml:lang="en-US">Operating Lease Rightofuse Assets And Liabilities Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:to="arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl0" xml:lang="en-US">Office Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfRsusActivityAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfRsusActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfRsusActivityAbstract_lbl" xml:lang="en-US">Schedule Of Rsus Activity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfRsusActivityAbstract" xlink:to="arbe_ScheduleOfRsusActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl0" xml:lang="en-US">Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PrivateWarrantsMember_lbl0" xml:lang="en-US">Private Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PrivateWarrantsMember" xlink:to="arbe_PrivateWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RevaluationOfConvertibleLoan_lbl1" xml:lang="en-US">Revaluation Of Convertible Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevaluationOfConvertibleLoan" xlink:to="arbe_RevaluationOfConvertibleLoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnlabeledAbstract" xlink:to="arbe_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl0" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl0" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RoyaltyPercentage_lbl1" xml:lang="en-US">Royalty Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RoyaltyPercentage" xlink:to="arbe_RoyaltyPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl0" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl0" xml:lang="en-US">Selling and Marketing Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_NumberOfTradingVolumeSharesPerDay_lbl1" xml:lang="en-US">Number Of Trading Volume Shares Per Day</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumberOfTradingVolumeSharesPerDay" xlink:to="arbe_NumberOfTradingVolumeSharesPerDay_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer4Member_lbl0" xml:lang="en-US">Customer4 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer4Member" xlink:to="arbe_Customer4Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer1Member_lbl0" xml:lang="en-US">Customer1 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer1Member" xlink:to="arbe_Customer1Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl0" xml:lang="en-US">Convertible Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsTextBlock_lbl0" xml:lang="en-US">Other Current Assets [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsTextBlock" xlink:to="us-gaap_OtherCurrentAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PaymentForChangeInBankDeposits_lbl1" xml:lang="en-US">Payment For Change In Bank Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PaymentForChangeInBankDeposits" xlink:to="arbe_PaymentForChangeInBankDeposits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl0" xml:lang="en-US">Prepaid Expense and Other Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl0" xml:lang="en-US">Number of Reportable Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl0" xml:lang="en-US">Repayments of Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer3Member_lbl0" xml:lang="en-US">Customer3 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer3Member" xlink:to="arbe_Customer3Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SecuritiesSoldPerUnits_lbl1" xml:lang="en-US">Securities Sold Per Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SecuritiesSoldPerUnits" xlink:to="arbe_SecuritiesSoldPerUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl0" xml:lang="en-US">Number of Operating Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl0" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashCurrent_lbl0" xml:lang="en-US">Restricted Cash, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TwoThousandTwentyOneMember_lbl0" xml:lang="en-US">Two Thousand Twenty One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TwoThousandTwentyOneMember" xlink:to="arbe_TwoThousandTwentyOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_Customer2Member_lbl0" xml:lang="en-US">Customer2 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_Customer2Member" xlink:to="arbe_Customer2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfLeaseCostAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfLeaseCostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfLeaseCostAbstract_lbl" xml:lang="en-US">Schedule Of Lease Cost Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfLeaseCostAbstract" xlink:to="arbe_ScheduleOfLeaseCostAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ConvertibleBonds_lbl1" xml:lang="en-US">Convertible Bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBonds" xlink:to="arbe_ConvertibleBonds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PercentageOfOrdinarySharesOutstanding_lbl1" xml:lang="en-US">Percentage Of Ordinary Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PercentageOfOrdinarySharesOutstanding" xlink:to="arbe_PercentageOfOrdinarySharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PIPEMember_lbl0" xml:lang="en-US">PIPEMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PIPEMember" xlink:to="arbe_PIPEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl0" xml:lang="en-US">Adjustment of Warrants Granted for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl1" xml:lang="en-US">Property Plant And Equipment Useful Life Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:to="arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl0" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl0" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl0" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl0" xml:lang="en-US">SWITZERLAND</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CN_lbl0" xml:lang="en-US">CHINA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CN" xlink:to="country_CN_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralPartnersOfferingCosts_lbl0" xml:lang="en-US">General Partners&apos; Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralPartnersOfferingCosts" xlink:to="us-gaap_GeneralPartnersOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_AggregateCommissionReceived_lbl1" xml:lang="en-US">Aggregate Commission Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_AggregateCommissionReceived" xlink:to="arbe_AggregateCommissionReceived_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OtherGeographicalMember_lbl0" xml:lang="en-US">Other Geographical Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OtherGeographicalMember" xlink:to="arbe_OtherGeographicalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_DirectPublicOfferingMember_lbl0" xml:lang="en-US">Direct Public Offering Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_DirectPublicOfferingMember" xlink:to="arbe_DirectPublicOfferingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl0" xml:lang="en-US">GERMANY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfShareBasedCompensationExpenseAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfShareBasedCompensationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfShareBasedCompensationExpenseAbstract_lbl" xml:lang="en-US">Schedule Of Share Based Compensation Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfShareBasedCompensationExpenseAbstract" xlink:to="arbe_ScheduleOfShareBasedCompensationExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl" xml:lang="en-US">Schedule Of The Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl0" xml:lang="en-US">Debt Instrument, Issued, Principal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_GovernmentAuthorities_lbl1" xml:lang="en-US">Government Authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_GovernmentAuthorities" xlink:to="arbe_GovernmentAuthorities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl0" xml:lang="en-US">Cost of Sales [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ConvertibleBondsMember_lbl0" xml:lang="en-US">Convertible Bonds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ConvertibleBondsMember" xlink:to="arbe_ConvertibleBondsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl0" xml:lang="en-US">Noninterest Expense Offering Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_RevenueByGeographyAbstract_lbl0" xml:lang="en-US">Revenue By Geography Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_RevenueByGeographyAbstract" xlink:to="arbe_RevenueByGeographyAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Adjusted Net Income Loss Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock" xlink:to="arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl0" xml:lang="en-US">Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_UnderwrittenPublicOffering_lbl1" xml:lang="en-US">Underwritten Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_UnderwrittenPublicOffering" xlink:to="arbe_UnderwrittenPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_NumberOfConsecutiveTradingDays_lbl1" xml:lang="en-US">Number Of Consecutive Trading Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NumberOfConsecutiveTradingDays" xlink:to="arbe_NumberOfConsecutiveTradingDays_lbl1"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract_lbl" xml:lang="en-US">Schedule Of Revenue Disaggregated By Geography Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:to="arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl1" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_TrancheAWarrantsMember_lbl0" xml:lang="en-US">Tranche AWarrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_TrancheAWarrantsMember" xlink:to="arbe_TrancheAWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfCompensationToEmployeesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfCompensationToEmployeesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfCompensationToEmployeesAbstract_lbl" xml:lang="en-US">Schedule Of Compensation To Employees Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfCompensationToEmployeesAbstract" xlink:to="arbe_ScheduleOfCompensationToEmployeesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_NasdaqMember_lbl0" xml:lang="en-US">Nasdaq Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_NasdaqMember" xlink:to="arbe_NasdaqMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl0" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SeverancePercentageOfMonthlySalary_lbl1" xml:lang="en-US">Severance Percentage Of Monthly Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SeverancePercentageOfMonthlySalary" xlink:to="arbe_SeverancePercentageOfMonthlySalary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl0" xml:lang="en-US">Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ITACMember_lbl0" xml:lang="en-US">ITACMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ITACMember" xlink:to="arbe_ITACMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract_lbl" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_EarningsPerShareReconciliationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_ScheduleOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_ScheduleOfDeferredTaxAssetsAbstract" xlink:to="arbe_ScheduleOfDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_WarrantsMember_lbl0" xml:lang="en-US">Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_WarrantsMember" xlink:to="arbe_WarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl0" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue_lbl0" xml:lang="en-US">Additional Collateral, Aggregate Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalCollateralAggregateFairValue" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_OptionsAbstract_lbl0" xml:lang="en-US">Options Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_OptionsAbstract" xlink:to="arbe_OptionsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_BidPricePerShare_lbl1" xml:lang="en-US">Bid Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_BidPricePerShare" xlink:to="arbe_BidPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl0" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_SaleOfPreFundedWarrantShares_lbl1" xml:lang="en-US">Sale Of Pre Funded Warrant Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_SaleOfPreFundedWarrantShares" xlink:to="arbe_SaleOfPreFundedWarrantShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivableCurrent_lbl0" xml:lang="en-US">Grants Receivable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivableCurrent" xlink:to="us-gaap_GrantsReceivableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl0" xml:lang="en-US">Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl0" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IT_lbl0" xml:lang="en-US">ITALY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IT" xlink:to="country_IT_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl0" xml:lang="en-US">Grants Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="arbe_IssuanceCostsRelatedToConvertibleBonds_lbl1" xml:lang="en-US">Issuance Costs Related To Convertible Bonds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="arbe_IssuanceCostsRelatedToConvertibleBonds" xlink:to="arbe_IssuanceCostsRelatedToConvertibleBonds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0" xml:lang="en-US">Property, Plant and Equipment, Salvage Value, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl0" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>arbe-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 28 18:58:39 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedBalanceSheet" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedIncomeStatement" roleURI="http://www.arberobotics.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquityType2or3" roleURI="http://www.arberobotics.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConsolidatedCashFlow" roleURI="http://www.arberobotics.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_General" roleURI="http://www.arberobotics.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SignificantAccountingPolicies" roleURI="http://www.arberobotics.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_Revenue" roleURI="http://www.arberobotics.com/role/Revenue"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PrepaidExpensesandOtherReceivables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PropertyandEquipment" roleURI="http://www.arberobotics.com/role/PropertyandEquipment"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_Leases" roleURI="http://www.arberobotics.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_CommitmentsandContingentLiabilities" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_WarrantsLiabilities" roleURI="http://www.arberobotics.com/role/WarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConvertibleBonds" roleURI="http://www.arberobotics.com/role/ConvertibleBonds"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquity" roleURI="http://www.arberobotics.com/role/ShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholders" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_TaxesonIncome" roleURI="http://www.arberobotics.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SegmentInformation" roleURI="http://www.arberobotics.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SubsequentEvents" roleURI="http://www.arberobotics.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_AccountingPoliciesByPolicy" roleURI="http://www.arberobotics.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SignificantAccountingPoliciesTables" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_RevenueTables" roleURI="http://www.arberobotics.com/role/RevenueTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PrepaidExpensesandOtherReceivablesTables" roleURI="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PropertyandEquipmentTables" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_LeasesTables" roleURI="http://www.arberobotics.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquityTables" roleURI="http://www.arberobotics.com/role/ShareholdersEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_NetLossPerShareAttributibletoOrdinarySharholdersTables" roleURI="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_TaxesonIncomeTables" roleURI="http://www.arberobotics.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofRevenueDisaggregatedbyGeographyTable" roleURI="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofPrepaidExpensesandOtherReceivablesTable" roleURI="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofPropertyandEquipmentTable" roleURI="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofLeaseCostTable" roleURI="http://www.arberobotics.com/role/ScheduleofLeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofMaturitiesofLeaseLiabilitiesTable" roleURI="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofStockOptionActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofRSUsActivityTable" roleURI="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofCompensationtoEmployeesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofShareBasedCompensationExpenseTable" roleURI="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" roleURI="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofAdjustedNetlossTable" roleURI="http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" roleURI="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofCompanysLossBeforeIncomeTaxesTable" roleURI="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofReconciliationIncomeTaxBenefitTable" roleURI="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ScheduleofDeferredTaxAssetsTable" roleURI="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_GeneralDetails" roleURI="http://www.arberobotics.com/role/GeneralDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SignificantAccountingPoliciesDetails" roleURI="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_RevenueDetails" roleURI="http://www.arberobotics.com/role/RevenueDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_PropertyandEquipmentDetails" roleURI="http://www.arberobotics.com/role/PropertyandEquipmentDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_CommitmentsandContingentLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_WarrantsLiabilitiesDetails" roleURI="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ConvertibleBondsDetails" roleURI="http://www.arberobotics.com/role/ConvertibleBondsDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_ShareholdersEquityDetails" roleURI="http://www.arberobotics.com/role/ShareholdersEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_TaxesonIncomeDetails" roleURI="http://www.arberobotics.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SegmentInformationDetails" roleURI="http://www.arberobotics.com/role/SegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="arbe-20241231.xsd#arbe_r_SubsequentEventsDetails" roleURI="http://www.arberobotics.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#ai" roleURI="http://xbrl.sec.gov/dei/role/document/AuditInformation"/>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBonds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="ConvertibleBonds" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfConvertibleLoan" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfConvertibleLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="RevaluationOfConvertibleLoan" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceCostsRelatedToConvertibleBonds" xlink:href="arbe-20241231.xsd#arbe_IssuanceCostsRelatedToConvertibleBonds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IssuanceCostsRelatedToConvertibleBonds" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentForChangeInBankDeposits" xlink:href="arbe-20241231.xsd#arbe_PaymentForChangeInBankDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentForChangeInBankDeposits" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfShortTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" xlink:href="arbe-20241231.xsd#arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/General" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/Revenue" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCurrentAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherCurrentAssetsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/PropertyandEquipment" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/WarrantsLiabilities" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ConvertibleBonds" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquity" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/TaxesonIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SegmentInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermDepositsPolicyPolicyTextBlock" xlink:href="arbe-20241231.xsd#arbe_ShortTermDepositsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ShortTermDepositsPolicyPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditLossFinancialInstrumentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CreditLossFinancialInstrumentPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContingentLiabilityReserveEstimatePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentLiabilityReserveEstimatePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ContingentLiabilityReserveEstimatePolicy" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleBondsPolicyTextBlock" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConvertibleBondsPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:href="arbe-20241231.xsd#arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentUsefulLifeTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/RevenueTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquityTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAdjustedNetIncomeLossTableTextBlock" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="ScheduleOfAdjustedNetIncomeLossTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/TaxesonIncomeTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract" xlink:to="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable" xlink:to="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueDisaggregatedByGeographyAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OtherGeographicalMember" xlink:href="arbe-20241231.xsd#arbe_OtherGeographicalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="OtherGeographicalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_StatementGeographicalAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_CN" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CN"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_CN" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_HK" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_HK"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_HK" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_SE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_SE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_SE" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_DE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_DE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_DE" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_IT" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IT"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IT" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_CH" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_CH"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_CH" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RevenueByGeographyAbstract" xlink:href="arbe-20241231.xsd#arbe_RevenueByGeographyAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="RevenueByGeographyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueByGeographyAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueByGeographyAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="GovernmentAuthorities" xlink:href="arbe-20241231.xsd#arbe_GovernmentAuthorities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="GovernmentAuthorities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_DepositAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_GrantsReceivableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfPropertyAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_OfficeEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_VehiclesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGrossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofLeaseCostTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfLeaseCostAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfLeaseCostAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseRightofuseAssetsAndLiabilitiesNet" xlink:href="arbe-20241231.xsd#arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="OperatingLeaseRightofuseAssetsAndLiabilitiesNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_OperatingLeaseLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="ShareholdersEquityScheduleofStockOptionActivityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_StockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofStockOptionActivityDetailsTable" xlink:to="ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OptionsAbstract" xlink:href="arbe-20241231.xsd#arbe_OptionsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems" xlink:to="OptionsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZEr5dnmkj55Vn3PE+1u+YOtkjz23BDixtN+DSa6ODpxKHuuFDR2EFRAYrDV15EdRUb4go9VfBQD5Y7eBMcK7Hjxo+qJGH9V7C79vIfu+QZ4vbgUilPQJBxah1LJB9I5F32xF2kD18NTd7R+hFy80oo6GKOF4xVC7lqFetvxJsjxnLtzhmOcaZXkZ4mMypqUK4r4HmWLxKAfdfyeWOZvMs/nIe/4OF/RqWfSIQR5RTYQ+kEKKdMS3qF] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofRSUsActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRsusActivityAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfRsusActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRsusActivityAbstract" xlink:to="ShareholdersEquityScheduleofRSUsActivityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsTable" xlink:to="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofRSUsActivityDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompensationToEmployeesAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfCompensationToEmployeesAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompensationToEmployeesAbstract" xlink:to="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable" xlink:to="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedCompensationExpenseAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfShareBasedCompensationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationExpenseAbstract" xlink:to="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_CostOfSalesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable" xlink:to="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfWarrants" xlink:href="arbe-20241231.xsd#arbe_RevaluationOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="RevaluationOfWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_WarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_StockOptionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationIncomeTaxBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxAssetsAbstract" xlink:href="arbe-20241231.xsd#arbe_ScheduleOfDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/GeneralDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralDetailsTable" xlink:href="arbe-20241231.xsd#arbe_GeneralDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PublicUtilitiesGeneralDisclosuresLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="GeneralDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PublicWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_PublicWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PublicWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_PrivateWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PrivateWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PIPEMember" xlink:href="arbe-20241231.xsd#arbe_PIPEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PIPEMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ITACMember" xlink:href="arbe-20241231.xsd#arbe_ITACMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="ITACMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleBondsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantMember" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PreFundedWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrancheAWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheAWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="TrancheAWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrancheBWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheBWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="TrancheBWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralDetailsTable" xlink:to="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionCosts" xlink:href="arbe-20241231.xsd#arbe_TransactionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="TransactionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralPartnersOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralPartnersOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_GeneralPartnersOfferingCosts" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_OtherExpenses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuritiesSoldPerUnits" xlink:href="arbe-20241231.xsd#arbe_SecuritiesSoldPerUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="SecuritiesSoldPerUnits" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantInLieuOfOrdinaryShare" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantInLieuOfOrdinaryShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="PreFundedWarrantInLieuOfOrdinaryShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PublicUtilitiesGeneralDisclosuresLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_SignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="SignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_FinancingReceivableAllowanceForCreditLosses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeverancePercentageOfMonthlySalary" xlink:href="arbe-20241231.xsd#arbe_SeverancePercentageOfMonthlySalary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="SeverancePercentageOfMonthlySalary" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_SeveranceCosts1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsLineItems" xlink:to="us-gaap_OtherIncome" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/RevenueDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrantsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_GrantsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltyPercentage" xlink:href="arbe-20241231.xsd#arbe_RoyaltyPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="RoyaltyPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantsReceived" xlink:href="arbe-20241231.xsd#arbe_GrantsReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="GrantsReceived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/WarrantsLiabilitiesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesDetailsTable" xlink:href="arbe-20241231.xsd#arbe_WarrantsLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesDetailsLineItems" xlink:href="arbe-20241231.xsd#arbe_WarrantsLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="WarrantsLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsTable" xlink:to="WarrantsLiabilitiesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalCollateralAggregateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCollateralAggregateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_AdditionalCollateralAggregateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerivativeWarrantLiabilityShares" xlink:href="arbe-20241231.xsd#arbe_DerivativeWarrantLiabilityShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="DerivativeWarrantLiabilityShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ConvertibleBondsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleBondsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract" xlink:to="ConvertibleBondsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleBondsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleBondsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleBondsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleBondsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TheTrusteeMember" xlink:href="arbe-20241231.xsd#arbe_TheTrusteeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="TheTrusteeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NasdaqMember" xlink:href="arbe-20241231.xsd#arbe_NasdaqMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="NasdaqMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleBondsDetailsTable" xlink:to="us-gaap_DebtConversionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BidPricePerShare" xlink:href="arbe-20241231.xsd#arbe_BidPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="BidPricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateCommissionReceived" xlink:href="arbe-20241231.xsd#arbe_AggregateCommissionReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="AggregateCommissionReceived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradingPricePerShare" xlink:href="arbe-20241231.xsd#arbe_TradingPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="TradingPricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfConsecutiveTradingDays" xlink:href="arbe-20241231.xsd#arbe_NumberOfConsecutiveTradingDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="NumberOfConsecutiveTradingDays" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfTradingVolumeSharesPerDay" xlink:href="arbe-20241231.xsd#arbe_NumberOfTradingVolumeSharesPerDay"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="NumberOfTradingVolumeSharesPerDay" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtConversionLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/ShareholdersEquityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersEquityDetailsTable" xlink:href="arbe-20241231.xsd#arbe_ShareholdersEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareholdersEquityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DirectPublicOfferingMember" xlink:href="arbe-20241231.xsd#arbe_DirectPublicOfferingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="DirectPublicOfferingMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandSixteenIncentivePlanMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="TwoThousandSixteenIncentivePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOneMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandTwentyOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="TwoThousandTwentyOneMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandSixteenIncentivePlanMember_0" xlink:href="arbe-20241231.xsd#arbe_TwoThousandSixteenIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandSixteenIncentivePlanMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOneEquityIncentivePlanMember" xlink:href="arbe-20241231.xsd#arbe_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandTwentyOneEquityIncentivePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantMember" xlink:href="arbe-20241231.xsd#arbe_PreFundedWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PreFundedWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrancheAWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheAWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="TrancheAWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrancheBWarrantsMember" xlink:href="arbe-20241231.xsd#arbe_TrancheBWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="TrancheBWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersEquityDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssuanceValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssuanceValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonUnitIssuanceValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonUnitIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwrittenPublicOffering" xlink:href="arbe-20241231.xsd#arbe_UnderwrittenPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="UnderwrittenPublicOffering" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfPreFundedWarrantShares" xlink:href="arbe-20241231.xsd#arbe_SaleOfPreFundedWarrantShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="SaleOfPreFundedWarrantShares" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantToPurchaseOfOrdinaryShares" xlink:href="arbe-20241231.xsd#arbe_WarrantToPurchaseOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="WarrantToPurchaseOfOrdinaryShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOrdinarySharesOutstanding" xlink:href="arbe-20241231.xsd#arbe_PercentageOfOrdinarySharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PercentageOfOrdinarySharesOutstanding" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/TaxesonIncomeDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsTable" xlink:href="arbe-20241231.xsd#arbe_TaxesonIncomeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="TaxesonIncomeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SegmentInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SegmentInformationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="SegmentInformationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="srt_MajorCustomersAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="Customer1Member" xlink:href="arbe-20241231.xsd#arbe_Customer1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Customer2Member" xlink:href="arbe-20241231.xsd#arbe_Customer2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Customer3Member" xlink:href="arbe-20241231.xsd#arbe_Customer3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Customer4Member" xlink:href="arbe-20241231.xsd#arbe_Customer4Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="Customer4Member" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationDetailsTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.arberobotics.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="arbe-20241231.xsd#arbe_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleBondsMember" xlink:href="arbe-20241231.xsd#arbe_ConvertibleBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleBondsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/Cover" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitiesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_NameChangeEventTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NameChangeEventTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_NameChangeEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="14.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20241231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OrdinarySharesParValueNIS0000216PerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsMember" xlink:href="arbe-20241231.xsd#arbe_WarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/AuditInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesParValueNIS0000216PerShareMember" xlink:href="arbe-20241231.xsd#arbe_OrdinarySharesParValueNIS0000216PerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="OrdinarySharesParValueNIS0000216PerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsMember" xlink:href="arbe-20241231.xsd#arbe_WarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="WarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable_0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable_0" xlink:to="dei_EntityAddressesAddressTypeAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $F G # 2(  A$! Q$!_\0
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MW_T%H/U_PH_X3?PW_P!!:#]?\*/JF(_D?W/_ "#ZS1_G7WHWZ*P/^$W\-_\
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M I:X9.\FS1!1114@%%%% !6))_K7_P!XUMUB2?ZU_P#>-;T=V3(;111720%
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MEM'YD0.UF+'TZGD^N:T*0      = *6N.;4I-I6+6P4445(PHHHH Y3XC?\
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M#;SE "LF I'0KM X[YJ9SC!7D5&+D[(]MHI <@'UI:HD**** "BBB@ HHHH
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MU&?:I4TY<O4KE=N8]9HHHJB0HHHH **** .4^(W_ ")=W_O)_P"A"O$*]O\
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M?\+5T3_GUOO^^%_^*KQ^BO6_L+!]G]YYW]K8GNON/8/^%JZ)_P ^M]_WPO\
M\51_PM71/^?6^_[X7_XJO'Z*/["P?9_>']K8GNON/8/^%JZ)_P ^M]_WPO\
M\51_PM71/^?6^_[X7_XJO'Z*/["P?9_>']K8GNON/8/^%JZ)_P ^M]_WPO\
M\51_PM71/^?6^_[X7_XJO'Z*/["P?9_>']K8GNON/?\ PYXHL_$T5Q)9Q3((
M&"MYH SD9XP36W7G'PC_ ./+5?\ KK'_ "->CU\CF%"%#$RIPV7^2/I,'5E5
MH1G/=A1117"=84444 %%%% !14<T\5NF^:5(T_O.P _6L]O$FB(VUM5M,_\
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M[\<@=JN%><I).%D_Z[$3HPC%M2NSL_A'_P >6J_]=8_Y&O1Z\X^$?_'EJO\
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M4 %%-<X1B.N*X27Q/J36<]MN3>X*K+C#+4N<8M*3M<XL5C:>&MS];_@:6O\
MCFRTB0P0*+B<':?FPJGTSWI+KQF1:J;.T$DY0$B1MJAB.GK7E>K:;?&4,L9D
MC4<%#DY^E;GAB5M5%O9&X,5ZDR*0R]8\C)^O45[.+P=-86%;"R4K/WM;_AV[
MGS]+,,9B*O+!I7_ 9XCUSQI;R_\ $PDGLHFY7R!M3_OH?U-<V^MZK(C(^IW;
M*XPP,S8(_.O7?%5__8L,*RW%Q-'<%EVL$88&,Y!'O7#71T2!S)%IK,;B+<-S
M !<^@[5Z&&SG#PA:=))KLE^NWXG?7RRM*5XU&UYW_0YO2M.CU&62-IC&RC(
M7.:VM-O=3\&7R74,AFLV8"6,'Y6'N.Q]#6)',=-U**5%RO4GV[BM^75]/O()
M("S?.I !0U>+Q>*E6C.$7.A-:JU[='YWZG@3C4PU71ZH]DM;^VN].COXI%^S
MR1B0.3@ 8[U+!/%<P)/"X>)QN5AT(]:\'74-:GT"+149DLT9B1T+Y.<'V]J[
MFQ\7W-CH]I96VG%GAB5"\C8!('85YN+RU4%=33=WU6BZ-ZGT-/.:+?OZ:?CY
M'H=%<%IOBK4O[1\W4F'V8(0(HE'7M74:3KD>K2RI'"\8C .6/7->14Y82Y5)
M/TU.S#YC0KM*+U?1[FK1112/0.4^(W_(EW?^\G_H0KQ)%WR(F<;F _,U[;\1
MO^1+N_\ >3_T(5XE&VR1'QG:P./H:^WR#_=7ZO\ )'RF<?[PO1'4#PC!<7\]
ME:7[M-;3+'.98MJX;NO//T-17'AJSM[>6Z;4&-ND)D 55=]VX+C@D<Y'.:HZ
MEXDU'4+QI1<RQQ^;YL<8;[A[<CKCWJK<ZO?W8<3W3N'4(R\ $ YQ@>_->A"E
MBG9RGZ_A?IZ^GF<<JF'UY8_U]_\ PYH:5I-MJ=I;S#<ODSD7IS_RRQN#>W0C
MZD5<7PO UO'<_:50R(MPL)9<>66X7KNSCOC%<Y!=W%M'/'!,\:3ILE53]]<Y
MP:G35]0CM%M$NY! O11C@9SC/7&><5<Z5=RO"=E^G_#_ ($0J44O>CK_ %_7
MJ;TF@V#7-^]E*9$A>>)HYH\!&"DJ5(/(XQSZ5%;Z%I\6IR6CSRSS0*ZS(T6U
M-VPD%6![$=^M8:ZE>J)@MS(//9FEY^^6&"3]034SZYJCHB->RE4&!T],<^O'
M'-3[&O:W/_7W>O8KVM'?E-'5/#*Z9IKSF\5YX1&9(_EP=^/NX.>,]P*YZKD^
MJ7US:):S73O F,(?;ID]3CWJG731C4C&U1W9A5E!R]Q61ZG\(_\ CRU7_KK'
M_(UZ/7G'PC_X\M5_ZZQ_R->CU\%F_P#OM3Y?DCZ_+?\ =8?UU84445Y9Z 5!
M>P?:K"XM_P#GK$R?F"*GHIIM.Z$U=69\T2Q-!,\+J5>-BK ]B.*Z7PE=^&K>
MRU"?4-2B6^\LI' ^5  P>O0DD=/:N_U;X=V&K>('U!Y6C@F1O.A3@E\8# ]O
M7ZUX]XC^'>OZ#=NHLY;NT)_=W$"[@1VR!R#7U.-S:.(I*G2=F]_\CY_"Y=*C
M4=2HKI;?YGM>J-'J/@E+:&5!)+;QE0V>V#R!DUP:Z)=BS>!0C222J4&2N[:K
M9Z@>HJ2W^(KVGAZSLUTR)M1BB$<TLRC (XX Y/XUS%YX@U6^O$NYKQQ+&<QF
M/Y GT Z5QX?(\15UG[J\]_N.JMFU&GI#WF=EX2TQHM<D-\!% L+QN2^,[AC
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M_067_OU_]>C_ (5)+_T%E_[]?_7KV/[8P7\_X/\ R/,_LS%?R?BCS6BO2O\
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M/SKS8:=?%F 1OE ).\8P>ASG%*NG7929G)0Q,H92W//ISS3]N_Y1_P!KU/\
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MK_:,,=JUK#%)Y7E,BER-V6())]N*C6_"RJ^QN+;R.OMC-==_PC&D_P#/-_\
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M.>@(''J:6\\6/9W\L1T^1K80I(LIRN2P4X/_ 'USZ<>M=9Y!_O"CR#_>'Y4
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M]X4>0?[PH BHJ7R#_>%'D'^\* (J*E\@_P!X4>0?[PH BHJ7R#_>%'D'^\*
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M:\CC5FD:([0IYSVQBK4.1!$&SNV+G/KBKGE)Z4>4GI7&>@5J*L^4GI1Y2>E
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M9\7P:0]RDL5P5CFCC;<J.>@^H/!Q61-I?B/PM?RI%'=0NRF/S8%)61?8C_\
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*.??_ #FBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &W 7L# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(T 2I,L@^217'LP--DAAD_UD$;?5151],4_=FC8_]-(1G\UQ3!9747^KZ?\
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MTF:;F@!V:0M29II- #BU,)I":3-(!V:,TVB@!<T9I*,T +FFFBDH 6DS24E
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M<,OX]Z8CBJ*LS>;"Y2ZMR&'<C!J/;"_W)"I]&_QH A(I#4S0NHSC(]1S41%
M#:0TXBFXH 2C%%+0 E&*6DQ0 8I,4M%(!*6BB@ I*6DH 0T4II* "DQ2TM "
M4E+10 E%+24 --)2FDH 3O393BQD/J0/U_\ K4ZF77RV2CU;^E RG(,+$/\
M9S^9K6T%-USGU8#]:RYA^^"C^%0/TK>\/1XE7COG]#0(ZI13JCEGBM8&FG<)
M&O5C1'<PW$7FPR+(A&<J:0STCX06^Z_U6ZY^5%C_ #.?Z5ZO7C/PJ\6Z!IMI
M?0WM^EO<33 C>#M( XYZ=S7L%M>6M['YEK<13I_>B<,/TI@34444 %%%% !1
M110 4444 %%%% !1110 55N=/M;L$2Q*2>XX-6J* .+UCX=:=J2MA$R1W&#^
M=>9:_P#"#4;,M+IS!T'\#\?KTKZ!HH ^0K[1]6TAR+JSFB'][;P?QZ52^TAO
M]8BM[]#7U]=Z597JE9[=&SU..M<3K?PDT/4]SP1"&0]U^7^7% CYXVPO]URA
M]&_QIK0R*,XW#U'->@:W\(-6T_<]F_FIR0&X/YCBN)O-)U329"MS:RQ$=3@X
MI@4325+]H#?ZQ Q^F#1MB;[KE#Z-_C0!%13VB=1G&1ZCFF4 %)112 **** $
MHI:2@!*0TM)0 HI::*=0 4444 )24ZDQ0 VDIU)B@!M,U$?+"@]_\*E498?6
MHKX;[Z&,'L/YT 0$!KJ0^AKI=!3#@^@)_E7-P?/(Y]6KK=%3",<=@*&,B\2F
MX\NU6+B%I,2'&0.F,UL7;1C3IYX8@DAC(6*)?EX7 ([Y)J"74X(;HVN29<#@
M@X.>V:8\SR=3@>@J;#,33-.O4M]LQCAR<G W-^705ZS\';%4\1W4H+G9;'EF
M/.6';I7  UZQ\'+<;-4N".1Y: ^W)JA'J=%%% !1110 4444 %%%% !1110
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M)N-%\*VEG=H$N%W-(H.<$D_TQ3 WZ*** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #4 F\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(SJ&T0QD9;+*6P<>@!)-7?,3S/+WKYFW=LSSCIG'I6(SVT.K2W,K!;/1K81
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M_D31_:MB#B2<1'TE4I_,"I&7**:CI(@>-U=3_$IR*=0 4444 %%%% !1110
M4444 %%%% !1110!%<7,%I TUQ*L<8X+-Z]@/4^U43J=[+DVFC7,B=GGD2'/
MT!R?S I;2+[;='4;A#\K%;5&'^K4<%\?WFYY[#%3WY.+4Y_Y>8_YUL^6&C5W
M^'X$)N6NR*XUE(G5-0M)[ L<!Y<-$3Z;U) _'%:=5XYH[QKB'RP\"_NV+#*N
M?XEQW Z'_P"M5+3\V%_)I)9F@\OSK0L<D)G#)GOM)&/8CTHM&:;BK-=!W:>I
MJT445B4%%%% !1110 4444 %%%% !1110 4444 %%%% %"\TQ9Y_M=M*;6^
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M#J&QD C/;(I2DY.[8U%+1$M%%%(84444 %%%% !1110 4444 %%%% !1110
M456DO[6*U-R\P$(8H6P>H)!'Z&I(;JWN$WPSQNN<9##KZ?6@#(\6-JBZ*O\
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MQ&'N3-%"+F01JH:,HI4<8 64$=#O'I4[^%M7_M72]0BU&-)A=M<ZE^\<+-G
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MC>TC>38CLY8"-3P%7. 3DX Z5V=%% !11@^E% !1110 4444 %%%% !1110
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M3<2.G&2-WU]#38M4O)Y6E$LC^;Y;6]J8B@8"1@2#U' 7.?6NJR<YR<T9/J:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %N D$# 2(  A$! Q$!_\0
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MX+Z%[VXDM@1;)=7!D2#/]T'I52\\4:Q:O;0SSZ182O:BYF%YO^7<Q"H ISD
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M0>1UJ73-;T[6#,+&Y$K0D"12I5ESTR" <'L: -"BL^77--AU(:>]TGVO@F(
MDJ""<GT&!U/%5!XMT9X+B6*[\SR86FP$8;T'=<CYA[C- &W16';>+-*GT6TU
M-YFCCN0 D91BY;&2H4#)Q[<5J65];:C:K<VDRRPMG#+ZCJ#Z'VH L4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% '":=X6O=)TJROK.TCCUFV
MN99)8U<#[3$\AW*S=,[<$9Z$"F'PY?HEYILEG>74-S<O()!?>7"R.VXEU'S
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\J 'T4SS#_SS?\ *CS#_P \W_*@!]%,\P_\\W_*CS#_ ,\W_*@!]%,\P_\
M/-_RH\P_\\W_ "H ?13/,/\ SS?\J/,/_/-_RH ?13/,/_/-_P J/,/_ #S?
M\J 'T4SS#_SS?\J/,/\ SS?\J 'T4SS#_P \W_*CS#_SS?\ *@!]%,\P_P#/
M-_RH\P_\\W_*@!]%,\P_\\W_ "H\P_\ /-_RH ?13/,/_/-_RH\P_P#/-_RH
M ?13/,/_ #S?\J/,/_/-_P J 'T4SS#_ ,\W_*CS#_SS?\J 'T4SS#_SS?\
M*CS#_P \W_*@!]%,\P_\\W_*CS#_ ,\W_*@!]%,\P_\ /-_RH\P_\\W_ "H
M?13/,/\ SS?\J/,/_/-_RH ?13/,/_/-_P J/,/_ #S?\J 'T4SS#_SS?\J/
M,/\ SS?\J 'T4SS#_P \W_*CS#_SS?\ *@!]%,\P_P#/-_RH\P_\\W_*@!]%
M,\P_\\W_ "H\P_\ /-_RH ?13/,/_/-_RH\P_P#/-_RH ?13/,/_ #S?\J/,
M/_/-_P J 'T4SS#_ ,\W_*CS#_SS?\J 'T4SS#_SS?\ *CS#_P \W_*@!]%,
M\P_\\W_*CS#_ ,\W_*@!]%,\P_\ /-_RH$A)QL<?44 /HHHH **** "BBB@
MHHHH HW6C:9?1-%=6%M-&TGFE7C!R_3=]<=Z2ZT32[U($N=.M9D@XB5X@0@]
M!Z#VJS=7=M8P-/=W$4$*]9)7"J/Q-13ZII]JD+SWUM$DY B9Y5 D_P!W)YH
MDFLK6X5UFMXI Z>6P9 <K_=^E.M[:&TMT@MXDBA085$& !]*;]MM?M+VWVF'
MST3S&BWC<J^I'8>]3 A@"""#R"* &Q?</^\?YT^F1?</^\?YT^@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^>C_ *4^B@!GEM_ST?\ 2CRV_P">C_I3Z* &>6W_ #T?]*/+;_GH_P"E/HH
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M3^^OYTV)05/ ^\>WO3]J_P!T?E2 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH
M3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z
M/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1
MM7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]
MT?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z
M7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_
M?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^=
M'F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_
MOK^='F)_?7\Z7:O]T?E1M7^Z/RH 3S$_OK^='F)_?7\Z7:O]T?E1M7^Z/RH
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M8KA)%F 7.74# /L!Z8Q5-4^C$G/J7_,3^^OYT!T)P'7\Z7:O]T?E1M'H/RK
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M9VH2.Y;I^E9UUKL<;^5$GGR] L9R*F5>I57)35H]E^O?YC5.%/WYN[[O]/\
M@&M\D0./Q)K*N]=A1_*MU-Q-T"IT_.JWV'4M2(:\D\J(_P#+%#@U?@MX;!-L
M,* ]\-DGZG%9<L(?$[O^NI?-.>VB*(T_4-2(:^F,47:&.M*VM;2RQ'#& QX.
M.3^)KC/$OQ1T?0G-JC_;KXG M;-MQSZ,W05S?]G>/?'>'U"X_P"$>TECE;>+
M(E<>_?\ /'THE*4EKHAQC&+TU9Y_XH\;>(+SQ;J-S'J=W:JDSPQ112E51%)
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M10 SR4]#^9H\E/0_F:?10 SR4]#^9H\E/0_F:?10 SR4]#^9H\E/0_F:?10
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MY4>8?^>;_E3Z* &>8?\ GF_Y4>8?^>;_ )4^B@!GF'_GF_Y4>8?^>;_E3Z*
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MTT+?>+IMS[[72%/"_P 4O^?R%=;96$%E;K#!$L<:]%'\SZFNNT:/Q:R_!?\
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M%-\Q/[Z_G1YB?WU_.@!U%-\Q/[Z_G1YB?WU_.@!U%-\Q/[Z_G36FC0<NOYT
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M %J?10 S,G]Q?^^O_K49D_N+_P!]?_6I]% #,R?W%_[Z_P#K49D_N+_WU_\
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M 'U_]:GT4 ,S)_<7_OK_ .M1F3^XO_?7_P!:GT4 ,S)_<7_OK_ZU&9/[B_\
M?7_UJ?10 S,G]Q?^^O\ ZU&9/[B_]]?_ %J?10 S,G]Q?^^O_K49D_N+_P!]
M?_6JK?ZOIVE[?MUY# 6^Z';!/X5/:W=M?0">UGCFB;H\; BE=7L _,G]Q?\
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M@FU72;,'?=V\?MYF3^E9<_C'2E;; +BY;L(E('ZUHJ=6?PHASIQW9TJ6L:
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MO:N7P*XK]CSW7KF>\U^^FNB3+YS+@_P@'  ]L5TOPRN;B/7YK9"3;R0EI%[
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M16RGM$.?T%.7P6)CF]U*\N#W&<#]:HCQ^XZ:'J'Y?_6I?^%@2?\ 0$U#\O\
MZU+^T+?#IZ+_ ( _90ZZF[;^#](@P?L:N?65BU:T&GV]L,0PQ1C_ &$ KC/^
M%@2?] /4/R_^M1_PL"3_ * >H?E_]:LI8SF^*7YEQC".R.Z\M>_/UIP '0"N
M#_X6!)_T ]0_+_ZU'_"P)/\ H!ZA^7_UJS]O#N7='>T5P7_"P)/^@'J'Y?\
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MF?\ 3-_RH\S_ *9O^5 #Z*9YG_3-_P J/,_Z9O\ E0 ^BF>9_P!,W_*CS/\
MIF_Y4 /HIGF?],W_ "H\S_IF_P"5 #Z*9YG_ $S?\J/,_P"F;_E0 ^BF>9_T
MS?\ *@29(&QQ^% #Z*** "BBB@ HHHH **** "J5_H^G:HT37]E!<&(Y0R(#
MBKM% %>>QM+E76>VBD#Q^4P90<IZ?2FKIUFEB+)+>-;8#:(U& !2W]W]AL9K
MD0RSF-<B*(99SV K"C\57,TS6,6D.^J)(RO;B==BJH4EO,QC'S*,8SD_C1<+
M%BV\-Z?:[Q;PM%ECGRP!FI_[&@_Z>/S%9X\6CRXIX]+N#:[E2YD=@IA=GV;
M/XR&'./UJ[I>OOJ&JW%A+8O;21()1ND5CM)P-X'W&/4 ]J:;Z$\L>P_^QH/^
MF_YB@:1;GH;C\Q6O2*H48'KFGS,.5&5_8\'K<?F*/['@];C\Q5S4;QK&R>>.
MVDN9,JJ11]68D ?0<\GL*PX?%=Q=,;:TT>2;4(RXG@\]0L80X)#]&R3QQV.<
M8I<S#E1H)I5MC.)S^(J4:;;CHDWYBLH>+4Q;31:=<-82F-6N&8*5=^BA3][!
MX..GOBK7A[Q$->#LL4$:A%D4)<K(Q!Z$@#C]:+MCLBY_9\']R;\Z5+.WQD12
M'ZFK](JA1@4@LBL($'2.3]*7RE_N2?I2:C>-8V+SI;R7#C 2*,<LQ. /8<\G
ML*PXO%=Q<N;6UTB2748V<3V_GJ%C"G!._H<DX''KG&*!V-U54C*K)C\*=M_V
M9?TKGQXM4K;2V^FW#V4AC1IG8*5>0X"A?XL'AL=/>M#2]7NK[4KNRNM.%L]L
MB,S+.)%RV<+P!@X&?Q%%@-#;_LR_I2 !AD++C\*L4BJ%4 =*+ 0[?]F7]*-O
M^S+^E0ZG?26%JKP6DEU,\BQQQ(<9)[D_PCU-8D7BZ6ZB)LM'FN)849[I!*H\
MK#,N%/1R2K$8QD=QFD%CH  P!"RX/TI=O^S+^E<]-XQAM5CN#83G2V^5;K(R
MS>7OX3J1@8SZ_G6AH^N-J5Q+:W%I]EN4B2<)YJR!HVSM.1T/!X_G3L!H;?\
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MI5#1-6.KVCS&!8F20H?+F65#]&7KU_.M)@&4@]#0 WS#_P \W_2CS#_SS?\
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $" G # 2(  A$! Q$!_\0
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M4_YE]YLT5!;7EO=M,L$@<PR&*3 /##J*GK)IIV9HFGJ@HHHI#"BBB@ HHHH
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M&]/[R_G1Y4?]Q?RH\J/^XOY4 &]/[R_G1O3^\OYT>5'_ '%_*CRH_P"XOY4
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M6\$TJ&.WWR2/YS $%L_PC.!ZU<N?%&MP*;:U@DN[T7,NP&V($D @9D;(X&6
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M:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\
M"0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*
M- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(
MHT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^
M>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H
M/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\
MOD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&
M/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!
M_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%
M7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO
M^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T
M$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&
MD?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%
M'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[
M[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T
M$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1
M_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*
M7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4
MI?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_
M 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,
M?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?
M9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD
M4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \
M8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT
M'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\ 01MO^^Q5
MW[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0:1_T$;;_
M +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_  D&D?\
M01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_ +[%'_"0
M:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!&V_[[%'_
M  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0:1_T$;;_
M +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\ "0:1_P!!
M&V_[[%'_  D&D?\ 01MO^^Q5W[-!_P \8_\ OD4?9H/^>,?_ 'R*- U*7_"0
M:1_T$;;_ +[%'_"0:1_T$;;_ +[%7?LT'_/&/_OD4?9H/^>,?_?(HT#4I?\
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MI^[GO]/Y5K:1H\.EPY^_.WWY#_(>U:=%0H).YYM'+,/1K.M%>BZ1OO9=+_\
M#!7(^)K35?[6A73A<-!JD8L[EXR<6P!W>9[94NN1W*UUU%6>D>;WEAXAET_5
M+>&34+6"*WF:&.V0*TC^<V,'&2=@' ZYJW<:KXEC!M+"WOI;D7,KQ236^$:#
MR&,>YL 9WXXX.>#7>T4 >=Z6=:N_$=@7.K3Z=#/&XDOK?RF!,,H?. .-Q4<^
MV,]:NK:M_;\[7]GJ\NHF^W6UQ;LXB6#/R\YV!0O# \DYZ\5V]% 'FMI'XGTG
M1+&!)-1>&2UC>Y(A#2VW[P!A&,==IZ')XS4D#^*[F*Z=;K5(X[>"XEM?,MU5
MYV5QY2N,=USQP3GM7HU% 'GUS+XQ@M)+NU>YFN9_M2_9Y(ALB"G]V5XSG&<9
M//%48W\52PBZ8WP,45PD$QMF,@4F+JN 2>'P=N< X!KT^B@#*\-RWD_AZSDO
MUG6Z*?.+@ /U.,@ =L=A6K110 5!=VD-];-!.NY&_,'U%3T4$SA&<7&2NF<@
MNAZFTW]F-.WV!6W[^Q'I]?:NIM;2&RMU@@0*B_K[FIJ*F,4C@PF74<*W*%VW
MU>MET2\D%>?W\>I0^)?$%Q;PW8NBJ&P=8)7!/EH,!O\ 5A2V0<\]37H%%4>B
M<!9WOB5[BV^W'5([@QQE(XK53$\A+>:)#C 4' !R.,$9K,@OO&K:9=M<-?)(
M#&7"VI+!\G>J'&=O3D!@/4YKU*B@#S>6?Q/<WDL,T6H21201-Y;VRA8SF,G/
M&"V=_(/8Y P*DO;OQD+:Y55N%2TF2V>18OFG0L6:9, D_*47@'G=Q7HE% '$
MO::SJ_A;1/M_VC[6M]')*%38616./,7!XQM)K.MY_%EU+;PB;4XO-DC%^\EL
MJB!S)\PB)'*;<\\@<'/->CT4 <IJLC0:W>Q7,.IS6D^G*BFUC=BS MN *\*Q
M&/2LW2;/6Y- C;2-VG-)?B9[6YB<>1'\OR#=@D8&3C@DG%=[10 U P10Y!?
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M^E'VB+^_^E2T@92<!AGZT 1_:(O[_P"E'VB+^_\ I4A8*,L0/K1N7^\/SHT
MC^T1?W_TH^T1?W_TJ7.:* (OM$7]_P#2C[1%_?\ TJ6B@"+[1%_?_2C[1%_?
M_2I:* (OM$7]_P#2C[1%_?\ TJ6B@"+[1%_?_2C[1%_?_2I:* (OM$7]_P#2
MC[1%_?\ TJ6B@"+[1%_?_2C[1%_?_2I:* (OM$7]_P#2C[1%_?\ TJ6B@"+[
M1%_?_2C[1%_?_2I:* (OM$7]_P#2C[1%_?\ TJ6B@"+[1%_?_2C[1%_?_2I:
M* (OM$7]_P#2C[1%_?\ TJ6B@"+[1%_?_2C[1%_?_2I:* (OM$7]_P#2C[1%
M_?\ TJ6B@"+[1%_?_2C[1%_?_2I:* (OM$7]_P#2C[1%_?\ TJ6B@"+[1%_?
M_2C[1%_?_2I:* (OM$7]_P#2C[1%_?\ TJ6B@"+[1%_?_2C[1%_?_2I:* (O
MM$7]_P#2C[1%_?\ TJ6B@"+[1%_?_2C[1%_?_2I:* (OM$7]_P#2C[1%_?\
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MI;KZM[^U5/$E]_;LS^'--ACN)FQ]HG<92V'KG^]5;1B?!-Z=-U%%-G=/F'4
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MR;3CDD?C0!?L?$FF:@MRT4SHMNGF.TJ% 8^?G&>J\'GVK1FNK>WMC<SSQQ0
M;C)(P50/4DUR\7A.ZOH-6AUVX@N3J"[?-@#(R*,A5 S@*H)X[DDFKVJ>'!/I
M%C9V+QH;&9)HDN 7C<J",-SG'.?8XH UTOK262...Z@=Y%WHJR EE]0.X]ZL
M5S7ASPH-#O9+N66*::2'9E8]H0EV<A?1<M@#VKI: "BBB@ HHHH *3()(!&1
MUI:YB_CO-#U%M1@9YK:4_O48YQ_GM4R=M3CQF*>&BJCC>-]6NB[VZ^9T]86L
M:VT,@L; >9>/Q\O.S_Z]07_B%KI8[720SSS#EL?<_P#KU?T?18]-C,CGS+I_
MOR'M["I;YM(G!5Q4\9+V&$?N_:GV\H]W^1:TV&Y@L8X[N;S9AU;^GO5NBBM%
MH>Q3@J<%!=.^H4444%A65JE]HVFWEM=:E<P03A76%I&P=IQNQ[<#-:M9&JZ#
M%JMW'<22E2EM-;A=@/\ K  3^&* ,W^Q_"%NSW92U4;G3<93M7&)&51G ' 8
M@>E58HO UY,T<,]K)/<R J5G;?N&2 ISE>IP!@'/%,/@(2P&T366^QJ9"8O)
M4L)'B\MB6ST[XQ^-:DWA&WF^U$3[#/\ 9>1&/E\ALC\^GM0!3@OO"&M:' OG
M0);62+*J&4H\ Z=0<^QP>^*=;Z?X-N([2PM?LN9 'MDAE8/A-PRI!R,98'ZX
M-4)/AY&UA'#>:P6CLXMMJX@6/R_G#DN0?FY4>G'OS6QX?\)PZ'=_:UN?/E>)
MD=O+P"6<N6')(ZXZGIUH H75SX,\/Z?>QH+?%BJ/);Q,68&-LJ ,]0S?AGFK
MFK3>&M.TU;C5%AA64272QL_S,S*=Y'/7!QGWJI/X!2X5X'U)OLJ-*]O&(%W1
MM(<L6;/SCDX''7OBKNN>'UUZ=Y[+5$MY'M'LYB(EF!C?G@$_*??]* *5G<>$
M]&@O)8[E45K/SI[9W+D)@NV1R2Q#<]3P*DTVT\&V][:_9&MQ=3+'+"'E8M@
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M,T6666PMO*DE54=R[,2JYVC))X&3BM.B@ HHHH **** "BBB@ HHHH ****
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M '[-'VE?^><O_?LU-10!#]I7_GG+_P!^S1]I7_GG+_W[-344 0_:5_YYR_\
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M[RBN'T1O%O\ ;-A_:4<S1+'Y-R&(" J&'F*0?FW':<$ C-=Q0 4444 %%%%
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M%1V]Q#=6Z3V\BR12#<CJ<AAZBI* "BBHVN(4N([=I%$TBED0GE@,9(^F1^=
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MQI.K1!6V#YW382&QG)';/6I3X TF[ODOYKB2YWHGF[@A$Q5-@;(&1QCICI0
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M(5%M']NMQ=,HN760$KGME<C/X=*6#P7JDL5VT\2PG[/<_8HA>.P@E9PT?/\
MLXZ]NU>C44 >?7'@[6C:2/:77D:A<?:A/-Y['<KG*+^F..F356+P;KGV-A(
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M)10!'YK?\\9/T_QH\UO^>,GZ?XU)10!'YK?\\9/T_P :/-;_ )XR?I_C4E%
M$?FM_P \9/T_QH\UO^>,GZ?XU)10!'YK?\\9/T_QH\UO^>,GZ?XU)10!'YK?
M\\9/T_QH\UO^>,GZ?XU)10!'YK?\\9/T_P :/-;_ )XR?I_C4E% $?FM_P \
M9/T_QH\UO^>,GZ?XU)10!'YK?\\9/T_QH\UO^>,GZ?XU)10!'YK?\\9/T_QH
M\UO^>,GZ?XU)10!'YK?\\9/T_P :/-;_ )XR?I_C4E% $?FM_P \9/T_QH\U
MO^>,GZ?XU)10!'YK?\\9/T_QH\UO^>,GZ?XU)10!'YK?\\9/T_QH\UO^>,GZ
M?XU)10!'YK?\\9/T_P :I7-A;7=]!>3VCR20(R(&VE<-C.1GV%:-% %<JC2>
M8UIE]NW<57./3.>E!5#(CFT)=!A&*KE?ISQ5BB@#.NM.M+ORO-LCB.83X4*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #L 9\# 2(  A$! Q$!_\0
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M3#*A$1X*EL !CVZ\FJM]X6AN]+L+)+EU%DNU#(HD#C;CY@>#]>U2V7A]]/\
M#_\ 9<&HS$@DK/*H=N3G!!X(I>[8-1ESXC:RT-=0GL6:5WV1V\$BR%_=2.",
M9/X4VY\2LNHP6EE:+<^;;K<B1IUC&UC@8SU/%5;;P-9(R-=7$LZJSR>6O[I
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M-F'_ ./,,@/VD_Q$ =![]:[<6N",:5;C&<$,/\*I-H*R7,=R]IN>,816E!V
M]0#CI7#BJ=:;7LW8J+2W)M.U>T@L2LMV7$0W,S9)1>P:M2TO8+Z,R6[[T!QF
MJ:P.S1N=+@#="2PX'Y<\5I)&D2!(U55'0*,"NQ;$#JKWMI'?6DEM+G9(,'%6
M**8TVG=',75MH/A>W2:_O?LT<TNQ6E/#NP/'3ZU17Q=X.DB:<>(8&6%%+/\
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MI.FI:"9I=I)W$8 R<X [ =A44J?LX\J'*5W<EN/^/JU_WC_*K55;C_CZM?\
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M_LVT#$B!02-I(]*LHBQH$10J@8 ':J5^II%2ZCJ***984444 %%%% !1110
M4AZ&EHH Y]+K2Y(2CP809(53G'7.?UI[7NE1AI(HB[P\A5'XYK5:PM6 !@3
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M%%% !113?,3!.]<+U.>E #J*;O7=MW#.,XS2JP894@CU% "T444 %%%&<=:
M.$^(-[ \4%H&(F1]Q4CMCK5GP#>P'2S9!B9U=G( X /O6]K>BVFN6?DS85^L
M<HZJ:?I&E6FC6*V]OM_VW/5C[USJG+VO-T/3EB:3P2HV=[FC11170>8%%%%
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M++$=MRK8$K%<;2<\ #]<5-_PA6F?\_&H_P#@8_\ C1_PA6F_\_&H_P#@8_\
MC35D)W91ET?4)86>Q@:T+2-Y*,_,2F/!SSW;^=;F@Q3PVDB2V_D()/W8(PQ&
M!DD?7-4?^$*TW_GXU'_P,?\ QH_X0K3?^?G4?_ Q_P#&FVFK!8Z.BN<_X0K3
M?^?G4?\ P,?_ !H_X0K3?^?G4?\ P,?_ !J;+N/4Z.@]*YS_ (0K3?\ GYU'
M_P #'_QH_P"$*TW_ )^=1_\  Q_\:++N&IGI8W$L\MPVE7$=OYOSV>[ =0&
M8<\G)R?8"BXT;4EM(D\MC\L9F(.\D@-VSSU%:'_"%:;_ ,_.I?\ @8_^-)_P
MA6F_\_.I?^!C_P"-5S(FQKZ3#-;Z1:0W&?.2)5?)R<X]:NUS?_"%:;_S\ZE_
MX&/_ (T?\(3IO_/UJ7_@8]3IW*U.DHKF_P#A"=-_Y^M2_P# QZ/^$)TW_GZU
M+_P,>BR[AJ=)7*/HTSW$LYT[;$TH#6RRX$B#/S'U;/-3_P#"$Z;_ ,_6I?\
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M^]3_ / QZ/\ A"=._P"?O4__  ,>KYD39F]:)Y=G"F7.U ,R?>Z=_>IJYO\
MX0G3O^?O4_\ P,>C_A"=._Y^]3_\#'J++N5J=)17-_\ "$Z=_P _>I_^!CT?
M\(3IW_/WJ?\ X&/19=PU+?B-'DLXXX["2Z9WQE?^60[MC(S[5D/87<4DDAT^
M>X=69V9I.9HRN%3KUSC/TJY_PA.G?\_>I_\ @8]'_"$Z=_S^:G_X&/5)I:"L
MRM;6.L10V3VT2>5')N:"<LI1F;YB/]D#H*ZVN:_X0G3O^?S4_P#P,>C_ (0G
M3O\ G\U/_P #'I.SZ@KHZ6BN:_X0G3O^?S4__ QZ/^$)T[_G\U/_ ,#'I67<
M>ITM<YK-O/<ZO"D%E,I"Y^V(>_9>O ]32?\ "$Z=_P _FI_^!CTG_"$Z?_S^
M:I_X&-35EU%J9\VGW*VS*NE3^7)LCV!MQC<9WRCGOP!]*T-&LM0M=5<S1%U8
ML6FD^]L_@ /KZT?\(3I__/[JG_@8U'_"$Z?_ ,_NJ?\ @8U/F069TM%<U_PA
M.G_\_NJ?^!C4?\(3I_\ S^ZI_P"!C5-EW'J2Z_!+<WMI%%9S'^(W<?6+!X Y
M[G]*R9M/NXH7QI4TFY%BD&_=NDR<R@9YX_G6C_PA.G_\_NJ?^!C4?\(3I_\
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M_A;7@S_H+#_OTW^%>)0OH"VDD4VE7C2/._[Q8FRD9;@K]%[5+%=Z)&"?['N
M"NW8(6SC/.3[C\J/80\P]I(]H_X6UX,_Z"P_[]M_A1_PMKP9_P!!8?\ ?MO\
M*\6BN-&M[40#3[B0;LO(+9@[ YR >V,C\JBN9]&:V,4.D3>:^=\H@88^4[=H
M[<XS^-'L(![21[=_PMGP;_T%?_(3?X4?\+9\&_\ 05_\A-_A7S=]GN.]M/\
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M$8Y^M<!_PJ7PY_S_ .I?^.UZIK7_ !ZI_OUAUUTFU'1F,[7.'_X5+X<_Y_\
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M+8YK,_MBZ](_RJE*K)7N2U!=#D&^"NEL%#:SJ1"G<HW#@^M*/@MIJ@ :WJ8
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M4@G^=*GQ?\/NP":'?,<] 1_C2][L&G<]5TW_ )!\7T_K5NO)U^.>C(H5=)O
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>fin_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  U &P# 2(  A$! Q$!_\0
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M>S;K#1QV)I*N\PE3YZF(2IQP."E&$:>)Q-&$5*HW.5H48WE)\S;;=KV7Q_\
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MU?#2PUWQ3\8]"AMM.\=:SXE763;ZTDU]?*FH:%8:@B#2_#%_HUI:0Q6RIO\
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M2\7CHYOG-/'4ZN)5;"87ZM6EB:O^U3K*E.U/$5:%;Z''\ Y=D&65,WP-3/\
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MVK5Q./Q&%QE9SK4*M><Z5*G4J8AXG%1=/#4Z;]BZ_LX2JM\B;=RBBBOP@_2
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arbe Robotics Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001861841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">107 HaHashmonaim St<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv-Yafo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6329302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,163,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=arbe_OrdinarySharesParValueNIS0000216PerShareMember', window );">Ordinary shares, par value NIS 0.000216 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value NIS 0.000216 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARBE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=arbe_WarrantsMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ARBEW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Kobi Marenko<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">kobi.m@arberobotics.com<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">107 HaHashmonaim St<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv-Yafo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6329302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">73-7969804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=arbe_OrdinarySharesParValueNIS0000216PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=arbe_OrdinarySharesParValueNIS0000216PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=arbe_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=arbe_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Somekh Chaikin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Opinion on the Consolidated Financial Statements</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Arbe Robotics Ltd. and its subsidiaries, (hereinafter: &#8220;the Company&#8221;) as of December 31, 2024 and 2023,
the related consolidated statements of operations, changes in shareholders&#8217; equity and cash flows for each of the years in the three-year
period ended December 31, 2024, and the related notes (collectively, &#8220;the consolidated financial statements&#8221;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31,
2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31,
2024, in conformity with U.S generally accepted accounting principles.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 13,488<span></span>
</td>
<td class="nump">$ 28,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">280<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term bank deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,793<span></span>
</td>
<td class="nump">15,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">153<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other assets - funds held in escrow</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,417<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,026<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,631<span></span>
</td>
<td class="nump">47,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,782<span></span>
</td>
<td class="nump">1,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,374<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,156<span></span>
</td>
<td class="nump">3,049<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,787<span></span>
</td>
<td class="nump">50,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">624<span></span>
</td>
<td class="nump">1,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">551<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and payroll accruals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,283<span></span>
</td>
<td class="nump">2,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ConvertibleBonds', window );">Convertible bonds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,614<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">1,710<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">36,406<span></span>
</td>
<td class="nump">6,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,457<span></span>
</td>
<td class="nump">1,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">428<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,885<span></span>
</td>
<td class="nump">2,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>8SHAREHOLDERS&#8217; EQUITY:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares, NIS 0.000216 par value per share; 165,000,000 authorized shares as of December 31, 2024 and 130,000,000 as of December 31, 2023; 85,749,331 and 77,925,095 outstanding shares at December 31, 2024 and 2023, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">275,453<span></span>
</td>
<td class="nump">245,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(252,957)<span></span>
</td>
<td class="num">(203,640)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,496<span></span>
</td>
<td class="nump">42,093<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 60,787<span></span>
</td>
<td class="nump">$ 50,485<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents less than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ConvertibleBonds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible bonds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ConvertibleBonds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share)</a></td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary Shares, shares authorized</a></td>
<td class="nump">165,000,000<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary Shares, shares outstanding</a></td>
<td class="nump">85,749,331<span></span>
</td>
<td class="nump">77,925,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 3,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Costs of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,553<span></span>
</td>
<td class="nump">1,508<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(785)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,091<span></span>
</td>
<td class="nump">34,082<span></span>
</td>
<td class="nump">36,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,430<span></span>
</td>
<td class="nump">5,194<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,347<span></span>
</td>
<td class="nump">7,571<span></span>
</td>
<td class="nump">8,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">48,868<span></span>
</td>
<td class="nump">46,847<span></span>
</td>
<td class="nump">49,965<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49,653)<span></span>
</td>
<td class="num">(46,885)<span></span>
</td>
<td class="num">(47,731)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">336<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
<td class="nump">7,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per ordinary share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of ordinary shares used in computing basic net loss per ordinary share (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,949,032<span></span>
</td>
<td class="nump">72,021,520<span></span>
</td>
<td class="nump">63,489,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per ordinary share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,949,032<span></span>
</td>
<td class="nump">72,053,372<span></span>
</td>
<td class="nump">63,629,206<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#8217;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 199,469<span></span>
</td>
<td class="num">$ (119,646)<span></span>
</td>
<td class="nump">$ 79,823<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="nump">63,016,856<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,793<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to service providers</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">354<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options and vested RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">277<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options and vested RSUs (in Shares)</a></td>
<td class="nump">1,144,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(40,494)<span></span>
</td>
<td class="num">(40,494)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">208,893<span></span>
</td>
<td class="num">(160,140)<span></span>
</td>
<td class="nump">48,753<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="nump">64,160,890<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares and warrants, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">22,496<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares and warrants, net of issuance costs (in Shares)</a></td>
<td class="nump">11,794,873<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,012<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to service providers</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">629<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options and vested RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">703<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options and vested RSUs (in Shares)</a></td>
<td class="nump">1,969,332<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(43,500)<span></span>
</td>
<td class="num">(43,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">245,733<span></span>
</td>
<td class="num">(203,640)<span></span>
</td>
<td class="nump">42,093<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2023</a></td>
<td class="nump">77,925,095<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares and warrants, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">13,787<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of ordinary shares and warrants, net of issuance costs (in Shares)</a></td>
<td class="nump">4,293,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,542<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation to service providers</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,186<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options and vested RSUs</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">205<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options and vested RSUs (in Shares)</a></td>
<td class="nump">3,530,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(49,317)<span></span>
</td>
<td class="num">(49,317)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 275,453<span></span>
</td>
<td class="num">$ (252,957)<span></span>
</td>
<td class="nump">$ 22,496<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2024</a></td>
<td class="nump">85,749,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents less than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">14,542<span></span>
</td>
<td class="nump">13,012<span></span>
</td>
<td class="nump">8,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock-based compensation to service providers</a></td>
<td class="nump">1,186<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Revaluation of warrants</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(756)<span></span>
</td>
<td class="num">(8,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevaluationOfConvertibleLoan', window );">Revaluation of convertible bonds</a></td>
<td class="num">(81)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_IssuanceCostsRelatedToConvertibleBonds', window );">Issuance costs related to convertible bonds</a></td>
<td class="nump">737<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade receivable, net</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="num">(2,015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other receivables</a></td>
<td class="num">(474)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease ROU assets and liabilities, net</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Trade payables</a></td>
<td class="num">(553)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Employees and payroll accruals</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(375)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accrued expenses and other payables</a></td>
<td class="num">(376)<span></span>
</td>
<td class="num">(3,899)<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(32,502)<span></span>
</td>
<td class="num">(33,513)<span></span>
</td>
<td class="num">(40,362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_PaymentForChangeInBankDeposits', window );">Change in bank deposits</a></td>
<td class="nump">4,609<span></span>
</td>
<td class="num">(15,002)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(622)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(918)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">3,987<span></span>
</td>
<td class="num">(15,251)<span></span>
</td>
<td class="num">(1,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term loan</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,218)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of ordinary shares and warrants, net of issuance costs</a></td>
<td class="nump">13,787<span></span>
</td>
<td class="nump">22,496<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance costs related to convertible bonds</a></td>
<td class="num">(459)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">703<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">13,533<span></span>
</td>
<td class="nump">23,199<span></span>
</td>
<td class="num">(4,941)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate fluctuations on cash and cash equivalent</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(1,189)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(15,240)<span></span>
</td>
<td class="num">(25,612)<span></span>
</td>
<td class="num">(45,432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the year</a></td>
<td class="nump">28,750<span></span>
</td>
<td class="nump">54,315<span></span>
</td>
<td class="nump">100,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the year</a></td>
<td class="nump">13,768<span></span>
</td>
<td class="nump">28,750<span></span>
</td>
<td class="nump">54,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow', window );">Issuance of convertible bonds with proceeds placed in escrow</a></td>
<td class="nump">30,695<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
<td class="nump">797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Purchase of property and equipment</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flows activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">$ 1,928<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_IssuanceCostsRelatedToConvertibleBonds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance costs related to convertible bonds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_IssuanceCostsRelatedToConvertibleBonds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of convertible bonds with proceeds placed in escrow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_PaymentForChangeInBankDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment for change in bank deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_PaymentForChangeInBankDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RevaluationOfConvertibleLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RevaluationOfConvertibleLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>General [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">GENERAL</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">NOTE
1:- GENERAL</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">a.</td><td style="text-align: justify">Arbe Robotics Ltd. (the &#8220;Company&#8221;) was founded and registered on November 4, 2015 and commenced
its activities in January 2016. The Company, a global leader in perception radar solutions, is spearheading a radar revolution, enabling
safe driver-assist systems today while paving the way to full autonomous-driving. The Company&#8217;s radar technology is a critical sensor
for L2+ and higher autonomy. The Company is empowering automakers, Tier 1 suppliers, autonomous ground vehicles, commercial and industrial
vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. The Company&#8217;s ordinary
shares and Warrants are listed on the Nasdaq Capital Market under the symbols &#8220;ARBE&#8221; and &#8220;ARBEW,&#8221; respectively<span style="font-family: Times New Roman, Times, Serif">.</span>
The convertible bond are listed on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">b.</td><td style="text-align: justify">On October 26, 2017, the Company established a Delaware subsidiary, Arbe Robotics US Inc. Arbe Robotics
US Inc is engaged mainly in the Company&#8217;s sales and will operate as the Company&#8217;s distributor in the U.S.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">c.</td><td style="text-align: justify">On February 5, 2024, the Company established a Chinese subsidiary, Shanghai Arbe Technologies Co., Ltd
(&#8220;Arbe China&#8221;). Arbe China was formed to assist mainly in providing customer support in the China region.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">d.</td><td style="text-align: justify">On October 7, 2021, the Company consummated the merger (the &#8220;Merger&#8221;) pursuant to which the
Company&#8217;s wholly-owned subsidiary, Autobot MergerSub, Inc. (&#8220;Merger Sub&#8221;) was merged with an into Industrial Tech Acquisitions
Inc. (&#8220;ITAC&#8221;) pursuant to which ITAC became a wholly-owned&#160;subsidiary of the Company, and the Company issued ordinary
shares and warrants to the holders of ITAC common stock and warrants, respectively. In connection with the Merger, the name of ITAC was
changed to Autobot HoldCo, Inc.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in">In connection with
the Merger, and immediately prior to the closing of the Merger, the Company effected a recapitalization (the &#8220;Recapitalization&#8221;),
which was approved by the Company&#8217;s directors and shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Pursuant to the
Merger, Arbe issued to ITAC securityholders (a) 3,866,842 ordinary shares to the holders of ITAC common stock and (b) 10,735,680 Arbe
warrants to the holders of ITAC warrants, of which 7,623,600 warrants are public warrants and 3,112,080 warrants are private warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Total gross proceeds
resulted from the Merger and the related PIPE financing were approximately $118,288, of which total transaction costs amounted to approximately
$16,707. The total gross proceeds include the $100,000 from the sale of 10,000,000 ordinary shares to the PIPE investors at $10.00 per
share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">On December 31,
2024, the Company completed the liquidation of ITAC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">d.</td><td style="text-align: justify">On May 30, 2024, the Company registered its ordinary shares on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;),
and its ordinary shares are now traded on both Nasdaq and the Tel Aviv Stock Exchange. Pursuant to statutory exemption available for dual
listed companies under the Israeli securities and companies&#8217; laws, the Company&#8217;s reporting requirements are in substance in accordance
with the provisions applicable by Nasdaq on foreign private issuers.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">e.</td><td style="text-align: justify">On June 2, 2024, the Company completed an offering of convertible bonds in the principal amount of NIS
110,000,000 (approximately $<span style="-sec-ix-hidden: hidden-fact-49">30</span><span style="font-family: Times New Roman, Times, Serif">,</span>000). The bonds were issued solely to Israeli
investors and were not offered in the United States or to U.S. persons. The bonds bear interest on the principal amount at the rate of
6.5% per annum, mature on May 30, 2028, and are convertible into the Company&#8217;s ordinary shares at a conversion price of NIS 9.53
(approximately $2.60) per share. The bonds are listed for trading on the TASE. Refer to Note 9.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">f.</td><td style="text-align: justify">On November 4, 2024, the Company completed a public offering of its securities. The gross proceeds from
this offering were approximately $15 million, before deducting the underwriters&#8217; discounts and commissions and other offering expenses
payable by the Company of approximately $1.2 million. The securities were sold as a unit for $1.82 per unit, with each unit consisting
of one ordinary share (or one pre-funded warrant in lieu of one ordinary share), one Tranche A Warrant and one Tranche B Warrant. In the
offering, the Company issued an aggregate of 8,250,000 ordinary shares (or pre-funded warrants in lieu thereof) and by Tranche A Warrants
to purchase up to 8,250,000 ordinary shares at $2.35 per share and Tranche B Warrants to purchase up to 8,250,000 ordinary shares $1.82
per share. The Tranche A Warrants are immediately exercisable upon issuance and expire on November 4, 2029. The Tranche B Warrants are
immediately exercisable upon issuance and will expire on the earlier of (i) the 20<sup>th</sup> trading day after the Company has given
notice of a Triggering Event, as defined in the Tranche B Warrant or (ii) November 4, 2027. Refer to Note 10c.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">g.</td><td style="text-align: justify">The Company depends on one supplier for the development and productization of its products. If this supplier
fails to deliver or delays the delivery of the necessary products, the Company will be required to seek alternative sources of supply.
A change in supplier could result in manufacturing delays and increased costs, which could result in a possible loss of sales which would
adversely affect the Company&#8217;s business, prospects, results of operations and financial position.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">h.</td><td style="text-align: justify">As the Company operates internationally and substantially its revenue is derived from sales outside of
Israel, the business is affected by inflation, supply chain issues and economic conditions in countries in which the Company is seeking
to conduct business, security and cybersecurity issues, fiscal and monetary policies, tariffs, interest rates and regulations affection
the automotive industry, the timing by the automotive and other industries on the introduction of unmanned automobiles and other unmanned
devices, safety concerns and well as the effect of regional conflicts and steps taken by governments with respect to parties to such conflicts.&#160;As
an Israeli company, the Company is also subject to the effect on Israel and the Israeli economy of the present war with Hamas as well
as any other regional conflicts, including Hezbollah, Syria and Iran, which may develop and the relationship between Israel and other
countries, including the United States, China and the European Union.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">i.</td><td style="text-align: justify">The Company has incurred losses from operations since its inception and has negative cash flow from operating
activities. During January 2025, the company raised gross proceeds of $55.5 million in an underwritten offering and from the conversation
of our convertible bonds and the release of funds from escrow upon such conversion. Refer to Note 14.</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">NOTE
2:- SIGNIFICANT ACCOUNTING POLICIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">a.</td><td style="text-align: justify">Basis of presentation:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The consolidated financial statements
have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant
accounting policies followed in the preparation of the financial statements applied on a consistent basis for all years presented in these
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The consolidated
financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">b.</td><td style="text-align: justify">Use of estimates:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The preparation
of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions
including fair value of warrants, stock-based compensation and the underlying fair value of the Company&#8217;s ordinary shares issued
prior to the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company bases
these estimates on historical and anticipated results, trends and other assumptions that it believes are reasonable under the circumstances,
including assumptions as to future events. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">c.</td><td style="text-align: justify">Consolidated financial statements in U.S. dollars:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A substantial portion
the Company&#8217;s activity including transactions with customers, as well as equity transactions and cash investments, are incurred
in U.S. dollars. The Company&#8217;s management believes that the U.S. dollar is the currency of the primary economic environment in which
the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar<span style="font-family: Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The subsidiaries
functional currency is the currency of the primary economic environment in which the subsidiaries operate; normally, that is the currency
of the environment in which the subsidiaries primarily generate and expend cash. In making the determination of the appropriate functional
currency for the subsidiaries, the Company considers cash flow indicators, local market indicators, financing indicators and the subsidiaries&#8217;
relationship with both the parent company and other subsidiaries. The Company has determined the functional currency of its subsidiaries
to be the U.S. dollar.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Monetary accounts
maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting Standard
Codification (&#8220;ASC&#8221;) No. 830 &#8220;Foreign Currency Matters&#8221; (&#8220;ASC No. 830&#8221;). All transaction gains and
losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or expenses as
appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Transactions in foreign currency are
translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, <i>Foreign Currency Transaction</i>. Monetary
assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing
rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the
exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities denominated in currencies
other than the respective functional currencies are included in the consolidated statements of operations.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">d.</td><td style="text-align: justify">Concentration of credit risk:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Most of the Company&#8217;s
cash and cash equivalents, restricted cash, short-term deposits and funds held in escrow were deposited with Israeli banks and were comprised
mainly of cash deposits and short-term deposits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
Company&#8217;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#8217; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">e.</td><td style="text-align: justify">Cash and cash equivalents and restricted cash:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company considers all highly liquid
short-term deposits with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist
primarily of amounts invested in short-term deposits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Restricted cash consists of deposits
at a financial institution that serves as collateral for a credit card agreement and lease agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">f.</td><td style="text-align: justify">Short term deposits:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Short-term deposits are bank deposits
with an original maturity of more than three months and less than one year from the date of acquisition. The deposits are presented according
to their terms of deposit. As of December 31, 2024 and 2023, these bank deposit bearing annual interest rates in the range of&#160;4%-6%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">g.</td><td style="text-align: justify">Fair value of financial instruments:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The estimated fair value of financial
instruments has been determined by the Company using available market information and valuation methodologies. Considerable judgment is
required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company could realize in a current
market exchange. The following methods and assumptions were used by the Company in estimating the fair value of their financial instruments:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The carrying values of cash and cash
equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables, employees and payroll accruals,
accrued expenses and other current liabilities approximate their fair values due to the short-term maturities of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company applies ASC No. 820, &#8220;Fair
Value Measurements and Disclosures&#8221; (&#8220;ASC No. 820&#8221;), with respect to fair value measurements of all financial assets
and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term deposits and warrant liability at fair value.
Short-term deposits are classified within Level&#160;1 because these assets are valued using quoted market prices. Fair value represents
the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in
pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for
inputs used in the valuation methodologies in measuring fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 1&#8212;Observable inputs that reflect quoted prices (unadjusted)
for identical assets or liabilities in active markets.</td>
</tr></table>

<p style="margin: 0">&#160;</p>


<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 2&#8212;Include other inputs that are directly or indirectly
observable in the marketplace.</td>
</tr></table>

<p style="margin: 0">&#160;</p>


<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 3&#8212;Unobservable inputs which are supported by little
or no market activity.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The fair value hierarchy also requires
an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">In
connection with the October 7, 2021 merger with Industrial Tech Acquisition Corp. (&#8220;ITAC&#8221;), the Company (i) assumed a derivative
warrant liability related to Company&#8217;s warrants that were issued to the holders of private placement warrants that had been issued by
ITAC in connection with its initial public offering, and (ii) issued equity instrument in connection with warrants that had been issued
as part of ITAC&#8217;s initial public offering and, pursuant to the Merger, became warrants to purchase the Company&#8217;s ordinary
shares. The fair value of the Company&#8217;s public warrants is measured based on the market price of such warrants and are considered
a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private
placement warrants which are considered a Level 3 fair value measurement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
Company&#8217;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
Refer to Note 8.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">For
convertible bonds measurement under fair value, see 2u below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">h.</td><td style="text-align: justify">Trade receivables, net</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#8217;s best estimate of the amount of credit losses with respect to its existing trade receivable.
The Company&#8217;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#8220;CECL&#8221;) standard.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; ">The Company
estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#8217;s customers to
make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected
credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions
and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation of collectability,
customer creditworthiness, historical levels of credit losses, and future expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
allowance for credit losses for the year ended December 31, 2024, recorded for the first time, was $896 and <span style="-sec-ix-hidden: hidden-fact-51"><span style="-sec-ix-hidden: hidden-fact-52">not</span></span> material for the years
ended December 31, 2023 and 2022.</p><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">i.</td><td style="text-align: justify">Property and equipment:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Property and equipment
are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost
of assets disposed and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
statement of operation. Repair and maintenance costs are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and peripheral equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">15-33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">7-15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Vehicles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><div style="-sec-ix-hidden: hidden-fact-50">(*)</div></td><td style="text-align: left"></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">j.</td><td style="text-align: justify">Impairment of long-lived assets:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Long-lived assets
are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; a (&#8220;ASC 360&#8221;), whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when the carrying
value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to be recognized
is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December 31, 2024,
2023 and 2022, no impairment losses were identified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">k.</td><td style="text-align: justify">Accrued post-employment benefit:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The employees of
Arbe Ltd. are included under section 14 of the Israeli Severance Compensation Act, 1963 (&#8220;Section 14&#8221;). Pursuant to Section
14, the Company&#8217;s Israeli employees are entitled to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited
on their behalf to their chosen insurance funds. By making the payments in accordance with Section 14, the Company is released from any
future severance payments in respect of those employees. The obligation to make the monthly deposits is expensed as incurred. The deposits
pursuant to Section 14 are not recorded as an asset in the consolidated balance sheet, and there is no liability recorded as the Company
does not have a future obligation to make any additional payments. Severance costs amounted to approximately $1,227, $1,166 and $1,240
for the years ended December 31, 2024, 2023 and 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s U.S. subsidiary
has a 401(k) defined contribution plan covering one employee in the United States. The expense recorded by the U.S. subsidiary for matching
contributions for the years ended December 31, 2024, 2023 and 2022 were immaterial.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">l.</td><td style="text-align: justify">Stock-based compensation:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for stock-based compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, which requires the measurement
and recognition of compensation expense based on estimated fair values for all stock-based payment awards made to employees, nonemployees
and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing
model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the Company&#8217;s statements
of operations over the applicable service periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company measures its stock-based
payment awards made to employees, directors, and non-employee service providers based on estimated fair values. The fair value of each
option award is estimated on the grant date using the Black-Scholes option pricing model which requires several assumptions, of which
the most significant are the expected share price volatility and the expected option term. The Company recognizes forfeitures of equity-based
awards as they occur. For graded vesting awards, the Company recognizes compensation expenses based on the straight-line method over the
applicable service period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">m.</td><td style="text-align: justify">Net loss per ordinary share:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company computes net loss per
share using the two-class method required for participating securities. There were no participating securities in the years ended December
31, 2024, 2023 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company&#8217;s basic net loss
per ordinary share is calculated by dividing net loss by the weighted-average number of ordinary shares outstanding for the period, without
consideration of potentially dilutive securities. The diluted net loss per ordinary share is calculated by giving effect to all potentially
dilutive securities outstanding for the period using the treasury share method or the if-converted method based on the nature of such
securities. Diluted net loss per ordinary share is the same as basic net loss per share in periods when the effects of potentially dilutive
shares of ordinary shares are anti-dilutive. Refer to Note 11.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">n.</td><td style="text-align: justify">Other comprehensive loss:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company has no components of comprehensive
loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods presented.</p><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">p.</td><td style="text-align: justify">Revenue recognition:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company follows the provisions
of ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which apply to all contracts with customers. Under Topic
606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition
for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Identify the contract(s) with a customer;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Identify the performance obligations in the contract;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Determine the transaction price;</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Allocate the transaction price to the performance obligations
in the contract; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Recognize revenue when (or as) the entity satisfies a performance
obligation.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">At contract inception, once the contract
is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines
the performance obligations and assesses whether each promised good or service is distinct<span style="font-family: Times New Roman, Times, Serif">.</span>
The Company evaluates each performance obligation to determine if it is satisfied at a point in time or over time. Refer to Note 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i>Nature of Products and Services</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company derives its revenues mainly
from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional services. Revenue from chipsets
and prototype radar systems is recognized at the point in time when the control of the goods is transferred to the customer, generally
upon delivery, and the Company has no remaining performance obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i>Right of Return</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company&#8217;s general terms
and conditions for its contracts do not contain a right of return that allows the customer to return products and receive a credit. Therefore,
the Company does not estimate returns and generally recognizes revenue at contract price upon product delivery.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">q.</td><td style="text-align: justify">Cost of revenues:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Cost of revenue includes the manufacturing
cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">r.</td><td style="text-align: justify">Research and development expenses, net:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Research and development costs, net
of grants received, are charged to the consolidated statement of operations as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">s.</td><td style="text-align: justify">Income taxes:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company accounts for income taxes
in accordance with ASC 740, &#8220;Income Taxes&#8221;. This standard prescribes the use of the asset and liability method whereby deferred
tax asset and liability account balances are determined based on differences between the financial statement carrying amount and the tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are
expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is more
likely than not to be realized<span style="font-family: Times New Roman, Times, Serif">.</span> The Company recognizes the tax benefit
from a tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. A tax position that meets the more-likely-than-not recognition threshold is measured at
the largest amount that is greater than 50 percent likely of being realized upon settlement with the taxing authority using the facts,
circumstances, and information available at the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">t.</td><td style="text-align: justify">Contingent liabilities</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies.&#8221; A provision is recorded when it is both
probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions
are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
information and events pertaining to a particular matter. As of December&#160;31, 2024 and 2023, the Company is not a party to any litigation
that could have a material adverse effect on the Company&#8217;s business, financial position, results of operations or cash flows.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">u.</td><td style="text-align: justify">Convertible bonds:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company recognized
its convertible bonds as a liability and the cash held in escrow as other assets funds held in escrow, in the balance sheet. As the convertible
debt contained embedded features not closely related to the host contract, the Company elected to apply the fair value option to it. The
fair value of the convertible bonds is measured under FV level 1 and is based on the quoted price of the bonds on the TASE. The Company
elected to measure the bonds initially and subsequently at fair value. Thus, the convertible bonds&#8217; issuance costs expensed as incurred
to statement of operations. The fair value of the convertible debt is based on its quoted price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company recorded
financial income amounting to $81 for the year ended on December 31, 2024. Refer to Note 9.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">v.</td><td style="text-align: justify">Leases:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for leases under Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company elected
the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize a lease liability
and a right-of-use (&#8220;ROU&#8221;) asset on the balance sheet for leases with a term of twelve months or less. The Company recognizes
the associated lease payments on such leases in the consolidated statements of income on a straight-line basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Under Topic 842,
the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement date based
on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable payments
at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental borrowing
rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing
rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset is recorded
net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain
that the Company will exercise such options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Payments under the
Company&#8217;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common area maintenance,
real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. Refer to Note 6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">w.</td><td style="text-align: justify">Impact of recently issued accounting standard:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In November 2023,
the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their
reportable segments&#8217; significant expenses and other segment items on an annual basis. Public entities with a single reportable segment
are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements
in ASC 280 on an annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted.
The Company adopted ASU 2023-07 during the year ended December 31, 2024. Refer to Note 13.</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">x.</td><td style="text-align: justify">Recently not yet adopted accounting pronouncements<span style="font-family: Times New Roman, Times, Serif">:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic
220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense
categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning
after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is in the
process of assessing the impacts and method with no early adoption of the standard<span style="font-family: Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.15pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">ASU 2023-09, Improvements
to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components
of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The ASU will be effective for fiscal years
beginning after December 15, 2025, and allows adoption on a prospective basis, with a retrospective option. The Company is in the process
of assessing the impacts and method with no early adoption of the standard<span style="font-family: Times New Roman, Times, Serif">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b>NOTE 3:-
REVENUE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Disaggregation
of Revenues</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Revenue disaggregated
by geography for the years ended December 31, 2024, 2023 and 2022, based on the billing address of the Company&#8217;s customers, consists
of the following<span style="font-family: Times New Roman, Times, Serif">:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Revenue by geography:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">China (excluding Hong Kong)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">254</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">639</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,476</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">42.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sweden</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">224</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Israel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Italy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total revenue</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">768</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,470</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,517</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Remaining Performance
Obligation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s
remaining performance obligations are comprised of product and services revenue not yet performed. As of December&#160;31, 2024 and 2023
the aggregate amount of the transaction price allocated to remaining performance obligations was $290 and $977, respectively. The Company
expects to recognize 2024 remaining performance obligations as revenue during 2025.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Prepaid Expenses and Other Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">PREPAID EXPENSES AND OTHER RECEIVABLES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">NOTE 4:- PREPAID
EXPENSES AND OTHER RECEIVABLES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Government authorities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">668</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">385</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Grants receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">308</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">310</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt">Prepaid expenses and other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,455</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,262</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.5in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,026</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
5:-  Property and Equipment</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Cost:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 11.35pt">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,838</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,448</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 11.35pt">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">831</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">582</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 11.35pt">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 11.35pt">Vehicles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,962</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,588</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt">Property and equipment, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,374</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,309</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Depreciation expense
for the years ended December 31, 2024, 2023 and 2022 was $585, $557 and $481, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
6:- LEASES</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">The
Company has six non-cancelable operating lease agreements for office spaces in Israel. The leases have original lease periods expiring
until 2027, some of which may include options to extend the leases for up to three additional years. The Company does not assume exercise
of renewal options in its determination of the lease term unless the renewals are considered as reasonably certain to be exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Supplemental
cash flow information related to leases was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Cash payments and expenses related to operating leases</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(557</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(451</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Operating lease right-of-use assets and liabilities, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Maturities
of lease liabilities as of December 31, 2024, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">563</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">466</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">2028 and after</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">905</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,462</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">454</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,008</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Supplemental
balance sheet information related to operating leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use assets</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,782</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,740</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Current maturities of operating leases</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">551</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">436</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-term operating lease liabilities</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1,457</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1,306</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Weighted average remaining lease term (in years)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.73</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted average discount rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">9.5</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">9.4</td><td style="text-align: left">%</td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
7:- COMMITMENTS AND CONTINGENT LIABILITIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company participated
in programs sponsored mainly by the Israeli Innovation Authority (&#8220;IIA&#8221;), an Israeli government agency, for the support of
its research and development activities. Through December 31, 2024, the Company had obtained grants aggregating to $3,970 for certain
of its research and development projects. The Company is obligated to pay royalties to the IIA, amounting to 4% of the sales of the products
and other related revenues generated from such projects. The maximum aggregate royalties paid generally cannot exceed 100% of the grants
received, plus annual interest generally equal to 12-months secured overnight financing rate knows as SOFR applicable to dollar deposits,
as published on the first business day of each calendar year. The obligation to pay these royalties is contingent on sales of the products
and in the absence of such sales, no payment is required.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">WARRANTS LIABILITIES</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
8:- warrants liabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company issued
in 2019 warrants to purchase a number of convertible Series B-1 convertible preferred shares, for an aggregate exercise price of $550.
As a result of the Merger and the related Recapitalization, the warrants became convertible into the Company&#8217;s ordinary shares.
The Company classified the warrants as freestanding and treated as liability pursuant to ASC 480 and remeasured every reporting period
with any change to fair value recorded within financial expenses in the statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As a result of the
Merger with ITAC, the Company assumed a derivative warrant liability related to 3,112,080 private placement warrants assumed by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company utilizes
a Black-Scholes option pricing model to estimate the fair value of the private placement warrants and the convertible warrants (hereinafter:
the &#8220;warrants&#8221;) and are considered a Level 3 fair value measurement. Black-Scholes option pricing model takes into consideration
certain parameters in computation of the fair value of the warrants which the significant parameter is expected volatility. The Company
computed a sensitivity analysis of the fair value to changes of the expected volatility. The volatility impact of +/-5% on the warrants&#8217;
fair value is approximately $28.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The warrants are
measured at each reporting period, with changes in fair value recognized in the statement of operations. During 2024, 2023 and 2022, the
Company recognized $447, $756 and $8,425, respectively, with respect with those warrants as a finance income.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Bonds<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract', window );"><strong>Convertible Bonds [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">CONVERTIBLE BONDS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="text-transform: uppercase"><b>Note
9:- CONVERTIBLE BONDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">On June 2, 2024,
the Company issued convertible bonds in the principal amount of NIS 110,000,000 (approximately $30,000). The bonds were issued pursuant
to a deed of trust dated May 30, 2024, by and between the Company and Mishmeret Trust Company Ltd., as trustee (the &#8220;Trustee&#8221;)
pursuant to a public bid under Israeli law on June 3, 2024, at a price of NIS 1,031 (approximately $0.28) per bond in the principal amount
of NIS 1,000 (approximately $0.27) pursuant to a prospectus filed with the Israel Securities Authority and the TASE. Certain classified
investors who committed to purchase bonds in advance of the public bid, received a commission in the aggregate amount of NIS 1,028,073
(approximately $278), which was recorded as a reduction of their purchase price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The proceeds from
the sale of the bonds, which were approximately NIS 112,400,000 (approximately $30,500), are held in escrow and will be released to the
Company upon meeting certain conditions by March 31, 2025, or earlier if the bonds are converted at the election of the bonds&#8217; holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The bonds will be
released to the Company upon satisfaction of the following release conditions by March 31, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The Company wins a tender or contract to supply its products
as a single supplier of chips of imaging radar (directly or through one of the international Tier 1 manufacturers) to one of ten named
major automobile manufactures.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">The average closing trading price of the Company&#8217;s
ordinary shares on Nasdaq is not less than $3.10 per share during 30 consecutive trading days, and the average combined trading volume
on Nasdaq and TASE during such 30 trading days is at least 300,000 shares per day.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">The closing price of the Company&#8217;s ordinary shares
on Nasdaq on the date the Company presents to the Trustee the documentation confirming the fulfillment of the abovementioned conditions
precedent, is not less than $3.10.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As of the date hereof,
the Company does not meet the release conditions If the conditions are not meet by March 31, 2025, the Company is to use the funds in
escrow to prepay the bonds and the Company is obligated to pay any interest or other amounts due in excess of the amount held in escrow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">During January 2025, convertible bonds,
in the principal amount of NIS 78,462,184 ($ 22.4 million) were converted and funds were released from escrow. See also Note 14b.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The above release
conditions to be satisfied by March 31, 2025, were extended to December 31, 2025 following an approval by the holder of a majority of
the outstanding bonds signed on March 20, 2025, See also Note 14c.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">Note
10:-  Shareholders&#8217; equity</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">a.</td><td style="text-align: justify">In October 2021, the Company adopted its restated articles, pursuant to which the Company&#8217;s authorized
capital consisted of 130,000,000 ordinary shares, with a par value of NIS 0.000216 per share. </td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">b.</td><td style="text-align: justify">During June 2023, the Company raised $23,000 with Special Situations Funds, pursuant to which the Company
issued a total of 11,794,873 ordinary shares at a purchase price of $1.95 per share. Existing investors, including two affiliates of the
Company&#8217;s directors, also participated in this offering. The aggregate net proceeds, after issuance costs, received by the Company
from the offering were $22,496.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">c.</td><td style="text-align: justify">During September 2024, the Company increased its authorized capital to 165,000,000 ordinary shares. The
increase in authorized capital shares was approved by the Company&#8217;s shareholders at the 2024 annual general meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">d.</td><td style="text-align: justify">In November 2024, the Company sold, in an underwritten public offering, an aggregate of (i)&#160;4,293,957&#160;ordinary
shares, (ii) prefunded warrants to purchase an aggregate of&#160;3,956,043&#160;ordinary shares (which were issued in lieu of ordinary
shares), (iii) Tranche A Warrants to purchase up to an aggregate of&#160;8,250,000&#160;ordinary shares, and (iv) Tranche B Warrants to
purchase an aggregate of&#160;8,250,000&#160;ordinary shares. Each share or pre-funded warrant, as applicable, was sold together with&#160;one&#160;Tranche
A Warrant to purchase&#160;one&#160;ordinary share and&#160;one&#160;Tranche B warrant to purchase&#160;one&#160;ordinary share. The net
proceeds from the offering, after deducting underwriting discounts and commissions and offering expenses payable by us of approximately
$13.8&#160;million.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">The Warrants were
classified in permanent equity, as the Warrants are considered indexed to the Company&#8217;s own stock and meet the additional requirements
for equity classification in accordance with ASC 815-40-25-10.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">e.</span></td><td style="text-align: justify">On January 7, 2025, the Company raised gross proceeds of $33.1 million in an underwritten registered direct
public offering. Refer to Note 14.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">f.</td><td style="text-align: justify">Share options and RSU&#8217;s:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During 2016, the
Company adopted the 2016 Share Incentive Plan (the &#8220;2016 Plan&#8221;) which provides the Company with the ability to grant its employees,
directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined by the Board of
Directors at the date of grant. Pursuant to the 2016 Plan, 3,384,454 Ordinary Shares were reserved for issuance. Each option granted under
the Plan expires no later than seven years from the date of grant or 60 days after termination of engagement. The vesting period of the
share options is generally four years. In 2024, the term of the options granted under the 2016 Plan was extended to ten years from the
date of grants. The expense related to the extension is included in stock-based compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In August 2021, the
Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive Plan (the
&#8220;2021 Plan&#8221;) which became effective on October 7, 2021. The 2021 Plan covers (a) 4,079,427 ordinary shares plus (b) and without
the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January
1, 2031, a number of Shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December 31 of the immediately
preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar year in which
the increase will occur. As of December 31, 2024, there were 7,804,378 ordinary shares subject to options under the 2021 plan and 136,101
ordinary shares reserved and available for issuance under the 2021 Plan. Following the increase in the size of the reserved and available
option pool on December 18, 2024, by an additional 3,698,746 ordinary shares, there were a total of 4,230,715 ordinary shares reserved
and available for issuance under the 2021 Plan (including any remaining ordinary shares reserved and available for issuance under the
2016 Plan).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Upon the adoption
of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under the 2016
Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not been issued
or which expired unexercised may be issued pursuant to the 2021 Plan. The vesting period of the awards is generally four years. Generally,
under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the first anniversary of
the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Share option and
RSU&#8217;s plans:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A summary of the
stock option activity under the Company&#8217;s equity plans during the years ended December 31, 2024, 2023 and 2022 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding<br/>
share<br/>
options</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Weighted-</p> <p style="margin-top: 0; margin-bottom: 0">average<br/> exercise<br/> price ($)</p></td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Aggregate<br/> intrinsic<br/> value ($ in<br/> thousands)</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Options:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Outstanding as of December&#160;31, 2021</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">5,461,337</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">3.102</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">5.363</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">16,713,971</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,630,142</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6.833</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(468,814</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5.557</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(570,451</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">0.482</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding as of December&#160;31, 2022</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,052,214</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4.166</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5.570</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7,761,705</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">430,874</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2.728</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(351,671</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7.767</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,074,162</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">0.654</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding as of December&#160;31, 2023</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,057,255</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4.543</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5.662</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,352,517</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">80,000</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1.91</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(291,124</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6.08</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(255,756</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">0.81</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><b>Outstanding as of December&#160;31, 2024 </b></td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">4,590,375</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">4.62</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">5.87</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">1,364,975</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Exercisable as of December&#160;31, 2024</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">3,716,507</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">4.43</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">5.42</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">1,364,975</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Options available for future grants</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">531,969</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A summary of the Company&#8217;s
RSUs activity during the years ended December 31, 2024, 2023 and 2022 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Numbers of RSUs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">RSUs:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Outstanding as of December&#160;31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,968,794</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,619,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(417,025</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(573,583</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December&#160;31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,598,084</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,908,983</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(370,067</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(895,170</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December&#160;31, 2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,241,830</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,377,834</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(432,018</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,274,523</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Outstanding as of December&#160;31, 2024</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,913,123</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Fair value
factors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The following table
sets forth the parameters used in computation of the options compensation to employees and service providers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Expected term, in years</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.82</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.41-6.11</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">51.75</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">47%-51.75</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">47%-48</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.23</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">4.15%-4.55</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">1.74%-3.96</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected dividend yield</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Fair value<span style="font-family: Times New Roman, Times, Serif">:</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The fair value of
the ordinary shares is the market price of the ordinary shares on the date of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Expected volatility:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As the Company was
privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock options. Therefore,
the Company uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly
traded companies which were selected based upon industry similarities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Expected term
(years):</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Expected term represents
the period that the Company&#8217;s option grants are expected to be outstanding. There is not sufficient historical share exercise data
to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method to value option grants.
Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting term and the contractual
term of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Risk-free interest
rate:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company determined
the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect
as of the date of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Expected dividend
yield:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company does
not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
following table presents stock-based compensation expense to employees included in the Company&#8217;s consolidated statements of operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,684</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,721</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,726</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,384</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,786</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,537</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">287</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">276</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">127</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14,542</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,012</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,793</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>Share
based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits related
to the </span>stock<span>-based compensation for the years ended December&#160;31, 2024, 2023 and 2022.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-weight: normal">The
Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above grants of stock-based compensation issued
to service providers their fair value using Black-Scholes model, which requires inputs such as exercise price, estimated ordinary share
price, expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2024, 2023 and 2022, the
Company recognized the total fair value of the stock-based compensation of development-related service providers in the amounts of $1,186,
$629 and $354, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NOTE 11:- NET LOSS PER
SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-weight: normal; ">The
following table sets forth the computation of basic and diluted net loss per ordinary share for the periods presented: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;<b>Year ended </b>&#160;<b>December 31,</b></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2024</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><b><span style="text-decoration:underline">Basic</span></b></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><b>Numerator:</b></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt; width: 64%; text-align: left">Net loss</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(49,317</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(43,500</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(40,494</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-indent: -10pt"><b>Denominator:</b></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">80,949,032</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">72,021,520</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">63,489,983</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Loss per share attributable to ordinary shareholders, basic</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(0.61</td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(0.60</td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(0.64</td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>

</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Diluted</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Adjusted Net loss*</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(44,696</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(41,698</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Denominator:</b></p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">80,949,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">72,053,372</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">63,629,206</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left">Loss per share attributable to ordinary shareholders, diluted*</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.66</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#8217;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(49,317</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(43,500</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(40,494</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Revaluation of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(196</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,204</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Adjusted Net loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(44,696</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(41,698</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0pt"><span style="font-weight: normal">The
potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2024, 2023 and 2022 because including them would have been anti-dilutive are as follows:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Convertible bonds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,542,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,796,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,080</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Outstanding share options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,503,498</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,299,085</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,650,298</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">44,842,077</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">12,411,165</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,762,378</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NOTE 12:- TAXES ON INCOME</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">a.</td><td style="text-align: justify">General:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>Israeli tax rate:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Corporate tax
rate in Israel relevant to the Company is 23% in 2024, 2023 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><i>United States:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s
United States subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of 21%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">b.</td><td style="text-align: justify">Loss before income taxes:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The following
are the domestic (i.e. Israeli) and foreign components of the Company&#8217;s loss before income taxes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Domestic</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(49,317</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(43,500</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(40,494</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(43,500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(40,494</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">c.</td><td style="text-align: justify">Taxes on income:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The reconciliation
of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#8217;s reported income tax (benefit)
is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt">Loss before income taxes, as reported in the consolidated statements of operations</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">49,317</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">43,500</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">40,494</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Statutory tax rate</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax benefit at statutory tax rate</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,343</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(10,005</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(9,314</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of Non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">475</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Remeasurement of deferred taxes from currency exchange*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,517</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,322</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(566</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Reported income taxes benefit</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>*</b></td><td style="text-align: justify">The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.</td>
</tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">d.</td><td style="text-align: justify">Net operating loss carryforward:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>As
of December&#160;31, 2024, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $157,627 These
net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">e.</td><td style="text-align: justify">Deferred tax assets and liabilities:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Deferre d tax
assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The principal components
of the Company&#8217;s deferred tax assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 76%; text-align: left">Net operating loss carry forwards</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,254</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">28,032</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,252</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Employees and payroll accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">299</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total deferred tax assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,432</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,662</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,662</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Deferred tax assets, net of valuation allowance</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Based on the available
evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net operating loss carryforwards
and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has been provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">f.</td><td style="text-align: justify">Tax assessments:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Israeli
entity&#8217;s&#8217; income tax assessments are considered final through 2019<span style="font-size: 10pt; ">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">g.</td><td style="text-align: justify">Unrecognized Tax Benefits:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>As
of December&#160;31, 2024, 2023 and 2022, the Company did not have any unrecognized tax benefits and does not expect that the amount of
unrecognized tax benefits will change significantly within the next 12 months. The Company&#8217;s accounting policy is to accrue interest
and penalties related to an underpayment of income taxes as a component of income tax expense.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>NOTE 13:- SEGMENT INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
Company operates in one operating and reportable segment. Operating segments are defined as components of an enterprise about which separate
financial information is evaluated regularly by the chief operating decision maker, who is the Company&#8217;s chief executive officer,
in deciding how to allocate resources and assessing performance. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
segment structure reflects the financial information and reports used by the Company&#8217;s management, specifically its CODM, to make
decisions regarding the Company&#8217;s business, including resource allocations and performance assessments, as well as the current operating
focus in compliance with ASC&#160;280,&#160;Segment Reporting. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
Company&#8217;s chief operating decision maker allocates resources and assesses performance based upon discrete financial information
at the consolidated level. As a single reportable segment entity, the Company&#8217;s segment performance measure is net loss. The Company
adopted ASU 2023-07 in December 2024. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><b>Major Customers:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During the year ended December 31,
2024, the Company had four customers that accounted for 19.5%, 18.4%, 16.9% and 14.5%, respectively, of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During the year ended December 31,
2023, the Company had three customers that accounted for 38.9%, 18.1% and 12.7%, respectively, of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">During the year ended December 31,
2022, the Company had three customers that accounted for 33.4%, 19.4% and 18.9%, respectively, of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">No other customer accounted for 10%
or more of revenues in 2024, 2023 or 2022. The 10% customers were different customers in each of 2024, 2023 and 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>NOTE 14:- SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">a.</td><td style="text-align: justify">On January 7, 2025, the Company raised gross proceeds of $33.1 million in an underwritten registered public
offering, for the sale of 10,332,031 ordinary shares at a purchase price of $3.20 per share. The aggregate net proceeds received by us
from the offering were $30.9 million,&#160;net of underwriting discounts and other offering costs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">b.</td><td style="text-align: justify">During January 2025, convertible bonds in the principal amount of NIS 78,462,184 were converted into 8,233,177
ordinary shares, and $22.4 million (including interest) were released from the escrow to the Company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 20, 2025, following approval by the holders of a majority of the outstanding bonds, the the Company and the trustee entered into an amendment to the deed of trust pursuant to which, among other changes, date by which the Company must meet the conditions to the release of the funds from escrow was extended from March 31, 2025 to December 31, 2025.</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Risk Management</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We manage significant and persistent cybersecurity
risks due to the need to protect our business, including our intellectual property and intellectual property of others that is licensed
for our use, our confidential information and information concerning our personnel and others with whom we conduct business. As other
technology companies we occasionally face threats from actors who seek to disrupt our business as well as others who are engaging in malicious
activities or for reputation damage. Disclose of certain information as a result of a cybersecurity breach may result in a breach of privacy
laws. The substantial level of harm that could occur to us and our suppliers and customers were we to suffer impacts of a material cybersecurity
incident; and our use of third-party products, services and components requires us to maintain robust governance and oversight of these
risks and to implement mechanisms, technologies and processes designed to help us assess, identify, and eliminate these risks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we have not, as of the date of this Form
20-F, experienced a cybersecurity threat or incident that resulted in a material adverse impact to our business or operations, we cannot
assure you that we will not experience such an incident in the future. While we did suffer a cybersecurity incident in 2023 which did
not result in any material adverse impact to our business, we did not experience any disclosure of our proprietary information, and following
such incident we took additional steps to protect ourselves from cybersecurity incidents. Any cybersecurity incidents, whether or not
successful, could result in our incurring additional costs related to, for example, rebuilding our internal systems, implementing additional
threat protection measures, responding to regulatory inquiries or actions, paying damages or making payments to obtain access to our computer
systems, or taking other remedial steps with respect to third parties, as well as incurring significant reputational harm. We have seen
an increase in cyberattack volume, frequency, and sophistication. We seek to detect and investigate unauthorized attempts and attacks
against our network, products, and services, and to prevent their occurrence and recurrence where practicable through changes or updates
to our internal processes and tools and changes or updates to our products and services; however, while diligently taking actions to eliminate
and reduce cyber risks, we remain potentially vulnerable to known or unknown threats. In some instances, we, our suppliers, our customers,
and the users of our products and services can be unaware of a threat or incident or its magnitude and effects. Further, there are increasing
regulation requirements regarding responses to cybersecurity incidents, including reporting to regulators, which could subject us to additional
liability and reputational harm.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">we cannot
assure you that we will not experience such an incident in the future.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">While we did suffer a cybersecurity incident in 2023 which did
not result in any material adverse impact to our business, we did not experience any disclosure of our proprietary information, and following
such incident we took additional steps to protect ourselves from cybersecurity incidents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">In addition, and as part of our policy, our CISO is also responsible for informing the Audit Committee of material
cybersecurity threats and incidents, based on management&#8217;s assessment of risk.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our board of directors has overall oversight responsibility
for our risk management, and delegates cybersecurity risk management oversight to the audit committee of our board of directors (the &#8220;Audit
Committee&#8221;). Under our cybersecurity governance framework the Audit Committee, in its charter, is empowered to implement and oversee
our cybersecurity and information security policies and periodically review their compliance and mitigate potential cybersecurity threats.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">The Audit Committee is responsible for ensuring that management has in place processes designed to identify and assess cybersecurity risks,
and implement processes and programs designed to manage and mitigate and remediate such risks and incidents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Governance</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We aim to incorporate industry best practices
throughout our cybersecurity program. Our cybersecurity strategy focuses on implementing effective and efficient controls, technologies,
and other processes to assess, identify, and manage material cybersecurity risks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our cybersecurity program is designed to be aligned
with applicable industry standards, and we have engaged outside sources to assist in this effort. We have processes in place to assess,
identify, manage, and address material cybersecurity threats and incidents. We have ISO 27001:2013 certification, which is an early standard
for information security management. Steps taken by us include, among other things: an audit which was conducted by the company&#8217;s
internal auditor during 2023 through 2024 of the cybersecurity measures and practices of the Company, the engagement with professional
service providers (such as a chief information security officer (&#8220;CISO&#8221;) and security operations center services), security
awareness training for employees; mechanisms to detect and monitor unusual network activity; and containment and incident response tools.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We monitor issues that are internally discovered
or externally reported that may affect our products and have processes to assess those issues for potential cybersecurity impact or risk.
We also have a process in place to manage cybersecurity risks associated with third-party service providers. We are in the process of
implementing additional technical and organizational security measures to follow our information security program.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our CISO, who is a third party engaged by us,
and our VP infrastructure, lead the strategy and guidelines, and work with senior management and IT engineering, to operate and implement
cybersecurity of the Company. The CISO is responsible for handling the risk management by assessment, analysis, reporting, managing the
cyber protection following the relevant requirements, the work with the Information Technology team, implementing information security
awareness among the employees, and updating the company&#8217;s security policies. Our CISO provides annual analysis and updates to the
management on our cybersecurity and information security policies and programs, as well as ad hoc updates on information security and
cybersecurity matters. The CISO and management provide updates to the Audit Committee on the Company&#8217;s cybersecurity policies, risks
and mitigation strategies. In addition, and as part of our policy, our CISO is also responsible for informing the Audit Committee of material
cybersecurity threats and incidents, based on management&#8217;s assessment of risk. Our board of directors has overall oversight responsibility
for our risk management, and delegates cybersecurity risk management oversight to the audit committee of our board of directors (the &#8220;Audit
Committee&#8221;). Under our cybersecurity governance framework the Audit Committee, in its charter, is empowered to implement and oversee
our cybersecurity and information security policies and periodically review their compliance and mitigate potential cybersecurity threats.
The Audit Committee is responsible for ensuring that management has in place processes designed to identify and assess cybersecurity risks,
and implement processes and programs designed to manage and mitigate and remediate such risks and incidents. Both management and the Audit
Committee also report material cybersecurity risks to our full board of directors, based on management&#8217;s assessment of risk.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">a.</td><td style="text-align: justify">Basis of presentation:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The consolidated financial statements
have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant
accounting policies followed in the preparation of the financial statements applied on a consistent basis for all years presented in these
financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The consolidated
financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">b.</td><td style="text-align: justify">Use of estimates:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The preparation
of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions
including fair value of warrants, stock-based compensation and the underlying fair value of the Company&#8217;s ordinary shares issued
prior to the Merger.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company bases
these estimates on historical and anticipated results, trends and other assumptions that it believes are reasonable under the circumstances,
including assumptions as to future events. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Consolidated financial statements in U.S. dollars</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">c.</td><td style="text-align: justify">Consolidated financial statements in U.S. dollars:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A substantial portion
the Company&#8217;s activity including transactions with customers, as well as equity transactions and cash investments, are incurred
in U.S. dollars. The Company&#8217;s management believes that the U.S. dollar is the currency of the primary economic environment in which
the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The subsidiaries
functional currency is the currency of the primary economic environment in which the subsidiaries operate; normally, that is the currency
of the environment in which the subsidiaries primarily generate and expend cash. In making the determination of the appropriate functional
currency for the subsidiaries, the Company considers cash flow indicators, local market indicators, financing indicators and the subsidiaries&#8217;
relationship with both the parent company and other subsidiaries. The Company has determined the functional currency of its subsidiaries
to be the U.S. dollar.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Monetary accounts
maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting Standard
Codification (&#8220;ASC&#8221;) No. 830 &#8220;Foreign Currency Matters&#8221; (&#8220;ASC No. 830&#8221;). All transaction gains and
losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or expenses as
appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Transactions in foreign currency are
translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, <i>Foreign Currency Transaction</i>. Monetary
assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing
rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the
exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities denominated in currencies
other than the respective functional currencies are included in the consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">d.</td><td style="text-align: justify">Concentration of credit risk:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Most of the Company&#8217;s
cash and cash equivalents, restricted cash, short-term deposits and funds held in escrow were deposited with Israeli banks and were comprised
mainly of cash deposits and short-term deposits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
Company&#8217;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#8217; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and cash equivalents and restricted cash</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">e.</td><td style="text-align: justify">Cash and cash equivalents and restricted cash:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company considers all highly liquid
short-term deposits with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist
primarily of amounts invested in short-term deposits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Restricted cash consists of deposits
at a financial institution that serves as collateral for a credit card agreement and lease agreements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShortTermDepositsPolicyPolicyTextBlock', window );">Short term deposits</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">f.</td><td style="text-align: justify">Short term deposits:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Short-term deposits are bank deposits
with an original maturity of more than three months and less than one year from the date of acquisition. The deposits are presented according
to their terms of deposit. As of December 31, 2024 and 2023, these bank deposit bearing annual interest rates in the range of&#160;4%-6%.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">g.</td><td style="text-align: justify">Fair value of financial instruments:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The estimated fair value of financial
instruments has been determined by the Company using available market information and valuation methodologies. Considerable judgment is
required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company could realize in a current
market exchange. The following methods and assumptions were used by the Company in estimating the fair value of their financial instruments:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The carrying values of cash and cash
equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables, employees and payroll accruals,
accrued expenses and other current liabilities approximate their fair values due to the short-term maturities of these instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company applies ASC No. 820, &#8220;Fair
Value Measurements and Disclosures&#8221; (&#8220;ASC No. 820&#8221;), with respect to fair value measurements of all financial assets
and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term deposits and warrant liability at fair value.
Short-term deposits are classified within Level&#160;1 because these assets are valued using quoted market prices. Fair value represents
the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in
pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for
inputs used in the valuation methodologies in measuring fair value:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 1&#8212;Observable inputs that reflect quoted prices (unadjusted)
for identical assets or liabilities in active markets.</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 2&#8212;Include other inputs that are directly or indirectly
observable in the marketplace.</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Level 3&#8212;Unobservable inputs which are supported by little
or no market activity.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The fair value hierarchy also requires
an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">In
connection with the October 7, 2021 merger with Industrial Tech Acquisition Corp. (&#8220;ITAC&#8221;), the Company (i) assumed a derivative
warrant liability related to Company&#8217;s warrants that were issued to the holders of private placement warrants that had been issued by
ITAC in connection with its initial public offering, and (ii) issued equity instrument in connection with warrants that had been issued
as part of ITAC&#8217;s initial public offering and, pursuant to the Merger, became warrants to purchase the Company&#8217;s ordinary
shares. The fair value of the Company&#8217;s public warrants is measured based on the market price of such warrants and are considered
a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private
placement warrants which are considered a Level 3 fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
Company&#8217;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
Refer to Note 8.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">For
convertible bonds measurement under fair value, see 2u below.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock', window );">Trade receivables, net</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">h.</td><td style="text-align: justify">Trade receivables, net</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#8217;s best estimate of the amount of credit losses with respect to its existing trade receivable.
The Company&#8217;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#8220;CECL&#8221;) standard.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; ">The Company
estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#8217;s customers to
make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected
credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions
and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#8217;s ongoing evaluation of collectability,
customer creditworthiness, historical levels of credit losses, and future expectations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; ">The
allowance for credit losses for the year ended December 31, 2024, recorded for the first time, was $896 and <span style="-sec-ix-hidden: hidden-fact-51"><span style="-sec-ix-hidden: hidden-fact-52">not</span></span> material for the years
ended December 31, 2023 and 2022.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">i.</td><td style="text-align: justify">Property and equipment:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Property and equipment
are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost
of assets disposed and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
statement of operation. Repair and maintenance costs are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and peripheral equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">15-33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">7-15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Vehicles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><div style="-sec-ix-hidden: hidden-fact-50">(*)</div></td><td style="text-align: left"></td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">j.</td><td style="text-align: justify">Impairment of long-lived assets:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Long-lived assets
are reviewed for impairment in accordance with ASC 360, &#8220;Property, Plant and Equipment&#8221; a (&#8220;ASC 360&#8221;), whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when the carrying
value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to be recognized
is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December 31, 2024,
2023 and 2022, no impairment losses were identified.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Accrued post-employment benefit</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">k.</td><td style="text-align: justify">Accrued post-employment benefit:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The employees of
Arbe Ltd. are included under section 14 of the Israeli Severance Compensation Act, 1963 (&#8220;Section 14&#8221;). Pursuant to Section
14, the Company&#8217;s Israeli employees are entitled to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited
on their behalf to their chosen insurance funds. By making the payments in accordance with Section 14, the Company is released from any
future severance payments in respect of those employees. The obligation to make the monthly deposits is expensed as incurred. The deposits
pursuant to Section 14 are not recorded as an asset in the consolidated balance sheet, and there is no liability recorded as the Company
does not have a future obligation to make any additional payments. Severance costs amounted to approximately $1,227, $1,166 and $1,240
for the years ended December 31, 2024, 2023 and 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company&#8217;s U.S. subsidiary
has a 401(k) defined contribution plan covering one employee in the United States. The expense recorded by the U.S. subsidiary for matching
contributions for the years ended December 31, 2024, 2023 and 2022 were immaterial.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based compensation</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">l.</td><td style="text-align: justify">Stock-based compensation:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for stock-based compensation in accordance with ASC 718, &#8220;Compensation - Stock Compensation&#8221;, which requires the measurement
and recognition of compensation expense based on estimated fair values for all stock-based payment awards made to employees, nonemployees
and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing
model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the Company&#8217;s statements
of operations over the applicable service periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company measures its stock-based
payment awards made to employees, directors, and non-employee service providers based on estimated fair values. The fair value of each
option award is estimated on the grant date using the Black-Scholes option pricing model which requires several assumptions, of which
the most significant are the expected share price volatility and the expected option term. The Company recognizes forfeitures of equity-based
awards as they occur. For graded vesting awards, the Company recognizes compensation expenses based on the straight-line method over the
applicable service period.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net loss per ordinary share</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">m.</td><td style="text-align: justify">Net loss per ordinary share:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company computes net loss per
share using the two-class method required for participating securities. There were no participating securities in the years ended December
31, 2024, 2023 and 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company&#8217;s basic net loss
per ordinary share is calculated by dividing net loss by the weighted-average number of ordinary shares outstanding for the period, without
consideration of potentially dilutive securities. The diluted net loss per ordinary share is calculated by giving effect to all potentially
dilutive securities outstanding for the period using the treasury share method or the if-converted method based on the nature of such
securities. Diluted net loss per ordinary share is the same as basic net loss per share in periods when the effects of potentially dilutive
shares of ordinary shares are anti-dilutive. Refer to Note 11.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Other Comprehensive loss</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">n.</td><td style="text-align: justify">Other comprehensive loss:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company has no components of comprehensive
loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">p.</td><td style="text-align: justify">Revenue recognition:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company follows the provisions
of ASC Topic 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;), which apply to all contracts with customers. Under Topic
606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition
for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Identify the contract(s) with a customer;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Identify the performance obligations in the contract;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Determine the transaction price;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Allocate the transaction price to the performance obligations
in the contract; and</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify">Recognize revenue when (or as) the entity satisfies a performance
obligation.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">At contract inception, once the contract
is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines
the performance obligations and assesses whether each promised good or service is distinct<span style="font-family: Times New Roman, Times, Serif">.</span>
The Company evaluates each performance obligation to determine if it is satisfied at a point in time or over time. Refer to Note 3.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i>Nature of Products and Services</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company derives its revenues mainly
from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional services. Revenue from chipsets
and prototype radar systems is recognized at the point in time when the control of the goods is transferred to the customer, generally
upon delivery, and the Company has no remaining performance obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i>Right of Return</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company&#8217;s general terms
and conditions for its contracts do not contain a right of return that allows the customer to return products and receive a credit. Therefore,
the Company does not estimate returns and generally recognizes revenue at contract price upon product delivery.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of revenues</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">q.</td><td style="text-align: justify">Cost of revenues:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Cost of revenue includes the manufacturing
cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and development expenses, net</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">r.</td><td style="text-align: justify">Research and development expenses, net:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Research and development costs, net
of grants received, are charged to the consolidated statement of operations as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">s.</td><td style="text-align: justify">Income taxes:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">The Company accounts for income taxes
in accordance with ASC 740, &#8220;Income Taxes&#8221;. This standard prescribes the use of the asset and liability method whereby deferred
tax asset and liability account balances are determined based on differences between the financial statement carrying amount and the tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are
expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is more
likely than not to be realized<span style="font-family: Times New Roman, Times, Serif">.</span> The Company recognizes the tax benefit
from a tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. A tax position that meets the more-likely-than-not recognition threshold is measured at
the largest amount that is greater than 50 percent likely of being realized upon settlement with the taxing authority using the facts,
circumstances, and information available at the reporting date.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentLiabilityReserveEstimatePolicy', window );">Contingent Liabilities</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">t.</td><td style="text-align: justify">Contingent liabilities</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for its contingent liabilities in accordance with ASC No.&#160;450, &#8220;Contingencies.&#8221; A provision is recorded when it is both
probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions
are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
information and events pertaining to a particular matter. As of December&#160;31, 2024 and 2023, the Company is not a party to any litigation
that could have a material adverse effect on the Company&#8217;s business, financial position, results of operations or cash flows.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ConvertibleBondsPolicyTextBlock', window );">Convertible bonds</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">u.</td><td style="text-align: justify">Convertible bonds:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company recognized
its convertible bonds as a liability and the cash held in escrow as other assets funds held in escrow, in the balance sheet. As the convertible
debt contained embedded features not closely related to the host contract, the Company elected to apply the fair value option to it. The
fair value of the convertible bonds is measured under FV level 1 and is based on the quoted price of the bonds on the TASE. The Company
elected to measure the bonds initially and subsequently at fair value. Thus, the convertible bonds&#8217; issuance costs expensed as incurred
to statement of operations. The fair value of the convertible debt is based on its quoted price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company recorded
financial income amounting to $81 for the year ended on December 31, 2024. Refer to Note 9.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">v.</td><td style="text-align: justify">Leases:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company accounts
for leases under Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The Company elected
the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize a lease liability
and a right-of-use (&#8220;ROU&#8221;) asset on the balance sheet for leases with a term of twelve months or less. The Company recognizes
the associated lease payments on such leases in the consolidated statements of income on a straight-line basis over the lease term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Under Topic 842,
the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement date based
on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable payments
at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental borrowing
rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing
rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset is recorded
net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain
that the Company will exercise such options.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Payments under the
Company&#8217;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common area maintenance,
real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. Refer to Note 6.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Impact of recently issued accounting standard</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">w.</td><td style="text-align: justify">Impact of recently issued accounting standard:</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In November 2023,
the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their
reportable segments&#8217; significant expenses and other segment items on an annual basis. Public entities with a single reportable segment
are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements
in ASC 280 on an annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted.
The Company adopted ASU 2023-07 during the year ended December 31, 2024. Refer to Note 13.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recently not yet adopted accounting pronouncements</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">x.</td><td style="text-align: justify">Recently not yet adopted accounting pronouncements<span style="font-family: Times New Roman, Times, Serif">:</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic
220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense
categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning
after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is in the
process of assessing the impacts and method with no early adoption of the standard<span style="font-family: Times New Roman, Times, Serif">.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">ASU 2023-09, Improvements
to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components
of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The ASU will be effective for fiscal years
beginning after December 15, 2025, and allows adoption on a prospective basis, with a retrospective option. The Company is in the process
of assessing the impacts and method with no early adoption of the standard<span style="font-family: Times New Roman, Times, Serif">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ConvertibleBondsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy convertible bonds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ConvertibleBondsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShortTermDepositsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Policy disclosure of short term deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShortTermDepositsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentLiabilityReserveEstimatePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentLiabilityReserveEstimatePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org/705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossFinancialInstrumentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.M.2.Q4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483530/326-20-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479391/326-20-30-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-3C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479366/326-20-35-8A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-3D<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479175/326-30-30-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-3C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-3A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-3D<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 13A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479148/326-30-35-13A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479391/326-20-30-4A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479148/326-30-35-7A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-21<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossFinancialInstrumentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org/250/tableOfContent<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock', window );">Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and peripheral equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">15-33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">7-15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Vehicles</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">15</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><div style="-sec-ix-hidden: hidden-fact-50">(*)</div></td><td style="text-align: left"></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the useful lives of property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue Disaggregated by Geography</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">Revenue disaggregated
by geography for the years ended December 31, 2024, 2023 and 2022, based on the billing address of the Company&#8217;s customers, consists
of the following<span style="font-family: Times New Roman, Times, Serif">:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% of<br/>
 Revenue</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Revenue by geography:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">China (excluding Hong Kong)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">254</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">639</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,476</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">42.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Hong Kong</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sweden</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">224</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">284</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Israel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.4</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Italy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.5</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.6</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total revenue</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">768</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,470</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,517</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Prepaid Expenses and Other Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Receivables</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Government authorities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">668</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">385</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Grants receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">308</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">310</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 1.5pt">Prepaid expenses and other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,455</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,262</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0.5in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,500</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,026</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Cost:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 11.35pt">Computers and peripheral equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,838</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,448</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 11.35pt">Leasehold improvement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">831</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">582</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 11.35pt">Office furniture and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 11.35pt">Vehicles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">149</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,962</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,312</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,588</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,003</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 2.85pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt">Property and equipment, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,374</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,309</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Supplemental
cash flow information related to leases was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify">Cash payments and expenses related to operating leases</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(557</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(451</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Operating lease right-of-use assets and liabilities, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Supplemental
balance sheet information related to operating leases were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating lease right-of-use assets</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,782</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,740</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Current maturities of operating leases</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">551</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">436</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-term operating lease liabilities</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1,457</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">1,306</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Weighted average remaining lease term (in years)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.73</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5.5</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted average discount rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">9.5</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">9.4</td><td style="text-align: left">%</td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">Maturities
of lease liabilities as of December 31, 2024, were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"><span style="font-weight: normal; text-transform: none">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">563</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">466</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">2028 and after</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">905</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,462</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Less imputed interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">454</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,008</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders&#8217; Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A summary of the
stock option activity under the Company&#8217;s equity plans during the years ended December 31, 2024, 2023 and 2022 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding<br/>
share<br/>
options</b></span></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Weighted-</p> <p style="margin-top: 0; margin-bottom: 0">average<br/> exercise<br/> price ($)</p></td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> average<br/> remaining<br/> contractual<br/> life (years)</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Aggregate<br/> intrinsic<br/> value ($ in<br/> thousands)</td> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Options:</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-weight: bold">Outstanding as of December&#160;31, 2021</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">5,461,337</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">3.102</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">5.363</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 9%; text-align: right">16,713,971</td> <td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,630,142</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6.833</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(468,814</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5.557</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(570,451</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">0.482</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding as of December&#160;31, 2022</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,052,214</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4.166</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5.570</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7,761,705</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">430,874</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2.728</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(351,671</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7.767</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,074,162</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">0.654</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding as of December&#160;31, 2023</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,057,255</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4.543</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5.662</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,352,517</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">80,000</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1.91</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>Forfeited</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(291,124</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6.08</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(255,756</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">0.81</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><b>Outstanding as of December&#160;31, 2024 </b></td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">4,590,375</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">4.62</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">5.87</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">1,364,975</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Exercisable as of December&#160;31, 2024</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">3,716,507</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">4.43</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">5.42</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">1,364,975</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td>&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Options available for future grants</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="border-bottom: Black 4pt double; text-align: right">531,969</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td> <td style="padding-bottom: 4pt; text-align: right">&#160;</td> <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of RSUs Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">A summary of the Company&#8217;s
RSUs activity during the years ended December 31, 2024, 2023 and 2022 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Numbers of RSUs</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">RSUs:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; font-weight: bold">Outstanding as of December&#160;31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,968,794</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,619,898</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(417,025</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(573,583</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December&#160;31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,598,084</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,908,983</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(370,067</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(895,170</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December&#160;31, 2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,241,830</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,377,834</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(432,018</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,274,523</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 4pt">Outstanding as of December&#160;31, 2024</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,913,123</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Compensation to Employees</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The following table
sets forth the parameters used in computation of the options compensation to employees and service providers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Expected term, in years</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6.11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.82</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4.41-6.11</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">51.75</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">47%-51.75</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">47%-48</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.23</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">4.15%-4.55</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: right">1.74%-3.96</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected dividend yield</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share Based Compensation Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span>The
following table presents stock-based compensation expense to employees included in the Company&#8217;s consolidated statements of operations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,684</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,721</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,726</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,384</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,786</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,537</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">287</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">276</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">127</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total stock-based compensation expense</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14,542</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">13,012</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">8,793</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><span style="font-weight: normal; ">The
following table sets forth the computation of basic and diluted net loss per ordinary share for the periods presented: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">&#160;<b>Year ended </b>&#160;<b>December 31,</b></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2024</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td>
    <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><b><span style="text-decoration:underline">Basic</span></b></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 10pt; text-indent: -10pt"><b>Numerator:</b></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt; width: 64%; text-align: left">Net loss</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(49,317</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(43,500</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(40,494</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-indent: -10pt"><b>Denominator:</b></td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">80,949,032</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">72,021,520</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: right">63,489,983</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Loss per share attributable to ordinary shareholders, basic</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(0.61</td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(0.60</td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td>
    <td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td>
    <td style="border-bottom: Black 4pt double; text-align: right">(0.64</td>
    <td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>

</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Diluted</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Numerator:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Adjusted Net loss*</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(44,696</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(41,698</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Denominator:</b></p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">80,949,032</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">72,053,372</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">63,629,206</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left">Loss per share attributable to ordinary shareholders, diluted*</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.61</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.66</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-weight: normal">&#160;</span></p>

<table cellpadding="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td style="text-align: justify"><span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#8217;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock', window );">Schedule of Adjusted Loss Per Share</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(49,317</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(43,500</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(40,494</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Revaluation of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(196</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,204</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Adjusted Net loss</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(44,696</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(41,698</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0pt"><span style="font-weight: normal">The
potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2024, 2023 and 2022 because including them would have been anti-dilutive are as follows:</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Convertible bonds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,542,497</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,796,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,080</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Outstanding share options</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,503,498</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,299,085</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,650,298</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">44,842,077</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">12,411,165</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,762,378</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of adjusted net income (Loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Taxes on Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Company&#8217;s Loss Before Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The following
are the domestic (i.e. Israeli) and foreign components of the Company&#8217;s loss before income taxes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Domestic</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(49,317</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(43,500</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(40,494</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(49,317</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(43,500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(40,494</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation Income Tax Benefit</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The reconciliation
of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#8217;s reported income tax (benefit)
is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"><b>Year
ended December 31,</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt">Loss before income taxes, as reported in the consolidated statements of operations</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">49,317</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">43,500</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">$</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">40,494</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Statutory tax rate</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax benefit at statutory tax rate</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,343</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(10,005</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(9,314</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of Non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,573</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">475</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Remeasurement of deferred taxes from currency exchange*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,517</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,322</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(566</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Reported income taxes benefit</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>*</b></td><td style="text-align: justify">The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">The principal components
of the Company&#8217;s deferred tax assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 76%; text-align: left">Net operating loss carry forwards</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,254</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">28,032</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,252</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Employees and payroll accrual</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">299</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Property and equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total deferred tax assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,432</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,662</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42,432</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,662</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Deferred tax assets, net of valuation allowance</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details)<br> &#8362; / shares in Units, $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 07, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 04, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 02, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 02, 2024 </div>
<div>ILS (&#8362;) </div>
<div>&#8362; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralPartnersOfferingCosts', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 110,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SecuritiesSoldPerUnits', window );">Securities sold per unit (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_PreFundedWarrantInLieuOfOrdinaryShare', window );">Lieu amount of ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_PreFundedWarrantMember', window );">Pre-Funded Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,956,043<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheAWarrantsMember', window );">Tranche A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheBWarrantsMember', window );">Tranche B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember', window );">Convertible Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Principal amount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 9.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Gross proceeds (in Dollars) | $</a></td>
<td class="nump">$ 55,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=arbe_ITACMember', window );">ITAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,866,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,735,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Ordinary share issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Tranche A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PublicWarrantsMember', window );">Public Warrants [Member] | ITAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,623,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PrivateWarrantsMember', window );">Private Warrants [Member] | ITAC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,112,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PIPEMember', window );">PIPE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_TransactionCosts', window );">Transaction costs (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary shares par value (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems', window );"><strong>General [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Total gross proceeds (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other offering expenses payable (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_PreFundedWarrantInLieuOfOrdinaryShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of pre funded warrant in lieu of ordinary share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_PreFundedWarrantInLieuOfOrdinaryShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SecuritiesSoldPerUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of securities sold per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SecuritiesSoldPerUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralPartnersOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of offering costs allocated to the general partner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralPartnersOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesGeneralDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesGeneralDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=arbe_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=arbe_ITACMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=arbe_ITACMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_PIPEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_PIPEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit losses</a></td>
<td class="nump">$ 896<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SeverancePercentageOfMonthlySalary', window );">Deposits rate</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance Costs</a></td>
<td class="nump">$ 1,227<span></span>
</td>
<td class="nump">$ 1,166<span></span>
</td>
<td class="nump">$ 1,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Tax percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Financial income</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid', window );">Bank deposit bearing annual interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesDetailsLineItems', window );"><strong>Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid', window );">Bank deposit bearing annual interest rate</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SeverancePercentageOfMonthlySalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of monthly salary monthly severance rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SeverancePercentageOfMonthlySalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average rate paid on interest-bearing demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1406<br> -Paragraph a<br> -Subparagraph (2)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph c<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph a<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph a<br> -Subparagraph (3)<br> -Publisher SEC<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)<br></strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems', window );"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems', window );"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems', window );"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems', window );"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems', window );"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems', window );"><strong>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">$ 290<span></span>
</td>
<td class="nump">$ 977<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Revenue Disaggregated by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 1,470<span></span>
</td>
<td class="nump">$ 3,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China (excluding Hong Kong) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 639<span></span>
</td>
<td class="nump">$ 1,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">33.10%<span></span>
</td>
<td class="nump">43.50%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_HK', window );">Hong Kong [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 266<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SE', window );">Sweden [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 247<span></span>
</td>
<td class="nump">$ 1,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="nump">16.80%<span></span>
</td>
<td class="nump">36.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">Germany [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IT', window );">Italy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">Switzerland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=arbe_OtherGeographicalMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevenueByGeographyAbstract', window );"><strong>Revenue by geography:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">% of Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RevenueByGeographyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RevenueByGeographyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_HK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_HK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=arbe_OtherGeographicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=arbe_OtherGeographicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Receivables - Schedule of Prepaid Expenses and Other Receivables (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract', window );"><strong>Schedule of Prepaid Expenses and Other Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GovernmentAuthorities', window );">Government authorities</a></td>
<td class="nump">$ 668<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposits</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Grants receivable</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent', window );">Total</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 2,026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_GovernmentAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Authorities means any national, provincial, municipal or local government, administrative or regulatory body or department, court, tribunal, arbitrator or any body that exercises the function of a regulator.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_GovernmentAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">$ 557<span></span>
</td>
<td class="nump">$ 481<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,962<span></span>
</td>
<td class="nump">$ 3,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">2,588<span></span>
</td>
<td class="nump">2,003<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,374<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and peripheral equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">2,838<span></span>
</td>
<td class="nump">2,448<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">831<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract', window );"><strong>Cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfLeaseCostAbstract', window );"><strong>Schedule Of Lease Cost Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payments and expenses related to operating leases</a></td>
<td class="num">$ (557)<span></span>
</td>
<td class="num">$ (451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,782<span></span>
</td>
<td class="nump">1,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">$ 1,457<span></span>
</td>
<td class="nump">$ 1,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">4 years 8 months 23 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">9.50%<span></span>
</td>
<td class="nump">9.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease right-of-use assets and liabilities net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfLeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfLeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract', window );"><strong>Schedule of Maturities of Lease Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028 and after</a></td>
<td class="nump">905<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="nump">454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 2,008<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingent Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants value (in Dollars)</a></td>
<td class="nump">$ 3,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RoyaltyPercentage', window );">Royalty percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_GrantsReceived', window );">Maximum aggregate royalties paid</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_GrantsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received for maximum aggregate royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_GrantsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sales that royalties are paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantsLiabilitiesDetailsLineItems', window );"><strong>Warrants Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCollateralAggregateFairValue', window );">Aggregate exercise price</a></td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility impact rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantsLiabilitiesDetailsLineItems', window );"><strong>Warrants Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Warrants</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 756<span></span>
</td>
<td class="nump">$ 8,425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantsLiabilitiesDetailsLineItems', window );"><strong>Warrants Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_DerivativeWarrantLiabilityShares', window );">Derivative warrant liability shares (in Shares)</a></td>
<td class="nump">3,112,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_DerivativeWarrantLiabilityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_DerivativeWarrantLiabilityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_WarrantsLiabilitiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_WarrantsLiabilitiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCollateralAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of additional assets that would be required to be posted as collateral for derivative instruments with credit-risk-related contingent features if the credit-risk-related contingent features were triggered at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCollateralAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Bonds (Details)<br> &#8362; / shares in Units, $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jun. 03, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 03, 2024 </div>
<div>ILS (&#8362;) </div>
<div>&#8362; / shares</div>
</th>
<th class="th">
<div>Jun. 02, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 02, 2024 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Convertible Bonds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_BidPricePerShare', window );">Bid price per share | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="nump">&#8362; 1,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_AggregateCommissionReceived', window );">Commission received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">&#8362; 1,028,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_TradingPricePerShare', window );">Average closing trading price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_NumberOfTradingVolumeSharesPerDay', window );">Number of trading volume shares per day | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=arbe_NasdaqMember', window );">Nasdaq [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Convertible Bonds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_NumberOfConsecutiveTradingDays', window );">Number of consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember', window );">Convertible Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Convertible Bonds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_BidPricePerShare', window );">Bid price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_NumberOfConsecutiveTradingDays', window );">Number of consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember', window );">Convertible Bonds [Member] | The Trustee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Convertible Bonds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Convertible bonds principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">&#8362; 110,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_BidPricePerShare', window );">Bid price per share | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Convertible Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Convertible Bonds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Convertible bonds principal amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted and funds were released from escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,400<span></span>
</td>
<td class="nump">&#8362; 78,462,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Convertible Bonds [Member] | The Trustee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Convertible Bonds [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Convertible bonds principal amount</a></td>
<td class="nump">$ 30,500<span></span>
</td>
<td class="nump">&#8362; 112,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_AggregateCommissionReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of aggregate commission received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_AggregateCommissionReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_BidPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares are bid price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_BidPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_NumberOfConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_NumberOfConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_NumberOfTradingVolumeSharesPerDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of trading volume shares per day.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_NumberOfTradingVolumeSharesPerDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_TradingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of trading price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_TradingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=arbe_NasdaqMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=arbe_NasdaqMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=arbe_TheTrusteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=arbe_TheTrusteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 07, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 04, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 18, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in New Shekels per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="nump">&#8362; 0.000216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssuanceValue', window );">Ordinary shares issue value (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssued', window );">Ordinary shares issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,794,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Purchase price (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net of issuance costs (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,496<span></span>
</td>
<td class="nump">$ 13,787<span></span>
</td>
<td class="nump">$ 22,496<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Authorized ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoninterestExpenseOfferingCost', window );">Offering expenses (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,230,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Plan expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_PercentageOfOrdinarySharesOutstanding', window );">Percentage of ordinary shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,186<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_PreFundedWarrantMember', window );">Pre-Funded Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,956,043<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheAWarrantsMember', window );">Tranche A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SaleOfPreFundedWarrantShares', window );">Pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantToPurchaseOfOrdinaryShares', window );">Warrant to purchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheBWarrantsMember', window );">Tranche B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_SaleOfPreFundedWarrantShares', window );">Pre-funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_WarrantToPurchaseOfOrdinaryShares', window );">Warrant to purchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arbe_TwoThousandSixteenIncentivePlanMember', window );">Two Thousand Sixteen Incentive Plan [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,384,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=arbe_TwoThousandTwentyOneEquityIncentivePlanMember', window );">2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,079,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights', window );">Vesting period, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The vesting period of the awards is generally four years. Generally,
under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the first anniversary of
the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=arbe_TwoThousandSixteenIncentivePlanMember', window );">Two Thousand Sixteen Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Plan expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=arbe_TwoThousandTwentyOneMember', window );">2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,804,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Authorized ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,698,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member] | Tranche A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member] | 2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares were reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_UnderwrittenPublicOffering', window );">Underwritten public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,293,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_DirectPublicOfferingMember', window );">Direct Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net of issuance costs (in Dollars) | $</a></td>
<td class="nump">$ 33,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_PercentageOfOrdinarySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ordinary shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_PercentageOfOrdinarySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_SaleOfPreFundedWarrantShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_SaleOfPreFundedWarrantShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_UnderwrittenPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of underwritten public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_UnderwrittenPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_WarrantToPurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants purchase of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_WarrantToPurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssuanceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated value of common units of ownership issued by a limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssuanceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units issued of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=arbe_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=arbe_TrancheBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arbe_TwoThousandSixteenIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arbe_TwoThousandSixteenIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=arbe_TwoThousandTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=arbe_TwoThousandTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=arbe_TwoThousandSixteenIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=arbe_TwoThousandSixteenIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=arbe_TwoThousandTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=arbe_TwoThousandTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=arbe_DirectPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=arbe_DirectPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Stock Option Activity (Details) - Stock Option [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_OptionsAbstract', window );"><strong>Options:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding share options, ending balance</a></td>
<td class="nump">5,461,337<span></span>
</td>
<td class="nump">4,590,375<span></span>
</td>
<td class="nump">5,057,255<span></span>
</td>
<td class="nump">6,052,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price, ending balance (in Dollars per share)</a></td>
<td class="nump">$ 3.102<span></span>
</td>
<td class="nump">$ 4.62<span></span>
</td>
<td class="nump">$ 4.543<span></span>
</td>
<td class="nump">$ 4.166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (years), ending balance</a></td>
<td class="text">5 years 4 months 10 days<span></span>
</td>
<td class="text">5 years 10 months 13 days<span></span>
</td>
<td class="text">5 years 7 months 28 days<span></span>
</td>
<td class="text">5 years 6 months 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, ending balance (in Dollars)</a></td>
<td class="nump">$ 16,713,971<span></span>
</td>
<td class="nump">$ 1,364,975<span></span>
</td>
<td class="nump">$ 2,352,517<span></span>
</td>
<td class="nump">$ 7,761,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">430,874<span></span>
</td>
<td class="nump">1,630,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
<td class="nump">$ 2.728<span></span>
</td>
<td class="nump">$ 6.833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,716,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Weighted average remaining contractual life (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 5 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Aggregate intrinsic value (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,364,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options available for future grants, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(291,124)<span></span>
</td>
<td class="num">(351,671)<span></span>
</td>
<td class="num">(468,814)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.08<span></span>
</td>
<td class="nump">$ 7.767<span></span>
</td>
<td class="nump">$ 5.557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised, Outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255,756)<span></span>
</td>
<td class="num">(1,074,162)<span></span>
</td>
<td class="num">(570,451)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised, Weighted-average exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.654<span></span>
</td>
<td class="nump">$ 0.482<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_OptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_OptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of RSUs Activity (Details) - RSUs [Member] - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems', window );"><strong>Schedule of RSUs Activity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, Numbers of RSUs, ending balance</a></td>
<td class="nump">4,241,830<span></span>
</td>
<td class="nump">2,598,084<span></span>
</td>
<td class="nump">1,968,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted, Numbers of RSUs</a></td>
<td class="nump">4,377,834<span></span>
</td>
<td class="nump">2,908,983<span></span>
</td>
<td class="nump">1,619,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited, Numbers of RSUs</a></td>
<td class="num">(432,018)<span></span>
</td>
<td class="num">(370,067)<span></span>
</td>
<td class="num">(417,025)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease', window );">Vested, Numbers of RSUs</a></td>
<td class="num">(3,274,523)<span></span>
</td>
<td class="num">(895,170)<span></span>
</td>
<td class="num">(573,583)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, Numbers of RSUs, ending balance</a></td>
<td class="nump">4,913,123<span></span>
</td>
<td class="nump">4,241,830<span></span>
</td>
<td class="nump">2,598,084<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in the number of shares under non-option equity instrument agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Compensation to Employees (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems', window );"><strong>Schedule of Compensation to Employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">5 years 9 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">51.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems', window );"><strong>Schedule of Compensation to Employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">47.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.15%<span></span>
</td>
<td class="nump">1.74%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems', window );"><strong>Schedule of Compensation to Employees [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.75%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="nump">3.96%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders&#8217; Equity - Schedule of Share Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 14,542<span></span>
</td>
<td class="nump">$ 13,012<span></span>
</td>
<td class="nump">$ 8,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="nump">8,721<span></span>
</td>
<td class="nump">5,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,384<span></span>
</td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,187<span></span>
</td>
<td class="nump">1,786<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems', window );"><strong>Schedule of Share Based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,949,032<span></span>
</td>
<td class="nump">72,021,520<span></span>
</td>
<td class="nump">63,489,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share attributable to ordinary shareholders, basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (0.6)<span></span>
</td>
<td class="num">$ (0.64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Adjusted Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (44,696)<span></span>
</td>
<td class="num">$ (41,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,949,032<span></span>
</td>
<td class="nump">72,053,372<span></span>
</td>
<td class="nump">63,629,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share attributable to ordinary shareholders, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (0.61)<span></span>
</td>
<td class="num">$ (0.66)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#8217;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Adjusted Net loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Earnings Per Share Reconciliation [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_RevaluationOfWarrants', window );">Revaluation of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(196)<span></span>
</td>
<td class="num">(1,204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Adjusted Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (44,696)<span></span>
</td>
<td class="num">$ (41,698)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#8217;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_RevaluationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revaluation of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_RevaluationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">44,842,077<span></span>
</td>
<td class="nump">12,411,165<span></span>
</td>
<td class="nump">11,762,378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">11,542,497<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">23,796,082<span></span>
</td>
<td class="nump">3,112,080<span></span>
</td>
<td class="nump">3,112,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Outstanding share options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">9,503,498<span></span>
</td>
<td class="nump">9,299,085<span></span>
</td>
<td class="nump">8,650,298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Taxes on Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign holding percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward (in Dollars)</a></td>
<td class="nump">$ 157,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Taxes on Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign holding percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Taxes on Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign holding percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income  - Schedule of Company&#8217;s Loss Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Schedule of Company&#8217;s Loss Before Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">$ (49,317)<span></span>
</td>
<td class="num">$ (43,500)<span></span>
</td>
<td class="num">$ (40,494)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income  - Schedule of Reconciliation Income Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract', window );"><strong>Schedule of Reconciliation Income Tax Benefit [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes, as reported in the consolidated statements of operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 49,317<span></span>
</td>
<td class="nump">$ 43,500<span></span>
</td>
<td class="nump">$ 40,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at statutory tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (11,343)<span></span>
</td>
<td class="num">$ (10,005)<span></span>
</td>
<td class="num">$ (9,314)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Effect of Non-deductible expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,573<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Remeasurement of deferred taxes from currency exchange</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,770<span></span>
</td>
<td class="nump">7,508<span></span>
</td>
<td class="nump">5,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(566)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Reported income taxes benefit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>arbe_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Taxes on Income  - Schedule of Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">$ 36,254<span></span>
</td>
<td class="nump">$ 28,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">5,726<span></span>
</td>
<td class="nump">6,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Employees and payroll accrual</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">42,432<span></span>
</td>
<td class="nump">34,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(42,432)<span></span>
</td>
<td class="num">(34,662)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets, net of valuation allowance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Operating segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Reportable segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Customer One [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">38.90%<span></span>
</td>
<td class="nump">33.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Customer Two [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">18.40%<span></span>
</td>
<td class="nump">18.10%<span></span>
</td>
<td class="nump">19.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Customer Three [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">16.90%<span></span>
</td>
<td class="nump">12.70%<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Customer Four [Member] | Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue of customers</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=arbe_Customer4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=arbe_Customer4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event [Member]<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>ILS (&#8362;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 07, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds received offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Converted into odinary shares (in Shares) | shares</a></td>
<td class="nump">8,233,177<span></span>
</td>
<td class="nump">8,233,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Convertible Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Convertible bonds in the principal amoun (in New Shekels)</a></td>
<td class="nump">$ 22.4<span></span>
</td>
<td class="nump">&#8362; 78,462,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Convertible bonds principal amount</a></td>
<td class="nump">$ 22.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of ordinary shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,332,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price per share (in Dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=arbe_ConvertibleBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>81
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( (A]?%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( (A]?%J;\'4N\@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DLM.PS 017\%>9],7E1@I=F 6(&$1"40.\N>
MMA;Q0_:@I'^/$]H4!!_0I6>NSYR1II6>2Q?P.3B/@33&J]'T-G+IUVQ/Y#E
ME'LT(N8I85-SZX(1E)YA!U[(#[%#J(IB!09)*$$")F#F%R+K6B6Y#"C(A2->
MR07O/T,_PY0$[-&@I0AE7@+KIHG^,/8MG $3C#"8^%U M1#GZK_8N0/LF!RC
M7E+#,.1#/>?2#B6\/3V^S.MFVD825F+Z%36G@\<U.TU^K>_N-P^LJXKJ.BOJ
MK+K9E+>\:7C9O$^NO_S.PL8IO=479KSZ87P2[%KX<Q?=%U!+ P04    " "(
M?7Q:F5R<(Q &  "<)P  $P   'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4
M?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.'X416(UL>621A'^_1S80RY8-[9)-
MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( (A]?%JY+^MS1 @  )@W   8
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M@,,O@!1&T[C<%V@XL\?H<?B-WANG6SR^K5V-36XC;-)V"P8V.L65+J^,]OJ
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M'*KICDU@9.T:S$(:;%=N6.('!91-P/6EE.8EL#VK^T1E?P!02P,$%     @
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M$2RV1W* ^/V>4OY\(1T<SLW._@=02P,$%     @ B'U\6BHTH'AJ"   >BH
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MV^;EAK.<2P/0WZ^%J%_?F ><KILN_P]02P,$%     @ B'U\6MVV7XC*"P
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MY,7T-#V;G(7RZ?=(#%C(RA9%FX1[,9U,T@FLU$M/18/X3WF=WWW'E:R0KE<
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MHE+M6.V$?E)&L+F>JIS&@8$\]4']-<?<+Y>IN-]8+9GS+6"Z0X%*;CJ8W!V
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M1L*&CU_AP9N&/SAAZ$*R\\\E7_W3!KPO# 2-#\2@_P)Y\3=02P,$%     @
MB'U\6H+D(Z29'@  $EP  !@   !X;"]W;W)K<VAE971S+W-H965T.2YX;6RM
M7%N3VS:6?L>O8'DF4_:6)/?-E[035[4[=L9;B>URVYF'K7V@2$A"3!$*079;
M\^OWW'"CJ+9K=Q\2MR00.#@XU^\<\*<[VWUQ&ZW[XNNV:=W/#S9]O[M\_-A5
M&[TMW<+N= N_K&RW+7OXV*T?NUVGRYH>VC:/STY.GC[>EJ9]\/(G^NY#]_(G
M._2-:?6'KG##=EMV^U>ZL7<_/SA]X+_X:-:;'K]X_/*G7;G6-[K_O/O0P:?'
M89;:;'7KC&V+3J]^?G!U>OGJ L?3@#^,OG/)WP7N9&GM%_SPMO[YP0D2I!M=
M]3A#"?_<ZFO=-#@1D/&7S/D@+(D/IG_[V=_0WF$OR]+I:]O\R]3]YN<'SQ\4
MM5Z50]-_M'?_U+*?)SA?91M'_R_N>.S%^8.B&EQOM_(P4+ U+?];?A4^) \\
M/SGRP)D\<$9T\T)$Y2]E7[[\J;-W18>C83;\@[9*3P-QIL5#N>D[^-7 <_W+
M&[-NS<I49=L75U5EA[8W[;KX8!M3&>U^>MS#(CCT<243ON()SXY,>'I6_&[;
M?N.*UVVMZWR"QT!=(/',D_CJ[-X9?]'5HC@_G15G)V<7]\QW'K9\3O.=_^^V
M7/S7U=+U'8C+?T_MGN>^F)X;5>C2[<I*__P =,3I[E8_>/F/OYT^/7EQ#^47
M@?*+^V9_>?/VUW=OW[R]OGKWJ;BZOG[_^=VGM^]^+3Z\_^WM]=O7-U/DWC_A
MN_>?7JNSRWGQC9E5N2A>E<ZXPJX*VEC;EZA5E\6GC2XJVSK@7EWVNBY6IBW;
MRI1-X6",!@7NG=J4M[I8:MWBT[NR@W$&5;*R70VC-4A]ORG6NM5=V31[_$7O
M<+8R'M"N,S#OKH$C@F=[6/=S:W#,#:Y#I%UM=0<'6SS\?%/\>G7UX=&"Z'/Q
MQ%4ZH3_QE6W .#%-."_32!O$6?&KJ5T5Y6[7&'@,K0LQP;@>?D S87#6KH#-
M%'M==LYS+2SBM)J:<W' T,EA,$G5#+4FVF1+SM-Z;;>[LMW_XV_/STZ?O7#%
MW<8B3^U="ZN[8>E,;<H.-KXHKH ^ U1U%3\#I#=X'K"WMBY "UI7DOE,CU W
M!BQ1*7N)M,*PA5HNBL].(RG:]6:+)\-"DC!5P:_?E!F9&_V.Z?<L('BFX K^
M&@QP$\Q@"WX#!Q>]A4]?=%R3Z"\=^)H=D0^,*?NB7*W &Q"3@!K;(7O+;6 >
MC-<]/]J8<FD:TQN9JC:N:JP;.MH:T(42A"L?>X97P>WY8_FVEA#/$]J*A+9.
MW^IV$&KT5W#*#C[40X>2'!\BN08EL#6<;FKI0%.V#D__3^* A3^KS7%^*18P
MG&Y5FJZX+9N!=G)7=B 5O9L!X;;Z,D>76!<H/D 1JXS?Q@ .H&OVAW-,"2D8
M F!)MR_<IL3#-4 +G XH/:@1D(O/_*Z[M>Y81:Z#P (?%"E4LAN@8@/*:-$:
M-+PW.#&P'L1\F!^<-FRA[W1;\]XM3-$=2HP!;09Y!^;#L ZY7#K;ELM&ML<G
M:[IJV,)!HN;,$M:ETY4.M[$:>I0A/$Q4]JNJ'X! (0C8.#0H:R"F7;'J[!:F
MM^G&%@I\X?7WJ,[GQ<VBJ$'QP?A<%E>D]STR 4:2H( :3IT#A4FH<'$7J1E@
M/>3 1'? 0MC6'<14^"_J)3R8#4?65J7;P'3 PI[(FQ$G8?ZA T>@1L1FQQO(
M2G0]G <=$/F!^#C(#1\)SMU6>R]N($<8=!8:M-!N357H]M9TMJ49@8*[C:DV
M*4,*B'L[8CG0,Z"LH!<86MJ7R%14N?%R?A*A)B507%)BAE4R;9CH_[(/&IFN
MX#?SHF@QE 5O,!/QSE=1LLKW3<JT&' M[+C!U 7CQ*>^*-ZV:)B]C:HUN!KR
M'8EK!2_:69@+GX^<4&'GZ$?':\\R+I/K!65T+&HK<.9 =@VZ#Q8 QC86K0#0
M^D7WV0^B/$!=_#:8KW0]D4/5Z89H=QNS8U58@N'@DP&A!G9Y1QIM2NYQ4]NU
M :7Q+-'U6,+2HS>]RT4&3,E2CV5K@:&W[E$^?$R@,#'K2YH?'2K/22)!Q($4
MM <BRH9N"Z9NX$@-5DM5="IVN_'6QQ]K$EK#;VU==K6ZMC7Y(SK^A\C4LY,7
M5S?7]-?IBT?%.[LHGI^?%/(3)%Z05K7%M6?%[V4/['(R/IW"/^JGXM@FL47%
M&KA IZO D3L=PJ5DIUO//@F#"DZ,V7<R5U:83\90,3&Z,!VKF3?WT32#K0-S
M"3XN>NX2W'T4?)"+U&K"Y"O9>I "6%[1=AJ)O.!0[CD/,18^8H8@!:?LT1 7
MR*Z;8=G;'1@0X-G\[&16'/ ZH4C5Y'4JV&<,BRO@&+C'SK@OER!XKC_BVA4I
M97 $Z"4@$F!' (ZO!Q^-&\(?(:C8 )%S5 G0C)UU1F(KT MPU!O=$.>UJS!U
MNM.=]L-@!MKW6]>5X"#@!-LO_"B-0K4$2L'=H$(TI%1$3K;*Q.JDL6KLCH -
M-4I#I6$ORT:" S!!YA9],GKNX"/)_"!]Z\8NT?;F1@"B6[.FH 6I2)CJBN4>
M8SF*@-''T$]*8Q@E0B:6(2PE]"62!Z81'@JN.,3._I&BK&]):';E/H;=ND.3
MD<<U&=4JIFJUA>E:V_NY8<D&111^72@0[.MCIR\$90)PF;$FVG7,HS9FO8'U
M&@-3U&I*4$@ (.9;FY;L/81:'(V38'9:HX(C- &*"&?F?(@%NQ^Z"JRQ!.QL
M7,?TRE;2'4C.IZ(GQ"Q"@G:.>-A43 K6QWSO?C8BUX]2F+5DE@1"P7X@'20/
M3A@#F9O(=TX]O2Q58'F+<@W;)_-,F8K&O8;O(*Q<0;: -!89C9?\Y5@?X9!1
MO2*1Q'AP)&/>$S^V8%B\GTG.@.EPCG\"PTN)<CP2GSJ5%3#<D0RS"&9TQ+2:
M#2 HBN)L 1(.)#OE)O@$^O@+Z.UV"<+O424B!OXXGW%JGFT/9*&D+*MLVZ&4
M?!F.KNA8:]D1@+%<$[T7/\R?_K!0ZT7Q)DMZ\C/L!F(\R[L/[^M1GA0>4<DC
M%#50'IZ$#F ITH!H<$3O;6D:2E5"Z,,HKD_2@B4IMAH2#? F=DU!RK4H'CW\
MYU"O.1)T2G1<C#!1G:=WE-/(07"4F:9EVW)/IF*I?< %]C+$@:(W>62'"1$D
M78WYMR8W)PZQ5[(G_144%UC/LL%(#I+$.SK$ <@;#.Z09_F.*!8;)ZWP\9Y3
M!#WK*-EE1@0/XVV?RCS?A$68<(<'?F8F<9MP0> '/Q",N(S2VUUC]UH2>_B^
MLYBD554'(@PY*OVE$R0AQJM^Z@S.P%#E*YVB9T0\\J(>M$_1DVV-[2_J5<*T
MW LRE.:*$,EA2.*C0%A*_4'G\#M':MO@/WX)N,SQH/ L!(4S=A$P>"<H2'+&
MVW1N-#S L'C<S&@UPGDHP1F'7MD>4A&3%=C3'XMT!& )J^P12XID+M0QDUPU
M0".$UQ()@3S_!FER4YR"NE4EB+R<@4>LX!&:L19S\==@4?!$K\"ED=-/C!BD
MNVQM"6\1?64O=$=ZNO2BBLF,!=>$(M?R@NAS=Z6A'RB,18BC3':)RHT>A#"C
M+'!?ZOX.[9VGK.P8RB''=>4(R9JE)PE9;2FC!9]*SE;<YL93G%I1&FO;0QAH
M8FG9\T!2C1% Q3XB;C?9'5A%]GYSD)I4>2"J 3,+P0=E_*#^H+\&L@XT6C!!
M1))]+(2+$'2784L8(=L.W,1N ,K(O(E?.F+C\6=F2FZ_+]4__O;CTV<_OO#"
M0R'EV8OW2PPTR!_((L07R8>\[+#0% ^'MJS_'##X>:20>" <X;>@1A2 )>;%
M^/*<,!K.-2?C3,AX*[ W6ZJ4$HJ_P355/49A'?D7_J1L2CLQA5?9-66EQRN=
MRTJ?6WNP9<9!<"4W[ 2B76)$VO>-5K!H:[VD>!A-W-+4>8,=MB$@!\-2((\0
M/\-)P-:BQR,8E>'T0W+PU$%P#T8.DZ3KZ0-'"Z9 N%HIDX;D\7W56XR1GE&(
M= H/(_@J259;#^BIX$ _:6#)58S1P-AUNT4PPF\_75U'ZYL:PX?F$<LPRCJG
M3A0.J$,#2*@+VY2#VH; T6*&T+DS<NP=TL8VE$%0X0J7 "^)YTZF(']Z4]8<
M6,D,R[U"\J40D3'(4'QO&$T=0&4K6&!%VCFC<WEH8'LRC^"BT?=-S7@O*0J,
M =H>W(7G*&W_" U(P@R3&C>47!V)\/F,W,%6)RO:F/_<!\TKAN8/1/H(HB\T
MA67 D 6@)5C:J(UL/' R,F_A,0K@.AT,('(C>+9I]YV'%I L8?2(YO05G/R7
M^4T%0D&@*+'?F^ZMK6%.8(:/5Z>#0"]&:D*,HH&(U!:>VO/[J#U &+RP1CYT
M.O(/1$27U>:@Z",!#H?$C".E_KNRZQ98<8A>Y>#50GW4Z)Z!%^_ KA?/%X@.
MH96XU; :FI6E13PF=:M<#HG+08@+R=[9@'B]O5NH#6%<XVBVA8.GK]483$%J
M(1BH?2D-TFD+ N*+8ER5LY).(/ O:=G$,IPI$H/0"6%]&0% %$$ITMH["M_0
MA]9V6/:KH0D0ZDR.U;A),5]B*AA$)LME$I1,(,=Q^(EV1'^%I%_J+!G="S55
M"0G5WFR#HZKVGO/H_RPA8^WV!:>YD-W&_(BHK$4%A.I6WX7H'Q,#3D08=I(-
M>+M^_?KZMX#:.L%W<X@HIGTXF)3]\&#0%F*I'ZG LXBIL"S(I3'R61X9 &,D
MCN&(Y8G06V\5U85#WNIAKEDT07')(WL74GAW45AB.)S44')1:,Q*PR<=9E2Y
M.-A;J2""#I5@RV&7]1 1UB 9$V>>!81)K3/)\6>!)K&P$0Q4C+V%6B:!GQS3
MT&=$GR$#]8%#CE0G*3V'VGQ&1RN[[=HBD1&XY!)Z@Y&CG.1,!4"2.72'6#4$
MY0Y.*ME=@Y;4'>C53#!BKJT2K\62D6W-%'RDD;ZZ1."3QI:E0WAH%HV1'[XR
M':@]GBV8!_#.?W_^XU,B NR1,HOB0X?FM.<Z$ K?#L7N\LCW:FSP*H33R<*A
MD%6&Q--+BTG5!&(^-%:-0120$SFV[%V)#6ES;/F1T']1?-Y1*UUOQ&;#9ES9
MZ)GT)[A>Q2Z(VCA(+I&<T)7 41@(X[ =^.] 'D%*7#:R 0+/FE.X"+]/%!H+
M,I0)P$F@($E/"WHG->V9$#/=H8>AT!<K6[JE<T7:V<P+H$'YDR\Q+^!($SH-
MU@F;2K80>*:F>!95] C+O<$7'$:<5;2S AH25GBI?B _/_1:ZHSHE'8;PFR#
M,!2G3^;GY^K]:H7QT&KH(,9#N<XDIG@V/WVB_M#@F=".PM^_(::+T6YAMJ"M
MM\R]A__Q2,%_Q>2OS#'P5>#4_YVR8E)\(BL(NH"_>>^*T60").Q17JV";TP)
M6*@_(0'9XIGZPV[ 7LP;PA"8J9?%;^.O1%]NC;X3G31QCHEB&"(RYT\CHN2U
M<%9\:$J))5Y[UGH<J<R0)'@\09' *((EZA3W<>"VDY K*YMXH%/'=H4 %,8H
M(< &"4**]N"6,=B,1^05Q#"GTZDL2N7I]-=*ZYH=5+E>=QHK31BJ&4=JZ4L/
M6#)WT>]Q <17]0-42G.R TCXS8-C<*FR0'^?QD/P*?823+ A:E)*>88V@B['
MGB=NK3MFM17&/![:/YMA=IZ0[2,R2AD)GT#H;*&^$()-X"C8OW[.2*ITGK1Z
M97H![0/":E?JJ@,6_-:#I9'6%C9D'!,[R?-.+_P>?9'R!H6(Q/0Z;:"ZJOI9
M<?KCT_,@@3=ABEC?_I"D=_*[.KV83?I@OV ""Z.M1,"AX?.FJ@R6\P(8396G
M3B*9YXOS\Q\B#.Y'@_> ^'(6B["*<SH8LM2;LED5H1A382=3BUGPP%NFDNZB
M>+5/.T32,N1!BT%@0HXD&(R+R B)W\'H4X(!%SB<SNPC<-H/-5AYOK!T6\A<
MUWP6OK.0$M41CPBRF_0W:9U*[0X/"F4!3X#KIM[ONV@')$'+>@:SIH29]\N$
M>*!LIWA)G#%AE JE6NKE+'W -+%;@N1K#A817A#>+1*)%9>[%3,"3R9% F#2
MWT]G9V?/9OCOZ5..C?"KBQ.5AES'M;<8::^<&7B!404]"#FUJ(0NF;W:$(1Z
M<7+Z\,LC[-0GC!=;-SNSY HJI/"(Q-QR%(TU2"\(DRW&$OORB4<NBXT;+4]N
M"7A1;= VI\OF0>?W<D LU1;9B\C;0C5P'$=Z,/,Z>F@&PG6/MFT>\9O/3I\'
MOYE9J3FOGIDNL4X^90[M!J0]$2R0](,\1DP(DKD]CR>2M+3PY%NLTSV)K!;E
M'62D6'*LJ3@5-!S]0!L^*6[N1:388N^A[#AIE" >(DA]/S+$(-\T#8)S^8KV
MFN!-J=&V D/-!892!$.QI.6P$S=M!C>)4X<F/HRH1>]2)XX-"&P> _+#1L;S
M5Z1\K$E)3W+>U11"0*K7590K(M2,D6IH.\ZZ6[*25SPF]>UC"J<RD\2JG0?M
M#&M"),D=(O=+RA1FB0":$@"$N<D5&'E:#HT/BXXNAL??@2..%(#]4)-6;6;4
M3AWZ3K>8\B4W%<@_])N('7!GM,"DMQ8;$;D\*/E9&"?T8$">'T80 ]*<E::\
MPHVE5\F1L//8%Q;RO8X00&0&FBH4*Q)>&I@[XV2-*8UV.?1[;YZAC@K90L'.
MWFD.XO"[4?OXN(V(4BY'8*-_@L'LY$S[.SNG$JHG(V!&*RI=2N6/-@X1G92V
MB<$P#QEG<,+'QGE-F[+XZHC%G_9R6!*LPE;4X>9'^2UXI]J DB ]@0'BLN[H
MTIJNYR5*YQIV,) +0J4?]>/;H2>8CY X<5\IY@R_*P])!9!G9_$^C.$^,=,,
M5.(;,8]_ $+;X^=YN*4U; DQ);G08<D-),NIB>7NV4,J!QV9++^RETD>;59S
M0<&IJ$P_90+=EKW<$<$JADKW^LOW[9/4 NLSY?BLZ0$9UWIS&_- YH4[QG?E
M#_+P; D%@/%S/Q9QEK0 <'JZ4.VB>,_](=A*J3=X,1/8BX3EZH9A%V@"#@-'
M*\T4V4,$)J<-R'Z'OM?^<(DQ9P)/\G-,[EDMU ZW0;=FTE@C)Y:!&B>%'7 F
MCN!1O$L&D< GZI!]>O)T%F:B!.,:H[FR\BV'UP%O3A$#>"Q%#*@R! 9M[Z6U
MRB<)H/4"@DY,&VEQ18O'RS]=5L:ALZ=Y;!/+4W:+C:[%VB(_,.)CV\D\E-:+
M+E9(D\L<W(.1-G9(@9\[/G+]#GB&YR4[( J4I V$FJJD04M."K.M \K@W&UL
MQ/ !1K@5T!V>(H6R5!I;"Y3%70"ABAYF8Z9)1PR)4 4!#7(K.5W2'WY0.F[=
M",=;D2WI]<[%%HFW#!OL?:I&Q_G0/>(#+0-G7TP_(2M1N!US,)?D?C1A?/J7
MC$-IBPP%!7'@5<,]Q]/C_,$?65^-UZ>>>3_U1R]]X51("!_B<<#.$T:BXW<K
MZAY+EU)Q*0BW^[!,+ 1!8(0DI30@II3>E"#(Z3O.-&1 7._C0SU4C* SR92!
M+H;AO32I^TY.F@UY*> +63@JU&9:F:R-.EE3E0=6@I@FN(\/G:V'2G#S&T]H
M:KJXVYPCZV @N+M=D95":)^-[\;LPBU%H*2W_7Z'+:MU"83L'5UO8)YBDP(8
M)W)H:*<&$&!+?O368\TRR0IVR>A U.+,2/I5U7VKCI*37E(=PS@NU<XBT)D;
M.C[&^VW:+-XI5@,6/R TA\T@9.7#YI';BI6X(X<,N\2@":GXJ.&TVLDH39;E
M%F3B0-*)3X UMX^+!Y!"-GY14I=KY]?H> VV;M%7A7(9&5L:LDLEQAM@WP4N
M<2K6]6;9-;> "87<EJ?C:6*;?Q+7>\4O$^5EPT(L%CH"JQ?J+^PH=GUZC?5R
M_(T'304K*-MA!?,2U*LJ/Y1%!\("?T_+RYAWL+$1/VVF3T(1G&I&.KI=TBC7
MATJ,PY:<9N[K7/Q;Z"F#9RP7XKC=W0Y=/ 6IG<99%JJC!G^-O5YB0FYU8W=;
M7V!NG?0_7!X?1R30(.5Q U\#UC5?HP3GVJT3P4\!PR/M'1E4J:B'E:XG]>57
M[::1(Q;99)@ZAA9=Q"J+3/L)QTLDA&)H7&@8H&BMZLQ2CET:V&+](FVWW?N
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M?WC<=T&VXZD]:%';D3 7F@:,%7.:Z"B- =TO!-7,YF >Z/XCQO\ 4$L#!!0
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MRX]_S/"V"88.X/NUQJ]:O2 'S?UU]B]02P,$%     @ B'U\6O(%T1-V!@
MY0X  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULC5==4^,X%GWWK[B5
MF9J"JDSB..F&H8$JH'MJF9JFNQIV]F%K'V1;B;4C6QY))O#O]US)-@D-S#Y
M;%GWZ-RO(^ET:^R?KI+2TT.M&W<VJ;QO3^9S5U2R%FYF6MG@R]K86GB\VLW<
MM5:*,AC5>IZEZ?MY+50S.3\-8U_M^:GIO%:-_&K)=74M[..EU&9[-EE,AH%O
M:E-Y'IB?G[9B(V^E_V?[U>)M/J*4JI:-4Z8A*]=GDXO%R>6*YX<)?RBY=3O/
MQ)[DQOS)+]?EV21E0E++PC."P,^]O)):,Q!H_-5C3L8EV7#W>4#_-?@.7W+A
MY)71_U*EK\XFQQ,JY5ITVG\SVW_(WI]WC%<8[<)_VL:YV2\3*CKG3=T;@T&M
MFO@K'OHX[!@<IZ\89+U!%GC'A0++C\*+\U-KMF1Y-M#X(;@:K$%.-9R46V_Q
M5<'.GU^9YEY:KW(MZ=(TI3N=>\#RQWG10UQ&B.P5B$5&GTWC*T>?FE*6^P!S
M\!E)90.IR^Q-Q(^RF-%R,:4LS59OX"U')Y<!;_G_.DG_OLB=MRB)_[SD;T1;
MO8S&;7+B6E'(LPGZP$E[+R?G/_VP>)]^>(/K:N2Z>@O]_.K+S1^?OMU=7_[^
MB2Z_W'R\?8G@VQ WQLODEY.?Z3LL^M+0;UTC*8NQG2:^DG1EZE8TCZ2<ZV1)
MQ4ZT\A MU1#/:ZUJ"M4*3:(V7>/)K.GF^I86BW2:IN&/#D3;6O.@T"]2/]*/
MRS!\.*.[:D#;2BN'M=K.NDXT/O&&!+H)0P#U%H5/)2!*^BP>"2"1+N6/))J2
M<NFW4D96 WL>_ZQ<50/>TUV &+[][LO9E(2+R%+2 5O^],-QEJ4?[N)8>%M\
M.$P&3A0XM5VN54&Y*JE#>5NZ=E9(K4B++9D^G,N!G_!L8E4AQ^!,T^7BN["D
ML^SXD%K <4Q>"W#RA/%":(%Q=$C/V%KC6@A>YVBM-,*W5;X*V)$VW<JBL\HK
MZ>BB\Y7!<PP=S[F[N/TTHRLD'VI.A1;.J;629:)0$9 BB^15!@52U\IS<K F
MUB\JR.)3J8CR7C0Q ,&I,8!3J'@A(<(EF 80%[2]]UYL-E9NX-SS\IJFV?$T
M/5HFSR.0'1T?3D%)%15MD5W &ULRO,,*5I9=E/[(1-DGLB%%L2B!6*#N$#!K
MZM /3NB1??!J7(,K=Y]#K/]LNGJ]_M^A_E$9,*VD#KF6KF!5X+!OE=8H9Y#5
M$L1"2+%N,E1NUX)_#757S8:*(3,@I=@SQPWQ6<"I02[?3<E8DL)JA>)2.TX$
M!GUO<XA\^#1NC[O^<BLLCCY0930JWNTU;^2;/.-+>WR=\,JMQ1[PVF@< -B+
MWO1-+TZ2 W48EAV 8<I)]3(T(7R$>5!P9N"ZMD6TE7><3DZ[2T(-."R(9(;O
M'!"0*2K5.GY CC:!CRB%I8-2H7P\4(#M*VNZ387^'@M!-5[:1C!?].<=@RVP
M$3<=^]E9A.F0F0P6$*=&U&B=6OP7@*+#1FYRM.2NC9O!S=Y/@;S@%(2N,TP:
M2B5*_AW%9"?*?7Y<@FI7#<Y2Y"IDU[$>W0A7BK^@K]083UHZB%XE&E3B;)$&
MQ0ESJ80, 'Z9<B =5(%/1^.JI7A$U0^Z,'(S=8Z]IARGW1O=U3)Y6I8M6$4&
M>-=Q4M,]7.8FF)J 0B_[OND=8'Z8$^+2!V8(R%N!H&>!V&%DHKCP9K)7J&'K
M;E P?0'WNT"<; JXU?B0;8[/6MDZ)(4+N=.05LW?!S8B-_>2!S ];J!]82<M
M*UZ)+]-7,C*C"S? !(X5-,:L]S?FTLAHS$(0IK[00]<19&>$TSQ:O2 4^WL_
M!Z)SLO<Q:GG2*Q7KO)4MMN(=.>F+8P?!0.DW8M@8!&\LC[%QL'MP7QD8V%[>
M'6I$!C5\*#@F0RRC]N]+Y8P^QGKZ#<W#:8X.?'=2F29_<U0Y.IZNWF?3Q?&*
M#GZD+)NM<*C6&N$ZC.J^(Y#P+\8A?!@%C[>)D=8M*D9H9XC/7+18Y5$K0T$,
M)LE.2A"77/;ZB(WUI:R$U>1#$+H02)R&99TC;L.<'2U%&84-YQZ>YC$[4;39
M84%!?'B'-^M04+B5.0_'V#1FT:D-ERS*//+(TH''<]>*V4NGV_G.U0,GKTVX
M8#F$$4&/MY!Q=+S#7<2KR]/T> $$@0V+O)9KF*:SHW<3LO%2%5^\:<-%)C<>
M:AH>*]Q#I>4)^+XV8-J_\ +CS?;\?U!+ P04    " "(?7Q:=<+.WV(/   <
M*   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6RM6FN/V\BQ_<Y?T9C8
MP1C@</@F-6L;&#\VZR!9.S/K+(+@?FB1+8G7%%OA8^3)K\^I:I(B1Y+7>V^
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M_X1#?S9]'4#16:>;P9@8-%+UO^)QT.'(X'S^#8-T,$@][]Z19WDCG%@OC3Z
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MS[[W[NXYO$0;+IYE#J#02UDP.7%RI:HQQC+-H21RP"M@^F3)14F4#L4*RTH
MR2RH++#ONB-<$LJ<.+)[,Q%'O%8%93 32-9E2<3K% J^F3B>L]UXI*M<F0T<
M1Q59P1S44S43.L(=2T9+8))RA@0L)\Z--TY"DV\3?E'8R)TU,I,L.'\VP7TV
M<5S3$!20*L- ]&,-MU 4ADBW\:?E=+J2!KB[WK+?V=GU+ LBX987OVFF\HGS
MV4$9+$E=J$>^^0;M/$/#E_)"VE^T:7*'0P>EM52\;,&Z@Y*RYDE>6AUV -[H
M ,!O ?Y;0'@ $+2 X%1 V *LU+@9Q>J0$$7B2/ -$B9;LYF%%=.B]?B4F6N?
M*Z%/J<:I>$9>T5JB&0C["K$44$)E6G!9"T"7Z&F>H/.S"W2&*$,_<UY+PC(9
M8:5K&P:<MG6F31W_0!W/1P^<J5RBKRR#;)\ ZZ:[SOUMYU/_*&,"Z0 %WB?D
MNW[8T]#MZ?"@!YZ<#O>/3!-T]Q!8ON!_[J%/[H8N[*<S9C&6%4EAXF@WD"#6
MX,0?/W@C]TN?5.])EKP3V9Z,82=C>(P]_J&-\IZEO 1T_IU+>=$G74,QLA3&
M%M?Q97@=>%<17N^*TI<6#%UW/RWI2W/#Z[!+:P;!.__1$L3*>IU$*:^9:E[Z
M;K>QTZFV4VL[;_:US=Y8=\'_:!J/?B!B19E$!2PUI3NXTJXF&M]K L4KZP0+
MKK2OV&6N/Q4@3((^7W*NMH$IT'U\XK]02P,$%     @ B'U\6L?&A)80 @
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MH_]T\3>L\2'8)?]N=&9#L U_K% )*$<+\'YNX5KI@0CD7Q)?_AM02P,$%
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M#G(=!/?HR7X4=3W.<+1@"H2KD<$#7X[XO>@,1F\O*'A;P,O8<Y TN2E[]%3
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MZRD<0W:I$^V'IE,=75CGS*K&V0SJ9<M8-I4[!C2BPN^H;X[[L&I_S"B4!>0
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M=+XD'?[TT3LUH0NJ.6#_!),,?X0D&;I+^KB!3>KK;/)<F4F"WIQ[8^'7A"2
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M.;-A!]7R-1G93N]M&-%ZQV6P@TORB9UG]BDS-/>4?3W^AJQ$F5'(WFU4-2"
MX>T?$PK%(WH4OX4';VL^M3+^G&/\B?75<'TZ!>9 ?W#2Y[E"0GB&[("=1X3$
M&,VN:7HU7DJ%I2 SZOPRH?<+,2RB%.. -=+X[!^54+^!ISY9Y18_,_58,;S.
M1" ]7MSL<M*DIC@GP\Z\%-"%;"T-BB1:&:V-.EE28Q=6@F#/^]7WK2G[0KI3
M]P[1V'3Q>25.@KR!X/-1BJP4-M#8#6RKO;\< ##I3'?8XS!_F0,B!TL']IBF
M."0%QHD\/=JI'@384(#QX#HZ F0-N^2Z4M#BQ$BZ5=74JH,\LI.LM.*^!+7+
M0^$^-73,QFF;-@O7B:@>6XR01<%FL-CI,IR! PW-]Q-,AEUB-(E8?-# K68T
M?)5E^7 &42 ZRT4-&#[?(QY 9E?PBYRF[%NW1LMKL'4+OLIWR,G8TB/[6&*<
M 7;'="2 QU;^+#FX[:N)O@S!X!A,."@6I6!.\?-(>=FP$(D%#T_JR9 @'/]9
M3!_=N9,CBD[21^.!:1!_X<&*%,K-\!M7]9?J4M[T:]@>=5!4X1YE"88XR1V
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M\L."?A>H70#Y<Z7LUG +M#^@Y ]02P,$%     @ B'U\6D*2C6EC P  +P<
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MC*OF*FPF1E;N^EE(0Y>9&Z[HZP&5-:#WN91F.[$!VN^1^7]02P,$%     @
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MQCXT/FHGTBZ/LR3,TH2E63@:)<&/'=7;;8_T6+<YA3UF1P1"IL WCUT=8%W
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M6\UU-Z9GY]09;"VH".BH$J69J=*U@F==.VYGU.8"A]7AW#_D1!^[[8T7M&"
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M!DNO_OOVU?^]+P.JIZR.%R3;1^D<.FAQ -485.-034 UB=+,9.KBP!]@7B1
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MI9F9T\5$@'GGH@#:/$ U"M485.-034 UB=+,Z.GF(;!?LO#J2M_N=LXBM(J
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MV:+Y /N[K"RS>?/E3$53E=<WJ'Y_GV7E\S?U $]9_JW9O?'_ 5!+ P04
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M"B:+:XQ4UV!=8&3MS^A>&GOB_;"T=Q(HEV#7#U*:4^"._7#+I;\!4$L#!!0
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M0EVWP'6 >K]B3.XF^D3O+_#T+U!+ P04    " "(?7Q:D+O/\FT"  ")!@
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M#0O\5X"R -Q?2FEV$QN@__LD?P!02P,$%     @ B'U\6J7;%C6% P  I!
M !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&ULM5A=CYLX%/TK%JU6K=0.
M&$A"9A.D-M-J5]JJHTX_'JI]\, E6 5,;9.T_WYM8"!D'-I$[$N"X9[#.=?7
M\756>\:_B11 HA]Y5HBUE4I97MNVB%+(B;AB)13J2<)X3J0:\JTM2@XDKD%Y
M9KN.,[=S0@LK7-7W;GFX8I7,: &W'(DJSPG_^1HRME];V'JX\8%N4ZEOV.&J
M)%NX _FIO.5J9'<L,<VA$)05B$.RME[AZPU>:$ =\9G"7AQ<(VWEGK%O>O!W
MO+8<K0@RB*2F(.IK!QO(,LVD='QO2:WNG1IX>/W _K8VK\S<$P$;EGVAL4S7
M5F"A&!)29?(#V_\%K:&9YHM8)NI/M&]C'0M%E9 L;\%*04Z+YIO\:!-Q ,#^
M"8#; MS?!7@MP*N--LIJ6S=$DG#%V1YQ':W8]$6=FQJMW-!"3^.=Y.HI53@9
MWG)5$5S^1*2(T9OO%2W5'$GT$MVI@HFK#!!+T(F@9S<@"<W$<Q7^Z>X&/7OZ
M'#U%M$ ?4U8)%2M6ME0:]9OLJ-7SNM'CGM!S ]$5\O +Y#JN;X!O?A_N#>&V
MRDR7'K=+CUOS>2?X-DS(:Y.+!N:;87KM78N21+"VU.(2P'=@A7\\P7/G3Y.G
MB<@&#KW.H3?&/BP >)C;%VC+F3#.7T,WK^GTC\0N])9S=V7O#AT9@CS<!PV4
M^IU2?U3IJRBJ\BHC$F*U4%4J(DKT3X%)9,,T.WB_.PN"(Y&&(,?QS")GG<C9
M1>DL0)ITSAY)P-["/])I"G*69IWS3N=\5.>&Y64E@8M:J)),RQ0XR7K-Z.L[
MR.^!_VO2/4I^;OE/1#;(PZ++P^*R!;Z8TN%$9 .'0><PF':!!X^71> =KQU#
MD.\'YII<=DJ7HTK_ ;4?IRR+$<U+SG;PRS(<Y3MWDB8B&UC'3K\/.Y<58HN;
MR.14;$.7!]T&GK886[[#0@L\?%2,AJ!9<&*WP?W6CT?WW?!]DM (4%+Q@LJ*
MPU#S:%V.,Y\]9_]'?X#[!@%[%U;F:&=QMLN)V(8N^^8"CW<7YU?FX_8!^\=;
MMRG(.]%BX+['P.--QF=(:92!&*_!48ZS9V<BMJ'COEO!\PMK<-).9"JVH<N^
M%\&CC< %-;AXU&=C?WE<@^-!C5;[X BIS^_O"-_20J ,$H5RKA9J_GES)&X&
MDI7UJ?*>275&K2]3(#%P':">)XS)AX$^J'9_3(3_ 5!+ P04    " "(?7Q:
M[ZF2G6@#  !:"@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6RM5FUO
MTS 0_BM60&B3Z/*>=J.-M'4@D$!,C)?/;G-M+)*XV$Z[_7O.3I:EK1N!X$L;
M.W?//<_Y<K[ICHN?,@=0Y*$L*CES<J4V5ZXKESF45%[P#53X9L5%214NQ=J5
M&P$T,TYEX0:>E[@E99633LW>G4BGO%8%J^!.$%F7)16/-U#PW<SQG:>-+VR=
M*[WAIM,-7<,]J&^;.X$KMT/)6 F59+PB E8SY]J_FON>=C 6WQGL9.^9:"D+
MSG_JQ8=LYGB:$12P5!J"XM\6YE 4&@EY_&I!G2ZF=NP_/Z&_,^)1S()*F//B
M!\M4/G,F#LE@1>M"?>&[]] *BC7>DA?2_))=8YN,';*LI>)EZXP,2E8U__2A
M343/(8A/. 2M0W#@X)^*$+8.H1':,#.R;JFBZ53P'1':&M'T@\F-\48UK-+'
M>*\$OF7HI]*/@#F09$3NL4"RN@#"5\1LDCF7BIS=@J*LD.=H\NW^EIR]/"<O
M":O(UYS7DE:9G+H*>6@T=]G&O&EB!B=B^@'YQ"N52_*VRB#;!W!10*<B>%)Q
M$PPBWL+R@H3^:Q)X060A-/]S]W" 3M@E-31XX0F\+I>?]W)YO9!*8-W:,M8
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MH\(]RIU1]I;:.)//)>?4V"H;#424,)?"4%%9&SY3LJ:,&HH:SA=H"&7Z LZ
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MU]83(H7R(A%7E+JP5#I^N,?%._7B S"]WHX%8TFL!6;0@!GT@OF&"4<;3->
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MS5UU:'P&5#.AF@75;)36S/*ZYTR[>\Y_MH+HT9#H/G[O*H!VJZ&:!M5TJ&9
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M#T4U&]4<5'-1S4,U']4"5 M1+4*UF-+:$='T0[63^J%_YL(HVAC57BR"FNB
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M9EGY]$D]P&.6?UDM]M7_ 5!+ P04    " "(?7Q:M"7RRX@%   6&P  &0
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MR!Y 7R:RK0.F!')]2:G8#M0-FD8Q_ =02P,$%     @ B'U\6DY\5X\(!
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MB!9RET7;%!!=H<(0S23%$9K33.X[3HJ5NWU2SX#>!R!(DO(/TO';(D#OWWY
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M"FIK\Y@2#(1K QA?<ZX.#3U!_<EF^B]02P,$%     @ B'U\6MH$0,"9 P
M9 H  !D   !X;"]W;W)K<VAE971S+W-H965T-3,N>&ULK59=D]HV%'W/K] X
MF4PRLUE_8M@-,,,"G7:F27>6IGW(]$'@"U97EH@D0_+O<R4;ER6"[D->P)+N
M.;[G6CJZP[U4C[H$,.1KQ84>!:4QV]LPU*L2*JJOY18$KJREJJC!H=J$>JN
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MV][JHNL]G/K@P"18!SBU3;+]]K4-RX8<05F5AWW9!3/S8^8_'F)[=F3\N\@
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MN<M<IIC#F)8_BDSD0^O*0AG,<%.*)[K\"ET^ \67TI+K7[3L?!T+I0T7M.K
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M7$KA63LC6T/06D^-*15R!NEE+C\K@"D'>3ZC5*P-=4'_H1+_ 5!+ P04
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MM.OX:=SO'[#[ '/[$=@9Y8)7JJ8YEYY.K&W'<T:F5=][(O-!BN8?H&@_>&9
MW%]Y&K*"U@G#-(=;/-TOE:20L=W)ZAI6958=Z^1(XB!F9H(5E2GC*Y)!N@*)
M,SK'BY;I7Y^P?YE!@JTX9N8>E$D1ZBHH9XC$$9DD('&(YJ2@4G.0:LV*ZH,9
M+U+0(''TKVH4E>$BDR:[U#3Y*MG')R0X&_:K$B9?:W.76W/3K;E/1ZP+W9/&
MH;7(K-<XIR3H*[IL+.1F[M'8(4@8_WQ,M*AG'@.SIV51RD+@R6+ZQ]T-2466
M4:FZQ 2LLO5(6%YD-@!@>2@P0=K&[1-2^9WR$B^GI)ZKNZX\>CM7FQSDRMXI
M%8:OY+H:YYK5YMYZ86]K!^M3<Y]UK.,N.)]5%]UG7T+\8G5Y3Z:K"_0W*E<,
MLY_!$MWPNP-L"K*ZDU8O6A3VTK40&J]P]G&-]WB01@"_+X70VQ=CH/G/P.1_
M4$L#!!0    ( (A]?%HSEP"@#@,  %X)   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;*V6;V^;,!#&OXK%JJF5VD* D#]+D-IDT_IB4]2TW6L7CH!J
M,+5-TGS[G8&B-!!4:7L3,-P]_CWG^,QLQ\6+C $4>4M9)N=&K%0^-4T9Q)!2
M><USR/!-Q$5*%0[%QI2Y !J622DS;<ORS)0FF>'/RF<KX<]XH5B2P4H06:0I
M%?M;8'PW-P;&^X/[9!,K_<#T9SG=P!K48[X2.#(;E3!)(9,)SXB :&[<#*:+
MB8XO YX2V,F#>Z*=/'/^H@=WX=RP-! P")16H'C9P@(8TT*(\5IK&LV4.O'P
M_EW]1^D=O3Q3"0O._B2ABN?&V" A1+1@ZI[O?D+M9ZCU LYD^4MV=:QED*"0
MBJ=U,A*D259=Z5M=AX.$@7LBP:X3[,\F.'6"4QJMR$I;2ZJH/Q-\1X2.1C5]
M4]:FS$8W2:97<:T$ODTP3_D/] TDP7K>90%/@9 KLL9_2E@P(#PB2XA " @)
MQI$;*4%)<KX$11,F+S#V<;TDYV<7Y(PD&7F(>2%I%LJ9J1!-3V &-<9MA6&?
MP%A"<$V<P26Q+=OM2%]\/MWYF&YB09JJV$U5[%+/.:E7VU9HFY:VIUVF*A6W
M6T5OP*G,:0!S W>8!+$%P__Z9>!9W[HL_B>Q#X:=QK#3I^[_QGZ!G4%0E60;
MPKB4)*!"[ GVB1T5W4M:27JEI.X66]_Q["$NW_;05CO*'EN.W41]X'4;7K>7
M]QXK0$40$_R[X:[=8C?*L;>H+LQ*:7@ ,!S9WA%E.PBMG( <-I##7LCO:<[X
M'G!_:<J<[@5G#!M7( K*NDB'+0CG@*$";<?8DTDWI]=P>KV<*Z&77NU+3'@M
MDI.E]%J3#RSK"+ =,SK!-VKX1KU\#UQ1IGOS\9[L0ARUIG=MUSFN8CO*<3WO
MQ'J/&\YQ+^<3906M#B>&IR/- N@B'+?FONI"[ CK89PTC)->QH[.=DDRO?LC
MLOT<?^\$W7V*=/6[?]>I*F >G'[ZR^,7%9LDDX1!A,K6]0AK**K3O!HHGI<'
MXC-7>+R6MS%^ ('0 ?@^XER]#_09VWQ2^7\!4$L#!!0    ( (A]?%J&+,'Q
MT0,  -X6   9    >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;+5878^;.!3]
M*Q:5JJU4#1C(US1!FH16.U)''67:[4/5!T)N AJP6=M)9J7]\;6!X4N$G4R]
M+XEM[CWV/?8!WSL_4?;((P"!GM*$\(41"9%=FR8/(T@#?D4S(/+)CK(T$+++
M]B;/& 3;W"E-3-NRQF8:Q,3PYOG8/?/F]""2F, ]0_R0I@'[9PD)/2T,;#P/
MK.-])-2 Z<VS8 \/(+YE]TSVS IE&Z= >$P)8K!;&#?XVL<3Y9!;_!7#B3?:
M2(6RH?11=6ZW"\-2*X($0J$@ OEWA!4DB4*2Z_B[!#6J.95CL_V,_BD/7@:S
M"3BL:/(]WHIH84P-M(5=<$C$FI[^A#*@D<(+:<+S7W0J;2T#A0<N:%HZRQ6D
M,2G^@Z>2B(8#'I]QL$L'N^O@GG%P2@?GI0YNZ>#FS!2AY#SX@0B\.:,GQ)2U
M1%.-G,S<6X8?$[7O#X+)I['T$]X#[.4N"G1+BC.D]N(/'T00)_S=W!1R"F5H
MAB7<LH"SS\!A&]U1(B*./I(M;-L IEQ;M4#[>8%+>Q#1A_ *.?@]LBW;[5G0
MZN7N3H^[_W)W>R :IZ+;R?&<"^C^\5D:H5L!*?_9QWB!Z/8CJO?"-<^"$!:&
M%#X'=@3#>_L&CZT/?6SI!/,U@;68="LFW2%T[TL&3/)']H@7G/915T",<@CU
M!CQZ>&X>FWP,3G(I'YK 6GR,*CY&@WRL(:-,!)L$A@@9_2<A@[-<2H@FL!8A
MXXJ0\2 AJ_SE"0RM* DE':Q0VSKFC^C'':0;8#_1OZ@R^R)%V!A?PQ'( = 2
M2!C)3V+MU,?KX%(NU:A.,%\36&L+)M463+2_[28ZF=0)YFL":S$YK9B<#A[F
M>V#J#,N;&*([>=\JSJ9LAN7QY7U<%I@8-^1N7>'9J"/Y7C-G.FN;^?UFCEN9
MM2*;59'-M,KTZXF^7J:#2[GT<.D$\S6!M;8 6_4ET-(NU!)2$YE:T7Q=:&TZ
M&W=J_#^HM03MRG7J=N1ZSJ[S)??/V,W."!;;=7BV7LE&#'[CVSJ\FHL/FDXT
M7Q=:>R?J; +K3R>PUGQ"*YJO"ZU-9YU2X.&<XI6Z=7MU-IYU==MO9T^ZNNVW
M:WR/V^'5&0(>3A$NU>TG>F"_(5N=F<1**YJO"ZV]$75F@L?Z9:LUQ="*YNM"
M:]-99QEX\.K]6ME.>F7F=F_'PY-?3)76+,)L%/YDG/N\@,I12 ]$%"6V:K0H
MTBY5D585#COC-_CZ)B]9FC5,4?F]"]@^)APEL).0UM5$2H<5Q=2B(VB6EQ<W
M5$BR\V8$P1:8,I#/=Y2*YXZ:H"II>[\ 4$L#!!0    ( (A]?%I_&\Q0W0,
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( (A]?%KX&>K.M00  (4G   /
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MWQ[=/6],U1[S6?]+S>P-4$L! A0#%     @ B'U\6D;'34B5    S0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "(
M?7Q:F_!U+O(    K @  $0              @ '#    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "(?7Q:F5R<(Q &  "<)P  $P
M@ 'D 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( (A]?%JY+^MS
M1 @  )@W   8              " @24(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "(?7Q:2N)S6\(#  ","0  &
M@(&?$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ B'U\
M6O%/>@:6!@  =1L  !@              ("!EQ0  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( (A]?%HO4;%:F0(  *X&   8
M      " @6,;  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "(?7Q:^\/S\(D%  #]%   &               @($R'@  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ B'U\6F^$?K&D!@  0RL  !@
M             ("!\2,  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( (A]?%HJ-*!X:@@  'HJ   8              " @<LJ  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "(?7Q:W;9?B,H+  "-
M'   &               @(%K,P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ B'U\6H+D(Z29'@  $EP  !@              ("!:S\
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( (A]?%H;?U]T
M!@0  ,((   9              " @3I>  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ B'U\6EJ&)9B4 @  JP4  !D
M ("!=V(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "(
M?7Q:-I@%W.L"   O!@  &0              @(%"90  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( (A]?%JA!>[?.@0  $P)   9
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M970Q-RYX;6Q02P$"% ,4    " "(?7Q:I@'Y!L0$  #-"P  &0
M    @(%0C   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M (A]?%I<UYR\F0<  ,X1   9              " @4N1  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ B'U\6J+?N72Y!   40L  !D
M             ("!&YD  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "(?7Q:R+/U<NX#   ]"   &0              @($+G@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( (A]?%J@(4FU90(
M (@&   9              " @3"B  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ B'U\6L?&A)80 @  W 0  !D              ("!
MS*0  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "(?7Q:
M-=[%RPD-  !5+   &0              @($3IP  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( (A]?%H>;K?L&B   &MH   9
M      " @5.T  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ B'U\6@SJ\2OH @  C 8  !D              ("!I-0  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "(?7Q:0I*-:6,#   O!P
M&0              @('#UP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( (A]?%K;M&R&=0(  ) %   9              " @5W;  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ B'U\6MD_C2:E
M @  R04  !D              ("!"=X  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "(?7Q:5X#W68L#  ";"   &0
M@('EX   >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( (A]
M?%I3#<Y(X@4  -\.   9              " @:?D  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ B'U\6EB-IN76!   ) T  !D
M         ("!P.H  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M    " "(?7Q:S"8T<%<%  "G#   &0              @('-[P  >&PO=V]R
M:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( (A]?%I;8)W35@H   2"
M   9              " @5OU  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL
M4$L! A0#%     @ B'U\6JXAH)_$ P  CQ(  !D              ("!Z/\
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "(?7Q:.0AB
MJ-X#  !M$P  &0              @('C P$ >&PO=V]R:W-H965T<R]S:&5E
M=#,V+GAM;%!+ 0(4 Q0    ( (A]?%HOF5TH&@(  /$$   9
M  " @?@' 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
MB'U\6@/:B+#V!0  JRT  !D              ("!20H! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " "(?7Q:#L-TLZP"  #,!P  &0
M            @(%V$ $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( (A]?%J0N\_R;0(  (D&   9              " @5D3 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ B'U\6J7;%C6% P
MI!   !D              ("!_14! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " "(?7Q:[ZF2G6@#  !:"@  &0              @(&Y
M&0$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( (A]?%IR
M6$0<D (   4'   9              " @5@= 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ B'U\6OIQ%7I] @  U 4  !D
M     ("!'R ! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (A]?%K)'VOA-0,  #0*   9              "
M@:U$ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ B'U\
M6DY\5X\(!   MQ4  !D              ("!&4@! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " "(?7Q:N3QLX0($   9%0  &0
M        @(%83 $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( (A]?%IB2O%J@ 0  +X1   9              " @9%0 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ B'U\6MH$0,"9 P  9 H
M !D              ("!2%4! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " "(?7Q:F%_/P=4#  !)$@  &0              @($860$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( (A]?%H9U9-"
M/@,   ,/   9              " @21= 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ B'U\6F9#P>7# @  M @  !D
M ("!F6 ! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "(
M?7Q:P%@A_NH$   E$   &0              @(&38P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( (A]?%HSEP"@#@,  %X)   9
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M 0!X;"]S='EL97,N>&UL4$L! A0#%     @ B'U\6I>*NQS     $P(   L
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64$L%!@    !$ $0 DQ(  +F! 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>206</ContextCount>
  <ElementCount>305</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statements of Changes in Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Prepaid Expenses and Other Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables</Role>
      <ShortName>Prepaid Expenses and Other Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Warrants Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/WarrantsLiabilities</Role>
      <ShortName>Warrants Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Convertible Bonds</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConvertibleBonds</Role>
      <ShortName>Convertible Bonds</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995319 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/Revenue</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Prepaid Expenses and Other Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables</Role>
      <ShortName>Prepaid Expenses and Other Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PropertyandEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Shareholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Taxes on Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/TaxesonIncomeTables</Role>
      <ShortName>Taxes on Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncome</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996009 - Disclosure - General (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/GeneralDetails</Role>
      <ShortName>General (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/General</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable</Role>
      <ShortName>Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/RevenueTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable</Role>
      <ShortName>Revenue - Schedule of Revenue Disaggregated by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Prepaid Expenses and Other Receivables - Schedule of Prepaid Expenses and Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable</Role>
      <ShortName>Prepaid Expenses and Other Receivables - Schedule of Prepaid Expenses and Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofLeaseCostTable</Role>
      <ShortName>Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Commitments and Contingent Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails</Role>
      <ShortName>Commitments and Contingent Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Warrants Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/WarrantsLiabilitiesDetails</Role>
      <ShortName>Warrants Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/WarrantsLiabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Convertible Bonds (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ConvertibleBondsDetails</Role>
      <ShortName>Convertible Bonds (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ConvertibleBonds</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Shareholders??? Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders??? Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/ShareholdersEquityTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Shareholders??? Equity - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Shareholders??? Equity - Schedule of RSUs Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofRSUsActivityTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of RSUs Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Shareholders??? Equity - Schedule of Compensation to Employees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Compensation to Employees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Shareholders??? Equity - Schedule of Share Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable</Role>
      <ShortName>Shareholders??? Equity - Schedule of Share Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Adjusted Net loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Adjusted Net loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable</Role>
      <ShortName>Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/TaxesonIncomeTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Taxes on Income  - Schedule of Company???s Loss Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable</Role>
      <ShortName>Taxes on Income  - Schedule of Company???s Loss Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Taxes on Income  - Schedule of Reconciliation Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable</Role>
      <ShortName>Taxes on Income  - Schedule of Reconciliation Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Taxes on Income  - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable</Role>
      <ShortName>Taxes on Income  - Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SegmentInformation</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ea0235828-20f_arbe.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.arberobotics.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.arberobotics.com/role/SubsequentEvents</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>arbe-20241231.xsd</File>
    <File>arbe-20241231_cal.xml</File>
    <File>arbe-20241231_def.xml</File>
    <File>arbe-20241231_lab.xml</File>
    <File>arbe-20241231_pre.xml</File>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="ea0235828-20f_arbe.htm">ea0235828-20f_arbe.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fin_001.jpg</File>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="682">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="12">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="49">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0235828-20f_arbe.htm": {
   "nsprefix": "arbe",
   "nsuri": "http://www.arberobotics.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "arbe-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "arbe-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "arbe-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "arbe-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "arbe-20241231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0235828-20f_arbe.htm"
     ]
    }
   },
   "keyStandard": 277,
   "keyCustom": 28,
   "axisStandard": 21,
   "axisCustom": 0,
   "memberStandard": 31,
   "memberCustom": 21,
   "hidden": {
    "total": 89,
    "http://fasb.org/us-gaap/2024": 76,
    "http://www.arberobotics.com/20241231": 8,
    "http://xbrl.sec.gov/dei/2024": 5
   },
   "contextCount": 206,
   "entityCount": 1,
   "segmentCount": 56,
   "elementCount": 708,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 682,
    "http://xbrl.sec.gov/dei/2024": 49,
    "http://xbrl.sec.gov/cyd/2024": 12,
    "http://fasb.org/srt/2024": 2,
    "http://xbrl.sec.gov/ecd/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
     "longName": "995301 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ilsPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "6",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
     "longName": "995303 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
     "longName": "995304 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.arberobotics.com/role/ConsolidatedCashFlow",
     "longName": "995305 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.arberobotics.com/role/General",
     "longName": "995306 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.arberobotics.com/role/SignificantAccountingPolicies",
     "longName": "995307 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.arberobotics.com/role/Revenue",
     "longName": "995308 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables",
     "longName": "995309 - Disclosure - Prepaid Expenses and Other Receivables",
     "shortName": "Prepaid Expenses and Other Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.arberobotics.com/role/PropertyandEquipment",
     "longName": "995310 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.arberobotics.com/role/Leases",
     "longName": "995311 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.arberobotics.com/role/CommitmentsandContingentLiabilities",
     "longName": "995312 - Disclosure - Commitments and Contingent Liabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.arberobotics.com/role/WarrantsLiabilities",
     "longName": "995313 - Disclosure - Warrants Liabilities",
     "shortName": "Warrants Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.arberobotics.com/role/ConvertibleBonds",
     "longName": "995314 - Disclosure - Convertible Bonds",
     "shortName": "Convertible Bonds",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquity",
     "longName": "995315 - Disclosure - Shareholders\u2019 Equity",
     "shortName": "Shareholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders",
     "longName": "995316 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.arberobotics.com/role/TaxesonIncome",
     "longName": "995317 - Disclosure - Taxes on Income",
     "shortName": "Taxes on Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.arberobotics.com/role/SegmentInformation",
     "longName": "995318 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.arberobotics.com/role/SubsequentEvents",
     "longName": "995319 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c32",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c32",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.arberobotics.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.arberobotics.com/role/SignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Significant Accounting Policies (Tables)",
     "shortName": "Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.arberobotics.com/role/RevenueTables",
     "longName": "996002 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables",
     "longName": "996003 - Disclosure - Prepaid Expenses and Other Receivables (Tables)",
     "shortName": "Prepaid Expenses and Other Receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.arberobotics.com/role/PropertyandEquipmentTables",
     "longName": "996004 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.arberobotics.com/role/LeasesTables",
     "longName": "996005 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquityTables",
     "longName": "996006 - Disclosure - Shareholders\u2019 Equity (Tables)",
     "shortName": "Shareholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables",
     "longName": "996007 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders (Tables)",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.arberobotics.com/role/TaxesonIncomeTables",
     "longName": "996008 - Disclosure - Taxes on Income (Tables)",
     "shortName": "Taxes on Income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.arberobotics.com/role/GeneralDetails",
     "longName": "996009 - Disclosure - General (Details)",
     "shortName": "General (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c40",
      "name": "us-gaap:GeneralPartnersOfferingCosts",
      "unitRef": "ils",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c40",
      "name": "us-gaap:GeneralPartnersOfferingCosts",
      "unitRef": "ils",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails",
     "longName": "996010 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
     "longName": "996011 - Disclosure - Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)",
     "shortName": "Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c59",
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c59",
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.arberobotics.com/role/RevenueDetails",
     "longName": "996012 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
     "longName": "996013 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Geography (Details)",
     "shortName": "Revenue - Schedule of Revenue Disaggregated by Geography (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable",
     "longName": "996014 - Disclosure - Prepaid Expenses and Other Receivables - Schedule of Prepaid Expenses and Other Receivables (Details)",
     "shortName": "Prepaid Expenses and Other Receivables - Schedule of Prepaid Expenses and Other Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "arbe:GovernmentAuthorities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "arbe:GovernmentAuthorities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "us-gaap:OtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.arberobotics.com/role/PropertyandEquipmentDetails",
     "longName": "996015 - Disclosure - Property and Equipment (Details)",
     "shortName": "Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
     "longName": "996016 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.arberobotics.com/role/ScheduleofLeaseCostTable",
     "longName": "996017 - Disclosure - Leases - Schedule of Lease Cost (Details)",
     "shortName": "Leases - Schedule of Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable",
     "longName": "996018 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails",
     "longName": "996019 - Disclosure - Commitments and Contingent Liabilities (Details)",
     "shortName": "Commitments and Contingent Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:GrantsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:GrantsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails",
     "longName": "996020 - Disclosure - Warrants Liabilities (Details)",
     "shortName": "Warrants Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AdditionalCollateralAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AdditionalCollateralAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.arberobotics.com/role/ConvertibleBondsDetails",
     "longName": "996021 - Disclosure - Convertible Bonds (Details)",
     "shortName": "Convertible Bonds (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c126",
      "name": "arbe:BidPricePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c126",
      "name": "arbe:BidPricePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.arberobotics.com/role/ShareholdersEquityDetails",
     "longName": "996022 - Disclosure - Shareholders\u2019 Equity (Details)",
     "shortName": "Shareholders\u2019 Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c133",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c133",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable",
     "longName": "996023 - Disclosure - Shareholders\u2019 Equity - Schedule of Stock Option Activity (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c153",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c153",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable",
     "longName": "996024 - Disclosure - Shareholders\u2019 Equity - Schedule of RSUs Activity (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of RSUs Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c165",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c161",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
     "longName": "996025 - Disclosure - Shareholders\u2019 Equity - Schedule of Compensation to Employees (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Compensation to Employees (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable",
     "longName": "996026 - Disclosure - Shareholders\u2019 Equity - Schedule of Share Based Compensation Expense (Details)",
     "shortName": "Shareholders\u2019 Equity - Schedule of Share Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c172",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable",
     "longName": "996027 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable (Details)",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable",
     "longName": "996028 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Adjusted Net loss (Details)",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Adjusted Net loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c7",
      "name": "arbe:RevaluationOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "arbe:ScheduleOfAdjustedNetIncomeLossTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable",
     "longName": "996029 - Disclosure - Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share Attributible to Ordinary Sharholders - Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.arberobotics.com/role/TaxesonIncomeDetails",
     "longName": "996030 - Disclosure - Taxes on Income (Details)",
     "shortName": "Taxes on Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable",
     "longName": "996031 - Disclosure - Taxes on Income  - Schedule of Company\u2019s Loss Before Income Taxes (Details)",
     "shortName": "Taxes on Income  - Schedule of Company\u2019s Loss Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable",
     "longName": "996032 - Disclosure - Taxes on Income  - Schedule of Reconciliation Income Tax Benefit (Details)",
     "shortName": "Taxes on Income  - Schedule of Reconciliation Income Tax Benefit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable",
     "longName": "996033 - Disclosure - Taxes on Income  - Schedule of Deferred Tax Assets (Details)",
     "shortName": "Taxes on Income  - Schedule of Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.arberobotics.com/role/SegmentInformationDetails",
     "longName": "996034 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.arberobotics.com/role/SubsequentEventsDetails",
     "longName": "996035 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c203",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c203",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235828-20f_arbe.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other payables",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r37"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r156",
      "r527"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "us-gaap_AdditionalCollateralAggregateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalCollateralAggregateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate exercise price",
        "label": "Additional Collateral, Aggregate Fair Value",
        "documentation": "The aggregate fair value of additional assets that would be required to be posted as collateral for derivative instruments with credit-risk-related contingent features if the credit-risk-related contingent features were triggered at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r564",
      "r896",
      "r897",
      "r898",
      "r899",
      "r956",
      "r1008"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_AdjustmentOfWarrantsGrantedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentOfWarrantsGrantedForServices",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of warrants",
        "label": "Adjustment of Warrants Granted for Services",
        "documentation": "Adjustment for noncash service expenses paid for by granting of warrants."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_AggregateCommissionReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "AggregateCommissionReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commission received",
        "documentation": "Represent the amount of aggregate commission received.",
        "label": "Aggregate Commission Received"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r775",
      "r791",
      "r826"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r778",
      "r794",
      "r829"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r821",
      "r830",
      "r834",
      "r842"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation (in Dollars)",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r380"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive shares",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r218"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97",
      "r157",
      "r180",
      "r223",
      "r231",
      "r239",
      "r242",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r424",
      "r426",
      "r446",
      "r520",
      "r599",
      "r677",
      "r678",
      "r708",
      "r735",
      "r920",
      "r921",
      "r967"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r163",
      "r180",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r424",
      "r426",
      "r446",
      "r708",
      "r920",
      "r921",
      "r967"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r424",
      "r426",
      "r446",
      "r920",
      "r921",
      "r967"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT ASSETS:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable",
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_BidPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "BidPricePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bid price per share",
        "documentation": "Number of shares are bid price per share.",
        "label": "Bid Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r751",
      "r771"
     ]
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "CH",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Switzerland [Member]",
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "CN",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "China (excluding Hong Kong) [Member]",
        "label": "CHINA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r154",
      "r670"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents and restricted cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r83"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r61",
      "r177"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Decrease in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r61"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental non-cash disclosure:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r158",
      "r159",
      "r160",
      "r180",
      "r207",
      "r208",
      "r215",
      "r217",
      "r225",
      "r226",
      "r252",
      "r288",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r314",
      "r315",
      "r318",
      "r321",
      "r328",
      "r446",
      "r558",
      "r559",
      "r560",
      "r561",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r587",
      "r608",
      "r627",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r873",
      "r891",
      "r900"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r225",
      "r314",
      "r315",
      "r316",
      "r318",
      "r321",
      "r326",
      "r328",
      "r558",
      "r559",
      "r560",
      "r561",
      "r688",
      "r873",
      "r891"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants shares",
        "verboseLabel": "Warrants to purchase",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingent Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r282",
      "r283",
      "r653",
      "r911",
      "r916"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "verboseLabel": "Common Stock [Member]",
        "netLabel": "Ordinary Shares [Member]",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r726",
      "r727",
      "r729",
      "r730",
      "r731",
      "r732",
      "r896",
      "r897",
      "r899",
      "r956",
      "r1007",
      "r1008"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in New Shekels per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, shares authorized",
        "verboseLabel": "Authorized ordinary shares",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r587"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, shares outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r587",
      "r605",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, NIS 0.000216 par value per share; 165,000,000 authorized shares as of December 31, 2024 and 130,000,000 as of December 31, 2023; 85,749,331 and 77,925,095 outstanding shares at December 31, 2024 and 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r522",
      "r708"
     ]
    },
    "us-gaap_CommonUnitIssuanceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonUnitIssuanceValue",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issue value (in Dollars)",
        "label": "Common Unit, Issuance Value",
        "documentation": "Stated value of common units of ownership issued by a limited liability company (LLC)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonUnitIssued",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issue",
        "label": "Common Unit, Issued",
        "documentation": "Number of common units issued of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computers and peripheral equipment [Member]",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r34",
      "r35",
      "r249",
      "r652"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r34",
      "r35",
      "r249",
      "r555",
      "r652"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r34",
      "r35",
      "r249",
      "r652",
      "r876"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of credit risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r103"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of revenue of customers",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r34",
      "r35",
      "r249"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r34",
      "r35",
      "r249",
      "r652"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r139",
      "r183",
      "r424",
      "r425",
      "r426",
      "r427",
      "r475",
      "r658",
      "r879",
      "r880",
      "r881",
      "r919",
      "r922",
      "r923"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r139",
      "r183",
      "r424",
      "r425",
      "r426",
      "r427",
      "r475",
      "r658",
      "r879",
      "r880",
      "r881",
      "r919",
      "r922",
      "r923"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentLiabilityReserveEstimatePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentLiabilityReserveEstimatePolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Liabilities",
        "label": "Contingent Liability Reserve Estimate, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the claims loss reserve for insurance contracts with a life contingency (permanent life, some term life, accident and health, some annuities), describing the loss exposures and bases and methodologies for making the relevant accounting estimates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted into odinary shares (in Shares)",
        "label": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "arbe_ConvertibleBonds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ConvertibleBonds",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible bonds",
        "documentation": "Convertible bonds.",
        "label": "Convertible Bonds"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ConvertibleBondsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ConvertibleBondsDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Bonds (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ConvertibleBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ConvertibleBondsMember",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Bonds [Member]",
        "label": "Convertible Bonds Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ConvertibleBondsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ConvertibleBondsPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible bonds",
        "documentation": "Disclosure of accounting policy convertible bonds.",
        "label": "Convertible Bonds Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBonds"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONVERTIBLE BONDS",
        "label": "Convertible Debt [Table Text Block]",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible bonds [Member]",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r318",
      "r729",
      "r730",
      "r731",
      "r732"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs of revenues",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r180",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r446",
      "r677",
      "r920"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues [Member]",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenues",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditLossFinancialInstrumentPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables, net",
        "label": "Credit Loss, Financial Instrument [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r261",
      "r262",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "Customer1Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer One [Member]",
        "label": "Customer1 Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "Customer2Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Two [Member]",
        "label": "Customer2 Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "Customer3Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Three [Member]",
        "label": "Customer3 Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_Customer4Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "Customer4Member",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Four [Member]",
        "label": "Customer4 Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk [Member]",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r249"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]",
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r852"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board of Directors Oversight [Text Block]",
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r852"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]",
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759",
      "r853"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r759",
      "r853"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r854"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r759",
      "r853"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r754",
      "r848"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r753",
      "r847"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r753",
      "r847"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r753",
      "r847"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]",
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r755",
      "r849"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r757",
      "r851"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r757",
      "r851"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]",
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r758",
      "r852"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]",
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r756",
      "r850"
     ]
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "DE",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Germany [Member]",
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted and funds were released from escrow",
        "verboseLabel": "Convertible bonds in the principal amoun (in New Shekels)",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r20"
     ]
    },
    "us-gaap_DebtConversionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Bonds [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r38",
      "r39",
      "r86",
      "r87",
      "r183",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r706",
      "r892",
      "r912",
      "r913",
      "r914",
      "r961",
      "r962"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r299"
     ]
    },
    "us-gaap_DebtInstrumentIssuedPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIssuedPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible bonds principal amount",
        "label": "Debt Instrument, Issued, Principal",
        "documentation": "Amount of principal of debt issued."
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r183",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r706",
      "r892",
      "r912",
      "r913",
      "r914",
      "r961",
      "r962"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount rate",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid Expenses and Other Receivables",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets, net of valuation allowance",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carry forwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees and payroll accrual",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r783",
      "r784",
      "r798"
     ]
    },
    "srt_DemandDepositLiabilitiesInterestBearingAverageRatePaid": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DemandDepositLiabilitiesInterestBearingAverageRatePaid",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank deposit bearing annual interest rate",
        "label": "Demand Deposit Liabilities, Interest-Bearing, Average Rate Paid",
        "documentation": "Average rate paid on interest-bearing demand deposits."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_DepositAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "label": "Deposit Assets",
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r28"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WARRANTS LIABILITIES",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r428",
      "r436"
     ]
    },
    "arbe_DerivativeWarrantLiabilityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "DerivativeWarrantLiabilityShares",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative warrant liability shares (in Shares)",
        "documentation": "Derivative warrant liability.",
        "label": "Derivative Warrant Liability Shares"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_DirectPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "DirectPublicOfferingMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct Public Offering [Member]",
        "label": "Direct Public Offering Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue Disaggregated by Geography [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue Disaggregated by Geography",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r783",
      "r784",
      "r798"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771",
      "r822"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771",
      "r822"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share Attributible to Ordinary Sharholders [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic net loss per ordinary share (in Dollars per share)",
        "verboseLabel": "Loss per share attributable to ordinary shareholders, basic",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r205",
      "r207",
      "r215",
      "r216",
      "r217",
      "r222",
      "r420",
      "r423",
      "r440",
      "r441",
      "r517",
      "r532",
      "r672"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted net loss per ordinary share (in Dollars per share)",
        "verboseLabel": "Loss per share attributable to ordinary shareholders, diluted",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r207",
      "r215",
      "r216",
      "r217",
      "r222",
      "r420",
      "r423",
      "r440",
      "r441",
      "r517",
      "r532",
      "r672"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per ordinary share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r219"
     ]
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareReconciliationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET LOSS PER SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r218",
      "r220",
      "r221"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Effect of exchange rate fluctuations on cash and cash equivalent",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax percentage",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r700"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r389",
      "r409",
      "r700"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign holding percentage",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r392",
      "r700",
      "r895",
      "r952"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees and payroll accruals",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Option Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r149",
      "r167",
      "r168",
      "r169",
      "r184",
      "r185",
      "r186",
      "r190",
      "r197",
      "r199",
      "r201",
      "r224",
      "r253",
      "r256",
      "r278",
      "r329",
      "r407",
      "r408",
      "r415",
      "r416",
      "r417",
      "r421",
      "r422",
      "r423",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r439",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r458",
      "r470",
      "r531",
      "r546",
      "r547",
      "r548",
      "r564",
      "r627"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r775",
      "r791",
      "r826"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r772",
      "r788",
      "r823"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of warrants",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r5"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of financial instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivableAllowanceForCreditLosses",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Financing Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r115",
      "r116",
      "r117",
      "r161",
      "r260",
      "r263",
      "r264",
      "r976"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated financial statements in U.S. dollars",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r830"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r830"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r830"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r830"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r830"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r750",
      "r782"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r611"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative [Member]",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "arbe_GeneralDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "GeneralDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralPartnersOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralPartnersOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "General Partners' Offering Costs",
        "documentation": "The cumulative amount of offering costs allocated to the general partner."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "arbe_GovernmentAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "GovernmentAuthorities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government authorities",
        "documentation": "Government Authorities means any national, provincial, municipal or local government, administrative or regulatory body or department, court, tribunal, arbitrator or any body that exercises the function of a regulator.",
        "label": "Government Authorities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrantsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrantsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants value (in Dollars)",
        "label": "Grants Receivable",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_GrantsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrantsReceivableCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants receivable",
        "label": "Grants Receivable, Current",
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "arbe_GrantsReceived": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "GrantsReceived",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum aggregate royalties paid",
        "documentation": "Grants received for maximum aggregate royalties.",
        "label": "Grants Received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit (loss)",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r54",
      "r96",
      "r180",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r446",
      "r673",
      "r677",
      "r902",
      "r904",
      "r905",
      "r906",
      "r907",
      "r920"
     ]
    },
    "country_HK": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "HK",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hong Kong [Member]",
        "label": "HONG KONG"
       }
      }
     },
     "auth_ref": []
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IL",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israel [Member]",
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "country_IT": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IT",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Italy [Member]",
        "label": "ITALY"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ITACMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ITACMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ITAC [Member]",
        "label": "ITACMember"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r748",
      "r751",
      "r771"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r69"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Domestic",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r388"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable",
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total",
        "terseLabel": "Loss before income taxes, as reported in the consolidated statements of operations",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r92",
      "r96",
      "r518",
      "r529",
      "r673",
      "r677",
      "r902",
      "r904",
      "r905",
      "r906",
      "r907"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompanysLossBeforeIncomeTaxesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r388"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Company\u2019s Loss Before Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r443",
      "r444",
      "r445",
      "r543",
      "r545",
      "r612",
      "r666",
      "r701",
      "r978"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r443",
      "r444",
      "r445",
      "r543",
      "r545",
      "r612",
      "r666",
      "r701",
      "r978"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TAXES ON INCOME",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r384",
      "r389",
      "r396",
      "r397",
      "r398",
      "r399",
      "r404",
      "r410",
      "r412",
      "r413",
      "r414",
      "r563",
      "r700"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Reported income taxes benefit",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r200",
      "r201",
      "r223",
      "r234",
      "r242",
      "r387",
      "r389",
      "r411",
      "r534",
      "r700"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r385",
      "r386",
      "r399",
      "r400",
      "r403",
      "r406",
      "r557"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r700",
      "r952"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of deferred taxes from currency exchange",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r392",
      "r700",
      "r952"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax benefit at statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r700"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of Non-deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r395",
      "r952"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofReconciliationIncomeTaxBenefitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r952",
      "r953"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r889"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees and payroll accruals",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease ROU assets and liabilities, net",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r877",
      "r889"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other payables",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other receivables",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r821",
      "r830",
      "r834",
      "r842"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r752",
      "r846"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r752",
      "r846"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r752",
      "r846"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r175",
      "r176"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r785",
      "r786",
      "r787"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "arbe_IssuanceCostsRelatedToConvertibleBonds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "IssuanceCostsRelatedToConvertibleBonds",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs related to convertible bonds",
        "documentation": "Issuance costs related to convertible bonds.",
        "label": "Issuance Costs Related To Convertible Bonds"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of convertible bonds with proceeds placed in escrow",
        "documentation": "Issuance of convertible bonds with proceeds placed in escrow.",
        "label": "Issuance Of Convertible Bonds With Proceeds Placed In Escrow"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation to service providers",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Leases",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvement\t[Member]",
        "verboseLabel": "Leasehold improvement [Member]",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r468"
     ]
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesOperatingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and after",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and shareholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r88",
      "r524",
      "r708",
      "r893",
      "r910",
      "r960"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r153",
      "r180",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r425",
      "r426",
      "r427",
      "r446",
      "r708",
      "r920",
      "r967",
      "r968"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r41",
      "r42",
      "r43",
      "r44",
      "r180",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r425",
      "r426",
      "r427",
      "r446",
      "r920",
      "r967",
      "r968"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LONG-TERM LIABILITIES:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermConvertibleDebtCurrentAndNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Bonds [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r691",
      "r718",
      "r722",
      "r925",
      "r977",
      "r979",
      "r980",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r124",
      "r125",
      "r127",
      "r147",
      "r148",
      "r284",
      "r285",
      "r286",
      "r287",
      "r344",
      "r381",
      "r442",
      "r481",
      "r542",
      "r544",
      "r554",
      "r579",
      "r580",
      "r633",
      "r635",
      "r637",
      "r638",
      "r640",
      "r664",
      "r665",
      "r682",
      "r688",
      "r696",
      "r702",
      "r703",
      "r704",
      "r705",
      "r719",
      "r924",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r124",
      "r125",
      "r127",
      "r147",
      "r148",
      "r284",
      "r285",
      "r286",
      "r287",
      "r344",
      "r381",
      "r442",
      "r481",
      "r542",
      "r544",
      "r554",
      "r579",
      "r580",
      "r633",
      "r635",
      "r637",
      "r638",
      "r640",
      "r664",
      "r665",
      "r682",
      "r688",
      "r696",
      "r702",
      "r703",
      "r704",
      "r719",
      "r924",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r691",
      "r718",
      "r722",
      "r925",
      "r977",
      "r979",
      "r980",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "arbe_NasdaqMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "NasdaqMember",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nasdaq [Member]",
        "label": "Nasdaq Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.arberobotics.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GENERAL",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r112"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r63"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r63",
      "r93",
      "r151",
      "r164",
      "r165",
      "r169",
      "r180",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r200",
      "r201",
      "r213",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r420",
      "r423",
      "r441",
      "r446",
      "r530",
      "r607",
      "r625",
      "r626",
      "r733",
      "r920"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted Net loss",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r217"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently not yet adopted accounting pronouncements",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r150",
      "r187",
      "r188",
      "r191",
      "r192",
      "r202",
      "r203",
      "r250",
      "r254",
      "r255",
      "r418",
      "r419",
      "r421",
      "r423",
      "r434",
      "r438",
      "r469",
      "r471",
      "r472",
      "r484",
      "r485",
      "r486",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of recently issued accounting standard",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r784",
      "r785",
      "r786",
      "r787"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r779",
      "r795",
      "r821",
      "r830"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of property and equipment",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r20"
     ]
    },
    "us-gaap_NoninterestExpenseOfferingCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoninterestExpenseOfferingCost",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering expenses (in Dollars)",
        "label": "Noninterest Expense Offering Cost",
        "documentation": "Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial income, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "arbe_NumberOfConsecutiveTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "NumberOfConsecutiveTradingDays",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of consecutive trading days",
        "documentation": "Number of consecutive trading days.",
        "label": "Number Of Consecutive Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating segment",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r903"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable segment",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r681",
      "r903"
     ]
    },
    "arbe_NumberOfTradingVolumeSharesPerDay": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "NumberOfTradingVolumeSharesPerDay",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading volume shares per day",
        "documentation": "Represent the number of trading volume shares per day.",
        "label": "Number Of Trading Volume Shares Per Day"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and equipment [Member]",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r673",
      "r902",
      "r904",
      "r905",
      "r906",
      "r907"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Current maturities of operating leases",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Long-term operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash payments and expenses related to operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r463"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "arbe_OperatingLeaseRightofuseAssetsAndLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "OperatingLeaseRightofuseAssetsAndLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets and liabilities, net",
        "documentation": "Operating lease right-of-use assets and liabilities net.",
        "label": "Operating Lease Rightofuse Assets And Liabilities Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r707"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r707"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward (in Dollars)",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "arbe_OptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "OptionsAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options:",
        "label": "Options Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_OrdinarySharesParValueNIS0000216PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "OrdinarySharesParValueNIS0000216PerShareMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value NIS 0.000216 per share",
        "label": "Ordinary Shares Par Value NIS0000216 Per Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses and Other Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets - funds held in escrow",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r708"
     ]
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCurrentAssetsTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PrepaidExpensesandOtherReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PREPAID EXPENSES AND OTHER RECEIVABLES",
        "label": "Other Current Assets [Text Block]",
        "documentation": "The entire disclosure for other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other offering expenses payable (in Dollars)",
        "label": "Other Expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57"
     ]
    },
    "arbe_OtherGeographicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "OtherGeographicalMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other [Member]",
        "label": "Other Geographical Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial income",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r609",
      "r641",
      "r642",
      "r643"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r777",
      "r793",
      "r828"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r780",
      "r796",
      "r831"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r780",
      "r796",
      "r831"
     ]
    },
    "arbe_PIPEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PIPEMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PIPE [Member]",
        "label": "PIPEMember"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "arbe_PaymentForChangeInBankDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PaymentForChangeInBankDeposits",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in bank deposits",
        "documentation": "The amount of payment for change in bank deposits.",
        "label": "Payment For Change In Bank Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r803"
     ]
    },
    "arbe_PercentageOfOrdinarySharesOutstanding": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PercentageOfOrdinarySharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of ordinary shares outstanding",
        "documentation": "Percentage of ordinary shares outstanding.",
        "label": "Percentage Of Ordinary Shares Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PostemploymentBenefitPlansPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued post-employment benefit",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "arbe_PreFundedWarrantInLieuOfOrdinaryShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PreFundedWarrantInLieuOfOrdinaryShare",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lieu amount of ordinary share",
        "documentation": "Per share amount of pre funded warrant in lieu of ordinary share.",
        "label": "Pre Funded Warrant In Lieu Of Ordinary Share"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrant [Member]",
        "label": "Pre Funded Warrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other",
        "label": "Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other receivables",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPrepaidExpensesandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Prepaid Expense and Other Assets, Noncurrent",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r885"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement [Member]",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_PrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PrivateWarrantsMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Warrants [Member]",
        "label": "Private Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs related to convertible bonds",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total gross proceeds (in Dollars)",
        "verboseLabel": "Net proceeds received offering",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of ordinary shares and warrants, net of issuance costs",
        "verboseLabel": "Net of issuance costs (in Dollars)",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds (in Dollars)",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r12"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r146",
      "r245",
      "r483",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r668",
      "r689",
      "r717",
      "r719",
      "r720",
      "r723",
      "r724",
      "r882",
      "r917",
      "r918",
      "r925",
      "r977",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r146",
      "r245",
      "r483",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r668",
      "r689",
      "r717",
      "r719",
      "r720",
      "r723",
      "r724",
      "r882",
      "r917",
      "r918",
      "r925",
      "r977",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r468"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY AND EQUIPMENT",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r104",
      "r108",
      "r109"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r155",
      "r528"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGrossAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost:",
        "label": "Property, Plant and Equipment, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment [LIne Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r468"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r468",
      "r519",
      "r528",
      "r708"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r104",
      "r108",
      "r526"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Salvage Value, Percentage",
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r468"
     ]
    },
    "arbe_PropertyPlantAndEquipmentUsefulLifeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PropertyPlantAndEquipmentUsefulLifeTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets",
        "documentation": "Tabular disclosure of the useful lives of property, plant and equipment.",
        "label": "Property Plant And Equipment Useful Life Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PublicUtilitiesGeneralDisclosuresLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PublicUtilitiesGeneralDisclosuresLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Warrants [Member]",
        "label": "Public Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r124",
      "r125",
      "r127",
      "r147",
      "r148",
      "r284",
      "r285",
      "r286",
      "r287",
      "r342",
      "r344",
      "r371",
      "r372",
      "r373",
      "r381",
      "r442",
      "r479",
      "r480",
      "r481",
      "r542",
      "r544",
      "r554",
      "r579",
      "r580",
      "r633",
      "r635",
      "r637",
      "r638",
      "r640",
      "r664",
      "r665",
      "r682",
      "r688",
      "r696",
      "r702",
      "r703",
      "r704",
      "r705",
      "r719",
      "r727",
      "r915",
      "r924",
      "r958",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable",
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r122",
      "r124",
      "r125",
      "r127",
      "r147",
      "r148",
      "r284",
      "r285",
      "r286",
      "r287",
      "r342",
      "r344",
      "r371",
      "r372",
      "r373",
      "r381",
      "r442",
      "r479",
      "r480",
      "r481",
      "r542",
      "r544",
      "r554",
      "r579",
      "r580",
      "r633",
      "r635",
      "r637",
      "r638",
      "r640",
      "r664",
      "r665",
      "r682",
      "r688",
      "r696",
      "r702",
      "r703",
      "r704",
      "r705",
      "r719",
      "r727",
      "r915",
      "r924",
      "r958",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r772",
      "r788",
      "r823"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r343",
      "r473",
      "r474",
      "r521",
      "r525",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r604",
      "r606",
      "r632"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r343",
      "r473",
      "r474",
      "r521",
      "r525",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r604",
      "r606",
      "r632",
      "r966"
     ]
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfShortTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of short-term loan",
        "label": "Repayments of Short-Term Debt",
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development, net",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r666",
      "r677",
      "r975"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development [Member]",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses, net",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r762",
      "r773",
      "r789",
      "r824"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r763",
      "r774",
      "r790",
      "r825"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r781",
      "r797",
      "r832"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r883",
      "r890"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r73",
      "r523",
      "r549",
      "r553",
      "r562",
      "r588",
      "r708"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r184",
      "r185",
      "r186",
      "r190",
      "r197",
      "r199",
      "r201",
      "r253",
      "r256",
      "r278",
      "r407",
      "r408",
      "r415",
      "r416",
      "r417",
      "r421",
      "r422",
      "r423",
      "r429",
      "r431",
      "r432",
      "r435",
      "r439",
      "r456",
      "r458",
      "r546",
      "r548",
      "r564",
      "r1008"
     ]
    },
    "arbe_RevaluationOfConvertibleLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "RevaluationOfConvertibleLoan",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of convertible bonds",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Revaluation Of Convertible Loan"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_RevaluationOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "RevaluationOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofAdjustedNetlossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of warrants",
        "documentation": "Amount of revaluation of warrants.",
        "label": "Revaluation Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_RevenueByGeographyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "RevenueByGeographyAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue by geography:",
        "label": "Revenue By Geography Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r223",
      "r232",
      "r233",
      "r238",
      "r242",
      "r245",
      "r247",
      "r249",
      "r338",
      "r339",
      "r483"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r667",
      "r671"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligation",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% of Revenue",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r170",
      "r180",
      "r223",
      "r232",
      "r233",
      "r238",
      "r242",
      "r245",
      "r247",
      "r249",
      "r252",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r446",
      "r518",
      "r677",
      "r920"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities arising from obtaining right-of-use assets",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r707"
     ]
    },
    "arbe_RoyaltyPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "RoyaltyPercentage",
     "presentation": [
      "http://www.arberobotics.com/role/CommitmentsandContingentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty percentage",
        "documentation": "Percentage of sales that royalties are paid.",
        "label": "Royalty Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "country_SE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "SE",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sweden [Member]",
        "label": "SWEDEN"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SaleOfPreFundedWarrantShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SaleOfPreFundedWarrantShares",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants",
        "documentation": "The number of pre-funded warrants.",
        "label": "Sale Of Pre Funded Warrant Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of ordinary shares",
        "verboseLabel": "Sale of ordinary shares (in Shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock price per share (in Dollars per share)",
        "verboseLabel": "Purchase price per share (in Dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark [Member]",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r875"
     ]
    },
    "arbe_ScheduleOfAdjustedNetIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfAdjustedNetIncomeLossTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Adjusted Loss Per Share",
        "documentation": "Tabular disclosure of adjusted net income (Loss).",
        "label": "Schedule Of Adjusted Net Income Loss Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Ordinary Shares that were Excluded from the Computation of Diluted Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "arbe_ScheduleOfCompensationToEmployeesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfCompensationToEmployeesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Compensation To Employees Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/NetLossPerShareAttributibletoOrdinarySharholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation Income Tax Benefit",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r700",
      "r952"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company\u2019s Loss Before Income Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "arbe_ScheduleOfLeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfLeaseCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Lease Cost Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfMaturitiesOfLeaseLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturities of Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfOrdinarySharesThatWereExcludedFromTheComputationOfDilutedNetLossPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Ordinary Shares That Were Excluded From the Computation of Diluted Net Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfPrepaidExpensesAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepaid Expenses and Other Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfPropertyAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfPropertyAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r468"
     ]
    },
    "arbe_ScheduleOfReconciliationIncomeTaxBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfReconciliationIncomeTaxBenefitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation Income Tax Benefit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfRevenueDisaggregatedByGeographyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfRevenueDisaggregatedByGeographyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue Disaggregated By Geography Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfRsusActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfRsusActivityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Rsus Activity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfSetsForthTheComputationOfBasicAndDilutedNetLossPerShareAttributableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Sets Forth the Computation of Basic and Diluted Net Loss Per Share Attributable [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r79"
     ]
    },
    "arbe_ScheduleOfShareBasedCompensationExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfShareBasedCompensationExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Based Compensation Expense Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSUs Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r75"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Compensation to Employees",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "arbe_ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ScheduleOfTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of The Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SecuritiesSoldPerUnits": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SecuritiesSoldPerUnits",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities sold per unit (in Dollars per share)",
        "documentation": "Per share amount of securities sold per unit.",
        "label": "Securities Sold Per Units"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r123",
      "r126",
      "r128",
      "r135",
      "r136",
      "r137",
      "r138",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r247",
      "r248",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r576",
      "r577",
      "r578",
      "r634",
      "r636",
      "r639",
      "r644",
      "r651",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r669",
      "r690",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r721",
      "r727",
      "r925",
      "r977",
      "r979",
      "r980",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "arbe_SegmentInformationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SegmentInformationDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r223",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r249",
      "r674",
      "r675",
      "r676",
      "r677",
      "r679",
      "r680",
      "r681"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing [Member]",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance Costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "arbe_SeverancePercentageOfMonthlySalary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SeverancePercentageOfMonthlySalary",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits rate",
        "documentation": "Percentage of monthly salary monthly severance rate.",
        "label": "Severance Percentage Of Monthly Salary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow",
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r697"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period, description",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights",
        "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility impact rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited, Numbers of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Numbers of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Numbers of RSUs, ending balance",
        "periodEndLabel": "Outstanding, Numbers of RSUs, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested, Numbers of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Period Increase (Decrease)",
        "documentation": "Increase (decrease) in the number of shares under non-option equity instrument agreements."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares were reserved for issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options available for future grants, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate intrinsic value, ending balance (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Outstanding share options, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted-average exercise price, ending balance (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r355"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted-average exercise price (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r349",
      "r368",
      "r369",
      "r370",
      "r371",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price (in Dollars per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r698"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term, in years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Aggregate intrinsic value (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable, Weighted average remaining contractual life (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life (years), ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "arbe_ShareholdersEquityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofCompensationtoEmployeesDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Compensation to Employees [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofCompensationtoEmployeesDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofCompensationtoEmployeesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Compensation to Employees (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofRSUsActivityDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofRSUsActivityDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of RSUs Activity [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofRSUsActivityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofRSUsActivityDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRSUsActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of RSUs Activity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Based Compensation Expense [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofShareBasedCompensationExpenseDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofShareBasedCompensationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Share Based Compensation Expense (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofStockOptionActivityDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Stock Option Activity (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShareholdersEquityScheduleofStockOptionActivityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShareholdersEquityScheduleofStockOptionActivityDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity - Schedule of Stock Option Activity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares par value (in Dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_ShortTermDepositsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "ShortTermDepositsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term deposits",
        "documentation": "Policy disclosure of short term deposits.",
        "label": "Short Term Deposits Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term bank deposits",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r887"
     ]
    },
    "arbe_SignificantAccountingPoliciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SignificantAccountingPoliciesScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies - Schedule of the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r178"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r158",
      "r159",
      "r160",
      "r180",
      "r207",
      "r208",
      "r215",
      "r217",
      "r225",
      "r226",
      "r252",
      "r288",
      "r290",
      "r291",
      "r292",
      "r295",
      "r296",
      "r314",
      "r315",
      "r318",
      "r321",
      "r328",
      "r446",
      "r558",
      "r559",
      "r560",
      "r561",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r587",
      "r608",
      "r627",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r873",
      "r891",
      "r900"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r49",
      "r50",
      "r149",
      "r167",
      "r168",
      "r169",
      "r184",
      "r185",
      "r186",
      "r190",
      "r197",
      "r199",
      "r201",
      "r224",
      "r253",
      "r256",
      "r278",
      "r329",
      "r407",
      "r408",
      "r415",
      "r416",
      "r417",
      "r421",
      "r422",
      "r423",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r439",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r458",
      "r470",
      "r531",
      "r546",
      "r547",
      "r548",
      "r564",
      "r627"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r123",
      "r126",
      "r128",
      "r135",
      "r136",
      "r137",
      "r138",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r247",
      "r248",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r576",
      "r577",
      "r578",
      "r634",
      "r636",
      "r639",
      "r644",
      "r651",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r669",
      "r690",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r721",
      "r727",
      "r925",
      "r977",
      "r979",
      "r980",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r224",
      "r458",
      "r483",
      "r556",
      "r575",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606",
      "r610",
      "r611",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r627",
      "r728"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r224",
      "r251",
      "r458",
      "r483",
      "r556",
      "r575",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r606",
      "r610",
      "r611",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r627",
      "r728"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r776",
      "r792",
      "r827"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares and warrants, net of issuance costs (in Shares)",
        "verboseLabel": "Ordinary share issued",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r45",
      "r46",
      "r73",
      "r558",
      "r627",
      "r646"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options and vested RSUs (in Shares)",
        "negatedLabel": "Exercised, Outstanding share options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r45",
      "r46",
      "r73",
      "r355"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation to service providers",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares and warrants, net of issuance costs",
        "verboseLabel": "Gross proceeds",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r45",
      "r46",
      "r73",
      "r564",
      "r627",
      "r646",
      "r734"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of options and vested RSUs",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r49",
      "r50",
      "r73"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable",
      "http://www.arberobotics.com/role/ScheduleofStockOptionActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option [Member]",
        "verboseLabel": "Outstanding share options [Member]",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet",
      "http://www.arberobotics.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r49",
      "r50",
      "r66",
      "r589",
      "r605",
      "r628",
      "r629",
      "r708",
      "r735",
      "r893",
      "r910",
      "r960",
      "r1008"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "8SHAREHOLDERS\u2019 EQUITY:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders\u2019 Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r179",
      "r313",
      "r315",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r329",
      "r437",
      "r630",
      "r631",
      "r650"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r477"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r477"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r477"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails",
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r477"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_SubsequentEventsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "SubsequentEventsDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.arberobotics.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r478"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flows activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "arbe_TaxesonIncomeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TaxesonIncomeDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TheTrusteeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TheTrusteeMember",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Trustee [Member]",
        "label": "The Trustee Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r908",
      "r965"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]",
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "arbe_TradingPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TradingPricePerShare",
     "presentation": [
      "http://www.arberobotics.com/role/ConvertibleBondsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average closing trading price",
        "documentation": "Number of trading price per share.",
        "label": "Trading Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TrancheAWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TrancheAWarrantsMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche A Warrants [Member]",
        "label": "Tranche AWarrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TrancheBWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TrancheBWarrantsMember",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails",
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche B Warrants [Member]",
        "label": "Tranche BWarrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.arberobotics.com/role/GeneralDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs (in Dollars)",
        "documentation": "Represent the amount of transaction costs.",
        "label": "Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "arbe_TwoThousandSixteenIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TwoThousandSixteenIncentivePlanMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016 Share Incentive Plan [Member]",
        "verboseLabel": "Two Thousand Sixteen Incentive Plan [Member]",
        "label": "Two Thousand Sixteen Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TwoThousandTwentyOneEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TwoThousandTwentyOneEquityIncentivePlanMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Plan [Member]",
        "label": "Two Thousand Twenty One Equity Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_TwoThousandTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "TwoThousandTwentyOneMember",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Plan [Member]",
        "label": "Two Thousand Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofRevenueDisaggregatedbyGeographyTable",
      "http://www.arberobotics.com/role/TaxesonIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USA [Member]",
        "verboseLabel": "United States [Member]",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_UnderwrittenPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "UnderwrittenPublicOffering",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwritten public offering",
        "documentation": "The amount of underwritten public offering.",
        "label": "Underwritten Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.arberobotics.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r101",
      "r102",
      "r105",
      "r106"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofPropertyandEquipmentTable",
      "http://www.arberobotics.com/role/ScheduleoftheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles [Member]",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofOrdinarySharesthatwereExcludedfromtheComputationofDilutedNetLossPerShareTable",
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants [Member]",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732"
     ]
    },
    "arbe_WarrantToPurchaseOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "WarrantToPurchaseOfOrdinaryShares",
     "presentation": [
      "http://www.arberobotics.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant to purchase of ordinary shares",
        "documentation": "The number of warrants purchase of ordinary shares.",
        "label": "Warrant To Purchase Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r957",
      "r958",
      "r959"
     ]
    },
    "arbe_WarrantsLiabilitiesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "WarrantsLiabilitiesDetailsLineItems",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_WarrantsLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "WarrantsLiabilitiesDetailsTable",
     "presentation": [
      "http://www.arberobotics.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "arbe_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.arberobotics.com/20241231",
     "localname": "WarrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement",
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share (in Shares)",
        "verboseLabel": "Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r217"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.arberobotics.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of ordinary shares used in computing basic net loss per ordinary share (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r217"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://www.arberobotics.com/role/ScheduleofSetsForththeComputationofBasicandDilutedNetLossPerShareAttributableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4H",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/250/tableOfContent"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "a",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "a",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1405",
   "Paragraph": "c",
   "Publisher": "SEC"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "a",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-4A"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479391/326-20-30-5A"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479366/326-20-35-8A"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-17"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-21"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.M.2.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483530/326-20-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479175/326-30-30-1B"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "13A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-13A"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479148/326-30-35-7A"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3A"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3C"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-3D"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/705/tableOfContent"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0001013762-25-004037-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001013762-25-004037-xbrl.zip
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MJ[D\[ZMKH63VQ4]&#@[TY#'9_P%02P,$%     @ B'U\6DXX@J"\#0  QI\
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M NN)(=P UG,+CA$Q5GNP8"<D0<26;OW&<+?8 $D")WS8E=_%N+I(']75%]O
M4%AB1'(7RZ!X.V/"!";S "PSM51@==NP@*66X#NB%.<.;YAP%4*-M!E1RU.2
MXBYR)>O;UGV'&+Y7"@LE 2JWYM-"FV]?MP4'!91\$FK:3K>2@[ 0A)+/X_VZ
MG,[0&?.VD?,IQ*K!K"Z0M&A]O]!H$P JODJ4(W-_[,Y!'7U1PK2 L2;6LZ6Q
M6$JV8O +'[FO%>\[57V#99:#)7_Y3?K  ]^;=Q ;2 LO7533UIQ\6-4))KN
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M-G1QB<#<B>\S&(KQGG&;]8P$25S^)+-B&91:)/.5K3T='L#(+!O_#]]GUT[
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MT_%IUAJODJ=4>9Y&68EJ-,=C5A4Q1&GPD5MP_I[201KWQ*-%>C3'5CU %1J
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MB7Z_O[__[?3FYU?_<W)V>_/TJ9YEWXI-W0.EHMI[Z//:ZX7N7*\U-=4H^C$
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M_&&*R(IHJ=LG PG8MDTJ2M<G" W3!"<+->LT3!H6+!.,+)0,D^DED_R5\HY
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ML<-E@F39*L/;N_L92J!BQWK#1LR+H&<IJ]!/Y[N!QV&8JDBHE!Z&JQ==,8G
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M^GB!UXAB_EURV.'__BSVMCL?$**_VT1XS4?$CZ)7,/Y5@!^!] #D6P!R]F<
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M"D1H(:>@+%4G*NE'*)W+<O6A3ISF^*I:$*Z;7D(F38MLI7,/9?@>0;%1BDB
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MQ/;3C(Q9U;0HP4IU?<YI,\ZXZ!U"S/UACA(IJ"&\SXVZC@0AD3<Q<ER,HGQ
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M1BO]=JZE(/K!N[%)81EW&DO1$?EYYC?O3I?3Q?LQ&M^*C=0:E]W;&T2NJQ6
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MFM$2>0VF[]Y/;Y9H=G,U7[R?+&?S&]OY+^I,K3@&%$F@74=P_Q"3O4E 3)_
M6S:8A GAV) K$3(B:;H_OYO^XQX$:OJ!_.^=55VVD645^9$N55=J"C,-DPLY
M+1_<MVDO -+?3?@M$Y> ]OEV90+#1T7T+N3$&U#NZ#?L\DM?^5&$?8?V80G+
M)CW,:;D9BYRA98&2D,)TR?:T2])5&*VQ!^V@P5=*E$@O#4(F]AF.O' TC4V5
M\;4AXH.O2AP@#^.@T^GOKXEW6PGMI8)[*X:8WK/BQJPE?,>R8=60[<UC86"S
M*JVH>:<*>Q)_2INSE2@.W)7XF/KC:A#.SHM9L(K@SK_$[+_CWZ4"O'NT.*QN
M6?[R!+OW XZ;VHG_3G:O7%H'WL@2GG0+ FR5;9<EEPX2!Z6'B85;L@.ZHAB
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M.M+54&J4F$Q*GNC0O-P)^2.1&YL!B,H\JPF/G!A=#),BS3K5NZ$N3Z:KLC(
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MOA67@3(Y!GB&?\+10]@'KU[SKN7G$&6C43J\D6V_,Z:]UE/5BNF7SV3:PSS
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MQTN\@TP#X5&YK'@.=VP.JF:NZ"QP[3V0><!^H!/9.SGE"ZPQ384>QD].<@3
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M0IWB 7R(YQ.6L!2?7U6VT*LOO4".()]?=6K4*^:CC?TUV"D9?!$^HE-T[+4
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MUM-R$.,:)%[IR<03!*9;"'A'(.W^4%@H_Q:!8>;+6[_<9X\G+!6 Z=-D2,[
M%W,KS,;FB)&ERRRON"6WWLG.5=G><-H)7" KXA(;+,QI\/3K\5V?ZD)QED+H
MQK[S$0P;6U&O.UGTW/W=%(D3Y6 'OC2R RIL598,2R3TU$O(64B&]CB!=YJ>
MA//']-%,R>(=I.!-S-^USQ,Q+2%@.0%INUC6YI)ZDGI%AB3JNOD1\68:':I&
M(\U8C'D!7[@S3AP0[HU73)PUAXIM"ZG>,E7%GL4#3X(BT#Z[' $,Z< X;Z,V
MXLD4!D5@12"(?=AX< <L> ,Q50B)-F/=M^KO2;>G6@2V*;L$)/"O<H .IW=4
M()&D1YWAR[!Z(PTZXF9KX2EEW(JP9I2AO.9P&&(F(J:2SN25,,-6$C%#3J@S
M]+:)LUC&,@ 5X30N1M18F"W?L"W6T"U?S_<B;^K;N^_ND[P=)&7'AY%W;&#]
M'H,^27(Z.0C#CRPO)R+*9=@=[$M9<)WVS[QY^G*HF_*95EY(1DM/-347^<DF
M(VHV"V#C(GJK.:G'Q#F)@5&S$AUG@_CU95G)N*55$0@X7>4?(;ZL9DL=5QY%
M^MASU<*[J+=G&[#^4NZA<1L$3Q1NH/;&65,(]&C2#E\1/0%I?9AI>]X%48E'
M]\/Y$]&.D;>Q+[]2:2I+J'/N+7E@S* D+2BN.CVBNN! ZH00:AHH1U^^0QV&
M2$GKJT*<P+T8HOJ[WQKSY*K41]3W(.%<]53?!EQH6LNL8IB4^'*"C1"OI=[G
M?!N$5,J><\"3QC[9^ZL>'.TX6;%[Q1>0^BT<CQS62^>"6[,M.F-X^'UEY,4G
M!\RT$X1].7X&O)'DPBZPSMFA>2HKZ!5[P@S# 9I1^]:D-9ESLW#2B3M-3FG\
MU$9";6#?*P4?O[ ,"R\]#E^WCPD)TZ8XL.)Z=YY7=-.457T4(*: OF0?K9[.
MCVZ9.C_*SP!3L$?Q,*9M9:#ZWF35NN(H>,(+8BH%^"7< B&SZS>K.(0I'R^S
MHU"(]K00UC8B\8LYD#=QPRKSUZA^A6#E:>]I=P&R7,#;O+)];)WW[@X38M0=
MV4_<"+S AXDK05F3BTAD";C3@[CRUKPUEV6UHSEDBRS'7V.L::+'9HG'S<R2
M.(G+9M)N2*3="&-'1';"-!HQ0D6_DH9)+'1XE)8AR7$="1;<78DQ/(#?M?G4
MID$8)Y772,HQ.4YB7KQ^<+R/T4U%+P_%EFYEOIM8E;.+TWK'CE]*Q# - RH&
M)@7[=1 T<)OZJ8^J?WVMRKJ^J<I=;HTW\D>(>";QS6>L%@UR]8F)K2+IE'#\
MZC-SKEHT7G;&/HO?<9"O4?AB#AVGD]:V,J&1VQ>Z<<62HHK-P4%4<3F!C.)>
MC6V')8%Z5C1Y<6#'>)N!_9GNRHIJ4$M:RZ[V'CA/V;%*0M*I:<W<] <^L8&_
M2X4.#9,O ?%S"E,LV5M'L?B-!%U,W  ./&U/])H;T$&\[HTBQ0WY-JN?QB:6
MJ(H!L[I>LH;>[+,-7ZP[)5<^3?3C2^E B).!B<M%<$R[\VRS 3#S^I9N*%L1
M=%NEC0>U28TA[: 5R78-0#DIL'\!\5/1;=X0.-D6@^[D(AC-WO,R*.[QRYVG
MQFH\LA*/=R2U$$%8",$U;0?-L6^_LFH '^*J>*$2L\E^C;%G/\##Q'@Z]2TT
M7#]^G=CHC'HO&"W(.="N##^'F2[=P6# Z$B\PQ!)()0@*C$IC6!/U&Q_Q.KI
M:"70C"-O7@,M4!^\G)INT;C58S@1:DF&\C1B*4\'$=&76]X#?EP,;"]*!*H<
MV*E=6KS,$R Q'+2G"I.%1LDZ/O(W'AN;A^NSVGM3!!Y7QQKB8(\!_TZ\)8:+
MQZ1G(S%R0G-6/\'_($/C)=M3KF2KPE#XPUFQ[?[">%)$48>5A] B@6VJBU\;
MWAH.VC^)_EO66":;=R7:LAK3KXA1>"L>@?*8WB^[(\22"%('RK%GQ<*(6IGH
M ";6EO:^B2L'-!:;8"=$,22X\5Z]_O/JF]4=?7=[=O$M57=RO3Q3*OU%Q]3=
MC9.)R9S')Y[*_996M<CC&M&/@7^P,HEN,6UZ0^GSG-H!O(F?:QF2HZ!R1; N
MELE4*%^*0<(D C-;)1=^$"9[$:1YI,6&[841K>R,6?C7T9DGH+M=LIR><-)M
MJ3YCF1>[4:P$21C4.+E#$6H8&19Z+00;Q$,8*JX07D22C[X+[QU W]_^2E1_
MH1>'7M_W"2K0>Z[RX+A \ER;[KI#P@!)S@G=2[C3X+8'ZWG:-L6KP#[%LCHS
M]?4Q \>PW3";(.)J$76CW?1V):%NC&A%\I(D8\GXY3Z@*6$3'+4!($S;)M;<
MEV"SWE3E2[ZEV\^OWVO*#%8-"2^=YZ#7^US6[;M(4^H/DQ+V.M+-;&)_YBX*
M]5;P?[Z#%Y.\>$]:&/[VY<NQDD[!4M2!?C+118AYB#8>=7V A ?X"MC=!/@^
M6[;DLGBA50.H\9_+8FO--%:C>3<DN([Y>')?$F,&PJ=(F7,<1J0IX-&\B9QN
M5&XHW:I\.[6<<_I@_?#5$)VPJ*4#H]*J^ YR\-PC#_5+\C>-\S.EUG5\U$SQ
M*L67"=L@['AM7F\8QQNV)EC'#SBD[[+]2_9(56&QQ/YP?#)\FA7A$VDQ_1!A
M>SF9@NY;#"K*2.HM7]AX!L:4\'59E.H&%5>M!Z+,'*#U'#GF?>JOSDH-)AL/
MZ7'!VTU%Y^PER_<\>Z,T2N/D42"KJ7SJZ5 +U;-R?=0H&Y03ZS*TQ61?3&8*
M*NWC.!PU%9<GD[#MN1F7/=..6)#]8*'%GD1CHSLN#+'T#72<"&QES/ X;+B2
MY#DFPUTXG5D5S..*G#V#\S#U@3J"$YA$1S,RKK^@VPF.USRL=\RLY!LQN&T>
M'_>AW'U@(T5OF=12<]*%R2F $:E2!P-3!A=QS+FJ!QP-HN7:O[$Q<LNPW[!_
M0(]ON';^#U!+ P04    " "(?7Q:$NN?G0U"  #6/ 0 %0   &%R8F4M,C R
M-#$R,S%?<')E+GAM;.U]ZW/;N)+O]_TKO+E?[JVI3)YS,IDZ<[=DR\[XC&WY
MR'9RYFQMI6@2DCBA2(4/Q9J_?@$^)+Y  F"#33K>JCUC.Q*Z\>L&T&CTX^__
M];!VCK;$#VS/_?79JQ]?/CLBKNE9MKO\]=G=S?/)S<GY^;/_^O]'1__Q]_]\
M_OSH W&);X3$.KK?'9UXZ\V-:1_=^H8;+#Q_??1_P_7_.WI^M K#S2\O7GS[
M]NU'DWXF,&V?!%[DFR1@?SAZ_IP.F UYXA,VX"]'9[Y]=&GX1Z]_/GKU\R\_
M_?S+F_='=[<G1Z]?OOXI^<I__-VQW2_W1D".*-]N\.NS'*6'>]_YT?.7+UZ_
M?/GF1?;!9\DG?WE@?RA\_MN;^-.OWK]__R+^U_U' [ON@W385R_^=7EQ8Z[(
MVGANNT%HN"8C$-B_!/$?+SS3"&,D6_DZXGZ"_?8\^]AS]J?GKUX_?_/JQX?
M>I;@=G3T=]]SR)PLCF+.?PEW&_+KL\!>;QS&4/RWE4\6OSXS_'LVR.NWKUXG
M0_P?]I?/_N<3SPT\Q[88]L>&PZ9RLR(D?';$AKZ;GQ<FP;[D>_=>:)NQ"%^P
M#[W@CO%"/Y^?KPV?N.&*4)8,)X!@NSRDIEF<TP6V)C<A_7E-R:ER7AXFX1:&
MW9L516+E.1;=&4Z_1G:XNZ6#O/;\-S+<-HP2,PN.[(D1K,X<[YLJI/OO4_9
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MEMJ^#WJ?F*&]3:K8Z)F8 @-#,2H:I%XZG:0A1NV0\?V8%^K:WVY^*,BN8GX
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M#E<G]&Y%;U%^?V=#,W7TDA^@>M&"]."NE&F'[%+C[&K/;/T&A# GCVH?D1
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M_DB*'GUM!TL+,62CJT6&^171AAKDRYJV3AKKM9V4-Z1G#+,@Z40(:QU2J;8
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M%W4OGC"@\K1Z[-6Q5JD]:$9Y:%;YR&3!HK83T=.KIU4HQ\6(*MPJ XU36>K
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M\.IL)-7!,..,R_'=ZYI&T2>/Z9275$318A9 [G)9?Q7=IZS(#&?^#?&W]%X
MY#>O'1;77!-9BIE/JQX53 &QM_"4F6#JK0W;A9-2S=@XHFI3R))XZC#IXCJ/
MBUQD"YD:$$[=A89SI/"^B_G8T 8E=[Y8O@#&] V%)[X3Y1D#VI7X8X]G:VK
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M&;ZE*<6L.#::U[C[LB[$F14!Z[W^_3YH^L"ZEE#YZOBX48&UBEI(\ZP" EY
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MFB_1JL8%F0J@5^FB("6G9'O+&L+555'G;.ZU7\2NZRV";?V,,8H37?OVEF[
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M4?1K00)S[3Q53M2[^;473E2(5('P7S_5342OFWCMD[.(1?@T%$[DF'V<KXX
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MHB0?%UJ#C7CA/_ZWU>\NLPUAEREW>>$%P8GA^[N%Y[,MJ-H.$PA0$8K(-H:
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M)3-&N9: TI#GV;V)PKEKLTRYIH+MG84J3G= UZ5&(4L@J6Z5EZ6N:ILGAE-
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M8?Y2577\<B].U.HV-/5]8,1KLIRT.7TTOB<6&H9M1P?[>\3>E[(>_^-]$<B
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MR4N,IR'M?NED(H2[]*C><9PAW\,, 9%FA)4IZ!^N#B#@AE)/,Q;S)HAW!:F
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MT?W*H.,-1VAC=P)..*:?FY^:V:U!:*"FK"]22%Z5RF'P2Y9>[!3R^WET7FN
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M]9&W6E\TWNPBW-H!@P%GAO2,51*_UK><X-RYEGKE35M''\"[H6ON ,44X/U
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MWD]0K,(Q<FJZX8[I&I+,DB[XBU4M*#P&.1U6[^SA<WP<83NH^2T](X6Q:2W
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MB'"MJPT"?(Q94 %KNPS-0.:-U"35&S-#_=!U760]C!([?A;<M-QTEL?%H<]
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MS4Y+)7+0=E-Y0,%J"EQ/R0X 'ZOC]]?J8SM[)G7',U"BY!JYT5X: 8?)-SH
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M#1UQT6XN3+Z#J0Y'@)KN#G)B<1MQ9YHHP"3%R67HY<$$/!FHE#/5:$(M^SN
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MYIS.X:QMFNC:C''824YQYF2XR'L?K,,I?/:\>V-Q%A[<!76%9PLCB,LOB^8
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M-S?MU@J/[H#*>+-C%.C&CF^$C.\#Y1\K%[NJN\*CXDCJ>(,@V99>_&$0^TJ
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MZ%&YHVV("LNB:_20JO5>$_J4.:[BF=J0\2:F&[04F*%O2B["7VDE3Y+1*+_
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MY'+QUZB9X*MGTIY"[_.CH(I<N2]$KCB4/?/.=! D".6/26& A6!%NDU\>G7
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M_S)(LBNE..#J9;9=;!PK<I?HRQ?,[+(&$*FC?)M8'UC_OS]_@;]@7\BNOJU
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M<Q#IK'RFN\\I!M2F#Q*2F-CT$AYU0(T'JW$XD)-8%KKJ"MA2W+G2I"4=W 6
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M[[Z*E>Z4[CUXSS%9!MFKG9!I)WW90W].54C('#\W(C/[VBNZQZ-H>,1"<?_
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MXM9K@.\NI'Q&(Y#C'1G@LW7(G72'9K%4\^X]GVV<6EAJ:V.0XR,'I)):I7R
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M"+6M_+I]C#RKA#D7KDB=I6C*Q5>9:Y6]L$P]L^#! N?,>Y Y70%4T7"0NMX
M&L&+#/V4XX/CQ$8^;R=Y772C%V^J8NV<D$S;2V:1S^:A'D%TXO.%>*ZB[G*5
M!3;'99M+3$[4FW7@#@O5['!^Q$V+7\0  M+</RFYF4:ABE(-7(/ E9MU;G@T
M=J"\>XCI)9\NAVI& L_Z K_F]AD* 5?"'"CW5Y+V*ZP:G/S\1=# TYH,(F!Z
M7.8VI"?8ODFBI3OP2W4VDQMFDVDM&#+@^7=IEVUPRK.7HP0TS*Z)*$)0!-:
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M\AT?M2OP9#Q2'8&]DT>/A&KC!$]%KSV5>C"'!P_;_#7>?^_DR<-](7 O\;V
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M*6%+/D[/])AT2P2F![I1\[R",D(%/?@]-9,7JNY>-1-G'_=E9G6X'3I#VWR
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M]5[!BG*4)-B1S;&@4P!()G)T:T!7&>0BI1%T*=O&L .C[G#R:) 7K/#$,B]
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MF&PDL-2X,.[8E2;G*\NZ*(B8=D'-3+)M7LE(@YA3D8 !YIB] Q8 $]48,4R
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M]_:J,OVZ6/-[&M.Y^[O%&S[4"'-DCBVK0BDA,O^9:Y]!?,.?B#(O+KV"[*!
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M-)B,PF?923^B20"%M(JD&]C-0L;.#MJ'0>>.;J%S0^C<O8-;Z-RG)Z$"T4I
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MX[,])6*FTA3[I@=HKQ(;*A9*=QL;)NY#$B>FJ0US>.E(SR5?Q@7H4A+/C<I
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M\$3Y,8QN8N/R=E_61 W4WY2R*8OTT3?9#U0;O3,PLFFJ10U$TJIF@W>9&V8
M#RG]?HUF7QVUFRV0D2405C.FUH]*2DX3!V\J"%'K)NE$N5KYAJ.BF+VZ'S#7
MMN&?/\A;6+L40@N:,1$8&F:8Z?WX[R67@E4<A]OQE.\C*M$YQ03N #/VK?R"
MAK[KAV40?D2@UW5>;Q"X]E.ZI1SG6!$"%/B[#I//\33Y%,_R88")>[> B0W
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M9Z*JM\V#:(2Q+5()6TCS"OFS ))!'Z4&EJ9@QBQ3HQ5FCT73%UL"E3!<#+D
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MJ[=OH84#,?5!90&&P)8Z^?+9H 4S'<&04'H!BT\<,.5*X"R0' $Z?ZX8'F)
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M6%K(PSZU:9FSO,82:_F8=0X=HY%V,>2Z@\^\%ED02%MF6^[/G]02D4Q81CP
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MC]7X^^.&[C5Q0Z^'#/V>,Y@4Q2Q_\>NO5U=7'7$^P%77.<.@N?[*E1@;GP@
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M#('U1\?PWY@\D;7C!$'1U@,_4<4/?\?7>KW=;[[AC:#M#[C\H->\%$]I _:
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M[0K'8Q!>Y(=67[@D_N>]30<)QNXW^LW'_ 8<7&JT<HP=IN@QYGG]MP0NJ;(
MYM]<@+=P 5B&,YRP8QM;->G0(H?;=?T98>1UNKT=?Z !%C*?,B,$TXQNMSO
M&@$RCH ;LS\O2L:<K+T>>#!#F2('-9VY8)FWXC=3IL7/6V9$F#+!G3D1=(R1
M:IT#V"^E7V1*;= ,A&/ AVO1):*57U:V(/>XK?R5$B]Y0?<-%#2L/:^G#;C
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MUP4&X<H+'A<_Y"G'XL'P''=D&V[(G=,=I#UVF_70_6)_S&ESO J)<P)3_(J
MZB6UV^2@^&9W1U\14N4I*=OQ$'QR55#W"W$NY)51*4JCP_FIB6&^-DFKI 6&
M\!E&Q(9\D4QVB[PR\/]2T5?8OZ2:0FJ^_J0FZ65:!.8*,R_-,1T6KQX9)J_3
M#%0YUN)/T<DT_.R_I6:D-&&:'SKR*(XEU3#A2+*JR6E/&_0J CME5+^WU:W&
M<YH9_Y&[ 5[K!BQPQ@@OMWFTSK*T #H:<<M,GC4Z=A9-RL;++BE-"DMPS+G
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MYB5!<P0^TC@+ <,-'2VS@1"FQ_&,FMV[7LU&2A\A[Q.98I357,$M!#.\-+9
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M'!DFYK%4GD@14V@Z9:/7#054@P%I%G##G/B>#*,,=@,M:A11NG:I^;C'EM5
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MRB6L!8*B!$4"VUF@"C)-*"V-PFLY!@;PEMSDGVNKGJ$&!N(PH(H_BD3Q1<E
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M"$VK1M,I26[7KSW_ C^W?JU'%72"/=47C;L%%M*4B ;B8:7;Y_S,K7^DSE:
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M%!OB<2WN<6IUCE3-1W!\L"\^1B4H_J2"8R7%(E2\,*Y?9QCA/US\2<TE%5M
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M_*& 2\>.!ZD9J FK9.I*[&MBKBQ)HQ$L#<<L956$JZO5\9PPXI1GQI]5.7+
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ML3%W'W-C_L5!8K"HRC!.M9P['HZ3E,68A+JH[D ZR#/<B5B[!_9<:-V82OY
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M(\-[%.)GI-U'Y$*R*R8?)=D\3$I!,3O7B677IC;Q2%0,GR%<&*+UC:HMP>9
MSI-$M2=S3]]/AZ)_V: 4'CPTMJ"+Z .%T/[O_SD^.#Q^_HAQ- MNI^)4Y+#,
M<HR<*,P.&%]@$J>^9 7 +"$_G7F0*4"48QV;E2LA:PIOS4&@FS@O*_(_K:N5
MZ?0<I7^35-V(_>K$'H.W C' I'\94K[#;(49&Z[D!:C>'A(>65T<ZNGXB+43
ML/N\\^2X VOZ*LM /X1T[J7:N!\R'HIC0J);1@8-:,Y DQGFFJ DR6YQ.?C,
MWAR'&[WP$'HACR8Y.JR4L9#$K@YEZHCI,"IOHX@%6HXY"HB[QYM8E['*&ALA
MQXMJOY.+ZRB*,)70A!R5OGO>ZF!N.(&=EA?/-Z?H9K<\XF[!(_(&<1X4(*3,
MU706E3%!R#6@KHX&EZVQ$=Z-\#Z6\$:?9DD62^7UW)+0&5J'V&)Q7I-6"ACF
M8^8PDGPW8XU8(U_1O4E=3XLHF8C*5O_D[BX;SV<C]BL6>U4>H_()QBZ9.QX0
MR.@X&U6<@*3TLG&&U(]T2$W,#T&KX!6U*)@&A% F!PR<*BD[H@%XB?OK1_>X
M?AUJ45EA+A">:J'\)&.YSMG(]Q;NJ3//A.DS"X_@<>D-.:B+?$_P,N$Q,+(<
M&SRE*>GM6T2AUHUS-K@=(#8A)%#+V^8.G1%7(L$>2_"MPMW6&F!I)DIV:JEV
M(9PB[%(Q;R"J$K_6_!^EG?&,(DT* E]88_-'28BI3[Z@6=+G^LZPM<&#V3C/
MFZ/E88)J*5<44&K5A@*8<P*G,9$L>E%DHY@.FXWEOY'3U<HIZ&%,Q45. -*(
M:55>9SG\8JRJP\)97(;)1DXW<KI*.94JDN=@8&PD;R-YJ\P*<Z0[4M5)#CZ8
M@GN2 G*,497^?72';<6.R[E!N-7<$V$&4(8\NBE>W9- CSR/IXCR(R,?(T?(
M'MSP0]8-@V:@.EUH<R;;MUP\+-()XQQC<U[3?^MAL5D;3%!!I#L>H\B($$S-
MZ$,0< 6G9@PK?"OW4'AA_UQ7*XXBA9WVNA&UFN>$$8>,R*R&6/<ZBG3Y7/TM
M ZL//%R*.%!% IPCQS'>W>1,PYLP3G"7>52M&/H(+K.8%6WDTYQK\6B&8>-2
MQM6JIZ5I<W]>']NW+X\49#GMZ2(%<DS./F'VG[W^TZQ*BRA98=3E?B14#S3?
M;T%,42;@I 1A>OQUIO_1A'_]G0<B_#L"!7+^]N3MZ?G):__\[:MW']Z<(*O?
M*CG]'CC6*%QX_JDN6,8R6U0L'.E%H7]')\\K+J:#4^O<A(6_MXWPKLJMVFX$
MO.E9*<RD#:,KS :E'J)W_5?/^H].3O=5Q.1U=(6-.[BH$\.+3X';\H$6^L+4
M4=5?VZ4J%&I#[P4>%7;EU5[/WB@*3'EJ0@NK*ZUZ C/:H=SN56UPL*DV:%0;
M[&ZJ#9[\%I &!,/?7L980Y>.5YFU>P)[G^B-B \^Q8(P;,64$+<]HL+#F"O>
MQC(W>&QRX56SJ>\M-I$DGRE,%2D!W&&N8!KJ'EA@[K?=1/$"5%3"Y?^EN482
M9K)7>3W$^GJ(">8KD?,%L;]4?\$G?L3W!\\@Y""(Y 2C3S-*&B*IC8!&5G;X
MK\)4!+5S 6M+!$S8C?,:JY*_.WD^8Q\\M-E%HZ2(;JG24;%D.-0W@1!:9)X$
M<JQ9'/$L*LY58U."J<EA)-X^V8C$=0P_1@DD'QRW@*HLY^>UFJ08Z0BIL)%;
M,CR\4#X[K!\(BURX_@.Y<,<]__*/,__=JU=G'XBJ_?7YQ>7YV]_7T(5[AV0J
MI(=>"XO+2U1DR7>W.]\U-7^ <6O_!JU'_^WY!9(][@SZ!PC/\^@*YD81_A[3
M-9LZH!:JLJG,0^J');;\V[ 8A_\!;SD#N_%-F'^,2KNZ>CX=9DFANZA]>*'Z
MZ-*CK(__4NSGGL,.X[>\A]5Q%,:"1R@/Y?+DXJSQ;/L9ZT[F@'/%JY?,]=RT
MF!!\C>>LL% I@=H>9ME''XF:YKC>4Q8*53IN=3-"8X-2(+CC,%"8Q[H8:#WG
M%^/8^HW!;(=3"W=$AZ6FYK=V97U[Q=@'#JG?X"(DXZ*-=*F>\G_#Z0S\'^(<
MTEV_WZ41AZ>D^5O@[^[\6E2SW\KK7W_&__JOD@R)C.!M/6EJ&TFWX3YL^KT
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M)>-0!9N[Z@-]X<*NVB5\8D6V0TR*H[\6TZ&^OZC#\X(A2&??Q)JH (G,X5Y
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MTE^\':,D6H*4+0%P"E%-!P;AT8@ZR#,%TG!8!-UV3^%F6*L6F-[VEL8%LI,
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MIKC\A[BPD3"8'6?R'F?/CD;Q1F4-!B[/5 F0N"+51?V02'F"DJT#@+/Q5Q]
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M32/Y4.Z[*':\#Y]I,]#.L9UNKC<9=/" S\.,(HD ]QA?MM?5M1Z^3G2RCV"
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MPO#+P:N2B<$IAWF #[#/RV4N[)>SD?7H\0'__BS^V=#G?YMGCY[2)3]\$SV
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M_./38SRVJ>@;!EQF/,[*-\*28XWSJ*PEC1_#A#JC8=)TC<+\BH3)Y;"Y4^;
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M7)&G, W(][EE)]4ZAAD<93_P1 4;$B&8<2*$!'O&_BA8<7/LRJ+X4"V6"[<
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M [>U3[DNF, V/J]&'TH'D@E1^J/'[X:'+I5"X*'+VQ//P34&N48Y&_9D0'C
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MZFU2"!"L6'PQ\L!2UU&QQ!$B)4,EX,]L8R<A#IK'DS&*Z5&;LR[88(3)!9+
M9;%0E/XA[W3*3@I$1&815$(RT\,0OD!/YDKVW VB/:5R AXKLNHXEF[,2U@C
M:F7$"5?X(IPMDQ4F06N@PA6Q#%? 0+"%B(ZFZ?=(S2?^H+J)8_M!#%QH9+G(
M"JMB!N$\82S%S'-Q61R5?J(IC1V&"/^ J\F[B%-*;Y*2=,=4Q[*/F_B;96Z+
M4-]<*B%7,K&^BF5?_@)CO?+\<,P!/R+TYU,8C1YP&VGJ\ D!:L!7/GGI,HC
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M>!&RRR/@[@3/_R538H,KG*BR67OR8B=8;UBP4L&Q8J'(K(-"T>WD:R=?2XV
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M".XKAOG?J-O)K0 UM/7ZZ0YKQ  DRCI596Z<Z$;$L;'?^8]-3V5K;T1;-U=
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M^F=^YB ]@=S1\KHGAI%<@(^CZ*TL;7GU2XM';37K^$9F6]FLU,"H8!3W1.F
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M@W7#Y^E'#,/83W#NR>82F2VSDEMF+$$\[O/VH(CH+5)2L_CZVQ/7W^+UAV_
MFB"# &XR(72_%EKVO1? V_O]9Q1X;)W:)<D7D=4ALU?VO;B@=(EY<M^V[3U9
MV9Z[L<]++]6N4J?O<,+M!S@)<YP8[!,)4F?AR8 /^W=^'V4I>0X4DEQ7G1?L
M&SB>J6_Y%%KRON,Q)&!ZF+C@YAH0$HAT$8:(QY^4=URP09GC0%U[R&:=(<X]
MI(^+M.&G<.K" I1'V<@MW#P2$O)A)$RC_:^!KV*"\0=[__:B=G-.]5@6OE;
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M5(ZK.P-^<R&29??LE/8,Z:1>UYS?&>MOSU"43$L8& '1.=@%1Q9QNZ_#H+.
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M94B:RVJI /Q_/OSZ$;^_-0'5>2=36=UDMMY:JL$34!#!YT72>OB:W7&'/OC
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M@WE#RV>4),0O&^J4^LQ\A%K?/WS/6YHN%P:-K=RTR:S O;?J_2JI8&;UXS9
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MM*=:&O<-X)):GP7IWU:[TIF_=>2VQ U;_F3ZB:9_#!)9HS^J5=!1?OG9."_
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MTS_$4"OSX$?0&MC9^86+)2D(HE+YF!/M:[5&92'=)XWVW4IC*>U!WQ%02FZ
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M'(IF\29_?$YA&K@SNJ\M3_.B5_C\%:'+6^UE'79_#M%I\G'0"K RE,O+\3O
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MH[/I%1.OA1*MF.?3&-DW3O?]%*M:OP\C?QLOU))0ST[Y7T;*=WRH#N]2:/)
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MPI!5!>JE.%!G (*?9+II>D(?2JH-H#1VE@4^Y<44]C7>@4E6$.9::I@+2YK
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M;NQ0V&X%ZTC=V^0=Q3(G;P6XL<QB.:$V"DC-$V3C34(V$%'VJ8B(C10@4@%
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M;SPQ060_K4WI'2'+3S4DCV6U>TY(R*EXX@5>)%/CE:M_Y)J458:4VV1.8RQ
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M="2\8'48PU<W#X[#4-Y[ ;XDG7DL/@-CX!/N"1XA1J$OE'3'E6AI'-/#JIU
MB8J*45JCZMF&N(9FI9F()%T':[2Y.G$)W\!+X9E=.SX\(!6+WY@)$WWJA[)[
MI7)1^)ZZ75 N7@R/WR8QWU5.8>MCTBHLWY]Q?:)>K?4B.N$1G,%-187$=!!P
M>&G#,0(>([,5Y0!.!F;YI5R+?3SUV(AY*%H((>1SS0%TBT@@R_I9\*S%CV=^
MUWH_K"UV@4(K0(G8ES/Y:E@>P4BS7?:8S]=:%,L5K0^"$F_WF1U(>?0[\YZ8
M1S<]+S/&+S*X"8RI%< N\0K87 $*Z3Z /T]8C)X@SEU52T)]K=;Y#(+/,T%B
M>Z^"SA5-W=BA;?B^-;*8&7\!PC<\!K<#3 Q%/<W/8S0W(SH?K[C]_@R^@JS0
M?[C0F]TJ/>RQ"9B/='7 G0QO]QBJ@S@6+Q6GO5@!:C@PA[$!LAH'& &=]6<D
M-#P^Q)"KJ>-CP'?BUL%^H+)$B9#>,,= %+"+8BZ@ZU;>[<E=9#--L!G1_/JQ
M?Q%7J'G%/-A9.#]2X$M>4/9: ?VLZ,E44T]B-;L:%-TW_^)O#[W(#\2\X?FK
M*N?/%W]2CV ;]>U:K5ZJ=A-T[BF]!>2*;0R)=53&YZ00UI&@T/OE)558S +8
MBK\9Z$X< %%^&(Y=TJVHK"*):3S@$]=DI$:"_( M!D*3GA<=[E 72]\&(0]5
M"1?^\0.H_ SD :9&?M+P,6&FRB>DK<HS*.<*-NK?T*+2&^J$A*S".50RK<WX
MDP00K%$.34)'DP4@P0P'KJ9VQA:>#DSEBE697*1&N#Q>)9-$&^P.".<A'L-P
M1%1&408.\2@^NW DZ8#$;$*-OY&6"[HM*-^HIV'U><-^]2T_81:X%!+$X1]3
M7Q+]CCEJ<*CP&__GY_*N+2-Y-]/9_P(ZAHG+@^40)?M(KB?:LR^OT2,B![ /
MY#3#>[N/IYK7_IQS:/XS7 NZ-+,:7MCV-,GL<F([*:Y@3:$RD!Y,),_]0><"
M3*[\BF='BS?Q?"-1;D="K&8K3-#KGITG9+F_;V$8B2B/::&.8P3<8IW7<DK\
MRI4G"Q69N(X#!_QO9B[H,G.JC'XYPZ*Z2278Z28/B_XJ0R[GK%J]OEWE?_2%
M^%\]=W+MHP(X9.LR5^_LO-E<#(ZO*M5>JS<..O%VM7IVWFDMAJ<SE&^OU9L'
MGGOM[+Q;:M:3*N2K1=T%VXJ/^"_!V/7C%H(AM'(T/N#"8>N7@M^SS#C\7-;*
M7@2-YI2]F)J]6*^>LA<+?3Y.*8JG%,53BN*V*8K;8 %"V_F2#=++Y'>JM826
M(GF+GN0LP%2'/C^FZ*CO$0K@YI]7]X_77[Y=Z5]N;R[%L=QYGEFUTDHQ#PYM
MBMPZ^G_/'*;718!<"Q;<]3'GR<!%_A=FQA2,"<0(V"(BC-;&S?7#*J]>:WVO
M7A1(&@11".F:YG<G9Y'HU;-L/ZZZ8HY%K5JJ5NF_1?7[PSJ&]=QBUFZEE&4U
M2Q5Q;$R<O)"/W,G"-XQR*<5V2E>[%KCDJ<40ZDB'2?@!"B_X]7?C58=1A9DX
MX-T&!RQX8<R).WSA\]\M?PQ"A0&CTA#R;]\"LU)"]9Y&9DS_H'C8'OEGTL&F
MJ>Y_@\=VA_K ,F'E<(N$.!';>$'G"'%L0\X/;&8C"NUDX+_VAE[E+Q;NSA !
M:^0G2N,W^/NB+[E=Q2A[J=I8S&)8E^7:&X(#,LT?."QE_JVS\VHEP8_S$7T4
MQ&=I<D'+MB^=P^P+X>MW(0JZA]F7#NW+H@?DHSYWJCR7S/"9#_:V+4)B"G8+
M+I2AS#J*H%O2@_[8?[BJZ!?"+QW%^S0++@<_<#UT.*,;&X&#$D$D8[KAK6&8
MSX: 2!"CA <=_08<70(SI4%@?,R=%]"*,)B[UDVSZ4D/([87X4P6,#5++YDN
M\52]6ZIV%@NR:MN<]W5*@V=9QM+;!>O:=1).?$D$%UZH;96(L!H\7(BPF"A
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M\Q)+(:Q4FJ&]K4=1V:"*@GR;43 3WCD:9AX"79S78T#FC[/AX$OKH84=5\.
M;;RZN5AC*'Q ;R,$AR$;FV%5\PS9WD]CS=4^YD/>C;+)$,(5[X8>X"T!Z"HM
M-7B_B[UA!QSR$V$^PT@8:0Y*I#;H4XX&-Y:+&F+[Y%@@KO8SA@O9CK<BV=^0
M_"&RVW;YQ=A[0$<#"#!YZVA;'WFRV*OTXI*?(W@_H/$IOMO\26I0/6Q<$BP
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MG,%IF5B2VJ%55CI6,)O6G8Q6&XF+TV]7^)5?3?KO2+,;L8K$H$ Y]<%_2-8
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MF\C=V3'2'U;_Z:81)GU< 4DZ:@K^;/\YP<]:&_$_?=%T@Q0J6N?6=&J9X>5
MGJ;:G!58F\C;P=(<')G3I>H\,HO%D;G35/KII]749-XI8>>162J.S"(F<R]S
M,F<[IY3;*2TU,,7&F':OI%^1@YL-.,1A#4R=6O,[+1)8SQRC\M5*J=U.5H7D
M$P?B>YM3:;O%X/>1DMGGSC*@9)_FS+IR4U9K2I:6)-N=DMTV28XI4K\IM=-?
M3/C,BV65[_*L1)*0"9=3QC),='E7*)EYA5J.O"]?E#;'WM>DNM(3.\FEN(+T
M2I79\NC5J>E5&KU2I;(\>G5SI%=FVGTI&A&DL?:JYWBKT0')IU2LRK&M,9/X
MV2NF+31"-/3> ?WJGQC+<-HMJ;O<\4ZI&L?A1)OJQOO)^J,?#?Z](A''!!4D
M9F)9KFFY*&14O-\<"6]3X\30@!3(//[RD(2T:VQ[8Z-M;PJOFB-H?I:$#$_4
MOI%!;Q;9_0ESU6BK_JMFTSEXAJX-83B<CF!@(DQPHUM 84+=3+-=?YS;TBK1
M1M#6#SW\C)EQ\'T'?X9."@C6]49F"2P&<(40Z66EB43^L'+"9L6D,_V "<T>
MHM!T"3_U%0GPKIXI(2L0QN(CT;Y5EV72>TWV"U,W-^<DV@Y9+TQ-WYF=$+&5
M6)B:Y6GY7YB:Y6GW<F$J:^Y'ZF(-WAY<YL[42--V_%N[;)9DRTP%FZJ[G<2U
M&$G:+CE'<DF-S=WN^L;F_4)R2<W%765]<W%*)!>RXNQ^<9N"2Y1_XTIDW7;L
M2=\I*[!Q&U-H(N6Q@T;'^MOQLS[&]Z03@?[W&.(^QTK_:'#L3Y],9-&WS:)P
MC[+L%1>Y'H8X[';RF\=?*05+/1J(6Q1QK:38QOAGQ8FUC0+,C%@]F"R/O:;,
MR56O&ZN!*7_=6*R^N]+I\X*N!-E4>4;43+^<$NZJDC*SBT?VI(0P<!EEVE4E
M96;7FQQ(*>9>BIWW/C..TRWQ>=ZGIJN3O)K^@A[0:&Z3'-GEV\B8C]'XRK:F
MYXO1U_'QW\RT3 >J!HL=]9T,B3#H>V:Y^"NZ9BQE&6'GE>8*K\A& O*.+TSP
M^5GSOYE3OU/4*376[5\35JQ>$X9HI,T=2'0">"2_^(RFPJLU-\;"L_:"\">0
MB3_OZL<^3<D>.LWQ<I+.22'KVY(Q/8?=LCL'TF/;%+:^);*2=O' ]3;K?[);
M6@*YOP8K]Q?M)$A^^BHF_!*E?)+0J1()ORQ/RW_"+\O3U@F_JCRXS(3?N662
MEX$U'%KFF)?,W]K[!';YPC>*=KJ%B+MYH*=D;V;2VGE%.AJ((BP>;W;Z.^8+
MUZ*Q</HD3%>H[97IBCT\K+C[8;-MX/UM*3V64^1S@[2J59%6&5M.N:GVE6:[
MM[EGJ:0P\P9D]ZJ"[,[10&Z*HH1QO3G)SR>N^U7!=3<[7!>=U IUK'DA#VM&
M:JDKGQ)=SUS]=E682SD:])O=MHQ=G/11U'TO4MA 9+$J1%:!R%*_CS5(MR9R
M.B)+52$R=-\WE6X;$SHG2:[GTQPX,$6[#X^6JQF5SJTF+WC@6;7T2<J\U\$N
MJ)J^ N) QT%4Y>(,41Y\N>B(8E-4TKL'!TK=JMS4(:R%*:LJ4E-6T_L%*0:
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MSH%L\KUF/GDDAA]_U4U].I^6IHGYR@EU*UL&M$Q6[:TFZX*LE8Q![2BM::S
MRGW:9^]QBT!7L2$[^-">E7YT*QF[VE$)U-RR+;=4LE"(5]UR.YGH(Y245X0L
M+5A![%+)J""ORF7_V:72T;Q4M/R*GO61@4J+#^2V;:#2(;U4)/R,- <]6\;X
M>CJSK1<2OM_'6G*ED@$[T-I!5N5'9#W9V@R+G&90(HY@A[+]?G)^4X!OQO5U
M4:ED1(\G\A8DAI4-PO%")ZX';"F5#<;Q0MYBAO8HE8VN\4(GKD=H*Y4-A_%"
MWF(&T2J5#40EH--/OQR\4UK9P!$OY"W(*:UDQ(8G.G'ME*J5C.;P1-Z"]EKN
M<XBF>#'DS2E5]SE$4[08YNB4JOL<HGFX/'2G5-WG$$TAY"W&*57W.413O!AR
MYY3N<XBF:#',TRG=YQ!-\6+(G5.ZSR&:HL4P3Z=TGT,T7QX.W2GM[7.(IA#R
M%N.4]O8Y1%.\&/+FE/;V.413M!CFZ)3V]CE$4[P8\N:4]O8Y1%.T&.;HE/;V
M.41S<?"1TMX^AV@*(6]!3ND^AVB*%T/NG-)]#M$4+89Y.J7['*(I7@QY<TK[
M^QRB*5H,<W1*^_L<HKG^?.A.:7^?0S2%D+<8I[2_SR&:XL60-Z>TO\\AFJ+%
M,$>GM+_/(9KBQ9 [IW2?0S1%BV&>3ND^AVBN'P_>*=WG$$TAY"W(*=WG$$WQ
M8LB;4RJV(493TY9KCU1LBS61]M0=%=M2P;3]X?\='PO_^]NO7Y7_^]__CF;S
MM]_-;G_\C_KR]/N[^>5B_OJC:O?57Z2_OCR^.X;Z,OJG;?SL?G(?T,__J/*W
M-W'TV6W_<74E/?SRZ>7M[/SW]LOXP?[CTNZ.S>FWO[K=KZ9\=_D?<?Z?WV_=
M;W_](\EG%_J;>_.?BP=-N;V8O?WRTWQ^=7$O75[=G_YN7WP5NY?C^R_#SI/5
M_SHY^Y^+[N\J.OMU](OZTU]OUG_^_OG'G_I?U7.U_W(]F?_G?_[HO R?ONC&
MW?_\?/:F/8N??S[K7W>O9.GM2OIV(?9N'L?J_7^>K]Y[;<M2?OSE]JKS]O5<
M-?Z^0N[+V\_.7V_F9_>?Y^GM2/OCO]_^Z$Q_?9_]_>67CMWY:?K;Y[=?3B?C
MR3OZ[?:/EU^=3^Y<,G]Z^?G+M]OQU]_,SU__*_WC_/+UD_GVQ^/HOZ/+R?\)
MYP_WQ\>#/9.88CQ\L2WOJ5H[_^G0W7NQW:EIR[MO+[:[-9'VUK%7:MKR[]BK
M-9'VUK'OU;3EWP7M5Y%(=[8UGH_<6_L!V2_Z"(7V,-VZS\@.TZ[(:=E\NZ1B
M)4-=O-*Z(!=5K&3HBU>B\>VRBD6'PO::U@6YL&(E@SB\$HUOEU:L9%"'5UH7
MY.**E0ORU!NHF'2L7$"GNG3,U6!6+N93_2TQN=*S<G&>>@D7FY"5BP55F)!Y
M2J14N4!/]5:IY4J_RL5\PFO4];&NV>\/FH%N)P^N-?H6I=J=K;_@"QFF\ @E
MD[^#"=!*E8O_!$ZKH3G.[>0WS;:Q%-S:]_K3LQNEN_>WPKQ9SDE=N:A154C-
M7517JES0J"JDYBX^*%4VU'2!ANXU]F'L.3PD%"$\M\P7[)'I0P.=6>8X\0TV
MS<OOD8%),+[#Y'M_Q.SD:",7?\ Y>P__)034XS-ZM.>.B]!&</(S*,IQ6TIK
M4")?RI;UBH^.98%!>1L,ROE@L+)QJ5IXJ\YZE0VA9<YZAT#MRL;9]EO1I UT
MH+_G& N7+_A_XL&II0\4%Z.*\'X7\W#(V4W&^TM?RI3WY<J&)JNAZ?B*<LB5
M#62F5C8WFC/6_JZ+30/25S:66:J1JXY=$;>Q*V)N[%9\/'67[)%X++;SRA[)
MQ<<;=TND84];;N>#BN+C<3L'K\/(2!J\CGPI6[FJ;-%5T,CC1;$9J<AS:SJU
M3/*'L@ISL-WNY\;]E0UHY4.[M'9X0R+[^NZV).N+_38QM998^E*V6J*R\:LU
M*2[B\]W9Z&INCM$X6:(K+R41(5VV2J*RP:A-I(-K&X;VU/M @65"? MKI[(A
MF(04/ZLIOD3QRH9A^)7Q@M1SI[)A%'Z%M2C252 DP;G>JFSEU)KK V'^"]U&
M(_=N/L3/N9U,,(+,IW)JJ$A0KJUN$<E;?"E;HE>VA@J*UF^T:;B_\O'5>GRV
MYHYFCA_T-Q<A\]H<P>M?H #:3)@NV.KJ#*7S[CMTDUDF_M'9X?J<A^H5E1P+
MZ#N5BUI!G^ZC[H*NN#;'^HL^GOMC9S)DI /(.W4J&_1:KSX>7_&3WV]-1.4Z
M%?7S<IWRD]_*Q9-2R&] R0++WXJB6^6"2?G1K?QX=Y4XIUO9H%2%:"?V\J%=
M\>$E;E%1V7!-%;P/OCW/;F5;^DY?-7O,*#4"A74[@[JW<EP5,4^#4]G8$E?4
MBHCD$KV2B:28ITA6-I;$+Y&Y:[KL5B[8PR61"YK&UJUL?(8K:O'=\MZM7/R&
M2R(7-&ZF6[FH#9?4XOMVHE0VP,(5D0L*ARF5K=A90:U[Y+BV/G+1F-#MBZF[
MSOW#E[+"87G>+)7*QH XIAW?5Q!EWT(_/)"\H N)LF^!(!YHQ_?U1-FWL! /
M)"_HLJ+L6[2'!]IQ?G79MY 1#R0OZB)3N4@05(3<:^:31S/X\5?=U*?S:4F)
M3OZ\W<K%BU@TU=YJFBYHJE8N/,2=G'+GYJJ5"R)Q)Z?\T;2RP:5K<V1-45 M
M]]D::1"[C7E&2+-'SZ<89^@%&189_G_Y-L-/VUQW>3@NL5K9@%.5V8 _;5#9
MV%65V8 _YZVR\:Q$;/" #$,WGS 7_*K9WY"+_YV0!P[&'%0V*%9-!N#/$%0V
M1%9-!N#/!%0NSI:* 7Y$)K(U S/ Z7B*;_F.:VO0?U#;@2@75"XRMP=<P)TQ
MZ%4NEK<'7,"=1>A5+OJ7B@O.+<>]G<!TE?+&?'&F_7O['1LLG^+\:?K]#@.6
M3W'^M'IE(WZG^+%CW9B#J7Y H[FMNSIR+M]&QGR,QE>V-85917.7\,'MY%*S
M37S-<^Z0_?"LV>CLG?V 98X)1O3?V6B";-NKL:AS!PL6JFRT\%!9B#^[4]EX
MXZ&R$'^&K+(1RT)8J/!QXYS;K,J&-P^ 6_@S3Y4-@QX MW!GB?J5#9<6PBW)
M^VP/Q1CU*QM9/0R&X<X>]2L;F#T,AN'/)%4NKDM+M?^R[/.YXUI39#OAQ9G>
M[\3-]]_4'(KOVC"+T"8<>*\[W\[>SY Y>IYJ]M(43A)'OD<OR)RC&[3)_<D"
MD'CGEX^)V(=KTTH9OW+A[42,+]6,7S/^>L:O7% ^$>/+->/7C+^>\2N72DC$
M^)V:\6O&7\_XE4N U#Y^%1F?OVA(Y7(YM8]?,WX6C%^YM%3MX]>,OSOC2^W*
M9=AJ5Z>*C,];'%]J5RY36+LZ->-GP?B5RWC6KD[-^%DP?N4RM^&5Y>CO.7[
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MC]E<F@E6J*<BLA:2W"EL4S'6.<,TN"5<;#KB[XR%MW^*!<$2F</9%+BU<ST
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M?$86\\SO!):_45A*;],/,-PO,NB'&W\ 4$L#!!0    ( (A]?%ITU(RF.@<
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MEER8^$A_!+K1>[N.X&,IT+304X2I<;U>%*&D. 9<%SX6.3JX%-&*-V)*:8!
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M?=RH]2L"_6H@>U>@7RG\ U!+ P04    " "(?7Q:HN1Z&*P"  "O"0  &@
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MV%P,5*<W$1U<?[?N&)CI)&C/*/;8UOTD%U^Y\9P%2&NE)AU)Y^\DLP /%X=
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M^FE]7!(I .7<^S'^"V2L[&M2R9V!-*9/9 '9CK*;8H I_G8C_T>B:='04[F
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MYUGJE =[]Y]GG07\)R\G:^E_ 5!+ P04    " "(?7Q:JIFCK=M6   @8@
M#0   &EM86=E7S P,2YJ<&>TN@58E-W6,'PC*B$2"DJ#='?78, 04E+"$ K2
MW<T@2$J7@G37@$@WTDKGT-W=S<PW/L]YXISWO.]Y_^^_OIEK7S.S]UIK[]5K
M[;F1X\AY %].6E8:0$-# ]Z@W@!R"G@.8-Z]BW'W#B8&!@86%B8V#N%]G'OW
M<$@>/,0CI""EHJ0@)2>GIN-@I*9AHR4G9Q)D9N/BYN/CHV(4%A?B$>/@Y>/Y
M100-$PL+YQX.\?W[Q#Q/R)_P_']^(9L! DPTAENVZ&@TP"T"-'0"-&0;0 4
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M77]6_ZRA:5'P.M@%NL>(^,#:QKK+@W>FN8D$Z#QS'!#[#: >%,99/_'?\4]
M'Z '*P5( /X:"425@$N$SL%(@%*[Y,8IXH+TV/WZ"*4^K_S#ZZC3!)NK(E!Q
M$0KKL%_R#_RE$RJ"WFPD8%/N .9O>_CB:_.NA)21),3ZZ22/;('=>;=*9;B6
M=336&YS3@1^4/$<[.#X[!L(_R*GD=B;'9K)YR@E(B*W8E-]%O!R('SMH*Z4C
M8#.W)U &\(I9!\)I?,.211M ] C]C[PKGQQ\&PXTOL7H3M8VP\CXRSJJ-81"
M8VBB)[:ZEHCWM-U[5^HER(96ZT=,@I>#7]BV"\;#>6*)[S2@K0V/U69:60^[
M]=Z6UK&:5;;NS#&-G\2*TWA-&Z69]NXV-B5+W)*I]M3DY,81HO&E,&5MY(:W
MZ9#5[:.B(TQE61;R0$N<2(_ET=H74F&W:/R5N0#B6_'5[_88>O%1)DE-J"(%
M$ 4S7L*1@.O8C($LH@()S/(W4$SPD$D1:LJB26Y)$:)UIA+H/,UZS29(("\V
MW$T^5,=*[%OV!E\&2'KS[C2[_$ @FZNJ*II8:F867CG.4^23RG6R4P7:?Z(K
M6U[)LFF5]N3B[4I)[\E28B3-K2P:W\Q[_E1,I\?%:T&9-@MGB*;B#_:-:YB>
M2OGZVEQ0]D<O'GAO^[O*1$GC$L<D+44*PR(>*A&Z?^#*R=F?DP&J?%[2RNQ/
MF%&-&(:2KFO,WC$Q\J7660F2%/3R,HV>Q8(X?I6B=:^]"X+A/51*EN/ZIKES
M ]5+_[E3DVKBD"];I-LJ7F]A'N)/\:Y?V8W<(44B+A]LJ:(3$QU3J\&,<D1E
MKOP=T-(&"W;*,$(B.D?_'NGT6$8(ZX>!/VQF^02$WYVMZ_H^7BW1PG7!PL/$
M;L:-VJG3X;A ^;SC=$S8N@313Q]6GR%L'$'2G:/J;XR^VG*">**;"8'4SUH\
M)9,/M6'"ZLPQ>S V*^096Q5LT.?, M1<:GK:$1):L;BX>VL,7Y[PVL6=";EY
M:L&^>YRZ+53)TAZJ+U@R1W:A"=&7==@UB_DE-E'\[)Y/YM[=6PZ7!5KYOP>]
MG%[0?DF1!E<;VQ?KYFTEDTMBC;L3.##44,_S?+E>I5Q_F@4;H;82DC7B]M9"
MM ZJ#Y_&QBOD\61TH(<'L&4GFB0^R^*M^4''3>$1+B3>R5\A4Y"7KOXLCQC
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MUUW_^()2J;+HX#K2)H[=>[>)MS[+&#O[\SQ:M)E%\D%?.D/J_,[3-"00D3
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M=4O#638)?0AQ^J\](^UG97^<E_FM1@B9RY<46NKI)/W.J)!GF_SV3P< \QU
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MW\J:4J..)E)P*\Q_JBTY&?::EL@A 7]9SIL[GQ WT)/UO__8&D>,?X>"YI%
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MKT_L%ET-'"]ZW.MG,GF7,;.S\],F(;E*M_GC/#:8D9H0&() OQ($GV637UF
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M4R2O3LGN-AJ; >M"\UL8^C)CRB%):CSEI%N3/@T75XP$Q\($,>>SYWO(PJ\
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MIY.G;X@PW"=M^XJG+KTRJQU$S&G(:B=_'-NWL'/5+(>O.D.B ZMR:VBVA$B
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M:-[G,,:5WSM>U[SR<;*7BW?;/'BRUK]B?V9L="(^^EZ6"=V 9X8@EP5JYO[
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MB/U?7K,  0CM+GD@$D 6..?FS _!^V^!0AA"K4.<IIV&/80R1!Z"CDNO[&<
M6]((MD;Z295"']X"+<@$[UI4A9U4@9]=&T(W91V2+"5OEP.)8[]AX>]0.229
MB3^]!6QR'$9T72YW;@&,P4%6!4WK">&)-LTC.5L2T@),M< W3)<,"%8'DJ+3
MA=H\BYKVVN:-4,)]V7OO/][?.U.J,E*6AV^#@IW@F6^60#<8%&W+^@QYKG9Q
MAME"@Y/ISJ6G\0VWP$RYOIKLSM@-+F&!Q53U-<B9UV1A]V3GC3&K9,0(@8UM
M39\I-D,(J:;Y,=G T7EU.M)[X!B>WE-D+32G6*[A <6L':E\+8<JC,':]7^-
M)[NL3ZZK9EE=,C^7CGBG@8^9*VXK?PX;_E$6UAA7*C-!F.$?;/&CW_WMU2U@
M,2;)#>4W#[;>TN"K#6)+3UM+ECE.^JP<E@0/<0]T5*/S@UI%+!-26\:55,R_
M>)Y6IZVD^CF*,Q?]'U#M[UEO4/F 5=R,@"A8=]HO>P*H\?_ <&G%S;^"$TD"
M6VJ^D?+79RN:KO[FOYT2S1P+L5\%D[]Z]#K0K?W:/L?Y4_"IY*-5OT%NE4N;
MC&:P/8&U>((V57YN.V.X9'15Q[,G5P;O);?45:[$''/&\2SVI,/$1 U=8:4"
M!Q:#N.7CVE[3/%<)IO,=GN%[ZVIZKMY@U,Z6SH3]+F\5Y-A$NI8P2=F[X5KE
MM,1@Q5^CQ(D/;(;[4HW<JJ>Y9._F&VHVFN-#M5/_B;:2FKP2^1.T?\0,1%4W
MH*JD;=$;"*H#MKESSBH3;@%#@;1;8(S<[D8A#IETSE-M<3/C=&/S!+,/*KAC
M1"FZY^9EQT-<O9AH#Y.3%2TVW7Z_C9F]V&><YY;\LBBRXY)XPJP&*5)',;'[
M?$3O%J@3.-^M)KN9<;YY./*KW)H0DO4PD$TG9P O(97S?4'A'PQBAKK7ZNY<
MXX"V$OG? 8WBRP!EO/ 4:84;'%^LVE):"Z$M^6ZW431#9"!R9B.!>?@;^.YQ
MIJJM<YY>=*]EH10(9<;M<5<+QD5GWUT!W:6D:-V<"]^XB\GA%%H1GY]!&.QK
M55^K1-Y&3HC@J^WB@[%3[Y'(9(['RX(-WAG"GQ_0KC#R2.%?U?,(5@5'NLT3
MOKD%*O7JKJ<M>@M3GH7U'U?B@^/3.]G]]R"PZ3AU7IKW*Q53\@O%I>5*Y 9L
MF.3:<K\#^7WA+]G!B#EU)Y>0GNPPYIYS<S_^7RK64#ZUXHA;8,#1,TS;K5Y5
MZ"KS%/23^A9@D 0-PQ(&/;THOM2)N0I3D?!\%-.WNKQB])L4X2VX::O^Z4@S
M1#5W>=-6GM6D18 ^74"&69Z*Y.%?E+^PC7Q39@/V0]O27TEF.BIXN\9"7'!5
MP0ME_ 4$>?$A"RV,"^9GL5NBR[G6'V,)!G_J5O:+=_68;(PV5W",C%>B$^
M8!P2)]7JR2(Z4B-V"7]T^>.RB<#*X0HZU&NQ15"!].6G2#&G8XQ;P N-1AH-
M-%HE=UPTWKV@<V64NI;MKAHZ[?WHDF@?KK:Z$BNFG-7-L#;+U%\7+BOQM,CC
MFBG[L01'E:3!+O\7%[Q. D>PX^?\&#0S+SOR7<2#S6X=LV&MG<M;@"4V)8'^
MT_"<LZWCH%RHS A3=WMPA,AF],GJ.7O=\_Q&LTP?.Q.#.T6,_Y>V+=%@//.V
M02:*KVQ/'C7HR^XGG6LAM8J,FY!4WH.X*<_#@L'W$6]0>K#1581$U(,'<;X%
MLQLW&$+7I<56(NZJ7I]DO 8\UM[HX1FG;@,B]\]B./:_N"]I^-P">*'&2*LJ
M7F<GV\>4ST/B[Z]\4OE(P5953#ZXUC(B9(<VTFIP+5EZ)KP7&.[O+'NE('OQ
M_>ZND+T;\C>ZB"<:Z3!0Z4LSM$N]<RH!DUQ[4XR3I^NUK3,4<\\,[<<]D?4Z
M=UJ,;M49]/)R5*.<_HJ0MDXLD?I%5:Z%\;LW-Y+%!XQ!.2:?7!SI/UB'U+8M
M)0P9WQ1?1U7< O;-=)KA34R;SJH>MT! E=O%&&_=*\R^>;HW!A87MCA'*%G]
M#>&YS="%P;M9KM#JG\7 ^%Q2&O%EI+F_QU6.KH- _!:PK9%5_Y8?PG4+=/61
MA$R><S\@MG;9EDWF.(OJEAVMK.(==N]M##XH^EI>9T?/">+0"^W1'ZTJC&5J
M2N9=,TIW75/3'?MV4[<C/"8<;33$NV>;(BR(B68\S;E:LAV,UR@27M3IG+(H
M> LL@1R#8!F>E"EG\QT8;MEKADD_3RL#*S[EU+:^=N=SM@8%'1&=F$(CVV:M
MUJK7E[ZK&VJG6:TA7VG9*#)?#V%O&7)61'.:V%/6I[*O275GQ5#QA@0O0\-_
M<?_Z%\'[G] V:_DXURQ/E<G''YF%'CA<I*$DO+O/7A7E9SM^GA&@.__P8U_G
M^JQ[\;Q_H/UL> 4RI1\LA&.F6@69R[(\C@M6CS2RKY7L_9(58\Q8]\BO] 3C
MB*B5^^<JN@1V'H47Z7K33(+FEEW3O U_CPN>(NE>+!:Y0> ,=I>)R:OC"D/"
MQ?YPQH&H9B\OS+=/G;I>4>72:S#*22;M<E>^)I/NF@T?]?5XE,?Z1U9:/C83
MXUFDA&S(GKZF>['83'6;?._"40:YMI*UT6_$\B_H+&]02Y313KP;RLNSF)F9
M#\Q8]_>!<]4H=[,"AX-N5#?$A_3#H1:*2/_G-%6QG\L6&DG8'S,;0!.Q[R5M
M*TO2 B<O2/1A8[O++2G[#UZ.^LI<O8JY^A6XDQ/7:3CK\T:$VG-N4K([CY2G
M5DM(V*VW#BKIL]_ELS7H,?R=D3H:&LACH?#"Z7L*!?1ENSK^,^G-/H\Z4J&L
M+#Q[Q$<^@>2J>FGN&-KCK0 !E&5-+W;D,S)^<6,^(=JD=3N0BQR!^$FG+ON/
MXJA3Z$1#V[C)?9&W3:9+]4SZ6>(XHM_A0V@H#!W.$W5N>"SF:7VL/5:1>/:9
M^.=!/H\6^ 5*RKKZ[S.N?(]B^&6TQGBU5R#I@9822]_WPN3LK0(T]61Q.1R/
MKU*7L$^ IZGIMPG_3#K'COJ560F/7VN]UY=3&2H__JS_CT1(N3RS@/Q]W1HY
M,C$Y5.H#T]6M8Z^J3+T?[S[_--'$5FKV@F]O]KJ)S.\:PS@\N),WLM"Z)9/D
MZ-&WO+F8XN<*6D4CWJ8R^7D88@-H[?1 M41J9Y!88Z*LS W):B=>GNEGF&"Q
ML3?Y<A;AM<>4B#41T<O%;J44:=\#T0_L=.75R>/4\/G7*,@CW!.HH@^^T<&'
M0,YJ81G\PX !VTS39.<:=C*5@"5(*)9FGOHRWU%A-@KA)X6N[823%<:O1$JQ
M:0I&'0X":G\7F[] \:YJ1_2&<<39R[3D?>+B@H_JAQ+>&!03*2=(.6KU39<T
M>+[?F?<@8#R"2U^4W580<_H/L8"N5.T>X%0DR()F4W36-B7/U__,Z#[(5\%H
MSI7;]7L(-IT6-@)PT=:O^Z4PIO\1?M9M)=*2/KM,\E6<*>PK4RB_PR!P5\N_
M!7:\/ UV29G=(T3O=(U2=CZ-,?8J(931X+ U-7]'J^BIHL]&Y8=&@X>89J3D
MW,>)7_Z@[MG2_'0XF6Q5..U ^L53Y\RG7O6LK$DU$PG=MT3#5-V9+!-\ZVW3
M)Y"R.1^F58=,'8(3/^N6ZF&;.Y9@J30$WP*D=4:Y&<9.7AC3N/H"]P^ I'YK
MPEV +M24 3%I,L^V4"@F$$IJ0YCW,1YG^$643E)2,TQ;XZ&&$KD.]6\;4K^P
M#1$U/M_2KD"=]X(A-UYETT'5N7*?+$"H>R?+AG]GZS27((Y2M*2)^TYSZ?*8
MWV%T#^H-L6RXQ8C1U<9UBD1,MG)-V(["J&;AZ>XIQ5?*3TI7:= ),,W<OV0F
M$F)UFA<,D[OV"JFVFCD83X/W0$FC"576QJPQ;<,L^_)A7[_27'_-)12R>--U
MAC3!_%2YGR=%TO7Y<F56QL:UO^X#D-"]7>Q8'J 0 2/;PN4AGJ/Q46],],9(
MS'O5;BWSA.ACU:5&^<MZEPR!3V>@!I@W;@\2&..KSJU[GJ*S5C3T!2[J[C;^
M7?Z4'*W=8H>1)*V?0-+A\R,9ZQ:#O+/K5R$$%IA'QGBHGQ[9#IT.K>+UZ:-S
MZKXHNW24D&)_['#,NUN@N1TWO&-HURUJ?[DQ=)US-4+/,]X61_9EH.38]?39
M_C&9L]N[3IJ3RV]8*A%5(HV[[+0G D6C&@A:\3-HGM(+%$<!Y=.V3E,1L(<*
M5+5D.2VK&S7R@5!66Q.^O6C5Q)4PA8GDZ@LA))+F1'?@:AY;NYA:OVKCOVC-
MKML&./.C_@,*?%?@-N'S//"*/B+7AN&U!#E20UX4T=YPW?.]O$^;MDVZ;F \
MJ4;8U[YFQN;YC6\DXY/7M,GO^DR%R2JBW;-MV.0?3,$#W[!6JO-9"DKB)G'F
M9:Y3 XG8TI)A<F"[B+T <Y^ VNV,Y#7$IY:R47DIM:LSIHNHHN"U>/&Y'%WC
M/8Y879/QIP(E?>5!08/X5=,F:$SM"S&6U:UN&2?XY9N\#)#4@?M\WCQNM4GP
M%B!028W\<""JK\OY@9Q;7=)6V"#@ZFTRU27!D^=;IZ%5I[D>4(2'$W6O74;K
M,+!=Q2VC^%?1(?JAHJ:=E';\)ND# 3()+!9\^M5B+.VL8^3B)[*]R44%S0V^
M'B:N88YWGR1/5][;DQ#23SS&[; 4I]<$7$D=+8BS)6(D'W)N#BU)(S'*!$BJ
MAX_1%4*N[=Q040??4F)I4ATI,*KS>M2K'4M-%G$>D6X,&;SLT,$O8878;<M*
M)D*;?</JW$OUG&)Z7F6A@.R6T+N<<'X]97SW=ZTC:%^ C"Q*#LU'0<YZ>XZ%
M@<O*8"NLXF=GJ3(N;W\.)T.5E\Y'XY6,GNE=[98/R<#@@9SSS5'[YNTV5;Z,
MX8!E6VB -/NW28P*US]8+"0.\0B"RVDNB/I:8ABX?0-X\X=A3K9L\:)G(U("
M3-[4AAW.'HEJP.JQB>Y"AXO#N:"J5'*W<9!S,8AZ9U 0_\HQ@;U7-.TK80V7
MLHZ?C:CD62YF;0UR;/FY$^P(9<^@(_C8>+J6(5"-O4+'66?.AV^_V6-X36V]
MYT-;6J:*P3R_+"W@]=N5@3YSN?&ODKET:O'47DAWQYU;]/$6R Y\COZ^X+LY
MG6&+8Z7"2!6;0%KW18X#ND"RV7?35\>$#L^%Z05GH3CYB"<IA*.F:Y&S SC/
M(#EI[WH@&TD9WXY99TT'-,M<35W;9=;S$L]P7C<^@U$NK CS*/N"\8!!!M)O
MB4,KLW28KYS!O4+M>V#XEVAP _,?O5)V%,6V=D[%1AVV=J2=3N@X*[%^W/#0
M=,>2N:</V2*GF<T["I7E5*H',(V.R0@"NC[_0C6XG9[D8FO+2=!@,YW_?M>"
M?]_3?R[:F.=A_8Z#K:^!5F:0J1N>RF-\KV'YT5PM BQ;8\P:GB WN%'JQ@++
ML@1UMV&6US6T(#]$XBH0R\9T6:>/J,XH6HGR^P?5A>/ZH#8+C\<-/V9E4\_L
M'U&_?CA '^W:YR[X<M/1+PI8$_Z%97^*L]$RMF<9BD9ZH< O-9K782VH<DAT
M\\F!+\D#[.?7Z;\J4J8>/LH_<R\&H(LA,/A$CM9O^M-@!=JPGK*IT?>@_@C'
M=DCUPB." X(NF3 HL]0Y9;"9VV,EI=8(J\_DB<(!>>\U<L"7L\#/FAPX01EQ
MG5.3(YI@L2<:&Y@JOC[H +>[P/@/E34M!L9TA7 -_@0!%A[BI'M7K6YPV:=R
M55%1P,98YYL70[> '5GK&.6$>!@IU6<_PL#&JM=9B?;_M)ZI1;P3.=40CN)Z
M+5@>"NEYR.H8]T6-T<P@EAQM6.U[HY%Y#_WH%[*O,@,4JOP]$6S!!^\Y-C$-
M,CNIA+0V2FKJYVI_,2RQ2(B6$]3KQ5S/@!ER8KWTGF I;+K5V"?T?4'51GX+
M8[6-1H,KBU/+%FDW_QB8HCH0FY6/4I%EWWO/;^JMM\?A,T:/+3(Z(@=>NF9-
M17O[;-1B2>G^.R870?X8PO$S\5-PTF3%XF;BPN*\#&\Z1X+-<2%&/_43K"][
M=:BIGW%8]9NY!*6>I52J"&3-2Z?]/?V =(6 LNG9><(NLDN#P//PU135V+J=
MU:Y7&()@K OO% Y'CVP_'VEHT5T%A'TW?KUM<'[.A:"@@UQHWC2J'32$R.^9
M2_^-F='W@MKSG6SE_I&;\$&OU2V^_3BNR"0_1*#:\VKG(L5W[^0")Q9%W#>P
M*0;;8+S_5&"LV$UO]4>'!I;1 L/&H"^M>9M4F2X:[C!3O*!0C*&&$N"1XJ<_
M?V:2]M)J;''_>89P+#\Q^Z+WD:"K@UH=%#G^],BX\F ZB]N<;V(."1 7T.@F
M$DK,^[F9GCS!%J *)_"S"AN,=%:S6.HJY->F'$#WO1;2U^T\GZI5<Y\\.V,V
MX:__FD=I7M:>0FTUT8!"HLSO<OJT>V[7F_)L+MI7^_6\*02U6/$;DT01[I:W
M,'P6?C,"Q9B*^)Z' W1TRS@W8F"=H"B:[SZ=,HBV ?'PF>AQRXOT"(,!G7 #
M&DMRJ]87)]*2D_ WA1I%)OWDB0\U0H _B,O/&VCVCH.2*Y4 ZW?X@TF/CV>Y
MK!&Q)".IS'T;64'2VUFM%%8NZ*9J!,HB=!/*&%TRWYN9#L/F:;=*<O'\S!/&
M3J:=-"BY$H.<IGLY@&6W8;!^WS]OIOTW0Q*K]WSL])#0$#>N77R?)5+)'@N_
MEC$9NZWTK R][Z?C@<?ZO?>#NH-'$:,^24B:D[*U?6C&B?Y+9\;!(SYBR#2;
M>E9%V'BPM@&7\"3JT9W-D/NMX>VUC<)8XHFDO6P&9$W@VW:1^LQX8WW>W72Y
MIQS3^FPQ^!%&S*;-1>(I*QY'>2?TP0?)6_.3'\,G9OC,\=T<*'5EOE8M>Y^0
M$DQDY+$\%624G!W:EEUYB"%VEZ.;9)-OO>[J6\=?F_P)S3OF8Q=@'*?#BJ.1
M"ESFLCN71Q@S'Y580LK([0!84H;)U]S\*$[@[U#(4Z9'"2 7,$XO=285%2%3
MFJP242H$PV**!$S+W!MY4HE!K1.%+$7^S61<1E/Y)5U3/@Z0V"^(1D;VU076
M.-ULK& R#>86A"YK0]-KHBR,.98X;3C16)CQ6S."P@\$N$]S&7),3+[H)T(+
M$R!"@AB>:8%;R[!0.GKU5>+@RU.$R6,\T=I&@>3/49P5?;^;98AK(O!4Y_T(
MCNP=Z5U6-)+\N34YLFEX4SC[<[ADCMW&(!M;4346>V*77@/R&5@1!@MA,<0-
M@[HQB>N.\N9/OZS;:J<P$: @H^.&Q&P3+?%JYQ SL!<#:MZKI.[J3?;<BZ7#
M0WSJ]XQ[A+>  G\P;4)*R3^8R'\%-S3]9A"DN3HH.A^T3S[?L\EMP@EBZ7_B
MZ\0^8^^#D1/0ZT8Y\>Q9#_@X;LN@M8/0];V5J.R4\X/CG:V?GJ58TTC3/NRW
MJ[L<>=@_M3X]5/\T9T17ZH/S,-S[^$-6X$$URM1#9')IZC0OXX1[<9N@GC))
MI&A@-(60=I&W0U5<8B,FYL:KP-[CK$%JJ79>OI>.0[/RM*?HX9SS4W%FT.XA
M/U_G_O4G\B#QX=$JO8'"NU)\]N1W&[':TY6[1W 3:/#;($C.*C?%:V%1[\P_
M(E&":F&AOPB%]DTYM@PX?@U^?AP\D7RT>D:S_$LHX>?X(TIR(SL8;7>PA_@F
M=IYTG/-+D1&J?.3I+7"O,<S[1:6'+8;M!G^FXW/L >8')FZ;KD$'VX'EJFI@
M]TPOND=N!^W4:!YQ6WIK+_'SLG\\I@B#"'!>I'DNNP<GB^IGVC1>N-P/]HZ2
M.(KWN4:#Y.A@@EN6R&[:EAUFU,UC<6R-E^$V0S/D_,-FM($B)+!8F'RX'(7*
MAV(#PJEOX[_K1PH-/25'&O*XTY@$9%,J$#<^,5M:BB6JXE!+ GFA$).%C7$H
M1SEL@FWR?O9=@U31\ VH[:=.K/J2K'?P-7;PCURLK:C\;U;*.FHPW<V\8<8B
M\[*,YU;/-*!\6S:6U);+C:QQ1::_UYQ2A\?#8&]M"6/G2,W.LMRKO0NW4Y:J
M"3K&D]*B<:*%>%]7NSK+N^B]8@A*R\5L0'HE8M>'&UM'KN"V.:,!1&OZ_<-6
M]Y+S/] YL2W @VSTNV6%3!"/SU05<=*%H)U\W3URP/!&@@E7_5MC<+VSDK\C
M;E%=J,J$U[UAVH]=T>,AP<WZGF<9LT=JA>EKL?M/1U62:)9O]N# *?1GU'0=
M=0V2(8'CB$*];X&/UXN3C4:-;QU[#N)Q6FG+P=EW8][<Q@QECY7DKGQ]P(/)
M+KM%C$R^WTA_\]KR1L2A,?;?"ZZC)%-_4\DI[)5\(K\>#3'EW3IM8VM'#D_.
MEKN=V"],#RN9ZJSV*7$$JS/ST<=Y@1<WB()0?]I'M/:(#QF/Y-!# ( PQ+NH
M<+$E8&<8E-VF[HV[:T^@SMG]^W<"(?(8Z$08M%5,*231OE1VSU=I0)M^KR[&
MUT)C:C$9"I=UL@C0Y3B*/PG/DD79VFJT*D0;U8[GI\B.YF#6?#8^%TYL6TRX
MS'&QVN4.8%34)"B*BL!\BRXG%7,R*,9^0AJE,*)$\6]_"5!46:47P?U]R36H
MH8ACQ#@J#/X.ZQ[EB!FN3?;Z0T%Q/%*I/3F93UK2#H-,EC.S[<O+RQM8(93_
M)HPXSM\=,PW#;00.Z#0(F_U12S04W&7YKY7PROB!34Q><D#?,5I+9H4+B>J'
M/^R6W >"TLJEL;0 '6<SE/L&7=/9Z>43(IU"QV"P:MCN&X?P7M[9'%N,E$.U
M]1JJ1(/XW2$L?P\#%6YJ=R(%26V#]=F/6?9%$_'X3LCU+48TU P+[( X2/>4
MAO6P=#,_]]OOA3$49YL3Q-&5(3_E2?=.0JGU(D3?=^QEG!0EZ*I#K:<52GKU
M64QW1Y)^HGAZ+V\T38ED?F#)#E/5_+7E1Q#-UQ[M/UU2MT,0^23BWN,;K;TW
M&H[IHP]MFC+$X/P-1Z'5?5B^\Q+26Y>&$5)*Q5NI!L5?R%P2/.B:+E8E(O7A
M&Q<ABS0A#(AIK_P0J3F-GSX5,^\X]DR**CX/R<FSS>Q]4X?\&@/;U.-8+V2V
M0@UU?V0C2AQ2CX)?2)J:#=6PJG@)NX"M5/]ZS;X/H9;?'F<NP7V\S=F(-U;2
M]7DEO0'#+$U2B4(U-WN*1_/+#<] 'T2:_U94J<6'Q/]*&P$1U:88 _.H-:+>
MW^EP ")@CB6@+EKSO?ZX>Z]S0<D.&7%J5?;3>6?@8^H56%A+.%%M79,DSNX1
MS.UJZ0F68W5^B'CT$O:.QTZJY%O)TRZK_4<C"GPV)&41,?G)8$O,MR3?#AB2
M'_PT-;R9&#W%05"/6GE/2:8>@'EFVG'(O? *'%8/I[#9FPE@E;_?5[[[W&%U
M@+. .C^$<VEZ_FDO2+[,W)A',]74]<T@V'7NU2^!R8\M=-\SJ^_UO$0*S;5E
MP?2)L=#JT0EBFW_.2;@4^VUM_CN_U=']_$^? 8)V-9EE3$4<G$RG4":NL])>
M[/>%9*]62WGU^*'N!S$XTKY>][V_"XMO?Y4N]=FLXGFV!H.LN[>S]%%/U,G=
M[3$_-L)%WM&9(!HR=<)/?N[9Q.ZQ^HJRUJ:@BTAAFBV3)85(&MK]24>9J.CW
M9&>$UF0D]\2OR^/JLX]Z>9YRWN>EJ-1;4',=Y'R1C/EY]7MJH@><2!'^@-LL
MQP18RQT_M9]<5]T@NM?@'=O:'R>%!03!I."?E!1EVDHAG\5-!]-Z6(>Q9P[/
M JO*XY>^A*@=9-G--EWGZ&JKN& (MGQ4I%6]!7PGY'A/A=%>GU,9-H%=N*6N
MJK559N8<-2B_][("/D/B*[7PXC)C#:DG2A!BW[A5MM[%OF4^5AZ/3IL/'5(,
M1-15_9#LND;6QEQ"6T3F1$-#A!IZ^%O?Q![*560<!/R#<#\L"_Z+ZX,CU9,E
MGO-'MX"U+>>SHS0LT,!TNS?OJU/4N*%V4@]'E*!'5@:PRCHAHL6VM@"94M9F
MF1.&^#ZW7,@B(!6S"YN'59K";P'MYB9BDZ>1O*&U@=6[#?,*&\^(P&"/ WA^
MTZ,<77G(*7L(4VWRQD=DAM(<) $JB**&H"MI_E.4#25*>YU%'ASR3-E[,L?,
M\A!<15NU;L>]/8[9B#/9W'*7ZW[,"4IJFCS5<)18Y8NX9$L:J+N2@%+K0V3V
ME^.EX;N$2J0[2%P?1^)QPUWW1J*73CA,KR$E].+B&V [[(SM-&R%&!#7=G&\
MO2K!]BIZ_[G1*:,Z@,HTFEBQ\U;$>>M,*F7G_",:X>J'M8JJ=D8403+>+C*.
MLS?UIF=5N,H5J9>X\A/I:$D=FF.I[MMS@A*R+Z\>MZ8\</2/UF#IJSY[<TQ@
M9\_\-K$="K[_M.PE3:FIR01K<D$\5W*>P0P!VVLI+CM+.5C,1^JO4H2("705
M166MTEQ"<R_3Y'$#F)"6%<W,60YG61.E9A<\RR9VR4)1,UJO)=O@K0;K1:NI
MZ6Q:%!:Z,D;8N"N5Q&E5.8=$[R"-S/L0B<Q #9VFE$5J9T7?][(R6C6HW5V/
M1OZ@=Y>P;$1CL8;P)(ETS^6^(GVS1ZBRVYSXH$FOM%KAOW9<K<C7]]F3B]1$
M ^><=&PA<T,>=6%18W>K[<SH_D%1>7MP.5UYU\?V#RVAMM9B'ZS5J'L/NB5V
M]%.-Q_?RGQMZCO)PZN'46)OQK0?$;*1(=US?\Z9A@@G;7&8 [>;JOTZHDG6'
M&E-@]YH?-K*I7:VZBM/%Y;6?EK&</T'PM_=[1DQ+.0EOFJ5%L\\8$418BH'V
M<:MJ(><%$)]<PL?2NL8-5+$NKK$$:"WIFGD,/@-YCZ4E.. -N]P+@Y/5+Y 0
M<^4;LV$\*N2%V]H^H??Q%!P+FM\K/<BN50EHC_+-GC]6R_%U&BA*0VO&+NG!
M\&,X]0OUF/S7B0B:WI)$NN1;LU!5P29KK=J_7'U=.XO=)W_#<[6!\!QO%/^S
M &-N)EHCOHP4"PZP)]B^RK,]2AV\, W6S09.A^FYNR0GRSG2GLV0HN=_;VE!
ME/*&';WZVE/]^!.TU,N8'%IBB6-);8?A*;R;+2'U!/L^>Y$7.%6+H83^D9N4
MS LZ\BK7 1G=N)ZH[.,G+5?LF;[.M>B'#]1:6;SCWE+:T+L*RE6]<3L53I>I
M0^NNKRU5\O)8';)%V!,E>__8,[2,1/ K\ZLYJYBY&;BX>!5]L,]8[FRU,R"1
MSV$CZ6$ZE0)-E8A,.$L,:?X9%G<'%_;QJON@?NY.E@K<4(J. ,IK9>G2R:;)
M(A[F?8BJ]7RH;TL%HI9X+M59("9$T"/FV-Q JY(/M?T<!.T<'92)!2,)#U@U
MN.8WGWPXIK.?]051KR X=W[_!^?_XS^'X-N9_P%02P,$%     @ B'U\6C@"
M\O,470  ZV\   T   !I;6%G95\P,#0N:G!G[+QU5%S/MR_8! @$#1H<@@2"
M!G<((7@:=PT!@G2@<7>".X0F 0+!M2%8XY#@K@V$QIUNW!TF^7Y_[[Y[?V]F
MUIM9]]V[WLP]O?8?9]>GJLZNL^O4MM7WO^Z7 (^5Y97D 6AH:("WOW^ ^UF
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M<&4&:H7EUH!*7F"K K43K7%(5-=@8Y^C]\MQL"?F6J>%PP#XDD\Q1U3=,N9
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M=0(P%CW-=Q2;.JPT^_*%#[1P(E/F"21!!AULU+F)6 AW31L%%SL\TT';XJ^
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M:*@\C8_3@>M ,>C?$X<X42Q.7E\'?T"T-,?A_;U#%G\&>W^39IRZ_C'E_XC
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M49R!/+D<7:J//[LIPSRS2PXQ]^TO+L9^.'+\6'E0 ],Z,FTR3N8?C&E!#HQ
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M9=8IW'H2[UOZ.M!^<UY]"3P4>.??2PEYG\09$\5N+W%-\<P-XPIA^ K[?P*
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MQ3\ <.W_I%?[V\(DW$#H5S42@B?2CYU7N"(X;_BE'?[<>V\FRY_V,^<^OD8
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M1B\YR?G2>0%3TCVP'CLH5@.E$97X:=*U?]L7#QR\RC;^]Q7Q[W09?T_[E.Y
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MJ-8*E,'L^6022*N2,N:A!G@L?C4.)^4 PE$UO%/&_897O MPV+'KCL*4$'K
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MENRN0@DKIX5?"FUAY;NCPZ$DE70 M:8F*6P4C#B9=[-8>!U"4ZB<"[_S!<)
M/<0Z!!M;4_)M\)NL- ^27QP)>OB"+$]S&1O==K@C3@LE]:PT\-\R55&-$EIV
M[^<MI  >)UD%MZE>RS101<.U'CFLEH?W/TU!L*+GW]X\5+LZW,$8AOSG>P',
MZR7M9X_A%X#O*#G(Z&Z/[>F!A^>?J_]<_>^[:GY 9)A1;+1L8+C$T[\X.6F2
MA/[3S80F4/ ,B#MNW=QVE=F4MW_]$;X9FSOVVC7%/\^+D8"<3UV<B,6Z@.=[
M(YB7BUTQ\)T-'T(?1[H%P19.A=TGVA[MUP6YBL@]:CSMND@/](3D(8X-HL*-
MEM26W&>H!I1)<^8IHMNZN!@[I"BK!R#SV_#*VGC>E&%[6^$48U#3IPO247]9
M D-V9('#.7\^UEH1JGTLC-3P0)>,219_[$IX[RV2IZVYLD@6]K?RW .!72TF
ML#.?D/0Q^,GE1W[/)*7C^?M<BSK"#429ITPHIE@A2R@V#:+IGG.&65LE&9+N
M<S^47].NC=>(3X4L=^.O/ ;=N/?K ?:GQA5C=,T4.7F@:D0R>-_Q*;:Q'0;'
M><QH("++%"XK;KP+X8-7HE<#P$?QU).)%8F<%@8="<0=F7&:$-C+XT"Y$I0M
MA3Q66V>9J+<)XKSZS$FI%'(J[*+J04'W?^P>)[X ,AU? #]J9/ZM>M/]3%K(
M0W?-P<5[2KQ#:@5LT7-8M*QW6<8PI;&W2FP((Z[1.3 N_"'9$JYYNF:KM5 D
M@B6G>W-_P1^U%8\7R<]/J:)3'1=C1@_7UI$M9SO;GNKZ&?1'1P>[L-/,)Y9Y
M.MOJTZ1*&![71:R/+K2)AQ)NQI/ZP%/=LJUX X/PJ/ZP+<(?XWD UW_9!;=/
MGM]>>L?-T;P : L/^GS0=ZK\(-+;D$(#:W\@+UUM[_#S!6#(3.MM5Z@O'&MG
M3;ZH6-?;Z>;0SA*?"\@EL&M;\Q?*^E\XBP[;I)(3KLQ/$U[&DY+6@OD&Y4$(
M(/B.E$Z2E6<#O(TX;:5T*>DE<5#&><,?.X*!&T?6)A03#"=.;/2_L(5/'F.[
M&;K349-Z<70V[,"%@B<2G[\20K#]V$\^%JW<=W,].5944,I7/W R(9P=WY]$
MJK3.R2\<JP<X_A<[E@_R+X!Q ;_3Q7)!H_!X/:-1L%N!;(GM!Z=6NQ:; +XX
M1$3M>J=;D]2I"9>')W6#UMJ6VIA9JMK 36ZY]\%W(7<T7@Q;=Q.(+X!_CR+3
M&&'@49Q%DR2"PE\;O*;6OC33K:+7D;[GC,U^K"SA0/J8QOVYVNQ&R-;(>99;
MT@YQ4#=&3FM"7^0F\0L <WGYP--9?7^.#W73/3&>D"3@@D/8N1^7-Q:C"K\'
MG<>DQB(&P:YV"(HO7HWM(?"=FA]W\/B'2%GV92Q]P97EC+K^2KFRQER::WU6
MI(@%M0C(>I2GC,B]U<!/--I*R^%:A@7FKBLI891_0#BP0]]+\UQ8HV$ZTKG-
M&A@N"?R2(1&H#QCY<;0.;;.7&-<[%+4Y92@G?V^']P*P6? #R7"]K[KCHPQ'
M1@TE,X[S!?>#.@%1\P[_<>2HZWO,*>(0[1$5?T<^&=^LM3Q72Q0M]QAZ3:/[
M2%]GDQ;Q&#B.RYSC[7S)R^B2P;%N6DA8\-3FVZR-E9HYOE)D4F;3R@@DUC#H
MVO?:D2DH4UC_^74F/TNW->N8J'T32AWE\]G/GLVNS&3L='#FRA#O?[1S7E%-
M:-L:#AT101 T2!<0I$D7! 2VFZX&(?0NO1MZ@$A1 1%"#[WW$HI  *D!)'2D
M0T*17@,A=$4\[C'V/O>>MSON\WF8;VO\8W[K8:Y_K37&GU!RD@65]^EP.;TZ
M&_2JW1'*F;XTIGQ?9H*=-UILE51P/'N92UQQ<"N]QL^;..O [I);96E&N RH
MCG0]D9.>$YG1)K7\]$HF!J34:K5 )T&"'Q&R&9#$O^%W\C.QN\H[-1YG53,B
MV,9ZPT=T:"DOH.RF9,R3CNF5 8OQ'J5?F.)Y.^,2;FJ@,3H:BH_?FOD3*.,A
M'GZ^V%;X._(P/38MU#+?$>4;'<Z-_;G5J)U+^;SNY05NJ7-[:(A?_-IK$GM[
M80Q9B$0 71))A:JJ2(]8/Y-G7^F13!]:H<XJD[[SUCD85#:K'H1Z"'-M=#NS
MDBCU^@4@&7$DG6)F;^MY9+"MV/J15_=&WXXG," JX??5LQ2[PM0$7RA\*15E
M?#/;B-8VMEA]4YGQ'S>14>R""*B<$5,>JL/):=Z+]ZTYPQ0I&4X+'VOS>/FO
M/9!_R627^9UD?IHJ^EM#K5%#JNB3P0HUM+6 A+O2+$\;F-"[$&B<HS-M.U+F
MZHNQW:TWK3X+4=0\J80N7 1D5[Y.*@+MWB6*S)A>/%F$R2QBW)C"C!*4@90Z
MG6)HEA/F1)\5[4"7"S?=:>+JWKK!BL:]^1K$&MD\045VA 29WI/13<Q26]D8
M!3?5P?'CVI$%^O)IRBRZ:H9<@#=9%38#;%?"7U\UIR^<:/L@;JZC^4,Z K,C
MV _'*^;]9U0;ZW]896NZ@5<T7WU(5?,3#)FW930RL%L*0Y*$L\98@.MN2/FB
M]CX2TYIY_ P.8G=-4A[?0!Z<MI4O:B2:MTKT@6E[P*)=BF^^Y=ZX'N/UK+X)
MU9A-E%W_#.B*R:Q1(,./LDVQ*-CDETL^]4]\EW8O<?#JQG"CGZ(A%U%R/'_*
MFQ7FH=_H,*EE9ES^ <&GLU>X6:U_XRV&AS/+$$508-!VGE@:?CP7N8HR4"6Y
MIS;/M'K@ + ]92)!0E;,[TZ1#9?^00*&A!DE6VG%42F$@+Z"-PWKC_9^3\K1
M1DJQQYZ%@OO\2EJ;]-TX;OMX=>BC+/;!YVSC K!R<.XS/WV]T&,D/^%8QA>K
M/G>@6NZD_-XWQO=3,M93EHR02]%X:)XALKNHHAB&[>&_OP8PD6RA!2C )M ;
MJ-QLH51=1UMC'DBRG1RYH:++,O!Y>P%=D:^/P FIB4$Z'VT@+<,L60B5UE)#
M0]@ 5M[%$2%K P2_#*$ //_/<(.H].U8PX2!4TYNS9\3B>CO/YUD$)N*0<\%
MZ9Z,X=+F?#LRMH]DRMO6]V[?'E8X:%#? .46+^W<=)KN=<+]G&(W^D[365_;
M?$CQM7V21%M?Z7/$9'#$45G29Y$1,PL)G80\%2\P[#'?HH7EQT?'/R8GA<<W
MI&P-]KK3&S3*2_/ @%PK$BP"R7X\F<28T;)S2B.0'];U21IFJC8NBB^>+-38
MIU%*6#2VIQ;O %*1Y4E7&W\.CZ$L\$X<( J)M**^/0#BN  YU4PD<#TTXLHW
M;\WH8>I^M5BLG!V'C>\Q:P=-!?-F:!76U&@9=7]'7^)!:(HH] ]-,G=/R(1<
MV9U.K/?.UR_EYM*5=E/(J;CROK$+5\U>K[>9#DCGT>4,S2]]3G:<CC^>[#'\
M @B;"N$Z @!]$>:$\(8\5>8A'9%Z\<HR-^$_73<=YS"\MV)3%)T#@\^?^G#R
M:(5AQX8&VT1ZR)EG-=9LUM%]F^RP'20F5"KOE<@)N\&&D4C>O=D7?12?PVF-
M@EJ)!0<.<"%+%4(;(H(K>]K0US%*G%O9M18VJT,5 .AOFV[ESC>R*&JK9&15
MI=HC/(W!L[YF6B6OX%B0-&S(4N_&OLCFFT3F+_%Z+ER0BJPE=,BST4EF,L*<
M$OUOC\ .-0-]W53B<QL'\*&%<J]*6!1?2+R0<(:!U#X=LHU*%R-Y)5CM&]*0
M+*Q!H!$Z%4PISV*(I)M/[+6MKV9FIEP?VOO;\&/7@/H23.P?ES^I>4V,%TVL
M$\R+)DFQV&DLU%>KL,O0YJ8QF8Q8"7G<M9/2C,Z[S%F#HWS=O8D5?S*CZ+,F
MK+EK,^-QBLYZWV[<W[]XN-&4L!G G]'$?8OY>>@G2G7@-CP),'=233TO4E0R
MQ],,AUH OYHR%OA+W%Z#30MEGI7O/GIW?WP"%&UJU ^YQH4!0ECB2%5<F0<I
MV#B:D%*$'@BK!M_T 6_Z0C>.2CRLM%RGE 0*= =9)-.<TWSAN;T-\Q<>Z44L
M":'45=Z_@L1_92,+4\ZEA0DJD:/SAQIOH0.9Z@I[I,N4M>_?S+>1%2S)]GJ;
MOC2);%6R*S$QRQ)<=.1-UA6)!'!8X7**Y\GPFH'?*N1Q?S8^DBP>-')["D 2
M,2U4Y PYJ4?'%=K+JS+)S._Q>W7"CZX+@WJ_E;_1Y^]@!P4 >LU-T6^<TOU%
M='=6^.#Z-U-^#% _"PW3Z!7O+^XN/S=]EFQ=WW##Y4TM+I01H0ML0K\HB)L;
M#2YR,?5_T=6+E;HU_$DHLJI1CMU&N4#!NW.CO'_97 *[+$I9('7KN2??^\9J
M"0^H& G;9B!]$4!@\I+C@S_5'&GD'-_/_I\[")H_#H_".NDDAXW'+?\\!+:V
MA'?=)VX$&D)YT$$">NC-O%[Z(@<T856K 6IQ;1/^'(U<T"=31I^%T2UEY!PX
M1"V.>?N,Y3:I>$D/I3RZ 1&NL^'#L6P!R$*5R2W8QY:;M"./<7;)/,1D%-T=
M(&8=,YY3O!5@ 1^7R;*FJ-, >-W]5L/2^:2;_PA)\^_L+E+6%@V/RHWZ9F7"
MT'MVT&L7I>YV3A1A.M55A'U123S':]5/\<.!R2286+%45HY\J>>=>&;:UCK6
MN_N$L75*05OZTD\-RV\DHWTKGM>-,^TH@"&%C8->&J% 50'+WF 1M4H:M+>Q
M]]1P0H54M=H!N#)MX?Y? J29U=2SG)^03MIWM&0/K #O)27#189DRJ)IUP+$
ME!Z^\#+P>4BU^SAY?J9V$9DTP1NYS1:MA@$*Y5@PA>.C#@1RZ1\W$D2+UH<I
MACZ@'-[5US[3G]+A<BMAH1($F7D9K!)49VU=*B+W2XCN".V8WD=^\>B8IJT_
MPF1/JG:B +V$]HS PJU!IT!!C5T>X&DH,6_K&H T@ A I@ODDL:?,;F]H\20
M'P__MF%O\_VAE?M%DPT/WB^6R:BD< J[S.GX,BWH=8]KEG=7..DABX@UMQ@E
M$OE?=\\L?J81E&.N]/[I7%U_FC+C(>2+FB;2K%]J+N/:0/KUZ4,]-2\Z["??
MREQ7!LKB=CQI?@)G7JH:#T'QOP!A'@W78<_==1\$#3KI3LMDH<*=TGK558AX
M%KRNF>,3OB16>57X.!E$9,#L>L(SE6^V#'B,O!$\P(]YZ:4R!ZS WU3_;<_M
MQFH;YN1,/;5? (<[]FY-46![%O;!ZIFRC0;KL6J\CWPJ/,4:Z@$)<K^:D[_L
MNS8B\RUA,/H!%1"CM?O7N^5'M D2GN)$4<[]THT3A_PR(=#L$\?8C$_N&UT>
M1]!3["1\\9WHJ<FIF_\9Q>V_QY6<*17T"U ';VLQ+/BK"\@WO"-6XS3%0BT/
M<IJGL!C(/K IT%$LNYVH_XK@WGPJPP@@@?MH^S2CH\4CWU.16^V]4@>-M(E&
M 08("UD+$1&5> \#Z:88L5W6VV2)H0D@YZF_ORTW]X(4N:?MIAJ<IG>VQ&\/
M4#(RX4-W#T S00H^+*\Z:E)-G.."*S+I@,$^$1#3>K"GD-'V]RD+'_F=>F*C
MBYMU;00#5]+;^V--I9W\[4(1TY>/D!:[*7I8_% EQ_4)SP'K:/7Z[KHF^_[1
M'\9X\REF!_$!T+*E?/=G#L18N+9II%VS03)\CZQE8\<3<UCEI3-VPL[!EZ,K
M!"D1WLJQ=T'H>U.:A^9P"NCTS[R-]F7>GKQ)C69A(MEXPDXHSH,45Q5OC2U^
MPOU$J&>=<1FG9<CM)BE^CX*EA#4<294%0MIO(Y04WZ,YG4FMUN%RG*+JU;+;
M%BFJ (C%0\)^2=F+-VCWQ%[7RX^O9Y[3S]GU/['"F$736Z8LEBZ=6UJVU\-$
MC?(2)J5[LKWF.1<]GC;0K-:Q.1Q6/\T/4=@XZ/J\1M0\=63$&IA]>?V0?M^&
MZ O+%!53V_?SWOQ]6L92+^'$3$TA7B6Q?.LU+BA+Q2Z)6N$ 3_"/E9;O F2C
M(I<,95+6!^M'5>0HM)E9QR!-X@9_$];W%Z ARG*/76O&I&:B( TQOF'<>LPH
MZ8J*Z>XEV=.4ISY^,K4%_A^3 Y8V%V37Q0TFKL=#U=G!OP#O+?,3#<?2](MH
MOGKO"!5[W7T3ZJ/8-5@A%V]]81.-\J0*+O+^!@"0 ;Q)HQZH/0!:BX%K:B$E
M+0MMIB?6JDSZ[*%_R9H%QQQG^>FY2!8.K? :D\<79M 1*3$CRQ,Y%FU"-54V
M7SCN-8^=L%[7AGIO40QYMH""AAA\ 1!,E2-9:CNA^J-"E]N^444_SRVV%HUX
MU"N]OJO=@)]R2-91^O/D[!UQ""\*L7]WX?9:P7Q!C1.XD;"ZH0.C=R[.83AY
MX#YY@]L&),PI^#2B/V)H46YD_O L^.Y$[)?T?/-NBJ\3]^)4:6.O.= KI25&
MMD&BO=>^ZU!JG1N:VB>LS0U4J:[Y]IVM8Q=LP42BYIJM&,9U,B6;[?#/)1?X
M_311,^W/!,N;GWH'W\7HG5/+;D:[*1P]:SB/*9OOK#Q%&%RYQI4B'+I4-FZS
M6M*^4%-L#T. @,XSC!J]@>!0*R[J:QR!E3^N]V#.-?## !\3Q8:1Y,K%66IW
M3E!\ZR[40G=%O('$K):?KY$M\.ZF5#6U<[FK6_70!SM6>W#X6@F'ML"/0LYV
ME9^.'AS.,5?Y2Z $S=3*U^&PTQZMVA6/4M=HFR(?+%V>7[#;ZX<)?,VH)G^V
M[JR8QCR6M=>.9$D17=_77LZJV:=U=S.T2YA+[B<]&E(#G6EN1Q\:G[8S'RK6
M.8GAZA$UN&Y:99'>P^L5G.+M9]SALNA5N-"D0"[=G>[/=+4N*Z:!N!].5(EN
M4GKSBLM)(!Z)N(&2_3 JU&/?4E?OX%M&YL->Z]I2D,4/[SR@B*PWK]7Y@:Q)
MIR/B<$F+4%4 U!R>MJ+9\ "_!M_$CU&S./R $O' .DG&-L[USBVO:+WZ!:&>
M@/!4_D]WQ"0+%[W'E\1_&$D$E19<&<>1L*RR"TW6*@.WE3D".=]+!XX]-JLD
M&$O=$7)S/!NZTI,HU>GA3+65P\@..X&6<2U(^>Y=)DZ[;#1O[\5'J*B-8(G<
M1;OKW;W? U5QHO51E2;,UIUQ8[I7CL<EU53'B;:J]$=AGQR-IF5*AYEAWO]*
MSE#?:+P\3#S^!;BK,/T+D"WQ)F=5]Z4RPP7R%T#!]J=2;ZQTQV9T3LGY9)(.
M^1N7X%$6)=!AP;#'Q2K_]I4T'Q,)9_K242]HXM+QR/3*O_][<(SF?S7_JUGD
M9>WF!Z-8.XWEC>.Y1XDUO!&]YC!K$,-$8E8NE6UC8G>*G]?WBGVV642ATP=W
MN^8-5!-LMBQ1T(\2('N\^Z*^A=B*XXG<N+7\1\@("8L[=,<9D\( MJPEO*61
MJ1Y0;%ZI'%-F#E-CF35>S@S#.*]';F=#R\B21W!^+'*RN/[+'1,!4J6_"<;^
MW55"%"#V;P0IZ#^@A?DA//\P</P-6B:02WWYS[:H_TWJK/7_TA3L^Q(B+GLF
M^WLM[#\CQ?];_^<B^37W+U!+ P04    " "(?7Q:"QSP-V0P  "!.   #0
M &EM86=E7S P-BYJ<&?5>G58E%N[_HMT2TF(#-*2TLV(B( H2#<# L* -$@[
MA(@B,(!T*B$=(IU*"])(2W<W PPSO]&]OZW[G+._$__]AFM=U[OF7>M9]_W4
M>AX /8:>!2[?NZMR%\#"P@+,,#\ >A)0  CP\/#Q< GP\?$)"0F(2*A)28B)
M2>@IJ<BIKS& F*XQ,#(RL_%S,K/PLC(R<HG?X+TI*"(B N*4E)40DN$7%A'Z
M(02+@)"0A)B$CI243N@ZXW6A__4'_0F@(  VL=*QL5B 2Q18V!18Z%8 ! !8
MN%@_/\"?'ZQ+V#BX>/@$A$3$F 45EX%+6-C8EW"P<7%Q<#!O_3#O 1P*7,KK
M@O)X5!KF^"S.U$(!4>\(6&]_^$RC.;#+)OS()9"0Z HM'3T#.P<GUPUN$5$Q
M<0E)*84[BG>5E%7N:6GKZ.KI&QA:6%H]MK:!VKJZN3_U\/3R#GH>_"+DY:O0
MZ#<QL7'Q"8E)&9E9V>]S<O/RRSZ65U165=?4-K>TMK5W='[I&AP:_C8R.C8^
M,3>_L+BTO+*ZMKZW?W!X='R".#W[P0L+P,;ZU^>_Y$6!X74)!P<;!_\'+ZQ+
M'C\64.#@7A?$HY37P#=WIF(1"B"@OAWU[L-G0E9AS5V:1RX#1%?81.;8]WY0
M^\GL?T8L\/_$["]BOWA- "386!CC85, 8."D9B5B8EIER>Q#>W9"VB<]F49^
M S>;DD=#R^=WXGGLCPWH>'C$[Z>UT('#[=;/'MDQ^(SUL&8)42P_GZT-BJXY
ME.6Y L,U(J3?Y%\IYV-S69 S.[B\.R/FXXS0X3?-JCOD@U,6ZHZV[_?:^12(
MZ-D0DM:+$Y='U+""#$O$7V=>J75ML>F177VBR!LH2 ^I+^P(_[07:B!SG6;C
M-"GV\,1ANT1@%Y\X-53L$$C9FT[D#!I@3IOH.ITK3U)@E6>S$PI48G/X\D4&
M)6HZ:PL9J5@<$'FYDQ,4;_4@;!:7\UNM5LG1V*8([C?+P/M"[RB8B.(^8<$=
MZI,*_.9L' [KB-EJW*^H5I"$LI&)+2SC!QUM:8Y[^AVB 7(T8/4Y]ZLR6^%^
M[M/%%1PF@NSM,5%ZUWFQLO[1AVEM27I^49.?63HAWY5GPRQ1U)/IE&7K-PT-
M#/GZDAVJ6.ZF6ES5G[605:?1G?PTHMPYJD?9F]_'&==4>VO+7Q^W78*NHZ;@
M"A/IT)-B317:+1424VU"*;S]>&<S+)F]E&?4%_W#JHY4ZCZYQA.3T-5E0D/6
MVB4%0=-JT^KW\O,UR*9RTS5'>YLJO&F5^MEF,7P'Y<,^^KS->DGV%R6BB^(M
MW4E/$S-LJ,#B&G7%W /];^U9T( :E#ZS'FKP"IMGF5)-+C%[^T46E6>TQ"%Q
MD3E?ZNRKEZ\C9>8BQ<EO/;B3=D-_MO'<*B9R:N)N&9U.RVE ]<,L#\XPG<D+
M2F*,:BHCO@Y\LM#?][?$@N\6MLR&2_=8&K"KBB=:^UA)D*S?E'-LB$#T:=Q>
M6F>(-O9,LQKB$]ARZTB[,6YA)?3<)HNO"LK4$:1AZCE(>A-49=!-KYJ[E3WF
M\9PWN<IYC*S"%D1L.&FD:H]SP%[WG7VP76TK+$OPL\QLE%IZB]C!.NG3 TD^
MMRKVFP1L2A\=A_#2:QG"XMMNOK(*G!C?YI?9PQ',))].#3BQ+O/W_O8QOQOO
MM2O,RW)7ME:X7KK%VJ8/1]>2B:CB0X2\N8=L?;JM^$V)%B^VXD%_IH*(]N*6
MM_:# ILY]=%0@=>)[[FQNDF<\+$#5/8/2>]1>G[>FGVSQ6#1X<(:H3Q/68"O
M9Y:YO/5E1Q,--!N$^ CGJ%[DLE,4Y=>FCIM,5KFU2PV7(<#W_&X4LCR_$V%Q
M<,W+FD#^,V<5#25":F325=]8U8Z[USI@&$]0T/CFRLZ-0Y&+3\,0Q+U2AK&U
M YCMJSL0"Q(AE:M5#FM5U]95X9=-C;)3[+.J)OFM;%HYW#]-"*=.)[R'-?.T
M&*?>=<VGO]-D/U&#0UKW]' R0E #CC?1\Z%DVZH.5B[;&NS_<+.[ZNTJ<)CY
MG51)=>&J?OFDST<[22B'3=9+LX3*%&F0#L2P4D;UD>AD./?=_<47WQWNA#W3
M4TB9/7^4VS)K+\*BZ,XV>KF-,)"NFYK@>?2S;2%U>L[!5-K 3:+@^CBCH@SF
M[(A!'*]/G1N13GXV)]C3UT/:!TSYTL<V3:87I?-[F%\OZ?&T>Z<)AZX'=.*$
M^>B)^\Q==[<X9F^\\:2'54J$:\;KM6\6/"9LEL*$Y')10[U3WJ,/N0_U%R/Q
M)$6%JN0+CM@R0KGO4FLH O_;H>C,6'9']T:8^L7L6S0@E7<LC0;."*LN3@W[
M,U(_]9U?0P,7.),H9!'(H@D-O$V&S<06$7%5TZ.!O^:9FQYHX)#*\7R_XITB
M[:7 "0@>SOK]6S+P&UX%AQK*ET*YWF*&+!=V;/J\TO.B8K9 DT?L<1Q<ZSK5
MS+,1L2 D[PX^&NBW!9TO-34WNHQ00-H,HRMO.K)WRJ(LVC1IA6@7+^6$URD-
M';3Y;/"^'_SHP^3:IB*\=@YYV4C=4!<Z,J/W:CDVD"7806552D\+PN%I3B-C
MG\T]FUM_WV(#8C":'MYR-RCT]=3:.YUAM3F=DIVM\NX; OQ+%/),Q));;T(_
M&N]$V"_5[CY]1W+]?EB!_U?@_-.1:'/L=(X\/2)@+F!46_U\KJFY2''^.Y-G
M:V0?VTMOH>9%T& ]7_DU[<HY$O#)!;B]-IR;LWPH\X6;!LN*!+?22CV,NW8@
MC&:^-T467U,WV@:3,Q'W1/IV^M# ,Q"2YW;7&3%"9L.E31B>2)1R0>KU^ BU
MB@8Z8(@ECS1RYM4<T$'_&>PV+-6<WB3YT<V!'#)+-XR]##X]WI#:3G]K6-2;
M*1C*8>\?S-<WI]^T6R8C6)Y>)8;U64X5%FSMJPL3N%7^!MBJU0KJW[7[4B+0
ML_5UE/<UA3.<6S#X;#3]9>MPCE8<C\*Z2V%2!']@GO3VL<UQ.L+ E!8-I!^C
M@28^%,W'#$3(@ST<S2_O>ZWT(T;9[\VB1 ^"O?N:R4_Q;2%'WV"Q.HQW<N1T
M[9,L/7TYZ$>"/'2G#O.Y,NK@D43%#O$^W!VL]A)L O0%-*:C.^IHP(04 $'1
MP'M*-# CXE> 2E!% [ZC@8C1#E,6"*UIBR-,-$LL.F$A5#@@8.ILN>'-YXF*
MWIHY:=+;6V)]O# Y/"SF!7"$L&96\H?5>9>S:F_!(HXB5A?)*_HMQ4Y^T&^X
M.4@?S@7DNG=F[_6XI>M1%M?'7_;2J,PG"%@\V5(A(R.CDA")(!P&\'&:O0Z7
MZ^M:]4Y Y(5B:Q-!4P_RC+_P5KGXCK$B\,V\WK_Q9G=YQP1EFS!UM!@.WS3S
MU[RE+E^Z.!PYQ;84^ *7C, \] !.9-RS8.<G;%3;Z*,ZR1/W4LB,.+A=N>/^
MV7P#$3GBHA8-^*,!;GN1S6\)22KCTG&Y&:%1N-0:M_Y'X^[!G><%]T+]B+%T
M*E0L0_LH!/6B1F1;<G%FT[NBW/QDM<G+VCMJS*.?O4_8FMK=4IWC:'(OG#95
M\,OA[G;:?_]X\9(*#2V2&W09N]H8>OW"=V$-]<"GZ5@M'0W(.6'T+TI0,1#6
M^#!B^$N*_8+D83$:V"(:J5IU]3-,7&  -8=[J._A!B-/)ER5<#98YY]$8WTI
M<3^_#SJ8 )^O:H/&I6#(TQ:,]09AEFMHX&"%_.+ ^&B/LG@H7<'0[9WZ'*_?
M>_+3+=#%(7=$J>)(K(S8?NM@Z57Y2#)4%FA)Z]<F'5%5:1X^,9^8\BI2AL4K
M:KCFEH>BZK'?&7..^?,N)AV1A.HH%OBFB=9YY0R",AVI:%PQ;)ZLEK2T66@P
M8.*O\TD"Y^Q<]S8B;P*IB 8(D-R-2@D6@LC3\92@%)J,<)!]3_>Q2=-<N.VR
M:=?4A>]KV%AMSHE]TRX[&!&Z+B-[57^MG:?FNH'XF^!8(WCNI1JJ @A?^5#R
M-;9\)>* I2BX\+I7F\F0KT+V]/J([@-K6TW/#VSYS[%N+'+U/2%?,O+3U=!3
MDCG@TC$N&UI\B@:@02@?)33@1R0WA(\\AJ/.:"#GG!C/3Y> [22!R]S0P.E!
M".JTT(U'(6UO&B[P\M"SZ$DQW\B=!,D#$#:=Z$K3;N$1_/2\%!. L9NPO]0\
M</$F!PWTI8!/>LREJ)=W6$>:'R-2V,%6*@7>3))H@*A/'W-('?GYN<F,OQL]
M4A3J07/4]@&:(G3JF"9HHO3+[B*_='_GYN'L:>2>02\GC<I@_K?T*(NMF[ ^
M&S2P\TYIP@P-I U@UM\N0 -_[?A-CFAC2-2[7QMT+&KT337V;UKS$D1J-?U%
M-/,7>Q%2$E)(\S3CJ,#(&1IX$*H:$%8:P[]S4NI5-.; 7!G _()NX14U=T:M
M/WZV]*]MD,U4,,IW#@TTVO0/ZEBQ9=X0BVLI6@Z5H#&T:?&XVJ9ZG !>*8>=
M].>C@?]*70STJV)0"_'K+7=7+;AN.?&DE>XVPJ'6'M8RJCY09_$4YFIWJ[!S
M6+C;+V7WNQ7)D-E?QQP)S;%_F/1Z($&<B6F(HW[(*ASGRC%.0I&%.\7*A[.1
MK?I.SC2]:!'RL$NSA]11:Q/&;Q.VMJ:P [6Q@]107X;0P$HOZ'SY=4[N9I2S
M_DU<9>83ZHJDR@(+&/FX?P2]"Y/@D*S\I?(\;"*NC,C /^[(?SM(+HQ0LAA5
M%*\AUWV2Q_B("),=D MPM0J\(C3 M(L&1MU0[K9V-@X U9UH^UYQDOET^88P
MNPN'WG5ZYJIZ[D[$&S/I4BE_']< XVC/H*X1SM*F<C%S-+#P50C[^ WR#E:_
MSU'QE.%L&%1W@?XS";@Y3RRPS+C#Y3@Y3?"Y;LPU_R-@(=MI/F\DV;1G++>\
MBF.HPD>9]U[W4^,[XL)B*HJ;#!5\ F:-85\<SOL9'^<5DO5<3>4'OA/R2H#B
M972C[T8Q*W_34;J5>:GN2BM9_DEEU(RABCW_4^6;SKI<[T4F/)0$W>W?(DR_
M<S0UG(NXJGXPU&JIP^Y0+]* T'I**2<YS]/1FRORHH'O=Z65')[O:3\3@.J=
M-864=S[A8ZN)EKTK>>VA93#1.+C(,\;TTI[\4#%XWLB'\$I_ ('&JY>1E#FK
MDDANRRG=H+HW=7+!'T9D! O6M6R.O5MIQ<U==@5DR%OPF;[SN,CRTW7-15 '
MX@T,ZT7YR@Z*FO!T/&RQRS296$NVLLMJ4'1V6"2ARUI78,IH*"O>C"Q4I[4K
MFFLBGK'-HTUD(]R_L:J?0G+N:N2NI354Y.XGYD/<V1IW\$X)8NL,51$O3=UZ
MMWBF]PHISY%G;<^??Q;<-H"W/LU&?*WT"0UN;5C02!V?DL:(^9YGI5(BW].<
M\0$64L:LH*:OKET+$;%&2@A[IMBGQ+8GM%>"@-N=;\N"8G6=OV /UO)!%/PT
MK"C6]9X&+Q">QWTR9EST.2Y0&_+M$1U2M5$LUY6P"_?H4'%W9YA\!^]):-W+
MO:Z-%;Q2DBN[[N6K-,^5U+$)]7&UQQ)P9SM>AW._\;\I*RFCIYMV-8H^8?TD
M1X@6V^E3UP)(?G3COAQMC-&I2A$D;ZR@OE$=)QK&.%]Y'+GY:BG>I21@<0^W
M+:9*:JNY.AZ/*]1_5<@UQ:V/4<_ 8$(M[LRLAMQ'=#3U1M3]''8L%,66H6B?
M6$KRW2A=>6.RO!)C:!K[2&?TO+5V9>#T980BE!SBX#/J[/&DZFF9T<<O=)%F
MY?85(?W'A<]W7T173JN$*O%)J>W7!Z=^?[;&ZR6B$'T2^?V,CG0^>>,&_Q.!
M1Y'KSJJ,%$K4099%S%VIK<X11WS;)47CQN-K!R(JN=^WK9B<*%BXZ-E?]GJM
M&9V8T@WN/&Z(F[^TX_7Q*SL<5VX-<EO6EF;W1<S@I*I+V?>&:F?ZFL@O_F-]
MD&R[/O4/8E%] J&.,RH,@<9&BDOU4=VDK0@!%J;;ER7QZJZ!'DH51]GY]LO@
M>;8DI.<OYXY[*BF5UH4N$S\1X5!@>!-KLL(7@-!=D0_0T'P((V)0S]437^#:
MKB GOI_T)+IRO]'"L%1@:65Y<MWN78*T/'-8P'6M*EGAB?HE)&[1:RT2AO3H
MVS%DQ2Y='6R@=]ATA9Q,-M5QJ:_DKD(GLK-.XO6B1(NB%%_@/&UY4(4RO+DY
M5J*(0Q'IPM/C+G#)]BQ,\-IQI#(<M#W/]IX:V9'FXMI7S%,W4/XY:RW/A@/Z
M--J#PE_(U5\::TQ;,V=SH2ODALE4W )*K@@V#>XJTC&"(\XJT( GIK:I,"(,
MIM90EE>D?HCU;P>-H='8N^K+I4]BI]3-N*B@#ASO'$[$@A^Q?M4E2UQ5EFR[
M+6H3_\JL)KQ#1Y *WJI=9JO[H=-"Z-HG:RR5]XUYMF_8K'I-L/,Z<!Y'6#+N
MK0N?F\Z@O*9@,W&9?SWEB.61.!$NZBF/^8?=.OTX!9/R%=]3=^OG,NM.4U>(
M:.I]_78EHA4R@:EMIZI_U+=*QPU-)_S@G6[=8.I#'@4P1M)Y/.AD*1<U6H5:
MZK@XM>W/",=6X-AX6%7SDOG\G@O9'4XD]T<5AY8+^S'6[2BLTV<INA?4Y:0D
MN>[$RE&W0EU:"KPXWVQ@NEV[233@LH!"5MAHJ-_J[_M+(+AB"PW4.&/J?\-R
MKLQ_?"-#,O#6QOH/,7W2\//]8=BOQU51.VA_I0'0-WW->225*0?*&T!I'.TD
M(6OK%>5 :8('^R]WM8T46=I'A4"%[GYUC72^N+&_?KPKG!7P;4 \9D'B\&R@
MA^)<TMX, P=S[7O\J80_'_/;B@9-VI:9S83D\4=R<MP>'SY]#/N7[C0N2APO
MNC$G?'NG*(O]CTK\=]__,N3/%06W0S&EPFI6W-G^#5WQB&EF-4LZ_HY^;]UP
M:DTJ\__6TS##(/Y$+-(82\:+W4G-ZW.?8V_YNB1S**2)H6I8T_*+6+F0W%#6
M'3&A&'Z?H)2 )-+EI!FVN+[]R_EBUG0R?I)%H,WS^WG[5#Q#+/G34VN&4JPF
MU*],&C65-"7S/AHEE,\7;SW"EHM:IA:D=9)XD'5T2'.SKJ*,H-\(&1T6V* ^
M.EDA-<$GH//<Q"A#^?G%7KMR@;W%D[[ZYNS*S5YI[X=O&#2]"V@B"KY<^CY>
M0X<O$]$4;!JJF,0>I<S=PAS4IH?J*2=1#I!GA;(.%F;PVE!0<P?XX]MF/WL?
MI;DN%<KU7E]#D1KXU]!D>A$7"JP,;JA&4\+Q+EL&:Z6X]\(,?4S7-%Y$<[VN
MEPG60"Q7&#9_\\?#^;36)K)6:5\GMG; F"8UXENX?ERZ :OOH5H3DEMPZ%)N
MO\CRX"P9%5F4>O!)YS+M 9F'4%I.&-7=JCSH&7NAO:M#W]7*_MR:[ '.H0H[
M<S\[;); A_AT[3<@IIH3S_HF#"8;ONAI*P<Q5W%_2&&D\)=M\![L*"CH['S$
MG&E^>EXC@5?X/OFQ/V[ +7S6C7N55W*[NHD"<YC/OQG>Y=<^OV*3$?H1R CE
M^N]'9"0!3EB2D*Q2-L#W5\.D:6E-3W_X%C<C\J8L 3@<"!0B -\##.<:KS^@
M:H$R=&8/*M3(+SJ;]+A.L^VV2@T_>Z+XJ-X4'D'GS=";X<#'FDQ#J/8F3+F>
M0D3I5@0%2R*VX(VT6SUNWV+?K>J>L;^-N,GP>%E%71<\9U@^FQ1ZOY8B!IK;
M[93QQF4VM06[T8878(L4W-%]\@N0EF_K9^E1XN&5;$ JU.'H>Y53KW#88 $>
MO2;!$350_O-7+W>=1_PEU%^*E\H\-,1CL?1K4]Z*J+#^)%YZC7<<C\/]J0LP
MB[UC-#']&EIL<"IL#BETB<B'GMV-A6;J%S4TSAQ/'5GL&*^G-)2(*PS%<;SY
MS"WF49.I2*TGO_P'AN<!PP%'F4[XT5Q8-EF=K)+S<?Z82A,SLCI[A837;A$K
M<BRA=@\W[MYUCDK':.O'NQN$@+_RETR7B$)9J?Y+ RI1*9;6@W_LNRFZ:I5V
M/"A1^-[!XVKNJ:#9(B \A8I-25)<4*%B+V@?4"&,*4\\,);@74A+Z%L);>(,
M<AMGLQ9>IW^DTC89@%QKV@V&IA_LY:*!60LT$&Z3I)PLU/L&K\@QS\2O^M:>
M\CODL$7T.*L#^2T\'MN:/L3M\KY3Q#!LEP\-M,/_-LL>#S=>72UV15TN$D8]
M$P4AB6%[F7]-2&![&=W5MF[NW;;''GI)]07VUB*\'ZY5<8]1?C"VYY0!P,;:
M,W_' L),FWY-12TYGVK$*PVS!Z>UXY7SL7IQ]7V]9_&Y3W;R=&0YB'IW0CEZ
M\I2 [6*,E>0NG@K(^!L( V_F)SS!/\'.G)[^.4N&%N!&1(2N@.>(AF K*QIH
MX%,'&F#X#]-D_H7AU559GA0T\)SG :;Y2<7TD=@@I,U_G)=M,R2N63CS[D^)
MQ3I?:TH^&-_^Y([E;]['R<DY1L0O8J]BSZ+.!^^F3PBJC\9^VB>K: -KIGF/
MN0AZL]%  !PEDOZ3[$$>["=7/2&.]L8W)"-GBEGB] ?1['I?OO3*VFZYPOZV
M"K3[?*WIX.C';'AMJD@M.G09#<P18AC\N.\^=6"TGRJ.>E8A@"3QYJU[D:-B
MG+DZ)-OZ,57ZR0,NTB=EL\I!8,&C)P=::*"9Z@>8D9]@E)#7I1R1%[80!-WA
MMW@-Z9C>D%P5AK=!77$2R4^Z!;ZVKA"H6P$!1H9\*7%%+NWD'^59;T20GE?.
MNL"HM&'_<+Y]SC"O6XR>.!H@4$M% V##>!2>[ \",P<G/PF,>S#EJ.A4D(F<
MHH&!B85%<(U6(.K;JW^M]_Y]_0^/&,AQ&NZ%J];;N;-TS<J$^KZ%V%1&IBR2
M7$QYO-O*L7&8LJFZOA3)HOCM(0GJH 3CH"-%&(=PVSD]'T8#NX*K&!-RJF%,
MV(!I:K&92A*I'CL:<L9;$UGU#F,+^6VG7JS;_J'-II4=K7^QD48].P)CV+SF
M7[+]G8UW^G]$9S4ERH<(9U*56(AH5GWOT:Z',B#;"@L[UU48,VECB[XFYQ.B
M:_T8*IDD5*V],2K1-U@,:Z;*@?5-Y_S+!!Y(E"T,07>DDOVVL&MD1*KUX;AL
MN<J2$L=RH$N71F+C(_ X]MOBRIJ2GZR0?V?5\Y/5FX_K1*MK-L5V/Z'#1']
M!_^D=/"34K;5E'<JGVM23_V)5/T-W)BNVRM;+WV.3>O)M53^12WI!S5.#!X8
M!D\Z@FX8XQ*VUCTY4T4?N=>T3EV>P,WLV\7I9[A6F@ _'H6[9<-\[GK"=TST
M/T"SSB?!_M@;&TI_[%[_L?L'2XRG;6.T%!"NGHB;.#A@//I/[[4P^*(W=E5=
M?:#4NJZ@>7'GH]?X_I+;L'M?DM7K0FG;8T62HQY%.GZOO9_2A>>U<#H"_R=1
MVDFW/_+HKR6%22&IGL1_T?KRIK@GV4MR(\W9Q-UYHBI$)/SJO9IAAQ)W1Y;O
MXE\JMUYU>,=U-T^(95J1+J7EY#UP%'JA9#3"'*3P<?A*B($RG="V)H$L0?$3
M!*LZ,[S*-@5^BK2MF$LG-4) [I_3-'S[UAPW93A_NT-N.FCB?=<D7,LAE"N/
M[O<ZX?\PL [@K^28/8O[VABRBQH_\CHIN*PQX$)BY6=UK9&\Z71HH-_%\7P.
MUMP@K8/@@>;;GB0%V>D)5GSMN2%/&5DCV::-!H))K=" _&3)^6'3@LE>WMV)
MS-1V#YD#U!7U,-BJI/C%;M.<>LB\>!A;FL1D*V5[\6?5,GY:V3.]M[#F%V5H
MX.W1Z,49!)/8J47C+_ =FG:Z,(D(#%6HFN4W#+DIH[*@3<G7]^I]H*7)DEQ?
M-6XO%AL9X3JNDOL\A&G25G,,='G9QH)2<N+203]VA$IG\?@S4J$XUC;#%T8.
M\QIJ3\/(NS+ .)&E%O-V\UTWZ=YVKL@U5L@-QA^&= O'^#G.DRCJ0B[;1R7;
MOL7F# L:RE;D?-G(W$;\U?U(D%NXH'B0C4AHTG/+I !YU8L,TN;]FC$H.FB(
MJ4*TJIFSHBQM$$QI0I>C&5Y+PX8]3.;9(P!5[=X&\4;0;:13*I8+8VI[N7'M
MFY!X)_R:A1R65S+R>Y>D;Q2KU7]EE;A.S3AK&9&J!$I]"M[-[FU31]QSOY;_
M0O2J$I%W1,.-EMG)P"S/DH>XWKZOU2<T]\^#NUGAJ.]["+V^ER$)4:^NW0*Q
MQ'%[.+<+:N_X&BQ\EQO/23>=4YXJ*"_%B203[)\=]4(#1-"3*YCX+7@XI:8R
M5C\LA+P<^FC:\94 Y*FX0[B:\U!3 U&VP!H^;Q\F[02_60"=D6&N(%\!!.:V
M(N9L!Q\R)J,0D-T2A;_;6 G)92=P1O8=-H-)[@PE?UHJR11QTB85'C/BX=U:
M-OFUCNUVYC)3;-[N2<>)'$6CD6KXP9KP3?++BZWJ>P((/95Y4-#36LZ0G0J)
M(Y_$Q<J7M:V/0(+7JHL@+\ D;4DM)7:E06ZW[.RL&>]("Y/OP+C9->-92[GZ
M$HX2L@P>J5!)FRB0A#E!#S5,O0;_+W\-^S%<:DM:(20VM3$3?JC,)>/F6V[[
M8PNL<K'JJ"M]0;!5'C00F8SD:4=QR O[WOF6:!8;X/99F\WOLW'\^#9X90)V
M?CPS9S+0\KE-K-=#4V7L3.GW?5P8G7V<[3LC)C\_G)F#B/NE+:#\,,FCR1Y%
MXZB*-ZH=Z).L,HW#5GO*MA(T28TJ(IO;LO0CQ2C>^G/ZX170R5I3,QQA9$J"
M"9#2/[;-"7W)[F:[6NZ3K>TK'A-6%Q]A)*MN.%!>VU]THL*1*JV^3%E8&4:A
M!Z7K<.Y1?4<N>*["U(T1:/>'P*W_)'"^SR,C841@\]6XZPLY!=*W%_.-(4.B
MIB,+]R(F"!Q$#(R#-7C3M!PY4UM]+J8T-IF9!M(6_E'> XR\QWX4UXE$7J6.
M!?,MWIQ(D,2D2;?EK.@#I=2!K,$EK(>8O'GW296LB_3"NRVETI $'Q6F@5^,
M_Q H]SO %R=*TUTB*F%,#A3W^6+#%C@O-K'5&EXK5T8T*Q<:/E05OOM![.G6
MJ<)9ZK / 7YYU!9XM[*>'N.IYI@6>_)W(V!L92H27\NH.\!KJ(UZ-GS 9O?(
M"Y^3*;6-+^18= E!N99V^WJG%XM]8;TU:YW?IL;F]66F0:4R6//XKO4%;LC%
MN>-N)NK*:!!XE1>\,P0+]HP1>,N7%?4@VU0$+HW:>_0DRZJ:Y]#T&Z^>-YM9
M^J://]'6V/4G"S*+Y_ NN#GYS>-HV5_[)V'!H+\AY6G+J!XHVKJ#K5X=Z=#=
MR9<@C9WB[V/!NI];;#V0--9&%B6>=#K#%?!"3JO*9JM7&#& ,<>@4M4/>(X7
MN+!]JI\2?:]B)$*0S__TN(9R-/!3K1^G8'U_/I>L]V^K5\1;S,BH[JFV>,A=
M;7I]_YNK[P"(V4MIYWA=T!!&WLALY%G;:C05&Z(;#/.YXAD)\_)KJ-/K62;\
MIBI"Q1V1U7Z+IFFVB,I@!*GB4,M33W7K\_2JVW/O=$B.-_MM(O*'.FSC1P^H
M.V,'V?3\MJGQGEAPCJ3_;P)5+]77?,2=C[9E1!@:7S;1=2)/GRD359ZB%PYK
M]IIO.B,WA<TH('F\W=A%W;XN:2B.G>6'GAJAJ/IH,/>5]P'J##2GA.1,X_EQ
MN:Q<'(*;R\\*Z]YL11T]H-FO^ML+.$)=1@^CLXV^\U6,!G7BG8X[S][_>V'P
M_.YJ'TN_^_VM'7P,5.O:FEZ7,44!QM=VHB!\OP/$?/7\H UVR%2/!AI#$!I'
M!B?DMO \WY>PE6C8# N<!72ZF'[261('FY/9@US@EX!WWJ%H!@T@GEW+TX/S
M$,KO;8Q[]>%=RS?Q]"2/J-,85)\2Y?N1OZW'"(B!G71F=H:@O#@O]GE6)$5G
MKM 5)<VTCI:)')Q*LM]^QXG->90W>-[>/OP=',JN+_=$;%L_* PKXK"Q^!P^
MP=_1WW@'?/ %O!.E%$6.W%<_7]3K$X8@)GA>O/1,TJ1E1SG'&,]2"DY%#'?[
M*714J;BLS1/>GNPR?S08$'?-N:,Z<TQN;HO68C7]3PZ_H#P?EG&NP4&QI FU
M\":W+])WR'CO*39F+A@P'[S?8V\U^[*4;[WL4!\AY5ON@S\EF['I1[Z(N6!D
MWJ!.J?W20*<+H!]2G@[[NKRNJ;^WD)\K1)[8H</H?L%#C+')%=B?)GE@GG7\
MZ+C@PY' G_@UCCUA*V&P'^IL^DV=U+\;Y,:%KE_+1'''\'\BWPW93?,L006-
MII_T8^Y-\.\2_/ZK37#4*<W^Z+_UI72GO_!A5E/_K[RD#G3;<YT /(<_(LZ=
M<=6UYAL6MW221Z!( ]7]W;;\5?[HB:YW7Q=V[GWO]CE_6I*R76\UK[IA8.]0
MD9QG%ONT_DD+B:R4;HZ_K[O7W#45\^O;(N-3A/8=;%1(95F_NB%/+R[#>1VJ
MJ,/OU)U9E*W1P"UW$FP2BG1#/^?D8!K3X]E)(Y%0+/-//99B%4ZA!O6E;RU3
M=-K)##.,H\57B[41M>P2PBU(6?BS6![/F$Q[*(M6G2-KH!]W0UAP;T1<Z"<3
MV[EVO6[68:)OI35V!7[;@)F3LQ:71,&'/ [#C#)'417S6L],G>:]/N^@\T<K
MYWFG6MJ+1V1N#@/& WL26/!$,EKIEUL1W):C''&B;OOC^I:7I8:.-6FEQ%<+
M148XI\59*-+LG%R$-;BJMS6AF]0:VNY75\K'*.3Y-E0XOD>*/SJBZ>LNJ;]^
MOU'308)^VU:B7G5%0GE"J-62A*(-NIFE+B5UCX>[6RMZ?E&1A9_.2=%V^!X_
M_]>L;4SR4>ZUZ&"B+=U3BR5M?.<L(]@BGO">T3*%(N)9Q2=8<_;N"A(-K$,0
M6][O*]  4Q[JPGS4A&/8[;%P12\(12,0 EY! YA6M0,*F]-$.*&![F-,D10Q
MZJCO4:I VAKF#K4WB-#'ZI#ET5Z:"I>F2]_-DY'&]$03\2AI3(-$%-^2?H &
M\I[9&74Q)^'ZVY8IGR?6?U['5]B4G$]]/W&G2K!>K]$Q+H&;BAZ4*MU=7;[I
MBNG2\GPQ5RWX#"-#"<D-(8/UH7X>ZJS(TUV]&6$J$'!&,E#X*A\2:QYU IW9
MS3@$GQ'.H.Q,W[R'=<H)O$.Y.]28&+Z:6.ZBV/2"(+D:R%&!'F@@:3AO5TLU
M_#7'Q[P\5IP0QM%WZ^+J4*)RLRM\$7;"YX\V!L%=>?<*8[=5'YJ0R3<2K3VA
M%ON8=SG');PE:..>'#$T'V"8?@_,DL[7.L\;A[V:[2@"[48?P.5F9+F;_*9,
MYWH-D4RE975&N>Y%"KW7B"-G>C/?S#8F\T;7;1A&02%?80DNTQ5#Y%2+G3A1
M(%[_5K+$-5UP);\ZN Z9>['C/(W/_(QH+?A>JJ,V<VH'OZ1<^<*NA9I#[7*N
M9P>_E)Z=??X#EJ\FVC$/6AAU5$37,B:;S+[WXW+$KI^0.RW.S!8G7L<]*GKP
M<E4U@AN$T/ &7>#LH '1XGK/R$B".$:FQ"Q,8":CDC\?;:F??&_;9H3_T@RF
M:B$2P&2MMYA^=KEB%$09:T92&A;^*:K]!OFK3\ST[[YLA8+]IF1[.]A_7UD.
M:WZ-22^KG+#3(O>.UFH@<9;^*$_+..V6 <E]K,^?,H[J0FK&%L!SBJNP0ZHF
MY C\%ZX2C6#DF.9]"R=\ZK/N2>UM")L/D]X_""]!Z.5K*%7F34FRCNW!*)!,
M@^6.9#/K8J.C97V.%)X+$M?AYFU0I##"IE93L6C#Z463>2T!G>4M6?5S2%?#
MPUSS%P!<0?7!2')X,B[!])PBM2Y[C+LC8M<QM]ATZ_M#[LG3+J30"J/.SE7/
MRNYF;S<JB*&JZ[76-'W]O4CGE%%"3$T7TM)TB-?P,Z.-ZK#SFU"$;?GU+)H9
MF0_>6XG[C.DK);+B3 ;)$;&= _M=KITR+O@.[S%5WYP3P@/E/]KT(PLS@/\V
MFYS>O)O:F__Y597VN?"M4+QO%F],Y,(Q06A]<6!J]/<COR4\$U^-5"J39=G3
M&^(Q& Y;+(S2@,KVCC[$%.?/9R!K^H.FWUL7K])&D=VRE$!NI"4OB(>L1':>
MB:Y9#&^#%C -4//<[LX%5@D,<P.(:FBJFDM#7$TTA2+ 'Q9O+]CANF#U>==<
MF^K/<N9(938V UJ(!*=&I?\.8A#VNPS3D_W7:BNV(>QJ@BG.)C;G&?5>SP0]
MW?5O#CBZD)]@(/<A3&N5+BZ5P$0+;6^[C-/2LP\?V7:,H)!@!6-RI( )*RI
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M4$L! A0#%     @ B'U\6DXX@J"\#0  QI\  !4              ( ! A(
M &%R8F4M,C R-#$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( (A]?%KYY'N4O4
M /<#!  5              "  ?$?  !A<F)E+3(P,C0Q,C,Q7V1E9BYX;6Q0
M2P$"% ,4    " "(?7Q:M&=6A':3  !O/@< %0              @ 'A8
M87)B92TR,#(T,3(S,5]L86(N>&UL4$L! A0#%     @ B'U\6A+KGYT-0@
MUCP$ !4              ( !BO0  &%R8F4M,C R-#$R,S%?<')E+GAM;%!+
M 0(4 Q0    ( (A]?%H#K:7X%_,# %]D'0 6              "  <HV 0!E
M83 R,S4X,C@M,C!F7V%R8F4N:'1M4$L! A0#%     @ B'U\6B]-_'XZ!P
MOR$  !H              ( !%2H% &5A,#(S-3@R.# Q97@Q,BTQ7V%R8F4N
M:'1M4$L! A0#%     @ B'U\6G34C*8Z!P  6R(  !H              ( !
MAS$% &5A,#(S-3@R.# Q97@Q,BTR7V%R8F4N:'1M4$L! A0#%     @ B'U\
M6F@I8)#H P  61   !H              ( !^3@% &5A,#(S-3@R.# Q97@Q
M,RTQ7V%R8F4N:'1M4$L! A0#%     @ B'U\6J+D>ABL @  KPD  !H
M         ( !&3T% &5A,#(S-3@R.# Q97@R,RTQ7V%R8F4N:'1M4$L! A0#
M%     @ B'U\6F7=@$T4#   PV<  !H              ( !_3\% &5A,#(S
M-3@R.# Q97@T+3$P7V%R8F4N:'1M4$L! A0#%     @ B'U\6AQC]K$[ @
M'P@  !D              ( !24P% &5A,#(S-3@R.# Q97@X+3%?87)B92YH
M=&U02P$"% ,4    " "(?7Q:TW$>'-X:   -'   "P              @ &[
M3@4 9FEN7S P,2YJ<&=02P$"% ,4    " "(?7Q:JIFCK=M6   @8@  #0
M            @ '":04 :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( (A]?%K0
M>WG@#"4  ' J   -              "  <C !0!I;6%G95\P,#(N:G!G4$L!
M A0#%     @ B'U\6FMX+KGD(@  ZR@   T              ( !_^4% &EM
M86=E7S P,RYJ<&=02P$"% ,4    " "(?7Q:. +R\Q1=  #K;P  #0
M        @ $."08 :6UA9V5?,# T+FIP9U!+ 0(4 Q0    ( (A]?%JB$8UK
M)%(  "QE   -              "  4UF!@!I;6%G95\P,#4N:G!G4$L! A0#
M%     @ B'U\6@L<\#=D,   @3@   T              ( !G+@& &EM86=E
>7S P-BYJ<&=02P4&     !, $P#9!   *^D&

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>ea0235828-20f_arbe_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:arbe="http://www.arberobotics.com/20241231"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="arbe-20241231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:OrdinarySharesParValueNIS0000216PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">arbe:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2025-03-01</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">arbe:ITACMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:PIPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2024-06-02</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-02</startDate>
            <endDate>2024-06-02</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-02</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2024-11-04</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-04</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-04</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-04</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:HK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">arbe:OtherGeographicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:TheTrusteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-02</startDate>
            <endDate>2024-06-02</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:TheTrusteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:TheTrusteeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">arbe:NasdaqMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">arbe:ConvertibleBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-31</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-30</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-30</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-30</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">arbe:TrancheBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <startDate>2024-11-30</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">arbe:DirectPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandSixteenIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:TwoThousandSixteenIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:TwoThousandTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">arbe:TwoThousandTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-18</instant>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
        </entity>
        <period>
            <instant>2024-12-18</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">arbe:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">arbe:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001861841</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-07</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="ilsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-19185">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0" id="ixv-19186">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-19187">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-19188">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-19189">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-19190">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-19191">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0" id="ixv-19192">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-19193">001-40884</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-19194">Arbe Robotics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-93">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-19195">107 HaHashmonaim St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-19196">Tel Aviv-Yafo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c0" id="ixv-19197">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c1" id="ixv-19198">Kobi Marenko</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1" id="ixv-19199">107 HaHashmonaim St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c1" id="ixv-19200">Tel Aviv-Yafo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c1" id="ixv-19201">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="c1" id="ixv-19202">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1" id="ixv-19203">73-7969804</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="c1" id="ixv-19204">kobi.m@arberobotics.com</dei:ContactPersonnelEmailAddress>
    <dei:Security12bTitle contextRef="c2" id="ixv-142">Ordinary shares, par value NIS 0.000216 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2" id="ixv-148">ARBE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-19205">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3" id="ixv-158">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3" id="ixv-163">ARBEW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3" id="ixv-19206">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-19207"
      unitRef="shares">105163188</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-19208">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-19209">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-19210">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-19211">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-19212">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-255">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-19213">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-19214">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-19215">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c0" id="ixv-19216">true</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:DocumentAccountingStandard contextRef="c0" id="ixv-19217">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c0" id="ixv-19218">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0" id="ixv-19219">1057</dei:AuditorFirmId>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c32" id="ixv-19220">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-12254">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="text-decoration:underline"&gt;Risk Management&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We manage significant and persistent cybersecurity
risks due to the need to protect our business, including our intellectual property and intellectual property of others that is licensed
for our use, our confidential information and information concerning our personnel and others with whom we conduct business. As other
technology companies we occasionally face threats from actors who seek to disrupt our business as well as others who are engaging in malicious
activities or for reputation damage. Disclose of certain information as a result of a cybersecurity breach may result in a breach of privacy
laws. The substantial level of harm that could occur to us and our suppliers and customers were we to suffer impacts of a material cybersecurity
incident; and our use of third-party products, services and components requires us to maintain robust governance and oversight of these
risks and to implement mechanisms, technologies and processes designed to help us assess, identify, and eliminate these risks.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;While we have not, as of the date of this Form
20-F, experienced a cybersecurity threat or incident that resulted in a material adverse impact to our business or operations, we cannot
assure you that we will not experience such an incident in the future. While we did suffer a cybersecurity incident in 2023 which did
not result in any material adverse impact to our business, we did not experience any disclosure of our proprietary information, and following
such incident we took additional steps to protect ourselves from cybersecurity incidents. Any cybersecurity incidents, whether or not
successful, could result in our incurring additional costs related to, for example, rebuilding our internal systems, implementing additional
threat protection measures, responding to regulatory inquiries or actions, paying damages or making payments to obtain access to our computer
systems, or taking other remedial steps with respect to third parties, as well as incurring significant reputational harm. We have seen
an increase in cyberattack volume, frequency, and sophistication. We seek to detect and investigate unauthorized attempts and attacks
against our network, products, and services, and to prevent their occurrence and recurrence where practicable through changes or updates
to our internal processes and tools and changes or updates to our products and services; however, while diligently taking actions to eliminate
and reduce cyber risks, we remain potentially vulnerable to known or unknown threats. In some instances, we, our suppliers, our customers,
and the users of our products and services can be unaware of a threat or incident or its magnitude and effects. Further, there are increasing
regulation requirements regarding responses to cybersecurity incidents, including reporting to regulators, which could subject us to additional
liability and reputational harm.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c0" id="ixv-19221">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="c0" id="ixv-19222">we cannot
assure you that we will not experience such an incident in the future.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-19223">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c0" id="ixv-19224">While we did suffer a cybersecurity incident in 2023 which did
not result in any material adverse impact to our business, we did not experience any disclosure of our proprietary information, and following
such incident we took additional steps to protect ourselves from cybersecurity incidents.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c0" id="ixv-12270">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We aim to incorporate industry best practices
throughout our cybersecurity program. Our cybersecurity strategy focuses on implementing effective and efficient controls, technologies,
and other processes to assess, identify, and manage material cybersecurity risks.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our cybersecurity program is designed to be aligned
with applicable industry standards, and we have engaged outside sources to assist in this effort. We have processes in place to assess,
identify, manage, and address material cybersecurity threats and incidents. We have ISO 27001:2013 certification, which is an early standard
for information security management. Steps taken by us include, among other things: an audit which was conducted by the company&#x2019;s
internal auditor during 2023 through 2024 of the cybersecurity measures and practices of the Company, the engagement with professional
service providers (such as a chief information security officer (&#x201c;CISO&#x201d;) and security operations center services), security
awareness training for employees; mechanisms to detect and monitor unusual network activity; and containment and incident response tools.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We monitor issues that are internally discovered
or externally reported that may affect our products and have processes to assess those issues for potential cybersecurity impact or risk.
We also have a process in place to manage cybersecurity risks associated with third-party service providers. We are in the process of
implementing additional technical and organizational security measures to follow our information security program.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our CISO, who is a third party engaged by us,
and our VP infrastructure, lead the strategy and guidelines, and work with senior management and IT engineering, to operate and implement
cybersecurity of the Company. The CISO is responsible for handling the risk management by assessment, analysis, reporting, managing the
cyber protection following the relevant requirements, the work with the Information Technology team, implementing information security
awareness among the employees, and updating the company&#x2019;s security policies. Our CISO provides annual analysis and updates to the
management on our cybersecurity and information security policies and programs, as well as ad hoc updates on information security and
cybersecurity matters. The CISO and management provide updates to the Audit Committee on the Company&#x2019;s cybersecurity policies, risks
and mitigation strategies. In addition, and as part of our policy, our CISO is also responsible for informing the Audit Committee of material
cybersecurity threats and incidents, based on management&#x2019;s assessment of risk. Our board of directors has overall oversight responsibility
for our risk management, and delegates cybersecurity risk management oversight to the audit committee of our board of directors (the &#x201c;Audit
Committee&#x201d;). Under our cybersecurity governance framework the Audit Committee, in its charter, is empowered to implement and oversee
our cybersecurity and information security policies and periodically review their compliance and mitigate potential cybersecurity threats.
The Audit Committee is responsible for ensuring that management has in place processes designed to identify and assess cybersecurity risks,
and implement processes and programs designed to manage and mitigate and remediate such risks and incidents. Both management and the Audit
Committee also report material cybersecurity risks to our full board of directors, based on management&#x2019;s assessment of risk.&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c0" id="ixv-19225">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-19226">In addition, and as part of our policy, our CISO is also responsible for informing the Audit Committee of material
cybersecurity threats and incidents, based on management&#x2019;s assessment of risk.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c0" id="ixv-19227">Our board of directors has overall oversight responsibility
for our risk management, and delegates cybersecurity risk management oversight to the audit committee of our board of directors (the &#x201c;Audit
Committee&#x201d;). Under our cybersecurity governance framework the Audit Committee, in its charter, is empowered to implement and oversee
our cybersecurity and information security policies and periodically review their compliance and mitigate potential cybersecurity threats.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c0" id="ixv-19228">The Audit Committee is responsible for ensuring that management has in place processes designed to identify and assess cybersecurity risks,
and implement processes and programs designed to manage and mitigate and remediate such risks and incidents.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c0" id="ixv-19229">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c0" id="ixv-19230">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <dei:AuditorOpinionTextBlock contextRef="c0" id="ixv-12819">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Opinion on the Consolidated Financial Statements&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have audited the accompanying consolidated
balance sheets of Arbe Robotics Ltd. and its subsidiaries, (hereinafter: &#x201c;the Company&#x201d;) as of December 31, 2024 and 2023,
the related consolidated statements of operations, changes in shareholders&#x2019; equity and cash flows for each of the years in the three-year
period ended December 31, 2024, and the related notes (collectively, &#x201c;the consolidated financial statements&#x201d;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31,
2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31,
2024, in conformity with U.S generally accepted accounting principles.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="c0" id="ixv-19231">Somekh Chaikin</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-19232">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-19233" unitRef="usd">13488000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c6" decimals="-3" id="ixv-19234" unitRef="usd">28587000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c5" decimals="-3" id="ixv-19235" unitRef="usd">280000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c6" decimals="-3" id="ixv-19236" unitRef="usd">163000</us-gaap:RestrictedCashCurrent>
    <us-gaap:ShortTermInvestments contextRef="c5" decimals="-3" id="ixv-19237" unitRef="usd">10793000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c6" decimals="-3" id="ixv-19238" unitRef="usd">15402000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c5" decimals="-3" id="ixv-19239" unitRef="usd">153000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c6" decimals="-3" id="ixv-19240" unitRef="usd">1258000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c5" decimals="-3" id="ixv-19241" unitRef="usd">30417000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c5" decimals="-3" id="ixv-19242" unitRef="usd">2500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c6" decimals="-3" id="ixv-19243" unitRef="usd">2026000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c5" decimals="-3" id="ixv-19244" unitRef="usd">57631000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c6" decimals="-3" id="ixv-19245" unitRef="usd">47436000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-19246" unitRef="usd">1782000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c6" decimals="-3" id="ixv-19247" unitRef="usd">1740000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-19248" unitRef="usd">1374000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-19249" unitRef="usd">1309000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-19250" unitRef="usd">3156000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c6" decimals="-3" id="ixv-19251" unitRef="usd">3049000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c5" decimals="-3" id="ixv-19252" unitRef="usd">60787000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c6" decimals="-3" id="ixv-19253" unitRef="usd">50485000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c5" decimals="-3" id="ixv-19254" unitRef="usd">624000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c6" decimals="-3" id="ixv-19255" unitRef="usd">1149000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-19256" unitRef="usd">551000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c6" decimals="-3" id="ixv-19257" unitRef="usd">436000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-19258" unitRef="usd">3283000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-19259" unitRef="usd">2916000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <arbe:ConvertibleBonds contextRef="c5" decimals="-3" id="ixv-19260" unitRef="usd">30614000</arbe:ConvertibleBonds>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-19261" unitRef="usd">1334000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-19262" unitRef="usd">1710000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-19263" unitRef="usd">36406000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-19264" unitRef="usd">6211000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-19265" unitRef="usd">1457000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c6" decimals="-3" id="ixv-19266" unitRef="usd">1306000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c5" decimals="-3" id="ixv-19267" unitRef="usd">428000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c6" decimals="-3" id="ixv-19268" unitRef="usd">875000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:LiabilitiesNoncurrent contextRef="c5" decimals="-3" id="ixv-19269" unitRef="usd">1885000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c6" decimals="-3" id="ixv-19270" unitRef="usd">2181000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="6"
      id="ixv-19271"
      unitRef="ilsPershares">0.000216</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c6"
      decimals="6"
      id="ixv-19272"
      unitRef="ilsPershares">0.000216</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-19273"
      unitRef="shares">165000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c6"
      decimals="INF"
      id="ixv-19274"
      unitRef="shares">130000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-19275"
      unitRef="shares">85749331</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ixv-19276"
      unitRef="shares">77925095</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c5" decimals="-3" id="ixv-19277" unitRef="usd">275453000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c6" decimals="-3" id="ixv-19278" unitRef="usd">245733000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c5" decimals="-3" id="ixv-19279" unitRef="usd">-252957000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c6" decimals="-3" id="ixv-19280" unitRef="usd">-203640000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-19281" unitRef="usd">22496000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" id="ixv-19282" unitRef="usd">42093000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c5" decimals="-3" id="ixv-19283" unitRef="usd">60787000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c6" decimals="-3" id="ixv-19284" unitRef="usd">50485000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-19286" unitRef="usd">768000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c7" decimals="-3" id="ixv-19287" unitRef="usd">1470000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c8" decimals="-3" id="ixv-19288" unitRef="usd">3517000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="-3" id="ixv-19289" unitRef="usd">1553000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c7" decimals="-3" id="ixv-19290" unitRef="usd">1508000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c8" decimals="-3" id="ixv-19291" unitRef="usd">1283000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" id="ixv-19292" unitRef="usd">-785000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c7" decimals="-3" id="ixv-19293" unitRef="usd">-38000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c8" decimals="-3" id="ixv-19294" unitRef="usd">2234000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-19295" unitRef="usd">35091000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c7" decimals="-3" id="ixv-19296" unitRef="usd">34082000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c8" decimals="-3" id="ixv-19297" unitRef="usd">36731000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c0" decimals="-3" id="ixv-19298" unitRef="usd">5430000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c7" decimals="-3" id="ixv-19299" unitRef="usd">5194000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c8" decimals="-3" id="ixv-19300" unitRef="usd">4621000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-19301" unitRef="usd">8347000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c7" decimals="-3" id="ixv-19302" unitRef="usd">7571000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c8" decimals="-3" id="ixv-19303" unitRef="usd">8613000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="-3" id="ixv-19304" unitRef="usd">48868000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c7" decimals="-3" id="ixv-19305" unitRef="usd">46847000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c8" decimals="-3" id="ixv-19306" unitRef="usd">49965000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-19307" unitRef="usd">-49653000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c7" decimals="-3" id="ixv-19308" unitRef="usd">-46885000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c8" decimals="-3" id="ixv-19309" unitRef="usd">-47731000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="-3" id="ixv-19310" unitRef="usd">336000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c7" decimals="-3" id="ixv-19311" unitRef="usd">3385000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c8" decimals="-3" id="ixv-19312" unitRef="usd">7237000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-19313" unitRef="usd">-49317000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-19314" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-19315" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-19316"
      unitRef="usdPershares">-0.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="2"
      id="ixv-19317"
      unitRef="usdPershares">-0.6</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c8"
      decimals="2"
      id="ixv-19318"
      unitRef="usdPershares">-0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-19319"
      unitRef="shares">80949032</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c7"
      decimals="0"
      id="ixv-19320"
      unitRef="shares">72021520</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c8"
      decimals="0"
      id="ixv-19321"
      unitRef="shares">63489983</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-19322"
      unitRef="usdPershares">-0.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="2"
      id="ixv-19323"
      unitRef="usdPershares">-0.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c8"
      decimals="2"
      id="ixv-19324"
      unitRef="usdPershares">-0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="ixv-19325"
      unitRef="shares">80949032</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c7"
      decimals="0"
      id="ixv-19326"
      unitRef="shares">72053372</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c8"
      decimals="0"
      id="ixv-19327"
      unitRef="shares">63629206</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-19328"
      unitRef="shares">63016856</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="-3" id="ixv-19329" unitRef="usd">199469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c11" decimals="-3" id="ixv-19330" unitRef="usd">-119646000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c12" decimals="-3" id="ixv-19331" unitRef="usd">79823000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c14" decimals="-3" id="ixv-19332" unitRef="usd">8793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c8" decimals="-3" id="ixv-19333" unitRef="usd">8793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c14" decimals="-3" id="ixv-19334" unitRef="usd">354000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c8" decimals="-3" id="ixv-19335" unitRef="usd">354000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c13"
      decimals="INF"
      id="ixv-19336"
      unitRef="shares">1144034</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c14" decimals="-3" id="ixv-19337" unitRef="usd">277000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c8" decimals="-3" id="ixv-19338" unitRef="usd">277000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c15" decimals="-3" id="ixv-19339" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-19340" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c16"
      decimals="INF"
      id="ixv-19341"
      unitRef="shares">64160890</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" id="ixv-19342" unitRef="usd">208893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="-3" id="ixv-19343" unitRef="usd">-160140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c19" decimals="-3" id="ixv-19344" unitRef="usd">48753000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20"
      decimals="INF"
      id="ixv-19345"
      unitRef="shares">11794873</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c21" decimals="-3" id="ixv-19346" unitRef="usd">22496000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c7" decimals="-3" id="ixv-19347" unitRef="usd">22496000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c21" decimals="-3" id="ixv-19348" unitRef="usd">13012000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c7" decimals="-3" id="ixv-19349" unitRef="usd">13012000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c21" decimals="-3" id="ixv-19350" unitRef="usd">629000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c7" decimals="-3" id="ixv-19351" unitRef="usd">629000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20"
      decimals="INF"
      id="ixv-19352"
      unitRef="shares">1969332</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c21" decimals="-3" id="ixv-19353" unitRef="usd">703000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c7" decimals="-3" id="ixv-19354" unitRef="usd">703000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="-3" id="ixv-19355" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-19356" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c23"
      decimals="INF"
      id="ixv-19357"
      unitRef="shares">77925095</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-19358" unitRef="usd">245733000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="-3" id="ixv-19359" unitRef="usd">-203640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" id="ixv-19360" unitRef="usd">42093000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c26"
      decimals="INF"
      id="ixv-19361"
      unitRef="shares">4293957</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c27" decimals="-3" id="ixv-19362" unitRef="usd">13787000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="-3" id="ixv-19363" unitRef="usd">13787000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c27" decimals="-3" id="ixv-19364" unitRef="usd">14542000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c0" decimals="-3" id="ixv-19365" unitRef="usd">14542000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c27" decimals="-3" id="ixv-19366" unitRef="usd">1186000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c0" decimals="-3" id="ixv-19367" unitRef="usd">1186000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c26"
      decimals="INF"
      id="ixv-19368"
      unitRef="shares">3530279</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c27" decimals="-3" id="ixv-19369" unitRef="usd">205000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c0" decimals="-3" id="ixv-19370" unitRef="usd">205000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c28" decimals="-3" id="ixv-19371" unitRef="usd">-49317000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-19372" unitRef="usd">-49317000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c29"
      decimals="INF"
      id="ixv-19373"
      unitRef="shares">85749331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c30" decimals="-3" id="ixv-19374" unitRef="usd">275453000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c31" decimals="-3" id="ixv-19375" unitRef="usd">-252957000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-19376" unitRef="usd">22496000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-19378" unitRef="usd">-49317000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-19379" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-19380" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-19381" unitRef="usd">585000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c7" decimals="-3" id="ixv-19382" unitRef="usd">557000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c8" decimals="-3" id="ixv-19383" unitRef="usd">481000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-19384" unitRef="usd">14542000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-19385" unitRef="usd">13012000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c8" decimals="-3" id="ixv-19386" unitRef="usd">8793000</us-gaap:ShareBasedCompensation>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c0" decimals="-3" id="ixv-19387" unitRef="usd">1186000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c7" decimals="-3" id="ixv-19388" unitRef="usd">629000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c8" decimals="-3" id="ixv-19389" unitRef="usd">354000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c0" decimals="-3" id="ixv-19390" unitRef="usd">-447000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c7" decimals="-3" id="ixv-19391" unitRef="usd">-756000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="c8" decimals="-3" id="ixv-19392" unitRef="usd">-8122000</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <arbe:RevaluationOfConvertibleLoan contextRef="c0" decimals="-3" id="ixv-19393" unitRef="usd">-81000</arbe:RevaluationOfConvertibleLoan>
    <arbe:IssuanceCostsRelatedToConvertibleBonds contextRef="c0" decimals="-3" id="ixv-19394" unitRef="usd">737000</arbe:IssuanceCostsRelatedToConvertibleBonds>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="-3" id="ixv-19395" unitRef="usd">-1105000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c7" decimals="-3" id="ixv-19396" unitRef="usd">-694000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c8" decimals="-3" id="ixv-19397" unitRef="usd">2015000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="-3" id="ixv-19398" unitRef="usd">474000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c7" decimals="-3" id="ixv-19399" unitRef="usd">187000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c8" decimals="-3" id="ixv-19400" unitRef="usd">-1219000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c0" decimals="-3" id="ixv-19401" unitRef="usd">224000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c7" decimals="-3" id="ixv-19402" unitRef="usd">86000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c8" decimals="-3" id="ixv-19403" unitRef="usd">-84000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c0" decimals="-3" id="ixv-19404" unitRef="usd">-553000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c7" decimals="-3" id="ixv-19405" unitRef="usd">-103000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="c8" decimals="-3" id="ixv-19406" unitRef="usd">-769000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="-3" id="ixv-19407" unitRef="usd">367000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c7" decimals="-3" id="ixv-19408" unitRef="usd">55000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c8" decimals="-3" id="ixv-19409" unitRef="usd">-234000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c7" decimals="-3" id="ixv-19410" unitRef="usd">-101000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c8" decimals="-3" id="ixv-19411" unitRef="usd">-375000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-19412" unitRef="usd">-376000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c7" decimals="-3" id="ixv-19413" unitRef="usd">-3899000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c8" decimals="-3" id="ixv-19414" unitRef="usd">884000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-19415" unitRef="usd">-32502000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c7" decimals="-3" id="ixv-19416" unitRef="usd">-33513000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c8" decimals="-3" id="ixv-19417" unitRef="usd">-40362000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <arbe:PaymentForChangeInBankDeposits contextRef="c0" decimals="-3" id="ixv-19418" unitRef="usd">-4609000</arbe:PaymentForChangeInBankDeposits>
    <arbe:PaymentForChangeInBankDeposits contextRef="c7" decimals="-3" id="ixv-19419" unitRef="usd">15002000</arbe:PaymentForChangeInBankDeposits>
    <arbe:PaymentForChangeInBankDeposits contextRef="c8" decimals="-3" id="ixv-19420" unitRef="usd">400000</arbe:PaymentForChangeInBankDeposits>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-19421" unitRef="usd">622000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c7" decimals="-3" id="ixv-19422" unitRef="usd">249000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c8" decimals="-3" id="ixv-19423" unitRef="usd">918000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-19424" unitRef="usd">3987000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c7" decimals="-3" id="ixv-19425" unitRef="usd">-15251000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c8" decimals="-3" id="ixv-19426" unitRef="usd">-1318000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="c8" decimals="-3" id="ixv-19427" unitRef="usd">5218000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="-3" id="ixv-19428" unitRef="usd">13787000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c7" decimals="-3" id="ixv-19429" unitRef="usd">22496000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c0" decimals="-3" id="ixv-19430" unitRef="usd">-459000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c0" decimals="-3" id="ixv-19431" unitRef="usd">205000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c7" decimals="-3" id="ixv-19432" unitRef="usd">703000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c8" decimals="-3" id="ixv-19433" unitRef="usd">277000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-19434" unitRef="usd">13533000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c7" decimals="-3" id="ixv-19435" unitRef="usd">23199000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c8" decimals="-3" id="ixv-19436" unitRef="usd">-4941000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c0" decimals="-3" id="ixv-19437" unitRef="usd">-258000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c7" decimals="-3" id="ixv-19438" unitRef="usd">-47000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c8" decimals="-3" id="ixv-19439" unitRef="usd">1189000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-19440" unitRef="usd">-15240000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c7" decimals="-3" id="ixv-19441" unitRef="usd">-25612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c8" decimals="-3" id="ixv-19442" unitRef="usd">-45432000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-3" id="ixv-19443" unitRef="usd">28750000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="-3" id="ixv-19444" unitRef="usd">54315000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c12" decimals="-3" id="ixv-19445" unitRef="usd">100936000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-19446" unitRef="usd">13768000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-3" id="ixv-19447" unitRef="usd">28750000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="-3" id="ixv-19448" unitRef="usd">54315000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow contextRef="c0" decimals="-3" id="ixv-19449" unitRef="usd">30695000</arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c0" decimals="-3" id="ixv-19450" unitRef="usd">660000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c7" decimals="-3" id="ixv-19451" unitRef="usd">1713000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c8" decimals="-3" id="ixv-19452" unitRef="usd">797000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c0" decimals="-3" id="ixv-19453" unitRef="usd">28000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c7" decimals="-3" id="ixv-19454" unitRef="usd">8000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c8" decimals="-3" id="ixv-19455" unitRef="usd">7000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="-3" id="ixv-19456" unitRef="usd">1928000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c8" decimals="-3" id="ixv-19457" unitRef="usd">250000</us-gaap:InterestPaidNet>
    <us-gaap:NatureOfOperations contextRef="c0" id="ixv-15288">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"&gt;NOTE
1:- GENERAL&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Arbe Robotics Ltd. (the &#x201c;Company&#x201d;) was founded and registered on November 4, 2015 and commenced
its activities in January 2016. The Company, a global leader in perception radar solutions, is spearheading a radar revolution, enabling
safe driver-assist systems today while paving the way to full autonomous-driving. The Company&#x2019;s radar technology is a critical sensor
for L2+ and higher autonomy. The Company is empowering automakers, Tier 1 suppliers, autonomous ground vehicles, commercial and industrial
vehicles, and a wide array of safety applications with advanced sensing and paradigm changing perception. The Company&#x2019;s ordinary
shares and Warrants are listed on the Nasdaq Capital Market under the symbols &#x201c;ARBE&#x201d; and &#x201c;ARBEW,&#x201d; respectively&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;
The convertible bond are listed on the Tel Aviv Stock Exchange (&#x201c;TASE&#x201d;).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October 26, 2017, the Company established a Delaware subsidiary, Arbe Robotics US Inc. Arbe Robotics
US Inc is engaged mainly in the Company&#x2019;s sales and will operate as the Company&#x2019;s distributor in the U.S.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;c.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February 5, 2024, the Company established a Chinese subsidiary, Shanghai Arbe Technologies Co., Ltd
(&#x201c;Arbe China&#x201d;). Arbe China was formed to assist mainly in providing customer support in the China region.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;d.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October 7, 2021, the Company consummated the merger (the &#x201c;Merger&#x201d;) pursuant to which the
Company&#x2019;s wholly-owned subsidiary, Autobot MergerSub, Inc. (&#x201c;Merger Sub&#x201d;) was merged with an into Industrial Tech Acquisitions
Inc. (&#x201c;ITAC&#x201d;) pursuant to which ITAC became a wholly-owned&#160;subsidiary of the Company, and the Company issued ordinary
shares and warrants to the holders of ITAC common stock and warrants, respectively. In connection with the Merger, the name of ITAC was
changed to Autobot HoldCo, Inc.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"&gt;In connection with
the Merger, and immediately prior to the closing of the Merger, the Company effected a recapitalization (the &#x201c;Recapitalization&#x201d;),
which was approved by the Company&#x2019;s directors and shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Pursuant to the
Merger, Arbe issued to ITAC securityholders (a) 3,866,842 ordinary shares to the holders of ITAC common stock and (b) 10,735,680 Arbe
warrants to the holders of ITAC warrants, of which 7,623,600 warrants are public warrants and 3,112,080 warrants are private warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Total gross proceeds
resulted from the Merger and the related PIPE financing were approximately $118,288, of which total transaction costs amounted to approximately
$16,707. The total gross proceeds include the $100,000 from the sale of 10,000,000 ordinary shares to the PIPE investors at $10.00 per
share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;On December 31,
2024, the Company completed the liquidation of ITAC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;d.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On May 30, 2024, the Company registered its ordinary shares on the Tel Aviv Stock Exchange (&#x201c;TASE&#x201d;),
and its ordinary shares are now traded on both Nasdaq and the Tel Aviv Stock Exchange. Pursuant to statutory exemption available for dual
listed companies under the Israeli securities and companies&#x2019; laws, the Company&#x2019;s reporting requirements are in substance in accordance
with the provisions applicable by Nasdaq on foreign private issuers.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;e.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On June 2, 2024, the Company completed an offering of convertible bonds in the principal amount of NIS
110,000,000 (approximately $&lt;span style="-sec-ix-hidden: hidden-fact-49"&gt;30&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;,&lt;/span&gt;000). The bonds were issued solely to Israeli
investors and were not offered in the United States or to U.S. persons. The bonds bear interest on the principal amount at the rate of
6.5% per annum, mature on May 30, 2028, and are convertible into the Company&#x2019;s ordinary shares at a conversion price of NIS 9.53
(approximately $2.60) per share. The bonds are listed for trading on the TASE. Refer to Note 9.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;f.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On November 4, 2024, the Company completed a public offering of its securities. The gross proceeds from
this offering were approximately $15 million, before deducting the underwriters&#x2019; discounts and commissions and other offering expenses
payable by the Company of approximately $1.2 million. The securities were sold as a unit for $1.82 per unit, with each unit consisting
of one ordinary share (or one pre-funded warrant in lieu of one ordinary share), one Tranche A Warrant and one Tranche B Warrant. In the
offering, the Company issued an aggregate of 8,250,000 ordinary shares (or pre-funded warrants in lieu thereof) and by Tranche A Warrants
to purchase up to 8,250,000 ordinary shares at $2.35 per share and Tranche B Warrants to purchase up to 8,250,000 ordinary shares $1.82
per share. The Tranche A Warrants are immediately exercisable upon issuance and expire on November 4, 2029. The Tranche B Warrants are
immediately exercisable upon issuance and will expire on the earlier of (i) the 20&lt;sup&gt;th&lt;/sup&gt; trading day after the Company has given
notice of a Triggering Event, as defined in the Tranche B Warrant or (ii) November 4, 2027. Refer to Note 10c.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;g.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company depends on one supplier for the development and productization of its products. If this supplier
fails to deliver or delays the delivery of the necessary products, the Company will be required to seek alternative sources of supply.
A change in supplier could result in manufacturing delays and increased costs, which could result in a possible loss of sales which would
adversely affect the Company&#x2019;s business, prospects, results of operations and financial position.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;h.&lt;/td&gt;&lt;td style="text-align: justify"&gt;As the Company operates internationally and substantially its revenue is derived from sales outside of
Israel, the business is affected by inflation, supply chain issues and economic conditions in countries in which the Company is seeking
to conduct business, security and cybersecurity issues, fiscal and monetary policies, tariffs, interest rates and regulations affection
the automotive industry, the timing by the automotive and other industries on the introduction of unmanned automobiles and other unmanned
devices, safety concerns and well as the effect of regional conflicts and steps taken by governments with respect to parties to such conflicts.&#160;As
an Israeli company, the Company is also subject to the effect on Israel and the Israeli economy of the present war with Hamas as well
as any other regional conflicts, including Hezbollah, Syria and Iran, which may develop and the relationship between Israel and other
countries, including the United States, China and the European Union.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;i.&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company has incurred losses from operations since its inception and has negative cash flow from operating
activities. During January 2025, the company raised gross proceeds of $55.5 million in an underwritten offering and from the conversation
of our convertible bonds and the release of funds from escrow upon such conversion. Refer to Note 14.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NatureOfOperations>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c33"
      decimals="0"
      id="ixv-19458"
      unitRef="shares">3866842</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c34"
      decimals="0"
      id="ixv-19459"
      unitRef="shares">10735680</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c35"
      decimals="0"
      id="ixv-19460"
      unitRef="shares">7623600</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c36"
      decimals="0"
      id="ixv-19461"
      unitRef="shares">3112080</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c37" decimals="-3" id="ixv-19462" unitRef="usd">118288000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <arbe:TransactionCosts contextRef="c37" decimals="-3" id="ixv-19463" unitRef="usd">16707000</arbe:TransactionCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c38" decimals="-3" id="ixv-19464" unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c37"
      decimals="0"
      id="ixv-19465"
      unitRef="shares">10000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c39"
      decimals="2"
      id="ixv-19466"
      unitRef="usdPershares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:GeneralPartnersOfferingCosts contextRef="c40" decimals="0" id="ixv-19467" unitRef="ils">110000000</us-gaap:GeneralPartnersOfferingCosts>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="c41" decimals="3" id="ixv-19468" unitRef="pure">0.065</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c42"
      decimals="2"
      id="ixv-19469"
      unitRef="ilsPershares">9.53</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c42"
      decimals="2"
      id="ixv-19470"
      unitRef="usdPershares">2.6</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c43" decimals="-6" id="ixv-19471" unitRef="usd">15000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:OtherExpenses contextRef="c43" decimals="-5" id="ixv-19472" unitRef="usd">1200000</us-gaap:OtherExpenses>
    <arbe:SecuritiesSoldPerUnits
      contextRef="c44"
      decimals="2"
      id="ixv-19473"
      unitRef="usdPershares">1.82</arbe:SecuritiesSoldPerUnits>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c45"
      decimals="0"
      id="ixv-19474"
      unitRef="shares">1</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c46"
      decimals="0"
      id="ixv-19475"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightOutstanding>
    <arbe:PreFundedWarrantInLieuOfOrdinaryShare
      contextRef="c47"
      decimals="0"
      id="ixv-19476"
      unitRef="shares">1</arbe:PreFundedWarrantInLieuOfOrdinaryShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c45"
      decimals="0"
      id="ixv-19477"
      unitRef="shares">8250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c48"
      decimals="0"
      id="ixv-19478"
      unitRef="shares">8250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c49"
      decimals="2"
      id="ixv-19479"
      unitRef="usdPershares">2.35</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c50"
      decimals="0"
      id="ixv-19480"
      unitRef="shares">8250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c51"
      decimals="2"
      id="ixv-19481"
      unitRef="usdPershares">1.82</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c52" decimals="-5" id="ixv-19482" unitRef="usd">55500000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-15429">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"&gt;NOTE
2:- SIGNIFICANT ACCOUNTING POLICIES&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Basis of presentation:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The consolidated financial statements
have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant
accounting policies followed in the preparation of the financial statements applied on a consistent basis for all years presented in these
financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The consolidated
financial statements include the accounts of the Company&#x2019;s wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Use of estimates:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The preparation
of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions
including fair value of warrants, stock-based compensation and the underlying fair value of the Company&#x2019;s ordinary shares issued
prior to the Merger.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company bases
these estimates on historical and anticipated results, trends and other assumptions that it believes are reasonable under the circumstances,
including assumptions as to future events. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;c.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Consolidated financial statements in U.S. dollars:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;A substantial portion
the Company&#x2019;s activity including transactions with customers, as well as equity transactions and cash investments, are incurred
in U.S. dollars. The Company&#x2019;s management believes that the U.S. dollar is the currency of the primary economic environment in which
the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The subsidiaries
functional currency is the currency of the primary economic environment in which the subsidiaries operate; normally, that is the currency
of the environment in which the subsidiaries primarily generate and expend cash. In making the determination of the appropriate functional
currency for the subsidiaries, the Company considers cash flow indicators, local market indicators, financing indicators and the subsidiaries&#x2019;
relationship with both the parent company and other subsidiaries. The Company has determined the functional currency of its subsidiaries
to be the U.S. dollar.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Monetary accounts
maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting Standard
Codification (&#x201c;ASC&#x201d;) No. 830 &#x201c;Foreign Currency Matters&#x201d; (&#x201c;ASC No. 830&#x201d;). All transaction gains and
losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or expenses as
appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Transactions in foreign currency are
translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, &lt;i&gt;Foreign Currency Transaction&lt;/i&gt;. Monetary
assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing
rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the
exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities denominated in currencies
other than the respective functional currencies are included in the consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;d.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Concentration of credit risk:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Most of the Company&#x2019;s
cash and cash equivalents, restricted cash, short-term deposits and funds held in escrow were deposited with Israeli banks and were comprised
mainly of cash deposits and short-term deposits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;The
Company&#x2019;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#x2019; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;e.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Cash and cash equivalents and restricted cash:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company considers all highly liquid
short-term deposits with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist
primarily of amounts invested in short-term deposits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Restricted cash consists of deposits
at a financial institution that serves as collateral for a credit card agreement and lease agreements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;f.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Short term deposits:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Short-term deposits are bank deposits
with an original maturity of more than three months and less than one year from the date of acquisition. The deposits are presented according
to their terms of deposit. As of December 31, 2024 and 2023, these bank deposit bearing annual interest rates in the range of&#160;4%-6%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;g.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fair value of financial instruments:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The estimated fair value of financial
instruments has been determined by the Company using available market information and valuation methodologies. Considerable judgment is
required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company could realize in a current
market exchange. The following methods and assumptions were used by the Company in estimating the fair value of their financial instruments:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The carrying values of cash and cash
equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables, employees and payroll accruals,
accrued expenses and other current liabilities approximate their fair values due to the short-term maturities of these instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company applies ASC No. 820, &#x201c;Fair
Value Measurements and Disclosures&#x201d; (&#x201c;ASC No. 820&#x201d;), with respect to fair value measurements of all financial assets
and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term deposits and warrant liability at fair value.
Short-term deposits are classified within Level&#160;1 because these assets are valued using quoted market prices. Fair value represents
the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in
pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for
inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1&#x2014;Observable inputs that reflect quoted prices (unadjusted)
for identical assets or liabilities in active markets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2&#x2014;Include other inputs that are directly or indirectly
observable in the marketplace.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3&#x2014;Unobservable inputs which are supported by little
or no market activity.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The fair value hierarchy also requires
an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;In
connection with the October 7, 2021 merger with Industrial Tech Acquisition Corp. (&#x201c;ITAC&#x201d;), the Company (i) assumed a derivative
warrant liability related to Company&#x2019;s warrants that were issued to the holders of private placement warrants that had been issued by
ITAC in connection with its initial public offering, and (ii) issued equity instrument in connection with warrants that had been issued
as part of ITAC&#x2019;s initial public offering and, pursuant to the Merger, became warrants to purchase the Company&#x2019;s ordinary
shares. The fair value of the Company&#x2019;s public warrants is measured based on the market price of such warrants and are considered
a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private
placement warrants which are considered a Level 3 fair value measurement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;The
Company&#x2019;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
Refer to Note 8.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;For
convertible bonds measurement under fair value, see 2u below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;h.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Trade receivables, net&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#x2019;s best estimate of the amount of credit losses with respect to its existing trade receivable.
The Company&#x2019;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#x201c;CECL&#x201d;) standard.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; "&gt;The Company
estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#x2019;s customers to
make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected
credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions
and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#x2019;s ongoing evaluation of collectability,
customer creditworthiness, historical levels of credit losses, and future expectations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0.6pt; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;The
allowance for credit losses for the year ended December 31, 2024, recorded for the first time, was $896 and &lt;span style="-sec-ix-hidden: hidden-fact-51"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-52"&gt;not&lt;/span&gt;&lt;/span&gt; material for the years
ended December 31, 2023 and 2022.&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;i.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Property and equipment:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Property and equipment
are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost
of assets disposed and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
statement of operation. Repair and maintenance costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;15-33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;7-15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-50"&gt;(*)&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;j.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impairment of long-lived assets:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Long-lived assets
are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d; a (&#x201c;ASC 360&#x201d;), whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when the carrying
value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to be recognized
is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December 31, 2024,
2023 and 2022, no impairment losses were identified.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;k.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Accrued post-employment benefit:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The employees of
Arbe Ltd. are included under section 14 of the Israeli Severance Compensation Act, 1963 (&#x201c;Section 14&#x201d;). Pursuant to Section
14, the Company&#x2019;s Israeli employees are entitled to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited
on their behalf to their chosen insurance funds. By making the payments in accordance with Section 14, the Company is released from any
future severance payments in respect of those employees. The obligation to make the monthly deposits is expensed as incurred. The deposits
pursuant to Section 14 are not recorded as an asset in the consolidated balance sheet, and there is no liability recorded as the Company
does not have a future obligation to make any additional payments. Severance costs amounted to approximately $1,227, $1,166 and $1,240
for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company&#x2019;s U.S. subsidiary
has a 401(k) defined contribution plan covering one employee in the United States. The expense recorded by the U.S. subsidiary for matching
contributions for the years ended December 31, 2024, 2023 and 2022 were immaterial.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;l.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Stock-based compensation:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company accounts
for stock-based compensation in accordance with ASC 718, &#x201c;Compensation - Stock Compensation&#x201d;, which requires the measurement
and recognition of compensation expense based on estimated fair values for all stock-based payment awards made to employees, nonemployees
and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing
model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the Company&#x2019;s statements
of operations over the applicable service periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company measures its stock-based
payment awards made to employees, directors, and non-employee service providers based on estimated fair values. The fair value of each
option award is estimated on the grant date using the Black-Scholes option pricing model which requires several assumptions, of which
the most significant are the expected share price volatility and the expected option term. The Company recognizes forfeitures of equity-based
awards as they occur. For graded vesting awards, the Company recognizes compensation expenses based on the straight-line method over the
applicable service period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;m.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Net loss per ordinary share:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company computes net loss per
share using the two-class method required for participating securities. There were no participating securities in the years ended December
31, 2024, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company&#x2019;s basic net loss
per ordinary share is calculated by dividing net loss by the weighted-average number of ordinary shares outstanding for the period, without
consideration of potentially dilutive securities. The diluted net loss per ordinary share is calculated by giving effect to all potentially
dilutive securities outstanding for the period using the treasury share method or the if-converted method based on the nature of such
securities. Diluted net loss per ordinary share is the same as basic net loss per share in periods when the effects of potentially dilutive
shares of ordinary shares are anti-dilutive. Refer to Note 11.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;n.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other comprehensive loss:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company has no components of comprehensive
loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods presented.&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;p.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Revenue recognition:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company follows the provisions
of ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;), which apply to all contracts with customers. Under Topic
606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition
for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identify the contract(s) with a customer;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identify the performance obligations in the contract;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Determine the transaction price;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Allocate the transaction price to the performance obligations
in the contract; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognize revenue when (or as) the entity satisfies a performance
obligation.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;At contract inception, once the contract
is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines
the performance obligations and assesses whether each promised good or service is distinct&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;
The Company evaluates each performance obligation to determine if it is satisfied at a point in time or over time. Refer to Note 3.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;i&gt;Nature of Products and Services&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company derives its revenues mainly
from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional services. Revenue from chipsets
and prototype radar systems is recognized at the point in time when the control of the goods is transferred to the customer, generally
upon delivery, and the Company has no remaining performance obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;i&gt;Right of Return&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company&#x2019;s general terms
and conditions for its contracts do not contain a right of return that allows the customer to return products and receive a credit. Therefore,
the Company does not estimate returns and generally recognizes revenue at contract price upon product delivery.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;q.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Cost of revenues:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Cost of revenue includes the manufacturing
cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;r.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Research and development expenses, net:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Research and development costs, net
of grants received, are charged to the consolidated statement of operations as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;s.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Income taxes:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company accounts for income taxes
in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. This standard prescribes the use of the asset and liability method whereby deferred
tax asset and liability account balances are determined based on differences between the financial statement carrying amount and the tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are
expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is more
likely than not to be realized&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt; The Company recognizes the tax benefit
from a tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. A tax position that meets the more-likely-than-not recognition threshold is measured at
the largest amount that is greater than 50 percent likely of being realized upon settlement with the taxing authority using the facts,
circumstances, and information available at the reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;t.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Contingent liabilities&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company accounts
for its contingent liabilities in accordance with ASC No.&#160;450, &#x201c;Contingencies.&#x201d; A provision is recorded when it is both
probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions
are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
information and events pertaining to a particular matter. As of December&#160;31, 2024 and 2023, the Company is not a party to any litigation
that could have a material adverse effect on the Company&#x2019;s business, financial position, results of operations or cash flows.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;u.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Convertible bonds:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company recognized
its convertible bonds as a liability and the cash held in escrow as other assets funds held in escrow, in the balance sheet. As the convertible
debt contained embedded features not closely related to the host contract, the Company elected to apply the fair value option to it. The
fair value of the convertible bonds is measured under FV level 1 and is based on the quoted price of the bonds on the TASE. The Company
elected to measure the bonds initially and subsequently at fair value. Thus, the convertible bonds&#x2019; issuance costs expensed as incurred
to statement of operations. The fair value of the convertible debt is based on its quoted price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company recorded
financial income amounting to $81 for the year ended on December 31, 2024. Refer to Note 9.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;v.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Leases:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company accounts
for leases under Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company elected
the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize a lease liability
and a right-of-use (&#x201c;ROU&#x201d;) asset on the balance sheet for leases with a term of twelve months or less. The Company recognizes
the associated lease payments on such leases in the consolidated statements of income on a straight-line basis over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Under Topic 842,
the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement date based
on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable payments
at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental borrowing
rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing
rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset is recorded
net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain
that the Company will exercise such options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Payments under the
Company&#x2019;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common area maintenance,
real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. Refer to Note 6.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;w.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impact of recently issued accounting standard:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;In November 2023,
the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their
reportable segments&#x2019; significant expenses and other segment items on an annual basis. Public entities with a single reportable segment
are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements
in ASC 280 on an annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted.
The Company adopted ASU 2023-07 during the year ended December 31, 2024. Refer to Note 13.&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;x.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recently not yet adopted accounting pronouncements&lt;span style="font-family: Times New Roman, Times, Serif"&gt;:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic
220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense
categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning
after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is in the
process of assessing the impacts and method with no early adoption of the standard&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.15pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;ASU 2023-09, Improvements
to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components
of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The ASU will be effective for fiscal years
beginning after December 15, 2025, and allows adoption on a prospective basis, with a retrospective option. The Company is in the process
of assessing the impacts and method with no early adoption of the standard&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-15432">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Basis of presentation:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The consolidated financial statements
have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant
accounting policies followed in the preparation of the financial statements applied on a consistent basis for all years presented in these
financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The consolidated
financial statements include the accounts of the Company&#x2019;s wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-15445">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Use of estimates:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The preparation
of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements
and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates and assumptions
including fair value of warrants, stock-based compensation and the underlying fair value of the Company&#x2019;s ordinary shares issued
prior to the Merger.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company bases
these estimates on historical and anticipated results, trends and other assumptions that it believes are reasonable under the circumstances,
including assumptions as to future events. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0" id="ixv-15458">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;c.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Consolidated financial statements in U.S. dollars:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;A substantial portion
the Company&#x2019;s activity including transactions with customers, as well as equity transactions and cash investments, are incurred
in U.S. dollars. The Company&#x2019;s management believes that the U.S. dollar is the currency of the primary economic environment in which
the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The subsidiaries
functional currency is the currency of the primary economic environment in which the subsidiaries operate; normally, that is the currency
of the environment in which the subsidiaries primarily generate and expend cash. In making the determination of the appropriate functional
currency for the subsidiaries, the Company considers cash flow indicators, local market indicators, financing indicators and the subsidiaries&#x2019;
relationship with both the parent company and other subsidiaries. The Company has determined the functional currency of its subsidiaries
to be the U.S. dollar.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Monetary accounts
maintained in currencies other than the U.S. dollar are remeasured into U.S. dollars in accordance with Statement of the Accounting Standard
Codification (&#x201c;ASC&#x201d;) No. 830 &#x201c;Foreign Currency Matters&#x201d; (&#x201c;ASC No. 830&#x201d;). All transaction gains and
losses of the remeasured monetary balance sheet items are reflected in the statements of operations as financial income or expenses as
appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Transactions in foreign currency are
translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, &lt;i&gt;Foreign Currency Transaction&lt;/i&gt;. Monetary
assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing
rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the
exchange rate at the date of the transaction. Gains and losses from remeasurement of assets and liabilities denominated in currencies
other than the respective functional currencies are included in the consolidated statements of operations.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-15515">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;d.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Concentration of credit risk:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Most of the Company&#x2019;s
cash and cash equivalents, restricted cash, short-term deposits and funds held in escrow were deposited with Israeli banks and were comprised
mainly of cash deposits and short-term deposits.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;The
Company&#x2019;s trade receivables are derived from customers located globally. The Company mitigates its credit risks by performing credit
evaluations of its customers&#x2019; financial conditions and requires customer advance payments in certain circumstances. The Company
generally does not require collateral.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c0" id="ixv-15528">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;e.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Cash and cash equivalents and restricted cash:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company considers all highly liquid
short-term deposits with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist
primarily of amounts invested in short-term deposits.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Restricted cash consists of deposits
at a financial institution that serves as collateral for a credit card agreement and lease agreements.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <arbe:ShortTermDepositsPolicyPolicyTextBlock contextRef="c0" id="ixv-15541">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;f.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Short term deposits:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Short-term deposits are bank deposits
with an original maturity of more than three months and less than one year from the date of acquisition. The deposits are presented according
to their terms of deposit. As of December 31, 2024 and 2023, these bank deposit bearing annual interest rates in the range of&#160;4%-6%.&lt;/p&gt;</arbe:ShortTermDepositsPolicyPolicyTextBlock>
    <srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid contextRef="c53" decimals="2" id="ixv-19483" unitRef="pure">0.04</srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid>
    <srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid contextRef="c54" decimals="2" id="ixv-19484" unitRef="pure">0.06</srt:DemandDepositLiabilitiesInterestBearingAverageRatePaid>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0" id="ixv-15551">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;g.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fair value of financial instruments:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The estimated fair value of financial
instruments has been determined by the Company using available market information and valuation methodologies. Considerable judgment is
required in estimating fair values. Accordingly, the estimates may not be indicative of the amounts the Company could realize in a current
market exchange. The following methods and assumptions were used by the Company in estimating the fair value of their financial instruments:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The carrying values of cash and cash
equivalents, short-term deposits, restricted cash, trade receivables, other current assets, trade payables, employees and payroll accruals,
accrued expenses and other current liabilities approximate their fair values due to the short-term maturities of these instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company applies ASC No. 820, &#x201c;Fair
Value Measurements and Disclosures&#x201d; (&#x201c;ASC No. 820&#x201d;), with respect to fair value measurements of all financial assets
and liabilities. In accordance with ASC No.&#160;820, the Company measures its short-term deposits and warrant liability at fair value.
Short-term deposits are classified within Level&#160;1 because these assets are valued using quoted market prices. Fair value represents
the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in
pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for
inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1&#x2014;Observable inputs that reflect quoted prices (unadjusted)
for identical assets or liabilities in active markets.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2&#x2014;Include other inputs that are directly or indirectly
observable in the marketplace.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3&#x2014;Unobservable inputs which are supported by little
or no market activity.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The fair value hierarchy also requires
an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;In
connection with the October 7, 2021 merger with Industrial Tech Acquisition Corp. (&#x201c;ITAC&#x201d;), the Company (i) assumed a derivative
warrant liability related to Company&#x2019;s warrants that were issued to the holders of private placement warrants that had been issued by
ITAC in connection with its initial public offering, and (ii) issued equity instrument in connection with warrants that had been issued
as part of ITAC&#x2019;s initial public offering and, pursuant to the Merger, became warrants to purchase the Company&#x2019;s ordinary
shares. The fair value of the Company&#x2019;s public warrants is measured based on the market price of such warrants and are considered
a Level 1 fair value measurement. The Company utilizes a Black-Scholes option pricing model to estimate the fair value of the private
placement warrants which are considered a Level 3 fair value measurement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;The
Company&#x2019;s private warrants are measured at each reporting period, with changes in fair value recognized in the statement of operations.
Refer to Note 8.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;For
convertible bonds measurement under fair value, see 2u below.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock contextRef="c0" id="ixv-15639">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;h.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Trade receivables, net&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;Trade
receivables are recorded at the invoiced amount and do not bear interest. Trade receivables are periodically assessed for allowance for
doubtful accounts, which is the Company&#x2019;s best estimate of the amount of credit losses with respect to its existing trade receivable.
The Company&#x2019;s accounts receivables accounting policy from January 1, 2023, following the adoption of the new current expected credit
losses (&#x201c;CECL&#x201d;) standard.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; "&gt;The Company
estimates CECL on trade receivables at inception for estimated losses resulting from the inability of the Company&#x2019;s customers to
make required payments, based on estimated current expected credit losses. The allowance represents the current estimate of lifetime expected
credit losses over the remaining duration of existing accounts receivable considering historical information, current market conditions
and reasonable and supportable forecasts when appropriate. The estimate is a result of the Company&#x2019;s ongoing evaluation of collectability,
customer creditworthiness, historical levels of credit losses, and future expectations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.6pt; "&gt;The
allowance for credit losses for the year ended December 31, 2024, recorded for the first time, was $896 and &lt;span style="-sec-ix-hidden: hidden-fact-51"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-52"&gt;not&lt;/span&gt;&lt;/span&gt; material for the years
ended December 31, 2023 and 2022.&lt;/p&gt;</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses contextRef="c5" decimals="-3" id="ixv-19485" unitRef="usd">896000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0" id="ixv-15693">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;i.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Property and equipment:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Property and equipment
are recorded at cost and depreciated over their estimated useful lives using the straight-line method. Upon retirement or sale, the cost
of assets disposed and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is included in
statement of operation. Repair and maintenance costs are expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;15-33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;7-15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-50"&gt;(*)&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock contextRef="c0" id="ixv-15703">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Depreciation is calculated using the
straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;15-33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;7-15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-50"&gt;(*)&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</arbe:PropertyPlantAndEquipmentUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c55" decimals="2" id="ixv-19486" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c56" decimals="2" id="ixv-19487" unitRef="pure">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c57" decimals="2" id="ixv-19488" unitRef="pure">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c58" decimals="2" id="ixv-19489" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c59" decimals="2" id="ixv-19490" unitRef="pure">0.15</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0" id="ixv-15746">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;j.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impairment of long-lived assets:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Long-lived assets
are reviewed for impairment in accordance with ASC 360, &#x201c;Property, Plant and Equipment&#x201d; a (&#x201c;ASC 360&#x201d;), whenever
events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment exists when the carrying
value of the asset exceeds the aggregate undiscounted cash flows expected to be generated by the asset. The impairment to be recognized
is measured by the amount by which the carrying amount of the assets exceeds their fair value. During the years ended December 31, 2024,
2023 and 2022, no impairment losses were identified.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PostemploymentBenefitPlansPolicy contextRef="c0" id="ixv-15756">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;k.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Accrued post-employment benefit:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The employees of
Arbe Ltd. are included under section 14 of the Israeli Severance Compensation Act, 1963 (&#x201c;Section 14&#x201d;). Pursuant to Section
14, the Company&#x2019;s Israeli employees are entitled to monthly deposits, at a rate of&#160;8.33% of their monthly salary, deposited
on their behalf to their chosen insurance funds. By making the payments in accordance with Section 14, the Company is released from any
future severance payments in respect of those employees. The obligation to make the monthly deposits is expensed as incurred. The deposits
pursuant to Section 14 are not recorded as an asset in the consolidated balance sheet, and there is no liability recorded as the Company
does not have a future obligation to make any additional payments. Severance costs amounted to approximately $1,227, $1,166 and $1,240
for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company&#x2019;s U.S. subsidiary
has a 401(k) defined contribution plan covering one employee in the United States. The expense recorded by the U.S. subsidiary for matching
contributions for the years ended December 31, 2024, 2023 and 2022 were immaterial.&lt;/p&gt;</us-gaap:PostemploymentBenefitPlansPolicy>
    <arbe:SeverancePercentageOfMonthlySalary contextRef="c0" decimals="4" id="ixv-19492" unitRef="pure">0.0833</arbe:SeverancePercentageOfMonthlySalary>
    <us-gaap:SeveranceCosts1 contextRef="c0" decimals="-3" id="ixv-19493" unitRef="usd">1227000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c7" decimals="-3" id="ixv-19494" unitRef="usd">1166000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c8" decimals="-3" id="ixv-19495" unitRef="usd">1240000</us-gaap:SeveranceCosts1>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0" id="ixv-15805">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;l.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Stock-based compensation:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company accounts
for stock-based compensation in accordance with ASC 718, &#x201c;Compensation - Stock Compensation&#x201d;, which requires the measurement
and recognition of compensation expense based on estimated fair values for all stock-based payment awards made to employees, nonemployees
and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing
model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the Company&#x2019;s statements
of operations over the applicable service periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company measures its stock-based
payment awards made to employees, directors, and non-employee service providers based on estimated fair values. The fair value of each
option award is estimated on the grant date using the Black-Scholes option pricing model which requires several assumptions, of which
the most significant are the expected share price volatility and the expected option term. The Company recognizes forfeitures of equity-based
awards as they occur. For graded vesting awards, the Company recognizes compensation expenses based on the straight-line method over the
applicable service period.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-15818">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;m.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Net loss per ordinary share:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company computes net loss per
share using the two-class method required for participating securities. There were no participating securities in the years ended December
31, 2024, 2023 and 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company&#x2019;s basic net loss
per ordinary share is calculated by dividing net loss by the weighted-average number of ordinary shares outstanding for the period, without
consideration of potentially dilutive securities. The diluted net loss per ordinary share is calculated by giving effect to all potentially
dilutive securities outstanding for the period using the treasury share method or the if-converted method based on the nature of such
securities. Diluted net loss per ordinary share is the same as basic net loss per share in periods when the effects of potentially dilutive
shares of ordinary shares are anti-dilutive. Refer to Note 11.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c0" id="ixv-15831">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;n.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other comprehensive loss:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company has no components of comprehensive
loss other than net loss. Thus, comprehensive loss is the same as net loss for the periods presented.&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0" id="ixv-15877">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;p.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Revenue recognition:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company follows the provisions
of ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;), which apply to all contracts with customers. Under Topic
606, revenues are recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects
the consideration that the Company expects to receive in exchange for those goods or services. To determine the appropriate revenue recognition
for arrangements that an entity determines are within the scope of Topic 606, the entity performs the following five steps:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identify the contract(s) with a customer;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identify the performance obligations in the contract;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Determine the transaction price;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Allocate the transaction price to the performance obligations
in the contract; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recognize revenue when (or as) the entity satisfies a performance
obligation.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;At contract inception, once the contract
is determined to be within the scope of Topic 606, the Company assesses the goods or services promised within the contract and determines
the performance obligations and assesses whether each promised good or service is distinct&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;
The Company evaluates each performance obligation to determine if it is satisfied at a point in time or over time. Refer to Note 3.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;i&gt;Nature of Products and Services&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company derives its revenues mainly
from sales of chipsets and prototype radar systems to be installed onto automotive vehicles and professional services. Revenue from chipsets
and prototype radar systems is recognized at the point in time when the control of the goods is transferred to the customer, generally
upon delivery, and the Company has no remaining performance obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&lt;i&gt;Right of Return&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company&#x2019;s general terms
and conditions for its contracts do not contain a right of return that allows the customer to return products and receive a credit. Therefore,
the Company does not estimate returns and generally recognizes revenue at contract price upon product delivery.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c0" id="ixv-15982">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;q.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Cost of revenues:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Cost of revenue includes the manufacturing
cost of radar sensors and chipsets, which primarily consists of components cost, assembly costs and personnel-related costs directly associated
with our customer support personnel.&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0" id="ixv-15992">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;r.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Research and development expenses, net:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;Research and development costs, net
of grants received, are charged to the consolidated statement of operations as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-16002">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;s.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Income taxes:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;The Company accounts for income taxes
in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. This standard prescribes the use of the asset and liability method whereby deferred
tax asset and liability account balances are determined based on differences between the financial statement carrying amount and the tax
bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are
expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is more
likely than not to be realized&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt; The Company recognizes the tax benefit
from a tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. A tax position that meets the more-likely-than-not recognition threshold is measured at
the largest amount that is greater than 50 percent likely of being realized upon settlement with the taxing authority using the facts,
circumstances, and information available at the reporting date.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="2" id="ixv-19496" unitRef="pure">0.50</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ContingentLiabilityReserveEstimatePolicy contextRef="c0" id="ixv-16013">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;t.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Contingent liabilities&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company accounts
for its contingent liabilities in accordance with ASC No.&#160;450, &#x201c;Contingencies.&#x201d; A provision is recorded when it is both
probable that a liability has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, provisions
are reviewed and adjusted to reflect the impact of negotiations, estimated settlements, legal rulings, advice of legal counsel and other
information and events pertaining to a particular matter. As of December&#160;31, 2024 and 2023, the Company is not a party to any litigation
that could have a material adverse effect on the Company&#x2019;s business, financial position, results of operations or cash flows.&lt;/p&gt;</us-gaap:ContingentLiabilityReserveEstimatePolicy>
    <arbe:ConvertibleBondsPolicyTextBlock contextRef="c0" id="ixv-16057">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;u.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Convertible bonds:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company recognized
its convertible bonds as a liability and the cash held in escrow as other assets funds held in escrow, in the balance sheet. As the convertible
debt contained embedded features not closely related to the host contract, the Company elected to apply the fair value option to it. The
fair value of the convertible bonds is measured under FV level 1 and is based on the quoted price of the bonds on the TASE. The Company
elected to measure the bonds initially and subsequently at fair value. Thus, the convertible bonds&#x2019; issuance costs expensed as incurred
to statement of operations. The fair value of the convertible debt is based on its quoted price.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company recorded
financial income amounting to $81 for the year ended on December 31, 2024. Refer to Note 9.&lt;/p&gt;</arbe:ConvertibleBondsPolicyTextBlock>
    <us-gaap:OtherIncome contextRef="c0" decimals="-3" id="ixv-19497" unitRef="usd">81000</us-gaap:OtherIncome>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0" id="ixv-16070">&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;v.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Leases:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company accounts
for leases under Accounting Standards Update No. 2016-02, Leases (Topic 842) (ASU 2016-02).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company elected
the package of practical expedients permitted under the transition guidance. The Company also elected not to recognize a lease liability
and a right-of-use (&#x201c;ROU&#x201d;) asset on the balance sheet for leases with a term of twelve months or less. The Company recognizes
the associated lease payments on such leases in the consolidated statements of income on a straight-line basis over the lease term.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Under Topic 842,
the Company determines if an arrangement is a lease at inception. ROU assets and liabilities are recognized at the commencement date based
on the present value of remaining lease payments over the lease term. For this purpose, the Company considers fixed and determinable payments
at the time of commencement. As most of the Company leases do not provide an implicit rate, the Company uses its incremental borrowing
rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing
rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments. The ROU asset is recorded
net of any lease incentives received. The lease terms may include options to extend or terminate the lease when it is reasonably certain
that the Company will exercise such options.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Payments under the
Company&#x2019;s lease agreements are primarily fixed, however, certain lease agreements contain variable costs such as common area maintenance,
real estate taxes, and insurance are not included in the lease liability and are recognized as they are incurred. Refer to Note 6.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-16089">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;w.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impact of recently issued accounting standard:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;In November 2023,
the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their
reportable segments&#x2019; significant expenses and other segment items on an annual basis. Public entities with a single reportable segment
are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements
in ASC 280 on an annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, with early adoption permitted.
The Company adopted ASU 2023-07 during the year ended December 31, 2024. Refer to Note 13.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="c0" id="ixv-16135">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;x.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recently not yet adopted accounting pronouncements&lt;span style="font-family: Times New Roman, Times, Serif"&gt;:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic
220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense
categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning
after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is in the
process of assessing the impacts and method with no early adoption of the standard&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;ASU 2023-09, Improvements
to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components
of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The ASU will be effective for fiscal years
beginning after December 15, 2025, and allows adoption on a prospective basis, with a retrospective option. The Company is in the process
of assessing the impacts and method with no early adoption of the standard&lt;span style="font-family: Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-16153">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"&gt;&lt;b&gt;NOTE 3:-
REVENUE&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Disaggregation
of Revenues&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Revenue disaggregated
by geography for the years ended December 31, 2024, 2023 and 2022, based on the billing address of the Company&#x2019;s customers, consists
of the following&lt;span style="font-family: Times New Roman, Times, Serif"&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of&lt;br/&gt;
 Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of&lt;br/&gt;
 Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of&lt;br/&gt;
 Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Revenue by geography:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;China (excluding Hong Kong)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;254&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;43.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,476&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;42.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Hong Kong&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-53"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-54"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-55"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-56"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sweden&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;284&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Israel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Italy&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-57"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-58"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-59"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-60"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Switzerland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-61"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-63"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-64"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2.6&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-68"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;768&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,470&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,517&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Remaining Performance
Obligation&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company&#x2019;s
remaining performance obligations are comprised of product and services revenue not yet performed. As of December&#160;31, 2024 and 2023
the aggregate amount of the transaction price allocated to remaining performance obligations was $290 and $977, respectively. The Company
expects to recognize 2024 remaining performance obligations as revenue during 2025.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c0" id="ixv-16160">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Revenue disaggregated
by geography for the years ended December 31, 2024, 2023 and 2022, based on the billing address of the Company&#x2019;s customers, consists
of the following&lt;span style="font-family: Times New Roman, Times, Serif"&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of&lt;br/&gt;
 Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of&lt;br/&gt;
 Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% of&lt;br/&gt;
 Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Revenue by geography:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left"&gt;China (excluding Hong Kong)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;254&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;639&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;43.5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,476&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;42.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Hong Kong&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-53"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-54"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;266&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-55"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-56"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sweden&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;284&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Israel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.7&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Italy&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-57"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-58"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-59"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-60"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Switzerland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-61"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-62"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-63"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-64"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-65"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-66"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2.6&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-67"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-68"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total revenue&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;768&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,470&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,517&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c61" decimals="-3" id="ixv-19498" unitRef="usd">254000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c62" decimals="3" id="ixv-19499" unitRef="pure">0.331</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c63" decimals="-3" id="ixv-19500" unitRef="usd">639000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c64" decimals="3" id="ixv-19501" unitRef="pure">0.435</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c65" decimals="-3" id="ixv-19502" unitRef="usd">1476000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c66" decimals="3" id="ixv-19503" unitRef="pure">0.42</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c69" decimals="-3" id="ixv-19504" unitRef="usd">266000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c70" decimals="3" id="ixv-19505" unitRef="pure">0.181</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c73" decimals="-3" id="ixv-19506" unitRef="usd">224000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c74" decimals="3" id="ixv-19507" unitRef="pure">0.292</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c75" decimals="-3" id="ixv-19508" unitRef="usd">247000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c76" decimals="3" id="ixv-19509" unitRef="pure">0.168</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c77" decimals="-3" id="ixv-19510" unitRef="usd">1276000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c78" decimals="3" id="ixv-19511" unitRef="pure">0.363</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c79" decimals="-3" id="ixv-19512" unitRef="usd">220000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c80" decimals="3" id="ixv-19513" unitRef="pure">0.286</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c81" decimals="-3" id="ixv-19514" unitRef="usd">148000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c82" decimals="3" id="ixv-19515" unitRef="pure">0.101</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c83" decimals="-3" id="ixv-19516" unitRef="usd">135000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c84" decimals="3" id="ixv-19517" unitRef="pure">0.038</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c85" decimals="-3" id="ixv-19518" unitRef="usd">20000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c86" decimals="3" id="ixv-19519" unitRef="pure">0.026</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c87" decimals="-3" id="ixv-19520" unitRef="usd">81000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c88" decimals="3" id="ixv-19521" unitRef="pure">0.055</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c89" decimals="-3" id="ixv-19522" unitRef="usd">284000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c90" decimals="3" id="ixv-19523" unitRef="pure">0.081</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c91" decimals="-3" id="ixv-19524" unitRef="usd">50000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c92" decimals="3" id="ixv-19525" unitRef="pure">0.065</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c93" decimals="-3" id="ixv-19526" unitRef="usd">50000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c94" decimals="3" id="ixv-19527" unitRef="pure">0.034</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c95" decimals="-3" id="ixv-19528" unitRef="usd">25000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c96" decimals="3" id="ixv-19529" unitRef="pure">0.007</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c101"
      decimals="-3"
      id="ixv-19530"
      unitRef="usd">124000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c102"
      decimals="3"
      id="ixv-19531"
      unitRef="pure">0.035</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c107"
      decimals="-3"
      id="ixv-19532"
      unitRef="usd">197000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c108"
      decimals="3"
      id="ixv-19533"
      unitRef="pure">0.056</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c111"
      decimals="-3"
      id="ixv-19534"
      unitRef="usd">39000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c112"
      decimals="3"
      id="ixv-19535"
      unitRef="pure">0.026</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c0" decimals="-3" id="ixv-19536" unitRef="usd">768000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c5" decimals="2" id="ixv-19537" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c7" decimals="-3" id="ixv-19538" unitRef="usd">1470000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c6" decimals="2" id="ixv-19539" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c8" decimals="-3" id="ixv-19540" unitRef="usd">3517000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c19" decimals="2" id="ixv-19541" unitRef="pure">1</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c5" decimals="-3" id="ixv-19542" unitRef="usd">290000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c6" decimals="-3" id="ixv-19543" unitRef="usd">977000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:OtherCurrentAssetsTextBlock contextRef="c0" id="ixv-16510">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;NOTE 4:- PREPAID
EXPENSES AND OTHER RECEIVABLES&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Government authorities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;668&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Grants receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;308&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Prepaid expenses and other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,455&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,262&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.5in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,500&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,026&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c0" id="ixv-16513">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Government authorities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;668&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Grants receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;308&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Prepaid expenses and other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,455&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,262&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0.5in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-bottom: 4pt; padding-left: 0.5in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,500&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,026&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <arbe:GovernmentAuthorities contextRef="c5" decimals="-3" id="ixv-19544" unitRef="usd">668000</arbe:GovernmentAuthorities>
    <arbe:GovernmentAuthorities contextRef="c6" decimals="-3" id="ixv-19545" unitRef="usd">385000</arbe:GovernmentAuthorities>
    <us-gaap:DepositAssets contextRef="c5" decimals="-3" id="ixv-19546" unitRef="usd">69000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets contextRef="c6" decimals="-3" id="ixv-19547" unitRef="usd">69000</us-gaap:DepositAssets>
    <us-gaap:GrantsReceivableCurrent contextRef="c5" decimals="-3" id="ixv-19548" unitRef="usd">308000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:GrantsReceivableCurrent contextRef="c6" decimals="-3" id="ixv-19549" unitRef="usd">310000</us-gaap:GrantsReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c5" decimals="-3" id="ixv-19550" unitRef="usd">1455000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets contextRef="c6" decimals="-3" id="ixv-19551" unitRef="usd">1262000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-19552" unitRef="usd">2500000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent contextRef="c6" decimals="-3" id="ixv-19553" unitRef="usd">2026000</us-gaap:PrepaidExpenseAndOtherAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0" id="ixv-16627">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;Note
5:-  Property and Equipment&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 11.35pt"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,838&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,448&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 11.35pt"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;831&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 11.35pt"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;133&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 11.35pt"&gt;Vehicles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,962&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,588&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,374&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,309&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Depreciation expense
for the years ended December 31, 2024, 2023 and 2022 was $585, $557 and $481, respectively.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-16630">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Cost:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 11.35pt"&gt;Computers and peripheral equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,838&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,448&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 11.35pt"&gt;Leasehold improvement&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;831&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;582&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 11.35pt"&gt;Office furniture and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;133&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 11.35pt"&gt;Vehicles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;149&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,962&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 2.85pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,588&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,003&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 2.85pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt; padding-left: 2.85pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,374&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,309&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c115"
      decimals="-3"
      id="ixv-19554"
      unitRef="usd">2838000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c116"
      decimals="-3"
      id="ixv-19555"
      unitRef="usd">2448000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c60" decimals="-3" id="ixv-19556" unitRef="usd">831000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c117"
      decimals="-3"
      id="ixv-19557"
      unitRef="usd">582000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c118"
      decimals="-3"
      id="ixv-19558"
      unitRef="usd">144000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c119"
      decimals="-3"
      id="ixv-19559"
      unitRef="usd">133000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c59" decimals="-3" id="ixv-19560" unitRef="usd">149000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c120"
      decimals="-3"
      id="ixv-19561"
      unitRef="usd">149000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c5" decimals="-3" id="ixv-19562" unitRef="usd">3962000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c6" decimals="-3" id="ixv-19563" unitRef="usd">3312000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-19564" unitRef="usd">2588000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-19565" unitRef="usd">2003000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-19566" unitRef="usd">1374000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-19567" unitRef="usd">1309000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c0" decimals="-3" id="ixv-19568" unitRef="usd">585000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c7" decimals="-3" id="ixv-19569" unitRef="usd">557000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c8" decimals="-3" id="ixv-19570" unitRef="usd">481000</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-16758">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;Note
6:- LEASES&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;The
Company has six non-cancelable operating lease agreements for office spaces in Israel. The leases have original lease periods expiring
until 2027, some of which may include options to extend the leases for up to three additional years. The Company does not assume exercise
of renewal options in its determination of the lease term unless the renewals are considered as reasonably certain to be exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Supplemental
cash flow information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Cash payments and expenses related to operating leases&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(557&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;Operating lease right-of-use assets and liabilities, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Maturities
of lease liabilities as of December 31, 2024, were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;563&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;466&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;2028 and after&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;905&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;454&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Supplemental
balance sheet information related to operating leases were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,740&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Current maturities of operating leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;551&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Long-term operating lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,457&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Weighted average remaining lease term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Weighted average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c0" id="ixv-16765">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Supplemental
cash flow information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify"&gt;Cash payments and expenses related to operating leases&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(557&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;Operating lease right-of-use assets and liabilities, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Supplemental
balance sheet information related to operating leases were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,740&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Current maturities of operating leases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;551&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Long-term operating lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,457&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,306&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Weighted average remaining lease term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Weighted average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.4&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="-3" id="ixv-19571" unitRef="usd">557000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c7" decimals="-3" id="ixv-19572" unitRef="usd">451000</us-gaap:OperatingLeasePayments>
    <arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet contextRef="c0" decimals="-3" id="ixv-19573" unitRef="usd">226000</arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet>
    <arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet contextRef="c7" decimals="-3" id="ixv-19574" unitRef="usd">2000</arbe:OperatingLeaseRightofuseAssetsAndLiabilitiesNet>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-16809">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Maturities
of lease liabilities as of December 31, 2024, were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;563&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;466&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;2028 and after&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;905&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify"&gt;Less imputed interest&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;454&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Total lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c5" decimals="-3" id="ixv-19575" unitRef="usd">563000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c5" decimals="-3" id="ixv-19576" unitRef="usd">528000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c5" decimals="-3" id="ixv-19577" unitRef="usd">466000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c5" decimals="-3" id="ixv-19578" unitRef="usd">905000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c5" decimals="-3" id="ixv-19579" unitRef="usd">2462000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c5" decimals="-3" id="ixv-19580" unitRef="usd">454000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c5" decimals="-3" id="ixv-19581" unitRef="usd">2008000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-19582" unitRef="usd">1782000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c6" decimals="-3" id="ixv-19583" unitRef="usd">1740000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-19584" unitRef="usd">551000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c6" decimals="-3" id="ixv-19585" unitRef="usd">436000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c5" decimals="-3" id="ixv-19586" unitRef="usd">1457000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c6" decimals="-3" id="ixv-19587" unitRef="usd">1306000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c5" id="ixv-19588">P4Y8M23D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c6" id="ixv-19589">P5Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c5" decimals="3" id="ixv-19590" unitRef="pure">0.095</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c6" decimals="3" id="ixv-19591" unitRef="pure">0.094</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-16970">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;Note
7:- COMMITMENTS AND CONTINGENT LIABILITIES&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company participated
in programs sponsored mainly by the Israeli Innovation Authority (&#x201c;IIA&#x201d;), an Israeli government agency, for the support of
its research and development activities. Through December 31, 2024, the Company had obtained grants aggregating to $3,970 for certain
of its research and development projects. The Company is obligated to pay royalties to the IIA, amounting to 4% of the sales of the products
and other related revenues generated from such projects. The maximum aggregate royalties paid generally cannot exceed 100% of the grants
received, plus annual interest generally equal to 12-months secured overnight financing rate knows as SOFR applicable to dollar deposits,
as published on the first business day of each calendar year. The obligation to pay these royalties is contingent on sales of the products
and in the absence of such sales, no payment is required.&#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GrantsReceivable contextRef="c5" decimals="-3" id="ixv-19592" unitRef="usd">3970000</us-gaap:GrantsReceivable>
    <arbe:RoyaltyPercentage contextRef="c0" decimals="2" id="ixv-19593" unitRef="pure">0.04</arbe:RoyaltyPercentage>
    <arbe:GrantsReceived contextRef="c0" decimals="2" id="ixv-19594" unitRef="pure">1</arbe:GrantsReceived>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c0" id="ixv-16977">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;Note
8:- warrants liabilities&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company issued
in 2019 warrants to purchase a number of convertible Series B-1 convertible preferred shares, for an aggregate exercise price of $550.
As a result of the Merger and the related Recapitalization, the warrants became convertible into the Company&#x2019;s ordinary shares.
The Company classified the warrants as freestanding and treated as liability pursuant to ASC 480 and remeasured every reporting period
with any change to fair value recorded within financial expenses in the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;As a result of the
Merger with ITAC, the Company assumed a derivative warrant liability related to 3,112,080 private placement warrants assumed by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company utilizes
a Black-Scholes option pricing model to estimate the fair value of the private placement warrants and the convertible warrants (hereinafter:
the &#x201c;warrants&#x201d;) and are considered a Level 3 fair value measurement. Black-Scholes option pricing model takes into consideration
certain parameters in computation of the fair value of the warrants which the significant parameter is expected volatility. The Company
computed a sensitivity analysis of the fair value to changes of the expected volatility. The volatility impact of +/-5% on the warrants&#x2019;
fair value is approximately $28.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The warrants are
measured at each reporting period, with changes in fair value recognized in the statement of operations. During 2024, 2023 and 2022, the
Company recognized $447, $756 and $8,425, respectively, with respect with those warrants as a finance income.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:AdditionalCollateralAggregateFairValue contextRef="c5" decimals="-3" id="ixv-19595" unitRef="usd">550000</us-gaap:AdditionalCollateralAggregateFairValue>
    <arbe:DerivativeWarrantLiabilityShares
      contextRef="c121"
      decimals="0"
      id="ixv-19596"
      unitRef="shares">3112080</arbe:DerivativeWarrantLiabilityShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c0" decimals="2" id="ixv-19597" unitRef="pure">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" id="ixv-19598" unitRef="usd">28000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c122"
      decimals="-3"
      id="ixv-19599"
      unitRef="usd">447000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c123"
      decimals="-3"
      id="ixv-19600"
      unitRef="usd">756000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c124"
      decimals="-3"
      id="ixv-19601"
      unitRef="usd">8425000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c0" id="ixv-17018">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="text-transform: uppercase"&gt;&lt;b&gt;Note
9:- CONVERTIBLE BONDS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;On June 2, 2024,
the Company issued convertible bonds in the principal amount of NIS 110,000,000 (approximately $30,000). The bonds were issued pursuant
to a deed of trust dated May 30, 2024, by and between the Company and Mishmeret Trust Company Ltd., as trustee (the &#x201c;Trustee&#x201d;)
pursuant to a public bid under Israeli law on June 3, 2024, at a price of NIS 1,031 (approximately $0.28) per bond in the principal amount
of NIS 1,000 (approximately $0.27) pursuant to a prospectus filed with the Israel Securities Authority and the TASE. Certain classified
investors who committed to purchase bonds in advance of the public bid, received a commission in the aggregate amount of NIS 1,028,073
(approximately $278), which was recorded as a reduction of their purchase price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The proceeds from
the sale of the bonds, which were approximately NIS 112,400,000 (approximately $30,500), are held in escrow and will be released to the
Company upon meeting certain conditions by March 31, 2025, or earlier if the bonds are converted at the election of the bonds&#x2019; holders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The bonds will be
released to the Company upon satisfaction of the following release conditions by March 31, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company wins a tender or contract to supply its products
as a single supplier of chips of imaging radar (directly or through one of the international Tier 1 manufacturers) to one of ten named
major automobile manufactures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The average closing trading price of the Company&#x2019;s
ordinary shares on Nasdaq is not less than $3.10 per share during 30 consecutive trading days, and the average combined trading volume
on Nasdaq and TASE during such 30 trading days is at least 300,000 shares per day.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The closing price of the Company&#x2019;s ordinary shares
on Nasdaq on the date the Company presents to the Trustee the documentation confirming the fulfillment of the abovementioned conditions
precedent, is not less than $3.10.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 92.7pt; text-align: justify; text-indent: -0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;As of the date hereof,
the Company does not meet the release conditions If the conditions are not meet by March 31, 2025, the Company is to use the funds in
escrow to prepay the bonds and the Company is obligated to pay any interest or other amounts due in excess of the amount held in escrow.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;During January 2025, convertible bonds,
in the principal amount of NIS 78,462,184 ($ 22.4 million) were converted and funds were released from escrow. See also Note 14b.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The above release
conditions to be satisfied by March 31, 2025, were extended to December 31, 2025 following an approval by the holder of a majority of
the outstanding bonds signed on March 20, 2025, See also Note 14c.&lt;/p&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c125" decimals="0" id="ixv-19602" unitRef="ils">110000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c125"
      decimals="-3"
      id="ixv-19603"
      unitRef="usd">30000000</us-gaap:DebtInstrumentIssuedPrincipal>
    <arbe:BidPricePerShare
      contextRef="c126"
      decimals="0"
      id="ixv-19604"
      unitRef="ilsPershares">1031</arbe:BidPricePerShare>
    <arbe:BidPricePerShare
      contextRef="c126"
      decimals="2"
      id="ixv-19605"
      unitRef="usdPershares">0.28</arbe:BidPricePerShare>
    <arbe:BidPricePerShare
      contextRef="c127"
      decimals="0"
      id="ixv-19606"
      unitRef="ilsPershares">1000</arbe:BidPricePerShare>
    <arbe:BidPricePerShare
      contextRef="c128"
      decimals="2"
      id="ixv-19607"
      unitRef="usdPershares">0.27</arbe:BidPricePerShare>
    <arbe:AggregateCommissionReceived contextRef="c126" decimals="0" id="ixv-19608" unitRef="ils">1028073</arbe:AggregateCommissionReceived>
    <arbe:AggregateCommissionReceived
      contextRef="c126"
      decimals="-3"
      id="ixv-19609"
      unitRef="usd">278000</arbe:AggregateCommissionReceived>
    <us-gaap:DebtInstrumentIssuedPrincipal contextRef="c129" decimals="0" id="ixv-19610" unitRef="ils">112400000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c129"
      decimals="-3"
      id="ixv-19611"
      unitRef="usd">30500000</us-gaap:DebtInstrumentIssuedPrincipal>
    <arbe:TradingPricePerShare
      contextRef="c5"
      decimals="2"
      id="ixv-19612"
      unitRef="usdPershares">3.1</arbe:TradingPricePerShare>
    <arbe:NumberOfConsecutiveTradingDays contextRef="c130" id="ixv-19613">P30D</arbe:NumberOfConsecutiveTradingDays>
    <arbe:NumberOfConsecutiveTradingDays contextRef="c131" id="ixv-19614">P30D</arbe:NumberOfConsecutiveTradingDays>
    <arbe:NumberOfTradingVolumeSharesPerDay
      contextRef="c0"
      decimals="0"
      id="ixv-19615"
      unitRef="shares">300000</arbe:NumberOfTradingVolumeSharesPerDay>
    <arbe:TradingPricePerShare
      contextRef="c5"
      decimals="2"
      id="ixv-19616"
      unitRef="usdPershares">3.1</arbe:TradingPricePerShare>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c132" decimals="0" id="ixv-19617" unitRef="ils">78462184</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="c132"
      decimals="-5"
      id="ixv-19618"
      unitRef="usd">22400000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-17056">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;Note
10:-  Shareholders&#x2019; equity&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In October 2021, the Company adopted its restated articles, pursuant to which the Company&#x2019;s authorized
capital consisted of 130,000,000 ordinary shares, with a par value of NIS 0.000216 per share. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;During June 2023, the Company raised $23,000 with Special Situations Funds, pursuant to which the Company
issued a total of 11,794,873 ordinary shares at a purchase price of $1.95 per share. Existing investors, including two affiliates of the
Company&#x2019;s directors, also participated in this offering. The aggregate net proceeds, after issuance costs, received by the Company
from the offering were $22,496.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;c.&lt;/td&gt;&lt;td style="text-align: justify"&gt;During September 2024, the Company increased its authorized capital to 165,000,000 ordinary shares. The
increase in authorized capital shares was approved by the Company&#x2019;s shareholders at the 2024 annual general meeting.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;d.&lt;/td&gt;&lt;td style="text-align: justify"&gt;In November 2024, the Company sold, in an underwritten public offering, an aggregate of (i)&#160;4,293,957&#160;ordinary
shares, (ii) prefunded warrants to purchase an aggregate of&#160;3,956,043&#160;ordinary shares (which were issued in lieu of ordinary
shares), (iii) Tranche A Warrants to purchase up to an aggregate of&#160;8,250,000&#160;ordinary shares, and (iv) Tranche B Warrants to
purchase an aggregate of&#160;8,250,000&#160;ordinary shares. Each share or pre-funded warrant, as applicable, was sold together with&#160;one&#160;Tranche
A Warrant to purchase&#160;one&#160;ordinary share and&#160;one&#160;Tranche B warrant to purchase&#160;one&#160;ordinary share. The net
proceeds from the offering, after deducting underwriting discounts and commissions and offering expenses payable by us of approximately
$13.8&#160;million.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;The Warrants were
classified in permanent equity, as the Warrants are considered indexed to the Company&#x2019;s own stock and meet the additional requirements
for equity classification in accordance with ASC 815-40-25-10.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;e.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 7, 2025, the Company raised gross proceeds of $33.1 million in an underwritten registered direct
public offering. Refer to Note 14.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 113.4pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;f.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Share options and RSU&#x2019;s:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;During 2016, the
Company adopted the 2016 Share Incentive Plan (the &#x201c;2016 Plan&#x201d;) which provides the Company with the ability to grant its employees,
directors and service providers options to purchase Ordinary Shares of the Company, at a purchase price as determined by the Board of
Directors at the date of grant. Pursuant to the 2016 Plan, 3,384,454 Ordinary Shares were reserved for issuance. Each option granted under
the Plan expires no later than seven years from the date of grant or 60 days after termination of engagement. The vesting period of the
share options is generally four years. In 2024, the term of the options granted under the 2016 Plan was extended to ten years from the
date of grants. The expense related to the extension is included in stock-based compensation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;In August 2021, the
Board of the Company approved and in September 2021 the shareholders approved, the Arbe Robotics Ltd. 2021 Equity Incentive Plan (the
&#x201c;2021 Plan&#x201d;) which became effective on October 7, 2021. The 2021 Plan covers (a) 4,079,427 ordinary shares plus (b) and without
the need to further amend the Plan on January 1 of each calendar year beginning on January 1, 2022 and ending on and including January
1, 2031, a number of Shares equal to the lesser of: (i) 5% of the total number of ordinary shares outstanding on December 31 of the immediately
preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar year in which
the increase will occur. As of December 31, 2024, there were 7,804,378 ordinary shares subject to options under the 2021 plan and 136,101
ordinary shares reserved and available for issuance under the 2021 Plan. Following the increase in the size of the reserved and available
option pool on December 18, 2024, by an additional 3,698,746 ordinary shares, there were a total of 4,230,715 ordinary shares reserved
and available for issuance under the 2021 Plan (including any remaining ordinary shares reserved and available for issuance under the
2016 Plan).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Upon the adoption
of the 2021 Plan, the Company will no longer grant any awards under the 2016 Plan, although previously granted options under the 2016
Plan will remain outstanding and governed by the 2016 Plan and awards available for grant under the 2016 Plan which had not been issued
or which expired unexercised may be issued pursuant to the 2021 Plan. The vesting period of the awards is generally four years. Generally,
under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the first anniversary of
the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Share option and
RSU&#x2019;s plans:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;A summary of the
stock option activity under the Company&#x2019;s equity plans during the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;br/&gt;
share&lt;br/&gt;
options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted-&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;average&lt;br/&gt; exercise&lt;br/&gt; price ($)&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Weighted&lt;br/&gt; average&lt;br/&gt; remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Aggregate&lt;br/&gt; intrinsic&lt;br/&gt; value ($ in&lt;br/&gt; thousands)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold"&gt;Options:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Outstanding as of December&#160;31, 2021&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;5,461,337&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;3.102&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;5.363&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;16,713,971&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,630,142&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6.833&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(468,814&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5.557&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Exercised&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(570,451&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;0.482&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Outstanding as of December&#160;31, 2022&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,052,214&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4.166&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5.570&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7,761,705&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;430,874&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2.728&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(351,671&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7.767&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Exercised&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,074,162&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;0.654&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Outstanding as of December&#160;31, 2023&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,057,255&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4.543&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5.662&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2,352,517&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;80,000&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1.91&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(291,124&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6.08&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(255,756&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.81&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 4pt"&gt;&lt;b&gt;Outstanding as of December&#160;31, 2024 &lt;/b&gt;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,590,375&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.62&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5.87&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,364,975&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 4pt"&gt;Exercisable as of December&#160;31, 2024&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,716,507&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.43&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5.42&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,364,975&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;Options available for future grants&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;531,969&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;A summary of the Company&#x2019;s
RSUs activity during the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Numbers of RSUs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;RSUs:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Outstanding as of December&#160;31, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,968,794&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,619,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(417,025&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(573,583&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Outstanding as of December&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,598,084&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,908,983&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(370,067&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(895,170&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Outstanding as of December&#160;31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,241,830&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,377,834&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(432,018&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,274,523&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Outstanding as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,913,123&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Fair value
factors:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The following table
sets forth the parameters used in computation of the options compensation to employees and service providers:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year
ended December 31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; text-align: left"&gt;Expected term, in years&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.82&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.41-6.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;47%-51.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;47%-48&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.23&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;4.15%-4.55&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;1.74%-3.96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Fair value&lt;span style="font-family: Times New Roman, Times, Serif"&gt;:&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The fair value of
the ordinary shares is the market price of the ordinary shares on the date of grant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Expected volatility:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;As the Company was
privately owned until October 2021, there is not sufficient historical volatility for the expected term of the stock options. Therefore,
the Company uses an average historical share price volatility based on an analysis of reported data for a peer group of comparable publicly
traded companies which were selected based upon industry similarities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Expected term
(years):&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Expected term represents
the period that the Company&#x2019;s option grants are expected to be outstanding. There is not sufficient historical share exercise data
to calculate the expected term of the stock options. Therefore, the Company elected to utilize the simplified method to value option grants.
Under this approach, the weighted-average expected life is presumed to be the average of the shortest vesting term and the contractual
term of the option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Risk-free interest
rate:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company determined
the risk-free interest rate by using a weighted-average equivalent to the expected term based on the U.S. Treasury yield curve in effect
as of the date of grant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Expected dividend
yield:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company does
not anticipate paying any dividends in the foreseeable future. Thus, the Company used 0% as its expected dividend yield.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;The
following table presents stock-based compensation expense to employees included in the Company&#x2019;s consolidated statements of operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,684&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,721&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,726&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,786&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Cost of revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;287&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;276&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;127&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;14,542&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13,012&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,793&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;Share
based compensation expenses are not deductible for income tax purposes, and therefore the Company did not recognize any tax benefits related
to the &lt;/span&gt;stock&lt;span&gt;-based compensation for the years ended December&#160;31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-transform: uppercase; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal"&gt;The
Company adopted ASU 2018-07 and accordingly measured at the grant dates of each of the above grants of stock-based compensation issued
to service providers their fair value using Black-Scholes model, which requires inputs such as exercise price, estimated ordinary share
price, expected dividend yield, estimated ordinary share price volatility and risk-free interest rate. During 2024, 2023 and 2022, the
Company recognized the total fair value of the stock-based compensation of development-related service providers in the amounts of $1,186,
$629 and $354, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="c133"
      decimals="0"
      id="ixv-19619"
      unitRef="shares">130000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c133"
      decimals="6"
      id="ixv-19620"
      unitRef="ilsPershares">0.000216</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonUnitIssuanceValue
      contextRef="c134"
      decimals="-3"
      id="ixv-19621"
      unitRef="usd">23000000</us-gaap:CommonUnitIssuanceValue>
    <us-gaap:CommonUnitIssued
      contextRef="c134"
      decimals="0"
      id="ixv-19622"
      unitRef="shares">11794873</us-gaap:CommonUnitIssued>
    <us-gaap:SharePrice
      contextRef="c134"
      decimals="2"
      id="ixv-19623"
      unitRef="usdPershares">1.95</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c135"
      decimals="-3"
      id="ixv-19624"
      unitRef="usd">22496000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c136"
      decimals="0"
      id="ixv-19625"
      unitRef="shares">165000000</us-gaap:CommonStockSharesAuthorized>
    <arbe:UnderwrittenPublicOffering
      contextRef="c137"
      decimals="0"
      id="ixv-19626"
      unitRef="shares">4293957</arbe:UnderwrittenPublicOffering>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c138"
      decimals="0"
      id="ixv-19627"
      unitRef="shares">3956043</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c139"
      decimals="0"
      id="ixv-19628"
      unitRef="shares">8250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c140"
      decimals="0"
      id="ixv-19629"
      unitRef="shares">8250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <arbe:SaleOfPreFundedWarrantShares
      contextRef="c141"
      decimals="0"
      id="ixv-19630"
      unitRef="shares">1</arbe:SaleOfPreFundedWarrantShares>
    <arbe:WarrantToPurchaseOfOrdinaryShares
      contextRef="c141"
      decimals="0"
      id="ixv-19631"
      unitRef="shares">1</arbe:WarrantToPurchaseOfOrdinaryShares>
    <arbe:SaleOfPreFundedWarrantShares
      contextRef="c142"
      decimals="0"
      id="ixv-19632"
      unitRef="shares">1</arbe:SaleOfPreFundedWarrantShares>
    <arbe:WarrantToPurchaseOfOrdinaryShares
      contextRef="c142"
      decimals="0"
      id="ixv-19633"
      unitRef="shares">1</arbe:WarrantToPurchaseOfOrdinaryShares>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="c143"
      decimals="-5"
      id="ixv-19634"
      unitRef="usd">13800000</us-gaap:NoninterestExpenseOfferingCost>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c144"
      decimals="-5"
      id="ixv-19635"
      unitRef="usd">33100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c145"
      decimals="0"
      id="ixv-19636"
      unitRef="shares">3384454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c0" id="ixv-19637">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c146" id="ixv-19638">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c146" id="ixv-19639">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c147"
      decimals="0"
      id="ixv-19640"
      unitRef="shares">4079427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <arbe:PercentageOfOrdinarySharesOutstanding contextRef="c5" decimals="2" id="ixv-19641" unitRef="pure">0.05</arbe:PercentageOfOrdinarySharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c148"
      decimals="0"
      id="ixv-19642"
      unitRef="shares">7804378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c149"
      decimals="0"
      id="ixv-19643"
      unitRef="shares">136101</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c150"
      decimals="0"
      id="ixv-19644"
      unitRef="shares">3698746</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c151"
      decimals="0"
      id="ixv-19645"
      unitRef="shares">4230715</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights contextRef="c152" id="ixv-19646">The vesting period of the awards is generally four years. Generally,
under the terms of the Plans, unless determined otherwise,&#160;25% of an award granted becomes exercisable on the first anniversary of
the date of grant and&#160;6.25% becomes exercisable once every quarter during the subsequent&#160;three years.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c152" id="ixv-19647">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c0" id="ixv-17178">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;A summary of the
stock option activity under the Company&#x2019;s equity plans during the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;br/&gt;
share&lt;br/&gt;
options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Weighted-&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;average&lt;br/&gt; exercise&lt;br/&gt; price ($)&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Weighted&lt;br/&gt; average&lt;br/&gt; remaining&lt;br/&gt; contractual&lt;br/&gt; life (years)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;Aggregate&lt;br/&gt; intrinsic&lt;br/&gt; value ($ in&lt;br/&gt; thousands)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold"&gt;Options:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; font-weight: bold"&gt;Outstanding as of December&#160;31, 2021&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;5,461,337&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;3.102&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;5.363&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;16,713,971&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,630,142&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6.833&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(468,814&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5.557&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Exercised&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(570,451&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;0.482&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Outstanding as of December&#160;31, 2022&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,052,214&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4.166&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5.570&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7,761,705&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;430,874&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2.728&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(351,671&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7.767&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Exercised&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,074,162&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;0.654&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-weight: bold"&gt;Outstanding as of December&#160;31, 2023&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,057,255&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4.543&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5.662&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2,352,517&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Granted&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;80,000&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1.91&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;Forfeited&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(291,124&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6.08&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Exercised&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(255,756&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0.81&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 4pt"&gt;&lt;b&gt;Outstanding as of December&#160;31, 2024 &lt;/b&gt;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,590,375&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.62&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5.87&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,364,975&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 4pt"&gt;Exercisable as of December&#160;31, 2024&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,716,507&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4.43&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5.42&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,364,975&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;Options available for future grants&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;531,969&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c153"
      decimals="INF"
      id="ixv-19648"
      unitRef="shares">5461337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c153"
      decimals="3"
      id="ixv-19649"
      unitRef="usdPershares">3.102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c154" id="ixv-19650">P5Y4M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c153"
      decimals="-3"
      id="ixv-19651"
      unitRef="usd">16713971000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c155"
      decimals="INF"
      id="ixv-19652"
      unitRef="shares">1630142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c155"
      decimals="3"
      id="ixv-19653"
      unitRef="usdPershares">6.833</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c155"
      decimals="INF"
      id="ixv-19654"
      unitRef="shares">468814</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c155"
      decimals="3"
      id="ixv-19655"
      unitRef="usdPershares">5.557</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c155"
      decimals="INF"
      id="ixv-19656"
      unitRef="shares">570451</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c155"
      decimals="3"
      id="ixv-19657"
      unitRef="usdPershares">0.482</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c156"
      decimals="INF"
      id="ixv-19658"
      unitRef="shares">6052214</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c156"
      decimals="3"
      id="ixv-19659"
      unitRef="usdPershares">4.166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c155" id="ixv-19660">P5Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c156"
      decimals="-3"
      id="ixv-19661"
      unitRef="usd">7761705000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c157"
      decimals="INF"
      id="ixv-19662"
      unitRef="shares">430874</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c157"
      decimals="3"
      id="ixv-19663"
      unitRef="usdPershares">2.728</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c157"
      decimals="INF"
      id="ixv-19664"
      unitRef="shares">351671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c157"
      decimals="3"
      id="ixv-19665"
      unitRef="usdPershares">7.767</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c157"
      decimals="INF"
      id="ixv-19666"
      unitRef="shares">1074162</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c157"
      decimals="3"
      id="ixv-19667"
      unitRef="usdPershares">0.654</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c158"
      decimals="INF"
      id="ixv-19668"
      unitRef="shares">5057255</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c158"
      decimals="3"
      id="ixv-19669"
      unitRef="usdPershares">4.543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c157" id="ixv-19670">P5Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c158"
      decimals="-3"
      id="ixv-19671"
      unitRef="usd">2352517000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c159"
      decimals="INF"
      id="ixv-19672"
      unitRef="shares">80000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c159"
      decimals="2"
      id="ixv-19673"
      unitRef="usdPershares">1.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c159"
      decimals="INF"
      id="ixv-19674"
      unitRef="shares">291124</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c159"
      decimals="2"
      id="ixv-19675"
      unitRef="usdPershares">6.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c159"
      decimals="INF"
      id="ixv-19676"
      unitRef="shares">255756</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c159"
      decimals="2"
      id="ixv-19677"
      unitRef="usdPershares">0.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c160"
      decimals="INF"
      id="ixv-19678"
      unitRef="shares">4590375</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c160"
      decimals="2"
      id="ixv-19679"
      unitRef="usdPershares">4.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c159" id="ixv-19680">P5Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c160"
      decimals="-3"
      id="ixv-19681"
      unitRef="usd">1364975000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c160"
      decimals="INF"
      id="ixv-19682"
      unitRef="shares">3716507</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c160"
      decimals="2"
      id="ixv-19683"
      unitRef="usdPershares">4.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c159" id="ixv-19684">P5Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="c160"
      decimals="-3"
      id="ixv-19685"
      unitRef="usd">1364975000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c160"
      decimals="INF"
      id="ixv-19686"
      unitRef="shares">531969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c0" id="ixv-17691">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;A summary of the Company&#x2019;s
RSUs activity during the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.95pt; text-align: left; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Numbers of RSUs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;RSUs:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; font-weight: bold"&gt;Outstanding as of December&#160;31, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,968,794&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,619,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(417,025&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(573,583&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Outstanding as of December&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,598,084&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,908,983&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(370,067&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(895,170&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Outstanding as of December&#160;31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,241,830&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,377,834&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(432,018&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,274,523&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;Outstanding as of December&#160;31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,913,123&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c161"
      decimals="INF"
      id="ixv-19687"
      unitRef="shares">1968794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c162"
      decimals="INF"
      id="ixv-19688"
      unitRef="shares">1619898</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c162"
      decimals="INF"
      id="ixv-19689"
      unitRef="shares">417025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
      contextRef="c162"
      decimals="INF"
      id="ixv-19690"
      unitRef="shares">573583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c163"
      decimals="INF"
      id="ixv-19691"
      unitRef="shares">2598084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c164"
      decimals="INF"
      id="ixv-19692"
      unitRef="shares">2908983</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c164"
      decimals="INF"
      id="ixv-19693"
      unitRef="shares">370067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
      contextRef="c164"
      decimals="INF"
      id="ixv-19694"
      unitRef="shares">895170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c165"
      decimals="INF"
      id="ixv-19695"
      unitRef="shares">4241830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c166"
      decimals="INF"
      id="ixv-19696"
      unitRef="shares">4377834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c166"
      decimals="INF"
      id="ixv-19697"
      unitRef="shares">432018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease
      contextRef="c166"
      decimals="INF"
      id="ixv-19698"
      unitRef="shares">3274523</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="c167"
      decimals="INF"
      id="ixv-19699"
      unitRef="shares">4913123</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-17809">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The following table
sets forth the parameters used in computation of the options compensation to employees and service providers:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year
ended December 31&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 64%; text-align: left"&gt;Expected term, in years&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.82&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.41-6.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;47%-51.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;47%-48&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.23&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;4.15%-4.55&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: right"&gt;1.74%-3.96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0" id="ixv-19700">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c7" id="ixv-19701">P5Y9M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c168" id="ixv-19702">P4Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c169" id="ixv-19703">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c0" decimals="4" id="ixv-19704" unitRef="pure">0.5175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c170"
      decimals="2"
      id="ixv-19705"
      unitRef="pure">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c171"
      decimals="4"
      id="ixv-19706"
      unitRef="pure">0.5175</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c168"
      decimals="2"
      id="ixv-19707"
      unitRef="pure">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c169"
      decimals="2"
      id="ixv-19708"
      unitRef="pure">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" id="ixv-19709" unitRef="pure">0.0423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c170"
      decimals="4"
      id="ixv-19710"
      unitRef="pure">0.0415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c171"
      decimals="4"
      id="ixv-19711"
      unitRef="pure">0.0455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c168"
      decimals="4"
      id="ixv-19712"
      unitRef="pure">0.0174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c169"
      decimals="4"
      id="ixv-19713"
      unitRef="pure">0.0396</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-19714" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c7" decimals="2" id="ixv-19715" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c8" decimals="2" id="ixv-19716" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-19717" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="c0" id="ixv-17970">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;The
following table presents stock-based compensation expense to employees included in the Company&#x2019;s consolidated statements of operations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,684&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,721&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,726&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,786&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Cost of revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;287&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;276&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;127&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;14,542&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13,012&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;8,793&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="c172"
      decimals="-3"
      id="ixv-19718"
      unitRef="usd">9684000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c173"
      decimals="-3"
      id="ixv-19719"
      unitRef="usd">8721000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c174"
      decimals="-3"
      id="ixv-19720"
      unitRef="usd">5726000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c175"
      decimals="-3"
      id="ixv-19721"
      unitRef="usd">2384000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c176"
      decimals="-3"
      id="ixv-19722"
      unitRef="usd">2229000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c177"
      decimals="-3"
      id="ixv-19723"
      unitRef="usd">1403000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c178"
      decimals="-3"
      id="ixv-19724"
      unitRef="usd">2187000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c179"
      decimals="-3"
      id="ixv-19725"
      unitRef="usd">1786000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c180"
      decimals="-3"
      id="ixv-19726"
      unitRef="usd">1537000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c181"
      decimals="-3"
      id="ixv-19727"
      unitRef="usd">287000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c182"
      decimals="-3"
      id="ixv-19728"
      unitRef="usd">276000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="c183"
      decimals="-3"
      id="ixv-19729"
      unitRef="usd">127000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-19730" unitRef="usd">14542000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c7" decimals="-3" id="ixv-19731" unitRef="usd">13012000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c8" decimals="-3" id="ixv-19732" unitRef="usd">8793000</us-gaap:ShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="-3" id="ixv-19733" unitRef="usd">1186000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c7" decimals="-3" id="ixv-19734" unitRef="usd">629000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c8" decimals="-3" id="ixv-19735" unitRef="usd">354000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0" id="ixv-18127">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;NOTE 11:- NET LOSS PER
SHARE ATTRIBUTIBLE TO ORDINARY SHARHOLDERS&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; "&gt;The
following table sets forth the computation of basic and diluted net loss per ordinary share for the periods presented: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;b&gt;Year ended &lt;/b&gt;&#160;&lt;b&gt;December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Basic&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt; width: 64%; text-align: left"&gt;Net loss&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(43,500&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(40,494&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;80,949,032&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;72,021,520&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;63,489,983&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;Loss per share attributable to ordinary shareholders, basic&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.61&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.60&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.64&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; width: 64%; text-align: left"&gt;Adjusted Net loss*&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(44,696&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(41,698&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;80,949,032&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;72,053,372&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;63,629,206&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;Loss per share attributable to ordinary shareholders, diluted*&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.61&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.61&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.66&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#x2019;s
net loss for 2024, 2023 and 2022 as set forth in the following table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(43,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(40,494&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Revaluation of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-69"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(196&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,204&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Adjusted Net loss&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(44,696&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(41,698&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-weight: normal"&gt;The
potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2024, 2023 and 2022 because including them would have been anti-dilutive are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Convertible bonds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,542,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,796,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,080&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,080&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Outstanding share options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,503,498&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,299,085&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,650,298&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;44,842,077&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;12,411,165&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,762,378&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-18131">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-weight: normal; "&gt;The
following table sets forth the computation of basic and diluted net loss per ordinary share for the periods presented: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&#160;&lt;b&gt;Year ended &lt;/b&gt;&#160;&lt;b&gt;December 31,&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2023&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Basic&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;b&gt;Numerator:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt; width: 64%; text-align: left"&gt;Net loss&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(43,500&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(40,494&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;Weighted-average shares used in computing loss per share attributable to ordinary shareholders, basic&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;80,949,032&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;72,021,520&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;63,489,983&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;Loss per share attributable to ordinary shareholders, basic&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.61&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.60&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.64&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; width: 64%; text-align: left"&gt;Adjusted Net loss*&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(44,696&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(41,698&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt; text-align: left"&gt;Weighted-average shares used in computing loss per share attributable to ordinary shareholders, diluted&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;80,949,032&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;72,053,372&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;63,629,206&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;Loss per share attributable to ordinary shareholders, diluted*&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.61&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.61&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.66&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&lt;span style="font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#x2019;s
net loss for 2024, 2023 and 2022 as set forth in the following table.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-19736" unitRef="usd">-49317000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-19737" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-19738" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c0"
      decimals="INF"
      id="ixv-19739"
      unitRef="shares">80949032</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c7"
      decimals="INF"
      id="ixv-19740"
      unitRef="shares">72021520</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c8"
      decimals="INF"
      id="ixv-19741"
      unitRef="shares">63489983</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-19742"
      unitRef="usdPershares">-0.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c7"
      decimals="2"
      id="ixv-19743"
      unitRef="usdPershares">-0.6</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c8"
      decimals="2"
      id="ixv-19744"
      unitRef="usdPershares">-0.64</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c0" decimals="-3" id="ix_0_fact" unitRef="usd">-49317000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c7" decimals="-3" id="ix_1_fact" unitRef="usd">-44696000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c8" decimals="-3" id="ix_2_fact" unitRef="usd">-41698000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="ixv-19748"
      unitRef="shares">80949032</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-19749"
      unitRef="shares">72053372</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ixv-19750"
      unitRef="shares">63629206</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ix_3_fact"
      unitRef="usdPershares">-0.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c7"
      decimals="2"
      id="ix_4_fact"
      unitRef="usdPershares">-0.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c8"
      decimals="2"
      id="ix_5_fact"
      unitRef="usdPershares">-0.66</us-gaap:EarningsPerShareDiluted>
    <arbe:ScheduleOfAdjustedNetIncomeLossTableTextBlock contextRef="c0" id="ixv-18360">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(43,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(40,494&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Revaluation of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-69"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(196&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,204&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Adjusted Net loss&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(44,696&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(41,698&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</arbe:ScheduleOfAdjustedNetIncomeLossTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-19754" unitRef="usd">-49317000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c7" decimals="-3" id="ixv-19755" unitRef="usd">-43500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c8" decimals="-3" id="ixv-19756" unitRef="usd">-40494000</us-gaap:NetIncomeLoss>
    <arbe:RevaluationOfWarrants contextRef="c7" decimals="-3" id="ixv-19757" unitRef="usd">-196000</arbe:RevaluationOfWarrants>
    <arbe:RevaluationOfWarrants contextRef="c8" decimals="-3" id="ixv-19758" unitRef="usd">-1204000</arbe:RevaluationOfWarrants>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c0" decimals="-3" id="ixv-19759" unitRef="usd">-49317000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c7" decimals="-3" id="ixv-19760" unitRef="usd">-44696000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c8" decimals="-3" id="ixv-19761" unitRef="usd">-41698000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c0" id="ixv-18448">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-weight: normal"&gt;The
potential ordinary shares that were excluded from the computation of diluted net loss per share attributable to ordinary shareholders
for the years ended December 31, 2024, 2023 and 2022 because including them would have been anti-dilutive are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Convertible bonds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,542,497&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-70"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-71"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,796,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,080&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,080&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Outstanding share options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,503,498&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,299,085&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,650,298&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;44,842,077&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;12,411,165&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,762,378&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c184"
      decimals="0"
      id="ixv-19762"
      unitRef="shares">11542497</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c187"
      decimals="0"
      id="ixv-19763"
      unitRef="shares">23796082</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c188"
      decimals="0"
      id="ixv-19764"
      unitRef="shares">3112080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c189"
      decimals="0"
      id="ixv-19765"
      unitRef="shares">3112080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c190"
      decimals="0"
      id="ixv-19766"
      unitRef="shares">9503498</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c191"
      decimals="0"
      id="ixv-19767"
      unitRef="shares">9299085</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c192"
      decimals="0"
      id="ixv-19768"
      unitRef="shares">8650298</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c0"
      decimals="0"
      id="ixv-19769"
      unitRef="shares">44842077</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c7"
      decimals="0"
      id="ixv-19770"
      unitRef="shares">12411165</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c8"
      decimals="0"
      id="ixv-19771"
      unitRef="shares">11762378</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-18585">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;NOTE 12:- TAXES ON INCOME&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;General:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;Israeli tax rate:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Corporate tax
rate in Israel relevant to the Company is 23% in 2024, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;United States:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Company&#x2019;s
United States subsidiaries are separately taxed under the U.S. tax laws at a corporate rate of 21%.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Loss before income taxes:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The following
are the domestic (i.e. Israeli) and foreign components of the Company&#x2019;s loss before income taxes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Domestic&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(43,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(40,494&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-72"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(43,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(40,494&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;c.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Taxes on income:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The reconciliation
of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#x2019;s reported income tax (benefit)
is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"&gt;Loss before income taxes, as reported in the consolidated statements of operations&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;49,317&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;43,500&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;40,494&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;Statutory tax rate&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Income tax benefit at statutory tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,343&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,005&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,314&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of Non-deductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,573&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Remeasurement of deferred taxes from currency exchange*&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,322&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(566&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;Reported income taxes benefit&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-79"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;*&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;d.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Net operating loss carryforward:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;As
of December&#160;31, 2024, the Company had a net operating loss carryforward for Israeli tax purposes of approximately $157,627 These
net operating loss carryforwards can be carried forward and offset against taxable income indefinitely.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;e.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Deferred tax assets and liabilities:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Deferre d tax
assets and liabilities are recognized for the tax effects of temporary differences between the carrying amounts of assets and
liabilities for financial reporting purposes and the amounts used for income tax purposes and for carryforwards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The principal components
of the Company&#x2019;s deferred tax assets are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 76%; text-align: left"&gt;Net operating loss carry forwards&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36,254&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;28,032&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Employees and payroll accrual&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;299&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42,432&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(42,432&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Deferred tax assets, net of valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;Based on the available
evidence, management believes that it is more likely than not that certain of its deferred tax assets relating to net operating loss carryforwards
and other temporary differences in Israel will not be realized and accordingly, a valuation allowance has been provided.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;f.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Tax assessments:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The Israeli
entity&#x2019;s&#x2019; income tax assessments are considered final through 2019&lt;span style="font-size: 10pt; "&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;g.&lt;/td&gt;&lt;td style="text-align: justify"&gt;Unrecognized Tax Benefits:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;As
of December&#160;31, 2024, 2023 and 2022, the Company did not have any unrecognized tax benefits and does not expect that the amount of
unrecognized tax benefits will change significantly within the next 12 months. The Company&#x2019;s accounting policy is to accrue interest
and penalties related to an underpayment of income taxes as a component of income tax expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c91" decimals="2" id="ixv-19772" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c93" decimals="2" id="ixv-19773" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c95" decimals="2" id="ixv-19774" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c79" decimals="2" id="ixv-19775" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c0" id="ixv-18610">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The following
are the domestic (i.e. Israeli) and foreign components of the Company&#x2019;s loss before income taxes:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Domestic&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(43,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(40,494&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-72"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-73"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-74"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(49,317&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(43,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(40,494&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c0" decimals="-3" id="ixv-19776" unitRef="usd">49317000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c7" decimals="-3" id="ixv-19777" unitRef="usd">43500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c8" decimals="-3" id="ixv-19778" unitRef="usd">40494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-19779" unitRef="usd">49317000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-19780" unitRef="usd">43500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c8" decimals="-3" id="ixv-19781" unitRef="usd">40494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0" id="ixv-18709">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The reconciliation
of the income tax benefit that would result from applying the Israeli statutory tax rate to the Company&#x2019;s reported income tax (benefit)
is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.85pt; text-align: center"&gt;&lt;b&gt;Year
ended December 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left; padding-bottom: 4pt"&gt;Loss before income taxes, as reported in the consolidated statements of operations&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;49,317&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;43,500&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;40,494&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;Statutory tax rate&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Income tax benefit at statutory tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,343&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,005&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,314&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of Non-deductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,573&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Remeasurement of deferred taxes from currency exchange*&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-75"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-76"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,322&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-77"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(566&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-78"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"&gt;Reported income taxes benefit&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-79"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;*&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-19782" unitRef="usd">49317000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c7" decimals="-3" id="ixv-19783" unitRef="usd">43500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c8" decimals="-3" id="ixv-19784" unitRef="usd">40494000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" id="ixv-19785" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c7" decimals="2" id="ixv-19786" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c8" decimals="2" id="ixv-19787" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="-3" id="ixv-19788" unitRef="usd">-11343000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c7" decimals="-3" id="ixv-19789" unitRef="usd">-10005000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c8" decimals="-3" id="ixv-19790" unitRef="usd">-9314000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c0" decimals="-3" id="ixv-19791" unitRef="usd">3573000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c7" decimals="-3" id="ixv-19792" unitRef="usd">3063000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c8" decimals="-3" id="ixv-19793" unitRef="usd">475000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c8" decimals="-3" id="ix_6_fact" unitRef="usd">3517000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="-3" id="ixv-19795" unitRef="usd">7770000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c7" decimals="-3" id="ixv-19796" unitRef="usd">7508000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c8" decimals="-3" id="ixv-19797" unitRef="usd">5322000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c7" decimals="-3" id="ixv-19798" unitRef="usd">-566000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c0" decimals="2" id="ixv-19800" unitRef="pure">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:OperatingLossCarryforwards contextRef="c5" decimals="-3" id="ixv-19801" unitRef="usd">157627000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0" id="ixv-18939">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;The principal components
of the Company&#x2019;s deferred tax assets are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 84.45pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 76%; text-align: left"&gt;Net operating loss carry forwards&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36,254&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;28,032&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Employees and payroll accrual&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;299&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;Property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42,432&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(42,432&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Deferred tax assets, net of valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c5" decimals="-3" id="ixv-19802" unitRef="usd">36254000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c6" decimals="-3" id="ixv-19803" unitRef="usd">28032000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c5" decimals="-3" id="ixv-19804" unitRef="usd">5726000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c6" decimals="-3" id="ixv-19805" unitRef="usd">6252000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c5" decimals="-3" id="ixv-19806" unitRef="usd">352000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c6" decimals="-3" id="ixv-19807" unitRef="usd">299000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-19808" unitRef="usd">100000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-19809" unitRef="usd">79000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsGross contextRef="c5" decimals="-3" id="ixv-19810" unitRef="usd">42432000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c6" decimals="-3" id="ixv-19811" unitRef="usd">34662000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c5" decimals="-3" id="ixv-19812" unitRef="usd">42432000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c6" decimals="-3" id="ixv-19813" unitRef="usd">34662000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0" id="ixv-19118">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;NOTE 13:- SEGMENT INFORMATION&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;The
Company operates in one operating and reportable segment. Operating segments are defined as components of an enterprise about which separate
financial information is evaluated regularly by the chief operating decision maker, who is the Company&#x2019;s chief executive officer,
in deciding how to allocate resources and assessing performance. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;The
segment structure reflects the financial information and reports used by the Company&#x2019;s management, specifically its CODM, to make
decisions regarding the Company&#x2019;s business, including resource allocations and performance assessments, as well as the current operating
focus in compliance with ASC&#160;280,&#160;Segment Reporting. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;The
Company&#x2019;s chief operating decision maker allocates resources and assesses performance based upon discrete financial information
at the consolidated level. As a single reportable segment entity, the Company&#x2019;s segment performance measure is net loss. The Company
adopted ASU 2023-07 in December 2024. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;span&gt;Revenue
by geographical region can be found in the revenue recognition disclosures in Note 3. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;Major Customers:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;During the year ended December 31,
2024, the Company had four customers that accounted for 19.5%, 18.4%, 16.9% and 14.5%, respectively, of revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;During the year ended December 31,
2023, the Company had three customers that accounted for 38.9%, 18.1% and 12.7%, respectively, of revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;During the year ended December 31,
2022, the Company had three customers that accounted for 33.4%, 19.4% and 18.9%, respectively, of revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"&gt;No other customer accounted for 10%
or more of revenues in 2024, 2023 or 2022. The 10% customers were different customers in each of 2024, 2023 and 2022.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments contextRef="c0" decimals="0" id="ixv-19814" unitRef="pure">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments contextRef="c0" decimals="0" id="ixv-19815" unitRef="pure">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c193"
      decimals="3"
      id="ixv-19816"
      unitRef="pure">0.195</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c194"
      decimals="3"
      id="ixv-19817"
      unitRef="pure">0.184</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c195"
      decimals="3"
      id="ixv-19818"
      unitRef="pure">0.169</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c196"
      decimals="3"
      id="ixv-19819"
      unitRef="pure">0.145</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c197"
      decimals="3"
      id="ixv-19820"
      unitRef="pure">0.389</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c198"
      decimals="3"
      id="ixv-19821"
      unitRef="pure">0.181</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c199"
      decimals="3"
      id="ixv-19822"
      unitRef="pure">0.127</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c200"
      decimals="3"
      id="ixv-19823"
      unitRef="pure">0.334</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c201"
      decimals="3"
      id="ixv-19824"
      unitRef="pure">0.194</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c202"
      decimals="3"
      id="ixv-19825"
      unitRef="pure">0.189</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-19148">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;NOTE 14:- SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;a.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On January 7, 2025, the Company raised gross proceeds of $33.1 million in an underwritten registered public
offering, for the sale of 10,332,031 ordinary shares at a purchase price of $3.20 per share. The aggregate net proceeds received by us
from the offering were $30.9 million,&#160;net of underwriting discounts and other offering costs.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;During January 2025, convertible bonds in the principal amount of NIS 78,462,184 were converted into 8,233,177
ordinary shares, and $22.4 million (including interest) were released from the escrow to the Company.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 20, 2025, following approval by the holders of a majority of the outstanding bonds, the the Company and the trustee entered into an amendment to the deed of trust pursuant to which, among other changes, date by which the Company must meet the conditions to the release of the funds from escrow was extended from March 31, 2025 to December 31, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c203"
      decimals="-5"
      id="ixv-19826"
      unitRef="usd">33100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c204"
      decimals="0"
      id="ixv-19827"
      unitRef="shares">10332031</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c205"
      decimals="2"
      id="ixv-19828"
      unitRef="usdPershares">3.2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c203"
      decimals="-5"
      id="ixv-19829"
      unitRef="usd">30900000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c132" decimals="0" id="ixv-19830" unitRef="ils">78462184</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c52"
      decimals="0"
      id="ixv-19831"
      unitRef="shares">8233177</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="c132"
      decimals="-5"
      id="ixv-19832"
      unitRef="usd">22400000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:OtherAssetsCurrent
      contextRef="c6"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:ConvertibleBonds
      contextRef="c6"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c6"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c9"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c13"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c15"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c13"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c15"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c13"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c15"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c13"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c14"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c16"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c22"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c20"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c22"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c20"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c22"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c22"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c20"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c21"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c23"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c26"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c28"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c26"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c28"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c26"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c28"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c26"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c28"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c26"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c27"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c29"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:RevaluationOfConvertibleLoan
      contextRef="c7"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:RevaluationOfConvertibleLoan
      contextRef="c8"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:IssuanceCostsRelatedToConvertibleBonds
      contextRef="c7"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:IssuanceCostsRelatedToConvertibleBonds
      contextRef="c8"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="c0"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="c0"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="c7"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c8"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c7"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c8"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow
      contextRef="c7"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <arbe:IssuanceOfConvertibleBondsWithProceedsPlacedInEscrow
      contextRef="c8"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c7"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GeneralPartnersOfferingCosts
      contextRef="c40"
      decimals="-3"
      id="hidden-fact-49"
      unitRef="usd">30000000</us-gaap:GeneralPartnersOfferingCosts>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage
      contextRef="c60"
      id="hidden-fact-50"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="c6"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="c19"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c67"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c68"
      id="hidden-fact-54"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c71"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c72"
      id="hidden-fact-56"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c97"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c98"
      id="hidden-fact-58"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c99"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c100"
      id="hidden-fact-60"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c103"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c104"
      id="hidden-fact-62"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c105"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c106"
      id="hidden-fact-64"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c109"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c110"
      id="hidden-fact-66"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="c113"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="c114"
      id="hidden-fact-68"
      unitRef="pure"
      xsi:nil="true"/>
    <arbe:RevaluationOfWarrants
      contextRef="c0"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c185"
      id="hidden-fact-70"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c186"
      id="hidden-fact-71"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c0"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c7"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c8"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c0"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c7"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="c0"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="c8"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c0"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c7"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c8"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c5"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c6"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-19919">0001861841</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-19920">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-19921">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityAddressPostalZipCode contextRef="c1" id="ixv-19922">6329302</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-19923">6329302</dei:EntityAddressPostalZipCode>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-3"
          xlink:label="hidden-fact-3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-2"
          xlink:label="hidden-fact-2"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents less than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-3"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-2"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-4"
          xlink:label="hidden-fact-4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-35"
          xlink:label="hidden-fact-35"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-31"
          xlink:label="hidden-fact-31"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-24"
          xlink:label="hidden-fact-24"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-11"
          xlink:label="hidden-fact-11"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-18"
          xlink:label="hidden-fact-18"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-14"
          xlink:label="hidden-fact-14"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-13"
          xlink:label="hidden-fact-13"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-25"
          xlink:label="hidden-fact-25"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents less than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-4"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-35"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-31"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-24"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-11"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-18"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-14"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-13"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-25"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-50"
          xlink:label="hidden-fact-50"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Leasehold improvements are amortized using the straight-line method over the shorter of the
lease term or the estimated useful life of the improvements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-50"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-weight: normal">Loss per share attributable
to ordinary shareholders, diluted, was adjusted and take into consideration warrants liabilities revaluations as part of the Company&#x2019;s
net loss for 2024, 2023 and 2022 as set forth in the following table.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-75"
          xlink:label="hidden-fact-75"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-76"
          xlink:label="hidden-fact-76"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Israeli Income Tax Regulations (rules regarding ledger management
of foreign invested companies and certain partnerships and the determination of their taxable income), 1986 allow Foreign Invested Companies
(i.e., foreign holding percentage of more than 25%) to report for tax purposes in US dollars. The Company implemented these regulations
on January 1, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-75"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-76"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
